0000021665-21-000007.txt : 20210218 0000021665-21-000007.hdr.sgml : 20210218 20210218161054 ACCESSION NUMBER: 0000021665-21-000007 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 135 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210218 DATE AS OF CHANGE: 20210218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COLGATE PALMOLIVE CO CENTRAL INDEX KEY: 0000021665 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 131815595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-00644 FILM NUMBER: 21649618 BUSINESS ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2123102000 MAIL ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 10-K 1 cl-20201231.htm 10-K cl-20201231
00000216652020FYfalseP3Yus-gaap:OtherAssetsus-gaap:OtherAccruedLiabilitiesCurrentus-gaap:OtherLiabilitiesNoncurrent00000216652020-01-012020-12-310000021665us-gaap:CommonStockMember2020-01-012020-12-310000021665cl:A0.000Notesdue2021Member2020-01-012020-12-310000021665cl:A0.500NotesDue2026Member2020-01-012020-12-310000021665cl:A1.375NotesDue2034Member2020-01-012020-12-310000021665cl:A0.875Notesdue2039Member2020-01-012020-12-31iso4217:USD00000216652020-06-30xbrli:shares00000216652021-01-310000021665us-gaap:ForeignExchangeContractMember2020-01-012020-12-310000021665us-gaap:CommodityContractMember2020-01-012020-12-3100000216652019-01-012019-12-3100000216652018-01-012018-12-31iso4217:USDxbrli:shares00000216652020-12-3100000216652019-12-310000021665us-gaap:CommonStockMember2017-12-310000021665us-gaap:AdditionalPaidInCapitalMember2017-12-310000021665cl:UnearnedCompensationMember2017-12-310000021665us-gaap:TreasuryStockMember2017-12-310000021665us-gaap:RetainedEarningsMember2017-12-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2017-12-310000021665us-gaap:NoncontrollingInterestMember2017-12-310000021665us-gaap:RetainedEarningsMember2018-01-012018-12-310000021665us-gaap:NoncontrollingInterestMember2018-01-012018-12-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-01-012018-12-310000021665us-gaap:AdditionalPaidInCapitalMember2018-01-012018-12-310000021665us-gaap:TreasuryStockMember2018-01-012018-12-310000021665cl:UnearnedCompensationMember2018-01-012018-12-310000021665us-gaap:CommonStockMember2018-12-310000021665us-gaap:AdditionalPaidInCapitalMember2018-12-310000021665cl:UnearnedCompensationMember2018-12-310000021665us-gaap:TreasuryStockMember2018-12-310000021665us-gaap:RetainedEarningsMember2018-12-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310000021665us-gaap:NoncontrollingInterestMember2018-12-310000021665us-gaap:RetainedEarningsMember2019-01-012019-12-310000021665us-gaap:NoncontrollingInterestMember2019-01-012019-12-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-12-310000021665us-gaap:AdditionalPaidInCapitalMember2019-01-012019-12-310000021665us-gaap:TreasuryStockMember2019-01-012019-12-310000021665cl:UnearnedCompensationMember2019-01-012019-12-310000021665us-gaap:CommonStockMember2019-12-310000021665us-gaap:AdditionalPaidInCapitalMember2019-12-310000021665cl:UnearnedCompensationMember2019-12-310000021665us-gaap:TreasuryStockMember2019-12-310000021665us-gaap:RetainedEarningsMember2019-12-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310000021665us-gaap:NoncontrollingInterestMember2019-12-310000021665us-gaap:RetainedEarningsMember2020-01-012020-12-310000021665us-gaap:NoncontrollingInterestMember2020-01-012020-12-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310000021665us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310000021665us-gaap:TreasuryStockMember2020-01-012020-12-310000021665cl:UnearnedCompensationMember2020-01-012020-12-310000021665us-gaap:CommonStockMember2020-12-310000021665us-gaap:AdditionalPaidInCapitalMember2020-12-310000021665cl:UnearnedCompensationMember2020-12-310000021665us-gaap:TreasuryStockMember2020-12-310000021665us-gaap:RetainedEarningsMember2020-12-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000021665us-gaap:NoncontrollingInterestMember2020-12-31cl:Dividend00000216652019-01-012019-03-3100000216652018-01-012018-03-3100000216652020-01-012020-03-3100000216652018-12-3100000216652017-12-31cl:business_segmentxbrli:pure0000021665cl:OralCareMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-012020-12-310000021665cl:OralCareMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2019-01-012019-12-310000021665cl:OralCareMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2018-01-012018-12-310000021665us-gaap:ProductConcentrationRiskMembercl:PersonalCareMemberus-gaap:SalesRevenueNetMember2020-01-012020-12-310000021665us-gaap:ProductConcentrationRiskMembercl:PersonalCareMemberus-gaap:SalesRevenueNetMember2019-01-012019-12-310000021665us-gaap:ProductConcentrationRiskMembercl:PersonalCareMemberus-gaap:SalesRevenueNetMember2018-01-012018-12-310000021665us-gaap:ProductConcentrationRiskMembercl:HomeCareMemberus-gaap:SalesRevenueNetMember2020-01-012020-12-310000021665us-gaap:ProductConcentrationRiskMembercl:HomeCareMemberus-gaap:SalesRevenueNetMember2019-01-012019-12-310000021665us-gaap:ProductConcentrationRiskMembercl:HomeCareMemberus-gaap:SalesRevenueNetMember2018-01-012018-12-310000021665cl:PetNutritionMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-012020-12-310000021665cl:PetNutritionMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2019-01-012019-12-310000021665cl:PetNutritionMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2018-01-012018-12-310000021665us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-012020-12-310000021665us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2019-01-012019-12-310000021665us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2018-01-012018-12-310000021665us-gaap:ShippingAndHandlingMember2020-01-012020-12-310000021665us-gaap:ShippingAndHandlingMember2019-01-012019-12-310000021665us-gaap:ShippingAndHandlingMember2018-01-012018-12-310000021665srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2020-01-012020-12-310000021665srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2020-01-012020-12-310000021665srt:MaximumMemberus-gaap:BuildingMember2020-01-012020-12-310000021665cl:LocalBrandsTrademarksCustomerRelationshipsAndNonCompeteAgreementsMembersrt:MinimumMember2020-01-012020-12-310000021665cl:LocalBrandsTrademarksCustomerRelationshipsAndNonCompeteAgreementsMembersrt:MaximumMember2020-01-012020-12-310000021665cl:HelloProductLLCMember2020-01-312020-01-310000021665cl:HelloProductLLCMember2020-01-310000021665us-gaap:TrademarksMembercl:HelloProductLLCMember2020-01-310000021665us-gaap:TrademarksMembercl:HelloProductLLCMember2020-01-312020-01-310000021665cl:HelloProductLLCMemberus-gaap:CustomerRelationshipsMember2020-01-310000021665cl:HelloProductLLCMemberus-gaap:CustomerRelationshipsMember2020-01-312020-01-310000021665cl:HelloProductLLCMembersrt:NorthAmericaMember2020-01-31iso4217:EUR0000021665cl:LaboratoiresFilorgaCosmtiquesMember2019-09-192019-09-190000021665cl:LaboratoiresFilorgaCosmtiquesMember2019-09-190000021665cl:LaboratoiresFilorgaCosmtiquesMemberus-gaap:TrademarksMember2019-09-190000021665cl:LaboratoiresFilorgaCosmtiquesMemberus-gaap:CustomerRelationshipsMember2019-09-190000021665cl:LaboratoiresFilorgaCosmtiquesMemberus-gaap:CustomerRelationshipsMember2019-09-192019-09-190000021665srt:EuropeMembercl:LaboratoiresFilorgaCosmtiquesMember2019-09-190000021665cl:LaboratoiresFilorgaCosmtiquesMember2020-07-012020-09-300000021665cl:NigeriaJointVentureMember2019-08-150000021665cl:NigeriaJointVentureMember2019-08-152019-08-150000021665cl:GlobalGrowthandEfficiencyProgramMember2020-10-012020-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-10-012020-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembercl:OtherIncomeExpenseNetMember2020-10-012020-12-310000021665cl:GlobalGrowthandEfficiencyProgramMember2020-01-012020-12-310000021665cl:GlobalGrowthandEfficiencyProgramMember2020-12-31cl:case0000021665cl:GrossProfitMembercl:GlobalGrowthandEfficiencyProgramMember2019-01-012019-12-310000021665cl:GrossProfitMembercl:GlobalGrowthandEfficiencyProgramMember2018-01-012018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2018-01-012018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembercl:OtherIncomeExpenseNetMember2019-01-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembercl:OtherIncomeExpenseNetMember2018-01-012018-12-310000021665cl:NonServiceRelatedPostretirementCostsMembercl:GlobalGrowthandEfficiencyProgramMember2019-01-012019-12-310000021665cl:NonServiceRelatedPostretirementCostsMembercl:GlobalGrowthandEfficiencyProgramMember2018-01-012018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMember2019-01-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMember2018-01-012018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembersrt:NorthAmericaMember2019-01-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembersrt:NorthAmericaMember2018-01-012018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembersrt:NorthAmericaMember2012-10-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembersrt:LatinAmericaMember2019-01-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembersrt:LatinAmericaMember2018-01-012018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembersrt:LatinAmericaMember2012-10-012019-12-310000021665srt:EuropeMembercl:GlobalGrowthandEfficiencyProgramMember2019-01-012019-12-310000021665srt:EuropeMembercl:GlobalGrowthandEfficiencyProgramMember2018-01-012018-12-310000021665srt:EuropeMembercl:GlobalGrowthandEfficiencyProgramMember2012-10-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembersrt:AsiaMember2019-01-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembersrt:AsiaMember2018-01-012018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembersrt:AsiaMember2012-10-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembercl:AfricaEurasiaMember2019-01-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembercl:AfricaEurasiaMember2018-01-012018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembercl:AfricaEurasiaMember2012-10-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembercl:PetNutritionMember2019-01-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembercl:PetNutritionMember2018-01-012018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembercl:PetNutritionMember2012-10-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:CorporateMember2019-01-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:CorporateMember2018-01-012018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:CorporateMember2012-10-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMember2012-10-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMember2019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:OneTimeTerminationBenefitsMember2019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembercl:IncrementalDepreciationMember2019-12-310000021665cl:AssetImpairmentMembercl:GlobalGrowthandEfficiencyProgramMember2019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:OtherRestructuringMember2019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:OneTimeTerminationBenefitsMember2017-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembercl:IncrementalDepreciationMember2017-12-310000021665cl:AssetImpairmentMembercl:GlobalGrowthandEfficiencyProgramMember2017-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:OtherRestructuringMember2017-12-310000021665cl:GlobalGrowthandEfficiencyProgramMember2017-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:OneTimeTerminationBenefitsMember2018-01-012018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembercl:IncrementalDepreciationMember2018-01-012018-12-310000021665cl:AssetImpairmentMembercl:GlobalGrowthandEfficiencyProgramMember2018-01-012018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:OtherRestructuringMember2018-01-012018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:OneTimeTerminationBenefitsMember2018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembercl:IncrementalDepreciationMember2018-12-310000021665cl:AssetImpairmentMembercl:GlobalGrowthandEfficiencyProgramMember2018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:OtherRestructuringMember2018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMember2018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:OneTimeTerminationBenefitsMember2019-01-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMembercl:IncrementalDepreciationMember2019-01-012019-12-310000021665cl:AssetImpairmentMembercl:GlobalGrowthandEfficiencyProgramMember2019-01-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:OtherRestructuringMember2019-01-012019-12-310000021665cl:ThirdPartyIncrementalCostMembercl:GlobalGrowthandEfficiencyProgramMember2019-01-012019-12-310000021665cl:ThirdPartyIncrementalCostMembercl:GlobalGrowthandEfficiencyProgramMember2018-01-012018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:ContractTerminationMember2019-01-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:ContractTerminationMember2018-01-012018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:LandAndBuildingMember2019-01-012019-12-310000021665cl:OralPersonalAndHomeCareMembersrt:NorthAmericaMember2020-12-310000021665cl:OralPersonalAndHomeCareMembersrt:NorthAmericaMember2019-12-310000021665srt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2020-12-310000021665srt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2019-12-310000021665srt:EuropeMembercl:OralPersonalAndHomeCareMember2020-12-310000021665srt:EuropeMembercl:OralPersonalAndHomeCareMember2019-12-310000021665cl:OralPersonalAndHomeCareMembersrt:AsiaPacificMember2020-12-310000021665cl:OralPersonalAndHomeCareMembersrt:AsiaPacificMember2019-12-310000021665cl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2020-12-310000021665cl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2019-12-310000021665cl:OralPersonalAndHomeCareMember2020-12-310000021665cl:OralPersonalAndHomeCareMember2019-12-310000021665cl:PetNutritionMember2020-12-310000021665cl:PetNutritionMember2019-12-310000021665us-gaap:TrademarksMember2020-12-310000021665us-gaap:TrademarksMember2019-12-310000021665us-gaap:OtherIntangibleAssetsMember2020-12-310000021665us-gaap:OtherIntangibleAssetsMember2019-12-310000021665us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember2020-12-310000021665us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember2019-12-310000021665cl:FilorgaReportingUnitMember2020-12-310000021665cl:FilorgaReportingUnitMembercl:ScenarioOneMember2020-12-310000021665cl:FilorgaReportingUnitMembercl:ScenarioTwoMember2020-12-310000021665cl:FilorgaReportingUnitMemberus-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember2020-12-310000021665cl:FilorgaReportingUnitMembercl:ScenarioOneMemberus-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember2020-12-310000021665cl:FilorgaReportingUnitMemberus-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMembercl:ScenarioTwoMember2020-12-310000021665cl:ReportingUnitsOtherThanFilorgaMember2020-12-310000021665us-gaap:NotesPayableOtherPayablesMember2020-12-310000021665us-gaap:NotesPayableOtherPayablesMember2019-12-310000021665us-gaap:CommercialPaperMember2020-12-310000021665us-gaap:CommercialPaperMember2019-12-310000021665cl:FinanceLeaseObligationMember2020-12-310000021665cl:FinanceLeaseObligationMember2019-12-310000021665cl:Sevenyearnotesat0.50percentnumberMember2019-03-310000021665cl:Sevenyearnotesat0.50percentnumberMember2019-01-012019-03-310000021665cl:Fifteenyearnotesat1.375percentMember2019-03-310000021665cl:Fifteenyearnotesat1.375percentMember2019-01-012019-03-310000021665cl:Twoyearnotesat0.00percentMember2019-12-310000021665cl:Twoyearnotesat0.00percentMember2019-10-012019-12-310000021665cl:Twentyyearnotesat0.875percentMember2019-12-310000021665cl:Twentyyearnotesat0.875percentMember2019-10-012019-12-310000021665cl:A1.75percentMember2019-03-310000021665cl:A245MediumTermNotesDue2021Member2020-12-310000021665cl:A245MediumTermNotesDue2021Member2020-10-012020-12-310000021665cl:A230MediumTermNotesDue2022Member2020-12-310000021665cl:A230MediumTermNotesDue2022Member2020-10-012020-12-310000021665cl:A245MediumTermNotesDue2021And230MediumTermNotesDue2022Member2020-10-012020-12-310000021665cl:AmendedDomesticRevolvingCreditFacility2650MillionCapacityMember2018-11-300000021665cl:AmendedDomesticRevolvingCreditFacility2650MillionCapacityMember2019-08-012019-08-310000021665cl:AmendedDomesticRevolvingCreditFacility1500MillionCapacityMember2020-08-3100000216652020-08-312020-08-31cl:country_and_territory0000021665us-gaap:OtherAssetsMemberus-gaap:InterestRateContractMember2020-12-310000021665us-gaap:OtherAssetsMemberus-gaap:InterestRateContractMember2019-12-310000021665us-gaap:InterestRateContractMemberus-gaap:OtherLiabilitiesMember2020-12-310000021665us-gaap:InterestRateContractMemberus-gaap:OtherLiabilitiesMember2019-12-310000021665us-gaap:OtherAssetsMemberus-gaap:ForwardContractsMember2020-12-310000021665us-gaap:OtherAssetsMemberus-gaap:ForwardContractsMember2019-12-310000021665us-gaap:ForwardContractsMemberus-gaap:OtherLiabilitiesMember2020-12-310000021665us-gaap:ForwardContractsMemberus-gaap:OtherLiabilitiesMember2019-12-310000021665us-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2020-12-310000021665us-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2019-12-310000021665us-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2020-12-310000021665us-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2019-12-310000021665us-gaap:OtherAssetsMemberus-gaap:ForeignExchangeContractMember2020-12-310000021665us-gaap:OtherAssetsMemberus-gaap:ForeignExchangeContractMember2019-12-310000021665us-gaap:ForeignExchangeContractMemberus-gaap:OtherLiabilitiesMember2020-12-310000021665us-gaap:ForeignExchangeContractMemberus-gaap:OtherLiabilitiesMember2019-12-310000021665us-gaap:OtherCurrentAssetsMemberus-gaap:CommodityContractMember2020-12-310000021665us-gaap:OtherCurrentAssetsMemberus-gaap:CommodityContractMember2019-12-310000021665us-gaap:OtherCurrentLiabilitiesMemberus-gaap:CommodityContractMember2020-12-310000021665us-gaap:OtherCurrentLiabilitiesMemberus-gaap:CommodityContractMember2019-12-310000021665us-gaap:OtherCurrentAssetsMember2020-12-310000021665us-gaap:OtherCurrentAssetsMember2019-12-310000021665us-gaap:FairValueInputsLevel2Member2020-12-310000021665us-gaap:FairValueInputsLevel2Member2019-12-310000021665us-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310000021665us-gaap:CarryingReportedAmountFairValueDisclosureMember2019-12-310000021665us-gaap:LongTermDebtMember2020-12-310000021665us-gaap:LongTermDebtMember2019-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:ForeignExchangeContractMember2020-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:DebtMember2020-12-310000021665us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMember2020-12-310000021665us-gaap:ForwardContractsMemberus-gaap:FairValueHedgingMember2020-12-310000021665us-gaap:CommodityContractMemberus-gaap:FairValueHedgingMember2020-12-310000021665us-gaap:FairValueHedgingMember2020-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2020-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:DebtMember2020-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:InterestRateContractMember2020-12-310000021665us-gaap:ForwardContractsMemberus-gaap:CashFlowHedgingMember2020-12-310000021665us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2020-12-310000021665us-gaap:CashFlowHedgingMember2020-12-310000021665us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2020-12-310000021665us-gaap:DebtMemberus-gaap:NetInvestmentHedgingMember2020-12-310000021665us-gaap:InterestRateContractMemberus-gaap:NetInvestmentHedgingMember2020-12-310000021665us-gaap:ForwardContractsMemberus-gaap:NetInvestmentHedgingMember2020-12-310000021665us-gaap:CommodityContractMemberus-gaap:NetInvestmentHedgingMember2020-12-310000021665us-gaap:NetInvestmentHedgingMember2020-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:ForeignExchangeContractMember2019-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:DebtMember2019-12-310000021665us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMember2019-12-310000021665us-gaap:ForwardContractsMemberus-gaap:FairValueHedgingMember2019-12-310000021665us-gaap:CommodityContractMemberus-gaap:FairValueHedgingMember2019-12-310000021665us-gaap:FairValueHedgingMember2019-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2019-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:DebtMember2019-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:InterestRateContractMember2019-12-310000021665us-gaap:ForwardContractsMemberus-gaap:CashFlowHedgingMember2019-12-310000021665us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2019-12-310000021665us-gaap:CashFlowHedgingMember2019-12-310000021665us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2019-12-310000021665us-gaap:DebtMemberus-gaap:NetInvestmentHedgingMember2019-12-310000021665us-gaap:InterestRateContractMemberus-gaap:NetInvestmentHedgingMember2019-12-310000021665us-gaap:ForwardContractsMemberus-gaap:NetInvestmentHedgingMember2019-12-310000021665us-gaap:CommodityContractMemberus-gaap:NetInvestmentHedgingMember2019-12-310000021665us-gaap:NetInvestmentHedgingMember2019-12-310000021665us-gaap:CostOfSalesMemberus-gaap:InterestRateContractMember2020-01-012020-12-310000021665us-gaap:InterestRateContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-12-310000021665cl:InterestIncomeExpenseNetMemberus-gaap:InterestRateContractMember2020-01-012020-12-310000021665us-gaap:CostOfSalesMemberus-gaap:InterestRateContractMember2019-01-012019-12-310000021665us-gaap:InterestRateContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-12-310000021665cl:InterestIncomeExpenseNetMemberus-gaap:InterestRateContractMember2019-01-012019-12-310000021665us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2020-01-012020-12-310000021665us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeContractMember2020-01-012020-12-310000021665cl:InterestIncomeExpenseNetMemberus-gaap:ForeignExchangeContractMember2020-01-012020-12-310000021665us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2019-01-012019-12-310000021665us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeContractMember2019-01-012019-12-310000021665cl:InterestIncomeExpenseNetMemberus-gaap:ForeignExchangeContractMember2019-01-012019-12-310000021665us-gaap:CommodityContractMemberus-gaap:CostOfSalesMember2020-01-012020-12-310000021665us-gaap:CommodityContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-12-310000021665us-gaap:CommodityContractMembercl:InterestIncomeExpenseNetMember2020-01-012020-12-310000021665us-gaap:CommodityContractMemberus-gaap:CostOfSalesMember2019-01-012019-12-310000021665us-gaap:CommodityContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-12-310000021665us-gaap:CommodityContractMembercl:InterestIncomeExpenseNetMember2019-01-012019-12-310000021665us-gaap:CostOfSalesMember2020-01-012020-12-310000021665us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-12-310000021665cl:InterestIncomeExpenseNetMember2020-01-012020-12-310000021665us-gaap:CostOfSalesMember2019-01-012019-12-310000021665us-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-12-310000021665cl:InterestIncomeExpenseNetMember2019-01-012019-12-310000021665us-gaap:ForeignExchangeContractMember2019-01-012019-12-310000021665us-gaap:ForwardContractsMember2020-01-012020-12-310000021665us-gaap:ForwardContractsMember2019-01-012019-12-310000021665us-gaap:CommodityContractMember2019-01-012019-12-310000021665us-gaap:DebtMember2020-01-012020-12-310000021665us-gaap:DebtMember2019-01-012019-12-310000021665cl:Program2018Member2018-06-180000021665cl:Program2018Member2020-01-012020-12-31cl:plan0000021665cl:IncentiveStockPlansMembercl:PerformanceBasedRestrictedStockUnitsMember2020-01-012020-12-310000021665cl:PerformanceBasedRestrictedStockUnitsMember2019-12-310000021665cl:PerformanceBasedRestrictedStockUnitsMember2020-01-012020-12-310000021665cl:PerformanceBasedRestrictedStockUnitsMember2020-12-310000021665cl:IncentiveStockPlansMembercl:PerformanceBasedRestrictedStockUnitsMember2020-12-310000021665cl:TimeVestedRestrictedStockUnitsMembercl:IncentiveStockPlansMember2020-01-012020-12-310000021665cl:TimeVestedRestrictedStockUnitsMembercl:IncentiveStockPlansMember2020-12-310000021665cl:TimeVestedRestrictedStockUnitsMember2019-12-310000021665cl:TimeVestedRestrictedStockUnitsMember2020-01-012020-12-310000021665cl:TimeVestedRestrictedStockUnitsMember2020-12-310000021665cl:TimeVestedRestrictedStockUnitsMembercl:IncentiveStockPlansMember2019-01-012019-12-310000021665cl:TimeVestedRestrictedStockUnitsMembercl:IncentiveStockPlansMember2018-01-012018-12-310000021665cl:StockOptionPlansMember2020-01-012020-12-310000021665cl:StockOptionPlansMember2019-01-012019-12-310000021665cl:StockOptionPlansMember2020-12-310000021665cl:StockOptionPlansMember2018-01-012018-12-310000021665us-gaap:DefinedBenefitPlanEquitySecuritiesMembercountry:US2020-12-310000021665us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:ForeignPlanMember2020-12-310000021665country:USus-gaap:FixedIncomeSecuritiesMember2020-12-310000021665us-gaap:ForeignPlanMemberus-gaap:FixedIncomeSecuritiesMember2020-12-310000021665country:UScl:RealEstateandOtherInvestmentsMember2020-12-310000021665us-gaap:ForeignPlanMembercl:RealEstateandOtherInvestmentsMember2020-12-310000021665country:US2020-12-310000021665us-gaap:ForeignPlanMember2020-12-310000021665us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMembercountry:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2020-12-310000021665us-gaap:ForeignPlanMemberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2020-12-310000021665us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2020-12-310000021665cl:DefinedBenefitPlanUSCommonStocksMembercountry:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2020-12-310000021665cl:DefinedBenefitPlanUSCommonStocksMemberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2020-12-310000021665cl:DefinedBenefitPlanUSCommonStocksMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2020-12-310000021665cl:DefinedBenefitPlanInternationalCommonStockMembercountry:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2020-12-310000021665us-gaap:ForeignPlanMembercl:DefinedBenefitPlanInternationalCommonStockMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2020-12-310000021665cl:DefinedBenefitPlanInternationalCommonStockMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2020-12-310000021665cl:DefinedBenefitPlanPooledFundsMembercountry:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2020-12-310000021665cl:DefinedBenefitPlanPooledFundsMemberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2020-12-310000021665cl:DefinedBenefitPlanPooledFundsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2020-12-310000021665cl:DefinedBenefitPlanFixedIncomeSecuritiesMemberus-gaap:FairValueInputsLevel2Membercountry:USus-gaap:PensionPlansDefinedBenefitMember2020-12-310000021665us-gaap:ForeignPlanMembercl:DefinedBenefitPlanFixedIncomeSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310000021665cl:DefinedBenefitPlanFixedIncomeSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-310000021665us-gaap:FairValueInputsLevel2Membercountry:USus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanGuaranteedInvestmentContractsMember2020-12-310000021665us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanGuaranteedInvestmentContractsMember2020-12-310000021665us-gaap:FairValueInputsLevel2Memberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMembercl:DefinedBenefitPlanGuaranteedInvestmentContractsMember2020-12-310000021665country:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Member2020-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Member2020-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Member2020-12-310000021665country:USus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMembercl:DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665country:USus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanFixedIncomeFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanFixedIncomeFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMembercl:DefinedBenefitPlanFixedIncomeFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665cl:DefinedBenefitPlanHedgeFundsMembercountry:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665us-gaap:ForeignPlanMembercl:DefinedBenefitPlanHedgeFundsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665cl:DefinedBenefitPlanHedgeFundsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665cl:DefinedBenefitPlanMultiAssetFundsMembercountry:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665cl:DefinedBenefitPlanMultiAssetFundsMemberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665cl:DefinedBenefitPlanMultiAssetFundsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665us-gaap:DefinedBenefitPlanRealEstateMembercountry:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665us-gaap:DefinedBenefitPlanRealEstateMemberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665us-gaap:DefinedBenefitPlanRealEstateMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665country:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310000021665country:USus-gaap:PensionPlansDefinedBenefitMembercl:OtherAssetsandLiabilitiesNetMember2020-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:OtherAssetsandLiabilitiesNetMember2020-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMembercl:OtherAssetsandLiabilitiesNetMember2020-12-310000021665country:USus-gaap:PensionPlansDefinedBenefitMember2020-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-310000021665us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMembercountry:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2019-12-310000021665us-gaap:ForeignPlanMemberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2019-12-310000021665us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2019-12-310000021665cl:DefinedBenefitPlanUSCommonStocksMembercountry:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2019-12-310000021665cl:DefinedBenefitPlanUSCommonStocksMemberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2019-12-310000021665cl:DefinedBenefitPlanUSCommonStocksMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2019-12-310000021665cl:DefinedBenefitPlanInternationalCommonStockMembercountry:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2019-12-310000021665us-gaap:ForeignPlanMembercl:DefinedBenefitPlanInternationalCommonStockMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2019-12-310000021665cl:DefinedBenefitPlanInternationalCommonStockMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2019-12-310000021665cl:DefinedBenefitPlanPooledFundsMembercountry:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2019-12-310000021665cl:DefinedBenefitPlanPooledFundsMemberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2019-12-310000021665cl:DefinedBenefitPlanPooledFundsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2019-12-310000021665cl:DefinedBenefitPlanFixedIncomeSecuritiesMemberus-gaap:FairValueInputsLevel2Membercountry:USus-gaap:PensionPlansDefinedBenefitMember2019-12-310000021665us-gaap:ForeignPlanMembercl:DefinedBenefitPlanFixedIncomeSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2019-12-310000021665cl:DefinedBenefitPlanFixedIncomeSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-12-310000021665us-gaap:FairValueInputsLevel2Membercountry:USus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanGuaranteedInvestmentContractsMember2019-12-310000021665us-gaap:ForeignPlanMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanGuaranteedInvestmentContractsMember2019-12-310000021665us-gaap:FairValueInputsLevel2Memberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMembercl:DefinedBenefitPlanGuaranteedInvestmentContractsMember2019-12-310000021665country:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Member2019-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Member2019-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Member2019-12-310000021665country:USus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMembercl:DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665country:USus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanFixedIncomeFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanFixedIncomeFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMembercl:DefinedBenefitPlanFixedIncomeFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665cl:DefinedBenefitPlanHedgeFundsMembercountry:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665us-gaap:ForeignPlanMembercl:DefinedBenefitPlanHedgeFundsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665cl:DefinedBenefitPlanHedgeFundsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665cl:DefinedBenefitPlanMultiAssetFundsMembercountry:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665cl:DefinedBenefitPlanMultiAssetFundsMemberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665cl:DefinedBenefitPlanMultiAssetFundsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665us-gaap:DefinedBenefitPlanRealEstateMembercountry:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665us-gaap:DefinedBenefitPlanRealEstateMemberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665us-gaap:DefinedBenefitPlanRealEstateMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665country:USus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310000021665country:USus-gaap:PensionPlansDefinedBenefitMembercl:OtherAssetsandLiabilitiesNetMember2019-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:OtherAssetsandLiabilitiesNetMember2019-12-310000021665cl:OtherAssetsandLiabilitiesNetMember2019-12-310000021665country:USus-gaap:PensionPlansDefinedBenefitMember2019-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2019-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-12-310000021665country:USus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310000021665country:USus-gaap:PensionPlansDefinedBenefitMember2019-01-012019-12-310000021665country:USus-gaap:PensionPlansDefinedBenefitMember2018-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2018-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2018-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2019-01-012019-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-01-012019-12-310000021665us-gaap:PensionPlansDefinedBenefitMember2020-12-310000021665us-gaap:PensionPlansDefinedBenefitMember2019-12-310000021665country:USus-gaap:PensionPlansDefinedBenefitMember2018-01-012018-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2018-01-012018-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2018-01-012018-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:OneTimeTerminationBenefitsMember2020-01-012020-12-3100000216652017-10-012017-12-3100000216652019-10-012019-12-310000021665country:CH2018-01-012018-12-310000021665srt:MinimumMember2020-01-012020-12-310000021665srt:MaximumMember2020-01-012020-12-310000021665us-gaap:EmployeeStockOptionMember2020-01-012020-12-310000021665us-gaap:EmployeeStockOptionMember2019-01-012019-12-310000021665us-gaap:EmployeeStockOptionMember2018-01-012018-12-310000021665us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-12-310000021665us-gaap:RestrictedStockUnitsRSUMember2019-01-012019-12-310000021665us-gaap:RestrictedStockUnitsRSUMember2018-01-012018-12-310000021665srt:MinimumMember2020-12-310000021665srt:MaximumMember2020-12-3100000216652017-07-3100000216652019-04-012019-04-3000000216652019-04-012019-06-300000021665us-gaap:SalesRevenueNetMember2020-12-310000021665us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-012020-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:OperatingIncomeLossMember2020-01-012020-12-310000021665us-gaap:CorporateNonSegmentMemberus-gaap:OperatingIncomeLossMember2020-01-012020-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:OperatingIncomeLossMember2019-01-012019-12-310000021665us-gaap:CorporateNonSegmentMemberus-gaap:OperatingIncomeLossMember2019-01-012019-12-310000021665cl:GlobalGrowthandEfficiencyProgramMemberus-gaap:OperatingIncomeLossMember2018-01-012018-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembersrt:NorthAmericaMember2020-01-012020-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembersrt:NorthAmericaMember2019-01-012019-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembersrt:NorthAmericaMember2018-01-012018-12-310000021665us-gaap:OperatingSegmentsMembersrt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2020-01-012020-12-310000021665us-gaap:OperatingSegmentsMembersrt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2019-01-012019-12-310000021665us-gaap:OperatingSegmentsMembersrt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2018-01-012018-12-310000021665srt:EuropeMemberus-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2020-01-012020-12-310000021665srt:EuropeMemberus-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2019-01-012019-12-310000021665srt:EuropeMemberus-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2018-01-012018-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembersrt:AsiaPacificMember2020-01-012020-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembersrt:AsiaPacificMember2019-01-012019-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembersrt:AsiaPacificMember2018-01-012018-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2020-01-012020-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2019-01-012019-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2018-01-012018-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2020-01-012020-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2019-01-012019-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2018-01-012018-12-310000021665us-gaap:OperatingSegmentsMembercl:PetNutritionMember2020-01-012020-12-310000021665us-gaap:OperatingSegmentsMembercl:PetNutritionMember2019-01-012019-12-310000021665us-gaap:OperatingSegmentsMembercl:PetNutritionMember2018-01-012018-12-310000021665cl:OralPersonalAndHomeCareMembercountry:US2020-01-012020-12-310000021665cl:OralPersonalAndHomeCareMembercountry:US2019-01-012019-12-310000021665cl:OralPersonalAndHomeCareMembercountry:US2018-01-012018-12-310000021665country:UScl:PetNutritionMember2020-01-012020-12-310000021665country:UScl:PetNutritionMember2019-01-012019-12-310000021665country:UScl:PetNutritionMember2018-01-012018-12-310000021665us-gaap:CorporateNonSegmentMember2020-01-012020-12-310000021665us-gaap:CorporateNonSegmentMember2019-01-012019-12-310000021665us-gaap:CorporateNonSegmentMember2018-01-012018-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembersrt:NorthAmericaMember2020-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembersrt:NorthAmericaMember2019-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembersrt:NorthAmericaMember2018-12-310000021665us-gaap:OperatingSegmentsMembersrt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2020-12-310000021665us-gaap:OperatingSegmentsMembersrt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2019-12-310000021665us-gaap:OperatingSegmentsMembersrt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2018-12-310000021665srt:EuropeMemberus-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2020-12-310000021665srt:EuropeMemberus-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2019-12-310000021665srt:EuropeMemberus-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2018-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembersrt:AsiaPacificMember2020-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembersrt:AsiaPacificMember2019-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembersrt:AsiaPacificMember2018-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2020-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2019-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2018-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2020-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2019-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2018-12-310000021665us-gaap:OperatingSegmentsMembercl:PetNutritionMember2020-12-310000021665us-gaap:OperatingSegmentsMembercl:PetNutritionMember2019-12-310000021665us-gaap:OperatingSegmentsMembercl:PetNutritionMember2018-12-310000021665us-gaap:CorporateNonSegmentMember2020-12-310000021665us-gaap:CorporateNonSegmentMember2019-12-310000021665us-gaap:CorporateNonSegmentMember2018-12-310000021665us-gaap:AccountingStandardsUpdate201602Member2019-01-010000021665us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-12-310000021665us-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-12-310000021665us-gaap:AccumulatedTranslationAdjustmentMember2018-01-012018-12-310000021665us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-12-310000021665us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-01-012019-12-310000021665us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-01-012018-12-310000021665us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-01-012020-12-310000021665us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-01-012019-12-310000021665us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2018-01-012018-12-3100000216652020-04-012020-06-3000000216652020-07-012020-09-3000000216652020-10-012020-12-3100000216652019-07-012019-09-300000021665cl:GrossProfitMember2020-01-012020-12-310000021665srt:SubsidiariesMember2020-01-012020-12-310000021665cl:GrossProfitMember2020-01-012020-03-310000021665srt:SubsidiariesMember2020-01-012020-03-310000021665cl:GlobalGrowthandEfficiencyProgramMember2020-07-012020-09-300000021665country:BR2019-01-012019-12-310000021665country:CH2019-01-012019-12-310000021665cl:GrossProfitMembercl:GlobalGrowthandEfficiencyProgramMember2019-01-012019-03-310000021665cl:GrossProfitMembercl:GlobalGrowthandEfficiencyProgramMember2019-04-012019-06-300000021665cl:GrossProfitMembercl:GlobalGrowthandEfficiencyProgramMember2019-07-012019-09-300000021665cl:GrossProfitMembercl:GlobalGrowthandEfficiencyProgramMember2019-10-012019-12-310000021665country:BR2019-10-012019-12-310000021665country:CH2019-10-012019-12-310000021665cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember2019-12-310000021665cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember2020-01-012020-12-310000021665cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember2020-12-310000021665us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-12-310000021665us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-01-012020-12-310000021665us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-12-310000021665cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember2018-12-310000021665cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember2019-01-012019-12-310000021665us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2018-12-310000021665us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-01-012019-12-310000021665cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember2017-12-310000021665cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember2018-01-012018-12-310000021665us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2017-12-310000021665us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2018-01-012018-12-31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
(Mark One)
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the fiscal year ended December 31, 2020
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                                  to                          .
Commission File Number 1-644
cl-20201231_g1.jpg
COLGATE-PALMOLIVE COMPANY
(Exact name of registrant as specified in its charter)
Delaware13-1815595
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
300 Park Avenue
New York, New York10022
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code 212-310-2000
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $1.00 par valueCLNew York Stock Exchange
0.000% Notes due 2021CL21ANew York Stock Exchange
0.500% Notes due 2026CL26New York Stock Exchange
1.375% Notes due 2034CL34New York Stock Exchange
0.875% Notes due 2039CL39New York Stock Exchange
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes No
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No
The aggregate market value of Colgate-Palmolive Company Common Stock held by non-affiliates as of June 30, 2020 (the last business day of its most recently completed second quarter) was approximately $62.8 billion.
There were 848,562,678 shares of Colgate-Palmolive Company Common Stock outstanding as of January 31, 2021.
DOCUMENTS INCORPORATED BY REFERENCE:
DocumentsForm 10-K Reference
Portions of Proxy Statement for the 2021 Annual Meeting of StockholdersPart III, Items 10 through 14




Colgate-Palmolive Company
Table of Contents

Part I  Page
     
Item 1.Business
Item 1A.  Risk Factors
Item 1B.Unresolved Staff Comments
Item 2.Properties
Item 3.Legal Proceedings
Item 4.Mine Safety Disclosures
    
Part II   
Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Item 6.Selected Financial Data
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 7A.Quantitative and Qualitative Disclosures About Market Risk
Item 8.Financial Statements and Supplementary Data
Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Item 9A.Controls and Procedures
Item 9B.Other Information
    
Part III   
Item 10.Directors, Executive Officers and Corporate Governance
Item 11.Executive Compensation
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 13.Certain Relationships and Related Transactions and Director Independence
Item 14.Principal Accountant Fees and Services
Part IV   
Item 15.Exhibits and Financial Statement Schedules
Item 16.Form 10-K Summary
     
Signatures





PART I

ITEM 1.    BUSINESS

(a) General Development of the Business

Colgate-Palmolive Company (together with its subsidiaries, “we,” "us," "our," the “Company” or “Colgate”) is a caring, innovative growth company reimagining a healthier future for all people, their pets and our planet. We seek to deliver sustainable, profitable growth and superior shareholder returns, as well as provide Colgate people with an innovative and inclusive work environment. We do this by developing and selling products globally that make people’s lives healthier and more enjoyable and by embracing our sustainability and social impact and diversity, equity and inclusion strategies across our organization. Our products are marketed in over 200 countries and territories throughout the world. Colgate was founded in 1806 and incorporated under the laws of the State of Delaware in 1923.

For recent business developments and other information, refer to the information set forth under the captions “Management’s Discussion and Analysis of Financial Condition and Results of Operations–Executive Overview,” “– Outlook,” “–Results of Operations” and “– Liquidity and Capital Resources” in Part II, Item 7 of this report.

(c) Narrative Description of the Business

We operate in two product segments: Oral, Personal and Home Care; and Pet Nutrition. We are a leader in Oral Care with global leadership in the toothpaste and manual toothbrush categories according to market share data. We sell our toothpastes under brands such as Colgate, Darlie, elmex, hello, meridol, Sorriso and Tom’s of Maine, our toothbrushes under brands such as Colgate, Darlie, elmex and meridol and our mouthwashes under brands such as Colgate, elmex and meridol. Our Oral Care business also includes pharmaceutical products for dentists and other oral health professionals.

We are a leader in many product categories of the Personal Care market with global leadership in liquid hand soap, according to market share data, which we sell under brands such as Palmolive, Protex and Softsoap. Our Personal Care products also include Irish Spring, Palmolive and Protex bar soaps, Irish Spring, Palmolive, Sanex and Softsoap shower gels, Lady Speed Stick, Sanex, Speed Stick and Tom’s of Maine deodorants and antiperspirants, EltaMD, Filorga and PCA Skin skin health products and Palmolive shampoos and conditioners.

We manufacture and market a wide array of products for the Home Care market, including Ajax, Axion and Palmolive dishwashing liquids and Ajax, Fabuloso and Murphy household cleaners. We are a market leader in fabric conditioners with leading brands, including Suavitel in Latin America, Soupline in Europe, and Cuddly in the South Pacific, according to market share data.

Sales of Oral, Personal and Home Care products accounted for 44%, 21% and 18%, respectively, of our total worldwide Net sales in 2020. Geographically, Oral Care is a significant part of our business in Asia Pacific, comprising approximately 81% of Net sales in that region for 2020.

Through our Hill’s Pet Nutrition segment (“Hill’s” or “Pet Nutrition”), we are a world leader in specialty pet nutrition products for dogs and cats with products marketed in over 80 countries and territories worldwide. Hill’s markets pet foods primarily under two brands. Hill’s Science Diet, which is called Hill’s Science Plan in Europe, is a range of products for everyday nutritional needs. Hill’s Prescription Diet is a range of therapeutic products to help nutritionally manage disease conditions in dogs and cats. Sales of Pet Nutrition products accounted for 17% of our total worldwide Net sales in 2020.

For more information regarding our worldwide Net sales by product category, refer to Note 1, Nature of Operations and Note 14, Segment Information to the Consolidated Financial Statements.

For additional information regarding market share data, see Market Share Information in Part II, Item 7 of this report.

1


Distribution; Raw Materials; Competition; Trademarks and Patents

Our Oral, Personal and Home Care products are sold to a variety of traditional and eCommerce retailers, wholesalers and distributors worldwide. Pet Nutrition products are sold by authorized pet supply retailers, veterinarians and eCommerce retailers. Our sales to Wal-Mart, Inc. and its affiliates represent approximately 12% of our Net sales in 2020. No other customer represents more than 10% of our Net sales. We support our products with advertising, promotion and other marketing (with increasing emphasis on digital) to build awareness and trial of our products. Our products are marketed by a direct sales force at individual operating subsidiaries or business units and by distributors or brokers.

The majority of raw and packaging materials used in our products is purchased from other companies and is available from several sources. No single raw or packaging material represents, and no single supplier provides, a significant portion of our total material requirements. For certain materials, however, new suppliers may have to be qualified under industry, governmental and/or Colgate standards, which can require additional investment and take some period of time. Raw and packaging material commodities, such as essential oils, resins, pulp, tropical oils, tallow, corn, poultry and soybeans, are subject to market price variations. For further information regarding the impact of changes in commodity prices, see Item 1A, “Risk Factors - Volatility in material and other costs could adversely impact our profitability” and Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

Our products are sold in a highly competitive global marketplace which has experienced increased retail trade concentration, the rapid growth of eCommerce, the integration of traditional and digital operations at key retailers and the growing presence of large-format retailers and discounters. Products similar to those that we produce and sell are available from multinational and local competitors in the U.S. and overseas. Certain of our competitors are larger and have greater resources than we do. In addition, the substantial growth in eCommerce has encouraged the entry of new competitors and business models. In certain geographies, we also face strong local competitors, who may be more agile and have better local consumer insights than we do. Private label brands sold by retailers are also a source of competition for certain of our products.

The retail landscape in many of our markets continues to evolve as a result of the rapid growth of eCommerce retailers, changing consumer preferences (as consumers increasingly shop online) and the increased presence of alternative retail channels, such as subscription services and direct-to-customer businesses. COVID-19 has accelerated these trends, either on a temporary or permanent basis, and we have witnessed consumers changing their purchasing patterns, including the nature and/or frequency of visits by consumers to retailers and dental, veterinary and skin health professionals as well as a shift, in many markets, to purchasing our products online. We face competition in several aspects of our business, including pricing, promotional activities, new product and brand introductions and expansion into new geographies and channels. Product quality, innovation, brand recognition, marketing capability and acceptance of new products and brands largely determine success in Colgate’s operating segments.

We consider trademarks to be of material importance to our business. We follow a practice of seeking trademark protection in the U.S. and throughout the world where our products are sold. Principal global and regional trademarks include Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA Skin, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet. Our rights in these trademarks endure for as long as they are used and/or registered. Although we actively develop and maintain a portfolio of patents, no single patent is considered significant to the business as a whole.












2


COVID-19

COVID-19 and government steps to reduce the spread and address the impact of COVID-19 have had and continue to have a profound impact on the way people live, work, interact and shop and have significantly impacted and may continue to impact economic activity around the world.

During 2020, many of the communities in which we manufacture, market and sell our products experienced unprecedented “stay at home” orders, travel or movement restrictions and other government actions to reduce the spread and address the impact of COVID-19, and have implemented varying policies to resume economic activity. Because the vast majority of our products (such as oral care products, soaps and other personal hygiene products, home cleaners and pet food) have been deemed essential for the health and well-being of people and their pets, we have, in most instances, been able to continue operating our business. In doing so, the health, safety and well-being of our employees has been and remains our first priority. In addition, some of our suppliers, customers, distributors and service providers have experienced disruptions to their businesses.

We saw a significant increase in demand across many of our categories in 2020, driven by consumer pantry-loading and increased consumption of our products in response to COVID-19. This was particularly true in certain categories, such as liquid hand soap, dish liquid, bar soap and cleaners, and we believe that some of the increase in consumption in these categories is sustainable in light of changes in consumer behavior related to COVID-19. As a result, we have seen and expect to continue to see heightened competitive activity from our competitors in certain categories, including more aggressive product claims and marketing challenges and the marketing of new products in high demand categories. At the same time, in 2020, we continued to experience declines in certain channels, including professional sales and travel retail, due to the economic slowdown and restricted consumer movement in many geographies throughout the world. We also continue to see changes in the purchasing patterns of our consumers, including the nature and/or frequency of visits by consumers to retailers and dental, veterinary and skin health professionals and a shift in many markets to purchasing our products online.
COVID-19 and government steps to reduce the spread and address the impact of COVID-19 have impacted and may continue to impact our consumers’ ability to purchase and our ability to manufacture and distribute our products. We expect the ongoing economic impact and health concerns associated with COVID-19 to continue to impact consumer behavior, shopping patterns and consumption preferences despite the lifting of government restrictions and the reopening of economies around the world.

For additional information regarding COVID-19’s impact on our business, see Part I, Item 1A “Risk Factors” and Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Executive Overview.”

Government Regulations

As a global company, we are subject to extensive governmental regulations, including environmental rules and regulations, in the U.S. and abroad. The most significant government regulations that impact our business are discussed below. It is our policy and practice to comply with all government regulations applicable to our business. In 2020, compliance with these regulations did not have, and we do not expect such compliance in the future to have, a material adverse effect on our capital expenditures, earnings or competitive position. For further discussion of how global legal and regulatory requirements may impact our business, see Part I, Item 1A, “Risk Factors.”

Product Development: Legal and regulatory requirements apply to most aspects of our products, including their development, ingredients, formulation, manufacture, packaging content, labeling, storage, transportation, distribution, export, import, advertising, sale and environmental impact. U.S. federal authorities, including the U.S. Food and Drug Administration, the Federal Trade Commission, the Consumer Product Safety Commission, the Occupational, Health and Safety Administration and the Environmental Protection Agency, regulate different aspects of our business, along with parallel authorities at the state and local levels and comparable authorities overseas.



3


Anti-Corruption, Anti-Bribery, Commercial Bribery and Competition: We are subject to anti-corruption laws and regulations, including the U.S. Foreign Corrupt Practices Act and other laws that generally prohibit the making or offering of improper payments to foreign government officials and political figures for the purpose of obtaining or retaining business or to gain an unfair business advantage, and laws that prohibit commercial bribery. In addition, our selling practices are regulated by competition law authorities in the U.S. and abroad.

Privacy and Data Protection: Our collection, storage, transfer and/or processing of customer, consumer, employee, vendor and other stakeholder information and personal data is subject to privacy, data use and data security regulations in the U.S. and abroad, including the General Data Protection Regulation and the California Consumer Privacy Act of 2018.

Human Capital Management

Human capital matters at Colgate are managed by our Global Human Resources function, led by our Chief Human Resources Officer, with oversight from the Personnel and Organization Committee of our Board of Directors (the "Board"). As of December 31, 2020, we had approximately 34,200 employees based in over 100 countries. Approximately 70% of our revenues are generated from markets outside the U.S. and 86% of our employees are located outside the U.S. Approximately 36% of our employees are based in Asia Pacific, 30% are based in Latin America, 15% are based in North America, 14% are based in Europe and 5% are based in Africa/Eurasia. Our global workforce covers a broad range of functions, from manufacturing employees to management personnel and certain of our employees are represented by unions or works councils.

Colgate’s Culture and Core Values

As we work to achieve Colgate’s purpose to reimagine a healthier future for all people, their pets and our planet, Colgate people, working around the world, share a commitment to our three core corporate values: Caring, Global Teamwork and Continuous Improvement. These values are reflected not only in the quality of our products and reputation, but also in our dedication to serving the communities where we live and work, as reflected in our sustainability and social impact and diversity, equity and inclusion strategies. With these values, we work to maintain a strong culture based on integrity, ethical behavior and a commitment to doing the right thing. Underlying these values and our strong culture is a commitment of all Colgate people to maintain the highest ethical standards and demonstrate ethical leadership, including compliance with Colgate policies and our Code of Ethics.

CARING: We care about people — Colgate people, consumers, customers, stockholders and business partners. We are committed to acting with compassion, integrity, honesty and high ethics in all situations and to providing our employees with an innovative and inclusive work environment. As a reflection of Colgate’s caring value, during the COVID-19 pandemic, protecting the health, safety and well-being of Colgate people has been and remains our first priority. Many of our employees globally have worked from home during the pandemic. We implemented additional health and safety measures and social distancing protocols to help ensure employee safety when work from home is not possible. We also offered Colgate people and their families enhanced mental health and wellness benefit offerings. Combined with the fact that the vast majority of our products have been deemed “essential” for the health and well-being of people and their pets, these efforts have, in most instances, enabled us to continue to operate during the pandemic providing consumers with the health and hygiene products they need and want.

GLOBAL TEAMWORK: All Colgate people are part of a global team, committed to working together across countries and throughout the world. Only by sharing ideas, technologies and talents can we achieve and sustain profitable growth.

CONTINUOUS IMPROVEMENT: We are committed to getting better every day in all that we do, as individuals and as teams. We continue to transform our learning strategy to better meet the evolving expectations of the modern workforce and create a continuous learning culture. All of our employees worldwide are provided with a series of training programs focused on building leadership skills. Our focus is to develop the strategic organizational capabilities that will drive current and future growth for Colgate by offering learning experiences that are closely aligned to our business strategy. Specifically, we are focused on implementing new ways of working and instilling a growth mindset to drive experimentation, digitization and innovation with agility and resilience.


4


Diversity, Equity & Inclusion

We believe our people are crucial to our ongoing business success. We celebrate differences, promote an inclusive environment and value the contributions of all Colgate people. As a truly global company, we are working to ensure that our workforce reflects the diversity of the communities in which we live and work. As of December 31, 2020, our global workforce was 60% male and 40% female, and women represented 41% of Colgate’s executives. Measuring the race/ethnicity of our workforce is challenging to do on a global basis. In the U.S., on an employee self-reported basis, the racial/ethnic composition of our workforce was approximately 67% White, 11% Hispanic, 9% Black, 8% Asian and 5% other.

We are committed to providing all of our employees with an inclusive work environment, learning opportunities and promotion and growth opportunities. A vital piece of our diversity, equity and inclusion strategy has been ensuring that our talent management process incorporates the advancement of women and people of all cultures, including underrepresented communities. To help further foster inclusiveness, we support employee resource groups for team members of many different underrepresented communities. Each of these resource groups contributes to our inclusive work environment by developing and implementing programs to promote business and community involvement as well as cultural awareness. We also partner with external organizations to develop an inclusive and supportive work environment.

Our global diversity, equity and inclusion strategy aims to further advance our commitment to become an even more diverse, equitable and inclusive organization. The four pillars of our strategy are People, Community, Supplier Diversity and Communication. Consistent with this strategy, we are working to implement policies, learning experiences and processes that promote awareness, empathy, advocacy and opportunity; become an ally for positive change for the underserved in communities in which we live and work; support minority and women-owned suppliers to enable success of diversity-owned businesses; and promote dialogue around diversity, equity and inclusion to increase awareness and advance the culture change to achieve our vision.

Succession Planning

We have a rigorous succession planning process, led by our Global Human Resources function. Our Board is also extensively involved in succession planning and people development with special focus on CEO succession. As part of the succession planning process, we review and discuss potential successors to key positions and examine backgrounds, capabilities and appropriate developmental assignments.

Compensation Philosophy

Given the importance of Colgate people to our business success, attracting, motivating and retaining high-quality talent is a key focus. We view compensation as an important tool to motivate leaders at all levels of the organization. For information regarding our compensation philosophy and executive compensation programs, please see our Proxy Statement to be filed with the United States Securities and Exchange Commission (the “SEC”) in connection with the 2021 Annual Meeting of Stockholders.

















5


Information about our Executive Officers

The following is a list of our executive officers as of February 18, 2021:
NameAgeDate First Elected OfficerPresent Title
Noel R. Wallace562009Chairman of the Board, President and
Chief Executive Officer
Stanley J. Sutula III552020Chief Financial Officer
Patricia Verduin612011Chief Technology Officer
Jennifer M. Daniels572014Chief Legal Officer and Secretary
Philip G. Shotts662018Vice President and Controller
John W. Kooyman562019Chief of Staff
Prabha Parameswaran622019Group President, Global Innovation Group
Panagiotis Tsourapas562019Group President, Latin America, Asia Pacific & Africa-Eurasia
Sally Massey472020Chief Human Resources Officer

Each of our executive officers listed above has served the Company or our subsidiaries in various executive capacities for the past five years with the exception of Stanley J. Sutula III, who joined the Company in 2020 as Chief Financial Officer. Prior to joining the Company, Mr. Sutula was Executive Vice President and Chief Financial Officer of Pitney Bowes Inc. (“Pitney Bowes”), which he joined in 2017. Prior to Pitney Bowes, Mr. Sutula served in various executive finance positions at International Business Machines Corporation.

Under our By-Laws, our officers hold office until their respective successors are chosen and qualified or until they have resigned, retired or been removed by the affirmative vote of a majority of our Board. There are no family relationships between any of our executive officers, and there is no arrangement or understanding between any executive officer and any other person pursuant to which the executive officer was elected.

(e) Available Information

Our website address is www.colgatepalmolive.com. The information contained on our website is not included as a part of, or incorporated by reference into, this Annual Report on Form 10-K. We make available, free of charge, on our website our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, interactive data files posted pursuant to Rule 405 of Regulation S-T, Current Reports on Form 8-K and amendments to such reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”) as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. Also available on our website are the Company’s Code of Conduct and Board Guidelines on Significant Corporate Governance Issues, the charters of the Committees of the Board, Specialized Disclosure Reports on Form SD, reports under Section 16 of the Exchange Act of transactions in Company stock by directors and executive officers and our proxy statements.

6


ITEM 1A.    RISK FACTORS

In addition to the risks described elsewhere in this report, set forth below is a summary of the material risks to an investment in our securities. These risks, some of which have occurred and/or are occurring and any of which could occur in the future, are not the only ones we face. Additional risks not presently known to us or that we currently deem immaterial may also have an adverse effect on us. If any of these risks actually occur, our business, results of operations, cash flows and financial condition could be materially and adversely impacted, which might cause the value of our securities to decline.

Business and Industry Risks

We face risks associated with significant international operations, including exposure to foreign currency fluctuations.

We operate on a global basis serving consumers in more than 200 countries and territories with approximately 70% of our Net sales originating in markets outside the U.S. While geographic diversity helps to reduce our exposure to risks in any one country or part of the world, it also means that we face risks associated with significant international operations, including, but not limited to:

changes in exchange rates for foreign currencies, which may reduce the U.S. dollar value of revenues, profits and cash flows from non-U.S. markets or increase our supply costs, as measured in U.S. dollars, in those markets;

exchange controls and other limits on our ability to import or export raw materials or finished product, including as a result of COVID-19, or to repatriate earnings from overseas;

political or economic instability, geopolitical events, environmental events, widespread health emergencies, such as COVID-19 or other pandemics or epidemics, natural disasters or social or labor unrest;

changing macroeconomic conditions in our markets, including as a result of volatile commodity prices, including the price of oil;

lack of well-established, reliable and/or impartial legal systems in certain countries where we operate and difficulties in enforcing contractual, intellectual property or other legal rights;

foreign ownership and investment restrictions and the potential for nationalization or expropriation of property or other resources; and

changes to trade policies and agreements and other foreign or domestic legal and regulatory requirements, including those resulting in potentially adverse tax consequences or the imposition of and/or the increase in onerous trade restrictions and/or tariffs, sanctions, price controls, labor laws, travel or immigration restrictions, including as a result of COVID-19 or other pandemics or epidemics, profit controls or other government controls.

Any or all of the foregoing risks could have a significant impact on our ability to sell our products on a competitive basis in international markets and may adversely affect our business, results of operations, cash flows and financial condition. In addition, a number of these risks may adversely impact consumer confidence and consumption, which could reduce sales volumes of our products or result in a shift in our product mix from higher margin to lower margin product offerings.

In addition, the impact of the United Kingdom’s exit from the European Union (commonly referred to as Brexit) continues to be unclear. Brexit continues to pose legal, political and economic uncertainty, which could subject us to heightened risks in the region, including disruptions to trade and the free movement of goods, services and people to and from the United Kingdom, increased foreign exchange volatility with respect to the British pound and disruptions to our workforce and that of our suppliers and business partners. We do not, however, believe Brexit has had or will have a material impact on our business, results of operations, cash flows or financial condition.

7


Furthermore, the imposition of tariffs and/or increase in tariffs on various products by the United States and other countries have introduced greater uncertainty with respect to trade policies and government regulations affecting trade between the United States and other countries and new and/or increased tariffs have subjected, and may continue in the future to subject, us to additional costs and expenditure of resources. Major developments in trade relations, including the imposition of new or increased tariffs by the United States and/or other countries, and any emerging nationalist trends in specific countries could alter the trade environment and consumer purchasing behavior which, in turn, could have a material effect on our business, results of operations, cash flows and financial condition.

In an effort to minimize the impact on earnings of foreign currency rate movements, we engage in a combination of selling price increases, where permitted, sourcing strategies, cost-containment measures and selective hedging of foreign currency transactions. However, the impact of these measures may not fully offset any negative impact of foreign currency rate movements on our business, results of operations, cash flows and financial condition.

Significant competition in our industry could adversely affect our business.

We face vigorous competition worldwide, including from strong local competitors and from other large, multinational companies, some of which have greater resources than we do. In addition, the substantial growth in eCommerce has encouraged the entry of new competitors and business models.

We face competition in several aspects of our business, including pricing, promotional activities, new product introductions and expansion into new geographies and channels. Some of our competitors may spend more aggressively on or have more effective advertising and promotional activities than we do, introduce competing products more quickly and/or respond more effectively to business and economic conditions and changing consumer preferences, including by launching innovative new products. Such competition also extends to administrative and legal challenges of product claims and advertising. Our success is increasingly dependent on our ability to effectively leverage digital technology and data analytics to gain new commercial insights and develop relevant marketing and advertising to reach customers and consumers. In addition, we have experienced and may continue to experience increased demand for many of our products in response to COVID-19. As a result, we have seen and expect to continue to see heightened competitive activity from our competitors in certain of our categories, including more aggressive product claims and marketing challenges and the marketing of new products in high demand categories. Our ability to compete also depends on the strength of our brands and on our ability to enforce and defend our intellectual property, including patent, trademark, copyright, trade secret and trade dress rights, against infringement and legal challenges by competitors.

We may be unable to anticipate the timing and scale of such initiatives or challenges by competitors or to successfully respond to them, which could harm our business. In addition, the cost of responding to such initiatives and challenges, including management time, out-of-pocket expenses and price reductions, may affect our performance. A failure to compete effectively could adversely affect our business, results of operations, cash flows and financial condition.

Increasing dependence on key retailers in developed markets, changes in the policies of our retail trade customers, the emergence of alternative retail channels and the rapidly changing retail landscape may adversely affect our business.

Our products are sold in a highly competitive global marketplace which has experienced increased trade concentration and the growing presence of large-format retailers, discounters and eCommerce retailers. With the growing trend toward retail trade consolidation, the rapid growth of eCommerce and the integration of traditional and digital operations at key retailers, we are increasingly dependent on certain retailers, and some of these retailers have and may continue to have greater bargaining strength than we do. They have used and may continue to use this leverage to demand higher trade discounts, allowances, slotting fees or increased investment, including through display media, paid search, preparation fees and co-op programs, which could lead to reduced sales or profitability. The loss of a key customer or a significant reduction in sales to a key customer could adversely affect our business, results of operations, cash flows and financial condition. For additional information regarding our customers, see “Distribution; Raw Materials; Competition; Trademarks and Patents” in Item 1 “Business.”



8


We also have been and may continue to be negatively affected by changes in the policies or practices of our retail trade customers, such as inventory de-stocking, limitations on access to shelf space, delisting of our products, or environmental, sustainability, supply chain or packaging initiatives and other conditions. For example, a determination by a key retailer that any of our ingredients should not be used in certain consumer products or that our packaging does not comply with certain environmental, supply chain or packaging standards or initiatives could adversely impact our business, results of operations, cash flows and financial condition. In addition, “private label” products sold by our retail customers, which are typically sold at lower prices than branded products, are a source of competition for certain of our products. In addition, the retail landscape in many of our markets continues to evolve as a result of the rapid growth of eCommerce retailers, changing consumer preferences (as consumers increasingly shop online) and the increased presence of alternative retail channels, such as subscription services and direct-to-customer businesses. The rapid growth in eCommerce and the emergence of alternative retail channels have created and may continue to create pricing pressures and/or adversely affect our relationships with our key retailers. If we are not successful in continuing to adapt or effectively react to changes in consumer preferences, purchasing patterns and market dynamics and/or expanding sales through eCommerce retailers and other alternative retail channels, our business, results of operations, cash flows and financial condition could be adversely affected.

The growth of our business depends on the successful identification, development and launch of innovative new products.

Our growth depends on the continued success of existing products, the successful identification, development and launch of innovative new and differentiated products and the expansion into adjacent categories, channels of distribution or geographies. Our ability to launch new products, to sustain existing products and to expand into adjacent categories, channels of distribution or geographies is affected by whether we can successfully:

identify, develop and fund technological innovations;

obtain and maintain necessary intellectual property protection and avoid infringing intellectual property rights of others;

obtain approvals and registrations of regulated products, including from the FDA and other regulatory bodies in the U.S. and abroad; and

anticipate and quickly respond to the needs and preferences of consumers and customers.

The identification, development and introduction of innovative new products that drive incremental sales involves considerable costs and effort, and any new product may not generate sufficient customer and consumer interest and sales to become a profitable product or to cover the costs of its development and promotion. Our ability to achieve a successful launch of a new product could also be adversely affected by preemptive actions taken by competitors in response to the launch, such as increased promotional activities and advertising. In addition, new products may not be accepted quickly or significantly in the marketplace.

Our ability to quickly innovate and to adapt and market our products to meet evolving consumer preferences and to adapt our packaging to meet evolving customer preferences is an essential part of our business strategy. The failure to develop and launch successful new products or to adapt our packaging and supply chain to meet such preferences could hinder the growth of our business and any delay in the development or launch of a new product could result in us not being the first to market, which could compromise our competitive position and adversely affect our business, results of operations, cash flows and financial condition.

If, in the course of identifying or developing new products, we are found to have infringed the trademark, trade secret, copyright, patent or other intellectual property rights of others, directly or indirectly, through the use of third-party ideas or technologies, such a finding could adversely affect our ability to develop innovative new products and adversely affect our business, results of operations, cash flows and financial condition. Even if we are not found to infringe a third party’s intellectual property rights, claims of infringement could adversely affect us, including by increasing costs and by delaying the launch of new products.


9


We face various risks related to pandemics, epidemics or similar widespread public health concerns, which may have a material adverse effect on our business, results of operations, cash flows and financial condition.

We face various risks related to pandemics, epidemics or similar widespread public health concerns, including the COVID-19 pandemic. A pandemic, epidemic or similar widespread health concern could have, and COVID-19 has had and will continue to have, a variety of impacts on our business, results of operations, cash flows and financial condition, including:

Our ability to continue to maintain and support the health, safety and well-being of our employees, including key employees;

Volatility in the demand for and availability of our products, which may be caused by the temporary inability of our consumers to purchase our products due to illness, financial hardship, quarantine, government actions mandating the closure of our distributors or retailers or imposing travel or movement restrictions, shifts in demand and consumption away from more discretionary or higher priced products to lower-priced products or pantry-loading activity;

Substantial increases in demand for certain of our products requiring us to increase our production capacity or acquire additional capacity at an additional cost and expense;

Changes in purchasing patterns of our consumers, including the frequency of in-store visits by consumers to retailers and dental, veterinary and skin health professionals and a shift to purchasing our products online from eCommerce retailers;

Disruptions to our global supply chain, including the closure of manufacturing and distribution facilities, due to, among other things, the availability of raw and packaging materials or manufacturing components; a decrease in our workforce or in the efficiency of such workforce, including as a result of illness, travel restrictions, absenteeism or governmental regulations; transportation and logistics challenges, including as a result of port and border closures and other governmental restrictions or reduced shipping capacity; or the impact of COVID-19 on our retailers, third party suppliers, contract manufacturers, logistics providers or distributors;

Failure of third parties on which we rely, including our retailers, suppliers, contract manufacturers, logistics providers, customers, commercial banks, joint venture partners and external business partners, to meet their obligations to us, or significant disruptions in their ability to do so, which may be caused by their own financial or operational difficulties;

Significant changes in the economic and political conditions of the markets in which we operate, which could restrict and have restricted our employees’ ability to work and travel, could mandate and have mandated or caused the closure of certain distributors or retailers, our offices, shared business service centers and/or operating and manufacturing facilities or otherwise could prevent and have prevented us as well as our third-party partners, suppliers or customers from sufficiently staffing operations, including operations necessary for the manufacture, distribution, sale and support of our products;

Disruptions and volatility in the global capital markets, which may increase the cost of capital and adversely impact our access to capital; and/or

Volatility in foreign exchange rates and in raw and packaging materials and logistics costs.

Despite our efforts to manage these impacts, their ultimate impact also depends on factors beyond our knowledge or control, including the duration, severity and geographic scope of an outbreak, such as COVID-19, the availability, widespread distribution and use of safe and effective vaccines and the actions taken to contain its spread and mitigate its public health and economic effects.




10


Damage to our reputation could have an adverse effect on our business.

Maintaining our strong reputation with consumers and our trade partners globally is critical to selling our branded products. Accordingly, we devote significant time and resources to programs designed to protect and preserve our reputation, such as our Ethics and Compliance, Diversity, Equity and Inclusion, Sustainability and Social Impact, Brand Protection and Product Safety, Regulatory and Quality initiatives. Negative publicity about us, our brands, our products, our supply chain, our ingredients, our packaging, our environmental, social and governance practices, including as they relate to diversity, equity and inclusion, or our employees, whether or not deserved, could jeopardize our reputation. Such negative publicity could relate to, among other things, health concerns, threatened or pending litigation or regulatory proceedings, environmental impacts (including deforestation, packaging, plastic, energy and water use and waste management), our environmental, social and governance practices, or other sustainability or policy issues. In addition, widespread use of digital and social media by consumers has greatly increased the accessibility of information and the speed of its dissemination. Negative publicity, posts or comments on social media about us, our brands, our products, our packaging or our employees, whether true or untrue, could damage our brands and our reputation. The success of our brands could also suffer if our marketing initiatives do not have the desired impact on a brand’s image or its ability to attract consumers.

Additionally, due to the scale and scope of our business, we must rely on relationships with third parties, including our suppliers, distributors, contractors, joint venture partners and other external business partners, for certain functions. While we have policies and procedures for managing these relationships, they inherently involve a lesser degree of control over business operations, compliance and environmental, social and governance practices, thereby potentially increasing our reputational and legal risk.

In addition, third parties sell counterfeit versions of our products, which are inferior or may pose safety risks. As a result, consumers of our brands could confuse our products with these counterfeit products, which could cause them to refrain from purchasing our brands in the future and in turn could impair our brand equity and adversely affect our business, results of operations, cash flows and financial condition.

Damage to our reputation or loss of consumer confidence in our products for these or any other reasons could adversely affect our business, results of operations, cash flows and financial condition, as well as require resources to rebuild our reputation.

Our success depends upon our ability to recruit, attract and retain key employees, including through the implementation of diversity, equity and inclusion initiatives, and the succession of senior management.

Our success largely depends on the performance of our management team and other key employees. If we are unable to recruit, attract and retain talented, highly qualified senior management and other key people, our business, results of operations, cash flows and financial condition could be adversely affected. Successfully executing organizational change, including management transitions at leadership levels of the Company and succession plans for senior management, is critical to our business success. While we follow a disciplined, ongoing succession planning process and have succession plans in place for senior management and other key executives, these do not guarantee that the services of qualified senior executives will continue to be available to us at particular moments in time. Further, changes in immigration laws and policies, including during the COVID-19 pandemic, have made in certain circumstances and may continue to make it more difficult for us to recruit or relocate highly skilled technical, professional and management personnel to meet our business needs. In addition, we are working to advance culture change through the implementation of diversity, equity and inclusion initiatives throughout our organization. If we do not (or are perceived not to) successfully implement these initiatives, our ability to recruit, attract and retain talent may be adversely impacted.

We have pursued and may continue to pursue acquisitions and divestitures, which could adversely impact our business.

We have pursued and may continue to pursue acquisitions of brands, businesses or technologies from third parties. Acquisitions and their pursuit involve numerous potential risks, including, among other things:

realizing the full extent of the expected benefits or synergies as a result of a transaction, within the anticipated time frame, or at all;
11



successfully integrating the operations, technologies, services, products and systems of the acquired brands or businesses in an effective, timely and cost-efficient manner;

receiving necessary consents, clearances and approvals in connection with a transaction;

diverting management’s attention from other business priorities;

successfully operating in new lines of business, channels of distribution or markets;

retaining key employees, partners, suppliers and customers of the acquired business;

conforming standards, controls, procedures and policies of the acquired business with our own;

developing or launching products with acquired technologies; and

other unanticipated problems or liabilities.

Moreover, acquisitions have resulted in and could in the future result in substantial additional debt, exposure to contingent liabilities, such as litigation or earn-out obligations, the potential impairment of goodwill or other intangible assets, or transaction costs. Any of these risks, should they materialize, could adversely impact our business, results of operations, cash flows and financial condition.

We have divested and may in the future periodically divest brands or businesses. These divestitures may adversely impact our business, results of operations, cash flows and financial condition if we are unable to offset the dilutive impacts from the loss of revenue associated with the divested brands or businesses, or otherwise achieve the anticipated benefits or cost savings from the divestitures. In addition, businesses under consideration for, or otherwise subject to, divestiture may be adversely impacted prior to the divestiture, which could negatively impact our business, results of operations, cash flows and financial condition.

Operational Risks

Our business results are impacted by our ability to manage disruptions in our global supply chain and/or key office facilities.

We are engaged in manufacturing and sourcing of products and materials on a global scale. Our operations and those of our suppliers, contract manufacturers or logistics providers have been and may continue to be disrupted by a number of factors, including, but not limited to:

environmental events;

widespread health emergencies, such as COVID-19 or other pandemics or epidemics;

strikes and other labor disputes;

disruptions in logistics;

loss or impairment of key manufacturing sites;

loss of key suppliers or contract manufacturers;

supplier capacity constraints;

raw material and product quality or safety issues;

industrial accidents or other occupational health and safety issues;
12



the impact on our suppliers of tighter credit or capital markets;

the lack of availability of qualified personnel, such as truck drivers;

governmental incentives and controls (including import and export restrictions, such as new or increased tariffs, sanctions, quotas or trade barriers); and

natural disasters, including climatic events (including any potential effect of climate change) and earthquakes, acts of war or terrorism, political unrest or uncertainty, fires or explosions, cyber-security incidents and other external factors over which we have no control.

In addition, we purchase certain key raw and packaging materials from single-source suppliers or a limited number of suppliers and new suppliers may have to be qualified under industry, governmental and Colgate standards, which can require additional investment and take a significant period of time.

We believe that the supplies of raw and packaging materials needed to manufacture our products are adequate. In addition, we have business continuity and contingency plans in place for key manufacturing sites and contract manufacturers and the supply of raw and packaging materials. Nonetheless, a significant disruption to the manufacturing or sourcing of products or materials for any reason, including those mentioned above, could interrupt product supply and, if not remedied, could have an adverse impact on our business, results of operations, cash flows and financial condition.

In addition, as a result of our global shared service organizational model, certain of our functions, such as marketing, payroll, finance and accounting, customer service and logistics, and human resources, are concentrated in key office facilities. A significant disruption to any of our key office facilities for any reason, including those mentioned above, could adversely affect our business, results of operations, cash flows and financial condition.

Volatility in material and other costs could adversely impact our profitability.

Raw and packaging material commodities, such as essential oils, resins, pulp, tropical oils, tallow, corn, poultry and soybeans, are subject to market price variations. Increases in the costs of and/or a reduction in the availability of commodities, energy and logistics and other necessary services, including during the COVID-19 pandemic, have affected and may continue to adversely affect our profit margins. If commodity and other cost increases continue in the future and we are unable to pass along such higher costs in the form of price increases, achieve cost efficiencies, such as in manufacturing and distribution, or otherwise manage the exposure through sourcing strategies, ongoing productivity initiatives and the limited use of commodity hedging contracts, our business, results of operations, cash flows and financial condition could be adversely impacted. In addition, even if we are able to increase the prices of our products in response to commodity and other cost increases, we may not be able to sustain the price increases. Also, sustained price increases may lead to declines in volume as competitors may not adjust their prices or consumers may decide not to pay higher prices, which could lead to sales declines and loss of market share and could adversely affect our business, results of operations, cash flows and financial condition. See “Our business results depend on our ability to manage disruptions in our global supply chain and/or key office facilities” above for additional information.














13


There is no guarantee that our ongoing efforts to reduce costs will be successful.

One way that we generate funds needed to support the growth of our business is through our continuous, Company-wide initiatives to lower costs and increase effective asset utilization, which we refer to as our funding-the-growth initiatives. These initiatives are designed to reduce costs associated with direct materials, indirect expenses, distribution and logistics, and advertising and promotional materials, among other things. The achievement of our funding-the-growth goals depends on our ability to successfully identify and realize additional savings opportunities. Events and circumstances, such as financial or strategic difficulties, delays and unexpected costs may occur that could result in our not realizing any or all of the anticipated benefits or our not realizing the anticipated benefits on our expected timetable. If we are unable to realize the anticipated savings of our funding-the-growth initiatives, our ability to fund other initiatives and achieve our profitability goals may be adversely affected. Any failure to implement our funding-the-growth initiatives in accordance with our expectations could adversely affect our business, results of operations, cash flows and financial condition. For additional information regarding our funding-the-growth initiatives, refer to Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Executive Overview.”

A cyber-security incident, data breach or a failure of a key information technology system could adversely impact our business.

We rely extensively on information technology systems (“IT Systems”), including some which are managed, hosted, provided and/or used by third parties, including cloud-based service providers, and their vendors, in order to conduct our business. Our uses of these systems include, but are not limited to:

communicating within our company and with other parties, including our customers and consumers;

ordering and managing materials from suppliers;

converting materials to finished products;

receiving and processing orders from, shipping products to and invoicing our customers and consumers;

marketing products to consumers;

collecting, storing, transferring and/or processing customer, consumer, employee, vendor, investor and other stakeholder information and personal data, including, but not limited to, such data from residents of the European Union who are covered by the General Data Protection Regulation, which went into effect on May 25, 2018, and residents of the State of California who are covered by the California Consumer Privacy Act of 2018, which went into effect on January 1, 2020;

processing transactions, including but not limited to employee payroll, employee and retiree benefits and payments to customers and vendors;

hosting, processing and sharing confidential and proprietary research, intellectual property, business plans and financial information;

summarizing and reporting results of operations, including financial reporting;

managing our banking and other cash liquidity systems and platforms;

complying with legal, regulatory and tax requirements;

providing data security; and

handling other processes involved in managing our business.


14


Although we have a broad array of information security measures in place, our IT Systems, including those of third-party service providers with whom we have contracted, have been, and will likely continue to be, subject to computer viruses or other malicious codes, unauthorized access attempts, phishing and other cyber-attacks. Cyber-attacks and other cyber incidents are occurring more frequently, are constantly evolving in nature, are becoming more sophisticated and are being made by groups, individuals and nation states with a wide range of expertise and motives. Such cyber-attacks and cyber incidents can take many forms, including cyber extortion, social engineering, password theft or introduction of viruses or malware, such as ransomware through phishing emails. We cannot guarantee that our security efforts will prevent breaches or breakdowns of our, or our third-party service providers’, IT Systems since the techniques used in these attacks change frequently and may be difficult to detect for periods of time. In addition, although we have policies and procedures in place to ensure that all personal information collected by us or our third-party service providers is securely maintained, data breaches due to human error or intentional or unintentional conduct have occurred and likely will continue to occur. Furthermore, we periodically upgrade our IT Systems or adopt new technologies. If such an upgrade or new technology does not function as designed, does not go as planned or increases our exposure to a cyber-attack or cyber incident, it may adversely impact our business, including our ability to ship products to customers, issue invoices and process payments or order raw and packaging materials. Although we have seen no material impact on our business operations from the cyber-security attacks and data breaches we have experienced to date, if we suffer a significant loss or disclosure of confidential business or stakeholder information as a result of a breach of our IT Systems, including those of third-party service providers with whom we have contracted, or otherwise, we may suffer reputational, competitive and/or business harm, incur significant costs and be subject to government investigations, litigation, fines and/or damages, which may adversely impact our business, results of operations, cash flows and financial condition.

Furthermore, while we have disaster recovery and business continuity plans in place, if our IT Systems are damaged, breached or cease to function properly for any reason, including the poor performance of, failure of or cyber-attack on third-party service providers, catastrophic events, power outages, cyber-security breaches, network outages, failed upgrades or other similar events and, if the disaster recovery and business continuity plans do not effectively resolve such issues on a timely basis, we may suffer interruptions in our ability to manage or conduct business as well as reputational harm, and may be subject to governmental investigations and litigation, any of which may adversely impact our business, results of operations, cash flows and financial condition.

Climate change and other sustainability matters may have an adverse impact on our business and results of operations.

It has been reported that carbon dioxide and other greenhouse gases in the atmosphere have an adverse impact on global temperatures, weather patterns and the frequency and severity of extreme weather and natural disasters. The predicted effects of climate change may also exacerbate challenges regarding the availability and quality of water and other ingredients. In addition, concern over climate change may result in new or additional legal and regulatory requirements to reduce or mitigate the effects of climate change on the environment. Despite our sustainability efforts, any failure to achieve our sustainability goals, including those aimed to reduce our impact on, improve or preserve the environment, or the perception (whether or not valid) that we have failed to act responsibly with respect to such matters or to effectively respond to new or additional legal or regulatory requirements regarding climate change, could result in adverse publicity and adversely affect our business and reputation. There is also increased focus, including by governmental and non-governmental organizations, investors, customers, consumers, our employees and other stakeholders on these and other sustainability matters, including responsible sourcing and deforestation, the use of plastic, energy and water, the recyclability or recoverability of packaging, including single-use and other plastic packaging and ingredient transparency. Our reputation could be damaged if we do not (or are perceived not to) act responsibly with respect to sustainability matters, which could adversely affect our business, results of operations, cash flows and financial condition.










15


Legal and Regulatory Risks

Our business is subject to legal and regulatory risks in the U.S. and abroad.

Our business is subject to extensive legal and regulatory requirements in the U.S. and abroad. Such legal and regulatory requirements apply to most aspects of our products, including their development, ingredients, formulation, manufacture, packaging content, labeling, storage, transportation, distribution, export, import, advertising, sale and environmental impact. U.S. federal authorities, including the U.S. Food and Drug Administration (the “FDA”), the Federal Trade Commission, the Consumer Product Safety Commission, the Occupational Safety and Health Administration and the Environmental Protection Agency, regulate different aspects of our business, along with parallel authorities at the state and local levels and comparable authorities overseas. In addition, our selling practices are regulated by competition law authorities in the U.S. and abroad.

New or more stringent legal or regulatory requirements, or more restrictive interpretations of existing requirements, could adversely impact our business, results of operations, cash flows and financial condition. For example, from time to time, various regulatory authorities around the world review the use of various ingredients and packaging content in consumer products. While we monitor and seek to mitigate the impact of any emerging information, a decision by a regulatory or governmental authority that any ingredient or packaging content in our products should be restricted or should otherwise be newly regulated could adversely impact our business and reputation, as could negative reactions by our consumers, trade customers or non-governmental organizations to our current or prior use of such ingredients or packaging. Additionally, an inability to develop new or reformulated products containing alternative ingredients, to obtain regulatory approval of such products or ingredients on a timely basis or to effectively market and sell such products could likewise adversely affect our business.

Because of our extensive international operations, we could be adversely affected by violations of worldwide anti-bribery laws, including those that prohibit companies and their intermediaries from making improper payments to government officials or other third parties for the purpose of obtaining or retaining business, such as the U.S. Foreign Corrupt Practices Act, and laws that prohibit commercial bribery. While our policies mandate compliance with these anti-bribery laws, we cannot provide assurance that our internal control policies and procedures will always protect us from reckless or criminal acts committed by our employees, joint venture partners or agents. Violations of these laws, or allegations of such violations, could disrupt our business and adversely affect our reputation and our business, results of operations, cash flows and financial condition.

While it is our policy and practice to comply with all legal and regulatory requirements applicable to our business, a finding that we are in violation of, or out of compliance with, applicable laws or regulations could subject us to civil remedies, including fines, damages, injunctions or product recalls, or criminal sanctions, any of which could adversely affect our business, results of operations, cash flows and financial condition. Even if a claim is unsuccessful, is without merit or is not fully pursued, the cost of responding to such a claim, including management time and out-of-pocket expenses, and the negative publicity surrounding such assertions regarding our products, processes or business practices could adversely affect our reputation, brand image and our business, results of operations, cash flows and financial condition. For information regarding our legal and regulatory matters, see Item 3 “Legal Proceedings” and Note 13, Commitments and Contingencies to the Consolidated Financial Statements.














16


Legal claims and proceedings could adversely impact our business.

As a global company serving consumers in more than 200 countries and territories, we are and may continue to be subject to a wide variety of legal claims and proceedings, including disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Regardless of their merit, these claims can require significant time and expense to investigate and defend. Since litigation is inherently uncertain, there is no guarantee that we will be successful in defending ourselves against such claims or proceedings, or that our assessment of the materiality of these matters, including any reserves taken in connection therewith, will be consistent with the ultimate outcome of such matters. In addition, if one of our products, or an ingredient contained in our products, is perceived or found to be defective, or unsafe or have a quality issue, we have had to and may in the future need to withdraw, recall or reformulate some of our products. Whether or not a legal claim or proceeding is successful, or a withdrawal, recall or reformulation is required or advisable, such assertions could have an adverse effect on our business, results of operations, cash flows and financial condition, and the negative publicity surrounding them could harm our reputation and brand image. The resolution of, or increase in the reserves taken in connection with, one or more of these matters in any reporting period could have a material adverse effect on our business, results of operations, cash flows and financial condition for that period. See Item 3 “Legal Proceedings” and Note 13, Commitments and Contingencies to the Consolidated Financial Statements for additional information on certain of our legal claims and proceedings.

Financial and Economic Risks

Uncertain or unfavorable global economic conditions, including as a result of COVID-19, may adversely affect our business.

Uncertain global economic conditions could adversely affect our business. Unfavorable global economic conditions, such as a recession, economic slowdown and/or reduced category growth rates, including as a result of COVID-19, could negatively impact our business and result in declining revenues, profitability and cash flows. Although we continue to devote significant resources to support our brands and market our products at multiple price points, during periods of economic uncertainty or unfavorable economic conditions, consumers may reduce consumption or discretionary spending and/or change their purchasing patterns by foregoing purchasing certain of our products or by switching to “private label” or lower-priced brands. These changes could reduce demand for and sales volumes of our products or result in a shift in our product mix from higher margin to lower margin product offerings. Additionally, our retailers may be impacted and they may increase pressure on our selling prices or increase promotional activity for lower-priced or value offerings as they seek to maintain sales volumes and margins. Furthermore, economic conditions can cause our suppliers, distributors, contract manufacturers, logistics providers or other third-party partners to suffer financial or operational difficulties, which may impact their inability to provide us with or distribute finished product, raw and packaging materials and/or services in a timely manner or at all. In addition, we could face difficulty collecting or recovering accounts receivables from third parties facing financial or operational difficulties.

Disruptions in the credit markets or changes to our credit ratings may adversely affect our business.

While we currently generate significant cash flows from ongoing operations and have access to global credit markets through our various financing activities, a disruption in the credit markets, interest rate increases, changes that may result from the implementation of new benchmark rates that replace the London Interbank Offered Rate (LIBOR) or changes to our credit ratings could negatively impact the availability or cost of funding. Reduced access to credit or increased costs could adversely affect our liquidity and capital resources or significantly increase our cost of capital. In addition, if any financial institutions that hold our cash or other investments or that are parties to our undrawn revolving credit facilities supporting our commercial paper programs or other financing arrangements, such as interest rate, foreign exchange or commodity hedging instruments, were to declare bankruptcy or become insolvent, they may be unable to perform under their agreements with us. This could leave us with reduced borrowing capacity or unhedged against certain interest rate, foreign currency or commodity price exposures. In addition, tighter credit markets may lead to business disruptions for certain of our suppliers, contract manufacturers or trade customers which could, in turn, adversely impact our business, results of operations, cash flows and financial condition.


17


Tax matters, including changes in tax rates, disagreements with taxing authorities and imposition of new taxes could negatively impact our business.

We are subject to taxes in the U.S. and in the foreign jurisdictions where we do business. Due to economic and political conditions, tax rates in the U.S. and various foreign jurisdictions have been and may be subject to significant change. Changes in the mix of our earnings between countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities related to changes in tax rates, changes in tax laws, including how existing tax laws are interpreted or enforced, or contemplated changes in long-standing tax principles, if finalized and adopted, could adversely impact our future effective tax rate and business, results of operations, cash flows and financial condition. For example, long-standing international tax norms that determine each country’s jurisdiction to tax cross-border international trade are evolving as a result of the Base Erosion and Profit Shifting reporting requirements (“BEPS”) recommended by countries that then made up the G8 and the G20 and the Organization for Economic Cooperation and Development. In connection with BEPS, companies are required to disclose more information to tax authorities on operations around the world, which may lead to greater audit scrutiny of profits earned in countries outside of the U.S. As this and other tax laws and related regulations change, our business, results of operations, cash flows and financial condition could be materially impacted. For more information regarding U.S. tax reform, see Note 11, Income Taxes to the Consolidated Financial Statements.

Furthermore, we are subject to regular reviews, examinations and audits by the Internal Revenue Service and other taxing authorities with respect to taxes inside and outside of the U.S. Although we believe our tax positions are reasonable, if a taxing authority disagrees with the positions we have taken, we have faced and in the future may face additional tax liabilities, including interest and penalties, in excess of reserves. The payment of such additional amounts upon final adjudication of any disputes could adversely impact our business, results of operations, cash flows and financial condition.















18


ITEM 1B.    UNRESOLVED STAFF COMMENTS

None.

19


ITEM 2.    PROPERTIES

We own or lease approximately 320 properties, which include manufacturing, distribution, research and office facilities worldwide. Our corporate headquarters is located in leased property at 300 Park Avenue, New York, New York.

In the U.S., we operate in approximately 70 properties, of which 13 are owned. Major U.S. manufacturing and warehousing facilities used by the Oral, Personal and Home Care product segment of our business are located in Cambridge, Ohio; Greenwood, South Carolina; and Morristown, Tennessee. The Pet Nutrition segment has major manufacturing and warehousing facilities in Bowling Green, Kentucky; Emporia, Kansas; Richmond, Indiana; and Topeka, Kansas.

Overseas, we operate in approximately 250 properties, of which 57 are owned, in over 80 countries. Major overseas manufacturing and warehousing facilities used by the Oral, Personal and Home Care product segment of our business are located in Australia, Brazil, China, Colombia, France, Greece, Guatemala, India, Italy, Mexico, Poland, South Africa, Thailand, Turkey and Venezuela. The Pet Nutrition segment has major manufacturing and warehousing facilities in the Czech Republic and the Netherlands.

The primary research center for Oral Care and Personal Care products is located in Piscataway, New Jersey, the primary research center for Home Care products is located in Mexico and the primary research center for Pet Nutrition products is located in Topeka, Kansas. Our global data center is also located in Piscataway, New Jersey.

We have shared business service centers in India, Mexico and Poland, which are located in leased properties.

All of the facilities we operate are well maintained and adequate for the purpose for which they are intended.


20


ITEM 3.    LEGAL PROCEEDINGS

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters, and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $425 million (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Companys 1995 acquisition of the Kolynos oral care business from Wyeth (the Seller).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $113 million. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001.

In each of September 2015, February 2017, June 2018, April 2019 and September 2020, the Company lost an administrative appeal and subsequently filed an appeal in Brazilian federal court. Currently, there are five appeals pending in the Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously.
 
21


In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.
 
In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $50 million, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.

Competition Matter

Certain of the Company’s subsidiaries were historically subject to actions and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status as of December 31, 2020 of such competition law matters pending against the Company during the year ended December 31, 2020 is set forth below.

In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11 million. The Company appealed the decision to the Greek courts. In April 2019, the Greek courts affirmed the judgment against the Company’s Greek subsidiary, but reduced the fine to $10.5 and dismissed the case against Colgate-Palmolive Company. The Company’s Greek subsidiary and the Greek competition authority have appealed the decision to the Greek Supreme Court.

22


Talcum Powder Matters

The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of December 31, 2020, there were 137 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 121 cases as of December 31, 2019. During the year ended December 31, 2020, 65 new cases were filed and 49 cases were resolved by voluntary dismissal, settlement or dismissal by the court. The value of the settlements in the years presented was not material, either individually or in the aggregate, to each such period’s results of operations.

A significant portion of the Company’s costs incurred in defending and resolving these claims has been, and the Company believes will continue to be, covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions and policy limits.

While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. With the exception of one case where the Company received an adverse jury verdict in the second quarter of 2019 that the Company has appealed, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases because the amount of any possible losses from such cases currently cannot be reasonably estimated.

ERISA Matter

In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals (the “Company Defendants”) in the United States District Court for the Southern District of New York (the “Court”). The relief sought includes recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. This action was certified as a class action in July 2017. In July 2020, the Court granted in part and denied in part the Company Defendants’ motion for summary judgment and dismissed certain claims on consent of the parties. In August 2020, the Court granted the plaintiffs’ motion for summary judgment on the remaining claims. The Company and the Plan are contesting this action vigorously and, in September 2020, appealed to the United States Court of Appeals for the Second Circuit.

ITEM 4.     MINE SAFETY DISCLOSURES

Not Applicable.

23


PART II

ITEM 5.    MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

For information regarding the market for the Company’s common stock, including stock price performance graphs, refer to “Market Information” included in Part IV, Item 15 of this report. For information regarding the number of common shareholders of record, refer to “Historical Financial Summary” included in Part IV, Item 15 of this report. For information regarding the securities authorized for issuance under our equity compensation plans, refer to “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” included in Part III, Item 12 of this report.

Issuer Purchases of Equity Securities

On June 18, 2018, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2018 Program”), which replaced a previously authorized share repurchase program. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

The following table shows the share repurchase activity for the three months in the quarter ended December 31, 2020:
Month
Total Number of Shares Purchased(1)
Average Price Paid per Share
Total Number of Shares Purchased
as Part of Publicly Announced Plans or Programs(2)
Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(3)
 (in millions)
October 1 through 31, 20202,379,383 $78.96 2,353,440 2,527 
November 1 through 30, 20206,518,404 $84.53 6,494,000 1,978 
December 1 through 31, 20201,770,867 $84.85 1,762,057 1,829 
Total10,668,654 $83.34 10,609,497  
_______
(1)Includes share repurchases under the 2018 Program and those associated with certain employee elections under the Company’s compensation and benefit programs.
(2)The difference between the total number of shares purchased and the total number of shares purchased as part of publicly announced plans or programs is 59,157 shares, which represents shares deemed surrendered to the Company to satisfy certain employee elections under the Company’s compensation and benefit programs.
(3)Includes approximate dollar value of shares that were available to be purchased under the publicly announced plans or programs that were in effect as of December 31, 2020.

ITEM 6.    SELECTED FINANCIAL DATA

Refer to the information set forth under the caption “Historical Financial Summary” included in Part IV, Item 15 of this report.
24

(Dollars in Millions Except Per Share Amounts)
ITEM 7.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Executive Overview

Business Organization

Colgate-Palmolive Company (together with its subsidiaries, “we,” “us” “our” the “Company” or “Colgate”) is a caring, innovative growth company reimagining a healthier future for all people, their pets and our planet. We seek to deliver sustainable, profitable growth and superior shareholder returns, as well as to provide Colgate people with an innovative and inclusive work environment. We do this by developing and selling products globally that make people’s lives healthier and more enjoyable and by embracing our sustainability and social impact and diversity, equity and inclusion strategies across our organization.

We are tightly focused on two product segments: Oral, Personal and Home Care; and Pet Nutrition. Within these segments, we follow a closely defined business strategy to grow our key product categories and increase our overall market share. Within the categories in which we compete, we prioritize our efforts based on their capacity to maximize the use of the organization’s core competencies and strong global equities and to deliver sustainable, profitable long-term growth.

Operationally, we are organized along geographic lines with management teams having responsibility for the business and financial results in each region. We compete in more than 200 countries and territories worldwide with established businesses in all regions contributing to our sales and profitability. Approximately 70% of our Net sales are generated from markets outside the U.S., with approximately 45% of our Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). This geographic diversity and balance help to reduce our exposure to business and other risks in any one country or part of the world.

The Oral, Personal and Home Care product segment is managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and eCommerce retailers, wholesalers and distributors. Through Hill’s Pet Nutrition, we also compete on a worldwide basis in the pet nutrition market, selling products principally through authorized pet supply retailers, veterinarians and eCommerce retailers. We are engaged in manufacturing and sourcing of products and materials on a global scale and have major manufacturing facilities, warehousing facilities and distribution centers in every region around the world.

On an ongoing basis, management focuses on a variety of key indicators to monitor business health and performance. These indicators include net sales (including volume, pricing and foreign exchange components), organic sales growth (net sales growth excluding the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure, and gross profit margin, operating profit, net income and earnings per share, in each case, on a GAAP and non-GAAP basis, as well as measures used to optimize the management of working capital, capital expenditures, cash flow and return on capital. In addition, we review market share data to assess how our brands are performing within their categories on a global and regional basis. The monitoring of these indicators and our Code of Conduct and corporate governance practices help to maintain business health and strong internal controls. For additional information regarding non-GAAP financial measures and the Company’s use of market share data and the limitations of such data, see “Non-GAAP Financial Measures” and “Market Share Information” below.













25

(Dollars in Millions Except Per Share Amounts)
COVID-19

The COVID-19 pandemic and government steps to reduce the spread and address the impact of COVID-19 have had and continue to have a profound impact on the way people live, work, interact and shop and have significantly impacted and will likely continue to impact economic activity around the world. We have a well-established Crisis Management Team (“CMT”) process, and the CMT, together with our senior management team and Colgate people around the world, continue to respond to and manage the challenges presented by COVID-19.

During the year ended December 31, 2020, many of the communities in which we manufacture, market and sell our products experienced unprecedented “stay at home” orders, travel or movement restrictions and other government actions to reduce the spread and address the impact of COVID-19, and have implemented varying policies to resume economic activity. The situation continues to be uncertain and varies by geography, as infection rates of COVID-19 continue to increase in many regions throughout the world, and authorities have taken different approaches to address the pandemic and resume economic activity. Because the vast majority of our products (such as oral care products, soaps and other personal hygiene products, home cleaners and pet food) have been deemed essential for the health and well-being of people and their pets, we have, in most instances, been able to continue operating our business.

In doing so, the health, safety and well-being of our employees has been and remains our first priority. Many of our employees globally continue to work from home. In those instances where our employees cannot perform their work at home, such as in our factories and in certain of our laboratories, or in geographies where circumstances have allowed us to offer employees the ability to return to the office, often on a voluntary and staggered basis, we have implemented additional health and safety measures and social distancing protocols, consistent with government recommendations and/or requirements, to help to ensure their safety, often at an additional cost. In addition, during the year ended December 31, 2020, we experienced some limited factory closures and, in some cases, we have seen increased instances of absenteeism. Furthermore, some of our suppliers, customers, distributors, logistics providers and service providers have experienced disruptions to their businesses.

We saw a significant increase in demand across many of our categories in the year ended December 31, 2020, such as liquid hand soap, dish liquid, bar soap and cleaners, driven by consumer pantry-loading and increased consumption of our products. We believe that some of the increase in consumption in these categories is sustainable in light of changes in consumer behavior related to COVID-19. In other categories, such as oral care and pet food, consumer demand trends continued to normalize in the second half of the year ended December 31, 2020. Across our business, changes in consumer demand for our products vary by product category and geography depending on, among other things, the severity of the COVID-19 outbreak and retailer availability. At the same time, during the year ended December 31, 2020, we experienced declines in certain channels, including professional sales and travel retail, due to the economic slowdown and restricted consumer movement in many geographies throughout the world. We also continue to see changes in the purchasing patterns of our consumers, including the nature and/or frequency of visits by consumers to retailers and dental, veterinary and skin health professionals and a shift in many markets to purchasing our products online. In some instances during the year ended December 31, 2020, we were not able to keep up with the increased consumer demand for our products, and our products were at times out of stock on retailers’ shelves. In some cases, we have incurred additional costs as we worked to meet this increased demand. Despite continuing to significantly ramp up production of in-demand products, we expect that some of our products may continue to be out of stock on retailers’ shelves for a period of time.

COVID-19 and government steps to reduce the spread and address the impact of COVID-19 have impacted and may continue to impact our consumers’ ability to purchase and our ability to manufacture and distribute our products. While we believe that, in the long-term, consumer demand for the products in our categories will continue to be strong, uncertainties continue surrounding the timing and extent of the pandemic and the recovery from it. These uncertainties include: the impact of the timing and scale of changes to travel and movement restrictions in certain geographies, the availability and widespread distribution and use of safe and effective COVID-19 vaccines and when communities will reach herd immunity, the timing and impact of consumer pantry-loading and destocking activity in certain markets, product demand trends and the impact of COVID-19 on the global economy. Our retail customers, contract manufacturers, logistics providers and other third parties are also being impacted by the global pandemic; their success in addressing COVID-19 and maintaining their operations could impact consumer access to and sales of our products. We expect the ongoing economic impact and health concerns associated with COVID-19 to continue to impact consumer behavior, shopping patterns and consumption preferences despite the lifting of government restrictions and the reopening of economies around the world.

26

(Dollars in Millions Except Per Share Amounts)
While we currently expect to be able to continue operating our business as described above and we intend to continue to work with government authorities and to follow the necessary protocols to maintain the health and safety of our employees and contract providers, uncertainty resulting from COVID-19 could result in an unforeseen additional disruption to our business, including our global supply chain and retailer network, and/or require us to incur additional operational costs.

For more information about the anticipated COVID-19 impact, see “Outlook” below.

Business Strategy

To achieve our business and financial objectives, we are focused on innovating our core businesses; improving our brand building activities with an elevated brand purpose model and the use of equity advertising; innovating to gain market share in high growth segments and adjacencies; expanding into new channels and markets; maximizing growth online; and investing to drive consumption in growing populations. We continue to develop initiatives to build strong relationships with consumers, dental, veterinary and skin health professionals and traditional and eCommerce retailers. In addition, we continue to invest behind our brands, not just in terms of advertising, but also to build key growth capabilities in areas such as innovation and data and analytics. We also continue to broaden our eCommerce offerings, including direct-to-consumer and subscription services. We continue to believe that growth opportunities are greater in those areas of the world in which economic development and rising consumer incomes expand the size and number of markets for our products. We are also working to integrate our sustainability and social impact and diversity, equity and inclusion strategies across our organization.

We are also changing the way we work to drive growth and how we approach innovation to respond to the dynamic retail landscape and the evolving preferences of our customers and consumers. The retail landscape, the ease of new entrants into the market in many of our categories and the evolving preferences of our customers and consumers demand that we work differently and faster in an agile, authentic and culturally relevant manner to drive innovation.

The investments needed to drive growth are supported by strong cash flow performance and our disciplined capital allocation strategy. These investments are developed through continuous, Company-wide initiatives to lower costs and increase effective asset utilization. Through these initiatives, which are referred to as our funding-the-growth initiatives, we seek to become even more effective and efficient throughout our businesses. These initiatives are designed to reduce costs associated with direct materials, indirect expenses, distribution and logistics and advertising and promotional materials, among other things, and encompass a wide range of projects, examples of which include raw material substitution, reduction of packaging materials, consolidating suppliers to leverage volumes and increasing manufacturing efficiency through SKU reductions and formulation simplification. We also continue to prioritize our investments in high growth segments within our Oral Care, Personal Care and Pet Nutrition businesses, including by expanding our portfolio in premium skin health.

Significant Items Impacting Comparability

On January 31, 2020, we acquired Hello Products LLC (“hello”), an oral care business, for cash consideration of $351. The acquisition was financed with a combination of debt and cash. This acquisition is part of our strategy to focus on high growth segments within our Oral Care, Personal Care and Pet Nutrition businesses. See Note 3, Acquisitions to the Consolidated Financial Statements for additional information.

The provision for income taxes for the year ended December 31, 2020 includes $71 of income tax benefits, of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As described more fully in “Results of Operations-Income Taxes,” below, both items were previously recorded in connection with the charge recorded in 2017 and revised in 2018 related to the Tax Cuts and Jobs Act (the “TCJA”).






27

(Dollars in Millions Except Per Share Amounts)
Our restructuring program, known as the “Global Growth and Efficiency Program,” concluded on December 31, 2019. Initiatives under the Global Growth and Efficiency Program fit within the program’s three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions and optimizing the global supply chain and facilities. During the year ended December 31, 2020, we adjusted the accrual balances related to certain projects approved prior to the conclusion of the Global Growth and Efficiency Program to reflect our revised estimate of remaining liabilities, which resulted in a reduction of $16 ($13 aftertax) to restructuring accruals. No new restructuring projects were approved for implementation during the year ended December 31, 2020. During the year ended December 31, 2019, we incurred costs of $132 ($102 aftertax) resulting from the Global Growth and Efficiency Program. For more information regarding the Global Growth and Efficiency Program, see “Restructuring and Related Implementation Charges” below and Note 4, Restructuring and Related Implementation Charges to the Consolidated Financial Statements.

In December 2019, the Swiss government enacted changes to its corporate tax regime, which included, among other items, the repeal of certain preferential tax regimes and an increase to the cantonal tax rate for future periods. Additionally, the government provided transition rules which allowed companies to record goodwill for tax purposes, partially offsetting the impact on cash taxes of the higher cantonal rate over the next ten years. As a result of these changes, we recorded a net benefit of $29 to the Provision for income taxes.

In September 2019, we acquired Laboratoires Filorga Cosmétiques S.A. (“Filorga”), a skin health business, for cash consideration of €1,548 (approximately $1,712). In the third quarter of 2020, we completed the purchase of the outstanding non-controlling interest of Filorga’s joint venture based in Hong Kong and covering the Hong Kong and China markets for approximately €85 (approximately $99) in cash. See Note 3, Acquisitions to the Consolidated Financial Statements for additional information.

In 2019, we received a favorable judgment regarding certain value-added tax previously paid in Brazil. As a result of the favorable judgment, during the fourth quarter of 2019, we filed an application with the Brazilian government to recover value-added tax previously paid and recorded a benefit of $30 pretax ($20 aftertax). The recovery will be utilized to offset corporate income tax payments in Brazil in future periods.




28

(Dollars in Millions Except Per Share Amounts)
Outlook

Looking forward, we expect global macroeconomic, political and market conditions to remain challenging, especially due to COVID-19. During the COVID-19 pandemic, we have seen improvement in category growth rates due to heightened demand for certain health and hygiene products, particularly liquid hand soap, dish liquid, bar soap and cleaners. We believe some of this increased consumption is sustainable due to consumer behavior changes resulting from COVID-19. However, we expect increased volatility across all of our categories and it is therefore difficult to predict category growth rates over the next six to twelve months. In the longer term, we expect category growth rates to remain below historical levels.

While the global marketplace in which we operate has always been highly competitive, we continue to experience heightened competitive activity in certain markets from strong local competitors, from other large multinational companies, some of which have greater resources than we do, and from new entrants into the market in many of our categories. Such activities have included more aggressive product claims and marketing challenges, as well as increased promotional spending and geographic expansion. We have seen increases in promotional activities in certain markets as retailers try aggressively to get consumers back into the stores after prolonged “stay at home” and other government restrictions ease, a trend we expect will continue. We have been negatively affected by changes in the policies or practices of our retail trade customers in key markets, such as inventory de-stocking, limitations on access to shelf space, delisting of our products or sustainability, supply chain or packaging initiatives. In addition, the retail landscape in many of our markets continues to evolve as a result of the rapid growth of eCommerce retailers, changing consumer preferences (as consumers increasingly shop online) and the increased presence of alternative retail channels, such as subscription services and direct-to-consumer businesses. These trends have been magnified due to COVID-19 in many of our geographies and we plan to continue to invest behind our eCommerce capabilities. This rapid growth in eCommerce and the emergence of alternative retail channels have created and may continue to create pricing pressures and/or adversely affect our relationships with our key retailers. In certain markets, we have incurred and are likely to continue to incur increased logistics costs due to higher eCommerce demand and volume and capacity constraints in the shipping and logistics industry. In addition, given that approximately 70% of our Net sales originate in markets outside the U.S., we have experienced and will likely continue to experience increasingly volatile foreign currency fluctuations and higher raw and packaging material costs. While we have taken, and will continue to take, measures to mitigate the effect of these conditions, in the current environment, it may become increasingly difficult to implement certain of these mitigation strategies. Should these conditions persist, they could adversely affect our future results.

As discussed above, we continue to closely monitor the impact of COVID-19 on our business. While we have taken, and will continue to take, measures to mitigate the effects of COVID-19, we cannot estimate with certainty the full extent of COVID-19’s impact on our business, results of operations, cash flows and/or financial condition. For more information about factors that could impact our business, including due to COVID-19, see “Risk Factors” in Part I, Item 1A of this Annual Report.

In summary, we believe that we are well prepared to meet the challenges ahead due to our strong financial condition, broad based experience operating in challenging environments, resilient global supply chain and focused business strategy. Our strategy is based on driving organic sales growth through innovation within our core businesses, leveraging faster growth in adjacent categories and expanding in high growth channels and markets; delivering margin expansion through operating leverage and efficiency; and maximizing the impact of our environmental, social and governance programs; and leading in the development of human capital, including our sustainability and social impact and diversity, equity and inclusion strategies. Our commitment to these priorities, the strength of our brands, the breadth of our global footprint and a commitment to driving efficiency in cash generation should position us well to manage through COVID-19 and increase shareholder value over time.

29

(Dollars in Millions Except Per Share Amounts)
Results of Operations

This section of this Annual Report on Form 10-K generally discusses 2020 and 2019 items and year-to-year comparisons between 2020 and 2019. Discussions of 2018 items and year-to-year comparisons between 2019 and 2018 that are not included in this Annual Report on Form 10-K can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019.

Net Sales

Worldwide Net sales were $16,471 in 2020, up 5.0% from 2019, as volume growth of 5.5% and net selling price increases of 3.0% were partially offset by negative foreign exchange of 3.5%. Acquisitions contributed 1.5% to volume. Organic sales (Net sales excluding, as applicable, the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure as discussed below, increased 7.0% in 2020.

Net sales in the Oral, Personal and Home Care product segment were $13,588 in 2020, up 3.0% from 2019, as volume growth of 4.5% and net selling price increases of 3.5% were partially offset by negative foreign exchange of 5.0%. Acquisitions contributed 2.0% to volume. Organic sales in the Oral, Personal and Home Care product segment increased 6.0% in 2020.

The increase in organic sales in 2020 versus 2019 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste category. The increase in Personal Care was primarily due to organic sales growth in the liquid hand soap and bar soap categories. The increase in Home Care was due to organic sales growth in the hand dish and liquid cleaner categories.

The Company’s share of the global toothpaste market was 39.8% for full year 2020, down 0.7 share points from full year 2019, and its share of the global manual toothbrush market was 31.1% for full year 2020, up 0.2 share points from full year 2019. Full year 2020 market shares in toothpaste were up in North America and Latin America, flat in Europe and down in Asia Pacific and Africa/Eurasia versus full year 2019. In the manual toothbrush category, full year 2020 market shares were up in North America, Latin America, Europe and Africa/Eurasia and down in Asia Pacific versus full year 2019. For additional information regarding the Company’s use of market share data and limitations of such data, see “Market Share Information” below.

Net sales for Hill’s Pet Nutrition were $2,883 in 2020, an increase of 14.0% from 2019, driven by volume growth of 10.5% and net selling price increases of 4.0%, partially offset by negative foreign exchange of 0.5%. Organic sales for Hill’s Pet Nutrition increased 14.5% in 2020.

The increase in organic sales in 2020 versus 2019 was primarily due to increases in organic sales in the Science Diet and Prescription Diet categories.

30

(Dollars in Millions Except Per Share Amounts)
Gross Profit/Margin

Worldwide Gross profit increased 7% to $10,017 in 2020 from $9,325 in 2019. Gross profit in both periods included acquisition-related costs. Gross profit in 2019 included charges resulting from the Global Growth and Efficiency Program. Excluding these items in both periods, as applicable, Gross profit increased to $10,021 in 2020 from $9,336 in 2019, reflecting an increase of $472 resulting from higher Net sales and an increase of $213 resulting from higher Gross profit margin.

Worldwide Gross profit margin increased to 60.8% in 2020 from 59.4% in 2019. Excluding the items described above in both periods, as applicable, Gross profit margin increased by 130 basis points (bps) to 60.8% in 2020, from 59.5% in 2019. This increase in Gross profit margin was primarily due to cost savings from the Company’s funding-the-growth initiatives (230 bps) and higher pricing (130 bps), partially offset by higher raw and packaging material costs (230 bps), which included foreign exchange transaction costs.

20202019
Gross profit, GAAP$10,017 $9,325 
Global Growth and Efficiency Program— 
Acquisition-related costs
Gross profit, non-GAAP$10,021 $9,336 

20202019Basis Point Change
Gross profit margin, GAAP60.8 %59.4 %140 
Global Growth and Efficiency Program— 0.1 
Acquisition-related costs— — 
Gross profit margin, non-GAAP60.8 %59.5 %130 

31

(Dollars in Millions Except Per Share Amounts)
Selling, General and Administrative Expenses

Selling, general and administrative expenses increased 8% to $6,019 in 2020 from $5,575 in 2019. Selling, general and administrative expenses in 2020 included benefits resulting from the Global Growth and Efficiency Program. Selling, general and administrative expenses in 2019 included charges resulting from the Global Growth and Efficiency Program. Excluding these items in both periods, as applicable, Selling, general and administrative expenses increased to $6,022 in 2020 from $5,515 in 2019, reflecting increased advertising investment of $254 and higher overhead expenses of $253.

Selling, general and administrative expenses as a percentage of Net sales increased to 36.5% in 2020 from 35.5% in 2019. Excluding the items described above in both periods, as applicable, Selling, general and administrative expenses as a percentage of Net sales increased by 150 bps to 36.6% in 2020 as compared to 35.1% in 2019. This increase in 2020 was due to increased advertising investment (110 bps) and higher overhead expenses (40 bps), primarily driven by higher logistics costs, both as a percentage of Net sales. In 2020, advertising investment increased as a percentage of Net sales to 11.9% from 10.8% in 2019 or 15.0% in absolute terms to $1,948 as compared with $1,694 in 2019.


20202019
Selling, general and administrative expenses, GAAP$6,019 $5,575 
Global Growth and Efficiency Program(60)
Selling, general and administrative expenses, non-GAAP$6,022 $5,515 

20202019Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP36.5 %35.5 %100 
Global Growth and Efficiency Program0.1 (0.4)
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP36.6 %35.1 %150 


32

(Dollars in Millions Except Per Share Amounts)
Other (Income) Expense, Net

Other (income) expense, net was $113 and $196 in 2020 and 2019, respectively. Other (income) expense, net in 2020 included benefits resulting from the Global Growth and Efficiency Program. Other (income) expense, net in both periods included acquisition-related costs. Other (income) expense, net in 2019 included charges resulting from the Global Growth and Efficiency Program and a benefit related to a value-added tax matter in Brazil.
20202019
Other (income) expense, net, GAAP$113 $196 
Global Growth and Efficiency Program13 (57)
Acquisition-related costs (2)(21)
Value-added tax matter in Brazil— 30 
Other (income) expense, net, non-GAAP$124 $148 

Excluding the items described above in both periods, as applicable, Other (income) expense, net was $124 in 2020 and $148 in 2019, comprised of the following:

20202019
Amortization of intangible assets$88 $62 
Equity income(12)(9)
Write-off of certain investments and fixed assets— 51 
Charges for a change in go-to-market strategy in certain countries— 15 
Other, net48 29 
Total Other (income) expense, net$124 $148 





33

(Dollars in Millions Except Per Share Amounts)
Operating Profit

Operating profit increased 9% to $3,885 in 2020 from $3,554 in 2019. In 2020, Operating profit included benefits resulting from the Global Growth and Efficiency Program and acquisition-related costs. In 2019, Operating profit included charges resulting from the Global Growth and Efficiency Program, acquisition-related costs and a benefit related to a value-added tax matter in Brazil. Excluding these items in both periods, as applicable, Operating profit in 2020 increased 5% due to an increase in Gross profit and decrease in Other (income) expense, largely offset by an increase in Selling, general and administrative expenses.

    Operating profit margin was 23.6% in 2020, an increase of 100 bps compared with 22.6% in 2019. Excluding the items described above in both periods, as applicable, Operating profit margin was 23.5% in 2020, an increase of 10 bps from 23.4% in 2019. This increase in Operating profit in 2020 was due to an increase in Gross profit (130 bps) and a decrease in Other (income) expense, net (30 bps), largely offset by an increase in Selling, general and administrative expenses (150 bps), all as a percentage of Net sales.
20202019% Change
Operating profit, GAAP$3,885 $3,554 %
Global Growth and Efficiency Program(16)125 
Acquisition-related costs 24 
Value-added tax matter in Brazil— (30)
Operating profit, non-GAAP$3,875 $3,673 %

20202019Basis Point Change
Operating profit margin, GAAP23.6 %22.6 %100 
Global Growth and Efficiency Program(0.1)0.8 
Acquisition-related costs — 0.2 
Value-added tax matter in Brazil— (0.2)
Operating profit margin, non-GAAP23.5 %23.4 %10 

Non-Service Related Postretirement Costs

Non-service related postretirement costs were $74 in 2020 compared to $108 in 2019. Non-service related postretirement costs in 2019 included charges resulting from the Global Growth and Efficiency Program. Excluding these charges, Non-service related postretirement costs were $74 in 2020 compared to $101 in 2019. The decrease in Non-service related postretirement costs in 2020 as compared to 2019 was primarily due to lower interest cost and higher expected return on plan assets.
20202019
Non-service related postretirement costs, GAAP$74 $108 
Global Growth and Efficiency Program— (7)
Non-service related postretirement costs, non-GAAP$74 $101 











34

(Dollars in Millions Except Per Share Amounts)
Interest (Income) Expense, Net

Interest (income) expense, net was $164 in 2020 compared with $145 in 2019. The increase in Interest (income) expense, net in 2020 as compared to 2019 was primarily due to a loss on the early extinguishment of debt in 2020 of $23, representing the difference between the redemption price and the carrying amount of the debt extinguished. Excluding the loss on the early extinguishment of debt, Interest (income) expense, net was $141 in 2020 compared to $145 in 2019.


20202019
Interest (income) expense, GAAP$164 $145 
Loss on early extinguishment of debt(23)— 
Interest (income) expense, non-GAAP$141 $145 

35

(Dollars in Millions Except Per Share Amounts)
Income Taxes

The effective income tax rate was 21.6% in 2020 and 23.4% in 2019. As reflected in the table below, the non-GAAP effective income tax rate was 23.6% in 2020 and 24.1% in 2019.
2020
Income Before Income Taxes
Provision For Income Taxes(1)
Effective Income Tax Rate(2)
As Reported GAAP$3,647 $787 21.6 %
Global Growth and Efficiency Program(16)(3)— 
Subsidiary and operating structure initiatives— 71 2.0 
Acquisition-related costs— 
Loss on early extinguishment of debt23 — 
Non-GAAP$3,660 $862 23.6 %

2019
Income Before Income Taxes
Provision For Income Taxes(1)
Effective Income Tax Rate(2)
As Reported GAAP$3,301 $774 23.4 %
Global Growth and Efficiency Program132 30 — 
Acquisition-related costs24 — 
Value-added tax matter in Brazil (30)(10)(0.1)
Swiss income tax reform— 29 0.8 %
Non-GAAP$3,427 $827 24.1 %
_______
(1)     The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2)     The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

The provision for income taxes for 2020 includes $71 of income tax benefits, of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As described more fully below, both items were previously recorded in connection with the charge recorded by the Company in 2017 and revised in 2018 related to the TCJA.

As part of the previously recorded charge for the TCJA, the Company had provided for foreign withholding taxes expected to be paid on the remittance of earnings from certain overseas subsidiaries no longer deemed indefinitely reinvested. As a result of a reorganization of the ownership structure of certain foreign subsidiaries, the Company determined that no withholding taxes will be due on the remittance by certain subsidiaries of earnings previously deemed reinvested and, accordingly, reversed $45 of previously recorded foreign withholding taxes in the first quarter of 2020.

Also as part of the previously recorded charge for the TCJA, the Company provided a valuation allowance against a deferred tax asset related to foreign tax credit carry-forwards that the Company did not expect to be able to use due to changes made by the TCJA. As a result of a new operating structure implemented within one of the Company’s divisions, the Company believes the use of these foreign tax credit carry-forwards will not be limited in the future and, accordingly, reversed the previously recorded valuation allowance of $26 in the first quarter of 2020.

The effective income tax rate in all years benefited from tax planning associated with the Company’s global business initiatives.

36

(Dollars in Millions Except Per Share Amounts)
Net income attributable to Colgate-Palmolive Company and Earnings per share

Net income attributable to Colgate-Palmolive Company was $2,695, or $3.14 per share on a diluted basis, in 2020 compared to $2,367, or $2.75 per share on a diluted basis, in 2019. In 2020, Net income attributable to Colgate-Palmolive Company included aftertax benefits resulting from the Global Growth and Efficiency Program, aftertax acquisition-related costs, a tax benefit related to subsidiary and operating structure initiatives and an aftertax loss on the early extinguishment of debt. In 2019, Net income attributable to Colgate-Palmolive Company included aftertax charges resulting from the Global Growth and Efficiency Program, aftertax acquisition-related costs, an aftertax benefit related to a value-added tax matter in Brazil and a tax benefit related to Swiss income tax reform.

Excluding the items described above in both periods, as applicable, Net income attributable to Colgate-Palmolive Company increased 8% to $2,633 in 2020 from $2,440 in 2019, and Earnings per common share on a diluted basis increased 8% to $3.06 in 2020 from $2.83 in 2019.
2020
Income Before Income Taxes
Provision For Income Taxes(1)
Net Income Including Noncontrolling InterestsLess: Income Attributable To Noncontrolling InterestsNet Income Attributable to Colgate-Palmolive Company
Diluted Earnings Per Share(2)
As Reported GAAP$3,647 $787 $2,860 $165 $2,695 $3.14 
Global Growth and Efficiency Program(16)(3)(13)— (13)(0.02)
Subsidiary and operating structure initiatives— 71 (71)— (71)(0.08)
Acquisition-related costs— — 
Loss on early extinguishment of debt23 18 — 18 0.02 
Non-GAAP$3,660 $862 $2,798 $165 $2,633 $3.06 

2019
Income Before Income Taxes
Provision For Income Taxes(1)
Net Income Including Noncontrolling InterestsLess: Income Attributable To Noncontrolling InterestsNet Income Attributable to Colgate-Palmolive Company
Diluted Earnings Per Share(2)
As Reported GAAP$3,301 $774 $2,527 $160 $2,367 $2.75 
Global Growth and Efficiency Program132 30 102 — 102 0.12 
Acquisition-related costs24 20 — 20 0.02 
Value-added tax matter in Brazil(30)(10)(20)— (20)(0.02)
Swiss income tax reform— 29 (29)— (29)(0.04)
Non-GAAP$3,427 $827 $2,600 $160 $2,440 $2.83 
_______
(1)     The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2)     The impact of non-GAAP adjustments on diluted earnings per share may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.
37

(Dollars in Millions Except Per Share Amounts)
Segment Results

The Company markets its products in over 200 countries and territories throughout the world in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of the operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes.

Oral, Personal and Home Care

    North America
 20202019% Change
Net sales$3,741 $3,424 9.5 %
Operating profit$988 $982 %
% of Net sales26.4 %28.7 %(230)bps

Net sales in North America increased 9.5% in 2020 to $3,741, driven by volume growth of 8.0% and net selling price increases of 1.5%, while foreign exchange was flat. The Company’s acquisition of hello contributed 1.5% to volume in North America. Organic sales in North America increased 8.0% in 2020. Organic sales growth was led by the United States.

The increase in organic sales in North America in 2020 versus 2019 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste category. The increase in Personal Care was primarily due to organic sales growth in the liquid hand soap category partially offset by a decline in organic sales in the underarm protection category. The increase in Home Care was primarily due to organic sales growth in the hand dish and liquid cleaner categories.

Operating profit in North America increased 1% in 2020 to $988, but decreased as a percentage of Net sales by 230 bps to 26.4%. This decrease in Operating profit as a percentage of Net sales was primarily due to an increase in Selling, general and administrative expenses (270 bps), partially offset by an increase in Gross profit (80 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (190 bps), partially offset by higher raw and packaging material costs (100 bps). This increase in Selling, general and administrative expenses was due to increased advertising investment (180 bps) and higher overhead expenses (90 bps), primarily driven by higher logistics costs.





    
38

(Dollars in Millions Except Per Share Amounts)
    Latin America
 20202019% Change
Net sales$3,418 $3,606 (5.0)%
Operating profit$975 $963 %
% of Net sales28.5 %26.7 %180 bps

Net sales in Latin America decreased 5.0% in 2020 to $3,418, as volume growth of 0.5% and net selling price increases of 8.5% were more than offset by negative foreign exchange of 14.0%. Organic sales in Latin America increased 9.0% in 2020. Organic sales growth was led by Brazil, Argentina, Mexico and Colombia.
The increase in organic sales in Latin America in 2020 versus 2019 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste and manual toothbrush categories. The increase in Personal Care was primarily due to organic sales growth in the bar soap and liquid hand soap categories. The increase in Home Care was primarily due to organic sales growth in the hand dish and liquid cleaner categories.

Operating profit in Latin America increased 1% in 2020 to $975, or 180 bps to 28.5% of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (140 bps) and a decrease in Selling, general and administrative expenses (20 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (330 bps) and higher pricing, which were partially offset by higher raw and packaging material costs (530 bps), which included foreign exchange transaction costs. This decrease in Selling, general and administrative expenses was due to decreased advertising investment (40 bps), partially offset by higher overhead expenses (20 bps).




39

(Dollars in Millions Except Per Share Amounts)
    Europe
 20202019% Change
Net sales$2,747 $2,450 12.0 %
Operating profit$652 $624 %
% of Net sales23.7 %25.5 %(180)bps

Net sales in Europe increased 12.0% in 2020 to $2,747, as volume growth of 11.0% and positive foreign exchange of 1.5% were partially offset by net selling price decreases of 0.5%. The Company’s acquisition of the Filorga skin health business contributed 7.5% to volume in Europe. Organic sales in Europe increased 3.0% in 2020. Organic sales growth was led by Poland, the Netherlands, France and Germany.

The increase in organic sales in Europe in 2020 versus 2019 was primarily due to an increase in Personal Care and Home Care organic sales. The increase in Personal Care was primarily due to organic sales growth in the liquid hand soap and body wash categories, partially offset by a decline in organic sales in the underarm protection category. The increase in Home Care was primarily due to organic sales growth in the bleach, hand dish, spray cleaner and fabric softener categories.

Operating profit in Europe increased 4% in 2020 to $652, while as a percentage of Net sales it decreased 180 bps to 23.7%. This decrease in Operating profit as a percentage of Net sales was due to increases in Selling, general and administrative expenses (230 bps) and Other (income) expense, net (80 bps), partially offset by an increase in Gross profit (130 bps), all as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (190 bps) and mix (80 bps), primarily due to the Company’s acquisition of Filorga, partially offset by higher raw and packaging material costs (90 bps). This increase in Selling, general and administrative expenses was due to higher overhead expenses (120 bps) and increased advertising investment (110 bps). This increase in Other (income) expense, net was primarily due to amortization expense related to the Filorga acquisition.


40

(Dollars in Millions Except Per Share Amounts)
    Asia Pacific
 20202019% Change
Net sales$2,701 $2,707 (0.5)%
Operating profit$773 $749 %
% of Net sales28.6 %27.7 %90 bps

Net sales in Asia Pacific decreased 0.5% in 2020 to $2,701, as volume declines of 1.5% and negative foreign exchange of 1.0% were partially offset by net selling price increases of 2.0%. Organic sales in Asia Pacific increased 0.5% in 2020. Organic sales growth was led by Australia, New Zealand and the Philippines, partially offset by organic sales declines in Thailand and China.
The increase in organic sales in 2020 versus 2019 was due to increases in Personal Care and Home Care organic sales, partially offset by a decline in Oral Care organic sales. The decrease in Oral Care was driven by a decline in organic sales in the manual toothbrush category, partially offset by organic sales growth in the mouthwash category. The increase in Personal Care was driven by organic sales growth in the liquid hand soap and body wash categories. The increase in Home Care was driven by organic sales growth in the hand dish, spray cleaner and cleaning wipes categories.

Operating profit in Asia Pacific increased 3% in 2020 to $773, or 90 bps to 28.6% of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (150 bps), partially offset by an increase in Selling, general and administrative expenses (50 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (240 bps) and higher pricing, partially offset by higher raw and packaging material costs (150 bps). This increase in Selling, general and administrative expenses was due to higher overhead expenses (40 bps) and increased advertising investment (10 bps).


    
41

(Dollars in Millions Except Per Share Amounts)
    Africa/Eurasia
 20202019% Change
Net sales$981 $981 — %
Operating profit$206 $187 10 %
% of Net sales21.0 %19.1 %190 bps

Net sales in Africa/Eurasia were $981 in 2020, even with 2019, as volume growth of 5.0% and net selling price increases of 3.5% were offset by negative foreign exchange of 8.5%. The Company’s acquisition of a 51% controlling interest in Colgate Toloram Pte. Ltd., a joint venture which owns the Nigeria-based Hypo Homecare Products Limited (the “Nigeria Joint Venture”), contributed 1.0% to volume in Africa/Eurasia. Organic sales in Africa/Eurasia increased 7.5% in 2020. Organic sales growth was led by Turkey, Russia and South Africa.
The increase in organic sales in 2020 versus 2019 was primarily due to increases in Oral Care and Personal Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste and manual toothbrush categories. The increase in Personal Care was primarily due to organic sales growth in the bar soap, body wash and liquid hand soap categories.
Operating profit in Africa/Eurasia increased 10% in 2020 to $206, or 190 bps to 21.0% of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross Profit (100 bps) and a decrease in Selling, general and administrative expenses (60 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (270 bps) and higher pricing, partially offset by higher raw and packaging material costs (330 bps), which included foreign exchange transaction costs. This decrease in Selling, general and administrative expenses was due to decreased advertising investment (40 bps) and lower overhead expenses (20 bps).

42

(Dollars in Millions Except Per Share Amounts)
    Hills Pet Nutrition
 20202019% Change
Net sales$2,883 $2,525 14.0 %
Operating profit$793 $703 13 %
% of Net sales27.5 %27.8 %(30)bps

Net sales for Hill’s Pet Nutrition increased 14.0% in 2020 to $2,883, as volume growth of 10.5% and net selling price increases of 4.0% were partially offset by negative foreign exchange of 0.5%. Organic sales in Hill’s Pet Nutrition increased 14.5% in 2020. Organic sales growth was led by the United States and Europe.

The increase in organic sales in 2020 versus 2019 was due to organic sales growth in the Science Diet and Prescription Diet categories.

Operating profit in Hill’s Pet Nutrition increased 13% in 2020 to $793, while as a percentage of Net sales it decreased 30 bps to 27.5%. This decrease in Operating profit as a percentage of Net sales was due to an increase in Selling, general and administrative expenses (90 bps) and an increase in Other (income) expense, net (30 bps), partially offset by an increase in Gross profit (90 bps), all as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (140 bps) and higher pricing, partially offset by higher raw and packaging material costs (170 bps). This increase in Selling, general and administrative expenses was due to increased advertising investment (270 bps), partially offset by lower overhead expenses (180 bps). This increase in Other (income) expense, net was primarily due to costs incurred in connection with the voluntary recall for which Hill's was not indemnified.

During the quarter ended March 31, 2019, Hill’s announced a voluntary recall, which was subsequently expanded, of select canned dog food products due to potentially elevated levels of Vitamin D resulting from a supplier error. In the United States, the voluntary recall was conducted in cooperation with the U.S. Food and Drug Administration. Following the announcement of the voluntary recall, and as of December 31, 2020, Hill’s and/or the Company have been named as defendants in 37 putative class action lawsuits, one putative class action filed on behalf of a European Union class and one individual action, all related to the voluntary recall and filed in various jurisdictions in the United States. In addition, two putative class actions related to the voluntary recall have been filed in Canada. Eight of the putative class actions lawsuits in the United States and one of the putative class action lawsuits in Canada have been voluntarily dismissed. During the quarter ended December 31, 2020, the parties to the putative class action lawsuits in the United States (other than the class action filed on behalf of a European Union class) entered into a settlement agreement, which was preliminarily approved by the court in February 2021. The amount of the settlement is not material to the Company’s results of operations for the year ended December 31, 2020. Hill’s is indemnified by the supplier related to the voluntary recall. Sales of products voluntarily recalled represent less than 2% of Hill’s annual Net sales. The sales loss and other costs associated with the voluntary recall and its subsequent expansion did not have a material impact on the Company’s Net sales or Operating profit for the year ended December 31, 2020 and are not expected to have a material impact in future periods.

43

(Dollars in Millions Except Per Share Amounts)
    Corporate
 20202019% Change
Operating profit (loss)$(502)$(654)(23)%

Corporate operations include Corporate overhead costs, research and development costs, stock-based compensation expense related to stock options and restricted stock unit awards, restructuring and related implementation costs and gains and losses on sales of non-core product lines. The components of Operating profit (loss) for the Corporate segment are presented as follows:
20202019
Global Growth and Efficiency Program$16 $(125)
Acquisition-related costs(6)(24)
Value-added tax matter in Brazil— 30 
Corporate overhead costs and other, net(512)(535)
Total Corporate Operating profit (loss)$(502)$(654)




44

(Dollars in Millions Except Per Share Amounts)
Restructuring and Related Implementation Charges

Global Growth and Efficiency Program

The Company’s restructuring program (the “Global Growth and Efficiency Program”), which commenced in the fourth quarter of 2012, concluded on December 31, 2019. Initiatives under the Global Growth and Efficiency Program fit within the program’s three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions and optimizing the global supply chain and facilities. Substantially all initiatives under the Global Growth and Efficiency Program had been implemented as of December 31, 2019.

In the third quarter of 2020, the Company adjusted the accrual balances related to certain projects approved prior to the conclusion of the Global Growth and Efficiency Program to reflect its revised estimate of remaining liabilities. This adjustment resulted in a reduction of $16 ($13 aftertax), of which $3 was recorded in Selling, general and administrative expenses and $13 was recorded in Other (income) expense, net. During the year ended December 31, 2020, the Company also made cash payments of $53 related to projects approved prior to the conclusion of the Global Growth and Efficiency Program, and the remaining accrual balance at December 31, 2020 was $31. No new restructuring projects were approved for implementation during the year ended December 31, 2020.

For the year ended December 31, 2019, restructuring and related implementation charges are reflected in the Consolidated Statements of Income as follows:
2019
Cost of sales$
Selling, general and administrative expenses60 
Other (income) expense, net57 
Non-service related postretirement costs
Total Global Growth and Efficiency Program charges, pretax$132 
Total Global Growth and Efficiency Program charges, aftertax$102 

Restructuring and related implementation charges and the adjustment recorded in the third quarter of 2020 were recorded in the Corporate segment as these initiatives were predominantly centrally directed and controlled and were not included in internal measures of segment operating performance. See Note 4, Restructuring and Related Implementation Charges to the Consolidated Financial Statements for additional information.


45

(Dollars in Millions Except Per Share Amounts)
Non-GAAP Financial Measures

This Annual Report on Form 10-K discusses certain financial measures on both a GAAP and a non-GAAP basis. The Company uses the non-GAAP financial measures described below internally in its budgeting process, to evaluate segment and overall operating performance and as a factor in determining compensation. The Company believes that these non-GAAP financial measures are useful in evaluating the Company’s underlying business performance and trends; however, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.

Net sales growth (GAAP) and organic sales growth (Net sales growth excluding the impact of foreign exchange, acquisitions and divestments) (non-GAAP) are discussed in this Annual Report on Form 10-K. Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding, the external factor of foreign exchange, as well as the impact of acquisitions and divestments, as applicable. A reconciliation of organic sales growth to Net sales growth for the years ended December 31, 2020 and 2019 is provided below.

Worldwide Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Interest (income) expense, net, effective income tax rate, Net income attributable to Colgate-Palmolive Company and Earnings per share on a diluted basis are discussed in this Annual Report on Form 10-K both on a GAAP basis and excluding, as applicable, the benefits and charges resulting from the Global Growth and Efficiency Program, the charge related to U.S. tax reform, acquisition-related costs, the benefits related to a value-added tax matter in Brazil and Swiss income tax reform, a benefit related to a reorganization of the ownership structure of certain foreign subsidiaries and a new operating structure implemented within one of the Company’s divisions and the loss on early extinguishment of debt prior to maturity. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, gains and losses from certain acquisitions, divestitures and certain unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. A reconciliation of each of these non-GAAP financial measures to the most directly comparable GAAP financial measures for the years ended December 31, 2020 and 2019 is presented within the applicable section of Results of Operations.

46

(Dollars in Millions Except Per Share Amounts)
The following tables provide a quantitative reconciliation of Net sales growth to organic sales growth for the years ended December 31, 2020 and 2019 versus the prior year:
Year ended December 31, 2020Net Sales Growth
(GAAP)
Foreign
Exchange
Impact
Acquisitions and Divestments
Impact
Organic
Sales Growth
(Non-GAAP)
Oral, Personal and Home Care    
North America9.5%—%1.5%8.0%
Latin America(5.0)%(14.0)%—%9.0%
Europe12.0%1.5%7.5%3.0%
Asia Pacific(0.5)%(1.0)%—%0.5%
Africa/Eurasia—%(8.5)%1.0%7.5%
Total Oral, Personal and Home Care3.0%(5.0)%2.0%6.0%
Pet Nutrition14.0%(0.5)%—%14.5%
Total Company5.0%(3.5)%1.5%7.0%

Year ended December 31, 2019Net Sales Growth
(GAAP)
Foreign
Exchange
Impact
Acquisitions and Divestments
Impact
Organic
Sales Growth
(Non-GAAP)
Oral, Personal and Home Care    
North America2.0%(0.5)%—%2.5%
Latin America—%(7.0)%—%7.0%
Europe(2.0)%(5.5)%3.0%0.5%
Asia Pacific(1.0)%(2.5)%—%1.5%
Africa/Eurasia1.5%(6.0)%0.5%7.0%
Total Oral, Personal and Home Care—%(4.0)%0.5%3.5%
Pet Nutrition6.0%(1.5)%—%7.5%
Total Company1.0%(3.5)%0.5%4.0%

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this Annual Report on Form 10-K are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).
Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce or certain discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors we use to provide data are reliable, but we have not verified the accuracy or completeness of the data or any assumptions underlying the data. In certain limited circumstances, the COVID-19 pandemic has impacted the ability of our third-party vendors to provide the Company with reliable updated market share data. In addition, market share information calculated by the Company may be different from market share information calculated by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

47

(Dollars in Millions Except Per Share Amounts)
Liquidity and Capital Resources

The Company expects cash flow from operations and debt issuances will be sufficient to meet foreseeable business operating and recurring cash needs (including for debt service, dividends, capital expenditures, share repurchases and acquisitions). The Company believes its strong cash generation and financial position should continue to allow it broad access to global credit and capital markets.

Cash Flow

Net cash provided by operations increased to $3,719 in 2020 as compared to $3,133 in 2019, primarily due to changes in working capital, higher net income and lower voluntary contributions to the Company’s pension plans, which were partially offset by higher income tax payments. The Company’s working capital as a percentage of Net sales was (4.4)% in 2020 and (1.6)% in 2019. This change in working capital as a percentage of Net sales is primarily due to higher accrued liabilities, higher accounts payable and higher accrued income taxes, partially offset by an increase in inventory. The Company defines working capital as the difference between current assets (excluding Cash and cash equivalents and marketable securities, the latter of which is reported in Other current assets) and current liabilities (excluding short-term debt). 

Investing activities used $779 of cash in 2020 compared to $2,099 during 2019. As more fully described below, investing activities in 2020 include the Company’s acquisition of hello. Investing activities in 2019 include the Company’s acquisition of Filorga and the Nigeria Joint Venture. Purchases of marketable securities and investments decreased in 2020 to $143 from $184 in 2019. Proceeds from the sale of marketable securities and investments decreased in 2020 to $124 from $131 in 2019.

Capital expenditures in the year ended December 31, 2020 were $410, an increase from $335 in 2019. Capital expenditures increased in 2020 primarily due to capacity expansion of manufacturing facilities and sustainability projects. Capital expenditures for 2021 are expected to be approximately 3.0% to 3.5% of Net sales. The Company continues to focus its capital spending on projects that are expected to yield high aftertax returns.

On January 31, 2020, the Company acquired hello for cash consideration of $351 as part of the Company’s continued strategy to focus on the high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses. On September 19, 2019, the Company acquired Filorga for cash consideration of €1,516 (approximately $1,674) plus additional consideration of €32 (approximately $38), the majority of which related to repayment of loans from former shareholders of Filorga. In July 2020, the Company completed the purchase of the outstanding non-controlling interest of Filorga’s joint venture based in Hong Kong and covering the Hong Kong and China markets for approximately €85 (approximately $99) in cash. On August 15, 2019, the Company acquired a 51% controlling interest in the Nigeria Joint Venture for $31.

These acquisitions were financed with a combination of debt and cash. As a result of the incremental debt related to these acquisitions, in accordance with the Company’s previously announced intention to moderate share repurchases, net of proceeds from the exercise of stock options, the Company continued to moderate its share repurchases, net in 2020. In addition, due to the initial uncertainties resulting from the COVID-19 pandemic and our intent to preserve cash, the Company discontinued all share repurchases other than those pursuant to equity plans during the second quarter of 2020. The Company resumed its moderated share repurchases, net in the third quarter of 2020. We expect share repurchases, net to return to historical levels in 2021.

Financing activities used $2,919 of cash during 2020 compared to $870 during 2019. The increase in cash used was primarily due to net payments on debt in 2020 as compared to net proceeds from the issuance of debt in 2019.

Long-term debt, including the current portion, decreased to $7,343 as of December 31, 2020, as compared to $7,587 as of December 31, 2019, and total debt decreased to $7,601 as of December 31, 2020 as compared to $7,847 as of December 31, 2019. The Company’s debt issuances and redemptions support the Company’s capital structure objectives of funding its business and growth initiatives while minimizing its risk-adjusted cost of capital.

48

(Dollars in Millions Except Per Share Amounts)
During the fourth quarter of 2020, the Company redeemed prior to maturity all of its outstanding 2.450% notes due 2021 with a principal amount of $300, originally issued on November 8, 2011, and all of its outstanding 2.300% notes due 2022 with a principal amount of $500, originally issued on May 3, 2012. These redemptions were financed with commercial paper borrowings and cash. The Company recorded a loss on this early extinguishment of debt of $23, which is included in Interest (income) expense, net in the Consolidated Statements of Income, representing the difference between the redemption price and the carrying amount of the debt extinguished.

During the first quarter of 2019, the Company issued €500 of seven-year notes at a fixed coupon rate of 0.500% and €500 of fifteen-year notes at a fixed coupon rate of 1.375%. During the fourth quarter of 2019, the Company issued €500 of two-year notes at a fixed coupon rate of 0.000% and €500 of twenty-year notes at a fixed coupon rate of 0.875%. The debt issuances were under the Company’s shelf registration statement. Proceeds from the debt issuances were used for general corporate purposes, which included the retirement of commercial paper and, in the case of the debt issuances in the first quarter of 2019, the repayment of the Company’s $500 1.750% fixed rate notes, which became due in March 2019, and €500 floating rate notes, which became due in May 2019.

At December 31, 2020, the Company had access to unused domestic and foreign lines of credit of $4,657 (including under the facilities discussed below) and could also issue long-term debt pursuant to an effective shelf registration statement. In November 2018, the Company entered into an amended and restated $2,650 revolving credit facility with a syndicate of banks that was scheduled to expire in November 2023. In August 2019, the term of the facility was extended by one year and it now expires in November 2024. In August 2020, the Company entered into a $1,500 364-day credit facility with a syndicate of banks that is scheduled to expire in August 2021. Commitment fees related to the credit facilities are not material.

Domestic and foreign commercial paper outstanding was $1,389 and $829 as of December 31, 2020 and December 31, 2019, respectively. The average daily balances outstanding of commercial paper in 2020 and 2019 were $1,050 and $1,868, respectively. The Company classifies commercial paper and certain current maturities of notes payable as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis, including, if necessary, by utilizing its available lines of credit (under the facilities discussed above).

The following is a summary of the Company’s commercial paper and global short-term borrowings as of December 31, 2020 and 2019:
 20202019
 Weighted Average Interest RateMaturitiesOutstandingWeighted Average 
Interest Rate
MaturitiesOutstanding
Global short-term borrowings4.8 %2021$1.8 %2020$10 
Commercial Paper (1)
(0.3)%20211,389 (0.4)%2020829 
Total$1,397 $839 
(1) Commercial paper includes a current portion of $250, included in Notes and loans payable, as of December 31, 2020 and 2019.
Certain of the agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote. Refer to Note 6, Long-Term Debt and Credit Facilities to the Consolidated Financial Statements for further information about the Company’s long-term debt and credit facilities.

Dividend payments in 2020 were $1,654, an increase from $1,614 in 2019. Dividend payments increased to $1.75 per share in 2020 from $1.71 per share in 2019. In the first quarter of 2020, the Company increased the quarterly common stock dividend to $0.44 per share from $0.43 per share, effective in the second quarter of 2020.




49

(Dollars in Millions Except Per Share Amounts)
The Company repurchases shares of its common stock in the open market and in private transactions to maintain its targeted capital structure and to fulfill certain requirements of its compensation and benefit plans. On June 18, 2018, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5,000 under the 2018 Program. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

Aggregate share repurchases in 2020 consisted of approximately 18.2 million common shares under the 2018 Program and 0.4 million common shares to fulfill the requirements of compensation and benefit plans, for a total purchase price of $1,476. Aggregate repurchases in 2019 consisted of 16.0 million common shares under the 2018 Program, and 1.2 million common shares to fulfill the requirements of compensation and benefit plans, for a total purchase price of $1,202. Share repurchases net of proceeds from exercise of stock options were $602 and $704 in 2020 and 2019, respectively.

Cash and cash equivalents increased $5 during 2020 to $888 at December 31, 2020, compared to $883 at December 31, 2019. Cash and cash equivalents held by the Company’s foreign subsidiaries was $832 and $798, respectively, at December 31, 2020 and 2019.

The following represents the scheduled maturities of the Company’s contractual obligations as of December 31, 2020:

 Total20212022202320242025Thereafter
Long-term debt including current portion(1)
$6,204 $631 $413 $896 $498 $130 $3,636 
Net cash interest payments on long-term debt(2)
1,515 109 111 96 79 72 1,048 
Operating Leases715 157 133 89 58 46 232 
Purchase obligations(3)
715 396 188 118 
U.S. tax reform payments 220 10 25 46 62 77 — 
Total$9,369 $1,303 $870 $1,245 $705 $328 $4,918 
_______
(1)The Company classifies commercial paper and notes maturing within the next 12 months as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis. The amounts in this table exclude such obligations.
(2)Includes the net interest payments on fixed and variable rate debt and associated interest rate swaps. Interest payments associated with floating rate instruments are based on management’s best estimate of projected interest rates for the remaining term of variable rate debt.
(3)The Company had outstanding contractual obligations with suppliers at the end of 2020 for the purchase of raw, packaging and other materials and services in the normal course of business. These purchase obligation amounts represent only those items which are based on agreements that are legally binding and that specify all significant terms including minimum quantity, price and term and do not represent total anticipated purchases.

Long-term liabilities associated with the Company’s postretirement plans are excluded from the table above due to the uncertainty of the timing of these cash disbursements. The amount and timing of cash funding related to these benefit plans will generally depend on local regulatory requirements, various economic assumptions (the most significant of which are detailed in “Critical Accounting Policies and Use of Estimates” below) and voluntary Company contributions. Based on current information, the Company is not required to make a mandatory contribution to its qualified U.S. pension plan in 2021. The Company does not expect to make any voluntary contributions to its U.S. postretirement plans in 2021. In addition, total benefit payments to be paid to participants for the year ending December 31, 2021 from the Company’s assets are estimated to be approximately $90.

Additionally, liabilities for unrecognized income tax benefits are excluded from the table above as the Company is unable to reasonably predict the ultimate amount or timing of a settlement of such liabilities. See Note 11, Income Taxes to the Consolidated Financial Statements for more information.

As more fully described in Part I, Item 3 Legal Proceedings and Note 13, Commitments and Contingencies to the Consolidated Financial Statements, the Company has commitments and contingencies with respect to lawsuits, environmental matters, taxes and other matters arising in the ordinary course of business.
50

(Dollars in Millions Except Per Share Amounts)
Off-Balance Sheet Arrangements

The Company does not have off-balance sheet financing or unconsolidated special purpose entities.

Managing Foreign Currency, Interest Rate, Commodity Price and Credit Risk Exposure

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies. The Company’s treasury and risk management policies prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose.

The sensitivity of our financial instruments to market fluctuations is discussed below. See Note 2, Summary of Significant Accounting Policies and Note 7, Fair Value Measurements and Financial Instruments to the Consolidated Financial Statements for further discussion of derivatives and hedging policies and fair value measurements.

Foreign Exchange Risk

As the Company markets its products in over 200 countries and territories, it is exposed to currency fluctuations related to manufacturing and selling its products in currencies other than the U.S. dollar. The Company manages its foreign currency exposures through a combination of cost-containment measures, sourcing strategies, selling price increases and the hedging of certain costs in an effort to minimize the impact on earnings of foreign currency rate movements. See “Results of Operations” above for a discussion of the foreign exchange impact on Net sales in each operating segment.

The assets and liabilities of foreign subsidiaries are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year.

The Company primarily utilizes foreign currency contracts, including forward and swap contracts, option contracts, foreign and local currency deposits and local currency borrowings to hedge portions of its exposures relating to foreign currency purchases, assets and liabilities created in the normal course of business and the net investment in certain foreign subsidiaries. The duration of foreign currency contracts generally does not exceed 12 months and the contracts are valued using observable market rates.

The Company’s foreign currency forward contracts that qualify for cash flow hedge accounting resulted in a net unrealized loss of $11 and $6 at December 31, 2020 and 2019, respectively. Changes in the fair value of cash flow hedges are recorded in Other comprehensive income (loss) and are reclassified into earnings in the same period or periods during which the underlying hedged transaction is recognized in earnings. At the end of 2020, an unfavorable 10% change in exchange rates would have resulted in a net unrealized loss of $96.

51

(Dollars in Millions Except Per Share Amounts)
Interest Rate Risk

The Company manages its mix of fixed and floating rate debt against its target with debt issuances and by entering into interest rate swaps in order to mitigate fluctuations in earnings and cash flows that may result from interest rate volatility. The Company utilizes forward-starting interest rate swaps to mitigate the risk of variability in interest rate for future debt issuances. The notional amount, interest payment and maturity date of the swaps generally match the principal, interest payment and maturity date of the related debt, and the swaps are valued using observable benchmark rates.

Based on year-end 2020 variable rate debt levels, a 1% increase in interest rates would have increased Interest (income) expense, net by $15 in 2020.

    The Company is assessing the impact of the discontinuation of LIBOR as a benchmark interest rate on its current financial instruments and contractual arrangements, including debt outstanding, and believes it will not be material as the Company does not have significant exposure to LIBOR in either its debt or other financing arrangements. The Company will continue to monitor its exposure in subsequent periods.

Commodity Price Risk

The Company is exposed to price volatility related to raw materials used in production, such as essential oils, resins, pulp, tropical oils, tallow, corn, poultry and soybeans. The Company manages its raw material exposures through a combination of cost containment measures, ongoing productivity initiatives and the limited use of commodity hedging contracts. Futures contracts are used on a limited basis, primarily in the Hills Pet Nutrition segment, to manage volatility related to anticipated raw material inventory purchases of certain traded commodities.

The Company’s open commodity derivative contracts that qualify for cash flow hedge accounting resulted in a net unrealized gain of $3 and $0 at December 31, 2020 and 2019, respectively. At the end of 2020, an unfavorable 10% change in commodity futures prices would have resulted in a net unrealized gain of $1.

Credit Risk

The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material as it is the Company’s policy to contract with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

Recent Accounting Pronouncements

In January 2021, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2021-1, “Reference Rate Reform (Topic 848): Scope.” This ASU clarifies that certain optional expedients and exceptions in Topic 848 apply to derivatives that are affected by the discounting transition. This guidance was effective upon issuance for the Company and is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In October 2020, the FASB issued ASU No. 2020-10, “Codification Improvements.” This ASU improves the consistency of the codification topics by including all disclosure guidance in the appropriate disclosure section and also clarifies the application of various provisions in the codification. This guidance was effective for the Company beginning on January 1, 2021 and is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (“GAAP”) to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This guidance was effective upon issuance of this ASU for contract modifications and hedging relationships on a prospective basis and is not expected to have a material impact on the Company’s Consolidated Financial Statements.

52

(Dollars in Millions Except Per Share Amounts)
In March 2020, the FASB issued ASU No. 2020-03, “Codification to Financial Instruments.” This ASU improves and clarifies various financial instruments topics, including the current expected credit losses (“CECL”) standard issued in 2016. The ASU addresses seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments related to Issue 1, Issue 2, Issue 4 and Issue 5 were effective upon issuance of this update. The amendments related to Issue 3, Issue 6 and Issue 7 were effective for the Company beginning on January 1, 2020. The guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)-Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This guidance was effective for the Company beginning on January 1, 2021. This guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In December 2019, the FASB issued ASU No. 2019-12, “Income taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This guidance was effective for the Company beginning on January 1, 2021. This guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In November 2019, the FASB issued ASU No. 2019-11, “Codification Improvements to Topic 326, Financial Instruments- Credit Losses.” This ASU clarifies and addresses certain items related to amendments in ASU 2016-13. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In April 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825).” This ASU clarifies three topics related to financial instruments accounting. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU No. 2017-04, “Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate implied fair value, essentially eliminating step two from the goodwill impairment test. The standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard was effective for the Company on a prospective basis beginning on January 1, 2020 and did not have an impact on the Company’s Consolidated Financial Statements.

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326).” This ASU introduces the current expected credit loss (CECL) model, which will require an entity to measure credit losses for certain financial instruments and financial assets, including trade receivables. Under this update, on initial recognition and at each reporting period, an entity will be required to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

53

(Dollars in Millions Except Per Share Amounts)
Critical Accounting Policies and Use of Estimates

The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. Actual results could ultimately differ from those estimates. The accounting policies that are most critical in the preparation of the Company’s Consolidated Financial Statements are those that are both important to the presentation of the Consolidated Financial Statements and require significant or complex judgments and estimates on the part of management. The Company’s critical accounting policies are reviewed periodically with the Audit Committee of the Board of Directors.

In certain instances, accounting principles generally accepted in the United States of America allow for the selection of alternative accounting methods. The Company’s significant policies that involve the selection of alternative methods are accounting for inventories and shipping and handling costs.

The Company accounts for inventories using both the first-in, first-out (FIFO) method (75% of inventories) and the last-in, first-out (LIFO) method (25% of inventories). There would have been no material impact on reported earnings for 2020 or 2019 had all inventories been accounted for under the FIFO method.

Shipping and handling costs may be reported as either a component of Cost of sales or Selling, general and administrative expenses. The Company accounts for such costs, primarily related to warehousing and outbound freight, as fulfillment costs and reports them in the Consolidated Statements of Income as a component of Selling, general and administrative expenses. Accordingly, the Company’s Gross profit margin is not comparable with the gross profit margin of those companies that include shipping and handling charges in cost of sales. If such costs had been included as a component of Cost of sales, the Company’s Gross profit margin would have been lower by 845 bps in 2020 and by 810 bps in both 2019 and 2018, with no impact on reported earnings.

    The areas of accounting that involve significant or complex judgments and estimates are pensions and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances, legal and other contingency reserves.

In accounting for pension and other postretirement benefit costs, the most significant actuarial assumptions are the discount rate and the expected long-term rate of return on plan assets. The discount rate used to measure the benefit obligation for U.S. defined benefit plans was 2.65% and 3.40% as of December 31, 2020 and 2019, respectively. The discount rate used to measure the benefit obligation for other U.S. postretirement plans was 2.88%, and 3.56% as of December 31, 2020 and 2019, respectively. Discount rates used for the U.S. and international defined benefit and other postretirement plans are based on a yield curve constructed from a portfolio of high-quality bonds whose projected cash flows approximate the projected benefit payments of the plans. The assumed expected long-term rate of return on plan assets for U.S. plans was 5.70% as of December 31, 2020 and 6.30% as of 2019. In determining the expected long-term rate of return, the Company considers the nature of the plans’ investments and the historical rate of return.

54

(Dollars in Millions Except Per Share Amounts)
Average annual rates of return for the U.S. plans for the most recent 1-year, 5-year, 10-year, 15-year and 25-year periods were 15%, 9%, 8%, 7% and 7%, respectively. In addition, the current assumed rate of return for the U.S. plans is based upon the nature of the plans’ investments with a target asset allocation of approximately 74% in fixed income securities, 21% in equity securities and 5% in real estate and other investments. A 1% change in the assumed rate of return on plan assets of the U.S. pension plans would impact future Net income attributable to Colgate-Palmolive Company by approximately $19. A 1% change in the discount rate for the U.S. pension plans would impact future Net income attributable to Colgate-Palmolive Company by approximately $3. A third assumption is the long-term rate of compensation increase, a change in which would partially offset the impact of a change in either the discount rate or the expected long-term rate of return. This rate was 3.50% as of December 31, 2020, and 2019. Refer to Note 10, Retirement Plans and Other Retiree Benefits to the Consolidated Financial Statements for further discussion of the Company’s pension and other postretirement plans.

The assumption requiring the most judgment in accounting for other postretirement benefits (other than the discount rate noted above) is the medical cost trend rate. The Company reviews external data and its own historical trends for health care costs to determine the medical cost trend rate. The assumed rate of increase for the U.S. postretirement benefit plans is 6.00% for 2021, declining to 4.75% by 2026 and remaining at 4.75% for the years thereafter. The effect on the total of service cost and interest costs components of a 1% increase in the assumed long-term medical cost trend rate would decrease Net income attributable to Colgate-Palmolive Company by $10.

The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units (both performance-based and time-vested), based on the fair value of those awards at the date of grant. The Company uses the Black-Scholes-Merton (Black-Scholes) option pricing model to estimate the fair value of stock option awards. The weighted-average estimated fair value of each stock option award granted in the year ended December 31, 2020 was $11.26. The Black-Scholes model uses various assumptions to estimate the fair value of stock option awards. These assumptions include the expected term of stock option awards, expected volatility rate, risk-free interest rate and expected dividend yield. While these assumptions do not require significant judgment, as the significant inputs are determined from historical experience or independent third-party sources, changes in these inputs could result in significant changes in the fair value of stock option awards. A one-year change in expected term would result in a change in fair value of approximately 4%. A 1% change in volatility would change fair value by approximately 6%. The Company uses a Monte-Carlo simulation to determine the fair value of performance-based restricted stock units at the date of grant. The Monte-Carlo simulation model uses substantially the same inputs as the Black-Scholes model.

Goodwill and indefinite-life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually or when events or changes in circumstances indicate an asset may be impaired. In assessing impairment, the Company performs either a quantitative or a qualitative analysis.

Determining the fair value of the Company’s reporting units for goodwill and the fair value of its intangible assets requires significant estimates and judgments by management. When a quantitative analysis is performed, the Company generally uses the income approach, which requires several estimates, including future cash flows consistent with management’s strategic plans, sales growth rates, foreign exchange rates and the selection of royalty rates and a discount rate. Estimating sales growth rates requires significant judgment by management in areas such as future economic conditions, category growth rates, product pricing, consumer tastes and preferences and future expansion expectations. In selecting an appropriate royalty rate, the Company considers recent market transactions for similar brands and products. In determining an appropriate discount rate, the Company considers the current interest rate environment and its estimated cost of capital. Other qualitative factors the Company considers, in addition to those quantitative measures discussed above, include assessments of general macroeconomic conditions, industry-specific considerations and historical financial performance. The Company generally engages a third-party valuation firm to assist it in determining the fair value of intangible assets acquired in business combinations.

55

(Dollars in Millions Except Per Share Amounts)
In determining the fair value of the Company’s reporting units, fair value is also determined using the market approach, which is generally derived from metrics of comparable publicly traded companies. As multiple valuation methodologies are used, the Company also performs a qualitative analysis comparing the fair value of a reporting unit under each method to assess its reasonableness and ensure consistency of results.

Determining the expected life of a brand requires management judgment and is based on an evaluation of several factors including market share, brand history, future expansion expectations, the level of in-market support anticipated by management, legal or regulatory restrictions and the economic environment in the countries in which the brand is sold.

As a result of the COVID-19 pandemic, in the first quarter of 2020, the Company assessed whether a “triggering event” had occurred indicating a possible impairment of its goodwill and indefinite-life intangible assets. As a result of this assessment, the Company determined that a “triggering event” had occurred relative to its recently acquired Filorga skin health business and, as required, performed a quantitative analysis, with the assistance of a third-party valuation firm, of the value of the Filorga reporting unit and its indefinite-life intangible assets. Based on the analysis, the Company determined that the fair value of the Filorga reporting unit and the related indefinite-life intangible assets continued to exceed their carrying values and were not impaired.

As of the date of the annual goodwill impairment test, the fair value of the Filorga reporting unit exceeded its carrying value by approximately 10%. Either a reduction in the long-term growth rate of 50 basis points or an increase in the discount rate of 25 basis points would result in the fair value of the Filorga reporting unit exceeding its carrying value by less than 5%. As of the date of the annual impairment test, the fair value of the Filorga indefinite-life intangible assets exceeded their carrying value by less than 10%. Either a reduction in the long-term growth rate of 50 basis points or an increase in the discount rate of 25 basis points would result in the fair value of the Filorga indefinite-life intangible assets approximating their carrying value. Given the inherent uncertainties in estimating the future impacts of the COVID-19 pandemic on global macroeconomic conditions and interest rates in general and on the Filorga business in particular, actual results may differ from management’s current estimates and could have an adverse impact on one or more of the assumptions used in our quantitative models related to the Filorga reporting unit and the related indefinite-life intangible assets, resulting in potential impairment charges in subsequent periods. Given the recent acquisition of Filorga, where there is inherently a lower surplus of fair value over carrying value, management will continue to assess triggering events that may necessitate additional qualitative or quantitative analyses of our reporting units and indefinite-life intangible assets in future periods.

Except for the recently acquired Filorga business, as described above, where there is inherently a lower surplus of fair value over carrying value, the estimated fair value of the Company’s reporting units substantially exceeds the recorded carrying value. The fair value of the Company’s indefinite-life intangible assets other than Filorga exceeds their recorded carrying value by at least 20%. Therefore, it is not reasonably likely that significant changes in these estimates would occur that would result in an impairment charge related to these assets.

The recognition and measurement of uncertain tax positions involves consideration of the amounts and probabilities of various outcomes that could be realized upon ultimate resolution.

Tax valuation allowances are established to reduce deferred tax assets, such as tax loss carryforwards, to net realizable value. Factors considered in estimating net realizable value include historical results by tax jurisdiction, carryforward periods, income tax strategies and forecasted taxable income.

Legal and other contingency reserves are based on management’s assessment of the risk of potential loss, which includes consultation with outside legal counsel and other advisors. Such assessments are reviewed each period and revised based on current facts and circumstances, if necessary. While it is possible that the Company’s cash flows and results of operations in a particular quarter or year could be materially affected by the impact of such contingencies, based on current knowledge it is the opinion of management that these matters will not have a material effect on the Company’s financial position, or its ongoing results of operations or cash flows. Refer to Note 13, Commitments and Contingencies to the Consolidated Financial Statements for further discussion of the Company’s contingencies.

56

(Dollars in Millions Except Per Share Amounts)
The Company generates revenue through the sale of well-known consumer products to trade customers under established trading terms. While the recognition of revenue and receivables requires the use of estimates, there is a short time frame (typically less than 60 days) between the shipment of product and cash receipt, thereby reducing the level of uncertainty in these estimates. Refer to Note 2, Summary of Significant Accounting Policies to the Consolidated Financial Statements for further description of the Company’s significant accounting policies.
57

(Dollars in Millions Except Per Share Amounts)
Cautionary Statement on Forward-Looking Statements

This Annual Report on Form 10-K may contain forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995 or by the SEC in its rules, regulations and releases that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin growth, earnings per share levels, financial goals, the impact of foreign exchange volatility, the impact of COVID-19, cost-reduction plans, tax rates, new product introductions, commercial investment levels, acquisitions, divestitures, share repurchases, or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of those statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. Actual events or results may differ materially because of factors that affect international businesses and global economic conditions, as well as matters specific to the Company and the markets it serves, including the uncertain economic and political environment in different countries and its effect on consumer spending habits, foreign currency rate fluctuations, exchange controls, tariffs, price or profit controls, labor relations, changes in foreign or domestic laws, or regulations or their interpretation, political and fiscal developments, including changes in trade, tax and immigration policies, increased competition and evolving competitive practices (including from the growth of eCommerce and the entry of new competitors and business models), the ability to operate and respond effectively during a pandemic, epidemic or widespread public health concern, including COVID-19, ability to manage disruptions in our global supply chain and/or key office facilities, ability to manage the availability and cost of raw and packaging materials and logistics costs, the ability to maintain or increase selling prices as needed, changes in the policies of retail trade customers, the emergence of alternative retail channels, the growth of eCommerce and the rapidly changing retail landscape (as consumers increasingly shop online), the ability to develop innovative new products, the ability to continue lowering costs and operate in an agile manner, the ability to maintain the security of our information technology systems from a cyber-security incident or data breach, the ability to address the effects of climate change and achieve our sustainability and social impact goals, the ability to complete acquisitions and divestitures as planned, the ability to successfully integrate acquired businesses, the ability to attract and retain key employees and integrate diversity, equity and inclusion initiatives across our organization, the uncertainty of the outcome of legal proceedings, whether or not the Company believes they have merit, and the ability to address uncertain or unfavorable global economic conditions, disruptions in the credit markets and tax matters. For information about these and other factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, refer to Part I, Item 1A “Risk Factors.”

ITEM 7A.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

See “Managing Foreign Currency, Interest Rate, Commodity Price and Credit Risk Exposure” in Part II, Item 7.

58


ITEM 8.    FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

See “Index to Financial Statements.”

ITEM 9.    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A.    CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

The Company’s management, under the supervision and with the participation of the Company’s Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of December 31, 2020 (the Evaluation). Based upon the Evaluation, the Company’s Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) are effective.

Management’s Annual Report on Internal Control Over Financial Reporting

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. Management, under the supervision and with the participation of the Company’s Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the Company’s internal control over financial reporting based upon the framework in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and concluded that it was effective as of December 31, 2020.

The Company’s independent registered public accounting firm, PricewaterhouseCoopers LLP, has audited the effectiveness of the Company’s internal control over financial reporting as of December 31, 2020, and has expressed an unqualified opinion in their report, which appears under Index to Financial Statements – Report of Independent Registered Public Accounting Firm.

Changes in Internal Control Over Financial Reporting

The Company is in the process of upgrading its enterprise IT system to SAP S/4 HANA. This change has not had and is not expected to have a material impact on the Company’s internal controls over financial reporting.

Except as noted above, there were no changes in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

ITEM 9B.    OTHER INFORMATION

None.


59



PART III

ITEM 10.    DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

See “Information about our Executive Officers” in Part I, Item 1 of this report.

Additional information required by this Item relating to directors, executive officers and corporate governance of the Company is incorporated herein by reference to the Company’s Proxy Statement for its 2021 Annual Meeting of Stockholders (the “2021 Proxy Statement”).

Code of Ethics

The Company’s Code of Conduct promotes the highest ethical standards in all of the Company’s business dealings. The Code of Conduct satisfies the SEC’s requirements for a Code of Ethics for senior financial officers and applies to all Company employees, including the Chairman of the Board, President and Chief Executive Officer, the Chief Financial Officer and the Vice President and Controller, and the Company’s directors. The Code of Conduct is available on the Company’s website at www.colgatepalmolive.com. Any amendment to the Code of Conduct will promptly be posted on the Company’s website. It is the Company’s policy not to grant waivers of the Code of Conduct. In the extremely unlikely event that the Company grants an executive officer a waiver from a provision of the Code of Conduct, the Company will promptly disclose such information by posting it on its website or by using other appropriate means in accordance with SEC rules.

ITEM 11.    EXECUTIVE COMPENSATION

The information regarding executive compensation set forth in the 2021 Proxy Statement is incorporated herein by reference.

60


ITEM 12.    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

(a)The information regarding security ownership of certain beneficial owners and management set forth in the 2021 Proxy Statement is incorporated herein by reference.

(b)The Registrant does not know of any arrangements that may at a subsequent date result in a change in control of the Registrant.

(c)Equity compensation plan information as of December 31, 2020:
 (a) (b) (c) 
Plan CategoryNumber of securities to be issued upon exercise of outstanding options, warrants and rights
(in thousands)
 Weighted-average exercise price of outstanding options, warrants and rights Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
(in thousands)
 
Equity compensation plans approved by security holders
29,278 
(1)
$72.06 
(2)
48,564 
(3)
Equity compensation plans not approved by security holders
Not applicable Not applicable Not applicable 
Total
29,278 
 
$72.06 
 
48,564 
 
_______
(1)Consists of 27,541 options outstanding and 1,737 restricted stock units awarded but not yet vested under the Company’s 2013 Incentive Compensation Plan and the Company’s 2019 Incentive Compensation Plan, respectively, as more fully described in Note 8, Capital Stock and Stock-Based Compensation Plans to the Consolidated Financial Statements.
(2)Includes the weighted-average exercise price of stock options outstanding of $72 and restricted stock units of $73.
(3)Amount includes 36,144 options available for issuance and 12,420 restricted stock units available for issuance under the Company’s 2019 Incentive Compensation Plan.

ITEM 13.    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

The information regarding certain relationships and related transactions and director independence set forth in the 2021 Proxy Statement is incorporated herein by reference.

ITEM 14.    PRINCIPAL ACCOUNTANT FEES AND SERVICES

The information regarding auditor fees and services set forth in the 2021 Proxy Statement is incorporated herein by reference.

61



PART IV

ITEM 15.    EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a)Financial Statements and Financial Statement Schedules

    See “Index to Financial Statements.”
 
(b)Exhibits:

62



Exhibit No.Description
  
3-A 
 
3-B 
 
4a)
b)
Indenture, dated as of November 15, 1992, between the Company and The Bank of New York Mellon (formerly known as The Bank of New York) as Trustee. (Registrant hereby incorporates by reference Exhibit 4.1 to its Registration Statement on Form S-3 and Post-Effective Amendment No. 1 filed on June 26, 1992, Registration No. 33-48840.)(1)
      
 c)
      
10-Aa)
b)
c)
d)
10-Ba)
b)
c)
d)
10-Ca)Colgate-Palmolive Company Executive Incentive Compensation Plan Trust, as amended. (Registrant hereby incorporates by reference Exhibit 10-B (b) to its Annual Report on Form 10-K for the year ended December 31, 1987, File No. 1-644.)*
      
 b)
      
10-Da)
63


b)
10-Ea)
 b)Colgate-Palmolive Company Executive Severance Plan Trust. (Registrant hereby incorporates by reference Exhibit 10-E (b) to its Annual Report on Form 10-K for the year ended December 31, 1987, File No. 1-644.)*
      
10-F 
    
10-Ga)
 b)
10-H 
10-I
10-J

10-K
10-La)
b)
    
10-M
10-N
64


21 
    
23 
    
24 
   
31-A 
31-B 
    
32 
   
101 The following materials from Colgate-Palmolive Company’s Annual Report on Form 10-K for the year ended December 31, 2020, formatted in Inline eXtensible Business Reporting Language (Inline XBRL): (i) the Consolidated Statements of Income, (ii) the Consolidated Balance Sheets, (iii) the Consolidated Statements of Changes in Shareholders’ Equity, (iv) the Consolidated Statements of Comprehensive Income, (v) the Consolidated Statements of Cash Flows, (vi) Notes to Consolidated Financial Statements, and (vii) Financial Statement Schedule.**
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).**
__________
*    Indicates a management contract or compensatory plan or arrangement.

**    Filed herewith.

*** Furnished herewith.

(1)    Registrant hereby undertakes to furnish the Commission, upon request, with a copy of any instrument with respect to long-term debt where the total amount of securities authorized thereunder does not exceed 10% of the total assets of the Registrant and its subsidiaries on a consolidated basis.

The exhibits indicated above that are not included with the Form 10-K are available upon request and payment of a reasonable fee approximating the registrant’s cost of providing and mailing the exhibits. Inquiries should be directed to:
Colgate-Palmolive Company
Office of the Secretary (10-K Exhibits)
300 Park Avenue
New York, NY 10022-7499


65


ITEM 16.    FORM 10-K SUMMARY

None.

66


COLGATE-PALMOLIVE COMPANY
SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  
Colgate-Palmolive Company
            (Registrant)
      
Date: February 18, 2021By/s/ Noel R. Wallace
   Noel R. Wallace
Chairman of the Board, President and
Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below on February 18, 2021, by the following persons on behalf of the registrant and in the capacities indicated.
     
(a)           Principal Executive Officer (d)           Directors:
/s/ Noel R. Wallace /s/ Noel R. Wallace
Noel R. Wallace
Chairman of the Board, President and
Chief Executive Officer
 Noel R. Wallace
(b)           Principal Financial Officer 
John P. Bilbrey, John T. Cahill,
Lisa M. Edwards, Helene D. Gayle,
C. Martin Harris, Martina Hund-Mejean,
Lorrie M. Norrington, Michael B. Polk,
Stephen I. Sadove*
   
/s/ Stanley J. Sutula III *By: /s/ Jennifer M. Daniels
Stanley J. Sutula III
Chief Financial Officer
 
Jennifer M. Daniels
As Attorney-in-Fact
   
(c)           Principal Accounting Officer 
    
/s/ Philip G. Shotts 
Philip G. Shotts
Vice President and Controller
 

67


Index to Financial Statements

  Page
Consolidated Financial Statements 
   
Report of Independent Registered Public Accounting Firm
   
Consolidated Statements of Income for the years ended December 31, 2020, 2019 and 2018
Consolidated Statements of Comprehensive Income for the years ended December 31, 2020, 2019 and 2018
  
Consolidated Balance Sheets as of December 31, 2020 and 2019
   
Consolidated Statements of Changes in Shareholders’ Equity for the years ended December 31, 2020, 2019 and 2018
  
Consolidated Statements of Cash Flows for the years ended December 31, 2020, 2019 and 2018
   
Notes to Consolidated Financial Statements
   
Financial Statement Schedule 
  
Schedule II - Valuation and Qualifying Accounts for the years ended December 31, 2020, 2019 and 2018
   
Selected Financial Data 
   
Market Information
   
Historical Financial Summary

All other financial statements and schedules not listed have been omitted since the required information is included in the financial statements or the notes thereto or is not applicable or required.

68


Report of Independent Registered Public Accounting Firm

To the Board of Directors and Shareholders of Colgate-Palmolive Company:

Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the consolidated financial statements, including the related notes and financial statement schedule, of Colgate-Palmolive Company and its subsidiaries (the “Company”) as listed in the accompanying index (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Change in Accounting Principle

As discussed in Note 15 to the consolidated financial statements, the Company changed the manner in which it accounts for leases in 2019.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Annual Report on Internal Control Over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
69


Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Goodwill and Indefinite-Lived Intangible Assets Interim Impairment Assessments - Filorga

As described in Notes 2 and 5 to the consolidated financial statements, the Company’s consolidated balance of goodwill and indefinite-lived intangible assets was $3.8 billion and $1.9 billion respectively as of December 31, 2020. Goodwill and indefinite-lived intangible assets are subject to impairment tests at least annually or when events or changes in circumstances indicate that an asset may be impaired. As a result of the COVID-19 Pandemic, in the first quarter of 2020, management determined that a “triggering event” had occurred relative to its recently acquired Filorga skin health business and, as required, performed a quantitative analysis. The results of the analysis indicated the estimated fair value of the reporting unit and indefinite-life intangible assets continue to exceed their carrying values and were not impaired. As disclosed by management, the fair value of the reporting units for goodwill and the fair value of its indefinite-lived intangible assets were determined using an income approach. These methods incorporate several estimates and assumptions, the most significant being future cash flows, sales growth rates, discount rate for the goodwill and indefinite-lived intangible assets, and the selection of royalty rates for the indefinite-lived intangible assets.

The principal considerations for our determination that performing procedures relating to the goodwill and indefinite-lived intangible assets interim impairment assessments of Filorga is a critical audit matter are (i) the significant judgment by management when determining the fair value measurements of the reporting unit and indefinite-lived intangible assets ; (ii) a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating management’s significant assumptions related to sales growth rates, discount rate for the goodwill and indefinite-lived intangible assets, and the royalty rate for the indefinite-lived intangible assets; and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management’s goodwill and indefinite-lived intangible assets impairment assessment, including controls over the valuation of the Filorga reporting unit and indefinite-lived intangible assets.
70


These procedures also included, among others (i) testing management’s process for determining the fair value measurements of the reporting unit and indefinite-lived intangible assets; (ii) evaluating the appropriateness of the income approach based on a discounted cash flow and relief from royalty models; (iii) testing the completeness and accuracy of underlying data used in the models; and (iv) evaluating the reasonableness of significant assumptions used by management related to the sales growth rates, discount rate for the goodwill and indefinite-lived intangible assets, and the royalty rate for the indefinite-lived intangible assets. Evaluating management’s assumptions related to sales growth rates, discount rate for the goodwill and indefinite-lived intangible assets and royalty rate for the indefinite-lived intangible assets involved evaluating whether the assumptions used by management were reasonable considering (i) the consistency with external market and industry data, and (ii) whether these assumptions were consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in evaluating the appropriateness of the income approach based on a discounted cash flow and relief from royalty models, and the discount rate and royalty rate assumptions.

/s/ PricewaterhouseCoopers LLP
New York, New York
February 18, 2021
We have served as the Companys auditor since 2002.

71


COLGATE-PALMOLIVE COMPANY
Consolidated Statements of Income
For the years ended December 31,
(Dollars in Millions Except Per Share Amounts)
202020192018
Net sales$16,471 $15,693 $15,544 
Cost of sales6,454 6,368 6,313 
Gross profit10,017 9,325 9,231 
Selling, general and administrative expenses6,019 5,575 5,389 
Other (income) expense, net113 196 148 
Operating profit3,885 3,554 3,694 
Non-service related postretirement costs74 108 87 
Interest (income) expense, net164 145 143 
Income before income taxes3,647 3,301 3,464 
Provision for income taxes787 774 906 
Net income including noncontrolling interests2,860 2,527 2,558 
Less: Net income attributable to noncontrolling interests165 160 158 
Net income attributable to Colgate-Palmolive Company$2,695 $2,367 $2,400 
Earnings per common share, basic$3.15 $2.76 $2.76 
Earnings per common share, diluted$3.14 $2.75 $2.75 

See Notes to Consolidated Financial Statements.

72


COLGATE-PALMOLIVE COMPANY
Consolidated Statements of Comprehensive Income
For the years ended December 31,
 (Dollars in Millions)
202020192018
Net income including noncontrolling interests$2,860 $2,527 $2,558 
Other comprehensive income (loss), net of tax:
     Cumulative translation adjustments(24)25 (237)
     Retirement plan and other retiree benefit adjustments(40)(100)38 
     Gains (losses) on cash flow hedges(2)(12)10 
Total Other comprehensive income (loss), net of tax(66)(87)(189)
Total Comprehensive income including noncontrolling interests2,794 2,440 2,369 
Less: Net income attributable to noncontrolling interests165 160 158 
Less: Cumulative translation adjustments attributable to noncontrolling interests6 (2)(19)
Total Comprehensive income attributable to noncontrolling interests171 158 139 
Total Comprehensive income attributable to Colgate-Palmolive Company$2,623 $2,282 $2,230 

See Notes to Consolidated Financial Statements.

73


COLGATE-PALMOLIVE COMPANY
 Consolidated Balance Sheets
As of December 31,
 (Dollars in Millions Except Share and Per Share Amounts)
20202019
Assets 
Current Assets  
Cash and cash equivalents$888 $883 
Receivables (net of allowances of $89 and $76, respectively)
1,264 1,440 
Inventories1,673 1,400 
Other current assets513 456 
Total current assets4,338 4,179 
Property, plant and equipment, net3,716 3,750 
Goodwill3,824 3,508 
Other intangible assets, net2,894 2,667 
Deferred income taxes291 177 
Other assets857 753 
Total assets$15,920 $15,034 
Liabilities and Shareholders’ Equity  
Current Liabilities  
Notes and loans payable$258 $260 
Current portion of long-term debt9 254 
Accounts payable1,393 1,237 
Accrued income taxes403 370 
Other accruals2,341 1,917 
Total current liabilities4,404 4,038 
Long-term debt7,334 7,333 
Deferred income taxes426 507 
Other liabilities2,655 2,598 
Total liabilities14,819 14,476 
Commitments and contingent liabilities  
Shareholders’ Equity  
Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued)
1,466 1,466 
Additional paid-in capital2,969 2,488 
Retained earnings23,699 22,501 
Accumulated other comprehensive income (loss)(4,345)(4,273)
Unearned compensation(1)(2)
Treasury stock, at cost(23,045)(22,063)
Total Colgate-Palmolive Company shareholders’ equity743 117 
Noncontrolling interests358 441 
Total equity1,101 558 
Total liabilities and equity$15,920 $15,034 

See Notes to Consolidated Financial Statements.

74


COLGATE-PALMOLIVE COMPANY
Consolidated Statements of Changes in Shareholders’ Equity
(Dollars in Millions)
 Colgate-Palmolive Company Shareholders’ Equity 
 Common StockAdditional Paid-In CapitalUnearned CompensationTreasury StockRetained EarningsAccumulated Other Comprehensive Income (Loss)Noncontrolling Interests
Balance, January 1, 2018$1,466 $1,984 $(5)$(20,181)$20,531 $(3,855)$303 
Net income    2,400  158 
Other comprehensive income (loss), net of tax     (170)(19)
Dividends ($1.66)/per share*
    (1,448) (143)
Stock-based compensation expense
 109      
Shares issued for stock options
 137  190    
Shares issued for restricted stock awards
(31)31 
Treasury stock acquired   (1,238)   
Other 5 2 2 132 (163)(1)
Balance, December 31, 2018$1,466 $2,204 $(3)$(21,196)$21,615 $(4,188)$299 
Net income2,367 160 
Other comprehensive income (loss), net of tax(85)(2)
Dividends ($1.71)/per share*
(1,472)(141)
Stock-based compensation expense
100 
Shares issued for stock options
210 305 
Shares issued for restricted stock awards
(29)29 
Noncontrolling interests assumed through acquisition125 
Treasury stock acquired(1,202)
Other3 1 1 (9)
Balance, December 31, 2019$1,466 $2,488 $(2)$(22,063)$22,501 $(4,273)$441 
Net income    2,695  165 
Other comprehensive income (loss), net of tax     (72)6 
Dividends ($1.75)/per share*
    (1,502) (152)
Stock-based compensation expense
 107      
Shares issued for stock options 400  462    
Shares issued for restricted stock awards
(31)31 
Noncontrolling interests acquired(99)
Treasury stock acquired   (1,476)   
Other 5 1 1 5 (3)
Balance, December 31, 2020$1,466 $2,969 $(1)$(23,045)$23,699 $(4,345)$358 
(1) As a result of the early adoption of ASU 2018-02, the Company reclassified the stranded tax effects in Accumulated other comprehensive income (loss) resulting from the Tax Cuts and Jobs Act to Retained earnings.

* Two dividends were declared in each of the first quarters of 2020, 2019 and 2018.

See Notes to Consolidated Financial Statements.

75


COLGATE-PALMOLIVE COMPANY
Consolidated Statements of Cash Flows
For the years ended December 31,
(Dollars in Millions)
 202020192018
Operating Activities  
Net income including noncontrolling interests$2,860 $2,527 $2,558 
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:  
Depreciation and amortization539 519 511 
Restructuring and termination benefits, net of cash(71)18 (7)
Stock-based compensation expense107 100 109 
Loss on early extinguishment of debt23   
Charge for U.S. tax reform  80 
Deferred income taxes(120)17 27 
Voluntary benefit plan contributions (113)(67)
Cash effects of changes in: 
Receivables138 19 (79)
Inventories(251)(77)(58)
Accounts payable and other accruals520 36 18 
Other non-current assets and liabilities(26)87 (36)
Net cash provided by operations3,719 3,133 3,056 
Investing Activities  
Capital expenditures(410)(335)(436)
Purchases of marketable securities and investments(143)(184)(169)
Proceeds from sale of marketable securities and investments124 131 156 
Payment for acquisitions, net of cash acquired(353)(1,711)(728)
Other3  7 
Net cash used in investing activities(779)(2,099)(1,170)
Financing Activities  
Short-term borrowing/(repayment) less than 90 days - net497 294 546 
Principal payments on debt (1)
(1,061)(1,441)(725)
Proceeds from issuance of debt 2,595  
Dividends paid(1,654)(1,614)(1,591)
Purchases of treasury shares(1,476)(1,202)(1,238)
Proceeds from exercise of stock options874 498 329 
Purchases of non-controlling interests in subsidiaries(99)  
Net cash used in financing activities(2,919)(870)(2,679)
Effect of exchange rate changes on Cash and cash equivalents(16)(7)(16)
Net (decrease) increase in Cash and cash equivalents5 157 (809)
Cash and cash equivalents at beginning of year883 726 1,535 
Cash and cash equivalents at end of year$888 $883 $726 
Supplemental Cash Flow Information  
Income taxes paid$845 $803 $847 
Interest paid$188 $185 $194 
(1) For the year ended December 31, 2020, Principal payments on debt includes cash charges of $20 related to the extinguishment of debt prior to maturity. See Note 6, Long-Term Debt and Credit Facilities for additional information.
See Notes to Consolidated Financial Statements.

76

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements
(Dollars in Millions Except Share and Per Share Amounts)

1.    Nature of Operations    

The Company manufactures and markets a wide variety of products in the U.S. and around the world in two product segments: Oral, Personal and Home Care; and Pet Nutrition. Oral, Personal and Home Care products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners and other similar items. These products are sold primarily to a variety of traditional and eCommerce retailers, wholesalers and distributors worldwide. Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The principal customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and eCommerce retailers. Principal global and regional trademarks include Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA Skin, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet.

The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years:
  202020192018
Oral Care44 %46 %47 %
Personal Care21 %20 %20 %
Home Care18 %18 %18 %
Pet Nutrition17 %16 %15 %
Total100 %100 %100 %

77

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
2.    Summary of Significant Accounting Policies

Principles of Consolidation

The Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50%, where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2020 and 2019, equity method investments included in Other assets in the Consolidated Balance Sheets were $56 and $50, respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are recorded at cost and periodically adjusted based on observable price changes or quoted market prices in active markets, if applicable.

Use of Estimates

The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances, legal and other contingency reserves. Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates.

Revenue Recognition

The Company’s revenue contracts represent a single performance obligation to sell its products to trade customers. Sales are recorded at the time control of the products is transferred to trade customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for the products. Control is the ability of trade customers to “direct the use of” and “obtain” the benefit from our products. In evaluating the timing of the transfer of control of products to trade customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are generally recognized when products are delivered to trade customers.

Net sales reflect the transaction prices for contracts, which include units shipped at selling list prices reduced by variable consideration. Variable consideration includes expected sales returns and the cost of current and continuing promotional programs. Current promotional programs primarily include product listing allowances and co-operative advertising arrangements. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements. The cost of promotional programs is estimated using the expected value method considering all reasonably available information, including the Company’s historical experience and its current expectations, and is reflected in the transaction price when sales are recorded. Adjustments to the cost of promotional programs in subsequent periods are generally not material, as the Company’s promotional programs are typically of short duration, thereby reducing the uncertainty inherent in such estimates.

Sales returns are generally accepted at the Company’s discretion and are not material to the Company’s Consolidated Financial Statements. The Company’s contracts with trade customers do not have significant financing components or non-cash consideration and the Company does not have unbilled revenue or significant amounts of prepayments from customers. The Company records Net sales excluding taxes collected on its sales to its trade customers. Shipping and handling activities are accounted for as contract fulfillment costs and classified as Selling, general and administrative expenses.

78

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
Shipping and Handling Costs

Shipping and handling costs are classified as Selling, general and administrative expenses and were $1,392, $1,275 and $1,255 for the years ended December 31, 2020, 2019 and 2018, respectively.

Marketing Costs

The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales.

Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.

Inventories

The cost of approximately 75% of inventories is determined using the FIFO method, which is stated at the lower of cost or net realizable value. The cost of all other inventories, in the U.S. and Mexico, is determined using the LIFO method, which is stated at the lower of cost or market. Inventories in excess of one year of forecasted sales are classified in the Consolidated Balance Sheets as non-current “Other assets.”

Property, Plant and Equipment

Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over-estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses.

Goodwill and Other Intangibles

Goodwill and indefinite-life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually or when events or changes in circumstances indicate that an asset may be impaired. These tests were performed and did not result in an impairment charge. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their estimated useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit.

Income Taxes

The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return. The Company recognizes interest expense and penalties related to unrecognized tax benefits within Provision for income taxes.
79

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
Financial Instruments

Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged. Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows.

The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7, Fair Value Measurements and Financial Instruments along with the related fair value measurement considerations.

Stock-Based Compensation

The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units (both performance-based and time-vested), based on the fair value of those awards at the date of grant over the requisite service period. The Company uses the Black-Scholes-Merton (Black-Scholes) option pricing model to estimate the fair value of stock option awards. In addition to performance conditions, performance-based restricted stock units also include a total shareholder return modifier. Because the total shareholder return modifier is considered a market condition, the Company uses a Monte-Carlo simulation model to determine the fair value of performance-based restricted stock units. The fair value of time-vested restricted stock units is determined based on the closing market price of the Company’s stock at the date of grant. Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8, Capital Stock and Stock-Based Compensation Plans.

Currency Translation

The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year.

For subsidiaries operating in highly inflationary environments, local currency-denominated non-monetary assets, including inventories, goodwill and property, plant and equipment, are remeasured at their historical exchange rates, while local currency-denominated monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company.












80

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
Recent Accounting Pronouncements

In January 2021, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2021-1, “Reference Rate Reform (Topic 848): Scope” This ASU clarifies that certain optional expedients and exceptions in Topic 848 apply to derivatives that are affected by the discounting transition due to reference rate reform. This guidance was effective upon issuance for the Company and is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In October 2020, the FASB issued ASU No. 2020-10, “Codification Improvements.” This ASU improves the consistency of the codification topics by including all disclosure guidance in the appropriate disclosure section and also clarifies the application of various provisions in the codification. This guidance was effective for the Company beginning on January 1, 2021 and is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (“GAAP”) to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This guidance was effective upon issuance of this ASU for contract modifications and hedging relationships on a prospective basis and is not expected to have a material impact on the Company’s Consolidated Financial Statements.
In March 2020, the FASB issued ASU No. 2020-03, “Codification to Financial Instruments.” This ASU improves and clarifies various financial instruments topics, including the current expected credit losses (“CECL”) standard issued in 2016. The ASU addresses seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments related to Issue 1, Issue 2, Issue 4 and Issue 5 were effective upon issuance of this update. The amendments related to Issue 3, Issue 6 and Issue 7 were effective for the Company beginning on January 1, 2020. The guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)-Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This guidance was effective for the Company beginning on January 1, 2021. This guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In December 2019, the FASB issued ASU No. 2019-12, “Income taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This guidance was effective for the Company beginning on January 1, 2021. This guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In November 2019, the FASB issued ASU No. 2019-11, “Codification Improvements to Topic 326, Financial Instruments - Credit Losses.” This ASU clarifies and addresses certain items related to amendments in ASU 2016-13. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In April 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825).” This ASU clarifies three topics related to financial instruments accounting. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.



81

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU No. 2017-04, “Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate implied fair value, essentially eliminating step two from the goodwill impairment test. The standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard was effective for the Company on a prospective basis beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326).” This ASU introduces the current expected credit loss (CECL) model, which requires an entity to measure credit losses for certain financial instruments and financial assets, including trade receivables. Under this update, on initial recognition and at each reporting period, an entity is required to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. The Company adopted the new standard, which primarily impacts the Company’s trade receivables and related methodology for assessing the collectability of its customer accounts, on January 1, 2020, on a “modified retrospective” basis. The adoption of this ASU did not have a material impact on the Company’s Consolidated Financial Statements.

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year presentation.

82

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
3.    Acquisitions

Hello Products LLC (“hello”)

On January 31, 2020, the Company acquired hello, an oral care business, for cash consideration of $351. The acquisition was financed with a combination of debt and cash. This acquisition is part of the Company’s strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses.

The total purchase price consideration of $351 has been allocated to the net assets acquired based on their respective estimated fair values as follows:

Receivables $11 
Inventories 13 
Other assets and liabilities, net (4)
Other intangible assets 160 
Goodwill171 
Fair value of net assets acquired$351 

Other intangible assets acquired include trademarks, valued at $115, which are considered to have a finite useful life of 25 years, and customer relationships valued at $45, which are considered to have a finite useful life of 17 years. Goodwill of $171 was allocated to the North America segment. The Company expects that goodwill will be deductible for tax purposes.

Pro forma results of operations have not been presented as the impact on the Company’s Consolidated Financial Statements is not material.

Laboratoires Filorga Cosmétiques (“Filorga”)

On September 19, 2019, the Company acquired the Filorga skin health business for cash consideration of €1,516 (approximately $1,674), which included interest on the equity purchase price plus additional consideration of €32 (approximately $38), the majority of which related to repayment of loans from former shareholders of Filorga. Filorga is a premium anti-aging skin health brand focused primarily on facial care. This acquisition is part of the Company’s strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses, including by expanding its portfolio in premium skin health.

The total purchase price consideration of $1,712 has been allocated to the net assets acquired based on their respective estimated fair values as follows:
Cash$30 
Receivables53 
Inventories70 
Other current assets18 
Other intangible assets1,051 
Goodwill923 
Other current liabilities(67)
Deferred income taxes(276)
Noncontrolling interests(90)
Fair value of net assets acquired$1,712 

83

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
Other intangible assets acquired include trademarks of $774, which are considered to have an indefinite useful life, and customer relationships of $277, which are considered to have a finite useful life of 14 years. Goodwill of $923 was allocated to the Europe segment. Goodwill will not be deductible for tax purposes.

In the third quarter of 2020, the Company completed the purchase of the outstanding non-controlling interest of Filorga’s joint venture based in Hong Kong and covering the Hong Kong and China markets for approximately €85 (approximately $99) in cash.

    The results of operations of Filorga are reported on a lag basis. As such, Filorga’s results of operations from December 1, 2019 through November 30, 2020 and from the Acquisition Date through November 30, 2019 are included in the Company’s Consolidated Results of Operations for the periods ended December 31, 2020 and 2019, respectively.

Pro forma results of operations have not been presented as the impact on the Company’s Consolidated Financial Statements is not material.

Nigeria Joint Venture

On August 15, 2019, the Company acquired a 51% controlling interest in Colgate Tolaram Pte. Ltd., a joint venture which owns the Nigeria-based Hypo Homecare Products Limited, for $31.

Pro forma results of operations have not been presented as the impact on the Company’s Consolidated Financial Statements is not material.


84

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
4.    Restructuring and Related Implementation Charges
 
The Company’s restructuring program (the “Global Growth and Efficiency Program”), which commenced in the fourth quarter of 2012, concluded on December 31, 2019. Initiatives under the Global Growth and Efficiency Program fit within the program’s three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions and optimizing the global supply chain and facilities. Substantially all initiatives under the Global Growth and Efficiency Program had been implemented as of December 31, 2019.

In the third quarter of 2020, the Company adjusted the accrual balances related to certain projects approved prior to the conclusion of the Global Growth and Efficiency Program to reflect its revised estimate of remaining liabilities. This adjustment resulted in a reduction of $16 ($13 aftertax), of which $3 was recorded in Selling, general and administrative expenses and $13 was recorded in Other (income) expense, net. During the year ended December 31, 2020, the Company also made cash payments of $53 related to projects approved prior to the conclusion of the Global Growth and Efficiency Program, and the remaining accrual balance at December 31, 2020 was $31. No new restructuring projects were approved for implementation during the year ended December 31, 2020.

For the years ended December 31, 2019 and 2018, restructuring and related implementation charges are reflected in the Consolidated Statements of Income as follows:  
20192018
Cost of sales$8 $31 
Selling, general and administrative expenses60 33 
Other (income) expense, net57 88 
Non-service related postretirement costs7 9 
Total Global Growth and Efficiency Program charges, pretax$132 $161 
Total Global Growth and Efficiency Program charges, aftertax$102 $125 

Restructuring and related implementation charges in the preceding table and the adjustment recorded in the third quarter of 2020 were recorded in the Corporate segment as these initiatives were predominantly centrally directed and controlled and were not included in internal measures of segment operating performance.

Total charges incurred for the Global Growth and Efficiency Program related to initiatives undertaken by the following reportable operating segments:
Total Program
20192018Charges
North America4 %18 %17 %
Latin America12 %10 %5 %
Europe4 %(2)%19 %
Asia Pacific6 %13 %4 %
Africa/Eurasia(1)%5 %5 %
Hills Pet Nutrition
2 %19 %8 %
Corporate73 %37 %42 %
Total100 %100 %100 %





85

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
Over the course of the Global Growth and Efficiency Program, the Company incurred total pretax charges of $1,854 ($1,380 aftertax) in connection with the implementation of various projects as follows:
Total Program Charges
as of December 31, 2019
Employee-Related Costs$706 
Incremental Depreciation128 
Asset Impairments58 
Other962 
Total$1,854 

Over the course of the Global Growth and Efficiency Program, the majority of the costs incurred related to the following projects: the implementation of the Company’s overall hubbing strategy; the consolidation of facilities; the extension of shared business services and streamlining of global functions; the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; redesigning the European commercial organization; restructuring how the Company will provide future retirement benefits to substantially all of the U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan; and the implementation of a Corporate efficiencies program.

The following table summarizes the activity for the restructuring and related implementation charges for the years ended December 31, 2019 and 2018 and the related accruals:

 
Employee-Related
Costs 
Incremental
Depreciation
Asset
Impairments
Other
Total
Balance at December 31, 2017$127 $ $ $107 $234 
Charges53 2 16 90 161 
Cash payments(107)  (60)(167)
Charges against assets(9)(2)(16) (27)
Foreign exchange(4)   (4)
Other   5 5 
Balance at December 31, 2018$60 $ $ $142 $202 
Charges25 36 6 65 132 
Cash payments(55)  (58)(113)
Charges against assets(7)(36)(6)(27)(76)
Foreign exchange3    3 
Other   (48)(48)
Balance at December 31, 2019$26 $ $ $74 $100 

Employee-Related Costs primarily included severance and other termination benefits and were calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also included pension and other retiree benefit enhancements amounting to $7 and $9 for the years ended December 31, 2019 and 2018, respectively, which are reflected as Charges against assets within Employee-Related Costs in the preceding table as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities. See Note 10, Retirement Plans and Other Retiree Benefits for additional information.


86

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
Incremental Depreciation was recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments were recorded to write down inventories and assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consisted primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the Global Growth and Efficiency Program. These charges for the years ended December 31, 2019 and 2018 included third-party incremental costs related to the development and implementation of new business and strategic initiatives of $32 and $42, respectively, and contract termination costs and charges resulting directly from exit activities of $5 and $48, respectively. These charges were expensed as incurred. Also included in Other charges for the year ended December 31, 2019 were other exit costs of $28 related to the consolidation of facilities.

Other decreases to the restructuring accruals reflect the reclassification of restructuring accruals to lease assets as a result of the Company’s adoption of ASU No. 2018-10, “Codification Improvement to Topic 842, Leases,” on January 1, 2019.
87

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
5.    Goodwill and Other Intangible Assets

The net carrying value of Goodwill as of December 31, 2020 and 2019 by segment was as follows:
  20202019
Oral, Personal and Home Care  
North America$912 $737 
Latin America171 212 
Europe2,415 2,234 
Asia Pacific190 186 
Africa/Eurasia121 124 
Total Oral, Personal and Home Care3,809 3,493 
Pet Nutrition15 15 
Total Goodwill$3,824 $3,508 

The change in the amount of Goodwill during 2020 is primarily due to the acquisition of hello (see Note 3, Acquisitions for further information) and the impact of foreign currency translation.

Other intangible assets as of December 31, 2020 and 2019 were comprised of the following:
  20202019
  Gross Carrying AmountAccumulated AmortizationNetGross Carrying AmountAccumulated AmortizationNet
Trademarks - finite life$902 $(422)$480 $771 $(381)$390 
Other finite life intangible assets786 (237)549 699 (169)530 
Indefinite life intangible assets1,865 — 1,865 1,747 — 1,747 
Total Other intangible assets$3,553 $(659)$2,894 $3,217 $(550)$2,667 

The change in the net carrying amounts of Other intangible assets during 2020 was primarily due to the acquisition of hello (see Note 3, Acquisitions for further information) and amortization expense of $88. Annual estimated amortization expense for each of the next five years is expected to be approximately $83.

As a result of the COVID-19 pandemic, in the first quarter of 2020, the Company assessed whether a “triggering event” had occurred indicating a possible impairment of its goodwill and indefinite-life intangible assets. As a result of this assessment, the Company determined that a “triggering event” had occurred relative to its recently acquired Filorga skin health business and, as required, performed a quantitative analysis, with the assistance of a third-party valuation firm, of the value of the Filorga reporting unit and its indefinite-life intangible assets. Based on the analysis, the Company determined that the fair value of the Filorga reporting unit and the related indefinite-life intangible assets continued to exceed their carrying values and were not impaired.

As of the date of the annual goodwill impairment test, the fair value of the Filorga reporting unit exceeded its carrying value by approximately 10%. Either a reduction in the long-term growth rate of 50 basis points or an increase in the discount rate of 25 basis points would result in the fair value of the Filorga reporting unit exceeding its carrying value by less than 5%. As of the date of the annual impairment test, the fair value of the Filorga indefinite-life intangible assets exceeded their carrying value by less than 10%. Either a reduction in the long-term growth rate of 50 basis points or an increase in the discount rate of 25 basis points would result in the fair value of the Filorga indefinite-life intangible assets approximating their carrying value.

88

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
Determining the fair value of the Filorga reporting unit and indefinite-life intangible assets requires significant judgments and estimates by management regarding several key inputs, including future cash flows consistent with management’s strategic plans, sales growth rates and the selection of royalty rates and a discount rate, among others. Estimating sales growth rates requires significant judgment by management in areas such as future economic conditions, category and industry growth rates, product pricing, consumer tastes and preferences and future expansion expectations.

Given the inherent uncertainties in estimating the future impacts of the COVID-19 pandemic on global macroeconomic conditions and interest rates in general and on the Filorga business in particular, actual results may differ from management’s current estimates and could have an adverse impact on one or more of the assumptions used in our quantitative models related to the Filorga reporting unit and the related indefinite-life intangible assets, resulting in potential impairment charges in subsequent periods. Given the recent acquisition of Filorga, where there is inherently a lower surplus of fair value over carrying value, management will continue to assess triggering events that may necessitate additional qualitative or quantitative analyses of our reporting units and indefinite-life intangible assets in future periods.

Except for the recently acquired Filorga business, as described above, where there is inherently a lower surplus of fair value over carrying value, the estimated fair value of the Company’s reporting units substantially exceeds the recorded carrying value. The fair value of the Company’s indefinite-life intangible assets other than Filorga exceeds their recorded carrying value by at least 20%. Therefore, it is not reasonably likely that significant changes in these estimates would occur that would result in an impairment charge related to these assets.
89

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
6.    Long-Term Debt and Credit Facilities

Long-term debt consisted of the following at December 31:
  Weighted Average Interest RateMaturities20202019
Notes1.9%2021-2078$6,170 $6,988 
Commercial paper(0.3)%20211,139 579 
Finance Lease ObligationsVariousVarious34 20 
7,343 7,587 
Less: Current portion of long-term debt(9)(254)
Total $7,334 $7,333 

The weighted-average interest rate on short-term borrowings included in Notes and loans payable in the Consolidated Balance Sheets as of December 31, 2020 and 2019 was 4.8% and 1.8%, respectively.

The Company classifies commercial paper and notes maturing within the next twelve months as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis. Excluding such obligations, scheduled maturities of long-term debt and finance leases outstanding as of December 31, 2020, were as follows:  
Years Ended December 31,
2021
$631 
2022413 
2023896 
2024498 
2025130 
Thereafter3,636 

The Company has entered into interest rate swap agreements and foreign exchange contracts related to certain of these debt instruments. See Note 7, Fair Value Measurements and Financial Instruments for further information about the Company’s financial instruments.

The Company’s debt issuances and redemptions support its capital structure strategy objectives of funding its business and growth initiatives while minimizing its risk-adjusted cost of capital. During the first quarter of 2019, the Company issued €500 of seven-year notes at a fixed coupon rate of 0.500% and €500 of fifteen-year notes at a fixed coupon rate of 1.375%. During the fourth quarter of 2019, the Company issued €500 of two-year notes at a fixed coupon rate of 0.000% and €500 of twenty-year notes at a fixed coupon rate of 0.875%. The debt issuances were under the Company’s shelf registration statement. Proceeds from the debt issuances were used for general corporate purposes, which included the retirement of commercial paper and, in the case of the debt issuances in the first quarter of 2019, the repayment of the Company’s $500 1.750% fixed rate notes, which became due in March 2019, and €500 floating rate notes, which became due in May 2019.

During the fourth quarter of 2020, the Company redeemed prior to maturity all of its outstanding 2.450% notes due 2021 with a principal amount $300, originally issued on November 8, 2011, and all of its outstanding 2.300% notes due 2022 with a principal amount of $500, originally issued on May 3, 2012. These redemptions were financed with commercial paper borrowings and cash. The Company recorded a loss on the early extinguishment of debt of $23, which is included in Interest (income) expense, net in the Consolidated Statements of Income, representing the difference between the redemption price and the carrying amount of the debt extinguished.


90

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
At December 31, 2020, the Company had access to unused domestic and foreign lines of credit of $4,657 (including under the facilities discussed below) and could also issue long-term debt pursuant to an effective shelf registration statement. In November 2018, the Company entered into an amended and restated $2,650 revolving credit facility with a syndicate of banks that was scheduled to expire in November 2023. In August 2019, the term of the facility was extended by one year and it now expires in November 2024. In August 2020, the Company entered into a $1,500 364-day credit facility with a syndicate of banks that is scheduled to expire in August 2021. Commitment fees related to the credit facilities are not material.

Certain agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote.

91

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
7.    Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Provided below are details of the Company’s exposures by type of risk and derivative instruments by type of hedge designation.

Valuation Considerations

The Company’s derivative instruments include interest rate swap contracts, forward-starting interest rate swaps, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are classified as follows:

Level 1: Based upon quoted market prices in active markets for identical assets or liabilities.
Level 2: Based upon observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Based upon unobservable inputs reflecting the reporting entity’s own assumptions.

Foreign Exchange Risk

As the Company markets its products in over 200 countries and territories, it is exposed to currency fluctuations related to manufacturing and selling its products in currencies other than the U.S. dollar. The Company manages its foreign currency exposures through a combination of cost containment measures, sourcing strategies, selling price increases and the hedging of certain costs in an effort to minimize the impact on earnings of foreign currency rate movements.

The Company primarily utilizes foreign currency contracts, including forward and swap contracts, option contracts, foreign and local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. The duration of foreign currency contracts generally does not exceed 12 months and the contracts are valued using observable market rates (Level 2 valuation).

Interest Rate Risk

The Company manages its targeted mix of fixed and floating rate debt with debt issuances and by entering into interest rate swaps in order to mitigate fluctuations in earnings and cash flows that may result from interest rate volatility. The Company utilizes forward-starting interest rate swaps to mitigate the risk of variability in interest rate for future debt issuances. The notional amount, interest payment and maturity date of the swaps generally match the principal, interest payment and maturity date of the related debt, and the swaps are valued using observable benchmark rates (Level 2 valuation).

92

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
Commodity Price Risk

The Company is exposed to price volatility related to raw materials used in production, such as essential oils, resins, pulp, tropical oils, tallow, corn, poultry and soybeans. The Company manages its raw material exposures through a combination of cost containment measures, sourcing strategies, ongoing productivity initiatives and the limited use of commodity hedging contracts. Futures contracts are used on a limited basis, primarily in the Hill’s Pet Nutrition segment, to manage volatility related to raw material inventory purchases of certain traded commodities, and these contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of the commodity contracts generally does not exceed 12 months.

Credit Risk

The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material as it is the Company’s policy to contract with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets as of December 31, 2020 and December 31, 2019:

 AssetsLiabilities
 AccountFair ValueAccountFair Value
Designated derivative instruments
 December 31, 2020December 31, 2019 December 31, 2020December 31, 2019
Interest rate swap contractsOther assets14 4 Other liabilities  
Forward-starting interest rate swapsOther assets5  Other liabilities  
Foreign currency contractsOther current assets7 6 Other accruals93 15 
Foreign currency contractsOther assets  Other liabilities 14 
Commodity contractsOther current assets3  Other accruals  
Total designated $29 $10  $93 $29 
Other financial instruments      
Marketable securitiesOther current assets37 23    
Total other financial instruments $37 $23    

93

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of December 31, 2020 and 2019. The estimated fair value of the Company’s long-term debt, including the current portion, as of December 31, 2020 and 2019, was $8,175 and $8,056, respectively, and the related carrying value was $7,343 and $7,587, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

The following amounts were recorded on the Consolidated Balance Sheet related to cumulative basis adjustment for fair value hedges as of:
December 31, 2020December 31, 2019
Long-term debt:  
Carrying amount of hedged item$413 $403 
Cumulative hedging adjustment included in the carrying amount$14 $4 

The following tables present the notional values as of:

 December 31, 2020
 Foreign
Currency
Contracts
Foreign Currency DebtInterest Rate SwapsForward-Starting Interest Rate SwapsCommodity Contracts 
Total
Fair Value Hedges $589 $ $400 $ $ $989 
Cash Flow Hedges 854   300 17 1,171 
Net Investment Hedges528 4,523    5,051 


 December 31, 2019
 Foreign
Currency
Contracts
Foreign Currency DebtInterest Rate SwapsForward-Starting Interest Rate SwapsCommodity Contracts 
Total
Fair Value Hedges $388 $ $400 $ $ $788 
Cash Flow Hedges 761    20 781 
Net Investment Hedges478 3,856    4,334 

94

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
The following table presents the location and amount of gains (losses) on hedges recognized on the Company’s Consolidated Statements of Income:
Twelve Months Ended December 31,
 20202019
Cost of sales Selling, general and administrative expensesInterest (income) expense, netCost of salesSelling, general and administrative expensesInterest (income) expense, net
Gain (loss) on hedges recognized in income:
Interest rate swaps designated as fair value hedges:
Derivative instrument$ $ $(10)$ $ $(11)
Hedged items  10   11 
Foreign currency contracts designated as fair value hedges:
Derivative instrument 29   10  
Hedged items (29)  (10) 
Foreign currency contracts designated as cash flow hedges:
Amount reclassified from OCI1   5   
Commodity contracts designated as cash flow hedges:
Amount reclassified from OCI(1)  1   
Total gain (loss) on hedges recognized in income$ $ $ $6 $ $ 



95

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
The following table presents the location and amount of unrealized gains (losses) on hedges included in OCI:
 Twelve Months Ended
December 31,
20202019
Foreign currency contracts designated as cash flow hedges:
Gain (loss) recognized in OCI$(11)$(9)
Forward-starting interest rate swaps designated as cash flow hedges:
Gain (loss) recognized in OCI5  
Commodity contracts designated as cash flow hedges:
Gain (loss) recognized in OCI3  
Foreign currency contracts designated as net investment hedges:
Gain (loss) on instruments(52)4 
Gain (loss) on hedged items52 (4)
Foreign currency debt designated as net investment hedges:
Gain (loss) on instruments(356)12 
Gain (loss) on hedged items356 (12)
Total unrealized gain (loss) on hedges recognized in OCI$(3)$(9)



96

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
8.    Capital Stock and Stock-Based Compensation Plans

Preference Stock

The Company has the authority to issue 50,262,150 shares of preference stock. 

Stock Repurchases

On June 18, 2018, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2018 Program”), which replaced a previously authorized share repurchase program. The Company commenced repurchases of shares of the Company’s common stock under the 2018 Program beginning June 19, 2018. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors. The Company repurchased its common stock at a cost of $1,476 during 2020 under the 2018 Program.

The Company may use either authorized and unissued shares or treasury shares to meet share requirements resulting from the exercise of stock options and the vesting of restricted stock unit awards.

A summary of common stock and treasury stock activity for the three years ended December 31 is as follows:
  Common Stock OutstandingTreasury Stock
Balance, January 1, 2018874,701,118 591,005,242 
Common stock acquired(18,786,897)18,786,897 
Shares issued for stock options6,040,920 (6,040,920)
Shares issued for restricted stock units and other957,651 (957,651)
Balance, December 31, 2018862,912,792 602,793,568 
Common stock acquired(17,219,642)17,219,642 
Shares issued for stock options8,145,777 (8,145,777)
Shares issued for restricted stock units and other862,852 (862,852)
Balance, December 31, 2019854,701,779 611,004,581 
Common stock acquired(18,701,843)18,701,843 
Shares issued for stock options13,018,354 (13,018,354)
Shares issued for restricted stock units and other875,311 (875,311)
Balance, December 31, 2020849,893,601 615,812,759 

97

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
Stock-Based Compensation

The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units, based on the fair value of those awards at the date of grant. The fair value of restricted stock units, generally based on market prices, is amortized on a straight-line basis over the requisite service period. The estimated fair value of stock options on the date of grant is amortized on a straight-line basis over the requisite service period for each separately vesting portion of the award. Awards to employees eligible for retirement prior to the award becoming fully vested are recognized as compensation cost from the grant date through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award.

The Company has one incentive compensation plan pursuant to which it issues restricted stock units (both performance-based and time-vested) and stock options to employees and shares of common stock and stock options to non-employee directors. The Personnel and Organization Committee of the Board of Directors, which is comprised entirely of independent directors, administers the incentive compensation plan. The total stock-based compensation expense charged against pretax income for this plan was $107, $100 and $109 for the years ended December 31, 2020, 2019 and 2018, respectively. The total income tax benefit recognized on stock-based compensation, excluding excess tax benefits discussed below, was approximately $20, $20 and $25 for the years ended December 31, 2020, 2019 and 2018, respectively.

Stock-based compensation expense is recorded within Selling, general and administrative expenses in the Corporate segment as these amounts are not included in internal measures of segment operating performance.

The Company uses the Black-Scholes option pricing model to estimate the fair value of stock option awards. The weighted-average estimated fair value of stock options granted in the years ended December 31, 2020, 2019 and 2018 was $11.26, $10.48 and $9.48, respectively. Fair value is estimated using the Black-Scholes option pricing model with the assumptions summarized in the following table:

  202020192018
Expected term of options6 years6 years4.5 years
Expected volatility rate21.8 %19.2 %17.7 %
Risk-free interest rate0.5 %1.5 %2.8 %
Expected dividend yield2.3 %2.3 %2.5 %

The weighted-average expected term of options granted each year was determined with reference to historical exercise and post-vesting cancellation experience, the vesting period of the awards and the contractual term of the awards, among other factors. Expected volatility incorporates implied share-price volatility derived from exchange traded options on the Company’s common stock. The risk-free interest rate for the expected term of the option is based on the yield of a zero-coupon U.S. Treasury bond with a maturity period equal to the option’s expected term.

98

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
Performance-based Restricted Stock Units

In 2019, the Company evolved its approach to granting long-term incentive compensation from granting time-vested restricted stock units following the conclusion of a three-year performance cycle to granting officers and other key employees a target number of unearned performance-based restricted stock units at the beginning of each three-year performance cycle. Awards are earned and vest following the conclusion of the performance period on the basis of achievement of performance goals established at the commencement of each three-year performance period.

A summary of performance-based restricted stock unit activity for the year ended December 31, 2020 is presented below:

  Shares
(in thousands)
Weighted Average Grant Date Fair Value Per Award
Performance-based restricted stock units as of January 1, 2020346 $67 
Activity:
Granted557 76 
Forfeited(38)69 
Performance-based restricted stock units as of December 31, 2020865 $73 


As of December 31, 2020, there was $41 of total unrecognized compensation expense related to unvested performance-based restricted stock unit awards, which will be recognized ratably over the remaining performance period.

The Company uses a Monte-Carlo simulation model to estimate the fair value of performance-based restricted stock units at the date of grant.

Time-Vested Restricted Stock Units

The Company also grants time-vested restricted stock unit awards. As described above, under the Company’s previous long-term incentive program, time-vested restricted stock unit awards were granted to officers and other key employees following a three-year performance period. Awards vest at the end of the restriction period, which is three years from the date of grant. The most recent award granted under the previous long-term incentive program was in 2018 for the 2015-2017 performance period. No awards were granted for the 2016-2018 or 2017-2019 performance periods. Awards for the 2018-2020 performance period will be granted in 2021. As of December 31, 2020, approximately 12,420,000 shares of common stock were available for future restricted stock unit awards.

A summary of restricted stock unit activity during 2020 is presented below:
  Shares
(in thousands)
Weighted Average Grant Date Fair Value Per Award
Restricted stock units as of January 1, 20202,203 $71 
Activity:
Granted727 77 
Vested(1,130)74 
Forfeited(63)71 
Restricted stock units as of December 31, 20201,737 $73 

99

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
As of December 31, 2020, there was $58 of total unrecognized compensation expense related to unvested restricted stock unit awards, which will be recognized over a weighted-average period of 2.1 years. The total fair value of restricted stock units vested during the years ended December 31, 2020, 2019 and 2018 was $58, $53 and $55, respectively.

Stock Options

The Company issues non-qualified stock options to non-employee directors, officers and other employees. Beginning in 2019, stock options have a contractual term of eight years. Prior to 2019, stock options generally had a contractual term of six years. Stock options generally vest ratably over three years. As of December 31, 2020, approximately 36,144,000 shares of common stock were available for future stock option grants.

A summary of stock option activity during 2020 is presented below:
  Shares
(in thousands)
Weighted Average Exercise PriceWeighted Average Remaining Contractual Life
(in years)
Intrinsic Value of Unexercised
In-the-Money Options
Options outstanding, January 1, 202036,185 $69 
Granted4,976 76   
Exercised(13,019)67   
Forfeited or expired(601)72   
Options outstanding, December 31, 202027,541 72 4$386 
Options exercisable, December 31, 202018,084 $70 3$274 

As of December 31, 2020, there was $32 of total unrecognized compensation expense related to unvested options, which will be recognized over a weighted-average period of 1.5 years. The total intrinsic value of options exercised during the years ended December 31, 2020, 2019 and 2018 was $136, $84 and $92, respectively.

The benefits of tax deductions in excess of grant date fair value resulting from the exercise of stock options and vesting of restricted stock unit awards for the years ended December 31, 2020, 2019 and 2018 were $8, $6 and $12, respectively, and are recognized in the provision for income taxes as a discrete item in the quarterly period in which they occur and classified as an operating cash flow. Cash proceeds received from options exercised for the years ended December 31, 2020, 2019 and 2018 were $874, $498 and $329, respectively.

100

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
9.    Employee Stock Ownership Plan

In 1989, the Company expanded its Employee Stock Ownership Plan (ESOP) through the introduction of a leveraged ESOP that funds certain benefits for employees who have met eligibility requirements. As of December 31, 2020 and 2019, there were 11,545,950 and 13,359,448 shares of common stock, respectively, outstanding and issued to the Companys ESOP.

During 2000, the ESOP entered into a loan agreement with the Company under which the benefits of the ESOP may be extended through 2035. As of December 31, 2020, the ESOP had outstanding borrowings from the Company of $1, which represents unearned compensation shown as a reduction in Shareholders’ equity.

Dividends on stock held by the ESOP are paid to the ESOP trust and, together with cash contributions from the Company, are (a) used by the ESOP to repay principal and interest, (b) credited to participant accounts or (c) used for contributions to the Company’s defined contribution plans. Stock is allocated to participants based upon the ratio of the current year’s debt service to the sum of total outstanding principal and interest payments over the life of the debt. As of December 31, 2020, 10,454,105 shares of common stock had been released and allocated to participant accounts and 1,091,845 shares of common stock were available for future allocation to participant accounts.

Dividends on the stock used to repay principal and interest or credited to participant accounts are deductible for income tax purposes and, accordingly, are reflected net of their tax benefit in the Consolidated Statements of Changes in Shareholders’ Equity.

Annual expense related to the ESOP was $0 in 2020, 2019 and 2018.

The Company paid dividends on the shares held by the ESOP of $23 in 2020, $25 in 2019 and $29 in 2018. The Company did not make any contributions to the ESOP in 2020, 2019 or 2018.

101

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
10.    Retirement Plans and Other Retiree Benefits

Retirement Plans

The Company and certain of its U.S. and foreign subsidiaries maintain defined benefit retirement plans. Benefits under these plans are based primarily on years of service and employees’ earnings.

In the U.S., effective January 1, 2014, the Company provides virtually all future retirement benefits through the Company’s defined contribution plan. As a result, service after December 31, 2013 is not considered for participants in the Company’s principal U.S. defined benefit retirement plan. Participants in the Company’s principal U.S. defined benefit retirement plan whose retirement benefit was determined under the cash balance formula continue to earn interest credits on their vested balances as of December 31, 2013 but no longer receive pay credits. Participants whose retirement benefit was determined under the final average earnings formula or career average earnings formula continue to have their accrued benefit adjusted for pay increases until termination of employment.
102

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
In the Company’s principal U.S. plans and certain funded foreign plans, funds are contributed to trusts in accordance with regulatory limits to provide for current service and for any unfunded projected benefit obligation over a reasonable period. The target asset allocation for the Company’s defined benefit plans is as follows:
  United StatesInternational
Asset Category
Equity securities21 %38 %
Fixed income securities74 %46 %
Real estate and other investments5 %16 %
Total100 %100 %

At December 31, 2020, the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:
 Level of Valuation
Input
Pension Plans 
  United StatesInternationalOther Retiree
Benefit Plans
     
Cash and cash equivalentsLevel 1$50 $12 $ 
U.S. common stocksLevel 1 1  
International common stocksLevel 1 8  
Pooled funds(1)
Level 165 117  
Fixed income securities(2)
Level 21,117 59 2 
Guaranteed investment contracts(3)
Level 21 55  
  1,233 252 2 
Investments valued using NAV per share(4)
  
Domestic, developed and emerging markets equity funds  456 183 1 
Fixed income funds(5)
  136 225  
Hedge funds(6)
   6  
Multi-asset funds(7)
  77 2  
Real estate funds(8)
34 30  
  703 446 1 
Other assets and liabilities, net(9)
(15)  
Total Investments$1,921 $698 $3 

103

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
At December 31, 2019, the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:
 Level of Valuation
Input
Pension Plans 
  United StatesInternationalOther Retiree
Benefit Plans
    
Cash and cash equivalentsLevel 1$41 $15 $1 
U.S. common stocksLevel 149 3 1 
International common stocksLevel 1 3  
Pooled funds(1)
Level 129 104 2 
Fixed income securities(2)
Level 21,067 14 20 
Guaranteed investment contracts(3)
Level 21 42  
  1,187 181 24 
Investments valued using NAV per share(4)
  
Domestic, developed and emerging markets equity funds  328 165 7 
Fixed income funds(5)
  177 196 3 
Hedge funds(6)
  3 17  
Multi-asset funds(7)
  155 2 2 
Real estate funds(8)
41 25 1 
704 405 13 
Other assets and liabilities, net(9)
(85)  
Total Investments  $1,806 $586 $37 
_______
(1)Pooled funds primarily invest in U.S. and foreign equity securities, debt and money market securities.
(2)The fixed income securities are traded over-the-counter and certain of these securities lack daily pricing or liquidity and as such are classified as Level 2. As of both December 31, 2020 and 2019, approximately 50% of the U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in other government bonds and corporate bonds.
(3)The guaranteed investment contracts (“GICs”) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption.
(4)Investments that are measured at fair value using net asset value (“NAV”) per share as a practical expedient have not been classified in the fair value hierarchy. The NAV is based on the value of the underlying investments owned, minus its liabilities, divided by the number of shares outstanding. There are no unfunded commitments related to these investments. Redemption notice period primarily ranges from 0-3 months and redemption frequency windows range from daily to quarterly.
(5)Fixed income funds primarily invest in U.S. government and investment grade corporate bonds.
(6)Consists of investments in underlying hedge fund strategies that are primarily implemented through the use of long and short equity and fixed income securities and derivative instruments such as futures and options.
(7)Multi-asset funds primarily invest across a variety of asset classes, including global stocks and bonds, as well as alternative strategies.
(8)Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager.
(9)This category primarily includes unsettled trades for investments purchased and sold and dividend receivables.
104

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
Equity securities in the U.S. plans include investments in the Company’s common stock representing 0% and 3% of U.S. plan assets at December 31, 2020 and December 31, 2019, respectively. In 2020 and 2019, the U.S. plans sold 739,869 and 588,334 shares, respectively, of the Company’s common stock to the Company. No shares of the Company’s stock were purchased by the U.S. plans in 2020 or 2019. The plans received dividends on the Company’s common stock of $0 in 2020 and $2 in 2019.

Other Retiree Benefits

The Company and certain of its subsidiaries provide health care and life insurance benefits for retired employees to the extent not provided by government-sponsored plans.

The Company uses a December 31 measurement date for its defined benefit and other retiree benefit plans. Summarized information for the Company’s defined benefit and other retiree benefit plans is as follows:
105

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)

  Pension PlansOther Retiree Benefit Plans
 202020192020201920202019
  United StatesInternational  
Change in Benefit Obligations      
Benefit obligations at beginning of year$2,272 $2,147 $876 $787 $1,050 $876 
Service cost1 1 17 14 20 15 
Interest cost74 90 21 22 37 41 
Participants’ contributions  5 2   
Acquisitions/plan amendments  30 3   
Actuarial loss (gain)171 181 65 82 61 166 
Foreign exchange impact  46 8 (9)1 
Termination benefits3 7     
Curtailments and settlements(3) (7)(9)  
Benefit payments(155)(154)(40)(35)(47)(49)
Other   2   
Benefit obligations at end of year$2,363 $2,272 $1,013 $876 $1,112 $1,050 
Change in Plan Assets  
Fair value of plan assets at beginning of year$1,806 $1,568 $586 $510 $37 $54 
Actual return on plan assets243 262 59 76 2 8 
Company contributions30 130 36 30 11 24 
Participants’ contributions  5 2   
Foreign exchange impact  26 12   
Settlements and acquisitions(3) 26 (9)  
Benefit payments(155)(154)(40)(35)(47)(49)
Other      
Fair value of plan assets at end of year$1,921 $1,806 $698 $586 $3 $37 
Funded Status  
Benefit obligations at end of year$2,363 $2,272 $1,013 $876 $1,112 $1,050 
Fair value of plan assets at end of year1,921 1,806 698 586 3 37 
Net amount recognized$(442)$(466)$(315)$(290)$(1,109)$(1,013)
Amounts Recognized in Balance Sheet    
Noncurrent assets$20 $ $18 $13 $ $ 
Current liabilities(30)(28)(14)(13)(45)(13)
Noncurrent liabilities(432)(438)(319)(290)(1,064)(1,000)
Net amount recognized$(442)$(466)$(315)$(290)$(1,109)$(1,013)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
  
Actuarial loss$902 $910 $255 $238 $429 $388 
Transition/prior service cost1 1 7 7  (1)
  $903 $911 $262 $245 $429 $387 
Accumulated benefit obligation$2,325 $2,236 $946 $816 $ $ 

106

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)

  Pension PlansOther Retiree Benefit Plans
  202020192020201920202019
  United StatesInternational  
Weighted-Average Assumptions Used to Determine Benefit Obligations
      
Discount rate2.65 %3.40 %1.61 %2.06 %2.88 %3.56 %
Expected long-term rate of return on plan assets5.70 %6.30 %2.93 %3.38 %5.70 %6.30 %
Long-term rate of compensation increase3.50 %3.50 %2.62 %2.83 %3.50 %3.50 %
ESOP growth rate % % % %10.00 %10.00 %
Medical cost trend rate of increase % % % %6.00 %6.00 %
Interest Crediting Rate2.48 %3.21 %0.83 %0.85 % % %

The actuarial losses incurred during 2020 were primarily driven by a decrease in discount rates applied against future expected benefit payments that resulted in an increase in the benefit obligation for both the U.S. pension and Other retiree benefit plans. The actuarial gains recorded during 2019 for both the U.S. pension and other retiree benefit plans were primarily a result of an increase in discount rates applied against future estimated benefit payments.
The overall investment objective of the plans is to balance risk and return so that obligations to employees are met. The Company evaluates its expected long-term rate of return on plan assets on an annual basis. In determining the expected long-term rate of return, the Company considers the nature of the plans’ investments and the historical rates of return. The assumed expected long-term rate of return on plan assets as of December 31, 2020 for the U.S. plans was 5.70%. Average annual rates of return for the U.S. plans for the most recent 1-year, 5-year, 10-year, 15-year and 25-year periods were 15%, 9%, 8%, 7% and 7%, respectively. Similar assessments were performed in determining rates of return on international pension plan assets to arrive at the Company’s 2020 weighted-average expected long-term rate of return on plan assets of 2.93%.

The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 6.00% in 2021 to 4.75% by 2026, remaining at 4.75% for the years thereafter.





107

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
Pension plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consisted of the following:
  20202019
Benefit Obligation Exceeds Fair Value of Plan Assets  
Projected benefit obligation$1,092 $2,862 
Fair value of plan assets299 2,094 
Accumulated benefit obligation882 875 
Fair value of plan assets134 166 

Other Retiree Benefit plans with accumulated postretirement benefit obligation in excess of plan assets as of December 31 consisted of the following:
  20202019
Benefit Obligation Exceeds Fair Value of Plan Assets  
Accumulated postretirement benefit obligation$1,112 $958 
Fair value of plan assets3 37 

Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows:
108

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
  Pension PlansOther Retiree Benefit Plans
  202020192018202020192018202020192018
  United StatesInternational   
Components of Net Periodic Benefit Cost
         
Service cost$1 $1 $1 $17 $14 $14 $20 $15 $16 
Interest cost74 90 86 21 22 21 37 41 38 
Expected return on plan assets
(111)(103)(115)(22)(19)(21)(2)(3)(2)
Amortization of transition and prior service costs (credits)
    1     
Amortization of actuarial loss
46 51 47 9 9 8 18 11 14 
Net periodic benefit cost$10 $39 $19 $25 $27 $22 $73 $64 $66 
Other postretirement charges
4 7 9  1 2    
Total pension cost$14 $46 $28 $25 $28 $24 $73 $64 $66 
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
         
Discount rate3.40 %4.38 %3.73 %

2.06 %2.80 %2.53 %3.56 %4.43 %3.80 %
Expected long-term rate of return on plan assets6.30 %6.60 %6.60 %3.38 %4.06 %4.04 %6.30 %6.60 %6.60 %
Long-term rate of compensation increase
3.50 %3.50 %3.50 %2.83 %2.86 %2.79 % % % %
ESOP growth rate % % % % % %10.00 %10.00 %10.00 %
Medical cost trend rate of increase % % % % % %6.00 %6.00 %6.00 %
Interest Crediting Rate3.21 %4.26 %3.73 %0.85 %0.85 %0.85 % % % %

109

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
The service related component of pension and other postretirement benefit costs is included in Operating profit. The non-service related components (interest cost, expected return on assets and amortization of actuarial gains and losses) are included in the line item “Non-service related postretirement costs,” which is below Operating profit.

Other postretirement charges in 2020, 2019 and 2018 include pension and other benefit enhancements amounting to $3, $7 and $9, respectively. Other postretirement charges from 2019 and 2018 were incurred pursuant to the Global Growth and Efficiency Program. Other postretirement charges in 2019 also include charges of $1, in part due to retirements under the Global Growth and Efficiency Program.

The Company made voluntary contributions of $0, $113 and $67 in 2020, 2019 and 2018, respectively, to its U.S. retirement plans.

Expected Contributions and Benefit Payments

The Company does not expect to make any voluntary contributions to its U.S. postretirement plans for the year ending December 31, 2021. Actual funding may differ from current estimates depending on the variability of the market value of the assets as compared to the obligation and other market or regulatory conditions.

Benefit payments expected to be paid from the Company’s assets to participants in unfunded plans are estimated to be approximately $90 for the year ending December 31, 2021.

Total benefit payments expected to be paid to participants in both funded and unfunded plans are estimated as follows:
  Pension Plans 
Years Ended December 31,United StatesInternationalOther Retiree Benefit PlansTotal
2021$154 $42 $49 $245 
2022156 41 49 246 
2023157 42 50 249 
2024156 46 51 253 
2025155 45 52 252 
2026-2030741 244 269 1,254 

110

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
11.    Income Taxes

The components of Income before income taxes are as follows for the years ended December 31:
  202020192018
United States$1,317 $1,050 $1,175 
International2,330 2,251 2,289 
Total Income before income taxes$3,647 $3,301 $3,464 

The Provision for income taxes consists of the following for the years ended December 31:
  202020192018
United States$259 $180 $213 
International528 594 693 
Total Provision for income taxes$787 $774 $906 

Temporary differences between accounting for financial statement purposes and accounting for tax purposes result in the current provision for taxes being higher (lower) than the total provision for income taxes as follows:
  202020192018
Goodwill and intangible assets$1 $34 $2 
Property, plant and equipment12 12 (15)
Pension and other retiree benefits10 (13)(7)
Stock-based compensation(7)(1)9 
Right-of-use assets/lease liabilities(1)  
Tax credits and tax loss carryforwards(1)3 (4)
Deferred withholding tax111 (21)(100)
Other, net18 (33)62 
Total deferred tax benefit (provision)$143 $(19)$(53)

111

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
The difference between the statutory U.S. federal income tax rate and the Company’s global effective tax rate as reflected in the Consolidated Statements of Income is as follows:
Percentage of Income before income taxes202020192018
Tax at United States statutory rate21.0 %21.0 %21.0 %
State income taxes, net of federal benefit1.0 0.6 1.0 
Earnings taxed at other than United States statutory rate3.3 4.6 5.6 
Charge for U.S. tax reform(1)
  2.3 
Foreign tax credit carryback(2)
  (1.7)
Benefit for foreign tax matters(3)
(2.0)(0.9)(0.4)
Foreign-derived intangible income benefit(1.6)(1.3)(1.1)
Other, net(0.1)(0.6)(0.5)
Effective tax rate21.6 %23.4 %26.2 %
_________
(1)On December 22, 2017, the Tax Cuts and Jobs Act (the “TCJA”) was enacted, which, among other things, lowered the U.S. corporate income tax rate to 21% from 35% and established a modified territorial system requiring a mandatory deemed repatriation tax on undistributed earnings of foreign subsidiaries. Beginning in 2018, the TCJA also requires a minimum tax on certain earnings generated by foreign subsidiaries while providing for tax-free repatriation of such earnings through a 100% dividends-received deduction. The Company’s effective income tax rate in 2017 included a provisional charge of $275, recorded in the fourth quarter of 2017, based on its initial analysis of the TCJA using information and estimates available as of February 15, 2018, the date on which the Company filed its Annual Report on Form 10-K for the year ended December 31, 2017. During 2018, the Company finalized its assessment of the impact of the TCJA and recognized an additional tax expense of $80 reflecting the impact of transition tax guidance issued by the U.S. Treasury and the update of certain estimates and calculations based on information available through the end of 2018. Any further guidance issued after December 31, 2018 may have an impact to the Company’s Provision for income tax in the period such guidance is effective.
(2)In 2018, the Company generated excess foreign taxes associated with its foreign branch operations which are being carried back to 2017. This item is not expected to be recurring.
(3)In 2020, the provision for income taxes includes $71 of income tax benefits recorded on a discrete period basis, of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As part of the previously recorded charge for the TCJA, the Company has provided for foreign withholding taxes expected to be paid on the remittance of earnings from certain overseas subsidiaries no longer deemed indefinitely reinvested. As a result of a recent reorganization of the ownership structure of certain foreign subsidiaries, the Company determined that no withholding taxes will be due on the remittance by certain subsidiaries of earnings previously deemed reinvested and, accordingly, reversed $45 of previously recorded foreign withholding taxes. Also as part of the previously recorded charge for the TCJA, the Company provided a valuation allowance against a deferred tax asset related to the foreign tax credit carryforwards that the Company did not expect to be able to use due to changes made by the TCJA. As a result of a new operating structure being implemented within one of the Company's divisions, the Company believes the use of these foreign tax credit carryforwards will not be limited in the future and, accordingly, reversed the previously recorded valuation allowance of $26. In 2019, the provision for income taxes includes a net benefit of $29 related to changes enacted by the Swiss government to its corporate tax regime, which included, among other items, the repeal of certain preferential tax regimes and an increase to the cantonal tax rate for future periods. Additionally, the government provided transition rules which allowed companies to record goodwill for tax purposes, partially offsetting the impact on cash taxes of the higher cantonal rate over the next ten years. In 2018, the provision for income taxes includes a benefit of $15 related to several Supreme Court and Administrative Court rulings in a foreign jurisdiction allowing certain tax deductions which had the effect of reversing prior decisions.


112

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
The components of deferred tax assets (liabilities) are as follows at December 31:
  20202019
Deferred tax liabilities: 
Goodwill and intangible assets$(603)$(598)
Property, plant and equipment(281)(303)
Right-of-use assets(131)(135)
Deferred withholding tax(95)(207)
Other(52)(46)
Total deferred tax liabilities(1,162)(1,289)
Deferred tax assets: 
Pension and other retiree benefits404 381 
Tax credits and tax loss carryforwards42 93 
Lease liabilities144 152 
Accrued liabilities250 221 
Stock-based compensation73 88 
Other125 83 
Total deferred tax assets1,038 1,018 
Valuation Allowance$(11)$(59)
Net deferred tax assets$1,027 $959 
Net deferred income taxes$(135)$(330)

20202019
Deferred taxes included within:  
Assets:
Deferred income taxes$291 $177 
Liabilities:
Deferred income taxes(426)(507)
Net deferred income taxes$(135)$(330)

Applicable U.S. income and foreign withholding taxes have been provided on substantially all of the Company’s accumulated earnings of foreign subsidiaries.

Net tax benefits of $101, $13 and $2 were recorded directly through equity in 2020, 2019 and 2018, respectively. The net tax benefits in 2020 and 2019 predominantly include current and future tax impacts related to benefit plans. The amount in 2018 includes current and future tax impacts related to employee equity compensation and benefit plans.

The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return.

113

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
Unrecognized tax benefits activity for the years ended December 31, 2020, 2019 and 2018 is summarized below:
  202020192018
Unrecognized tax benefits:   
Balance, January 1$173 $190 $214 
Increases as a result of tax positions taken during the current year18 14 14 
Decreases of tax positions taken during prior years(5)(21)(37)
Increases of tax positions taken during prior years57 20 9 
Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations
(19)(30)(6)
Effect of foreign currency rate movements
3  (4)
Balance, December 31$227 $173 $190 

If all of the unrecognized tax benefits for 2020 above were recognized, approximately $213 would impact the effective tax rate and would result in a cash outflow of approximately $223. Although it is possible that the amount of unrecognized benefits with respect to our uncertain tax positions will increase or decrease in the next twelve months, the Company does not expect material changes.

The Company recognized approximately $9 of interest expense, $0 of interest expense, $1 of interest benefit related to the above unrecognized tax benefits within income tax expense in 2020, 2019 and 2018, respectively. The Company had accrued interest of approximately $24, $23 and $27 as of December 31, 2020, 2019 and 2018, respectively.

The Company and its subsidiaries file U.S. federal income tax returns as well as income tax returns in many state and foreign jurisdictions. All U.S. federal income tax returns through December 31, 2013 have been audited by the IRS and there are limited matters which the Company plans to appeal for years 2010 through 2013, the settlement of which is not expected to have a material effect on the Company’s results of operations, cash flows or financial condition. With a few exceptions, the Company is no longer subject to U.S. state and local income tax examinations for income tax returns through December 31, 2015. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations for tax audits generally ranging from three to six years.

The Company has made an accounting policy election to treat Global Intangible Low-Taxed Income taxes as a current period expense rather than including these amounts in the measurement of deferred taxes.

114

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
12.    Earnings Per Share

For the years ended December 31, 2020, 2019 and 2018, earnings per share were as follows:
 202020192018
 Net income attributable to Colgate-Palmolive CompanyShares
(millions)
Per
Share
Net income attributable to Colgate-Palmolive CompanyShares
(millions)
Per
Share
Net income attributable to Colgate-Palmolive CompanyShares
(millions)
Per
Share
Basic EPS$2,695 856.8 $3.15 $2,367 859.1 $2.76 $2,400 870.6 $2.76 
Stock options and restricted stock units
2.5   2.0   2.4  
Diluted EPS$2,695 859.3 $3.14 $2,367 861.1 $2.75 $2,400 873.0 $2.75 

Basic earnings per common share is computed by dividing net income available for common stockholders by the weighted-average number of shares of common stock outstanding for the period.

Diluted earnings per common share is computed using the treasury stock method on the basis of the weighted-average number of shares of common stock plus the dilutive effect of potential common shares outstanding during the period. Dilutive potential common shares include outstanding stock options and restricted stock units.

As of December 31, 2020, 2019 and 2018, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 3,257,310, 19,901,202 and 18,039,961, respectively. As of December 31, 2020, 2019 and 2018, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 25,381, 4,516 and 9,529, respectively.

115

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
13.    Commitments and Contingencies

As of December 31, 2020, the Company has various contractual commitments for future multi-year purchases of raw, packaging and other materials totaling approximately $715.

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $425 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $113. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001.

In each of September 2015, February 2017, June 2018, April 2019 and September 2020, the Company lost an administrative appeal and subsequently filed an appeal in Brazilian federal court. Currently, there are five appeals pending in the Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously.
116

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
 
In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.
 
In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $50, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal, and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.

Competition Matter

Certain of the Company’s subsidiaries were historically subject to actions and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status as of December 31, 2020 of such competition law matters pending against the Company during the year ended December 31, 2020 is set forth below.

In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11. The Company appealed the decision to the Greek courts. In April 2019, the Greek courts affirmed the judgment against the Company’s Greek subsidiary, but reduced the fine to $10.5 and dismissed the case against Colgate-Palmolive Company. The Company’s Greek subsidiary and the Greek competition authority have appealed the decision to the Greek Supreme Court.
117

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)

Talcum Powder Matters

The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of December 31, 2020, there were 137 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 121 cases as of December 31, 2019. During the year ended December 31, 2020, 65 new cases were filed and 49 cases were resolved by voluntary dismissal, settlement or dismissal by the court. The value of the settlements in the years presented was not material, either individually or in the aggregate, to each such period’s results of operations.

A significant portion of the Company’s costs incurred in defending and resolving these claims has been, and the Company believes will continue to be, covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions and policy limits.

While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. With the exception of one case where the Company received an adverse jury verdict in the second quarter of 2019 that the Company has appealed, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases because the amount of any possible losses from such cases currently cannot be reasonably estimated.

ERISA Matter

In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals (the “Company Defendants”) in the United States District Court for the Southern District of New York (the “Court”). The relief sought includes recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. This action was certified as a class action in July 2017. In July 2020, the Court granted in part and denied in part the Company Defendants’ motion for summary judgment and dismissed certain claims on consent of the parties. In August 2020, the Court granted the plaintiffs’ motion for summary judgment on the remaining claims. The Company and the Plan are contesting this action vigorously and, in September 2020, appealed to the United States Court of Appeals for the Second Circuit.







118

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
14.    Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. 

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Approximately 70% of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Wal-Mart, Inc. and its affiliates represent approximately 12% of the Company’s Net sales in 2020. No other customer represents more than 10% of Net sales.

In 2020, Corporate Operating profit included benefits of $16 resulting from the Global Growth and Efficiency Program and a charge of $6 for acquisition-related costs. In 2019, Corporate Operating profit included charges of $125 resulting from the Global Growth and Efficiency Program, a charge of $24 for acquisition-related costs and a benefit of $30 from a value-added tax matter in Brazil. In 2018, Corporate Operating Profit included charges of $152 resulting from the Global Growth and Efficiency Program.

 202020192018
Net sales  
Oral, Personal and Home Care  
North America(1)
$3,741 $3,424 $3,348 
Latin America3,418 3,606 3,605 
Europe2,747 2,450 2,502 
Asia Pacific2,701 2,707 2,734 
Africa/Eurasia981 981 967 
Total Oral, Personal and Home Care13,588 13,168 13,156 
Pet Nutrition(2)
2,883 2,525 2,388 
Total Net sales$16,471 $15,693 $15,544 
_________
(1)    Net sales in the U.S. for Oral, Personal and Home Care were $3,447, $3,166 and $3,091 in 2020, 2019 and 2018, respectively.
(2)    Net sales in the U.S. for Pet Nutrition were $1,712, $1,441 and $1,304 in 2020, 2019 and 2018, respectively.
119

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
202020192018
Operating profit  
Oral, Personal and Home Care  
North America$988 $982 $1,037 
Latin America975 963 995 
Europe652 624 634 
Asia Pacific773 749 777 
Africa/Eurasia206 187 173 
Total Oral, Personal and Home Care3,594 3,505 3,616 
Pet Nutrition793 703 680 
Corporate(502)(654)(602)
Total Operating profit$3,885 $3,554 $3,694 

202020192018
Capital expenditures  
Oral, Personal and Home Care  
North America$65 $43 $53 
Latin America104 90 131 
Europe41 42 39 
Asia Pacific51 40 75 
Africa/Eurasia13 8 11 
Total Oral, Personal and Home Care274 223 309 
Pet Nutrition56 41 35 
Corporate79 71 92 
Total Capital expenditures$409 $335 $436 

202020192018
Depreciation and amortization  
Oral, Personal and Home Care  
North America$101 $94 $88 
Latin America81 84 82 
Europe94 72 70 
Asia Pacific95 100 103 
Africa/Eurasia9 8 8 
Total Oral, Personal and Home Care380 358 351 
Pet Nutrition58 55 53 
Corporate101 106 107 
Total Depreciation and amortization$539 $519 $511 

120

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
202020192018
Identifiable assets
Oral, Personal and Home Care   
North America$4,132 $3,576 $3,310 
Latin America2,251 2,384 2,225 
Europe5,386 5,104 2,883 
Asia Pacific2,272 2,155 2,148 
Africa/Eurasia605 590 502 
Total Oral, Personal and Home Care14,646 13,809 11,068 
Pet Nutrition1,210 1,175 1,033 
Corporate(1)
64 50 60 
Total Identifiable assets(2)
$15,920 $15,034 $12,161 
____________
(1)In 2020, Corporate identifiable assets primarily consist of investments in equity securities (95%). In 2019, Corporate identifiable assets primarily consist of derivative instruments (2%) and investments in equity securities (92%). In 2018, Corporate identifiable assets primarily consist of derivative instruments (7%) and investments in equity securities (88%). 
(2)Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $10,911 in 2020, one-third of total long-lived assets of $10,192 in 2019, and one-half of total long-lived assets of $8,259 in 2018.

121

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)

15.    Leases

The Company adopted ASU No. 2016-02 “Leases (Topic 842)” on January 1, 2019, resulting in the recognition of right-of-use assets of $458 and liabilities of $574. The Company enters into leases for land, office space, warehouses and equipment. A number of the leases include one or more options to renew the lease terms, purchase the leased property or terminate the lease. The exercise of these options is at the Company’s discretion and is therefore recognized on the balance sheet when it is reasonably certain the Company will exercise such options. As the Company’s leases typically do not contain a readily determinable implicit rate, the Company determines the present value of the lease liability using its incremental borrowing rate at the lease commencement date.

Substantially all of the Company’s leases are considered operating leases. Finance leases were not material as of December 31, 2020 and 2019.

As of December 31, 2020 and 2019, the Company’s right-of use assets and liabilities for operating leases were as follows:
20202019
Other assets$521 $502 
Other accruals$137 $145 
Other liabilities476 491 
Total operating lease liabilities $613 $636 

Lease liabilities for operating leases as of December 31, 2020 were as follows:
2021$157 
2022133 
202389 
202458 
202546 
Thereafter232 
Total lease commitments$715 
Less: Interest(102)
Present value of lease liabilities$613 

The components of the Company’s operating lease cost for the twelve months ended December 31, 2020 and 2019 were as follows:
20202019
Operating lease cost$155 $169 
Short-term lease cost3 5 
Variable lease cost20 30 
Total lease cost$178 $204 

Short-term lease cost represents the Company’s cost with respect to leases with a duration of 12 months or less and is not reflected on the Company’s Consolidated Balance Sheets. Variable lease costs are comprised of costs, such as the Company’s proportionate share of actual costs for utilities, common area maintenance, property taxes and insurance, that are not included in the lease liability and are recognized in the period in which they are incurred.

122

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
Supplemental cash flow information related to operating leases for the twelve months ended December 31, 2020 and 2019 was as follows:
Payments against amounts included in the measurement of lease liabilities: $193 and $202, respectively
Lease assets obtained in exchange for lease liabilities: $163 and $232, respectively.

As of December 31, 2020 and 2019, the weighted-average remaining lease term for operating leases was 8 and 8 years, respectively, and the weighted-average discount rate for operating leases was 4.2% and 4.1%, respectively.

There were no material operating leases that the Company had entered into and that were yet to commence as of December 31, 2020.




123

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
16.    Supplemental Income Statement Information

Other (income) expense, net202020192018
Global Growth and Efficiency Program$(13)$57 $88 
Amortization of intangible assets88 62 59 
Equity income(12)(9)(10)
Value-added tax matter in Brazil (30) 
Write-off of certain investments and fixed assets 51 1 
Acquisition-related costs2 21  
Charges for a change in go-to-market strategy in certain countries 15  
Other, net48 29 10 
Total Other (income) expense, net$113 $196 $148 

Interest (income) expense, net202020192018
Interest incurred$184 $193 $195 
Interest capitalized(1)(1)(2)
Interest income(19)(47)(50)
Total Interest (income) expense, net$164 $145 $143 

 202020192018
Research and development$290 $281 $277 
Advertising$1,948 $1,694 $1,590 








124

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
17.    Supplemental Balance Sheet Information

Inventories by major class are as follows at December 31:
Inventories20202019
Raw materials and supplies$454 $305 
Work-in-process45 49 
Finished goods1,256 1,056 
        Total Inventories, net
$1,755 $1,410 
              Non-current inventory, net(82)(10)
                    Current Inventories, net
$1,673 $1,400 

Inventories valued under LIFO amounted to $439 and $303 at December 31, 2020 and 2019, respectively. The excess of current cost over LIFO cost at the end of each year was $65 and $62, respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2020, 2019 and 2018. Inventory classified as non-current at December 31, 2020 was recorded on the Consolidated Balance Sheets as “Other assets.”

Property, plant and equipment, net20202019
Land$166 $153 
Buildings1,623 1,600 
Manufacturing machinery and equipment5,409 5,309 
Other equipment1,553 1,518 
 8,751 8,580 
Accumulated depreciation(5,035)(4,830)
Total Property, plant and equipment, net$3,716 $3,750 

Other accruals20202019
Accrued advertising and coupon redemption$728 $525 
Accrued payroll and employee benefits401 340 
Accrued taxes other than income taxes116 104 
Restructuring accrual21 85 
Pension and other retiree benefits89 54 
Lease Liabilities Due in One Year137 145 
Accrued interest39 43 
Derivatives93 16 
Other717 605 
Total Other accruals$2,341 $1,917 

Other liabilities20202019
Pension and other retiree benefits$1,815 $1,728 
Restructuring accrual10 15 
Long-Term Lease Liabilities476 491 
Other354 364 
Total Other liabilities$2,655 $2,598 

125

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
18.    Supplemental Other Comprehensive Income (Loss) Information

Other comprehensive income (loss) components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows:
 202020192018
PretaxNet of TaxPretaxNet of TaxPretaxNet of Tax
Cumulative translation adjustments$(119)$(30)$49 $27 $(233)$(218)
Pension and other benefits:
   Net actuarial gain (loss), prior
service costs and settlements
during the period
(125)(97)(204)(154)(21)(16)
   Amortization of net actuarial loss,
   transition and prior service costs(1)
74 57 72 54 69 54 
Retirement Plan and other retiree benefit
adjustments
(51)(40)(132)(100)48 38 
Cash flow hedges:
   Unrealized gains (losses) on cash flow
hedges
(3)(2)(9)(7)10 8 
   Reclassification of (gains) losses
   into net earnings on cash flow
   hedges(2)
  (6)(5)3 2 
Gains (losses) on cash flow hedges(3)(2)(15)(12)13 10 
Total Other comprehensive income (loss)$(173)$(72)$(98)$(85)$(172)$(170)
_________
(1)These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.
(2)These (gains) losses are reclassified into Cost of sales. See Note 7, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.

Accumulated Other Comprehensive Income (Loss)

Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments designated as cash flow hedges. At December 31, 2020 and 2019, Accumulated other comprehensive income (loss) consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $1,178 and $1,138, respectively, and cumulative foreign currency translation adjustments of $3,158 and $3,128, respectively. Foreign currency translation adjustments in 2020 primarily reflect losses from the Brazilian real and the Mexican peso. Foreign currency translation adjustments in 2019 primarily reflect gains from the Thai baht and the Mexican peso.
126

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
19.    Quarterly Financial Data (Unaudited)
  Total First
Quarter
 Second
Quarter
Third
Quarter
Fourth
Quarter
 
2020        
Net sales$16,471  $4,097  $3,897 $4,153 $4,324  
Gross profit10,017 
(1)
2,465 
(3)
2,369 2,540 2,643 
Net income including noncontrolling interests
2,860 
(2)
748 
(4)
675 745 
(5)
692 
(6)
Net income attributable to Colgate-Palmolive Company
2,695 
(2)
715 
(4)
635 698 
(5)
647 
(6)
Earnings per common share:   
Basic3.15 
(2)
0.83 
(4)
0.74 0.81 
(5)
0.76 
(6)
Diluted3.14 
(2)
0.83 
(4)
0.74 0.81 
(5)
0.75 
(6)
2019          
Net sales$15,693  $3,884 $3,866 $3,928 $4,015 
Gross profit9,325 
(7)
2,287 
(9)
2,308 
(11)
2,316 
(13)
2,414 
(15)
Net income including noncontrolling interests
2,527 
(8)
600 
(10)
618 
(12)
627 
(14)
682 
(16)
Net income attributable to Colgate-Palmolive Company
2,367 
(8)
560 
(10)
586 
(12)
578 
(14)
643 
(16)
Earnings per common share:
Basic2.76 
(8)
0.65 
(10)
0.68 
(12)
0.67 
(14)
0.75 
(16)
Diluted2.75 
(8)
0.65 
(10)
0.68 
(12)
0.67 
(14)
0.75 
(16)
____________
Note:    Basic and diluted earnings per share are computed independently for each quarter and the year-to-date period presented. Accordingly, the sum of the quarterly earnings per common share may not necessarily equal the earnings per share for the year-to-date period.

(1)Gross profit for the full year of 2020 includes a $4 charge for acquisition-related costs.
(2)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2020 include aftertax benefits of $13 resulting from the Global Growth and Efficiency Program, a $4 aftertax charge for acquisition-related costs, a $71 tax benefit related to subsidiary and operating structure initiatives and a $18 aftertax loss on the early extinguishment of debt.
(3)Gross profit for the first quarter of 2020 includes a $4 charge for acquisition-related costs.
(4)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2020 include a $4 aftertax charge for acquisition-related costs and a $71 tax benefit related to subsidiary and operating structure initiatives.
(5)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2020 include aftertax benefits of $13 resulting from the Global Growth and Efficiency Program.
(6)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2020 include a $18 aftertax loss on the early extinguishment of debt.
(7)Gross profit for the full year of 2019 includes $8 of charges resulting from the Global Growth and Efficiency Program and a $3 charge for acquisition-related costs.
127

COLGATE-PALMOLIVE COMPANY
 Notes to Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(8)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2019 include $102 of aftertax charges resulting from the Global Growth and Efficiency Program, a $20 aftertax charge for acquisition-related costs, a $20 aftertax benefit related to a value added tax matter in Brazil and a $29 tax benefit related to Swiss income tax reform.
(9)Gross profit for the first quarter of 2019 includes $11 of charges resulting from the Global Growth and Efficiency Program.
(10)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2019 include $22 of aftertax charges resulting from the Global Growth and Efficiency Program.
(11)Gross profit for the second quarter of 2019 includes $3 of charges resulting from the Global Growth and Efficiency Program.
(12)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the second quarter of 2019 include $31 of aftertax charges resulting from the Global Growth and Efficiency Program.
(13)Gross profit for the third quarter of 2019 includes $1 of charges resulting from the Global Growth and Efficiency Program.
(14)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2019 include $22 of aftertax charges resulting from the Global Growth and Efficiency Program and a $14 aftertax charge related to U.S. tax reform.
(15)Gross profit for the fourth quarter of 2019 includes $1 of benefit resulting from the Global Growth and Efficiency Program and a $3 charge for acquisition-related costs.
(16)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2019 include $27 of aftertax charges resulting from the Global Growth and Efficiency Program, a $6 charge for acquisition-related costs, a $20 aftertax benefit related to a value added tax matter in Brazil and a $29 tax benefit related to Swiss income tax reform.







128


COLGATE-PALMOLIVE COMPANY
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
(Dollars in Millions)
   Additions  
  Balance at Beginning of PeriodCharged to Costs and ExpensesOtherDeductionsBalance at End of Period
Year Ended December 31, 2020
Allowance for doubtful accounts and estimated returns
$76 $16 $ $3 $89 
Valuation allowance for deferred tax assets$59 $1 $ $49 $11 
Year Ended December 31, 2019     
Allowance for doubtful accounts and estimated returns
$82 $6 $ $12 $76 
Valuation allowance for deferred tax assets$54 $12 $ $7 $59 
Year Ended December 31, 2018     
Allowance for doubtful accounts and estimated returns
$77 $15 $ $10 $82 
Valuation allowance for deferred tax assets$9 $45 $ $ $54 


129


COLGATE-PALMOLIVE COMPANY

Market Information

The Company’s common stock is listed on the New York Stock Exchange and its trading symbol is CL.

Stock Price Performance Graphs

    The following graphs compare cumulative total shareholder returns on Colgate-Palmolive Company common stock against the S&P Composite-500 Stock Index and a peer company index for the twenty-year, ten-year and five-year periods each ended December 31, 2020. The peer company index is comprised of consumer products companies that have both domestic and international businesses. For 2020, the peer company index consisted of Campbell Soup Company, The Clorox Company, The Coca-Cola Company, ConAgra Brands, Inc., The Estee Lauder Companies, Inc., General Mills, Inc., Johnson & Johnson, Kellogg Company, Kimberly-Clark Corporation, The Kraft Heinz Company, Mondelez International, Inc., PepsiCo, Inc., The Procter & Gamble Company, Reckitt Benckiser Group plc and Unilever N.V.

    These performance graphs do not constitute soliciting material, are not deemed filed with the SEC and are not incorporated by reference in any of the Company’s filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K and irrespective of any general incorporation language in any such filing, except to the extent the Company specifically incorporates these performance graphs by reference therein.

cl-20201231_g2.jpg cl-20201231_g3.jpg
cl-20201231_g4.jpg
130


COLGATE-PALMOLIVE COMPANY

Historical Financial Summary
For the years ended December 31,
(Dollars in Millions Except Per Share Amounts)
(Unaudited)

 20202019201820172016 2015201420132012 2011 
Continuing Operations           
Net sales$16,471 $15,693 $15,544 $15,454  $15,195  $16,034  $17,277  $17,420 $17,085 $16,734 
Results of operations:     
Net income attributable to Colgate-Palmolive Company2,695 
(1)
2,367 
(2)
2,400 
(3)
2,024 
(4)
2,441 
(5)
1,384 
(6)
2,180 
(7)
2,241 
(8)
2,472 
(9)
2,431 
(10)
Earnings per common share, basic3.15 
(1)
2.76 
(2)
2.76 
(3)
2.30 
(4)
2.74 
(5)
1.53 
(6)
2.38 
(7)
2.41 
(8)
2.60 
(9)
2.49 
(10)
Earnings per common share, diluted3.14 
(1)
2.75 
(2)
2.75 
(3)
2.28 
(4)
2.72 
(5)
1.52 
(6)
2.36 
(7)
2.38 
(8)
2.57 
(9)
2.47 
(10)
Depreciation and amortization expense539 519 511 475  443  449  442 439 425 421 
Financial Position     
Current ratio1.0 1.0 1.1 1.4  1.3  1.2  1.2  1.1 1.2 1.2 
Property, plant and equipment, net3,716 3,750 3,881 4,072  3,840  3,796  4,080  4,083 3,842 3,668 
Capital expenditures410 335 436 553  593  691  757  670 565 537 
Total assets15,920 15,034 12,161 12,676  12,123  11,935  13,440  13,968 13,379 12,711 
Long-term debt7,334 7,333 6,354 6,566  6,520  6,246  5,625  4,732 4,911 4,417 
Colgate-Palmolive Company shareholders’ equity743 117 (102)(60) (243) (299) 1,145  2,305 2,189 2,375 
Share and Other     
Book value per common share1.30 0.66 0.23 0.28  0.03  (0.04) 1.55 2.79 2.60 2.71 
Cash dividends declared and paid per common share1.75 1.71 1.66 1.59  1.55  1.50  1.42  1.33 1.22 1.14 
Closing price85.51 68.84 59.52 75.45  65.44  66.62  69.19  65.21 52.27 46.20 
Number of common shares outstanding (in millions)849.9 854.7 862.9 874.7  883.1  892.7  906.7  919.9 935.8 960.0 
Number of common shareholders of record19,442 20,556 21,900 22,700  23,600  24,400  25,400  26,900 27,600 28,900 
Number of employees34,200 34,300 34,500 35,900  36,700  37,900  37,700  37,400 37,700 38,600 
_________
Note:    All per share amounts and numbers of shares outstanding were adjusted for the two-for-one stock split of the Company’s common stock in 2013.
    
(1)Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2020 include $13 of aftertax benefits resulting from the Global Growth and Efficiency Program, a $71 tax benefit related to subsidiary and operating structure initiatives, a $4 aftertax charge for acquisition-related costs, and a $18 aftertax loss on the early extinguishment of debt.
131


COLGATE-PALMOLIVE COMPANY

Historical Financial Summary
For the years ended December 31,
(Dollars in Millions Except Per Share Amounts)
(Unaudited)
(2)Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2019 include $102 of aftertax charges resulting from the Global Growth and Efficiency Program, a $20 aftertax charge for acquisition-related costs, a $20 aftertax benefit related to a value-added tax matter in Brazil and a $29 tax benefit related to Swiss income tax reform.
(3)Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2018 include $125 of aftertax charges resulting from the Global Growth and Efficiency Program, a $15 benefit from a foreign tax matter and an $80 charge related to U.S. tax reform.
(4)Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2017 include $246 of aftertax charges resulting from the Global Growth and Efficiency Program and a $275 charge related to U.S. tax reform.
(5)Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2016 include $168 of aftertax charges resulting from the Global Growth and Efficiency Program, a $63 aftertax gain on the sale of land in Mexico, $11 of aftertax charges for a litigation matter and $35 of benefits from tax matters.
(6)Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2015 include a $1,058 aftertax charge related to the change in accounting for the Company’s Venezuelan operations, $183 of aftertax charges resulting from the Global Growth and Efficiency Program, $22 of aftertax charges related to the remeasurement of the local currency-denominated net monetary assets of the Company's Venezuelan subsidiary (“CP Venezuela”) as a result of effective devaluations, $120 aftertax gain on the sale of the South Pacific laundry detergent business, a $14 aftertax charge for a litigation matter and a $15 charge for a tax matter.
(7)Net income attributable to Colgate-Palmolive Company and earnings per common share in 2014 include $208 of aftertax charges resulting from the Global Growth and Efficiency Program, $214 of aftertax charges related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets as a result of effective devaluations, $41 of charges for litigation matters, $3 of aftertax costs related to the sale of land in Mexico and a $66 charge for a tax matter.
(8)Net income attributable to Colgate-Palmolive Company and earnings per common share in 2013 include $278 of aftertax charges resulting from the Global Growth and Efficiency Program, a $111 aftertax charge related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets as a result of a devaluation, a $23 charge for a litigation matter and $12 of aftertax costs related to the sale of land in Mexico.
(9)Net income attributable to Colgate-Palmolive Company and earnings per common share in 2012 include $70 of aftertax charges resulting from the Global Growth and Efficiency Program, $18 of aftertax costs related to the sale of land in Mexico and $14 of aftertax costs associated with various business realignment and other cost-saving initiatives.
(10)Net income attributable to Colgate-Palmolive Company and earnings per common share in 2011 include an aftertax gain of $135 on the sale of the non-core laundry detergent business in Colombia, offset by $147 of aftertax costs associated with various business realignment and other cost-saving initiatives, $9 of aftertax costs related to the sale of land in Mexico and a $21 charge for a litigation matter.



132
EX-4.A 2 exhibit4a12312020.htm EX-4.A Document

EXHIBIT 4(a)
DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934
As of February 18, 2021, Colgate-Palmolive Company, a Delaware corporation (“Colgate” or the “Company”), had five classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (i) common stock, par value $1.00 per share (“Common Stock”), (ii) 0.000% Medium-Term Notes, Series H due 2021 (the “2021 Notes”), (iii) the 0.500% Medium-Term Notes, Series H due 2026 (the “2026 Notes”), (iv) the 1.375% Medium-Term Notes, Series H due 2034 (the “2034 Notes”) and (v) the 0.875% Medium-Term Notes, Series H due 2039 (the “2039 Notes” and together with the 2021 Notes, the 2026 Notes and 2034 Notes, the “Notes”). Each of the Company’s securities registered under Section 12 of the Exchange Act is listed on the New York Stock Exchange.
Description of Common Stock
The following description of the Common Stock is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to the Company’s Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”) and the Company’s By-laws, as amended and restated (“By-laws”), each of which are incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this exhibit is a part. We encourage you to read the Company’s Certificate of Incorporation, By-laws and the applicable provisions of the Delaware General Corporation Law (the “DGCL”) for additional information.
Authorized Capital Stock: The Company’s authorized capital stock consists of: 2,050,262,150 shares, divided into 250,000 shares of Preferred Stock without par value (“Preferred Stock”), 12,150 shares of $3.00 Convertible Second Preferred Stock without par value (“$3.00 Convertible Second Preferred Stock”), 50,000,000 shares of Preference Stock without par value (“Preference Stock”) and 2,000,000,000 shares of Common Stock. There are no shares of Preferred Stock, $3.00 Convertible Second Preferred Stock or Preference Stock issued and outstanding. The outstanding shares of our Common Stock are fully paid and non-assessable.
Voting Rights: The holders of Common Stock are entitled to one vote per share on all matters voted on by the stockholders, including the election of directors. Holders of Common Stock are not entitled to cumulative voting rights.
Dividend Rights: Subject to the rights of holders of outstanding shares of Preferred Stock and the $3.00 Convertible Second Preferred Stock, if any, the holders of Common Stock are entitled to receive dividends, if any, as may be declared from time to time by the Company’s Board of Directors in its discretion out of funds legally available for the payment of dividends.
Board of Directors: The Company’s Board of Directors is not classified and each member is elected annually by majority vote in uncontested elections. Under the Company’s by-laws, in uncontested elections for directors, if a nominee for director who is an incumbent director is not re-elected by a majority of the votes cast, the by-laws require the director to promptly tender his or her resignation to the Board of Directors. The Nominating, Governance and Corporate Responsibility Committee will then consider the resignation and make a recommendation to the Board of Directors. Stockholders do not have cumulative voting rights in the elections of directors.
Liquidation Rights: Subject to the preferential rights of the Preferred Stock and the $3.00 Convertible Second Preferred Stock, all the remaining assets of the Company shall belong to and be distributable among the holders of Common Stock, except to the extent, if any, that the holders of Preferred Stock of any series or Preference Stock of any series may be entitled to participate therein.


Other Rights and Preferences: The Common Stock has no sinking fund or redemption provisions or preemptive, conversion or exchange rights.
Certain Anti-takeover Provisions of the Certificate of Incorporation, By-laws and Delaware Law
Certain provisions of the Company’s Certificate of Incorporation, By-laws described below may have the effect of delaying, deferring or preventing a change of control of the Company:
The Company is incorporated in Delaware and is thus subject to the provisions of the DGCL, including Section 203 of the DGCL regarding business combinations with an interested stockholder.
Additional shares Common Stock, Preferred Stock, $3.00 Convertible Second Preferred Stock or Preference Stock are available for issuance under our Certificate of Incorporation which under certain circumstances and with such terms and conditions as to impede a change of control.
Listing: The Common Stock is traded on the New York Stock Exchange under the trading symbol “CL.”















Description of Notes
The following description of the 2021 Notes, 2026 Notes, 2034 Notes and 2039 Notes is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to the Indenture, dated as of November 15, 1992, between the Company and The Bank of New York Mellon (formerly known as The Bank of New York), as Trustee (as amended through the date hereof, the “Indenture”), which is filed as an exhibit to this Annual Report on Form 10-K and, as applicable, to the forms of 2021 Notes and 2039 Notes, which are filed as exhibits to the Form 8-A filed with the Securities and Exchange Commission (“SEC”) on November 12, 2019, and to the forms of the 2026 Notes and the 2034 Notes, which are filed as exhibits to the Form 8-A filed with the SEC on March 6, 2019. The 2021 Notes, 2026 Notes, 2034 Notes and 2039 Notes are traded on The New York Stock Exchange under the bond trading symbols of “CL21A,” “CL26,” “CL34” and “CL39,” respectively.
The Notes
The Notes were issued under the Indenture, which provides that debt securities may be issued under the Indenture from time to time in one or more series. The Indenture does not limit the amount of debt, secured or unsecured, which the Company can issue. The Notes are unsecured and rank equally with our other unsecured and unsubordinated indebtedness of the Company from time to time outstanding. The Company may issue additional Medium-Term Notes, Series H and increase the authorized amount of our Medium-Term Notes, Series H at any time without your consent.
The 2021 Notes
The Company issued €500,000,000 aggregate principal amount of the 2021 Notes on November 12, 2019. Interest on the 2021 Notes at a rate of 0.000% per annum is payable annually in arrears on November 12 of each year, commencing November 12, 2020. Unless earlier redeemed, the 2021 Notes will mature on November 12, 2021. As of February 18, 2021, €500,000,000 aggregate principal amount of the 2021 Notes was outstanding.
The 2026 Notes
The Company issued €500,000,000 aggregate principal amount of the 2026 Notes on March 6, 2019. Interest on the Notes at a rate of 0.500% per annum is payable annually in arrears on March 6 of each year, commencing March 6, 2020. Unless earlier redeemed, the 2026 Notes will mature on March 6, 2026. As of February 18, 2021, €500,000,000 aggregate principal amount of the 2026 Notes was outstanding.
The 2034 Notes
The Company issued €500,000,000 aggregate principal amount of the 2034 Notes on March 6, 2019. Interest on the Notes at a rate of 1.375% per annum is payable annually in arrears on March 6 of each year, commencing March 6, 2020. Unless earlier redeemed, the 2034 Notes will mature on March 6, 2034. As of February 18, 2021, €500,000,000 aggregate principal amount of the 2034 Notes was outstanding.
The 2039 Notes
The Company issued €500,000,000 aggregate principal amount of the 2039 Notes on November 12, 2019. Interest on the Notes at a rate of 0.875% per annum is payable annually in arrears on November 12 of each year, commencing November 12, 2020. Unless earlier redeemed, the 2039 Notes will mature on November 12, 2039. As of February 18, 2021, €500,000,000 aggregate principal amount of the 2039 Notes was outstanding.



Interest and Interest Rates
Unless otherwise specified in an applicable pricing supplement, each interest-bearing note will bear interest from the date of issue at the rate per annum or, in the case of a floating rate note, pursuant to the interest rate formula, stated in the applicable note and in the applicable pricing supplement until the principal of the note is paid or made available for payment. Interest payments on fixed rate notes and floating rate notes will equal the amount of interest accrued from and including the immediately preceding interest payment date in respect of which interest has been paid or made available for payment or from and including the date of issue, if no interest has been paid or made available for payment with respect to the note, to, but excluding, the related interest payment date or Maturity Date, as the case may be.
We will pay interest in arrears on each interest payment date specified in the applicable pricing supplement on which an installment of interest is due and payable and on the Maturity Date. We will pay interest to the persons in whose names the notes are registered as of the regular record date. However, interest that we pay on the Maturity Date, if any, will be payable to the persons to whom the principal will be payable. If any note is originally issued between a regular record date and the related interest payment date, we will make the first payment of interest on that note on the interest payment date immediately following the next succeeding regular record date to the registered holder on that next succeeding regular record date. The regular record date will be the fifteenth calendar day, whether or not a Business Day, immediately preceding the related interest payment date.
Business Day” means any day, other than a Saturday or Sunday, that is neither a legal holiday nor a day on which commercial banks are authorized or required by law, regulation or executive order to close in The City of New York; provided, however, that, with respect to non-United States dollar-denominated notes, the day is also not a day on which commercial banks are authorized or required by law, regulation or executive order to close in the Principal Financial Center, as defined below, of the country issuing the specified currency or, if the specified currency is euro, the day is also a day on which the Trans-European Automated Real-Time Gross Settlement Express Transfer (TARGET) System, or any successor, is open (a “Target Settlement Day”); provided, further, that, with respect to floating rate notes as to which LIBOR is an applicable Interest Rate Basis, the day is also a London Banking Day, as defined below, and that, with respect to floating rate notes as to which EURIBOR is an applicable Interest Rate Basis, the day is also a Target Settlement Day.
London Banking Day” means a day on which commercial banks are open for business, including dealings in the Designated LIBOR Currency, as defined below under “—Floating Rate Notes—LIBOR”, in London.
Principal Financial Center” means, unless otherwise specified in the applicable pricing supplement,
1)the capital city of the country issuing the specified currency, or
2)the capital city of the country to which the Designated LIBOR Currency relates,
except, in each case, that with respect to United States dollars, Australian dollars, Canadian dollars, Euros, New Zealand dollars, South African rand and Swiss francs, the “Principal Financial Center” will be The City of New York, Sydney, Toronto, London (solely in the case of the Designated LIBOR Currency), Wellington, Johannesburg and Zurich, respectively.
Issuance in Euro
Principal and interest payments in respect of the Notes and additional amounts, if any, will be payable in euro.
If euro is unavailable to us due to the imposition of exchange controls or other circumstances beyond our control or the euro is no longer used by the member states of the European Monetary Union that have adopted the euro as their currency or for the settlement of transactions by public institutions within the international banking community,


then all payments in respect of the Notes will be made in U.S. dollars until euro is again available to us or so used. The amount payable on any date in euro will be converted to U.S. dollars on the basis of the Market Exchange Rate (as defined below). Any payment in respect of the Notes so made in U.S. dollars will not constitute an event of default under the Indenture. Neither the Trustee nor the London Paying Agent shall be responsible for obtaining exchange rates, effecting conversions or otherwise handling redenominations.
Market Exchange Rate” means the rate mandated by the U.S. Federal Reserve Board as of the close of business on the second Business Day prior to the relevant payment date or, in the event the U.S. Federal Reserve Board has not mandated a rate of conversion, on the basis of the most recent euro/U.S. dollar exchange rate available on or prior to the second Business Day prior to the relevant payment date, as reported by Bloomberg.
Optional Redemption
Prior to the applicable Par Call Date (as defined below), the Notes may be redeemed at our option, at any time, in whole, or from time to time, in part, at a redemption price equal to the greater of:
100% of the principal amount of the Notes to be redeemed; or    
the sum of the present values of the remaining scheduled payments of principal and interest on the Notes being redeemed assuming that the Notes being redeemed matured on the applicable Par Call Date (not including any portion of any payments of interest accrued to the redemption date), discounted to the redemption date on an annual basis (ACTUAL/ACTUAL (ICMA)) at the applicable Comparable Government Bond Rate (as defined below), plus 10 basis points, in the case of the 2021 notes, plus 15 basis points, in the case of the 2026 Notes, plus 20 basis points, in the case of the 2034 Notes or the 2039 Notes.
On or after the applicable Par Call Date, the Notes may be redeemed at our option, at any time, in whole, or from time to time, in part, at a redemption price equal to 100% of the principal amount of the Notes being redeemed.
In each case, we will pay accrued and unpaid interest on the principal amount being redeemed to, but not including, the redemption date.
Notwithstanding the foregoing, installments of interest on Notes being redeemed that are due and payable on interest payment dates falling on or prior to a redemption date will be payable on the interest payment date to the holders as of the close of business on the relevant record date according to the Notes and the Indenture.
The “Comparable Government Bond Rate” will be determined by the Calculation Agent on the third Business Day preceding the redemption date and means, with respect to any date of redemption, the rate per annum equal to the yield to maturity calculated in accordance with customary financial practice in pricing new issues of comparable corporate debt securities paying interest on an annual basis (ACTUAL/ACTUAL (ICMA)) of the applicable Comparable Government Bond, assuming a price for the applicable Comparable Government Bond (expressed as a percentage of its principal amount) equal to the applicable Comparable Government Bond Price for such date of redemption.
Calculation Agent” means an independent investment banking or commercial banking institution of international standing appointed by us.
Comparable Government Bond” means the Federal Republic of Germany government security or securities selected by one of the Reference Government Bond Dealers appointed by us as having an actual or interpolated maturity comparable with the remaining term of the applicable tranche of Notes assuming such tranche matured on the applicable Par Call Date that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of euro-denominated corporate debt securities of a maturity comparable to the remaining term of such tranche of Notes assuming such tranche matured on the applicable Par Call Date.


Comparable Government Bond Price” means, with respect to any redemption date, (A) the arithmetic average of the Reference Government Bond Dealer Quotations for such redemption date, after excluding the highest and lowest such Reference Government Bond Dealer Quotations, or (B) if the Calculation Agent obtains fewer than four such Reference Government Bond Dealer Quotations, the arithmetic average of all such quotations.
Par Call Date” means (i) with respect to the 2021 Notes, October 12, 2021 (one month prior to the maturity date of the 2021 Notes), (ii) with respect to the 2026 Notes, January 6, 2026 (two months prior to the maturity date of the 2026 Notes), (iii) with respect to the 2034 Notes, December 6, 2033 (three months prior to the maturity date of the 2034 Notes) and (iv) with respect to the 2039 Notes, May 12, 2039 (six months prior to the maturity date of the 2039 Notes).
Reference Government Bond Dealer” means each of four banks selected by us, which are (A) primary European government securities dealers, and their respective successors, or (B) market makers in pricing corporate bond issues.
Reference Government Bond Dealer Quotations” means, with respect to each Reference Government Bond Dealer and any redemption date, the arithmetic average, as determined by the Calculation Agent, of the bid and offered prices for the applicable Comparable Government Bond (expressed in each case as a percentage of its principal amount) at 11:00 a.m., Central European Time (CET), on the third Business Day preceding such date for redemption quoted in writing to the Calculation Agent by such Reference Government Bond Dealer.
Notice of redemption will be mailed at least 15 but not more than 60 days before the redemption date to each holder of record of the applicable Notes to be redeemed at its registered address, provided that while the applicable Notes are represented by one or more global Notes, notice of redemption may, at our option, instead be given to holders of applicable Notes (and beneficial interests therein) in accordance with the applicable rules and regulations of Euroclear and Clearstream. The notice of redemption for the applicable Notes will state, among other things, the amount of the applicable Notes to be redeemed, the redemption date, and the redemption price and the place or places that payment will be made upon presentation and surrender of the applicable Notes to be redeemed. Unless we default in the payment of the redemption price, interest will cease to accrue on any Notes that have been called for redemption at the redemption date. If less than all of the applicable Notes of a tranche are to be redeemed, the Notes of such tranche to be redeemed will be selected in accordance with applicable depositary procedures; provided, however, that no Notes of a principal amount of €100,000 or less shall be redeemed in part.
The Notes are also subject to redemption prior to maturity if certain changes in U.S. tax law occur. If such changes occur, the Notes may be redeemed at a redemption price of 100% of their principal amount plus accrued and unpaid interest to the date of redemption. See “—Redemption for Tax Reasons.”
Redemption for Tax Reasons
If we have or will become obliged to pay additional amounts (as described below under the heading “—Payment of Additional Amounts”) as a result of any change in, or amendment to, the laws or regulations of the United States or any political subdivision or taxing authority thereof or therein affecting taxation, or any change in official position regarding the application or interpretation of such laws, regulations or rulings, which change or amendment becomes effective on or after the date of this pricing supplement, and we determine that such obligation cannot be avoided by the use of reasonable measures then available to us, we may, at our option, at any time, having giving not less than 15 nor more than 60 days’ prior written notice to Holders, redeem, in whole, but not in part, the 2021 Notes, the 2026 Notes, the 2034 Notes or the 2039 Notes at a redemption price equal to 100% of their principal amount, together with unpaid interest, if any, on the Notes being redeemed accrued to but excluding the redemption date, provided that no such notice of redemption shall be given earlier than 90 days prior to the earliest date on which we would be obliged to pay such additional amounts if a payment in respect to the applicable tranche of


Notes were due on such date. Prior to the transmission or publication of any notice of redemption pursuant to this paragraph, we shall deliver to the Trustee a certificate signed by two executive officers of the Company stating that we are entitled to effect such redemption and setting forth a statement of facts showing that the conditions precedent to our right to so redeem the Notes has occurred.
Payment of Additional Amounts
We will, subject to the exceptions and limitations set forth below, pay as additional amounts to a holder of a Note that is a United States Alien (as defined below) such amounts as may be necessary so that every net payment on such Note after deduction or withholding for or on account of any present or future tax, assessment or other governmental charge of whatever nature imposed upon or as a result of such payment by the United States (or any political subdivision or taxing authority thereof or therein), will not be less than the amount provided for in such Note to be then due and payable. However, we will not be required to make any payment of additional amounts for or on account of:
a)any tax, assessment or other governmental charge that would not have been imposed but for (i) the existence of any present or former connection between such holder (or between a fiduciary, settlor or beneficiary of, or a person holding a power over, such holder, if such holder is an estate or a trust, or a member or shareholder of such holder, if such holder is a partnership or corporation) and the United States, including, without limitation, such holder (or such fiduciary, settlor, beneficiary, person holding a power, member or shareholder) being or having been a citizen or resident or treated as a resident thereof or being or having been engaged in trade or business or present therein or having or having had a permanent establishment therein, or (ii) the presentation by the holder of a Note for payment more than 15 days after the date on which such payment became due and payable or on which payment thereof was duly provided for, whichever occurs later;
b)any estate, inheritance, gift, sales, transfer, personal property or any similar tax, assessment or other governmental charge;
c)any tax, assessment or other governmental charge that would not have been imposed but for such holder’s past or present status as a controlled foreign corporation, passive foreign investment company (including a qualified election fund) or foreign private foundation or other tax exempt organization with respect to the United States or as a corporation that accumulates earnings to avoid United States Federal income tax;
d)any tax, assessment or other governmental charge that is payable otherwise than by deduction or withholding from a payment on a Note;
e)any tax, assessment or other governmental charge required to be deducted or withheld by any paying agent from any payment on a Note, if such payment can be made without such deduction or withholding by any other paying agent;
f)any tax, assessment or other governmental charge that would not have been imposed but for the holder’s failure to comply with any applicable certification, information, documentation or other reporting requirement concerning the nationality, residence, identity or connection with the United States of the holder or beneficial owner of a Note if, without regard to any tax treaty, such compliance is required by statute or regulation of the United States as a precondition to relief or exemption from such tax, assessment or other governmental charge;
g)any tax, assessment or other governmental charge imposed by reason of the holder (i) owning or having owned, directly or indirectly, actually or constructively, 10% or more of the total combined voting power of all classes of stock of the Company entitled to vote, (ii) receiving interest described in Section 881(c)(3)(A) of the United States Internal Revenue Code or (iii) being a controlled foreign corporation with respect to the United States that is related to the Company by actual or constructive stock ownership;    
h)any tax, assessment or other governmental charge that is imposed on a payment pursuant to Sections 1471 through 1474 of the United States Internal Revenue Code (FATCA), any Treasury regulations and official


interpretations thereof, and any regulations or official law, agreement or interpretations thereof implementing an intergovernmental approach thereto; or
i)any combination of items (a), (b), (c), (d), (e), (f) (g) and (h);
nor shall such additional amounts be paid with respect to any payment on a Note to a holder that is a fiduciary or partnership or other than the sole beneficial owner of such payment to the extent a beneficiary or settlor with respect to such fiduciary or a member of such partnership or a beneficial owner would not have been entitled to the additional amounts had such beneficiary, settlor, member or beneficial owner been the holder of such Note.
For purposes of the foregoing, the holding of or the receipt of any payment with respect to a Note shall not constitute a connection between the holder (or between a fiduciary, settlor, beneficiary, member or shareholder of, or a person having power over, such holder if such holder is an estate, a trust, a partnership or a corporation) and the United States.
The term “United States Alien” means any person who, for United States Federal income tax purposes, is a foreign corporation, a non-resident alien individual, a non-resident alien fiduciary of a foreign estate or trust, or a foreign partnership one or more of the members of which is, for United States Federal income tax purposes, a foreign corporation, a nonresident alien individual or a non-resident alien fiduciary of a foreign estate or trust.
Further Issuances
We may, from time to time, without the consent of or notice to existing holders of the Notes, create and issue further Medium-Term Notes, Series H having the same terms and conditions as either tranche of Notes in all respects, except for issue date, issue price and, to the extent applicable, the first payment of interest and the initial interest accrual date. Additional Medium-Term Notes, Series H issued in this manner will be consolidated with and will form a single tranche of debt securities with the related previously outstanding applicable tranche of Notes; provided, however, that the issuance of such additional Notes will not be so consolidated for United States federal income tax purposes unless such issuance constitutes a “qualified reopening” within the meaning of the Internal Revenue Code of 1986, as amended (the “Code”), and the Treasury regulations promulgated thereunder.
Book-Entry Delivery and Settlement
The Notes of each tranche will be issued in the form of one or more global Notes in fully registered form, without coupons, and will be deposited with, or on behalf of, a common depositary for, and in respect of interests held through, Euroclear and Clearstream. Except as described herein, certificates will not be issued in exchange for beneficial interests in the global Notes.
Except as set forth below, the global Notes may be transferred, in whole and not in part, only to Euroclear or Clearstream or their respective nominees.
Beneficial interests in the global Notes will be represented, and transfers of such beneficial interests will be effected, through accounts of financial institutions acting on behalf of beneficial owners as direct or indirect participants in Euroclear or Clearstream. Those beneficial interests will be in denominations of €100,000 and integral multiples of €1,000 in excess thereof. Investors may hold Notes directly through Euroclear or Clearstream, if they are participants in such systems, or indirectly through organizations that are participants in such systems.
Owners of beneficial interests in the global Notes will not be entitled to have Notes registered in their names, and, except as described herein, will not receive or be entitled to receive physical delivery of Notes in certificated form. So long as the common depositary for Euroclear and Clearstream or its nominee is the registered owner of the global Notes, the common depositary for all purposes will be considered the sole holder of the Notes represented by the global Notes under the Indenture and the global Notes. Except as provided below, beneficial owners will not be


considered the owners or holders of the Notes under the Indenture, including for purposes of receiving any reports delivered by us or the Trustee pursuant to the Indenture. Accordingly, each beneficial owner must rely on the procedures of the clearing systems and, if such person is not a participant of the clearing systems, on the procedures of the participant through which such person owns its interest, to exercise any rights of a holder under the Indenture. Under existing industry practices, if we request any action of holders or a beneficial owner desires to give or take any action which a holder is entitled to give or take under the Indenture, the clearing systems would authorize their participants holding the relevant beneficial interests to give or take action and the participants would authorize beneficial owners owning through the participants to give or take such action or would otherwise act upon the instructions of beneficial owners. Conveyance of notices and other communications by the clearing systems to their participants, by the participants to indirect participants and by the participants and indirect participants to beneficial owners will be governed by arrangements among them, subject to any statutory or regulatory requirements as may be in effect from time to time. The laws of some jurisdictions require that certain purchasers of securities take physical delivery of such securities in certificated form. These limits and laws may impair the ability to transfer beneficial interests in global Notes.
Exchange of Global Notes for Certificated Notes
Subject to certain conditions, the Notes represented by the global Notes are exchangeable for certificated Notes in definitive form of like tenor in minimum denominations of €100,000 principal amount and integral multiples of €1,000 in excess thereof if:
(1) we have been notified that both Clearstream and Euroclear have been closed for business for a continuous period of at least 14 days (other than by reason of holiday, statutory or otherwise) or have announced an intention permanently to cease business or have in fact done so and no successor clearing system is available;
(2) we, at our option, notify the Trustee in writing that we elect to cause the issuance of certificated Notes in definitive form; or
(3) there has occurred and is continuing an Event of Default with respect to the Notes.
In all cases, certificated Notes in definitive form delivered in exchange for any global Note or beneficial interest therein will be registered in the names, and issued in any approved denominations, requested by or on behalf of the common depositary (in accordance with its customary procedures).
Payments (including principal and interest) and transfers with respect to Notes in certificated form may be executed at the office or agency maintained for such purpose in London (initially the corporate trust office of the London Paying Agent) or, at our option, by check mailed to the holders thereof at the respective addresses set forth in the register of holders of the Notes, provided that all payments (including principal and interest) on Notes in certificated form, for which the holders thereof have given wire transfer instructions at least ten calendar days prior to the applicable payment date, will be required to be made by wire transfer of immediately available funds to the accounts specified by the holders thereof. No service charge will be made for any registration of transfer, but payment of a sum sufficient to cover any tax or governmental charge payable in connection with that registration may be required.



Indenture Provisions:
Merger and Consolidation
We may consolidate or merge with or into any other corporation, and we may sell, lease or convey all or substantially all of our assets to any corporation, provided that:
the resulting corporation, if other than Colgate, is a corporation organized and existing under the laws of the United States of America or any U.S. state or the District of Columbia and assumes all of our obligations to:
a.pay or deliver the principal of or any premium, interest or additional amounts on the debt securities; and
b.perform and observe all of our other obligations under the indenture, and
we or any successor corporation, as the case may be, are not, immediately after any such consolidation, merger or sale of assets, in default under the indenture.
Modification and Waiver
We and the trustee may, without the consent of holders, modify provisions of the indenture for specified purposes, including, among other things, curing ambiguities and correcting inconsistencies. We and the trustee may modify and amend other provisions of the indenture with the consent of holders of at least a majority in principal amount of each series of debt securities affected. However, the consent of each holder of any debt security affected must be obtained if the amendment or modification:
changes the stated maturity of the principal of, or any premium or installment of interest or additional amounts on, any debt security;
reduces the principal amount due and payable at maturity or upon acceleration of maturity of, or the rate of interest or additional amounts payable on, or any premium payable on redemption or otherwise on, any debt security;
adversely affects any right of repayment at the option of the holders;
changes the place of delivery of, or currency of, the payment of principal or any premium, interest or additional amounts on any debt security or impairs the right to institute suit for the enforcement of any such payment or delivery;
reduces the percentage in principal amount or aggregate issue price of the outstanding debt securities of any series, the consent of whose holders is required to modify or amend the indenture; or
modifies the foregoing requirements or reduces the percentage to less than a majority in principal amount of outstanding debt securities necessary to waive certain past defaults by Colgate under the indenture.
The holders of at least a majority in principal amount of the outstanding debt securities of any series may, with respect to that series, waive past defaults under the indenture and waive our compliance with certain provisions of the indenture, except as described below under “—Events of Default.”
Events of Default
Except as otherwise provided in the applicable prospectus supplement, each of the following constitutes an event of default with respect to each series of debt securities issued under the indenture:
default in the payment of any interest or additional amounts when due and continuing for 30 days;
default in the payment of any principal or premium when due and payable at maturity;
default in the payment of any sinking fund payment when due;


default in the performance, or breach, of any other obligation of ours under the indenture, or under provisions of a series of debt securities that are applicable to all series of debt securities, and continuance of the default for 60 days after we are given written notice of the default as provided in the indenture;
specified events of bankruptcy, insolvency or reorganization of Colgate; and
any other event of default with respect to debt securities of that series.
If an event of default occurs and is continuing for any series of debt securities, the trustee or the holders of at least 25% in principal amount of the outstanding debt securities of that series may declare the principal of all the debt securities of that series, or any lesser amount provided for in the debt securities of that series, due and payable immediately. At any time after such a declaration of acceleration with respect to the debt securities of any series has been made, but before the trustee has obtained a judgment or decree for payment of the money due, the holders of a majority in principal amount of the outstanding debt securities of that series by written notice may rescind any declaration of acceleration and its consequences, provided that all payments and/or deliveries due, other than those due as a result of acceleration, have been made and all other events of default have been remedied or waived.
The holders of at least a majority in principal amount of the outstanding debt securities of any series may waive an event of default with respect to that series, except a default:
in the payment of any amounts due and payable or deliverable under the debt securities of that series; or
in respect of an obligation of ours contained in, or a provision of, the indenture which cannot be modified under the terms of the indenture without the consent of each holder of outstanding debt securities affected.
The holders of a majority in principal amount of the outstanding debt securities of a series may direct the time, method and place of conducting any proceeding for any remedy available to the trustee or exercising any trust or power conferred on the trustee with respect to debt securities of that series, provided that the direction is not in conflict with any rule of law, the indenture or the debt securities of that series. The trustee must, within 90 days after a default occurs notify the holders of the applicable series of debt securities of the default, unless the default is cured or waived. The trustee may withhold notice of default, except default in payment of principal, any premium, interest or sinking fund payment, if it determines that it is in the interest of the holders to do so. Before proceeding to exercise any right or power under the indenture at the direction of the holders, the trustee is entitled to receive from those holders reasonable security or indemnity against the costs, expenses and liabilities which might be incurred by it in complying with any such direction.
Unless otherwise stated in the prospectus supplement, any series of debt securities issued under the indenture will not have the benefit of any cross-default provisions with other indebtedness of our company.
We will be required to furnish to the trustee annually a statement as to our performance of all of our obligations and conditions under the indenture.
Legal Defeasance and Covenant Defeasance
We at any time may terminate as to a series of debt securities all of our obligations (except for certain obligations regarding the defeasance trust and obligations to register the transfer or exchange of a debt security, to replace destroyed, lost or stolen debt securities and any related coupons and to maintain agencies with respect to the debt securities) arising under the indenture and the debt securities and coupons of that series. This option of ours is called a “legal defeasance.” We at any time may terminate as to a series of debt securities, among other obligations, our obligations arising under the covenant described under “Limitations Upon Liens” below. This option of ours is called a “covenant defeasance.”
We may exercise our legal defeasance option with respect to a series of debt securities even if we have previously exercised our covenant defeasance option in regard to that series of debt securities. If we exercise our legal


defeasance option with respect to a series of debt securities, that series may not be accelerated because of an Event of Default. If we exercise our covenant defeasance option with respect to a series of debt securities, that series may not be accelerated on the basis of breaches of the defeased covenant.
To exercise either option as to a series of debt securities, we must deposit in trust with the trustee cash or United States government obligations sufficient to pay the principal of, premium, if any, and interest on the debt securities of that series at their maturity or redemption and must comply with other specified conditions. In particular, we must obtain an opinion of tax counsel that the defeasance will not result in recognition for United States Federal income tax purposes of any gain or loss to holders of the series of debt securities. The opinion of tax counsel, in the case of legal defeasance, must refer to and be based upon a ruling of the Internal Revenue Service or a change in applicable United States Federal income tax law occurring after the date of the indenture.
Limitations Upon Liens
The debt securities will not be secured by any mortgage, pledge or other lien. Unless a prospectus supplement with respect to a particular series of debt securities states otherwise, the covenants described below will apply to each series of debt securities.
We covenant in the Indenture not to create or suffer to exist, or permit any of our Principal Domestic Subsidiaries to create or suffer to exist, any Lien on any Restricted Property, whether owned on the date of the indenture or thereafter acquired, without making effective provision (and we covenant and agree in the indenture that we will make or cause to be made effective provision) whereby the debt securities shall be directly secured by such Lien equally and ratably with (or prior to) all other indebtedness secured by such Lien as long as such other indebtedness shall be so secured; provided, however, that there shall be excluded from the foregoing restrictions:
Liens securing Debt not exceeding $10,000,000 which are existing on the date of the indenture on Restricted Property; and, if any property owned or leased as of the date of the indenture by us or one of our Principal Domestic Subsidiaries at any time thereafter becomes a Principal Domestic Manufacturing Property, any Liens existing on the date of the indenture on such property securing the Debt secured or evidenced thereby on the date of the indenture;
Liens on Restricted Property of a Principal Domestic Subsidiary as a security for Debt of such Subsidiary to us or to another Principal Domestic Subsidiary;
in the case of any corporation which becomes a Principal Domestic Subsidiary after the date of the indenture, Liens on Restricted Property of such Principal Domestic Subsidiary which are in existence at the time it becomes a Principal Domestic Subsidiary and which were not incurred in contemplation of it becoming a Principal Domestic Subsidiary;
any Lien existing prior to the time of acquisition of any Principal Domestic Manufacturing Property acquired by us or one of our Principal Domestic Subsidiaries after the date of the indenture through purchase, merger, consolidation or otherwise;
any Lien on any Principal Domestic Manufacturing Property (other than a Major Domestic Manufacturing Property) acquired or constructed by our company or a Principal Domestic Subsidiary after the date of the indenture which is placed on such Property at the time of or within 180 days after the acquisition thereof or prior to, at the time of or within 180 days after completion of construction thereof to secure all or a portion of the price of such acquisition or construction or funds borrowed to pay all or a portion of the price of such acquisition or construction;
extensions, renewals or replacements of any Lien referred to in the first, third, fourth or fifth bullet points above to the extent that the principal amount of the Debt secured or evidenced thereby is not increased, provided that the Lien is not extended to any other Restricted Property;
Liens imposed by law, such as carriers’, warehousemen’s, mechanics’, materialmen’s, vendors’ and landlords’ liens, and liens arising out of judgments or awards against us or any of our Principal Domestic


Subsidiaries with respect to which we or such Subsidiary at the time shall currently be prosecuting an appeal or proceedings for review and with respect to which it shall have secured a stay of execution pending such appeal or proceedings for review;
Liens securing the payment of taxes, assessments and governmental charges or levies, either (1) not delinquent or (2) being contested in good faith by appropriate legal or administrative proceedings and as to which we or a Principal Domestic Subsidiary, as the case may be, to the extent required by generally accepted accounting principles applied on a consistent basis, shall have set aside on its books adequate reserves;
minor survey exceptions, minor encumbrances, easements or reservations of, or rights of others for, rights of way, sewers, electric lines, telegraph and telephone lines and other similar purposes and zoning or other restrictions as to the use of any Principal Domestic Manufacturing Property, which exceptions, encumbrances, easements, reservations, rights and restrictions do not, in our opinion, in the aggregate materially detract from the value of such Principal Domestic Manufacturing Property or materially impair its use in the operation of our business and that of our Principal Domestic Subsidiaries; and
any Lien on Restricted Property not referred to above if, at the time such Lien is created, incurred, assumed or suffered to be created, incurred or assumed, and after giving effect thereto and to the Debt secured or evidenced thereby, the aggregate amount of all our outstanding Debt together with that of our Principal Domestic Subsidiaries secured or evidenced by Liens on Restricted Property which are not referred to above and which do not equally and ratably secure the debt securities, shall not exceed 15% of Consolidated Net Tangible Assets.
“Code” means the Internal Revenue Code of 1986, as amended.
Consolidated Net Tangible Assets” means the aggregate amount of assets (less applicable reserves and other properly deductible items) after deducting therefrom (1) all current liabilities and (2) all goodwill, trade names, trademarks, patents, unamortized debt discount and expense and other like intangibles of ours and our consolidated subsidiaries, all as set forth on the most recent balance sheet of ours and our consolidated subsidiaries prepared in accordance with generally accepted accounting principles as practiced in the United States.
Debt” means (1) indebtedness for borrowed money, (2) obligations evidenced by bonds, debentures, notes or other similar instruments, (3) obligations to pay the deferred purchase price of property or services (other than accounts payable in the ordinary course of business), (4) obligations as a lessee under leases which shall have been or should be, in accordance with generally accepted accounting principles, recorded as capital leases, and (5) obligations under direct or indirect guaranties in respect of, and obligations (contingent or otherwise) to purchase or otherwise acquire, or otherwise to assure a creditor against loss in respect of, indebtedness or obligations of others of the kinds referred to in clauses (1) through (4) above.
Domestic Subsidiary” means any Subsidiary a majority of the business of which is conducted within the United States of America, or a majority of the properties and assets of which are located within the United States of America, except any Subsidiary whose assets consist substantially of the securities of Subsidiaries which are not Domestic Subsidiaries.
Instruments” of any corporation means and includes (1) all capital stock of all classes of and all other equity interests in such corporation and all rights, options or warrants to acquire the same, and (2) all promissory notes, debentures, bonds and other evidences of Debt of such corporation.
Lien” means any mortgage, lien, pledge, security interest, encumbrance or charge of any kind, any conditional sale or other title retention agreement or any lease in the nature thereof, provided that the term “Lien” shall not include any lease involved in a sale and lease-back transaction.


Major Domestic Manufacturing Property” means any Principal Domestic Manufacturing Property the net depreciated book value of which on the date as of which the determination is made exceeds 3% of the Consolidated Net Tangible Assets.
Principal Domestic Manufacturing Property” means any building, structure or facility (including the land on which it is located and the improvements and fixtures constituting a part thereof) used primarily for manufacturing or processing which is owned or leased by us or any of our Subsidiaries, is located in the United States of America and the net depreciated book value of which on the date as of which the determination is made exceeds 1% of Consolidated Net Tangible Assets, except any such building, structure or facility which our Board of Directors by resolution declares is not of material importance to the total business conducted by us and our Subsidiaries as an entirety.
Principal Domestic Subsidiary” means (1) each Subsidiary which owns or leases a Principal Domestic Manufacturing Property, (2) each Domestic Subsidiary the consolidated net worth of which exceeds 3% of Consolidated Net Tangible Assets (as set forth in the most recent financial statements delivered pursuant to the indenture) and (3) each Domestic Subsidiary of each Subsidiary referred to in the foregoing clause (1) or (2) except any such Subsidiary the accounts receivable and inventories of which have an aggregate net book value of less than $5,000,000.
Restricted Property” means and includes (1) all Principal Domestic Manufacturing Properties, (2) all Instruments of all Principal Domestic Subsidiaries and (3) all inventories and accounts receivable of ours and our Principal Domestic Subsidiaries.
Subsidiary” means any Corporation of which at the time of determination we or one or more of our Subsidiaries owns or controls directly or indirectly more than 50% of the shares of Voting Stock.
Voting Stock” means stock of a Corporation of the class or classes having general voting power under ordinary circumstances to elect at least a majority of the board of directors, managers or trustees of such Corporation, provided that, for this purpose, stock which carries only the right to vote conditionally on the happening of an event shall not be considered voting stock whether or not such event shall have happened.
Other capitalized terms used but not defined in this prospectus shall have the meaning given those terms in the indenture.
The Trustee for the Notes
The Bank of New York Mellon serves as trustee under the Indenture and is the security registrar and paying agent with respect to the debt securities.
The indenture contains certain limitations on the right of the trustee, should it become a creditor of ours, to obtain payment of claims in certain cases, or to realize on certain property received in respect of any such claim as security or otherwise. The trustee is permitted to engage in other transactions with us; provided, however, that if the trustee acquires any conflicting interest it must eliminate such conflict or resign. We have banking relationships with The Bank of New York Mellon and certain of its affiliates.
Governing Law
The Indenture and the debt securities are governed by, and construed in accordance with, the laws of the State of New York.

EX-10.D(B) 3 exhibit10-db12312020.htm EX-10.D(B) Document

EXHIBIT 10-D (b)

AMENDMENT 4Q2020-I

COLGATE-PALMOLIVE COMPANY
SUPPLEMENTAL SALARIED EMPLOYEES’ RETIREMENT PLAN

WHEREAS, Colgate-Palmolive Company (the “Company”) maintains the Colgate-Palmolive Company Supplemental Salaried Employees’ Retirement Plan (the “Plan”) for the benefit of eligible employees of the Company and certain designated affiliated companies;

WHEREAS on December 10, 2015, the Board of Directors of the Company resolved that subject to certain restrictions, the Employee Relations Committee (the “Committee”) is authorized to take certain actions, including adopting plan amendments to certain plans or arrangements sponsored by the Company; and

WHEREAS, the Committee desires to amend the Plan to reflect certain actions approved by the Committee at its June 15, 2020 and December 2, 2020 meetings.

NOW THEREFORE, the Plan is hereby amended, effective in the following respects as of the dates indicated below:

COVID-19 PANDEMIC-RELATED RELIEF PROVISION

1.Effective as of March 1, 2020, a new Appendix B shall be added to the Plan to read in its entirety as follows:


“APPENDIX B
TEMPORARY COVID-19 PANDEMIC-RELATED RELIEF PROVISION
DOL and IRS Extension of Claims and Appeals Deadline Relief
    With respect to any requirement for Members and Beneficiaries to timely furnish a notice or document or comply with a claims procedure deadline during the period between March 1, 2020 and the earlier of (1) 60 days after the announced end of the COVID-19 National Emergency or (2) February 28, 2021, relief pursuant to EBSA Disaster Relief Notice 2020-01, the Extension of Certain Timeframes for Employee Benefit Plans, Participants, and Beneficiaries Affected by the COVID–19 Outbreak published in the Federal Register on May 4, 2020, and any other applicable guidance by the IRS, Department of Labor or Treasury Department, shall apply. The Employee Relations Committee or its delegatees and other responsible fiduciaries under the Plan shall act in good faith and furnish any required notice, disclosure, or document or comply with any applicable deadline as soon as administratively practicable under the circumstances or as set forth in such guidance.”






In all respects not modified herein, the Plan is ratified, confirmed and approved.

IN WITNESS WHEREOF, a duly authorized officer of the Company has executed this Amendment 4Q2020-I this 2nd day of December, 2020 to be effective as of the dates indicated herein.

COLGATE-PALMOLIVE COMPANY



By:     /s/ Laura Flavin                    
Laura Flavin
Vice President, Global Compensation and Benefits



EX-10.L(B) 4 exhibit10-lb12312020.htm EX-10.L(B) Document

EXHIBIT 10-L (b)

AMENDMENT 4Q2020-I

COLGATE-PALMOLIVE COMPANY
SUPPLEMENTAL SAVINGS AND INVESTMENT PLAN

WHEREAS, Colgate-Palmolive Company (the “Company”) maintains the Colgate-Palmolive Company Supplemental Savings and Investment Plan (the “Plan”) for the benefit of eligible employees of the Company and certain designated affiliated companies;

WHEREAS on December 10, 2015, the Board of Directors of the Company resolved that subject to certain restrictions, the Employee Relations Committee (the “Committee”) is authorized to take certain actions, including adopting plan amendments to certain plans or arrangements sponsored by the Company; and

WHEREAS, the Committee desires to amend the Plan to reflect certain actions approved by the Committee at its June 15, 2020 and December 2, 2020 meetings.

NOW THEREFORE, the Plan is hereby amended, effective in the following respects as of the dates indicated below:

CLARIFICATION REGARDING DEFINITION OF ELIGIBLE EMPLOYEE
1.Effective as of January 1, 2020, Section 2.7 of the Plan is amended in its entirety to read as follows:

“Section 2.7 “Eligible Employee” shall mean for Plan Years prior to 2011 (a) a non-union person who is employed by the Employer on a full-time or part-time basis as of January 1 of a Plan Year and is, or is expected to become, eligible to participate in the Base Plan during the Plan Year, or (b) a United States Employee in Foreign Service as of January 1 of a Plan Year who is eligible to participate in the Base Plan, and whose Recognized Earnings for such Plan Year in either case are expected to be limited by Code section 401(a)(17). For Plan Years beginning on or after January 1, 2011, “Eligible Employee” shall mean (a) a non-union person who is employed by the Employer on a full-time or part-time basis and is eligible to participate in the Base Plan, or (b) a United States Employee in Foreign Service who is eligible to participate in the Base Plan, and whose Recognized Earnings in either case are limited by Code section 401(a)(17). For Plan Years beginning on or after January 1, 2020, an “Eligible Employee” shall also include an EICP ABRC Member.”


COVID-19 PANDEMIC-RELATED RELIEF PROVISION

2.Effective as of March 1, 2020, a new Appendix A shall be added to the Plan to read in its entirety as follows:









“APPENDIX A
TEMPORARY COVID-19 PANDEMIC-RELATED RELIEF PROVISION
DOL and IRS Extension of Claims and Appeals Deadline Relief
    With respect to any requirement for Participant or Beneficiaries to timely furnish a notice or document or comply with a claims procedure deadline during the period between March 1, 2020 and the earlier of (1) 60 days after the announced end of the COVID-19 National Emergency or (2) February 28, 2021, relief pursuant to EBSA Disaster Relief Notice 2020-01, the Extension of Certain Timeframes for Employee Benefit Plans, Participants, and Beneficiaries Affected by the COVID–19 Outbreak published in the Federal Register on May 4, 2020, and any other applicable guidance by the IRS, Department of Labor or Treasury Department, shall apply. The Employee Relations Committee or its delegatees and other responsible fiduciaries under the Plan shall act in good faith and furnish any required notice, disclosure, or document or comply with any applicable deadline as soon as administratively practicable under the circumstances or as set forth in such guidance.”
In all respects not modified herein, the Plan is ratified, confirmed and approved.

IN WITNESS WHEREOF, a duly authorized officer of the Company has executed this Amendment 4Q2020-I this 2nd day of December, 2020 to be effective as of the dates indicated herein.

COLGATE-PALMOLIVE COMPANY



By:     /s/ Laura Flavin                    
Laura Flavin
Vice President, Global Compensation and Benefits



EX-21 5 exhibit2112312020.htm EX-21 Document

EXHIBIT 21

COLGATE-PALMOLIVE COMPANY
SUBSIDIARIES OF THE REGISTRANT
Name of CompanyJurisdiction of Organization
887357 Ontario Inc.Canada
Cleaning Dimensions, Inc.Delaware
COLGALIVE S.A.Dominican Republic
Colgate (BVI) LimitedBritish Virgin Islands
Colgate (Guangzhou) Company LimitedChina
Colgate (U.K.) LimitedUnited Kingdom
Colgate Business Services of the Americas, S.C.Mexico
Colgate Flavors and Fragrances, Inc.Delaware
Colgate Global Business Services Private LimitedIndia
Colgate HoldingsUnited Kingdom
Colgate Oral Pharmaceuticals, Inc.Delaware
Colgate Palmolive Ghana LimitedGhana
Colgate Palmolive Holding S.Com.P.A.Spain
Colgate Palmolive Nouvelle Caledonie SarlNew Caldonia
Colgate Palmolive Tanzania LimitedTanzania
Colgate Sanxiao Company LimitedChina
Colgate Tolaram Pte. Ltd.*Singapore
Colgate Venture Company, Inc.Delaware
Colgate, Inc.Delaware
Colgate-Palmolive (America), Inc.Delaware
Colgate-Palmolive (Asia) Pte, LtdSingapore
Colgate-Palmolive (Blantyre) LimitedMalawi
Colgate-Palmolive (Brunei) Sdn BhnBrunei
Colgate-Palmolive (Central America) Inc. y Compañia LimitadaGuatemala
Colgate-Palmolive (Central America), Inc.Delaware
Colgate-Palmolive (Centro America) S.A.Guatemala
Colgate-Palmolive (China) Co. LtdChina
Colgate-Palmolive (Costa Rica), S.A.Costa Rica
Colgate-Palmolive (Dominica), Inc.Delaware
Colgate-Palmolive (Dominican Republic), Inc.Delaware
Colgate-Palmolive (East Africa) LimitedKenya
Colgate-Palmolive (Eastern) Pte. Ltd.Singapore
Colgate-Palmolive (Egypt) S.A.E.Delaware/Egypt
Colgate-Palmolive (Fiji) Pte LimitedFiji
Colgate-Palmolive (Gabon), S.A.Gabon
Colgate-Palmolive (Gulf States) Ltd. *British Virgin Islands
Colgate-Palmolive (Guyana) Ltd.Guyana
Colgate-Palmolive (H.K.) LimitedHong Kong
Colgate-Palmolive (Hellas) S.A. I.C.Greece
Colgate-Palmolive (Hong Kong) Holding LimitedHong Kong
Colgate-Palmolive (India) Limited *India
Colgate-Palmolive (Kazakhstan), L.L.P.Kazakhstan
Colgate-Palmolive (Latvia) Ltd.Latvia
Colgate-Palmolive (Malaysia) Sdn BhdMalaysia
Colgate-Palmolive (Middle East Exports) Ltd.British Virgin Islands
Colgate-Palmolive (Myanmar) LimitedMyanmar
Colgate-Palmolive (New York), Inc.Delaware
Colgate-Palmolive (Poland) Sp. z o.o.Poland
Colgate-Palmolive (Proprietary) LimitedSouth Africa



Colgate-Palmolive (Research & Development), Inc.Delaware
Colgate-Palmolive (Romania) SRLRomania
Colgate-Palmolive (Thailand) LimitedThailand
Colgate-Palmolive (Uganda) LimitedUganda
Colgate-Palmolive (UK) LimitedUnited Kingdom
Colgate-Palmolive (Vietnam) Ltd.Vietnam
Colgate-Palmolive (Zambia) Inc.Delaware
Colgate-Palmolive (Zimbabwe), Inc.Delaware
Colgate-Palmolive A.B.Sweden
Colgate-Palmolive A/SDenmark
Colgate-Palmolive Adria Ltd.Slovenia
Colgate-Palmolive Arabia Ltd. *Saudi Arabia
Colgate-Palmolive Argentina S.A.Argentina
Colgate-Palmolive Asia Pacific LimitedHong Kong
Colgate-Palmolive Asia Pacific Treasury Services LimitedHong Kong
Colgate-Palmolive Belgium S.A.Belgium
Colgate-Palmolive Bolivia, Ltda.Bolivia
Colgate-Palmolive Cameroun S.A. *Cameroon
Colgate-Palmolive Canada, Inc.Canada
Colgate-Palmolive Caricom Service Co., Inc.Puerto Rico
Colgate-Palmolive Central European Management Inc.Delaware
Colgate-Palmolive Èeská republika spol. s r.o.Czech Republic
Colgate-Palmolive Chile S.A.Chile
Colgate-Palmolive Cia.Delaware
Colgate-Palmolive Comercial Ltda.Brazil
Colgate-Palmolive Commercial (Hellas) SP LLCGreece
Colgate-Palmolive Commerciale S.A.S.France
Colgate-Palmolive Commericale S.r.l.Italy
Colgate-Palmolive Compania AnonimaVenezuela
Colgate-Palmolive Company GmbHSwitzerland
Colgate-Palmolive Company, Distr. LLCPuerto Rico
Colgate-Palmolive Cyprus LimitedCyprus
Colgate-Palmolive de Paraguay Sociedad AnonimaParaguay
Colgate-Palmolive de Puerto Rico, Inc.Delaware
Colgate-Palmolive del Ecuador, S.A.I.C.Ecuador
Colgate-Palmolive del Peru (Delaware) Inc.Delaware
Colgate-Palmolive Development Corp.Delaware
Colgate-Palmolive East West Africa Region (Pty) LtdSouth Africa
Colgate-Palmolive Enterprises, Inc.Delaware
Colgate-Palmolive Espana, S.A.Spain
Colgate-Palmolive Europe SarlSwitzerland
Colgate-Palmolive Finance (UK) plcUnited Kingdom
Colgate-Palmolive Global Trading CompanyDelaware
Colgate-Palmolive Holding Argentina S.A.Argentina
Colgate-Palmolive Hungary Kft, Limited Liability CompanyHungary
Colgate-Palmolive IHQ Services (Thailand) LimitedThailand
Colgate-Palmolive Inc.Delaware
Colgate-Palmolive Inc. S.A.Uruguay
Colgate-Palmolive Industrial Ltda.Brazil
Colgate-Palmolive Industriel S.A.S.France
Colgate-Palmolive International Holding LLCDelaware
Colgate-Palmolive International LLCDelaware
Colgate-Palmolive Investment Co., Inc.Delaware
Colgate-Palmolive Investments (BVI) Ltd.British Virgin Islands
Colgate-Palmolive Investments (PNG) Ltd.Papua New Guinea



Colgate-Palmolive Investments, (UK) LimitedUnited Kingdom
Colgate-Palmolive Investments, Inc.Delaware
Colgate-Palmolive Israel Ltd.Israel
Colgate-Palmolive Italia, S.r.l.Italy
Colgate-Palmolive JSCRussia
Colgate-Palmolive Lanka (Private) LimitedSri Lanka
Colgate-Palmolive Latin America Inc.Delaware
Colgate-Palmolive LimitedNew Zealand
Colgate-Palmolive Manufacturing (Poland) Sp. z o.o.Poland
Colgate-Palmolive Marketing Sdn BhdMalaysia
Colgate-Palmolive Maroc, S.A.Morocco
Colgate-Palmolive Mocambique LimitadaMozambique
Colgate-Palmolive Nederland B.V.Netherlands
Colgate-Palmolive Norge A/SNorway
Colgate-Palmolive Participacoes e Investimentos Imobiliarios, Lda.Portugal
Colgate-Palmolive Peru S.A.Peru
Colgate-Palmolive Philippines, Inc.Philippines
Colgate-Palmolive Pty LtdAustralia
Colgate-Palmolive Retirement Trustee LimitedNew Zealand
Colgate-Palmolive S.p.A.Italy
Colgate-Palmolive Services (Hellas) LLCGreece
Colgate-Palmolive Services (Poland) Sp. z o.o.Poland
Colgate-Palmolive Services CEW GmbHGermany
Colgate-Palmolive Services, S.A.France
Colgate-Palmolive Slovensko, s.r.o.Slovakia
Colgate-Palmolive Support ServicesIreland
Colgate-Palmolive Temizlik Urunleri Sanayi ve Ticart S.A.Turkey
Colgate-Palmolive Transnational Inc.Delaware
Colgate-Palmolive Ukraine LLCUkraine
Colgate-Palmolive Unipessoal, LdaPortugal
Colgate-Palmolive, S.A. de C.V.Mexico
Colpal CBS, S de R. L. de C. V.Mexico
Consumer Viewpoint Center, Inc.New Jersey
Cotelle S.A.France
CP GABA GmbHGermany
CP International Holding C.V.Netherlands
CP West East Investment LimitedNigeria
Dimac Development Corp.Delaware
Dominica Coconut Products LimitedDominica
EKIB, Inc.Delaware
ELM Company LimitedBermuda
Elta MD Holdings, Inc.Delaware
Elta MD, Inc.Texas
Elta MD (Shanghai) Trade Co., Ltd.
China
Filorga Americas Inc.Delaware
Filorga Asia LimitedHong Kong
Filorga Benelux SABelgium
Filorga Cosmetiques PolskaPoland
Filorga Mexico Cosmetic, S.A. de C.V.*Mexico
Filorga Middle East DMCCUnited Arab Emirates
Filorga Portugal, Unipessoal, Lda.Portugal
Filorga RU, Limited Liability CompanyRussia
FZG Holdings LimitedHong Kong
GABA Europe Holding GmbHSwitzerland
GABA International Holding LLCDelaware



GABA Schweiz AGSwitzerland
GABA Therwil GmbHSwitzerland
Gamma Development Co., Ltd.Thailand
Global Trading and Supply LLCDelaware
Hamol, Ltd.Delaware
Hawley & Hazel (BVI) Company Ltd. *British Virgin Islands
Hello Products LLCDelaware
Hill’s Funding CompanyDelaware
Hill’s Pet Nutrition (NZ) LimitedNew Zealand
Hill’s Pet Nutrition (Thailand) Co., Ltd.Thailand
Hill’s Pet Nutrition Asia LimitedHong Kong
Hill’s Pet Nutrition B.V.Netherlands
Hill’s Pet Nutrition Canada Inc.Canada
Hill’s Pet Nutrition de Mexico, S.A. de C.V.Mexico
Hill’s Pet Nutrition de Puerto Rico, Inc.Puerto Rico
Hill’s Pet Nutrition Denmark ApSDenmark
Hill’s Pet Nutrition Espana, S.L.Spain
Hill’s Pet Nutrition GmbHGermany
Hill’s Pet Nutrition Holding B.V.Netherlands
Hill’s Pet Nutrition Indiana, Inc.Delaware
Hill’s Pet Nutrition Italia, S.r.l.Italy
Hill’s Pet Nutrition Korea Ltd.Korea
Hill’s Pet Nutrition Ltd.United Kingdom
Hill’s Pet Nutrition Manufacturing, B.V.Netherlands
Hill’s Pet Nutrition Manufacturing, s.r.oCzech Republic
Hill’s Pet Nutrition Norway ASNorway
Hill’s Pet Nutrition OOORussia
Hill's Pet Nutrition (OAC) LimitedUnited Kingdom
Hill’s Pet Nutrition Pty. LimitedAustralia
Hill’s Pet Nutrition s.r.o.Czech Republic
Hill’s Pet Nutrition Sales, Inc.Delaware
Hill’s Pet Nutrition SNCFrance
Hill’s Pet Nutrition South Africa Proprietary LimitedSouth Africa
Hill’s Pet Nutrition Sweden ABSweden
Hill’s Pet Nutrition Switzerland GmbHSwitzerland
Hill’s Pet Nutrition Taiwan, LtdTaiwan
Hill’s Pet Nutrition Trading (GZ) Co., LtdChina
Hill’s Pet Nutrition, Inc.Delaware
Hill’s Pet Nutrition, S.p.A.Italy
Hill’s Pet Products (Benelux) S.A.Belgium
Hill’s Pet Products, Inc.Delaware
Hill’s Veterinary Companies of America, Inc.Delaware
Hill’s-Colgate (Japan) Ltd.Japan
Hopro Liquidating Corp.Ohio
Hygiene Systemes et Services SATunisia
IES Enterprises, Inc.Massachusetts
Inmobiliaria Colpal, S. de R.L. de C.V.Mexico
Inmobiliaria Hills, S.A. de C.V.Mexico
Innovacion Creativa, S.A. de C.V.Mexico
Kolynos CorporationDelaware
Laboratoires Filorga Cosmetiques Espana S.L.U.Spain
Laboratoires Filorga Cosmetiques Italia S.R.L.Italy
Laboratoires Filorga Cosmétiques S.A.France
Lournay Sales, Inc.Delaware
Mennen de Chile, Ltd.Delaware



Mennen de Nicargua, S.A.Delaware
Mennen Interamerica, Ltd.Delaware
Mennen LimitedDelaware
Mennen South Africa, Ltd.Delaware
Mission Hills Property CorporationDelaware
Mission Hills, S.A. de C.V.Mexico
Norwood International, IncorporatedDelaware
Olive Music Publishing CorporationDelaware
P.T. Colgate Palmolive Indonesia *Indonesia
Paramount Research, Inc.Delaware
Penny, LLCDelaware
Pet Chemicals Inc.Florida
Physicians Care Alliance, LLCArizona
Productos Halogenados Copalven, C.A.Venezuela
Purity Holding CompanyDelaware
Purity Music Publishing CorporationDelaware
Refresh Company LimitedDominica
Samuel Taylor Holdings B.V.Netherlands
Sanxiao Company LimitedHong Kong
Services Development Co., Ltd.Thailand
Societe Generale de Negoce et de Services (GENESE) S.A.Tunisia
The GDN - The Global Distributive Network SASFrance
The Lournay Company, Inc.Delaware
The MPDP - The Medical and Pharmaceutic Distributive Platform SASFrance
The Murphy-Phoenix CompanyOhio
Tom’s of Maine Holdings, Inc.Delaware
Tom’s of Maine, Inc.Maine
Veterinary Companies of America, Inc.Delaware
Vipont Pharmaceutical, Inc.Delaware
Weda (Beijing) Co. Ltd.
China
* Indicates a company that is not wholly owned, directly or indirectly, by Colgate-Palmolive Company.





EX-23 6 exhibit2312312020.htm EX-23 Document

EXHIBIT 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-249768) and Form S-8 (Nos. 33-58746, 33-64753, 333-45679, 333-132038, 333-171448, 333-188528, and 333-231380) of Colgate-Palmolive Company of our report dated February 18, 2021 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP
New York, New York
February 18, 2021


EX-24 7 exhibit2412312020.htm EX-24 Document

EXHIBIT 24


POWER OF ATTORNEY



KNOW ALL PERSONS BY THESE PRESENTS:

    I, John P. Bilbrey, do hereby make, constitute and appoint Jennifer M. Daniels and Kristine Hutchinson, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf the Annual Report of Colgate-Palmolive Company on Form 10-K for the year ended December 31, 2020, and any and all amendments thereto and any other documents in connection therewith, and to file the same with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or either of them may lawfully do or cause to be done by virtue hereof.

    In witness whereof, I have executed this Power of Attorney this 4th day of February, 2021.


/s/ John P. Bilbrey
Name: John P. Bilbrey

EXHIBIT 24


POWER OF ATTORNEY



KNOW ALL PERSONS BY THESE PRESENTS:

    I, John T. Cahill, do hereby make, constitute and appoint Jennifer M. Daniels and Kristine Hutchinson, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf the Annual Report of Colgate-Palmolive Company on Form 10-K for the year ended December 31, 2020, and any and all amendments thereto and any other documents in connection therewith, and to file the same with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or either of them may lawfully do or cause to be done by virtue hereof.

    In witness whereof, I have executed this Power of Attorney this 3rd day of February, 2021.


/s/ John T. Cahill
Name: John T. Cahill






EXHIBIT 24


POWER OF ATTORNEY



KNOW ALL PERSONS BY THESE PRESENTS:

    I, Lisa M. Edwards, do hereby make, constitute and appoint Jennifer M. Daniels and Kristine Hutchinson, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf the Annual Report of Colgate-Palmolive Company on Form 10-K for the year ended December 31, 2020, and any and all amendments thereto and any other documents in connection therewith, and to file the same with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or either of them may lawfully do or cause to be done by virtue hereof.

    In witness whereof, I have executed this Power of Attorney this 10th day of February, 2021.


/s/ Lisa M. Edwards
Name: Lisa M. Edwards

EXHIBIT 24


POWER OF ATTORNEY



KNOW ALL PERSONS BY THESE PRESENTS:

    I, Helene D. Gayle, do hereby make, constitute and appoint Jennifer M. Daniels and Kristine Hutchinson, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf the Annual Report of Colgate-Palmolive Company on Form 10-K for the year ended December 31, 2020, and any and all amendments thereto and any other documents in connection therewith, and to file the same with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or either of them may lawfully do or cause to be done by virtue hereof.

    In witness whereof, I have executed this Power of Attorney this 4th day of February, 2021.

/s/ Helene D. Gayle
Name: Helene D. Gayle







EXHIBIT 24


POWER OF ATTORNEY



KNOW ALL PERSONS BY THESE PRESENTS:

    I, C. Martin Harris, do hereby make, constitute and appoint Jennifer M. Daniels and Kristine Hutchinson, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf the Annual Report of Colgate-Palmolive Company on Form 10-K for the year ended December 31, 2020, and any and all amendments thereto and any other documents in connection therewith, and to file the same with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or either of them may lawfully do or cause to be done by virtue hereof.

    In witness whereof, I have executed this Power of Attorney this 3rd day of February, 2021.


/s/ C. Martin Harris
Name: C. Martin Harris

EXHIBIT 24


POWER OF ATTORNEY



KNOW ALL PERSONS BY THESE PRESENTS:

    I, Martina Hund-Mejean, do hereby make, constitute and appoint Jennifer M. Daniels and Kristine Hutchinson, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf the Annual Report of Colgate-Palmolive Company on Form 10-K for the year ended December 31, 2020, and any and all amendments thereto and any other documents in connection therewith, and to file the same with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or either of them may lawfully do or cause to be done by virtue hereof.

    In witness whereof, I have executed this Power of Attorney this 3rd day of February, 2021.


/s/ Martina Hund-Mejean
Name: Martina Hund-Mejean





EXHIBIT 24


POWER OF ATTORNEY



KNOW ALL PERSONS BY THESE PRESENTS:

    I, Lorrie M. Norrington, do hereby make, constitute and appoint Jennifer M. Daniels and Kristine Hutchinson, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf the Annual Report of Colgate-Palmolive Company on Form 10-K for the year ended December 31, 2020, and any and all amendments thereto and any other documents in connection therewith, and to file the same with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or either of them may lawfully do or cause to be done by virtue hereof.

    In witness whereof, I have executed this Power of Attorney this 3rd day of February, 2021.


/s/ Lorrie M. Norrington
Name: Lorrie M. Norrington

EXHIBIT 24


POWER OF ATTORNEY



KNOW ALL PERSONS BY THESE PRESENTS:

    I, Michael B. Polk, do hereby make, constitute and appoint Jennifer M. Daniels and Kristine Hutchinson, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf the Annual Report of Colgate-Palmolive Company on Form 10-K for the year ended December 31, 2020, and any and all amendments thereto and any other documents in connection therewith, and to file the same with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or either of them may lawfully do or cause to be done by virtue hereof.

    In witness whereof, I have executed this Power of Attorney this 11th day of February, 2021.


/s/ Michael B. Polk
Name: Michael B. Polk





EXHIBIT 24


POWER OF ATTORNEY



KNOW ALL PERSONS BY THESE PRESENTS:

    I, Stephen I. Sadove, do hereby make, constitute and appoint Jennifer M. Daniels and Kristine Hutchinson, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf the Annual Report of Colgate-Palmolive Company on Form 10-K for the year ended December 31, 2020, and any and all amendments thereto and any other documents in connection therewith, and to file the same with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing necessary and proper to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and/or either of them may lawfully do or cause to be done by virtue hereof.

    In witness whereof, I have executed this Power of Attorney this 3rd day of February, 2021.


/s/ Stephen I. Sadove
Name: Stephen I. Sadove



EX-31.A 8 exhibit31a12312020.htm EX-31.A Document

EXHIBIT 31-A

I, Noel R. Wallace, certify that:
1.I have reviewed this Annual Report on Form 10-K of Colgate-Palmolive Company;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: February 18, 2021

/s/ Noel R. Wallace
Noel R. Wallace
Chairman of the Board, President and
Chief Executive Officer


EX-31.B 9 exhibit31b12312020.htm EX-31.B Document

EXHIBIT 31-B

I, Stanley J. Sutula III, certify that:
1.I have reviewed this Annual Report on Form 10-K of Colgate-Palmolive Company;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Date: February 18, 2021

/s/ Stanley J. Sutula III
Stanley J. Sutula III
Chief Financial Officer


EX-32 10 exhibit3212312020.htm EX-32 Document

EXHIBIT 32

The undersigned Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer of Colgate-Palmolive Company each certify, pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. § 1350, that:

(1)the Annual Report on Form 10-K for the year ended December 31, 2020 (the “Annual Report”) which this statement accompanies, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and

(2)information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of Colgate-Palmolive Company.

Date: February 18, 2021
/s/ Noel R. Wallace
Noel R. Wallace
Chairman of the Board, President and
Chief Executive Officer
/s/ Stanley J. Sutula III
Stanley J. Sutula III
Chief Financial Officer

A signed original of this written statement has been provided to Colgate-Palmolive Company and will be retained by Colgate-Palmolive Company and furnished to the Securities and Exchange Commission or its staff upon request.



EX-101.SCH 11 cl-20201231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000010001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 100010002 - Statement - Consolidated Statements of Income link:presentationLink link:calculationLink link:definitionLink 100020003 - Statement - Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 100030004 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 100040005 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100050006 - Statement - Consolidated Statements of Changes in Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 100060007 - Statement - Consolidated Statements of Changes in Shareholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100070008 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 140084001 - Statement - Consolidated Statements of Cash Flows (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 210011001 - Disclosure - Nature of Operations link:presentationLink link:calculationLink link:definitionLink 230023001 - Disclosure - Nature of Operations (Tables) link:presentationLink link:calculationLink link:definitionLink 240034002 - Disclosure - Nature of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 210041002 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 220052001 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 240064003 - Disclosure - Summary of Significant Accounting Policies - Principles of Consolidation, Shipping and Handling Costs, Inventories, & Property, Plant, and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 240074004 - Disclosure - Summary of Significant Accounting Policies - Goodwill and Other Intangibles (Details) link:presentationLink link:calculationLink link:definitionLink 210081003 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 230093002 - Disclosure - Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 240104005 - Disclosure - Acquisitions - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240114006 - Disclosure - Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 210121004 - Disclosure - Restructuring and Related Implementation Charges link:presentationLink link:calculationLink link:definitionLink 230133003 - Disclosure - Restructuring and Related Implementation Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 240144007 - Disclosure - Restructuring and Related Implementation Charges - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240154008 - Disclosure - Restructuring and Related Implementation Charges - Summary of Restructuring and Related Costs (Details) link:presentationLink link:calculationLink link:definitionLink 240164009 - Disclosure - Restructuring and Related Implementation Charges - Restructuring Charges Incurred, by Segment (Details) link:presentationLink link:calculationLink link:definitionLink 240174010 - Disclosure - Restructuring and Related Implementation Charges - Summary of Restructuring Charges, Cumulative to Date (Details) link:presentationLink link:calculationLink link:definitionLink 240184011 - Disclosure - Restructuring and Related Implementation Charges - Restructuring Activity and Related Accruals (Details) link:presentationLink link:calculationLink link:definitionLink 210191005 - Disclosure - Goodwill and Other Intangible Assets link:presentationLink link:calculationLink link:definitionLink 230203004 - Disclosure - Goodwill and Other Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 240214012 - Disclosure - Goodwill and Other Intangible Assets - Schedule of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 240224013 - Disclosure - Goodwill and Other Intangible Assets - Summary of Other Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 240234014 - Disclosure - Goodwill and Other Intangible Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 210241006 - Disclosure - Long-Term Debt and Credit Facilities link:presentationLink link:calculationLink link:definitionLink 230253005 - Disclosure - Long-Term Debt and Credit Facilities (Tables) link:presentationLink link:calculationLink link:definitionLink 240264015 - Disclosure - Long-Term Debt and Credit Facilities - Components of Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 240274016 - Disclosure - Long-Term Debt and Credit Facilities - Schedule of Long-Term Debt and Finance Lease Maturities (Details) link:presentationLink link:calculationLink link:definitionLink 240284017 - Disclosure - Long-Term Debt and Credit Facilities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 210291007 - Disclosure - Fair Value Measurements and Financial Instruments link:presentationLink link:calculationLink link:definitionLink 230303006 - Disclosure - Fair Value Measurements and Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 240314018 - Disclosure - Fair Value Measurements and Financial Instruments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240324019 - Disclosure - Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 240334020 - Disclosure - Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 240344021 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details) link:presentationLink link:calculationLink link:definitionLink 240354022 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Statements of Income (Details) link:presentationLink link:calculationLink link:definitionLink 240364023 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details) link:presentationLink link:calculationLink link:definitionLink 210371008 - Disclosure - Capital Stock and Stock-Based Compensation Plans link:presentationLink link:calculationLink link:definitionLink 230383007 - Disclosure - Capital Stock and Stock-Based Compensation Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 240394024 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240404025 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Summary of Common Stock and Treasury Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 240414026 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Fair Value Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 240424027 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Summary of Performance Restricted Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 240434028 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Summary of Restricted Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 240444029 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 210451009 - Disclosure - Employee Stock Ownership Plan link:presentationLink link:calculationLink link:definitionLink 240464030 - Disclosure - Employee Stock Ownership Plan (Details) link:presentationLink link:calculationLink link:definitionLink 210471010 - Disclosure - Retirement Plans and Other Retiree Benefits link:presentationLink link:calculationLink link:definitionLink 230483008 - Disclosure - Retirement Plans and Other Retiree Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 240494031 - Disclosure - Retirement Plans and Other Retiree Benefits - Schedule of Target Asset Allocation (Details) link:presentationLink link:calculationLink link:definitionLink 240504032 - Disclosure - Retirement Plans and Other Retiree Benefits - Allocation of Plan Assets and Level of Valuation Input, by Major Asset Category (Details) link:presentationLink link:calculationLink link:definitionLink 240514033 - Disclosure - Retirement Plans and Other Retiree Benefits - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240524034 - Disclosure - Retirement Plans and Other Retiree Benefits - Summary of Defined Benefit and Other Retiree Benefit Plans (Details) link:presentationLink link:calculationLink link:definitionLink 240534035 - Disclosure - Retirement Plans and Other Retiree Benefits - Benefit Obligation Exceeds Fair Value of Plan Assets (Details) link:presentationLink link:calculationLink link:definitionLink 240544036 - Disclosure - Retirement Plans and Other Retiree Benefits - Summary of Other Retiree Benefit Plans (Details) link:presentationLink link:calculationLink link:definitionLink 240554037 - Disclosure - Retirement Plans and Other Retiree Benefits - Summary of Net Periodic Benefit Costs (Details) link:presentationLink link:calculationLink link:definitionLink 240564038 - Disclosure - Retirement Plans and Other Retiree Benefits - Expected Contributions and Benefit Payments (Details) link:presentationLink link:calculationLink link:definitionLink 210571011 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 230583009 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 240594039 - Disclosure - Income Taxes - Components of Income Before Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 240604040 - Disclosure - Income Taxes - Provision for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 240614041 - Disclosure - Income Taxes - Income Tax Provision Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 240624042 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 240634043 - Disclosure - Income Taxes - Components of Deferred Tax Assets (Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 240634043 - Disclosure - Income Taxes - Components of Deferred Tax Assets (Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 240644044 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240654045 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 210661012 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 230673010 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 240684046 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 240694047 - Disclosure - Earnings Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 210701013 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 240714048 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 210721014 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 230733011 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 240744049 - Disclosure - Segment Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240754050 - Disclosure - Segment Information - Schedule of Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 210761015 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 230773012 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 240784051 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240794052 - Disclosure - Leases - Balance Sheet (Details) link:presentationLink link:calculationLink link:definitionLink 240804053 - Disclosure - Leases - Schedule of Minimum Lease Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 240804053 - Disclosure - Leases - Schedule of Minimum Lease Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 240814054 - Disclosure - Leases - Schedule of Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 210821016 - Disclosure - Supplemental Income Statement Information link:presentationLink link:calculationLink link:definitionLink 230833013 - Disclosure - Supplemental Income Statement Information (Tables) link:presentationLink link:calculationLink link:definitionLink 240844055 - Disclosure - Supplemental Income Statement Information (Details) link:presentationLink link:calculationLink link:definitionLink 210851017 - Disclosure - Supplemental Balance Sheet Information link:presentationLink link:calculationLink link:definitionLink 230863014 - Disclosure - Supplemental Balance Sheet Information (Tables) link:presentationLink link:calculationLink link:definitionLink 240874056 - Disclosure - Supplemental Balance Sheet Information - Schedule of Inventories by Major Class (Details) link:presentationLink link:calculationLink link:definitionLink 240874056 - Disclosure - Supplemental Balance Sheet Information - Schedule of Inventories by Major Class (Details) link:presentationLink link:calculationLink link:definitionLink 240884057 - Disclosure - Supplemental Balance Sheet Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240894058 - Disclosure - Supplemental Balance Sheet Information - Schedule of Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 240904059 - Disclosure - Supplemental Balance Sheet Information - Schedule of Other Accruals (Details) link:presentationLink link:calculationLink link:definitionLink 240914060 - Disclosure - Supplemental Balance Sheet Information - Schedule of Other Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 210921018 - Disclosure - Supplemental Other Comprehensive Income (Loss) Information link:presentationLink link:calculationLink link:definitionLink 230933015 - Disclosure - Supplemental Other Comprehensive Income (Loss) Information (Tables) link:presentationLink link:calculationLink link:definitionLink 240944061 - Disclosure - Supplemental Other Comprehensive Income (Loss) Information - Schedule of Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 240954062 - Disclosure - Supplemental Other Comprehensive Income (Loss) Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 210961019 - Disclosure - Quarterly Financial Data (Unaudited) link:presentationLink link:calculationLink link:definitionLink 230973016 - Disclosure - Quarterly Financial Data (Unaudited) (Tables) link:presentationLink link:calculationLink link:definitionLink 240984063 - Disclosure - Quarterly Financial Data (Unaudited) (Details) link:presentationLink link:calculationLink link:definitionLink 210991020 - Disclosure - Schedule II - Valuation and Qualifying Accounts link:presentationLink link:calculationLink link:definitionLink 241004064 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 12 cl-20201231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 13 cl-20201231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 14 cl-20201231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Target asset allocation Defined Benefit Plan, Plan Assets, Target Allocation, Percentage Intrinsic value of unexercised in-the-money options, options outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Change in Benefit Obligations Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] 1.375% Notes Due 2034 1.375% Notes Due 2034 [Member] 1.375% Notes Due 2034 [Member] Change in Plan Assets Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] Deferred income taxes Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Inventories valued under LIFO LIFO Inventory Amount Proceeds from sale of marketable securities and investments Proceeds from Sale and Maturity of Marketable Securities Other Other Accrued Liabilities Current Other Carrying value as of the balance sheet date of other obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Supplemental Income Statement Information Supplemental Income Statement Information [Text Block] This element is used to disclose supplemental income statement information for the periods disclosed. Statistical Measurement [Domain] Statistical Measurement [Domain] Liabilities and Shareholders’ Equity Liabilities and Equity [Abstract] Fair value of net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Personal Care Personal Care [Member] Personal Care products include bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants and other similar items. Brazilian internal revenue authority, matter 2 Tax Assessments With Interest And Penalties The amount of tax assessment with estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations related to investments held by a foreign subsidiary. Reporting unit, percentage of fair value in excess of carrying amount Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Security Exchange Name Security Exchange Name Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class [Table] Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class [Table] Disclosure of the carrying value of amortizable intangible assets by major class. Finite-lived intangible assets have a stated useful life over which their gross carrying value is amortized. Disclosure of the details of intangible assets not subject to amortization, excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company. Fair value of plan assets Fair value of plan assets at beginning of year Fair value of plan assets at end of year Defined Benefit Plan, Plan Assets, Amount Total current liabilities Liabilities, Current Settlements and acquisitions Defined Benefit Plan, Plan Assets, Payment for Settlement Less: Cumulative translation adjustments attributable to noncontrolling interests Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest Restricted stock awards - beginning of period (in dollars per share) Restricted stock awards - end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value 2025 Defined Benefit Plan, Expected Future Benefit Payment, Year Five Deferred withholding tax Effective Income Tax Rate Reconciliation, Deferred Withholding Tax, Amount Effective Income Tax Rate Reconciliation, Deferred Withholding Tax, Amount Shares issued for restricted stock awards Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Assets Assets: Assets [Abstract] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] Subsidiaries Subsidiaries [Member] Operating lease, payments Operating Lease, Payments Short-term borrowing/(repayment) less than 90 days - net Proceeds from Other Short-term Debt Supplemental Other Comprehensive Income (Loss) Information Comprehensive Income (Loss) Note [Text Block] 2023 Long-Term Debt, Maturity, Year Three Total long lived assets Total Long Lived Assets Amount of total long-lived assets, primarily property, plant and equipment and goodwill and other intangibles. Derivative and Financial Instruments, Fair Value [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Goodwill and intangible assets Deferred Tax Liabilities, Goodwill and Intangible Assets Useful life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Schedule Of Common And Treasury Stock Activity Schedule Of Common And Treasury Stock Activity [Table Text Block] Schedule Of Common And Treasury Stock Activity [Table Text Block] 2021 Lessee, Operating Lease, Liability, to be Paid, Year One Common stock acquired (in shares) Treasury Stock, Shares, Acquired Options - beginning balance (in shares) Options - ending balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 2024 Lessee, Operating Lease, Liability, to be Paid, Year Four Unrecognized compensation expense Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Goodwill and intangible assets Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount SWITZERLAND SWITZERLAND Buildings Building [Member] Other comprehensive income (loss), net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Common stock par value (in USD per share) Common Stock, Par or Stated Value Per Share Marketable securities Marketable Securities 2023 Defined Benefit Plan, Expected Future Benefit Payment, Year Three Other liabilities Total Other liabilities Other Liabilities, Noncurrent Deferred income taxes Deferred income taxes Deferred Income Tax Assets, Net Options - shares forfeited or expired (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price BRAZIL BRAZIL Other liabilities Other Liabilities [Abstract] Work-in-process Inventory, Work in Process, Net of Reserves Valuation allowance for deferred tax assets SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] Effect of exchange rate changes on Cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Inventories Current Inventories, net Inventory, Net Net investment hedges [Abstract] Summary of Net Investment Hedge Activity [Abstract] Investments accounted for using the equity method, maximum interest Equity Method Investment Ownership Percentage Maximum The maximum percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Percent of net sales Percentage of consolidated sales represented by one customer Concentration Risk, Percentage Medical cost trend rate of increase Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Medical Cost Trend Rate Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Medical Cost Trend Rate for next fiscal. Contractual term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Contractual commitments, amount Long-term Purchase Commitment, Amount Fair value of plan assets Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets Statement [Line Items] Statement [Line Items] Pooled funds Defined Benefit Plan, Pooled Funds [Member] Defined Benefit Plan, Pooled Funds [Member] Class of Stock [Domain] Class of Stock [Domain] Debt instrument term Debt Instrument, Term Statement [Table] Statement [Table] Interest cost Defined Benefit Plan, Interest Cost Type of Restructuring [Domain] Type of Restructuring [Domain] Statistical Measurement [Axis] Statistical Measurement [Axis] Deferred income taxes Deferred Income Taxes and Tax Credits Home Care Home Care [Member] Home Care products include laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches and other similar items. Other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Interest income Interest Income, Other Carrying amount of hedged item Hedged Liability, Fair Value Hedge Amount reclassified from OCI Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Entity Small Business Entity Small Business Principles of Consolidation Consolidation, Policy [Policy Text Block] Latin America Latin America [Member] Gain (loss) on hedged items Other Comprehensive Income (Loss), Hedged Item In Net Investment Hedge, Gain (Loss), Before Reclassification And Tax Other Comprehensive Income (Loss), Hedged Item In Net Investment Hedge, Gain (Loss), Before Reclassification and Tax Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Long-Term Debt and Credit Facilities Debt Disclosure [Text Block] Charges against assets Charges against assets Restructuring Reserve, Charges Against Assets Restructuring Reserve, Charges Against Assets Cost of sales Cost of Revenue Share Repurchase Program [Domain] Share Repurchase Program [Domain] Amendment Flag Amendment Flag Shares (millions) Weighted Average Number of Shares Outstanding, Diluted [Abstract] Incentive Stock Plans Incentive Stock Plans Member The Company has plans that provide for grants of restricted stock awards for officers and other employees. A committee of independent members of the Board of Directors administers the plan. Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class [Table Text Block] Disclosure of amortizable intangible assets, in total and by major class, including the gross carrying amount and accumulated amortization. Disclosure of the carrying value of intangible assets not subject to amortization, excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company. Corporate Corporate Corporate, Non-Segment [Member] Number of shares available for grant (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Other accruals Other accruals Other Accrued Liabilities, Current Restructuring and Related Implementation Charges Restructuring and Related Activities Disclosure [Text Block] Percent of total restructuring charges related to segment Percent Of Total Restructuring Charges Related To Segment For The Period Percent Of Total Restructuring Charges Related To Segment For The Period Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Total gain (loss) on hedges recognized in income Derivative, Gain (Loss) on Derivative, Net Fair Value Measurement [Domain] Fair Value Measurement [Domain] Consideration transferred, other Business Combination, Consideration Transferred, Other Financial Instruments Derivatives, Policy [Policy Text Block] Charge for U.S. tax reform Tax reform, provisional charge Tax Cuts and Jobs Act, Incomplete Accounting, Provisional Income Tax Expense (Benefit) 1 Tax Cuts and Jobs Act, Incomplete Accounting, Provisional Income Tax Expense (Benefit) 1 Seven Year notes at 0.50 Percent seven year notes at 0.50percent number [Member] seven year notes at 0.50percent number [Member] Statue of limitations on foreign jurisdictions for tax audits Statue Of Limitations Of Certain Foreign Entities Statue Of Limitations Of Certain Foreign Entities Property, Plant and Equipment by Type [Axis] Long-Lived Tangible Asset [Axis] Schedule of Share-based Compensation, Performance Restricted Stock and Time-based Restricted Stock Units Activity Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Beginning balance of valuation allowance and reserves Ending balance of valuation allowance and reserves SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Percentage of worldwide sales Revenue from External Customers by Products and Services [Table Text Block] Allowance for doubtful accounts receivable, current Accounts Receivable, Allowance for Credit Loss, Current Income Statement Location [Domain] Income Statement Location [Domain] 2022 Lessee, Operating Lease, Liability, to be Paid, Year Two Two Year Notes at 0.00 Percent two year notes at 0.00 percent [Member] two year notes at 0.00 percent [Member] Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Indefinite-lived intangible assets, percentage of fair value in excess of carrying amount Indefinite-Lived Intangible Assets, Percentage Of Fair Value In Excess Of Carrying Amount Indefinite-Lived Intangible Assets, Percentage Of Fair Value In Excess Of Carrying Amount Selling, general and administrative expenses Selling, General and Administrative Expense Domestic, developed and emerging markets equity funds Defined Benefit Plan, Domestic, Developed and Emerging Markets Equity Funds [Member] Domestic, Developed and Emerging Markets Equity Funds [Member] Foreign currency contracts Foreign Exchange Contract [Member] Schedule of Components of Operating Lease Expense Lease, Cost [Table Text Block] Total debt Long-term Debt and Lease Obligation, Including Current Maturities 2023 Lessee, Operating Lease, Liability, to be Paid, Year Three Number of cases resulting in adverse jury verdict Loss Contingency, Cases Resulting In Adverse Jury Verdict, Number Loss Contingency, Cases Resulting In Adverse Jury Verdict, Number Other assets Other Assets, Noncurrent Plan Name [Axis] Plan Name [Axis] Reporting Units Other Than Filorga Reporting Units Other Than Filorga [Member] Reporting Units Other Than Filorga Unearned Compensation Unearned Compensation [Member] Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for unearned compensation is also recorded. Total assets Identifiable assets Assets Interest incurred Interest Expense, Debt Restricted stock awards - beginning balance (in shares) Restricted stock awards - ending balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Corporate Corporate Segment [Member] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Reporting Unit [Domain] Reporting Unit [Domain] Amortization of transition and prior service costs (credits) Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Total benefit payments [Abstract] Defined Benefit Plan, Expected Future Benefit Payment [Abstract] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Cost of sales Cost of Sales [Member] Average annual rates of return for the most recent 15-year period Average Annual Rate Of Return For Most Recent Fifteen Year Period The average annual rate of return on pension plan assets for the most recent 15 year period. Acquisitions Mergers, Acquisitions and Dispositions Disclosures [Text Block] Stock-based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount Other finite life intangible assets Other Intangible Assets [Member] Cash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Total liabilities Liabilities Income Taxes [Line Items] Income Tax Contingency [Line Items] Interest Crediting Rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Weighted-Average Interest Crediting Rate Land and Building Land and Building [Member] ESOP growth rate Defined Benefit Plan Assumptions Used Calculating Benefit Obligation ESOP Growth Rate Expected growth rate of company stock held by the employee stock ownership plans used to determine benefit obligations for defined benefit plans. Restructuring and related cost incurred cost to date after tax Restructuring And Related Cost Incurred Cost To Date After Tax Restructuring And Related Cost Incurred Cost To Date After Tax Retirement Plan Type [Axis] Retirement Plan Type [Axis] Expected volatility rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Less: Interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Accumulated benefit obligation Defined Benefit Plan, Accumulated Benefit Obligation Participants’ contributions Defined Benefit Plan, Plan Assets, Contributions by Plan Participant Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 1 [Member] Inventories Increase (Decrease) in Inventories Weighted average interest rate Debt, Weighted Average Interest Rate Shares (in thousands) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Other non-current assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount International common stocks Defined Benefit Plan, International Common Stock [Member] This category includes information about ownership interests in international corporations and other legal entities for which ownership interest is represented by shares of common stock. Loss Contingency, Number Of Cases On Appeal Loss Contingency, Number Of Cases On Appeal Loss Contingency, Number of Cases On Appeal Additional Paid-In Capital Additional Paid-in Capital [Member] Oral, Personal and Home Care Oral, Personal and Home Care Oral, Personal and Home Care [Member] Oral, Personal and Home Care Other (income) expense, net Other (Income) Expense, Net [Member] Other (Income) Expense, Net [Member] Machinery and equipment Machinery and Equipment [Member] Schedule of Right-of-use Assets and Liabilities for Operating Leases Assets And Liabilities, Lessee [Table Text Block] Assets And Liabilities, Lessee [Table Text Block] Common stock balance, January 1 (in shares) Common stock balance, December 31 (in shares) Common Stock, Shares, Outstanding Schedule of Percent of Total Restructuring Charges Related To Segment for the period Schedule Of Percent Of Total Restructuring Charges Related To Segment For The Period [Table Text Block] Schedule of Percent Of Total Restructuring Charges Related To Segment for the period Equity method investments included in other assets Equity Method Investments Deferred tax assets: Deferred Tax Assets, Net [Abstract] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Other, net Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Options - beginning of period (in dollars per share) Options - end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Payment for acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Common stock authorized (in shares) Common Stock, Shares Authorized Fixed income securities Defined Benefit Plan, Fixed Income Securities [Member] Defined Benefit Plan, Fixed Income Securities [Member] Percentage of voting interests acquired Business Acquisition, Percentage of Voting Interests Acquired Property, plant and equipment, gross Property, Plant and Equipment, Gross Stock options and restricted stock units (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Proceeds from exercise of stock options Proceeds from Stock Options Exercised 2022 Defined Benefit Plan, Expected Future Benefit Payment, Year Two Termination benefits Defined Benefit Plan, Benefit Obligation, Special and Contractual Termination Benefits Net Sales and Operating Profit by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Net amount recognized Defined Benefit Plan, Funded (Unfunded) Status of Plan SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] Income Statement [Abstract] Income Statement [Abstract] Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Other assets and liabilities, net Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets And Liabilities, Other, Net Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets And Liabilities, Other, Net Expected benefit payments from company assets Expected Benefit Payments From Company Assets Expected Benefit Payments From Company's Assets to be paid in year one. Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Use of Estimates Use of Estimates, Policy [Policy Text Block] Consolidated Entities [Axis] Consolidated Entities [Axis] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Capital expenditures Payments to Acquire Property, Plant, and Equipment Consolidation Items [Domain] Consolidation Items [Domain] Accrued advertising and coupon redemption Accrued Advertising And Coupon Redemption Current Carrying value as of the balance sheet date of obligations incurred through that date and payable for advertising of the entity's goods and services as well as for coupon redemption. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Goodwill and Other Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Property, Plant, and Equipment [Abstract] Property, plant and equipment, net Property, Plant and Equipment [Abstract] Actual return on plan assets Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Valuation Allowance [Table] Valuation Allowance [Table] Equity income Income (Loss) from Equity Method Investments Property, plant and equipment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Depreciation, Amount Notes Notes Payable, Other Payables [Member] Schedule of Inventories by Major Class Schedule of Inventory, Current [Table Text Block] 2026-2030 Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years Restructuring accrual Restructuring Reserve, Noncurrent Non-current inventory, net Inventory, Noncurrent Schedule of Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] Guaranteed investment contracts Defined Benefit Plan, Guaranteed Investment Contracts [Member] This element represents investments in contracts with insurance companies measured at the cash surrender value of each contract. Transition/prior service cost Defined Benefit Plan Accumulated Other Comprehensive Income Net Transition Assets Obligations And Net Prior Service Cost Credit Before Tax The portion of accumulated other comprehensive income comprised of net prior service cost/credit and net transition assets (obligations), before tax. Quarterly Financial Data (Unaudited) Quarterly Financial Information [Text Block] Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities And Lapse Of Applicable Statute Of Limitations The gross amount of decreases in unrecognized tax benefits resulting from settlements with taxing authorities and lapses of the applicable statutes of limitations. Estimated useful life Property, Plant and Equipment, Useful Life Interest expense, net Interest expense, net [Table Text Block] Interest Expense, net [Table Text Block] Goodwill [Line Items] Goodwill [Line Items] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] United States Federal Income Tax Expense (Benefit), Continuing Operations Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Finished goods Inventory, Finished Goods, Net of Reserves Receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Effect of foreign currency rate movements Unrecognized Tax Benefits Effect Of Foreign Currency Rate Movements The impact in unrecognized tax benefits resulting from foreign currency rate movements. Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Consolidated Entities [Domain] Consolidated Entities [Domain] Other accruals Operating Lease, Liability, Current Entity-Wide Information, Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Schedule of Other Accruals Other Accruals [Table Text Block] Other Accruals [Table Text Block] Ultimate medical cost trend rate Defined Benefit Plan, Ultimate Health Care Cost Trend Rate Weighted-average interest rate on short term borrowings Short-term Debt, Weighted Average Interest Rate, at Point in Time Interest (income) expense, net Interest Income (Expense), Net [Abstract] Derivative Instruments, Gain (Loss) Derivative Instruments, Gain (Loss) [Table Text Block] Restricted stock awards - shares forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Schedule of Derivative Instruments Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Additional disclosures pertaining to stock based compensation [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] Percentage of investments in Company's common stock Defined Benefit Plan Percentage Of Equity Securities Invested In Employer Securities The percentage of equity securities of the defined benefit plan invested in the Company's common stock. Entity Registrant Name Entity Registrant Name Foreign currency translation adjustments Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Business Acquisition [Line Items] Business Acquisition [Line Items] Operating lease, weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Cash outflow from unrecognized tax benefit that would impact effective tax rate Cash Outflow from Unrecognized Tax Benefit that Would Impact Effective Tax Rate The total amount of cash outflow of unrecognized tax benefit that, if recognized, would impact effective tax rate Discrete Income Tax Provision (Benefit) Discrete Income Tax Provision (Benefit) Discrete Income Tax Provision (Benefit) Shipping and Handling Shipping and Handling [Member] Contract Termination Contract Termination [Member] Incremental Depreciation Incremental Depreciation [Member] Incremental Depreciation [Member] Total Global Growth and Efficiency Program charges, aftertax Restructuring And Related Cost, Incurred Cost, After Tax Restructuring And Related Cost, Incurred Cost, After Tax Schedule of Other Liabilities Other Liabilities [Table Text Block] Reporting unit, impairment analysis, projected reduction in fair value, percentage Reporting Unit, Impairment Analysis, Projected Reduction In Fair Value, Percentage Reporting Unit, Impairment Analysis, Projected Reduction In Fair Value, Percentage Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Percentage of corporate identifiable assets consisting of investments in equity securities Percentage Of Corporate Identifiable Assets Consisting Of Investments In Equity Securities Percentage of Corporate identifiable assets consisting of investments in equity securities. Other Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change Restructuring Reserve Beginning balance Ending balance Restructuring Reserve Employee-Related Costs One-time Termination Benefits [Member] Adjustments for New Accounting Pronouncements [Axis] Accounting Standards Update [Axis] Tax benefit from exercise of stock options and vesting of restricted stock unit awards Employee Service Share-Based Compensation, Tax Benefit From Exercise Of Stock Options And Vesting Of Restricted Stock Unit Awards Employee Service Share-Based Compensation, Tax Benefit From Exercise Of Stock Options And Vesting Of Restricted Stock Unit Awards Accounting Standards Update 2016-02 Accounting Standards Update 2016-02 [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Net deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Schedule of Comprehensive Income (Loss) Comprehensive Income (Loss) [Table Text Block] Restructuring Type [Axis] Restructuring Type [Axis] Goodwill Goodwill Goodwill Dividends declared per common share (in USD per share) Common Stock, Dividends, Per Share, Declared Face amount Debt Instrument, Face Amount Other current assets Other Assets, Current Schedule of Goodwill Schedule of Goodwill [Table Text Block] Percentage of consolidated Net sales represented by sales outside US Percentage Of Consolidated Net Sales Represented By Sales Outside US Percentage of Consolidated Net Sales represented by Sales outside US Equity [Abstract] Equity [Abstract] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Options - shares granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Entities [Table] Entities [Table] Customer Concentration Risk Customer Concentration Risk [Member] Diluted EPS (in shares) Weighted Average Number of Shares Outstanding, Diluted Derivative Contract Type [Domain] Derivative Contract [Domain] Other current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Number of operating segments (in segments) Number of Operating Segments Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Gain (loss) on instruments Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Debt Disclosure [Abstract] Debt Disclosure [Abstract] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Supplemental Income Statement Elements [Abstract] Supplemental Income Statement Elements [Abstract] Cash and cash equivalents Defined Benefit Plan, Cash and Cash Equivalents [Member] Restructuring Plan [Axis] Restructuring Plan [Axis] Accrued liabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Research and development and Advertising Research And Development And Advertising [Table Text Block] This element is used to disclose supplemental income statement information related to research and development and advertising expense. Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities hello Hello Product LLC [Member] Hello Product LLC [Member] Balance, January 1 Balance, December 31 Unrecognized Tax Benefits Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued) Common Stock, Value, Issued 2024 Defined Benefit Plan, Expected Future Benefit Payment, Year Four Common shares available for future allocation to participant accounts (in shares) Employee Stock Ownership Plan (ESOP), Number of Suspense Shares Long-term Debt Long-term Debt [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Document Fiscal Year Focus Document Fiscal Year Focus Annual estimated amortization expense, year 2 Finite-Lived Intangible Asset, Expected Amortization, Year Two Finite and indefinite-lived intangible assets [Line Items] Finite And Indefinite Lived Intangible Assets [Line Items] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Dividends paid Payments of Ordinary Dividends 0.000% Notes due 2021 0.000% Notes due 2021 [Member] 0.000% Notes due 2021 [Member] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Current portion of long-term debt Less: Current portion of long-term debt Long-term Debt, Current Maturities Benefit obligations at beginning of year Benefit obligations at end of year Defined Benefit Plan, Benefit Obligation Twenty Year Notes at 0.875 Percent Twenty year notes at 0.875 percent [Member] Twenty year notes at 0.875 percent [Member] Entity Current Reporting Status Entity Current Reporting Status U.S. plans assets sold to Company (in shares) Defined Benefit Plan, Plan Assets, Divestiture, Shares Defined Benefit Plan, Plan Assets, Divestiture, Shares Total Comprehensive income including noncontrolling interests Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Minimum number of countries and territories serving consumers (more than) (in countries and territories) Minimum Number Of Countries And Territories Serving Consumers Minimum Number Of Countries And Territories Serving Consumers Common stock issued (in shares) Common Stock, Shares, Issued Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Operating lease, liability Total operating lease liabilities Present value of lease liabilities Operating Lease, Liability Net deferred income taxes Deferred Tax Liabilities, Net Long-term debt Total debt, excluding current portion of long-term debt Long-term Debt, Excluding Current Maturities Segment Reporting [Abstract] Segment Reporting [Abstract] Share Repurchase Program [Axis] Share Repurchase Program [Axis] Asia Pacific Asia [Member] Local Brands, Trademarks, Customer Relationships, and Non-Compete Agreements Local Brands, Trademarks, Customer Relationships And Non Compete Agreements Member Finite-lived intangible assets consisting of: Payments made to third parties in exchange for their agreement not to engage in specified competitive practices in specified geographic territories for a specified period of time, an asset acquired in a business combination representing a customer relationship that exists between an entity and its customer, rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, and local brand value. Debt Instrument [Line Items] Debt Instrument [Line Items] Total Colgate-Palmolive Company shareholders’ equity Stockholders' Equity Attributable to Parent Nature of Operations Nature of Operations [Text Block] Loss contingency, claims dismissed or settled, number (in cases) Loss Contingency, Claims Settled and Dismissed, Number Purchase price consideration Business Combination, Consideration Transferred Entity Address, City or Town Entity Address, City or Town Accrued payroll and employee benefits Employee-related Liabilities, Current Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Reporting Unit Impairment Analysis [Domain] Reporting Unit Impairment Analysis [Domain] Reporting Unit Impairment Analysis Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Medical cost trend rate assumed for next fiscal year Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year Interest (income) expense, net Interest (Income) Expense, Net [Member] Interest (Income) Expense, Net [Member] 2025 Lessee, Operating Lease, Liability, to be Paid, Year Five Other assets Other Assets [Member] Pension and other retiree benefits Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount Type of Adoption [Domain] Accounting Standards Update [Domain] Outstanding borrowings in the ESOP Employee Stock Ownership Plan ESOP Debt Structure Employer Loan Amount The amount of advances from the Company to the ESOP which remain outstanding as of the balance sheet date. Short-term lease cost Short-term Lease, Cost Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Liabilities: Liabilities [Abstract] Valuation Allowance Deferred Tax Assets, Valuation Allowance Right-of-use assets Deferred Tax Liabilities, Leasing Arrangements Foreign exchange impact Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) Annual estimated amortization expense, year 3 Finite-Lived Intangible Asset, Expected Amortization, Year Three Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Schedule of Notional Amounts of Outstanding Derivative Positions Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Total Other comprehensive income (loss), net of tax Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Leases [Abstract] Leases [Abstract] Stock-Based Compensation [Abstract] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Abstract] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Total current assets Assets, Current Schedule of components of deferred income tax benefit Schedule of Components of Deferred Income Tax Benefit (Provision) [Table Text Block] Disclosure of the temporary differences between accounting for financial statement purposes and accounting for tax purposes that result in the current provision for taxes being higher (lower) than the total provision for income taxes. Total Comprehensive income attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Earnings Per Share [Abstract] Earnings per common share: Earnings Per Share [Abstract] Components of deferred tax assets (liabilities) Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Fair Value Measured at Net Asset Value Per Share Fair Value Measured at Net Asset Value Per Share [Member] State income taxes, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Pension and other benefits Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent Noncontrolling interests Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value Annual estimated amortization expense, year 5 Finite-Lived Intangible Asset, Expected Amortization, Year Five Document Fiscal Period Focus Document Fiscal Period Focus Diluted EPS Net Income (Loss) Available to Common Stockholders, Diluted Company contributions Defined Benefit Plan, Plan Assets, Contributions by Employer Fair Value, Inputs, Level 1, 2 and 3 Fair Value, Inputs, Level 1, 2 and 3 [Member] Entity Filer Category Entity Filer Category Common Stock Common Stock [Member] Cumulative translation adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Product and Service [Domain] Product and Service [Domain] Earnings taxed at other than United States statutory rate Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Percentage of consolidated Net sales coming from emerging markets Percentage Of Consolidated Net Sales Coming From Emerging Markets Percentage of Consolidated Net Sales coming from Emerging Markets Notes and loans payable Short-term Bank Loans and Notes Payable Amounts Recognized in Balance Sheet Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract] Projected benefit obligation Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation Sales Revenue, Net Revenue Benchmark [Member] Other (income) expense, net Other Income Expense Net Abstract Fixed interest rate Debt Instrument, Interest Rate, Stated Percentage Filorga Reporting Unit Filorga Reporting Unit [Member] Filorga Reporting Unit Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block] Earnings Per Share, Diluted [Abstract] Earnings Per Share, Diluted [Abstract] Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Net (decrease) increase in Cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Supplemental Balance Sheet Information Supplemental Balance Sheet Information [Text Block] This element is used to disclose supplemental balance sheet information for the periods disclosed. Employee Stock Option Share-based Payment Arrangement, Option [Member] Gain (loss) on hedged items Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge Preference Stock [Abstract] Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract] Treasury stock balance, January 1 (in shares) Treasury stock balance, December 31 (in shares) Treasury Stock, Shares Cumulative translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax 2025 Long-Term Debt, Maturity, Year Five United States Income (Loss) from Continuing Operations before Income Taxes, Domestic Expected long-term rate of return on plan assets Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Total equity Beginning balance Ending balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Additional paid-in capital Additional Paid in Capital Annual estimated amortization expense, year 1 Finite-Lived Intangible Asset, Expected Amortization, Year One Class of Stock [Axis] Class of Stock [Axis] Quarterly Financial Data [Abstract] Quarterly Financial Data [Abstract] Earnings per common share, diluted (in dollars per share) Diluted EPS (in dollars per share) Earnings Per Share, Diluted Common shares released and allocated to participant accounts (in shares) Employee Stock Ownership Plan (ESOP), Number of Allocated Shares Scenario One Scenario One [Member] Scenario One Unrecognized tax benefits activity Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Net income attributable to Colgate-Palmolive Company Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Goodwill and Other Intangibles Goodwill and Intangible Assets, Policy [Policy Text Block] Schedule of Long-term Debt Instruments Schedule of Long-term Debt Instruments [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Interest (income) expense recognized related to unrecognized tax benefits Unrecognized Tax Benefits, Interest on Income Taxes Expense Entity Emerging Growth Company Entity Emerging Growth Company Deferred withholding tax Deferred Tax Liabilities, Deferred Withholding Tax Deferred Tax Liabilities, Deferred Withholding Tax Indefinite-lived intangible assets (excluding goodwill) Indefinite-lived Intangible Assets (Excluding Goodwill) Total deferred tax benefit (provision) Deferred Income Tax Expense (Benefit) 2.45% Notes Due 2021 and 2.30% Notes Due 2022 2.45% Medium-Term Notes Due 2021 And 2.30% Medium-Term Notes Due 2022 [Member] 2.45% Medium-Term Notes Due 2021 And 2.30% Medium-Term Notes Due 2022 Tax credits and tax loss carryforwards Deferred Tax Assets Tax Loss And Tax Credit Carryforwards The tax effect as of the balance sheet date of the amount of future tax deductions arising from all unused tax loss and tax credit carryforwards which have been reduced by a valuation allowance. Finite-lived intangible assets, accumulated amortization, net Finite-Lived Intangible Assets, Accumulated Amortization Maximum Maximum [Member] Shares authorized (in shares) Preferred Stock, Shares Authorized Noncontrolling Interests Noncontrolling Interest [Member] Stock-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Principal payments on debt Repayments of Other Debt Effective tax rate Effective Income Tax Rate Reconciliation, Percent Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Other Retiree Benefit Plans Other Postretirement Benefits Plan [Member] Trading Symbol Trading Symbol Reporting unit, impairment analysis, increase in discount rate, percentage Reporting Unit, Impairment Analysis, Increase In Discount Rate, Percentage Reporting Unit, Impairment Analysis, Increase In Discount Rate, Percentage Real estate and other investments Real Estate and Other Investments [Member] Real Estate and Other Investments Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] International Income (Loss) from Continuing Operations before Income Taxes, Foreign Entity Shell Company Entity Shell Company Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Amended Domestic Revolving Credit Facility 2650 Million Capacity Amended Domestic Revolving Credit Facility 2650 Million Capacity [Member] Amended Domestic Revolving Credit Facility 2650 Million Capacity [Member] Number of new approved restructuring projects Number Of New Approved Restructuring Projects Number Of New Approved Restructuring Projects Other, net Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount Entity Public Float Entity Public Float Document Type Document Type Voluntary contributions to postretirement plans Defined Benefit Plan Voluntary Contributions By Employer Voluntary contributions made by the Company to its postretirement plans. ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Shareholders’ Equity Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract] Reporting Unit [Axis] Reporting Unit [Axis] Accounts payable and other accruals Increase (Decrease) in Accounts Payable and Accrued Liabilities Treasury Stock Treasury Stock [Member] Other accruals Payables and Accruals [Abstract] Segments [Axis] Segments [Axis] Valuation allowances type [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] Retirement Plans and Other Retiree Benefits Retirement Benefits [Text Block] Gains (losses) on cash flow hedges Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax Weighted average grant date fair value of restricted stock awards - shares vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Increase (decrease) in fine imposed by Greek competition authority Increase (Decrease) In Fine Imposed By Greek Competition Authority Increase (Decrease) In Fine Imposed By Greek Competition Authority Other current assets Other Current Assets [Member] Benefit payments Defined Benefit Plan, Plan Assets, Benefits Paid Derivative asset Derivative Asset Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Deferred income taxes Deferred income taxes Deferred Income Tax Liabilities, Net Reporting Unit Impairment Analysis [Axis] Reporting Unit Impairment Analysis [Axis] Reporting Unit Impairment Analysis Other intangible assets, net Intangible assets, net (excluding goodwill) Intangible Assets, Net (Excluding Goodwill) Interest capitalized Interest Costs Capitalized Adjustment (Benefit) charge for previously disclosed tax matters Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Percent Fine imposed by greek competition authority Fine Imposed By Greek Competition Authority Fine Imposed by Greek Competition Authority Operating profit Operating profit Operating Income (Loss) Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Commitments and contingent liabilities Commitments and Contingencies Noncontrolling interests acquired Noncontrolling Interest, Increase from Business Combination Purchases of treasury shares Repurchased stock Payments for Repurchase of Common Stock Vesting period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Multi-Asset funds Defined Benefit Plan, Multi-Asset Funds [Member] Multi-Asset Funds [Member] Entity Address, State or Province Entity Address, State or Province Defined benefit plans disclosures Schedule of Defined Benefit Plans Disclosures [Table Text Block] Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Other comprehensive income (loss), Pretax Other Comprehensive Income (Loss), before Tax Accounts payable Accounts Payable, Current Retained earnings Retained Earnings (Accumulated Deficit) Withholding Tax Due Withholding Tax Due Withholding Tax Due Other assets Operating Lease, Right-of-Use Asset Loss on early extinguishment of debt Gain (Loss) on Extinguishment of Debt Property, plant and equipment Deferred Tax Liabilities, Property, Plant and Equipment Other financial instruments Financial Instruments, Owned, at Fair Value [Abstract] Product Concentration Risk Product Concentration Risk [Member] Income taxes paid Income Taxes Paid Shareholders’ Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Restructuring and termination benefits, net of cash Restructuring, net of cash The amount of noncash restructuring costs net of cash payments. Acquisitions/plan amendments Defined Benefit Plan, Benefit Obligation, Increase (Decrease) For Plan Amendment And Business Combination Defined Benefit Plan, Benefit Obligation, Increase (Decrease) For Plan Amendment And Business Combination Income Taxes Income Tax, Policy [Policy Text Block] Total lease cost Lease, Cost Raw materials and supplies Inventory, Raw Materials and Supplies, Net of Reserves Options exercisable (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.75 Percent 1.75 percent [Member] 1.75 percent [Member] Cash charges for extinguishment of debt prior to maturity Payment for Debt Extinguishment or Debt Prepayment Cost Manufacturing machinery and equipment Machinery and Equipment, Gross Other Payments for (Proceeds from) Other Investing Activities Liability Class [Axis] Liability Class [Axis] Domestic Plan Domestic Plan [Member] Stock-based compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition North America North America [Member] Forfeited or expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Thereafter Long-Term Debt, Maturity, after Year Five Net sales Net sales Revenue from Contract with Customer, Excluding Assessed Tax Advertising Advertising Expense Dividends paid by the Company on shares held by the ESOP Employee Stock Ownership Plan (ESOP), Dividends Paid to ESOP Business Acquisition [Axis] Business Acquisition [Axis] Geographical [Domain] Geographical [Domain] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Accrued interest Interest Payable, Current Entity Voluntary Filers Entity Voluntary Filers Acquisition-related costs Business Combination, Acquisition Related Costs Other postretirement charges Defined Benefit Plan Other Postretirement Charges include pension and other benefit enhancements amounting incurred pursuant to the Global Growth and Efficiency Program. Credit Facility [Axis] Credit Facility [Axis] Estimated fair value of long-term debt Debt Instrument, Fair Value Disclosure Land Land Weighted-Average Assumptions Used to Determine Benefit Obligations Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Business Combinations [Abstract] Business Combinations [Abstract] Amended Foreign Revolving Credit Facility 1500 Million Capacity Amended Domestic Revolving Credit Facility 1500 Million Capacity [Member] Amended Domestic Revolving Credit Facility 1500 Million Capacity [Member] Other (income) expense, net Total Other (income) expense, net Other Operating Income (Expense), Net Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Weighted average remaining contractual life, options exercisable (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Scenario Two Scenario Two [Member] Scenario Two Selling, general and administrative expenses Selling, General and Administrative Expenses [Member] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Average annual rates of return for the most recent 25-year period Average Annual Rate Of Return For Most Recent Twenty Five Year Period The average annual rate of return on pension plan assets for the most recent 25 year period. Total Global Growth and Efficiency Program charges, pretax Restructuring and related charges (benefits) Restructuring and Related Cost, Incurred Cost Balance Sheet Related Disclosures [Abstract] Balance Sheet Related Disclosures [Abstract] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Foreign Tax Credit Carryback Effective Income Tax Rate Reconciliation, Tax Credit Carrybacks, Foreign, Percent Effective Income Tax Rate Reconciliation, Tax Credit Carrybacks, Foreign, Percent Repayments of Debt Repayments of Debt Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Expected long-term rate of return on plan assets Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Expected Long Term Return On Plan Assets Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Expected Long Term Return On Plan Assets Defined Benefit Plan, Plan Assets, Allocations [Abstract] Defined Benefit Plan, Plan Assets, Allocations [Abstract] Funded Status Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract] Defined Benefit Plan, Plan Assets, Category [Axis] Defined Benefit Plan, Plan Assets, Category [Axis] Net cash provided by operations Net Cash Provided by (Used in) Operating Activities Entity Central Index Key Entity Central Index Key Indefinite life intangible assets Unclassified Indefinite-lived Intangible Assets [Member] Cash flow hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Instrument [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Geographical [Axis] Geographical [Axis] Treasury Stock Summary Of Treasury Stock Activity [Roll Forward] A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. Oral Care Oral Care [Member] Oral Care products include toothpaste, toothbrushes, mouth rinses and other similar items. Average annual rates of return for the most recent 5-year period Average Annual Rate Of Return For Most Recent Five Year Period The average annual rate of return on pension plan assets for the most recent 5 year period. Other, additions SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account Segments [Domain] Segments [Domain] Segments [Domain] Non-service related postretirement costs Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] 2024 Long-Term Debt, Maturity, Year Four Cumulative hedging adjustment included in the carrying amount Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) Performance Shares Performance Based Restricted Stock Units [Member] Performance Based Restricted Stock Units [Member] Income Statement Location [Axis] Income Statement Location [Axis] 0.875% Notes due 2039 0.875% Notes due 2039 [Member] 0.875% Notes due 2039 [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Time-Vested Stock Time-Vested Restricted Stock Units [Member] Time-Vested Restricted Stock Units [Member] Notional value of derivative Derivative, Notional Amount Amortization of intangible assets Amortization of Intangible Assets Segment Information Segment Reporting Disclosure [Text Block] Shares issued for restricted stock and other (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Non-service related postretirement costs Non-Service Related Postretirement Costs [Member] Non-Service Related Postretirement Costs [Member] Derivatives Derivative Liability, Current Title of 12(b) Security Title of 12(b) Security Finite-lived intangible assets, net Finite-Lived Intangible Assets, Net Weighted-average estimated fair value of stock options granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Global Growth and Efficiency Program Global Growth and Efficiency Program [Member] Global Growth and Efficiency Program [Member] Noncurrent assets Assets for Plan Benefits, Defined Benefit Plan Accrued income taxes Accrued Income Taxes, Current Annual ESOP expense Employee Stock Ownership Plan (ESOP), Compensation Expense Total Inventories, net Inventory, Net, Including Noncurrent Inventory, Net, Including Noncurrent Unrecognized tax benefits: Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Other Stockholders' Equity, Other Depreciation and amortization Depreciation, Depletion and Amortization Product and Service [Axis] Product and Service [Axis] Gain (loss) on derivative instrument Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments Unrecognized compensation expense, weighted-average period of recognition in years Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Other Other Restructuring [Member] 2022 Long-Term Debt, Maturity, Year Two Deferred taxes included within: Deferred Tax Assets, Net, Classification [Abstract] Other (income) expense, net Other (income) expense, net [Table Text Block] Other (income) expense, net [Table Text Block] Basic EPS Net Income (Loss) Available to Common Stockholders, Basic Gain (loss) recognized in OCI Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Finance Lease Obligations Finance Lease Obligation [Member] Finance Lease Obligation [Member] Investments accounted for using the equity method, minimum interest Equity Method Investment Ownership Percentage Minimum The minimum percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Debt Instrument [Axis] Debt Instrument [Axis] Charges for a change in go-to-market strategy in certain countries Restructuring And Related Cost, Incurred Cost Related To Changes In Market Strategy Restructuring And Related Cost, Incurred Cost Related To Changes In Market Strategy Fair Value Hedges Fair Value Hedging [Member] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Schedule of Quarterly Financial Information Quarterly Financial Information [Table Text Block] Operating Segments Operating Segments [Member] Treasury stock acquired Treasury Stock, Value, Acquired, Cost Method Curtailments and settlements Defined Benefit Plan, Benefit Obligation, (Increase) Decrease For Curtailment And Settlements Defined Benefit Plan, Benefit Obligation, (Increase) Decrease For Curtailment And Settlements Derivative liability Derivative Liability Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Income tax expense (benefit) allocated directly to equity Income Tax Effects Allocated Directly to Equity Entity Information [Line Items] Entity Information [Line Items] Variable lease cost Variable Lease, Cost U.S. plans assets purchased to Company (in shares) Defined Benefit Plan, Plan Assets, Purchases, Shares Defined Benefit Plan, Plan Assets, Purchases, Shares Research and development Research and Development Expense Percentage of corporate identifiable assets consisting of derivative instruments Percentage Of Corporate Identifiable Assets Consisting Of Derivative Instruments Percentage of Corporate identifiable assets consisting of derivative instruments. Reclassifications Reclassification, Comparability Adjustment [Policy Text Block] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Restructuring Plan [Domain] Restructuring Plan [Domain] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Restructuring reduction after tax Restructuring Reserve, Accrual Adjustment, After Tax Restructuring Reserve, Accrual Adjustment, After Tax Schedule Of Cash Flow And Net Investment Hedges Included In Accumulated Other Comprehensive Income (Loss) Schedule Of Cash Flow And Net Investment Hedges Included In Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule Of Cash Flow And Net Investment Hedges Included In Accumulated Other Comprehensive Income (Loss) [Table Text Block] Pension and other retiree benefits Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent Other liabilities Long-Term Lease Liabilities Operating Lease, Liability, Noncurrent Annual estimated amortization expense, year 4 Finite-Lived Intangible Asset, Expected Amortization, Year Four Filorga Laboratoires Filorga Cosmétiques [Member] Laboratoires Filorga Cosmétiques [Member] Retirement plan and other retiree benefit adjustments Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Current Assets Assets, Current [Abstract] Third party Incremental Cost Third party Incremental Cost [Member] Third party Incremental Cost Investments fair value Investments, Fair Value Disclosure Total Comprehensive income attributable to Colgate-Palmolive Company Comprehensive Income (Loss), Net of Tax, Attributable to Parent Program 2018 Program 2018 [Member] Program 2018 [Member] Expected dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Effective tax rate reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] 2021 Long-Term Debt, Maturity, Year One Long-term rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Deductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Restructuring and related cost, incurred cost, including noncontrolling interest, after tax Restructuring And Related Cost, Incurred Cost, Including Noncontrolling Interest, After Tax Restructuring And Related Cost, Incurred Cost, Including Noncontrolling Interest, After Tax Number of countries in which entity operates Number of Countries in which Entity Operates Asia Pacific Asia Pacific [Member] City Area Code City Area Code Principles of Consolidation [Abstract] Principles Of Consolidation Abstract Document Period End Date Document Period End Date Percent of restructuring charges related to segment, total program accumulated charges PercentOfRestructuringChargesReportableSegmentProgramChargesIncurredToDate PercentOfRestructuringChargesReportableSegmentProgramChargesIncurredToDate Pet Nutrition Pet Nutrition [Member] Pet Nutrition Net Investment Hedges Net Investment Hedging [Member] Stock repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Net income including noncontrolling interests Net income including noncontrolling interests Net income Net income including noncontrolling interests Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Reclassification from AOCI, Net of Tax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Common Stock Outstanding Summary Of Common Stock Activity [Roll Forward] Summary Of Common Stock Activity [Roll Forward] Foreign Currency Debt Debt [Member] Quarterly Financial Information Disclosure [Abstract] Quarterly Financial Information Disclosure [Abstract] Extinguishment of debt, gain (loss), net of tax Extinguishment of Debt, Gain (Loss), Net of Tax Other comprehensive income (loss), before reclassifications, Pretax Other Comprehensive Income (Loss), before Reclassifications, before Tax Provision for income taxes Provision for Income Taxes [Table Text Block] Disclosure of the domestic and foreign components of the provision for income Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Stock-based compensation expense Share-based Payment Arrangement, Noncash Expense Capital expenditures Payments to Acquire Productive Assets Other Defined Benefit Plan Change in Plan Asset Other Other change in plan assets Cover page. Cover [Abstract] Restructuring reduction Restructuring Reserve, Accrual Adjustment Other comprehensive income (loss), before reclassifications, Net of Tax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Components of income before income taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Designated derivative instruments Summary of Derivative Instruments [Abstract] Fixed income securities Fixed Income Securities [Member] Carrying value of long-term debt Long-term Debt Leases Lessee, Operating Leases [Text Block] Participants’ contributions Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant Service cost Defined Benefit Plan, Service Cost Customer Relationships Customer Relationships [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Equity Components [Axis] Equity Components [Axis] Gains (losses) on cash flow hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Loss contingency, pending claims, number (in cases) Loss Contingency, Pending Claims, Number ESOP growth rate Defined Benefit Plan Assumptions Used Calculating Net Periodic Cost Esop Growth Rate Expected growth rate of company stock held by the employee stock ownership plans used to determine benefit obligations for defined benefit plans. Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Total deferred tax assets Deferred Tax Assets, Gross Minimum Minimum [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Benefit from foreign tax matter Benefit From Foreign Tax Matter Benefit From Foreign Tax Matter Accumulated benefit obligation Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation Number of stockholder approved plans, current Number of Stockholder Approved Plans, Current Number of Stockholder Approved Plans, Current Europe Europe Europe [Member] Defined Benefit Plan, Plan Assets, Category [Domain] Defined Benefit Plan, Plan Assets, Category [Domain] Equity securities Defined Benefit Plan, Equity Securities [Member] Less: Net income attributable to noncontrolling interests Less: Net income attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Amortization of actuarial loss Defined Benefit Plan, Amortization of Gain (Loss) Entity Interactive Data Current Entity Interactive Data Current Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) United States UNITED STATES Schedule of Allocation of Plan Assets Schedule of Allocation of Plan Assets [Table Text Block] Options - shares exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Schedule of Share-based Compensation, Stock Options, Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Commodity contracts Commodity Contract [Member] Stock-Based Compensation Share-based Payment Arrangement [Policy Text Block] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Africa/Eurasia Africa Eurasia [Member] A specified group of foreign regions about which segment information is provided by the entity. Foreign exchange Restructuring Reserve, Foreign Currency Translation Gain (Loss) Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Real estate funds Defined Benefit Plan, Real Estate [Member] Total deferred tax liabilities Deferred Tax Liabilities, Gross 2021 Defined Benefit Plan, Expected Future Benefit Payment, Year One Marketing Costs Advertising Cost [Policy Text Block] Stock-based compensation, additional disclosures [Abstract] Share-based Payment Arrangement, Additional Disclosure [Abstract] Finite & indefinite lived intangibles, gross Intangible Assets, Gross (Excluding Goodwill) Number of reportable segments (in segments) Number of Reportable Segments Total pension cost Pension and Other Postretirement Benefits Cost (Reversal of Cost) Retirement Plan Type [Domain] Retirement Plan Type [Domain] Charged to Costs and Expenses, additions SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Consolidation Items [Axis] Consolidation Items [Axis] 2.45% Notes Due 2021 2.45% Medium-Term Notes Due 2021 [Member] 2.45% Medium-Term Notes Due 2021 Forward-starting interest rate swaps Forward Contracts [Member] Receivables (net of allowances of $89 and $76, respectively) Accounts Receivable, after Allowance for Credit Loss, Current Unrecognized pension and other retiree benefit costs, aftertax Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Total lease commitments Lessee, Operating Lease, Liability, to be Paid Other Deferred Tax Assets, Other Acquisition-related costs Business Combination, Acquisition Related Costs, Net Business Combination, Acquisition Related Costs, Net International Foreign Plan [Member] Accrued interest related to unrecognized tax benefits Unrecognized Tax Benefits, Interest on Income Taxes Accrued Interest Crediting Rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Number of product segments (in segments) Number Of Product Segments Number of Product Segments Trademarks Trademarks [Member] Payments for Restructuring Cash payments Payments for Restructuring Document Transition Report Document Transition Report Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Excess of current cost over LIFO cost Excess of Replacement or Current Costs over Stated LIFO Value Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Investments accounted for using the cost method, maximum interest Cost Method Investment Ownership Percentage Maximum The maximum percentage of ownership of common stock or equity participation in the investee accounted for under the cost method of accounting. This maximum is up to, but not including, the maximum value. Components of Net Periodic Benefit Cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract] Receivables Increase (Decrease) in Receivables Other liabilities Other Liabilities [Member] Credit Facility [Domain] Credit Facility [Domain] Earnings per common share, basic (in dollars per share) Basic EPS (in dollars per share) Earnings Per Share, Basic Other Restructuring Reserve, Translation and Other Adjustment Unrecognized tax benefits that would impact effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate International Foreign Income Tax Expense (Benefit), Continuing Operations Expected term of options Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Schedule of Restructuring and Related Costs Incurred to Date Schedule of Restructuring and Related Costs Incurred to Date [Table Text Block] Schedule of Restructuring and Related Costs Incurred to Date [Table Text Block] Entity File Number Entity File Number Accrued taxes other than income taxes Accrual for Taxes Other than Income Taxes, Current Noncurrent liabilities Liability, Defined Benefit Plan, Noncurrent Other accruals Other Current Liabilities [Member] Operating lease, weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Long-term rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Net amount recognized Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position Dividends (in dollars per share) Dividends, Common Stock Total stock-based compensation expense charged against pretax income Share-based Payment Arrangement, Expense Balance Sheet Location [Axis] Balance Sheet Location [Axis] Charge for U.S. tax reform Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent Medical cost trend rate of increase Defined Benefit Plan Assumptions Used Calculating Net Periodic Medical Cost Trend Rate Defined Benefit Plan Assumptions Used Calculating Net Periodic Medical Cost Trend Rate Other, net Other (income) expense, net Other operating income, not previously categorized, from items that are associated with the entity's normal revenue producing operation, and the amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Document Annual Report Document Annual Report Commercial paper Commercial Paper [Member] Intrinsic value of unexercised in-the-money options, options exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Total income tax benefit from stock compensation Share-based Payment Arrangement, Expense, Tax Benefit Proceeds from issuance of debt Proceeds from Other Debt Income tax benefit related to changes in swiss preferential tax regime and increase to cantonal tax rate Income Tax Benefit Related To Changes In Swiss Preferential Tax Regime And Increase To Cantonal Tax Rate Income Tax Benefit Related To Changes In Swiss Preferential Tax Regime And Increase To Cantonal Tax Rate Retirement Benefits [Abstract] Retirement Benefits [Abstract] Quarterly financial data (Unaudited) [Abstract] Selected Quarterly Financial Information [Abstract] Company contributions to the ESOP Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP Shares issued for stock options (in shares) Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Inventories [Abstract] Inventories Inventory, Net [Abstract] Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Restricted stock awards - shares granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Stock Repurchases [Abstract] Payments for Repurchase of Equity [Abstract] Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Schedule of Entity-Wide Information, Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Other Deferred Tax Liabilities, Other Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Total liabilities and equity Liabilities and Equity Other equipment Property, Plant and Equipment, Other, Gross Buildings Buildings and Improvements, Gross Loss Contingencies [Line Items] Loss Contingencies [Line Items] Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Income Taxes Income Tax Disclosure [Text Block] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Operating lease cost Operating Lease, Cost Hedging Relationship [Axis] Hedging Relationship [Axis] Deferred tax liabilities: Deferred Tax Liabilities, Gross [Abstract] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Cost of sales Gross Profit Gross Profit [Member] Gross Profit [Member] Increases of tax positions taken during prior years Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Increases as a result of tax positions taken during the current year Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Estimated useful life of finite-lived intangible assets Finite-Lived Intangible Asset, Useful Life Equity Component [Domain] Equity Component [Domain] Unearned compensation Unearned Compensation Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for unearned compensation is also recorded. Schedule of Expected Benefit Payments Schedule of Expected Benefit Payments [Table Text Block] Gross profit Gross profit Gross Profit Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net Cash flow hedges [Abstract] Effect of Cash Flow Hedges on Results of Operations [Abstract] Entity Tax Identification Number Entity Tax Identification Number Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Foreign exchange impact Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) Capital Stock and Stock-Based Compensation Plans Share-based Payment Arrangement [Text Block] Interest rate swap contracts Interest Rate Contract [Member] Net income attributable to Colgate-Palmolive Company Net income attributable to Colgate-Palmolive Company Net Income (Loss) Attributable to Parent Cash effects of changes in: Increase (Decrease) in Operating Capital [Abstract] Purchases of non-controlling interests in subsidiaries Purchases of non-contolling interests in subsidiaries Payments to Noncontrolling Interests Percent of fixed income assets invested in US treasury or agency securities Percentage Of Fixed Income Portfolio Invested In Us Treasury Or Agency Securities Percentage of fixed income portfolio invested in U.S. treasury or agency securities. Fifteen Year notes at 1.375 Percent Fifteen year notes at 1.375 percent [Member] Fifteen year notes at 1.375 percent [Member] Current Fiscal Year End Date Current Fiscal Year End Date 2.30% Notes Due 2022 2.30% Medium-Term Notes Due 2022 [Member] 2.30% Medium-Term Notes Due 2022 Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] Right-of-use assets/lease liabilities Effective Income Tax Rate Reconciliation, Nondeductible Expense, Leases, Amount Approximate percentage of inventories determined using the first-in, first-out (FIFO) method Percentage of FIFO Inventory Operating Profit Operating Income (Loss) [Member] Asset Impairments Asset Impairment [Member] Asset Impairment [Member] Other intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Shares (in thousands) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Pension and other retiree benefits Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions And Other Retiree Benefits The tax effect as of the balance sheet date of the amount of estimated future tax deductions arising from pension costs and other retiree benefits, which can only be deducted for tax purposes when actual costs are incurred, and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken. Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Supplemental Cash Flow Information Supplemental Cash Flow Information [Abstract] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Pretax charges related to the Restructuring Program to date Restructuring and Related Cost, Cost Incurred to Date Range of reasonably possible losses Loss Contingency, Estimate of Possible Loss Foreign Withholding Income Tax Foreign Withholding Income Tax Foreign Withholding Income Tax Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] U.S. common stocks Defined Benefit Plan, US Common Stocks [Member] This category includes information about ownership interests in United States corporations and other legal entities for which ownership interest is represented by shares of common stock. Benefit payments Defined Benefit Plan, Benefit Obligation, Benefits Paid Tax credits and tax loss carryforwards Effective Income Tax Reconciliation, Tax Loss And Tax Credit Carryforwards The sum of the differences between total income tax expense (benefit) as reported in the Income Statement for the period and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations attributable to tax loss and tax credit carryforwards. Other assets and liabilities, net Other Assets and Liabilities, Net [Member] Other Assets and Liabilities, Net [Member] Schedule of Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Shares in ESOP (in shares) Employee Stock Ownership Plan (ESOP), Shares in ESOP Unused borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Fair value of plan assets Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets Finite-lived intangible assets, gross Finite-Lived Intangible Assets, Gross Amounts recognized in accumulated other comprehensive income Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax Value-added tax matter in Brazil Benefit From Foreign Tax Matter, Brazil Benefit From Foreign Tax Matter, Brazil Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Actuarial loss Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax [Abstract] Hedging Relationship [Domain] Hedging Relationship [Domain] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Schedule of Operating Lease Liabilities Lessee, Operating Lease, Liability, Maturity [Table Text Block] 0.500% Notes Due 2026 0.500% Notes Due 2026 [Member] 0.500% Notes Due 2026 [Member] Number of dividends declared per quarter Number Of Dividends Declared Per Quarter Number of Dividends Declared Per Quarter Basic EPS (in shares) Weighted Average Number of Shares Outstanding, Basic Foreign-derived intangible income benefit Venezuela Remeasurement Charges (Benefit), Tax Impact, Percent Venezuela Remeasurement Charges (Benefit), Tax Impact, Percent Nigeria Joint Venture Nigeria Joint Venture [Member] Nigeria Joint Venture [Member] Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Activity related to fair value hedges Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Restructuring accrual Restructuring Reserve, Current Lease liabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Lease Liabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Lease Liabilities Cash Flow Hedges Cash Flow Hedging [Member] Loss Contingencies [Table] Loss Contingencies [Table] Carrying Value Reported Value Measurement [Member] Plan Name [Domain] Plan Name [Domain] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Right-of-use asset obtained in exchange for operating lease liability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Shipping and Handling Costs Shipping And Handling Costs Policy [Policy Text Block] Shipping And Handling Costs Policy [Policy Text Block] Defined Benefit Plan Dividends Received On Employer Securities Defined Benefit Plan Dividends Received On Employer Securities The amount of dividends received by the defined benefit plan on the Company's common stock. Interest (income) expense, net Total Interest (income) expense, net Interest expense, net The aggregate interest and debt related expenses associated with nonoperating financing activities of the entity, less the amount of income derived from investments in debt securities and on cash and cash equivalents, the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money. Actuarial loss (gain) Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Cash and Cash equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Inventories Inventory, Policy [Policy Text Block] Provision for income taxes Total Provision for income taxes Tax benefit Income Tax Expense (Benefit) Year which ultimate medical cost trend rate is reached Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Property, Plant and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Schedule of Maturities of Long-term Debt Schedule of Maturities of Long-term Debt [Table Text Block] Purchases of marketable securities and investments Payments to Acquire Marketable Securities Employee Stock Ownership Plan Employee Stock Ownership Plan ESOP Disclosures [Text Block] Employee Stock Ownership Plan ESOP Disclosures [Text Block] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Average annual rates of return for the most recent 1-year period Average Annual Rate Of Return For Most Recent One Year Period The average annual rate of return on pension plan assets for the most recent 1 year period. Local Phone Number Local Phone Number Reclassification from AOCI, Pretax Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Fixed income funds Defined Benefit Plan, Fixed Income Funds [Member] Defined Benefit Plan, Fixed Income Funds [Member] Payments to acquire business Payments to Acquire Businesses, Gross Total intrinsic value of options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Cash flow hedges Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Brazilian internal revenue authority, matter 1 Tax Assessments With Interest The amount of tax assessment with estimated interest accrued as of the balance sheet date arising from income tax examinations related to an acquisition. Decreases of tax positions taken during prior years Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Shares issued for stock options Stock Issued During Period, Value, Stock Options Exercised Schedule of Finite-Lived Intangible Assets by Major Class [Table] Schedule of Finite-Lived Intangible Assets [Table] Reporting unit, impairment analysis, reduction in long-term growth rate, percentage Reporting Unit, Impairment Analysis, Projected Reduction In Long-Term Growth Rate, Percentage Reporting Unit, Impairment Analysis, Projected Reduction In Long-Term Growth Rate, Percentage Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] Award Type [Axis] Award Type [Axis] Weighted Average Grant Date Fair Value Per Award Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Valuation Allowance [Line Items] Valuation Allowance [Line Items] Discount rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Total fair value of shares vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Retained Earnings Retained Earnings [Member] Measurement Basis [Axis] Measurement Basis [Axis] Loss contingency, new claims filed, number (in cases) Loss Contingency, New Claims Filed, Number Schedule of Net Benefit Costs Schedule of Net Benefit Costs [Table Text Block] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Other Other Noncurrent Liability Obligations not otherwise itemized or previously categorized that are due beyond one year (or operating cycle, if longer) from the balance sheet date. Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Weighted average remaining contractual life, options outstanding (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Award Type [Domain] Award Type [Domain] Current liabilities Pension and other retiree benefits Liability, Defined Benefit Plan, Current Average annual rates of return for the most recent 10-year period Average Annual Rate Of Return For Most Recent Ten Year Period The average annual rate of return on pension plan assets for the most recent 10 year period. Allowance for doubtful accounts and estimated returns Allowance For Doubtful Accounts And Estimated Returns Member Allowance established for amounts due that are unlikely to be received, and the valuation allowance for the amount of products sold that the entity expects to be returned by the purchaser. Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Write-off of certain investments and fixed assets Write-Off Of Certain Investments And Fixed assets Write-Off Of Certain Investments And Fixed assets Options exercisable - end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Treasury stock, at cost Treasury Stock, Value Earnings Per Share Earnings Per Share [Text Block] Pension Plans Pension Plan [Member] Term extension Line of Credit Facility, Term Extension Line of Credit Facility, Term Extension Discount rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Fair Value Measurements and Financial Instruments Financial Instruments Disclosure [Text Block] Hedge funds Defined Benefit Plan, Hedge Funds [Member] Defined Benefit Plan, Hedge Funds [Member] Current Liabilities Liabilities, Current [Abstract] Tax at United States statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Stock Option Plans Stock Option Plans Member The Company's stock option plans provide for the issuance to directors, officers and other employees of non-qualified stock options that generally have a contractual term of six years and vest over three years. Voluntary benefit plan contributions Payment for Pension and Other Postretirement Benefits Income Tax Contingency [Table] Income Tax Contingency [Table] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Earnings Per Share, Basic [Abstract] Earnings Per Share, Basic [Abstract] EX-101.PRE 15 cl-20201231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 16 cl-20201231_g1.jpg begin 644 cl-20201231_g1.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X0!:17AI9@ 34T *@ @ !0,! 4 M ! 2@,# $ ! %$0 $ ! 0 %$1 0 ! %$2 M 0 ! 8:@ "QC__; $, " 8&!P8%" <'!PD)" H,% T, M"PL,&1(3#Q0=&A\>'1H<'" D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T M,O_; $,!"0D)# L,& T-&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,O_ !$( '8#^@,!(@ "$0$#$0'_ MQ ? !!0$! 0$! 0 0(#! 4&!P@)"@O_Q "U$ " 0,# @0# M!04$! 7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*" M"0H6%Q@9&B4F)R@I*C0U-C+CY.7FY^CIZO'R\_3U]O?X^?K_Q ? 0 # 0$! M 0$! 0$! 0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$! ! G< M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B7J" M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(RKR\_3U]O?X^?K_V@ , P$ A$#$0 _ /?Z*** M"BD=UC0N[!549))P *Y74OB)X?TXE$N'NY!_#;+N'_?1P/R-:4Z4ZCM!7,ZE M:G25YR2.KHKS*X^+?S$6VD?+V:6;D_@!_6JA^+.HY.--M0.V6:NI9=B']G\4 M<3S7"+[7X,]8HKR;_A;.I?\ 0.M/^^F_QH_X6SJ7_0.M/^^F_P :?]FXCM^( MO[6PO\WX,]9HKR;_ (6SJ7_0.M/^^F_QKT'POJMSK>@P:C=0I"\Q;:B9QM!( M[_2L:V$JT8\TUH;T,=1KRY:;N_0V**\VUSXEW>FZW>65M9VTL4$AC#L6R2.# MT/KFL_\ X6SJ7_0.M/\ OIO\:TCE^(DDTM_,REFF%C)QGZK8:K#YMA=Q7"=]C9(^HZC\:N5R--.S.U-25T%%%%(84444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %96O^(++P[IYNKMLL>( MXE/S2'T'^-7[NZAL;.:ZN'V0PH7=O0"O ?$6NW'B'5Y;V8D)]V*//")V'^/O M7;@L)[>>OPH\_,,:L-#3XGM_F3>(/%>J>(IC]IF*6V?DMXSA!]?4^Y_2L.BB MOI(0C"/+%61\E4J3J2YIN["BBBK("BBB@ KZ(TZ!-%\.6T4G"VEL-YZ?=7)/ M\Z\,\,V7]H>)M.MNH:=2W^Z/F/Z U['XZO?L/@[4&'WI4$*C/7<<']":\?,G MSU*=)=?^&/>RA>SI5*[Z?IJ>%W$[W5S+<2G,DKEV/N3DU'117KI6/";;=V%% M%%,1/:7ES87*7%I/)#,AX=&P:]6\'?$%-5>/3]5VQWAXCF'"RGT/HWZ'VZ5Y M%0"0%QE3#2O%Z=4?35%<=\/_%!US339W;YOK4 $GK(G M9OKV/X>M=C7S%6E*E-PENC["C6C6IJI#9A11169J%%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 >?\ Q4U9K;2K;3(R0UTQ>3']Q>WXDC\J M\EKL/B9=&X\8219XMX4C_,;O_9JX^OJ,!34*$?/7[SX[,JKJ8F7EI]P4445V M' %%>B^#_AY#J%C'J6KE_*F :&!&QE>S,??L!77?\*]\+?\ 0+_\F)?_ (JO M/JYE1IR<=7Z'IT&B"/[)AY]&8?UJ'_A7OA;_H%_\ DQ+_ /%5WK-J/5/\/\SS'DE? MI)?C_D>%T5[/J7PST*ZMF6R22SGQ\KK(SC/N&)X^F*\BU'3[C2M1GL;I0LT+ M;6 /'L1[$8-=6'Q=.O?DW.+%8&KAK.>SZHJT445U'&:WAG5VT3Q!:7H;$:OM ME'JAX;].?J*^A 00"#D&OF6OH/PM=->^%M,GI/U->BBBO%/H IDLL<$3RRNL<:*69V. H'4DT^O OC7XYGN=2?PO8 M2E+6WP;QE/\ K)#R%^@&/J3[4 ;_ (J^.EA82R6OAZU%_*I*FYF)6$'V Y8? ME[9KSJ\^,?C:[EWIJ<=JG_/."W3'YL"?UK%\&>#[_P 9ZXMA9_NXD&^XN&&5 MB3/7W)[#O] 2/HK1/A9X1T6V2/\ LF&]E &^:\42ECZX/RC\!0,\*A^+OCB& M0/\ VV9 .JO;Q$'_ ,=KZ5\.75W?>&=+N[_'VNXM8Y9@JX 9E!(QVZUF7OP\ M\(7\31R^'=/0$8S!"(3^:8-%M!M]"TJ0Q7MW'MWHV&AA'&0>Q/0' MV- %SQG\7]&\,3265DG]IZ@APZ1OMCC/HSX//L ??%>5:E\:_&-\Y^SW%M8) MGA;>!2<>F7W?IBN*T71[S7]8MM+L(]]S.$<-_;KG'9K>(@_\ CM=KX7^/ M%P+E+?Q+:1&!C@W5JI#)[LG.1],?0UW'B_X7>'-9T.Y%CIEK87\<;/!+:QB, M;@. P& 0>E?+M 'VW!/%(.?,;)[]/E*_G73_!>\FN_AQ:K,Q;[/-)$A)R=H.0/PW8^E?/G MC#5O[<\8:MJ(8.DUR_EL.A0':G_CH% 'KOPN\?\ BGQ?XL-GJ%Q"UE#;O-*$ M@5<]% SVY;/X5[/7C?[/^E>5I&K:LP.9YEMTR.R#<W\/ZGVH^*7C1O!_AG-HX&I7I,5MT^3CYGQ[9'XD5 M\O*MSJ%Z%'F7%U<28&26>1V/ZDDT#/1-5^.'BR^=Q9&TT^,GY?*A#L![E\@_ MD*R/^%L>./\ H/2?]^(O_B:]3\&_!32M/M(KOQ(GVV^8!C;[B(HO;C[Q]^GM MWKMAX0\&B/8-!T3'O:Q$_GC- 'BOACXN^,KK7=.T^>ZMKL75U'"3+;J#AF"_ MP;?6OHVN1A^'W@^#6[75;+3X;:]MW#QFWE*J2/\ 8SC]*ZZ@05YO\4_B.WA" MWAT_2VC;5Y\.2P#"&//4CU/0#ZGTKJO&'BFS\(>'I]3NB&8\ #T X'L!0-'7_\+K\:?\_=K_X#+7K' MPD\::CXPTO46U66*2ZMIU \M N$9>.![AN:\:^(W@J/P5-HULDGF/-9;IW[- M,'.XCVP5 ]A74? "_$/B35=/.?\ 2+591]4;&/\ Q\_E0!Z/\5?%]YX/\-6] MQIKHM[<7(C0NH8!0"6.#] /QKQW_ (77XT_Y^[7_ ,!EKZ)U?P]I&O"$:KI\ M%X(<^6)EW;9?%OP[X8\.^!Y);+1K*WO+B>.&&2.(!EYW''_ %2 M/QH X/\ X77XT_Y^[7_P&6C_ (77XT_Y^[7_ ,!EKS^&&2XGCAB4O)(P1%'< MDX KZOLOAMX3MK&W@ET*QEDCB5&D>/)<@8))[DT @4_G7!:E\:_%7]J7?V&ZMA9^>_D VZDB/<=O/TQ7L'B6 MWTKP/X!URYTFS@L=T# >2N,R,-BG\V%?*5 'H?\ PNOQI_S]VO\ X#+1_P + MK\:?\_=K_P" RUZ!X0TKX:P>$=+75;CP[+?M KSM/=1%P[?,0(/%UIJ=[K$T3P0ND4(CB"? M-@ELX]BOYFO2:HZ5HVFZ':M:Z790VD#.9&CA7:"Q &?K@#\JX>7XV^#XI7C\ MV\?:Q7.E;WB MK5?[$\*:KJ0(#V]L[IDXR^,*/SQ0!X7K_P 9_$\'B'48=.N+9;**Y=( 8%8[ M Q .??&:SO\ A=?C3_G[M?\ P&6O/*^G/#/@CPMIO@/39M,8/&WAX:C'#Y M$\;F*>'.0K@ \'N""#_^JOE36#9'6[\Z:NVP-S)]F'/$>X[>O/3%?0/P(TV> MT\%7%W,I5;R[9XO=5 7/YAA^% ,]1KPOQ[\9=1L_$4EAX:E@%K:YCEF>,/YL MG?;GL.GOSVQ72?%_Q[_PCVE'1-.EQJEXAWLIP8(CP3GLQZ#\3Z5XOX#\'S^, M_$D5BN]+2/\ >74RC[D>>@/]X]!^?8T ;G_"Z_&G_/W:_P#@,M?0?A+59=;\ M(Z5J4Y#3W%LCRE1@%\8;CMSFOD_Q1IJZ-XKU;3HT*16]W)'&I.<(&.WGZ8KZ M%^"=^MY\.+>$-EK.XEA;/;)WC]'% ,]$KP+QM\7?$6E^,M3T_2;FV6RMI?)0 M-"K'WD]W,2C4""OG37_C/XG@\0ZC#IUQ;+917+I M# K'8&(!S[XS7NGBK5?[$\*:KJ0(#V]L[IDXR^,*/SQ7R#INGW&JZC!8VJ@S M3-M7)P!W)/L "?PH&CT&Q^,WC&XU"VA>[MMDDJHV+9>A(%?2E?$*LR,&5BK* M<@@X(-?5'Q2\7#PIX2E,$FW4+W,%M@X*Y'S/_P !'ZD4 SSSQQ\8]8LO%5U9 M>'YK=;&V/E;VB#^8X^\C6)Y5KE7<8SE4^=A^2F@#ZSTT70TNT%\X M>\\E//8+M!? W8'89SQ6#XO\?:)X,@'V^8R7;KF*TAYD;W/]T>Y_#-6/&OB> M+PCX6NM5<*\J@)!&Q^_(?NCZ=2?8&ODG4=0N]6U&>_OIFFNIW+R2,>2?\.P' M84 >DZQ\=O$EY(ZZ9;VFG0G[IV>;(/Q;Y?\ QVL _%GQP3G^WI/^_$7_ ,37 MIO@#X-Z?;:?#J7B:W^TWLH#K:,2$A!Z!A_$WJ#P.G/6NZO?A[X1O[1K:3P]I M\:LN-\$"Q./<,H!S0!XOHGQT\1V4R+JT5OJ4&?G.P128]BOR_P#CM>[^&_$> MG>*M&BU/3)2\+DJRL,-&PZJP['_]=?*'BW0O^$9\5:AH_F&1;:7".>K(0&4G MWP1FO2OV?KZ9=9U?3\N8)+=9\<[0RMM_ D-^./:@#N_BQXSOO!^A64FER1I> MW-QM'F(&^15);@^Y7\Z\PT?XM^-]6UJQTZ.[MMUU.D((M5XW,!G]:E^/.J_: M_&%IIRL"EE; L/1W.3_XZ$K,^"^E?VE\1+:9@3'8PO<'CC.-H_5@?PH ^G:* M**!'E_Q<\?ZIX0ETNUT>2))YU>24R('PHP%X/J=WY5R'@SXG^,?$GC'2])EN M[;R;B;][MME!**"S8]#M4\US?QBU7^T_B-?("#'9HELISZ#)_P#'F:M[X!Z7 M]I\4ZAJ3A,M! M=F/=C[H="3^&4'Z5XKX2N#:>,M$G#%?+OX"2#VWC(_*@#[&K$\6>);3PGX=N M=5NB#Y8VQ19P99#]U1_G@ GM6T2%!)( '4FOE_XJ^-_^$M\1&"TDSI=B2D&# MQ*W\4GX]![#WH$3?\+J\:N^%N;7+'A5ME/X"O9H=7U_0_AK>:WXAGC;5$MFG M6,1A%B8CY$..IR1GW.*\U^"_@(:C=KXGU*(&TMW_ -#C8?ZR0'[_ -%/3W^E M=?\ ';5?L?@F&P4C??7*J1G^!/F/ZA*!GF?_ NOQI_S]VO_ (#+1_PNOQI_ MS]VO_@,M<)8VZ7>H6UM),D*32K&TKL J D L2> !UKZ473OA*JA?,\+G QDW M46?_ $*@#R;_ (77XT_Y^[7_ ,!EKW7X>ZIJNM^"[+4]8=6NKK>XVH% 3<0O M ]0,_C6?I_AOX;:M,T.FV>@7DJKO9+:2.1@N<9(4GCD5V-K:P6-I%:VL2100 MH$CC08"J. !0(FHHKS'XS^,I?#^@QZ383&.^U$$,ZG#1PCAB/0GI^= #?%7Q M9^SZJ=!\)V)U;52WEEP"T:-W Y8COT ]3S5"/P=\3_$*^?K/BPZ6K\B"U-='\+O T'A3P]%=7$(.K7D8>=R,F,'D1CTQW]3]!7>4 >.3?# M'Q[9 R:;X\N)I!R%FGFC!^O+#\Q7J'AV#4K7P]8PZO/Y^HI$!<29!W/WY %: M=>7_ !G\9S:!HL6CV$ICOM04[W4_-'".#CT+'C/H#0 [Q9\7(K+4_P"Q/"]E M_:^K%C'E06C5O0!>7([XP/>L^'P]\6M>'GZAXB@TF-^1#$0&3VPB_7JQ-='\ M,? =OX2T*.YN(5.L72!KB0\F,'D1CT XSZG\*[N@#Q:^\+?%?P[ USIOB9]5 M2+YO*,I>0\_W9 0>.V<]@*VOAO\ %4^)[S^Q=:ACM]5 /EL@*K-CJ,'[K #. M.^#TZ5Z?7SOXQMDTCX^6,MB?+:>\M9F"<89F4-^?)/\ O&@9[+X]UM_#_@?5 M=1BD,$^%/'7BP>,="AU/5[Z2UNKF(-'(_#H[; MG>N[^/.I2'2=(T*W#M->W)D*K_$%& #]2X_[YKC/B1I\?A3QSX:" K#:6-K^ M\P>3&Y!.1W^4'CUH ^D:9--';P23S2+'%&I=W8X"@(-3\07%SH^HW5EI8;RK=8R5 M#A?XC_M'.?8$"O>=&NKG1OA_;7VKW$DUS;V'VFYDE;+%MN]@3[=/PKPS6?#E MK_PL;P_X)LR)(+(11W+8QYDC'S)G_%<#'8*!VKU?XQ:K_9?PYO(T;;)>.EJG MT)RP_P"^5:@9YUX/O/B=XXAO+C3?$D<$5NZJQN#M#$Y.%VHW3CKZBMV^\._& M"QLI;E?$UKY;/H3M7_Q MU5/XU?\ '_CC3O"6A7(>XC?4I8REM;*B:5(-0N?BSXXC\-:5* MR^']/?S+NX3I(0<%L_FJ^O)Z= #E/$/COQO>Q'Q)!?76GZ1=W+06L43X VC] M?<]SGTX^@O"VH/JWA32+^0DR7%I%(Y)S\Q4;OUS7 ?&?1+>V^&=I%91+#!IM MS%L11P$VLF/S8!I(3[ .<#\B* .TO+J.QLI[N8XB@C: M1R>RJ,G^5?+,7Q/\7Q:G'J#:K=-!]H\SR&?]VP!!*?3! ^AKW+XO:O\ V3\. MK]5<++>%;5,]]QRP_P"^0U<'IG@$ZG\!]\<)_M)I7U*$=2V/EV_\"1>!ZD4 M>V:9J-OJVEVNHVC;K>YB66,D8.",\^]6J\>^!'B?[7I-UX=G?][9DS6X)ZQ, M?F'X,?\ QZO5=7U&/2-&O=1EQY=K \S>^U2>.<0O)E?(?AAC_9. M['^Z*L_ 73I+J\USQ!<_/*Y$"R'J68[Y/_9*T/CUH'VK0;+7(E)>RD\J4C_G MF_0GZ, /^!4#/7@00"#D&O.OB?\ $/\ X1BT&DZ2WF:Y= ! @W&!3P&QW8]A M^/UQT^+5MI7PLTR\#K/K(;'2OMOB;5;NZO[A01;2R96W7T]V M/?TZ>N>SHHH \1^)$!A\:7+G/[Z.-Q_WR%_]EKDZ]*^+.GD3:?J2KPRF!S[C MYE_FWY5YK7U6"GST(ORM]Q\9F-/DQ,UYW^_4****ZCB/??">N6VMZ#;/$Z^= M%&LU;M?-,%Q-;2B6WFDBD'1XV*D?B*N?V[K'_ $%;[_P(?_&O M%J93>3<):'T%+.TH)3CJ?15%?.O]NZQ_T%;[_P "'_QJQI^IZS?:C:VBZK?Y MGE6,8N'[D#UK-Y3)*[DC6.=PDTE!GT%165XBO?[+\-7]TC;6B@8(<]&(POZD M5X5_;NL?]!6^_P# A_\ &N;"X*6(BY)VL=>,S"&%DHM7N?15%?.O]NZQ_P!! M6^_\"'_QH_MW6/\ H*WW_@0_^-=7]D3_ )CC_MRG_(SZ(DE2&-I)75(U&69C M@ >I->#>,]7AUOQ/3FW=G!C\R^LP4(QL@HHHKT3R@KW_P (0F#PAI2'O;J__?7/]:\) MTZRDU'4K:RB!WSR*@QVR>M?1T4200I%&,(BA5'H!Q7C9M-7MI#TDB)^4@]R!P?>@:/:?@)9V\7@R]NT*M/->LLA MY 55VJ?S)_X%7JM?*'@7XAZEX&GF6WB2ZLIR&EMI&*C&F+D?-OO< 'V^3G]* /;:^5_BY?2WOQ*U02'Y;?9#&/10@/\ ,D_C M7N/PY\8:IXVL[W4KNRM[2RCD$,"QEF9F RQ+'@CE0,#UKR;XV>%[K3?%DFMI M&S6.H!29 .$E"@%3Z9 R/7)]* 1=^ -I!+XEU.Z< SP6H6//8,W)_0#\:^@Z M^.?"_B;4/"6MQZIIS)YJJ4='&5D0]5/MP/R%>K']H4_9N/#?^D9Q_P ?GRX] M?N9_#]: /4?&OB"#PSX2O]1F=0XB*0*?XY6&% _'GZ U\?UT7BWQKK'C*^6X MU.51%'GR;>(8CC^@[GW/-=O\+OA;=:I>P:YKMLT.G1,)(8)!AKAAT)!_@^O7 MZ4 =WHL4G@7X&R3RD1W8LY)SN&,2R_-6^R>#[73E8![Z MY&Y3U*(-Q_\ 'BE?.@QD9Z=\4 CZR^&>E_V1\.]'@((>6'[0^1@YD._] 0/P MKK:\(B_: D@A2*/PS$J(H51]L/ ' _@K8\-?&J[\1^)+#2(O#T<;74H0R?:R M=B]6;&SG !.*!'(_'B]EF\;VUJS'RK>S78ONS,2?T _"J/P4TZ&_^(D,DPW? M9+>2X0'^\,*/RW9_"NC^//AJZ&HVGB.&-GM6B%O.0,^6P)*D^QSCZCW%>7^& M/$E]X4UV#5K J98\JR/]V13U4^W_ -:@9]9>*);R+PMJC:=#)->FV=8$C7+% MR,# ^IS7R#J>EWVC7K6>HVLEM_;&0F M.PMWE![!V^0#\F8_A7TA=74%E:RW5S*L4$*%Y)'. J@9)->3_ +2?L_AS4M5 M="'N[@1*3W1!U'XLP_"N>^,WQ _M"Y?PQIRGK[_3D MXWXA^-IO&GB%IU+)IUOF.TB/9>[$?WFZ_D.U9'AKQ)>^%=5_M+3XK9[D(45I MX]^S/4CG@XXSZ$UJ_#SP9+XS\2);-N6PM\27<@[)GA1[MT_,]J^C/^%=^#_^ MA=T__OT* /FKQ9XWU?QFUHVJ_9\VH<1F&/;][&<\G^Z*T?A+J!T_XDZ42VU) MV>!_?-Z3?'3-8L M;\ DVMQ', .ORL#_ $H ^TZ\'_:!U7?J.CZ0CG]U$]S(O;+':O\ Z"WYU[LC MK(BNARK $'U%?*7Q1U;^U_B+JTJONB@D^S)[",;3C_@08_C0"&_##2?[8^(F MD0LA:.&7[2_L(QN&?^!!1^-?6->#?L_Z3YFI:OJ[H<0Q+;1MVRQW-^6U?SKW MF@&>3?'O5OLWA:PTQ'P]Y<[V'JB#G_QYE_*O ].TZ[U;4;?3[&$S75PX2*,$ M#<3[G@?C7HGQSU;[=XYCL5?,=A;*A7T=OF/Z%?RKC?"/B%?"WB6VUEK(7C6X M;9$9-@R5*YS@],F@#<_X5!X[_P"@%_Y-P?\ Q==C\,/AGXBT7QK!J>N:;]FM M[:)VC;SXWS(1M PK$]&)_"G?\-"S_P#0MQ_^!A_^(KH_ _Q9NO&?B6/25T.. MVC\MY9)AFT9R2HZ]Z /2;^&:YTZY@MYA#/)$Z1RE=P1B" V,C.#SC- M>)_\,]3_ /0R1_\ @&?_ (NO=**!'FWP_P#A3_PA6N3:I+JBWKM 8440>7MR M02?O'TQ^)J+XZ:I]B\")9+C??7*(1G^%?G)_-5_.O3J^>OCYJGVGQ3I^FKRM MG;%SST:0\C\D7\Z!GEMA876IWT-E90M-;/;$O@?JU[ M=1W'B,K8V:G+6Z.&ED'ID9"CWSGVKU_Q1X@TWP#X2-P(HT2%!#9VJG&]L?*H M]N.3Z"M^]O;;3K*:\NYEAMX$+R2.OE+Q_XTN/&OB!KM@T=E#F.TA)^Z MGJ?]HX!/X#M0&Y@:KJ=WK6J7.I7TIENKAR\C'U]!Z #@#L!70^%_B)K7@^PD MM-*BLE65]\CR0[G8]!DYZ#M7:?![X=6^L12Z]KEHLUD M^?2O6/\ A7G@_P#Z%W3_ /OT* /E;7-8NO$&LW.JWHC%S<,&D\M=JY X'X5 M['^SYJ!-OK>FMT5X[A/Q!5OY+7$_%_0[+0/''V?3[6.VMI;6.58HQA0VTD('8D8^XY M8?\ ?(:OEM$:1U1%+,QP% R2?2O;/V@=6S+H^CHXX#W4B]^?E0_H]>/:1?)I MFLV5^\'GK;3I,8BVW?M8'!.#@'% (^P]!TQ=&\/Z?IB\BUMXX<^I50"?Q/-: M%>%_\-"S_P#0MQ_^!A_^(KI? OQ8NO&GB1-*&AQVR")Y9)1 M@0?'75?L?@:.Q4C??7*H1G^!/G)_,+^=>:?!K1AJ?BVYNG4^7964KAO1W&P? MHS'\*T_CWJOVKQ78Z:I!2SMMYYZ/(H?!7PC M_;7B)M:NH@UEII!3<.'GZK_WS][Z[: *?C[25\(>%/#WAK*?;)0^H7^#D^8V M%0?0 .OX5K? /2_M/BG4-2;E;.V"#CHTAX/Y(WYUSGQ;U;^U?B-J6U@T5H5M M4QVV#YA_WV6KUOX&:7]B\"/?-]Z_N7<''\*_(!^:M^= '._M!WT@&AZ>"1$? M-F8>I&U1^66_.O,_ %I!?>/M#M[G'E&[1B#T)7Y@/Q( _&O9/CEX7NM7T.TU MBSC:1].+B9%&28FQEO\ @)7\B3VKY\MKB:TNHKFWD:.>%Q)&Z]58'((_&@#[ M:IDTT=O!)/-(L<4:EW=C@*!R237AFF_M W,5FL>I:$EQ<*G^MAN/+#M[J5./ MS/TKDO&?Q6UKQ?;&Q$:6&G-RT$+%FD_WF[CV ^M 6.?\9:VGB+QAJFJQ#$5 MQ.?*XQE JD^^ *]<^ .B20V&J:W*N$N&6WA)'4+DL?ID@?\!->9^"/ .J^- M-058(V@T]&_?WC+\JCN%_O-[#\<5]&ZT;3P5\.[W[ @A@L+)D@!/\6,+D]R6 M(^I- ,^8_&FJ_P!M^--7U ,&26Y<1D=T4[5_\= KUW]G_2O+TO5]68',TRVZ M$CLHW''_ 'V/RKP6O3O!_P 7V\(^&K?1XM"2X\IG9IC<[2Y9B!'OF^]?W+N#C^%?D _-6_.OFVOLGPQI?]B>%M+TT_>MK9$?C&6Q\Q M_/- V<]\7;$WWPTU3:N7A\N8?\!<9_\ ''(K%-KWM5^U>+;+35(*65MN//1W.3^BI7T17Q_P"- M]5_MKQMK%^""DERRH0>J+\J_HHH!%30/#FK>)[]['1[3[3@:AH?C&V\86$9,+O$[R 9$ M4\> N?0$*OX@T CWVBN'\-_%;POKUA')<:C!IMWM'FP7<@CVGOACP1^.?4"M MF7QSX3A0NWB322!_%?%;2=0\*_$.W\6V<;-; MS2Q3*X'RK*@ *-CU"Y]\GTH&CZ$HKD_#OQ&\,^(K*.6+4[>VN&7+VUS((W0] MQS][ZC-:>H>+?#VE(6O=;L(<9^5IU+''HH.3^ H$:[ND4;22,%1069F. .Y MKY]\,!O'WQQGUE$+6-K,;@,02 D8"Q?0DA3CZ^E:?BSQ]J/Q!F;PMX+LYY+> M?Y;BZ*E=Z]Q_L)ZD\GI]?0_!7A&R^'_AB1'D5[@J9[VY QN(&<#_ &0,X_$] MZ .!U=?^$L_:&LK/!:VTE4+\\?NQYF?^^V"GZ56_:$MMMWH-R%^_'-&6QZ%" M!_X\:N_!*WDU;7?$?BFY0"2XE,:G.<%V,CC_ - J[\?[?=X5TNYQS'?>7_WT MC'_V6@9UWB+QE;>&? <6MR;7EF@3[-&3_K)&7('T[GV%--= M9GU+40TD;2=4B/);V+?H /6N*\)6-]\4-;TBVOD9-!T"TBA=1T#[-$%XP7^3CZ D_A0!YG\)T;Q/\4=;\32CIZ'H%M\\A#3&,?Q,QV)_)OSKHO@7I/V+P/)J# M;[^Y9@AUR?Q \ M:V_@OP^]SE7OY\I:0G^)O[Q_V1U/X#O0(Y+XN>.)+*%/"6ADMJ5X%CF\GK&C M<",8_B;I[#ZBLK1_@WXJTRT'V/Q?)IKS*K316K2*-V.A*L-V.F:M_"'P;<7- MP_C772TMYV3W%>QT >%^*/AIXMM_#.HW5_XUN]0M;:!I MY+:625E<(-W0L1VSTK8^ %Z)/#&J66_+07@DVYY = !^&4/ZUZAJUH+_ $:^ MLV4,MQ;R1$$9R&4C^M>&?L_7PCU_5[ GF>U24?\ &Q_[4H&7_CO?R7VKZ%X MD?V/\ #O2X MV&);A#=/QC)T&YL#@.R[HF/\+CD?X?0U\^ MS0R6\\D,R%)8V*NK#D$=17TO7 >/?!+ZF6U73(P;L#]]"/\ EJ!W'^T/U_GZ MF78I4I>SGL_S/'S7!.M%5(+WE^*/)**5E9&*L"K X((P0:2O?/EPHHHI@%=5 M\.[+[9XQM6/W;=6F;\!@?J17*UZ;\);(_P#$ROV Q\L*']6_]EKEQL^2A)_+ M[SMRZG[3$P7G?[M35^*5[]G\,QVPZW,Z@_[J_-_/;7CM=_\ %:]\W6[.S'2" M N?JQ_P45P%9Y=#DPZ\]33-:G/BI>6@4445W'G!1110 445TOA/PA=^)+M79 M6BT]&_>S'C/^ROJ?Y5G4J1IQ(K$V>K6,5U!U <F5(Y4^XK1HH \KO/@+X:GE9[:] MU&V!.?+#JZK],KG\R:BB^ /AT?Z[5-4?_<:-?YH:]9HH S/#^@V/AG18-*TY M'6VAW%=[;F)))))^IJY>6=MJ%I):WEO'<6\HVO'*H96'N#4]% 'FFI_ WPG? M2F2U:]L"<_)#*&3\G!/ZUGQ_ #0 ^9=6U)E]%\M3^>TUZW10!R.@_#+PGX>E M6>UTQ9KE<$373&5@1W / /N *ZZBB@#D?&/P[TKQO<6LVIW=_%]F1EC6VD15 MY())W*>>!^5KV5Q?S7,2LJ"YD1E7<,$C" YP2.O=:M\$/"FHS&:U^V:>Q))2WD!3)]F!Q] 0*])HH \ MC7]G_0PPW:OJ)7N $']*O6GP)\)VYS--J5S[23JH_P#'5!_6O3J* ,>Q\-6. ME>&CH.EO/96NQU5X7S(FXDDAF!YR3UZ5PA^ ?A8DDZAK))ZDS1?_ !NO4Z* M,+PIX2TSP;I)T_3!*R,YDDEF(+NQ]2 !P.!Q6[110!B^*?#%CXNT1]*U"2>. M!G5]T# ."IXP2"/TKA?^%!>%?^@AK/\ W^B_^-UZI10!!96HLK"WM%DDE6") M8Q)(06;:,9. !DX[ 5YM/\"?#5S<23S:EK3RRL7=C-%R2X8,Y8@#J !C ':M^BB@#SK6_@UX?U_6KO5;S4-6^ MT74AD<)+&%'L,QG@# ZU0_X4%X5_Z"&L_P#?Z+_XW7JE% 'E?_"@O"O_ $$- M9_[_ $7_ ,;KH_!_PVT3P5?7%YITUY-//%Y1:Y=&VKG) VJ.I _(5V-% !11 M10 5Y_XA^#^@>)==NM8OK[5%N;DJ76*6,*,*% *$] .]>@44 -=5110!@>+/"=KXPTQ-.OKV^M[8/O=+5U7S M".F[PLX;2UB6*WA01Q MQJ,!5 P!4U%% ''>,/AKHOC6_M[W49[V&:&+R@;9T7=RGN3^=9NA?!OP M_P"'M;M-6L[[56N+9]Z"26,J>,8(" XP?6O0Z* .'\5?"O1/&&M'5-1O-22; MRUB"02($"C/0%">Y[UA_\*"\*_\ 00UG_O\ 1?\ QNO5** /*_\ A07A7_H( M:S_W^B_^-UTG@_X;Z+X)O+F[TZ:\FFGC$;&Y=&VKG/&U1U./R%=A10!Y]X@^ M#^@>)==NM7O;[5%N;D@NL4L8484* 4)Z =ZZSPYX?L_"^A6VD6!E:W@W;6E M(+L68L22 !U/I6K10!YA;>UC$:%R"Q [G R>O2KU% !7":]\(O">O3/*]#ETB]GN(;>5E9S;LJL=IR!D@C&0.U;%% 'E?_ H+PK_T$-9_[_1?_&Z/ M^%!>%?\ H(:S_P!_HO\ XW7JE% 'E\/P&\*PSQR&\U:0(P;8\L95L'H?W?2N MN\7^#=/\:Z;!8:C<7<,,,WG+]F=5);!'.Y3V)KHJ* /,K/X&>%[*^M[I;S59 M&@D60))+&58@YP<1CCBO3:** @$$$9!KRO_ (4%X5_Z"&L_]_HO_C=>J44 M<1X4^%?A_P (:L=2LGO+BY"%$:Z=&$>>I7:HYQQGTKMZ** &2Q^;"\>YDWJ5 MW+U&>X]Z\N_X4%X5_P"@AK/_ '^B_P#C=>J44 >5_P#"@O"O_00UG_O]%_\ M&Z/^%!>%?^@AK/\ W^B_^-UZI10!S_A'P?IO@O2Y=/TU[B2.68S.]PP9BQ ' M4 #& .U=!110 4R:&*XA>&:-)8G!5T=0RL/0@]:?10!P]]\(O!5].9CI/D,> MHMYG1?\ OD' _ 5#%\&?!$;9;39I!Z/=28_0BN^HH K6%A:Z78PV5C D%M"N MV.-!PHI]W9VU_:R6MY;Q7%O(,/%*@96'N#4U% 'GM_\ !7P;>N[QVMU9ELG_ M $>E6** ,O0? M#NE>&;!K'1[06MLTAD9 [-EB "26)/0#OVIVNZ!IGB73OL&KVOVFUWB39YC) M\PZ'*D'O6E10!F:%X=TGPS8&QT>S6UMRYD90S,68]R6))Z#O2:]X&_$M^E]K&G MFZN$4(I:XE4 #G&T,!^G-=%10 V.-(HUCC541 %55& .@%.HHH *YS1/ ?A MGPYJ;ZCI.F"UNG1D+K/(PVD@D;2Q&.!VKHZ* ,'0_!?A_P -W]Q?:5I_D75P MI664S22%@3D_>8]^:WJ** &R1I+&T#]&U*#4;#1Q M%=0-NC("TSH;>[(_U M\0Y/^\.A_G[UYWJ?PTUVR8FV6*]BSP8FVMCW4_T)KVBBNRACJU%63NO,X<1E MU"N^:2L^Z/G2XT/5K5B)],O(\=2T+8_/%5_L5W_SZS?]^S7TG178LWEUC^)P M/(X=)O[CYL^Q7?\ SZS?]^S7M7P]T]K#PA;[T*23N\K@C!Y.!^@%=35;4;M; M#3+J\;[L$+2'\!FN?$XZ6)BJ?+;4Z<)ET,+-U.:^AX3XPOO[0\6ZE."2HF,: M_1?E_I6)2N[2.SL268Y)/]O2#B&$1CTRQ_P7]:BO5]C3<^QIA:'MZL:?\T5X\LVJ->[%(]Z&24D_>DV>> MZ'\+K6V9)M8N/M+C!\F+*IGW/4_I7?0016T"0P1I%$@VJB# 4>@%245Y]:O4 MK.\W<]2AAJ5!6IJP4445B;A1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 5R?Q&OOL?@^X0-M>Y=81^>3^BFNL MKFO%_A>;Q1!:PI?+;1PLSL#'OW$@ =QC'/YUOAG!58N;T3.?%*E?\*CE_Z#*?\ @.?_ (JC_A4:U[+\,++[/X5-R1S=3LX/L/E_F#6)_PJ.7_ *#*?^ Y_P#BJ]#T M?3ETG1[2P5M_D1!"V,;CW./ GRAPHIC 17 cl-20201231_g2.jpg begin 644 cl-20201231_g2.jpg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�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�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end GRAPHIC 18 cl-20201231_g3.jpg begin 644 cl-20201231_g3.jpg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pAT<%AQ9?Q"$6M;WK)68RN3M_R5\^_1Z2027=GT"*Y9!6;&[1R#KMVO M=U> 8V9\7IW-U2!0U59,&;W 2Q:E+'LU64><'0-!"/0?Y,@Y_"X^%'_89_\ M7F>P_P#V(++#NK/,;@[M^MH)4_4W-\.MN'U>V(F6NC'-SE\?F<)9T);02%KC M-FPZ1QVRV= N)848%I1+N #B$@.E6CM?'6^R<9^>G%_GO#7F"\=<_0RDV22K M2E\G7-)S_)9E*CTPE V\N56+.7F46#)T31M8=]@3+W10G0:/-TG 5HP>A<]V M1P_R]Z U&GHGKFL/[6JJ2R]FGA$5_+2PX'].5QY$[M[0Z_?E92V&2,7V1&^J M@?0VLVF,^K\1EB$$&PY_KZ!Q2JX%"*P@;5]Q0:N(A&H'#&/[5CB[N/WDD$EW9] BN605FQNT<@Z[=KW=7@&-F?%Z=S=4@4-563!F M]P$L6I2Q[-5E'G!T#00CT'^3(.?PN/A1_P!AG_UYGL/_ -B"R=W6?D[YY=S1 MFNHIU/S'$+50U+'440KIW/?Y[$)O%XHW 2@21I'8\!EL5L%0PE[1@'M(H44_=5636#NZW_T0\*2?H*%!R;_ (GS_3^<(1!_3KOS MZY$[OI.)<#GZM9M#I.Z%MT>E M*XC296M/2FC."<86,\HDPNLW^%Q\*/\ L,_^O,]A_P#L067#\STD(AGY22Z7?129ZF#R7^44[?I/*W+[9(Y"L4?%6N4"+^ MM],&PE .=\K%[7\;/-[T3LZ.W'V/SJ9<-C1.!M]9QY_P!W'?D );84UR"2 M2E$S@8JNM.$QP\P#[+G X2LU(8M-T<$LPX11)("XB(_POGA@@5I5R3AWZ2I$ MI(5IC?\ F7[ ,^FH3&A.),^0WH 98_D,!K?P%K8=_#^76]9/[M;R^X)]$RHQ M_P Y'-T0N5QA:<]#%I,>[S.#3=E;%*L"\]F1SVLY-#)IIA-7 V=M )>)']48 MQ?2^8P>Q9+Y$X=Y-X,K@^I^1:.AU)0ALZWVUYZ#2_4\BS M)^7]H5[]URO3,YQ_3K]Y59-8.[K?_1#PI)^@H4')O^)\_P!/YPA$&3KM74#D M4!5U9)H?'976[C&=0QV@TN:4$\ M'QT9\WQW\:C89^'<\78#:*6XH[P56>YDB==/21+(99;4TKY.X 4$JBAE5!,K M#?ZD F(/(#LM/]Q_9ROY= !K6]ZW="222G)*3IRBR"""P$D$$@"42224'0"R MBBP:" LLL =:"'6M:UK7PUGZ93+T'^'R\A>J+GL'H2^N2!3VW[3?/RCGDO%? MW3\:V^O/V)(W:5Z88?=4?C+6$*)"47HI$B3DAT#7P!K?QWO^N>OP^GD-RI=% M?]"T)R/^0=P58]#D,#E_]O?3DH^XG@Q M:QJ_N"9W1(HNY_%"X' ^FL1*"O] M_P";Y?FT'>LB=:^(WECW+9XKHZQ!W8+35*U'SQ6L6IVBZXAU35="4'W= M%H+ V%!'8XT)QFF*5)A+>WDDEG+W%:<8I6*C?J*EJLTP\\PPXP8Q1MG/F]Q? M9/9-<^@4TIK[ZZZJ9A21FO[:_M$M9N^X&1"AE3:E1?D&TSI#63K])%-7,'U% MK*I.%]I^.Q[$65LN<.0J(\[N.DW:JST1)I_Y.Q7"*AA*NX/[0+1%]6, BJ6$ MA;/[/QS857%_",(BDOU@L@5'^[]3ZGU=[,W-7&1$[2X0Y4]#:I9J1[!JXRW* MOC\\:;,:HN">V77@2)JQL4EC34\'.]63*$/ZXM(S2]P*TD4*C40QGA-$2(TD MD9=7G\+CX4?]AG_UYGL/_P!B"RQ!-YD\(D\<1[S^5H(<"W<*Y*%4,DDTLC>B]=!XR\>O-?S MZE[I87(_*L.JZ?NZ!4U'SM?);%LZ:(FI> @MP:F"5V[,YX_QAL<@)@:5)VU0 MD)4Z#_Q0C^._C-N[*8K3HNH[&HBY(W^6-56U$'N!V#%?OA_CWY0121(S&]X: MOOR+.K'(VK[8D-$#ZZ)8F4E_'X@,"+X;SH')W(W/7#M)1WG3EROO[+Z;BCC( MG9@AWY5S>:_8'"5O:V1/ZC\H;$DLME2K[>\N!QWR'+C %?/\A>@ T$.J][+_ M ]GC3;EK'73-N$*R-G:IU+?%_Y+RBU:]A3HZA*LKZP(O5KP8X."L MP2S2IF."M!OZ:C1I>M U;;!H)":PAT9KNMHA&8! 86RH(Y$(3#&)LC,4BT?: MR )6UDC\?9DR-J9VI F+" E.G*+*+#KX!#K6=KS@Y-'&:8QN01&1)!+X_*6- MVCCZA K6H!K69\0*&QS2!7-RA(X(Q*42H8-&D&E'%[%\P!A%K6]4._PN/A1_ MV&?_ %YGL/\ ]B"R:7'7C[YQ\"J+44B9$SFNDEM*50=F>TRE,M1.3/4DLGKY4K4H;5B0LU)M.QEZ2&A^8G0!;W MO=R&0>Y=\WN+^,+3ONZ^:J:_LVLWIU^')KQDO]HEK3'\MWL9W"GH>VQYN['YQAET&Q(LY/%Y M"L7RJ&SF/(5*Q.X*FMGL.NI#$)VWLJQ:E 8>B*<0I#A:W\Y8OF%\>U\=<"<= M< 09SKOCZA(924:?EJ=PD9C&)Z?)3*5:,LTI ;+9[,7:1SN5_=A1Y@4@7%R4 M@2Z-,T3H'U!_-+_.B6G6<*NFL;&IRRF2%6WJTJU-L?U"#BC0A&&CS^%Q\*/\ L,_^O,]A_P#L M063TXU\J> O/^-W##N3N>FRMXI?Z1B;[BCKW.[4MIFGC=&T$H:VIL=F^YIU8 M28IL"VS-S(4)DX22%I2L05 3=!!H,>:\_#[^.-5W(WWW">%*S;[':'HF1,YK MI);2E4'9GM,I3+43DSU)+)Z^5*U*&U8D+-2;3L9>DAH?F)T 6][WQR.1RP2W[FGTZE,?C7QD$M M<%'TVA(WD_\ 2/D^3Z990 ?!T[YF<1=E7/2'0?25*"L>WN<5[6YTQ+-V5;T0 M!#%[-*T$V;5 8[ Y]%XK(!$2=L(4[TZ(5P3-%Z*'H1/Q+W/#&=$M.LX5=-8V M-3EE,YDAKFV8'+ZSG[ 2[O; <^0J>1]PBTJ9RGV-.+/(V4QS8G4\D*MO5I5J M;8_J$'%&A",-'G\+CX4?]AG_ ->9[#_]B"R>G&OE3P%Y_P ;N&'?A]_'&J[D;[[A/"E9M]CM#T3(F][N0R$7&GG'QEY]_P!K'_*'3?\ 9)_;A(FJ M5VC_ .Y#M6>_E._LGWW]UK__ ')TYFGW+]E_*-;_ ,)N^R$C^M_O@%\@/EP_ MU]XQ^8?>,UW974O(D!L*Q30H0.$^9'RP*IFK\!L2GH6\,JE5.S" /LM"B0G_ M $2].9ZO02BB0:_W2"=%R(Y&X1Y X.A2ZO\ D6@8#1\<=Q-@Y .+HEBR2RLY MF1_8&I1,IQ(EKU-YDJ;TPAZ*-=7%88 9QH]"^J'?X M7'PH_P"PS_Z\SV'_ .Q!9-_BCR/\\_.QYL5_X\YY(J5TMF/MD5L(U39]T64G MDD?9U2Q:WMBANMNQIXW(R"E#@=L>TI1 S@CV$P0PZUK6!DGX>OQD17.5?:?@ M>IM3XE^)DA;>:]64HJD+J02627O^P)3.3:(VW:T5H>T.XWM$([XF[)V:(0]W M*$DDIR2DZO_I1E4Y?()'?MLC;" M%/\ Z):T'T_D^F7\I6Q WT[M7R@\\_1%RCC[V'S%#K=D\32 ;F*9EODZKN=I MF2P*IW54K@TO=8VF4KSSBFU6M/0%'G#- 4$P6Q;S[RSR!S-Q-5R*F.5 M:9AE*5PC4[7&,421J-JGEUVG)2#?)5)'94YRF92(Y*F+*,<79:M7&%E@"(W8 M0AUJ2.,I%MW\.3XT7Q:UE7=;''9DNM"WIY++,L24&]$]6M I!-9P^KI+)WC3 M0P7FU,#06X/+D<:!(@2I424 M%$$E% .1.5?"#REXEO&(](\Q77!G;]4U71O2?/##,*@I!:6NJ:NXG M*[$IJ+00PAB_)E(E86RDIA711#4@8/\ HJ9$+YT:8K^0HH'^W*_/X7'PH_[# M/_KS/8?_ +$%EATV\QN#K)Y,@O#=@\WPZ;6D^ U8DFQE:,Q[P5^).K7I/J1@XB[$X_O/SCZGG:U$V5Q KJ-=G M1CE+RY@7',L97N\HKZHI?$Y-*"TP ,Y2Z.A0N:H6TI2S[4),2IV8,^)R7DM; M6Z[(]"8Y)%,D;HE$ID>M;$<%L*R&PYC&V3 M-*6 PU82?L\LT.R= " 8[+,8R%]6^A?']U=87-P[6=O?E+U'SXPJ)-;U8?D! M:#-^2+(E711L/6_EK((4U5X__36S=K!]-K=EIV_M7QT#82S=ES0QC&5T>BWJ M5R?Y;0NN9[U>[SAHCUIRAUB$3,@\+63-4<\LS2%Y6@7)4:E,)$G"A'K83!;W MH0OY,J8_B\O&W_X=.@/^HE\_]5,N/\]/1OFCT\I>3WWRNYS!VKV(V@]5"\*) MM$U4.=03)@BD*F;@2G;%BA0:>WA9)^W" ?H6@B,$8#X?$&_C._&,8R%?97HO MQ)Y]1ALE?871<#I9&^&% 8&1TV]2>>R(LP\:8:Z-UC!&B4V/(6I&>7L*I8B: MCTB3?P^N87\=?&4[_/87$H.ZV7+I0QQ&OV&-J9B_S&5N">,QZ/Q9$WB=ES\_ MN;X- F9&Q V@$M_3_@ MSA60Q^(=4='Q*KYA)F@V2-D/+9II.Y<3%2#S$ILQ?8O6T8F+]%H4!20:7MY< MTZ-K^

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end GRAPHIC 19 cl-20201231_g4.jpg begin 644 cl-20201231_g4.jpg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cl-20201231_htm.xml IDEA: XBRL DOCUMENT 0000021665 2020-01-01 2020-12-31 0000021665 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0000021665 cl:A0.000Notesdue2021Member 2020-01-01 2020-12-31 0000021665 cl:A0.500NotesDue2026Member 2020-01-01 2020-12-31 0000021665 cl:A1.375NotesDue2034Member 2020-01-01 2020-12-31 0000021665 cl:A0.875Notesdue2039Member 2020-01-01 2020-12-31 0000021665 2020-06-30 0000021665 2021-01-31 0000021665 us-gaap:ForeignExchangeContractMember 2020-01-01 2020-12-31 0000021665 us-gaap:CommodityContractMember 2020-01-01 2020-12-31 0000021665 2019-01-01 2019-12-31 0000021665 2018-01-01 2018-12-31 0000021665 2020-12-31 0000021665 2019-12-31 0000021665 us-gaap:CommonStockMember 2017-12-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000021665 cl:UnearnedCompensationMember 2017-12-31 0000021665 us-gaap:TreasuryStockMember 2017-12-31 0000021665 us-gaap:RetainedEarningsMember 2017-12-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000021665 us-gaap:NoncontrollingInterestMember 2017-12-31 0000021665 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0000021665 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-12-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0000021665 us-gaap:TreasuryStockMember 2018-01-01 2018-12-31 0000021665 cl:UnearnedCompensationMember 2018-01-01 2018-12-31 0000021665 us-gaap:CommonStockMember 2018-12-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000021665 cl:UnearnedCompensationMember 2018-12-31 0000021665 us-gaap:TreasuryStockMember 2018-12-31 0000021665 us-gaap:RetainedEarningsMember 2018-12-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000021665 us-gaap:NoncontrollingInterestMember 2018-12-31 0000021665 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0000021665 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-12-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0000021665 us-gaap:TreasuryStockMember 2019-01-01 2019-12-31 0000021665 cl:UnearnedCompensationMember 2019-01-01 2019-12-31 0000021665 us-gaap:CommonStockMember 2019-12-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000021665 cl:UnearnedCompensationMember 2019-12-31 0000021665 us-gaap:TreasuryStockMember 2019-12-31 0000021665 us-gaap:RetainedEarningsMember 2019-12-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000021665 us-gaap:NoncontrollingInterestMember 2019-12-31 0000021665 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0000021665 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-12-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0000021665 us-gaap:TreasuryStockMember 2020-01-01 2020-12-31 0000021665 cl:UnearnedCompensationMember 2020-01-01 2020-12-31 0000021665 us-gaap:CommonStockMember 2020-12-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000021665 cl:UnearnedCompensationMember 2020-12-31 0000021665 us-gaap:TreasuryStockMember 2020-12-31 0000021665 us-gaap:RetainedEarningsMember 2020-12-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000021665 us-gaap:NoncontrollingInterestMember 2020-12-31 0000021665 2019-01-01 2019-03-31 0000021665 2018-01-01 2018-03-31 0000021665 2020-01-01 2020-03-31 0000021665 2018-12-31 0000021665 2017-12-31 0000021665 cl:OralCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-12-31 0000021665 cl:OralCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-12-31 0000021665 cl:OralCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-12-31 0000021665 cl:PersonalCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-12-31 0000021665 cl:PersonalCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-12-31 0000021665 cl:PersonalCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-12-31 0000021665 cl:HomeCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-12-31 0000021665 cl:HomeCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-12-31 0000021665 cl:HomeCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-12-31 0000021665 cl:PetNutritionMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-12-31 0000021665 cl:PetNutritionMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-12-31 0000021665 cl:PetNutritionMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-12-31 0000021665 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-12-31 0000021665 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-12-31 0000021665 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-12-31 0000021665 us-gaap:ShippingAndHandlingMember 2020-01-01 2020-12-31 0000021665 us-gaap:ShippingAndHandlingMember 2019-01-01 2019-12-31 0000021665 us-gaap:ShippingAndHandlingMember 2018-01-01 2018-12-31 0000021665 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2020-01-01 2020-12-31 0000021665 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2020-01-01 2020-12-31 0000021665 srt:MaximumMember us-gaap:BuildingMember 2020-01-01 2020-12-31 0000021665 srt:MinimumMember cl:LocalBrandsTrademarksCustomerRelationshipsAndNonCompeteAgreementsMember 2020-01-01 2020-12-31 0000021665 srt:MaximumMember cl:LocalBrandsTrademarksCustomerRelationshipsAndNonCompeteAgreementsMember 2020-01-01 2020-12-31 0000021665 cl:HelloProductLLCMember 2020-01-31 2020-01-31 0000021665 cl:HelloProductLLCMember 2020-01-31 0000021665 cl:HelloProductLLCMember us-gaap:TrademarksMember 2020-01-31 0000021665 cl:HelloProductLLCMember us-gaap:TrademarksMember 2020-01-31 2020-01-31 0000021665 cl:HelloProductLLCMember us-gaap:CustomerRelationshipsMember 2020-01-31 0000021665 cl:HelloProductLLCMember us-gaap:CustomerRelationshipsMember 2020-01-31 2020-01-31 0000021665 srt:NorthAmericaMember cl:HelloProductLLCMember 2020-01-31 0000021665 cl:LaboratoiresFilorgaCosmtiquesMember 2019-09-19 2019-09-19 0000021665 cl:LaboratoiresFilorgaCosmtiquesMember 2019-09-19 0000021665 cl:LaboratoiresFilorgaCosmtiquesMember us-gaap:TrademarksMember 2019-09-19 0000021665 cl:LaboratoiresFilorgaCosmtiquesMember us-gaap:CustomerRelationshipsMember 2019-09-19 0000021665 cl:LaboratoiresFilorgaCosmtiquesMember us-gaap:CustomerRelationshipsMember 2019-09-19 2019-09-19 0000021665 srt:EuropeMember cl:LaboratoiresFilorgaCosmtiquesMember 2019-09-19 0000021665 cl:LaboratoiresFilorgaCosmtiquesMember 2020-07-01 2020-09-30 0000021665 cl:NigeriaJointVentureMember 2019-08-15 0000021665 cl:NigeriaJointVentureMember 2019-08-15 2019-08-15 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2020-10-01 2020-12-31 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember cl:GlobalGrowthandEfficiencyProgramMember 2020-10-01 2020-12-31 0000021665 cl:OtherIncomeExpenseNetMember cl:GlobalGrowthandEfficiencyProgramMember 2020-10-01 2020-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2020-12-31 0000021665 cl:GrossProfitMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 cl:GrossProfitMember cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 cl:OtherIncomeExpenseNetMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 cl:OtherIncomeExpenseNetMember cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 cl:NonServiceRelatedPostretirementCostsMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 cl:NonServiceRelatedPostretirementCostsMember cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 srt:NorthAmericaMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 srt:NorthAmericaMember cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 srt:NorthAmericaMember cl:GlobalGrowthandEfficiencyProgramMember 2012-10-01 2019-12-31 0000021665 srt:LatinAmericaMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 srt:LatinAmericaMember cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 srt:LatinAmericaMember cl:GlobalGrowthandEfficiencyProgramMember 2012-10-01 2019-12-31 0000021665 srt:EuropeMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 srt:EuropeMember cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 srt:EuropeMember cl:GlobalGrowthandEfficiencyProgramMember 2012-10-01 2019-12-31 0000021665 srt:AsiaMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 srt:AsiaMember cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 srt:AsiaMember cl:GlobalGrowthandEfficiencyProgramMember 2012-10-01 2019-12-31 0000021665 cl:AfricaEurasiaMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 cl:AfricaEurasiaMember cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 cl:AfricaEurasiaMember cl:GlobalGrowthandEfficiencyProgramMember 2012-10-01 2019-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember cl:PetNutritionMember 2019-01-01 2019-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember cl:PetNutritionMember 2018-01-01 2018-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember cl:PetNutritionMember 2012-10-01 2019-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember us-gaap:CorporateMember 2019-01-01 2019-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember us-gaap:CorporateMember 2018-01-01 2018-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember us-gaap:CorporateMember 2012-10-01 2019-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2012-10-01 2019-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2019-12-31 0000021665 us-gaap:OneTimeTerminationBenefitsMember cl:GlobalGrowthandEfficiencyProgramMember 2019-12-31 0000021665 cl:IncrementalDepreciationMember cl:GlobalGrowthandEfficiencyProgramMember 2019-12-31 0000021665 cl:AssetImpairmentMember cl:GlobalGrowthandEfficiencyProgramMember 2019-12-31 0000021665 us-gaap:OtherRestructuringMember cl:GlobalGrowthandEfficiencyProgramMember 2019-12-31 0000021665 us-gaap:OneTimeTerminationBenefitsMember cl:GlobalGrowthandEfficiencyProgramMember 2017-12-31 0000021665 cl:IncrementalDepreciationMember cl:GlobalGrowthandEfficiencyProgramMember 2017-12-31 0000021665 cl:AssetImpairmentMember cl:GlobalGrowthandEfficiencyProgramMember 2017-12-31 0000021665 us-gaap:OtherRestructuringMember cl:GlobalGrowthandEfficiencyProgramMember 2017-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2017-12-31 0000021665 us-gaap:OneTimeTerminationBenefitsMember cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 cl:IncrementalDepreciationMember cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 cl:AssetImpairmentMember cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 us-gaap:OtherRestructuringMember cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 us-gaap:OneTimeTerminationBenefitsMember cl:GlobalGrowthandEfficiencyProgramMember 2018-12-31 0000021665 cl:IncrementalDepreciationMember cl:GlobalGrowthandEfficiencyProgramMember 2018-12-31 0000021665 cl:AssetImpairmentMember cl:GlobalGrowthandEfficiencyProgramMember 2018-12-31 0000021665 us-gaap:OtherRestructuringMember cl:GlobalGrowthandEfficiencyProgramMember 2018-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2018-12-31 0000021665 us-gaap:OneTimeTerminationBenefitsMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 cl:IncrementalDepreciationMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 cl:AssetImpairmentMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 us-gaap:OtherRestructuringMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 cl:ThirdPartyIncrementalCostMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 cl:ThirdPartyIncrementalCostMember cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 us-gaap:ContractTerminationMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 us-gaap:ContractTerminationMember cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 us-gaap:LandAndBuildingMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember 2020-12-31 0000021665 srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember 2019-12-31 0000021665 srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember 2020-12-31 0000021665 srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember 2019-12-31 0000021665 srt:EuropeMember cl:OralPersonalAndHomeCareMember 2020-12-31 0000021665 srt:EuropeMember cl:OralPersonalAndHomeCareMember 2019-12-31 0000021665 srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember 2020-12-31 0000021665 srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember 2019-12-31 0000021665 cl:AfricaEurasiaMember cl:OralPersonalAndHomeCareMember 2020-12-31 0000021665 cl:AfricaEurasiaMember cl:OralPersonalAndHomeCareMember 2019-12-31 0000021665 cl:OralPersonalAndHomeCareMember 2020-12-31 0000021665 cl:OralPersonalAndHomeCareMember 2019-12-31 0000021665 cl:PetNutritionMember 2020-12-31 0000021665 cl:PetNutritionMember 2019-12-31 0000021665 us-gaap:TrademarksMember 2020-12-31 0000021665 us-gaap:TrademarksMember 2019-12-31 0000021665 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0000021665 us-gaap:OtherIntangibleAssetsMember 2019-12-31 0000021665 us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember 2020-12-31 0000021665 us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember 2019-12-31 0000021665 cl:FilorgaReportingUnitMember 2020-12-31 0000021665 cl:FilorgaReportingUnitMember cl:ScenarioOneMember 2020-12-31 0000021665 cl:FilorgaReportingUnitMember cl:ScenarioTwoMember 2020-12-31 0000021665 us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember cl:FilorgaReportingUnitMember 2020-12-31 0000021665 us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember cl:FilorgaReportingUnitMember cl:ScenarioOneMember 2020-12-31 0000021665 us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember cl:FilorgaReportingUnitMember cl:ScenarioTwoMember 2020-12-31 0000021665 cl:ReportingUnitsOtherThanFilorgaMember 2020-12-31 0000021665 us-gaap:NotesPayableOtherPayablesMember 2020-12-31 0000021665 us-gaap:NotesPayableOtherPayablesMember 2019-12-31 0000021665 us-gaap:CommercialPaperMember 2020-12-31 0000021665 us-gaap:CommercialPaperMember 2019-12-31 0000021665 cl:FinanceLeaseObligationMember 2020-12-31 0000021665 cl:FinanceLeaseObligationMember 2019-12-31 0000021665 cl:Sevenyearnotesat0.50percentnumberMember 2019-03-31 0000021665 cl:Sevenyearnotesat0.50percentnumberMember 2019-01-01 2019-03-31 0000021665 cl:Fifteenyearnotesat1.375percentMember 2019-03-31 0000021665 cl:Fifteenyearnotesat1.375percentMember 2019-01-01 2019-03-31 0000021665 cl:Twoyearnotesat0.00percentMember 2019-12-31 0000021665 cl:Twoyearnotesat0.00percentMember 2019-10-01 2019-12-31 0000021665 cl:Twentyyearnotesat0.875percentMember 2019-12-31 0000021665 cl:Twentyyearnotesat0.875percentMember 2019-10-01 2019-12-31 0000021665 cl:A1.75percentMember 2019-03-31 0000021665 cl:A245MediumTermNotesDue2021Member 2020-12-31 0000021665 cl:A245MediumTermNotesDue2021Member 2020-10-01 2020-12-31 0000021665 cl:A230MediumTermNotesDue2022Member 2020-12-31 0000021665 cl:A230MediumTermNotesDue2022Member 2020-10-01 2020-12-31 0000021665 cl:A245MediumTermNotesDue2021And230MediumTermNotesDue2022Member 2020-10-01 2020-12-31 0000021665 cl:AmendedDomesticRevolvingCreditFacility2650MillionCapacityMember 2018-11-30 0000021665 cl:AmendedDomesticRevolvingCreditFacility2650MillionCapacityMember 2019-08-01 2019-08-31 0000021665 cl:AmendedDomesticRevolvingCreditFacility1500MillionCapacityMember 2020-08-31 0000021665 2020-08-31 2020-08-31 0000021665 us-gaap:OtherAssetsMember us-gaap:InterestRateContractMember 2020-12-31 0000021665 us-gaap:OtherAssetsMember us-gaap:InterestRateContractMember 2019-12-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember 2020-12-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember 2019-12-31 0000021665 us-gaap:OtherAssetsMember us-gaap:ForwardContractsMember 2020-12-31 0000021665 us-gaap:OtherAssetsMember us-gaap:ForwardContractsMember 2019-12-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:ForwardContractsMember 2020-12-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:ForwardContractsMember 2019-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2020-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2020-12-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000021665 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember 2020-12-31 0000021665 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember 2020-12-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember 2020-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CommodityContractMember 2020-12-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CommodityContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentAssetsMember 2020-12-31 0000021665 us-gaap:OtherCurrentAssetsMember 2019-12-31 0000021665 us-gaap:FairValueInputsLevel2Member 2020-12-31 0000021665 us-gaap:FairValueInputsLevel2Member 2019-12-31 0000021665 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0000021665 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000021665 us-gaap:LongTermDebtMember 2020-12-31 0000021665 us-gaap:LongTermDebtMember 2019-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2020-12-31 0000021665 us-gaap:DebtMember us-gaap:FairValueHedgingMember 2020-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2020-12-31 0000021665 us-gaap:ForwardContractsMember us-gaap:FairValueHedgingMember 2020-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:FairValueHedgingMember 2020-12-31 0000021665 us-gaap:FairValueHedgingMember 2020-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2020-12-31 0000021665 us-gaap:DebtMember us-gaap:CashFlowHedgingMember 2020-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2020-12-31 0000021665 us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember 2020-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2020-12-31 0000021665 us-gaap:CashFlowHedgingMember 2020-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:DebtMember us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:ForwardContractsMember us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2019-12-31 0000021665 us-gaap:DebtMember us-gaap:FairValueHedgingMember 2019-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2019-12-31 0000021665 us-gaap:ForwardContractsMember us-gaap:FairValueHedgingMember 2019-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:FairValueHedgingMember 2019-12-31 0000021665 us-gaap:FairValueHedgingMember 2019-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2019-12-31 0000021665 us-gaap:DebtMember us-gaap:CashFlowHedgingMember 2019-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2019-12-31 0000021665 us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember 2019-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2019-12-31 0000021665 us-gaap:CashFlowHedgingMember 2019-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0000021665 us-gaap:DebtMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0000021665 us-gaap:ForwardContractsMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0000021665 us-gaap:NetInvestmentHedgingMember 2019-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0000021665 us-gaap:InterestRateContractMember cl:InterestIncomeExpenseNetMember 2020-01-01 2020-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0000021665 us-gaap:InterestRateContractMember cl:InterestIncomeExpenseNetMember 2019-01-01 2019-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0000021665 us-gaap:ForeignExchangeContractMember cl:InterestIncomeExpenseNetMember 2020-01-01 2020-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0000021665 us-gaap:ForeignExchangeContractMember cl:InterestIncomeExpenseNetMember 2019-01-01 2019-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0000021665 us-gaap:CommodityContractMember cl:InterestIncomeExpenseNetMember 2020-01-01 2020-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0000021665 us-gaap:CommodityContractMember cl:InterestIncomeExpenseNetMember 2019-01-01 2019-12-31 0000021665 us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0000021665 cl:InterestIncomeExpenseNetMember 2020-01-01 2020-12-31 0000021665 us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0000021665 cl:InterestIncomeExpenseNetMember 2019-01-01 2019-12-31 0000021665 us-gaap:ForeignExchangeContractMember 2019-01-01 2019-12-31 0000021665 us-gaap:ForwardContractsMember 2020-01-01 2020-12-31 0000021665 us-gaap:ForwardContractsMember 2019-01-01 2019-12-31 0000021665 us-gaap:CommodityContractMember 2019-01-01 2019-12-31 0000021665 us-gaap:DebtMember 2020-01-01 2020-12-31 0000021665 us-gaap:DebtMember 2019-01-01 2019-12-31 0000021665 cl:Program2018Member 2018-06-18 0000021665 cl:Program2018Member 2020-01-01 2020-12-31 0000021665 cl:PerformanceBasedRestrictedStockUnitsMember cl:IncentiveStockPlansMember 2020-01-01 2020-12-31 0000021665 cl:PerformanceBasedRestrictedStockUnitsMember 2019-12-31 0000021665 cl:PerformanceBasedRestrictedStockUnitsMember 2020-01-01 2020-12-31 0000021665 cl:PerformanceBasedRestrictedStockUnitsMember 2020-12-31 0000021665 cl:PerformanceBasedRestrictedStockUnitsMember cl:IncentiveStockPlansMember 2020-12-31 0000021665 cl:TimeVestedRestrictedStockUnitsMember cl:IncentiveStockPlansMember 2020-01-01 2020-12-31 0000021665 cl:TimeVestedRestrictedStockUnitsMember cl:IncentiveStockPlansMember 2020-12-31 0000021665 cl:TimeVestedRestrictedStockUnitsMember 2019-12-31 0000021665 cl:TimeVestedRestrictedStockUnitsMember 2020-01-01 2020-12-31 0000021665 cl:TimeVestedRestrictedStockUnitsMember 2020-12-31 0000021665 cl:TimeVestedRestrictedStockUnitsMember cl:IncentiveStockPlansMember 2019-01-01 2019-12-31 0000021665 cl:TimeVestedRestrictedStockUnitsMember cl:IncentiveStockPlansMember 2018-01-01 2018-12-31 0000021665 cl:StockOptionPlansMember 2020-01-01 2020-12-31 0000021665 cl:StockOptionPlansMember 2019-01-01 2019-12-31 0000021665 cl:StockOptionPlansMember 2020-12-31 0000021665 cl:StockOptionPlansMember 2018-01-01 2018-12-31 0000021665 us-gaap:DefinedBenefitPlanEquitySecuritiesMember country:US 2020-12-31 0000021665 us-gaap:DefinedBenefitPlanEquitySecuritiesMember us-gaap:ForeignPlanMember 2020-12-31 0000021665 us-gaap:FixedIncomeSecuritiesMember country:US 2020-12-31 0000021665 us-gaap:FixedIncomeSecuritiesMember us-gaap:ForeignPlanMember 2020-12-31 0000021665 cl:RealEstateandOtherInvestmentsMember country:US 2020-12-31 0000021665 cl:RealEstateandOtherInvestmentsMember us-gaap:ForeignPlanMember 2020-12-31 0000021665 country:US 2020-12-31 0000021665 us-gaap:ForeignPlanMember 2020-12-31 0000021665 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanUSCommonStocksMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanUSCommonStocksMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanUSCommonStocksMember us-gaap:FairValueInputsLevel1Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanInternationalCommonStockMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanInternationalCommonStockMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanInternationalCommonStockMember us-gaap:FairValueInputsLevel1Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanPooledFundsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanPooledFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanPooledFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanFixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanFixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanFixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanGuaranteedInvestmentContractsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanGuaranteedInvestmentContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanGuaranteedInvestmentContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000021665 us-gaap:FairValueInputsLevel12And3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 us-gaap:FairValueInputsLevel12And3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 us-gaap:FairValueInputsLevel12And3Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanFixedIncomeFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanFixedIncomeFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanFixedIncomeFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanHedgeFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanHedgeFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanHedgeFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanMultiAssetFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanMultiAssetFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:DefinedBenefitPlanMultiAssetFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000021665 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000021665 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000021665 cl:OtherAssetsandLiabilitiesNetMember country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:OtherAssetsandLiabilitiesNetMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 cl:OtherAssetsandLiabilitiesNetMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000021665 country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000021665 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanUSCommonStocksMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanUSCommonStocksMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanUSCommonStocksMember us-gaap:FairValueInputsLevel1Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanInternationalCommonStockMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanInternationalCommonStockMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanInternationalCommonStockMember us-gaap:FairValueInputsLevel1Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanPooledFundsMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanPooledFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanPooledFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanFixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanFixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanFixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanGuaranteedInvestmentContractsMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanGuaranteedInvestmentContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanGuaranteedInvestmentContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0000021665 us-gaap:FairValueInputsLevel12And3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 us-gaap:FairValueInputsLevel12And3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 us-gaap:FairValueInputsLevel12And3Member us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanFixedIncomeFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanFixedIncomeFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanFixedIncomeFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanHedgeFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanHedgeFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanHedgeFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanMultiAssetFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanMultiAssetFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:DefinedBenefitPlanMultiAssetFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0000021665 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0000021665 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0000021665 cl:OtherAssetsandLiabilitiesNetMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:OtherAssetsandLiabilitiesNetMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 cl:OtherAssetsandLiabilitiesNetMember 2019-12-31 0000021665 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0000021665 country:US us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0000021665 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0000021665 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0000021665 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0000021665 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-12-31 0000021665 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0000021665 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0000021665 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-12-31 0000021665 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-12-31 0000021665 us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000021665 us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000021665 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-31 0000021665 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-31 0000021665 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-12-31 0000021665 us-gaap:OneTimeTerminationBenefitsMember cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-12-31 0000021665 2017-10-01 2017-12-31 0000021665 2019-10-01 2019-12-31 0000021665 country:CH 2018-01-01 2018-12-31 0000021665 srt:MinimumMember 2020-01-01 2020-12-31 0000021665 srt:MaximumMember 2020-01-01 2020-12-31 0000021665 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0000021665 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0000021665 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0000021665 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0000021665 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-12-31 0000021665 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-12-31 0000021665 srt:MinimumMember 2020-12-31 0000021665 srt:MaximumMember 2020-12-31 0000021665 2017-07-31 0000021665 2019-04-01 2019-04-30 0000021665 2019-04-01 2019-06-30 0000021665 us-gaap:SalesRevenueNetMember 2020-12-31 0000021665 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000021665 us-gaap:OperatingIncomeLossMember cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-12-31 0000021665 us-gaap:CorporateNonSegmentMember us-gaap:OperatingIncomeLossMember 2020-01-01 2020-12-31 0000021665 us-gaap:OperatingIncomeLossMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-12-31 0000021665 us-gaap:CorporateNonSegmentMember us-gaap:OperatingIncomeLossMember 2019-01-01 2019-12-31 0000021665 us-gaap:OperatingIncomeLossMember cl:GlobalGrowthandEfficiencyProgramMember 2018-01-01 2018-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember 2018-01-01 2018-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember 2018-01-01 2018-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:EuropeMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:EuropeMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:EuropeMember cl:OralPersonalAndHomeCareMember 2018-01-01 2018-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember 2018-01-01 2018-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:AfricaEurasiaMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:AfricaEurasiaMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:AfricaEurasiaMember cl:OralPersonalAndHomeCareMember 2018-01-01 2018-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:OralPersonalAndHomeCareMember 2018-01-01 2018-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:PetNutritionMember 2020-01-01 2020-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:PetNutritionMember 2019-01-01 2019-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:PetNutritionMember 2018-01-01 2018-12-31 0000021665 country:US cl:OralPersonalAndHomeCareMember 2020-01-01 2020-12-31 0000021665 country:US cl:OralPersonalAndHomeCareMember 2019-01-01 2019-12-31 0000021665 country:US cl:OralPersonalAndHomeCareMember 2018-01-01 2018-12-31 0000021665 country:US cl:PetNutritionMember 2020-01-01 2020-12-31 0000021665 country:US cl:PetNutritionMember 2019-01-01 2019-12-31 0000021665 country:US cl:PetNutritionMember 2018-01-01 2018-12-31 0000021665 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-12-31 0000021665 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-12-31 0000021665 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember 2020-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember 2019-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember 2018-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember 2020-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember 2019-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember 2018-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:EuropeMember cl:OralPersonalAndHomeCareMember 2020-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:EuropeMember cl:OralPersonalAndHomeCareMember 2019-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:EuropeMember cl:OralPersonalAndHomeCareMember 2018-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember 2020-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember 2019-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember 2018-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:AfricaEurasiaMember cl:OralPersonalAndHomeCareMember 2020-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:AfricaEurasiaMember cl:OralPersonalAndHomeCareMember 2019-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:AfricaEurasiaMember cl:OralPersonalAndHomeCareMember 2018-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:OralPersonalAndHomeCareMember 2020-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:OralPersonalAndHomeCareMember 2019-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:OralPersonalAndHomeCareMember 2018-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:PetNutritionMember 2020-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:PetNutritionMember 2019-12-31 0000021665 us-gaap:OperatingSegmentsMember cl:PetNutritionMember 2018-12-31 0000021665 us-gaap:CorporateNonSegmentMember 2020-12-31 0000021665 us-gaap:CorporateNonSegmentMember 2019-12-31 0000021665 us-gaap:CorporateNonSegmentMember 2018-12-31 0000021665 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0000021665 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-12-31 0000021665 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-12-31 0000021665 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-12-31 0000021665 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-12-31 0000021665 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-12-31 0000021665 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-12-31 0000021665 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-12-31 0000021665 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-12-31 0000021665 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-12-31 0000021665 2020-04-01 2020-06-30 0000021665 2020-07-01 2020-09-30 0000021665 2020-10-01 2020-12-31 0000021665 2019-07-01 2019-09-30 0000021665 cl:GrossProfitMember 2020-01-01 2020-12-31 0000021665 srt:SubsidiariesMember 2020-01-01 2020-12-31 0000021665 cl:GrossProfitMember 2020-01-01 2020-03-31 0000021665 srt:SubsidiariesMember 2020-01-01 2020-03-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2020-07-01 2020-09-30 0000021665 country:BR 2019-01-01 2019-12-31 0000021665 country:CH 2019-01-01 2019-12-31 0000021665 cl:GrossProfitMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-03-31 0000021665 cl:GrossProfitMember cl:GlobalGrowthandEfficiencyProgramMember 2019-04-01 2019-06-30 0000021665 cl:GrossProfitMember cl:GlobalGrowthandEfficiencyProgramMember 2019-07-01 2019-09-30 0000021665 cl:GrossProfitMember cl:GlobalGrowthandEfficiencyProgramMember 2019-10-01 2019-12-31 0000021665 country:BR 2019-10-01 2019-12-31 0000021665 country:CH 2019-10-01 2019-12-31 0000021665 cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember 2019-12-31 0000021665 cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember 2020-01-01 2020-12-31 0000021665 cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember 2020-12-31 0000021665 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-12-31 0000021665 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-01-01 2020-12-31 0000021665 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-12-31 0000021665 cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember 2018-12-31 0000021665 cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember 2019-01-01 2019-12-31 0000021665 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-12-31 0000021665 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-01-01 2019-12-31 0000021665 cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember 2017-12-31 0000021665 cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember 2018-01-01 2018-12-31 0000021665 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-12-31 0000021665 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-01-01 2018-12-31 iso4217:USD shares iso4217:USD shares cl:Dividend cl:business_segment pure iso4217:EUR cl:case cl:country_and_territory cl:plan 0000021665 2020 FY false P3Y us-gaap:OtherAssets us-gaap:OtherAccruedLiabilitiesCurrent us-gaap:OtherLiabilitiesNoncurrent 10-K true 2020-12-31 --12-31 false 1-644 COLGATE-PALMOLIVE COMPANY DE 13-1815595 300 Park Avenue New York, NY 10022 212 310-2000 Common Stock, $1.00 par value CL NYSE 0.000% Notes due 2021 CL21A NYSE 0.500% Notes due 2026 CL26 NYSE 1.375% Notes due 2034 CL34 NYSE 0.875% Notes due 2039 CL39 NYSE Yes No Yes Yes Large Accelerated Filer false false true false 62800000000 848562678 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.393%"><tr><td style="width:1.0%"/><td style="width:57.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Documents</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Form 10-K Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Portions of Proxy Statement for the 2021 Annual Meeting of Stockholders</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part III, Items 10 through 14</span></td></tr></table> -11000000 3000000 16471000000 15693000000 15544000000 6454000000 6368000000 6313000000 10017000000 9325000000 9231000000 6019000000 5575000000 5389000000 -113000000 -196000000 -148000000 3885000000 3554000000 3694000000 74000000 108000000 87000000 164000000 145000000 143000000 3647000000 3301000000 3464000000 787000000 774000000 906000000 2860000000 2527000000 2558000000 165000000 160000000 158000000 2695000000 2367000000 2400000000 3.15 2.76 2.76 3.14 2.75 2.75 2860000000 2527000000 2558000000 -24000000 25000000 -237000000 40000000 100000000 -38000000 -2000000 -12000000 10000000 -66000000 -87000000 -189000000 2794000000 2440000000 2369000000 165000000 160000000 158000000 6000000 -2000000 -19000000 171000000 158000000 139000000 2623000000 2282000000 2230000000 888000000 883000000 89000000 76000000 1264000000 1440000000 1673000000 1400000000 513000000 456000000 4338000000 4179000000 3716000000 3750000000 3824000000 3508000000 2894000000 2667000000 291000000 177000000 857000000 753000000 15920000000 15034000000 258000000 260000000 9000000 254000000 1393000000 1237000000 403000000 370000000 2341000000 1917000000 4404000000 4038000000 7334000000 7333000000 426000000 507000000 2655000000 2598000000 14819000000 14476000000 0 0 1 1 2000000000 2000000000 1465706360 1465706360 1466000000 1466000000 2969000000 2488000000 23699000000 22501000000 -4345000000 -4273000000 1000000 2000000 23045000000 22063000000 743000000 117000000 358000000 441000000 1101000000 558000000 15920000000 15034000000 1466000000 1984000000 -5000000 -20181000000 20531000000 -3855000000 303000000 2400000000 158000000 -170000000 -19000000 1.66 1448000000 143000000 109000000 137000000 190000000 -31000000 31000000 1238000000 -5000000 -2000000 -2000000 -132000000 163000000 1466000000 2204000000 -3000000 -21196000000 21615000000 -4188000000 299000000 2367000000 160000000 -85000000 -2000000 1.71 1472000000 141000000 100000000 210000000 305000000 -29000000 29000000 125000000 1202000000 -3000000 -1000000 -1000000 9000000 1466000000 2488000000 -2000000 -22063000000 22501000000 -4273000000 441000000 2695000000 165000000 -72000000 6000000 1.75 1502000000 152000000 107000000 400000000 462000000 -31000000 31000000 -99000000 1476000000 -5000000 -1000000 -1000000 -5000000 3000000 1466000000 2969000000 -1000000 -23045000000 23699000000 -4345000000 358000000 2 2 2 2860000000 2527000000 2558000000 539000000 519000000 511000000 -71000000 18000000 -7000000 107000000 100000000 109000000 -23000000 0 0 0 0 80000000 -120000000 17000000 27000000 0 113000000 67000000 -138000000 -19000000 79000000 251000000 77000000 58000000 520000000 36000000 18000000 26000000 -87000000 36000000 3719000000 3133000000 3056000000 410000000 335000000 436000000 143000000 184000000 169000000 124000000 131000000 156000000 353000000 1711000000 728000000 -3000000 0 -7000000 -779000000 -2099000000 -1170000000 497000000 294000000 546000000 1061000000 1441000000 725000000 0 2595000000 0 1654000000 1614000000 1591000000 1476000000 1202000000 1238000000 874000000 498000000 329000000 99000000 0 0 -2919000000 -870000000 -2679000000 -16000000 -7000000 -16000000 5000000 157000000 -809000000 883000000 726000000 1535000000 888000000 883000000 726000000 845000000 803000000 847000000 188000000 185000000 194000000 20000000 Nature of Operations    <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manufactures and markets a wide variety of products in the U.S. and around the world in two product segments: Oral, Personal and Home Care; and Pet Nutrition. Oral, Personal and Home Care products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners and other similar items. These products are sold primarily to a variety of traditional and eCommerce retailers, wholesalers and distributors worldwide. Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The principal customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and eCommerce retailers. Principal global and regional trademarks include Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA Skin, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.063%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home Care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 2 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.063%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home Care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 0.44 0.46 0.47 0.21 0.20 0.20 0.18 0.18 0.18 0.17 0.16 0.15 1 1 1 Summary of Significant Accounting Policies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50%, where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2020 and 2019, equity method investments included in Other assets in the Consolidated Balance Sheets were $56 and $50, respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are recorded at cost and periodically adjusted based on observable price changes or quoted market prices in active markets, if applicable. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances, legal and other contingency reserves. Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s revenue contracts represent a single performance obligation to sell its products to trade customers. Sales are recorded at the time control of the products is transferred to trade customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for the products. Control is the ability of trade customers to “direct the use of” and “obtain” the benefit from our products. In evaluating the timing of the transfer of control of products to trade customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are generally recognized when products are delivered to trade customers. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales reflect the transaction prices for contracts, which include units shipped at selling list prices reduced by variable consideration. Variable consideration includes expected sales returns and the cost of current and continuing promotional programs. Current promotional programs primarily include product listing allowances and co-operative advertising arrangements. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements. The cost of promotional programs is estimated using the expected value method considering all reasonably available information, including the Company’s historical experience and its current expectations, and is reflected in the transaction price when sales are recorded. Adjustments to the cost of promotional programs in subsequent periods are generally not material, as the Company’s promotional programs are typically of short duration, thereby reducing the uncertainty inherent in such estimates. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales returns are generally accepted at the Company’s discretion and are not material to the Company’s Consolidated Financial Statements. The Company’s contracts with trade customers do not have significant financing components or non-cash consideration and the Company does not have unbilled revenue or significant amounts of prepayments from customers. The Company records Net sales excluding taxes collected on its sales to its trade customers. Shipping and handling activities are accounted for as contract fulfillment costs and classified as Selling, general and administrative expenses.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs are classified as Selling, general and administrative expenses and were $1,392, $1,275 and $1,255 for the years ended December 31, 2020, 2019 and 2018, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketing Costs</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost of approximately 75% of inventories is determined using the FIFO method, which is stated at the lower of cost or net realizable value. The cost of all other inventories, in the U.S. and Mexico, is determined using the LIFO method, which is stated at the lower of cost or market. Inventories in excess of one year of forecasted sales are classified in the Consolidated Balance Sheets as non-current “Other assets.”</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over-estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and Other Intangibles</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and indefinite-life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually or when events or changes in circumstances indicate that an asset may be impaired. These tests were performed and did not result in an impairment charge. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their estimated useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return. The Company recognizes interest expense and penalties related to unrecognized tax benefits within Provision for income taxes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged. Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7, Fair Value Measurements and Financial Instruments along with the related fair value measurement considerations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units (both performance-based and time-vested), based on the fair value of those awards at the date of grant over the requisite service period. The Company uses the Black-Scholes-Merton (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Black-Scholes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) option pricing model to estimate the fair value of stock option awards. In addition to performance conditions, performance-based restricted stock units also include a total shareholder return modifier. Because the total shareholder return modifier is considered a market condition, the Company uses a Monte-Carlo simulation model to determine the fair value of performance-based restricted stock units. The fair value of time-vested restricted stock units is determined based on the closing market price of the Company’s stock at the date of grant. Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8, Capital Stock and Stock-Based Compensation Plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency Translation</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For subsidiaries operating in highly inflationary environments, local currency-denominated non-monetary assets, including inventories, goodwill and property, plant and equipment, are remeasured at their historical exchange rates, while local currency-denominated monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2021-1, “Reference Rate Reform (Topic 848): Scope” This ASU clarifies that certain optional expedients and exceptions in Topic 848 apply to derivatives that are affected by the discounting transition due to reference rate reform. This guidance was effective upon issuance for the Company and is not expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU No. 2020-10, “Codification Improvements.” This ASU improves the consistency of the codification topics by including all disclosure guidance in the appropriate disclosure section and also clarifies the application of various provisions in the codification. This guidance was effective for the Company beginning on January 1, 2021 and is not expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (“GAAP”) to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This guidance was effective upon issuance of this ASU for contract modifications and hedging relationships on a prospective basis and is not expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-03, “Codification to Financial Instruments.” This ASU improves and clarifies various financial instruments topics, including the current expected credit losses (“CECL”) standard issued in 2016. The ASU addresses seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments related to Issue 1, Issue 2, Issue 4 and Issue 5 were effective upon issuance of this update. The amendments related to Issue 3, Issue 6 and Issue 7 were effective for the Company beginning on January 1, 2020. The guidance did not have a material impact on the Company’s Consolidated Financial Statements. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)-Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This guidance was effective for the Company beginning on January 1, 2021. This guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, “Income taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This guidance was effective for the Company beginning on January 1, 2021. This guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FASB issued ASU No. 2019-11, “Codification Improvements to Topic 326, Financial Instruments - Credit Losses.” This ASU clarifies and addresses certain items related to amendments in ASU 2016-13. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825).” This ASU clarifies three topics related to financial instruments accounting. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU No. 2017-04, “Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate implied fair value, essentially eliminating step two from the goodwill impairment test. The standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard was effective for the Company on a prospective basis beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326).” This ASU introduces the current expected credit loss (CECL) model, which requires an entity to measure credit losses for certain financial instruments and financial assets, including trade receivables. Under this update, on initial recognition and at each reporting period, an entity is required to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. The Company adopted the new standard, which primarily impacts the Company’s trade receivables and related methodology for assessing the collectability of its customer accounts, on January 1, 2020, on a “modified retrospective” basis. The adoption of this ASU did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div>Certain prior year amounts have been reclassified to conform to the current year presentation. Principles of ConsolidationThe Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50%, where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2020 and 2019, equity method investments included in Other assets in the Consolidated Balance Sheets were $56 and $50, respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are recorded at cost and periodically adjusted based on observable price changes or quoted market prices in active markets, if applicable. 0.20 0.50 56000000 50000000 0.20 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances, legal and other contingency reserves. Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s revenue contracts represent a single performance obligation to sell its products to trade customers. Sales are recorded at the time control of the products is transferred to trade customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for the products. Control is the ability of trade customers to “direct the use of” and “obtain” the benefit from our products. In evaluating the timing of the transfer of control of products to trade customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are generally recognized when products are delivered to trade customers. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales reflect the transaction prices for contracts, which include units shipped at selling list prices reduced by variable consideration. Variable consideration includes expected sales returns and the cost of current and continuing promotional programs. Current promotional programs primarily include product listing allowances and co-operative advertising arrangements. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements. The cost of promotional programs is estimated using the expected value method considering all reasonably available information, including the Company’s historical experience and its current expectations, and is reflected in the transaction price when sales are recorded. Adjustments to the cost of promotional programs in subsequent periods are generally not material, as the Company’s promotional programs are typically of short duration, thereby reducing the uncertainty inherent in such estimates. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales returns are generally accepted at the Company’s discretion and are not material to the Company’s Consolidated Financial Statements. The Company’s contracts with trade customers do not have significant financing components or non-cash consideration and the Company does not have unbilled revenue or significant amounts of prepayments from customers. The Company records Net sales excluding taxes collected on its sales to its trade customers. Shipping and handling activities are accounted for as contract fulfillment costs and classified as Selling, general and administrative expenses.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs are classified as Selling, general and administrative expenses and were $1,392, $1,275 and $1,255 for the years ended December 31, 2020, 2019 and 2018, respectively.</span></div> 1392000000 1275000000 1255000000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketing Costs</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost of approximately 75% of inventories is determined using the FIFO method, which is stated at the lower of cost or net realizable value. The cost of all other inventories, in the U.S. and Mexico, is determined using the LIFO method, which is stated at the lower of cost or market. Inventories in excess of one year of forecasted sales are classified in the Consolidated Balance Sheets as non-current “Other assets.”</span></div> 0.75 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over-estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses.</span></div> P3Y P15Y P40Y <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and Other Intangibles</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and indefinite-life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually or when events or changes in circumstances indicate that an asset may be impaired. These tests were performed and did not result in an impairment charge. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their estimated useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit.</span></div> P5Y P40Y <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return. The Company recognizes interest expense and penalties related to unrecognized tax benefits within Provision for income taxes.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged. Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7, Fair Value Measurements and Financial Instruments along with the related fair value measurement considerations.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units (both performance-based and time-vested), based on the fair value of those awards at the date of grant over the requisite service period. The Company uses the Black-Scholes-Merton (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Black-Scholes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) option pricing model to estimate the fair value of stock option awards. In addition to performance conditions, performance-based restricted stock units also include a total shareholder return modifier. Because the total shareholder return modifier is considered a market condition, the Company uses a Monte-Carlo simulation model to determine the fair value of performance-based restricted stock units. The fair value of time-vested restricted stock units is determined based on the closing market price of the Company’s stock at the date of grant. Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8, Capital Stock and Stock-Based Compensation Plans.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency Translation</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year.</span></div>For subsidiaries operating in highly inflationary environments, local currency-denominated non-monetary assets, including inventories, goodwill and property, plant and equipment, are remeasured at their historical exchange rates, while local currency-denominated monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2021-1, “Reference Rate Reform (Topic 848): Scope” This ASU clarifies that certain optional expedients and exceptions in Topic 848 apply to derivatives that are affected by the discounting transition due to reference rate reform. This guidance was effective upon issuance for the Company and is not expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU No. 2020-10, “Codification Improvements.” This ASU improves the consistency of the codification topics by including all disclosure guidance in the appropriate disclosure section and also clarifies the application of various provisions in the codification. This guidance was effective for the Company beginning on January 1, 2021 and is not expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (“GAAP”) to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This guidance was effective upon issuance of this ASU for contract modifications and hedging relationships on a prospective basis and is not expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-03, “Codification to Financial Instruments.” This ASU improves and clarifies various financial instruments topics, including the current expected credit losses (“CECL”) standard issued in 2016. The ASU addresses seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments related to Issue 1, Issue 2, Issue 4 and Issue 5 were effective upon issuance of this update. The amendments related to Issue 3, Issue 6 and Issue 7 were effective for the Company beginning on January 1, 2020. The guidance did not have a material impact on the Company’s Consolidated Financial Statements. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)-Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This guidance was effective for the Company beginning on January 1, 2021. This guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, “Income taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This guidance was effective for the Company beginning on January 1, 2021. This guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FASB issued ASU No. 2019-11, “Codification Improvements to Topic 326, Financial Instruments - Credit Losses.” This ASU clarifies and addresses certain items related to amendments in ASU 2016-13. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825).” This ASU clarifies three topics related to financial instruments accounting. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU No. 2017-04, “Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate implied fair value, essentially eliminating step two from the goodwill impairment test. The standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard was effective for the Company on a prospective basis beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326).” This ASU introduces the current expected credit loss (CECL) model, which requires an entity to measure credit losses for certain financial instruments and financial assets, including trade receivables. Under this update, on initial recognition and at each reporting period, an entity is required to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. The Company adopted the new standard, which primarily impacts the Company’s trade receivables and related methodology for assessing the collectability of its customer accounts, on January 1, 2020, on a “modified retrospective” basis. The adoption of this ASU did not have a material impact on the Company’s Consolidated Financial Statements.</span></div> ReclassificationsCertain prior year amounts have been reclassified to conform to the current year presentation. Acquisitions<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hello Products LLC (“hello”)</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2020, the Company acquired hello, an oral care business, for cash consideration of $351. The acquisition was financed with a combination of debt and cash. This acquisition is part of the Company’s strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price consideration of $351 has been allocated to the net assets acquired based on their respective estimated fair values as follows:</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.545%"><tr><td style="width:1.0%"/><td style="width:87.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets acquired include trademarks, valued at $115, which are considered to have a finite useful life of 25 years, and customer relationships valued at $45, which are considered to have a finite useful life of 17 years. Goodwill of $171 was allocated to the North America segment. The Company expects that goodwill will be deductible for tax purposes.</span></div><div style="padding-left:18pt;text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma results of operations have not been presented as the impact on the Company’s Consolidated Financial Statements is not material.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Laboratoires Filorga Cosmétiques (“Filorga”)</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 19, 2019, the Company acquired the Filorga skin health business for cash consideration of €1,516 (approximately $1,674), which included interest on the equity purchase price plus additional consideration of €32 (approximately $38), the majority of which related to repayment of loans from former shareholders of Filorga. Filorga is a premium anti-aging skin health brand focused primarily on facial care. This acquisition is part of the Company’s strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses, including by expanding its portfolio in premium skin health. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price consideration of $1,712 has been allocated to the net assets acquired based on their respective estimated fair values as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.363%"><tr><td style="width:1.0%"/><td style="width:87.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.693%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,712 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets acquired include trademarks of $774, which are considered to have an indefinite useful life, and customer relationships of $277, which are considered to have a finite useful life of 14 years. Goodwill of $923 was allocated to the Europe segment. Goodwill will not be deductible for tax purposes.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2020, the Company completed the purchase of the outstanding non-controlling interest of Filorga’s joint venture based in Hong Kong and covering the Hong Kong and China markets for approximately €85 (approximately $99) in cash.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     The results of operations of Filorga are reported on a lag basis. As such, Filorga’s results of operations from December 1, 2019 through November 30, 2020 and from the Acquisition Date through November 30, 2019 are included in the Company’s Consolidated Results of Operations for the periods ended December 31, 2020 and 2019, respectively.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma results of operations have not been presented as the impact on the Company’s Consolidated Financial Statements is not material. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nigeria Joint Venture</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 15, 2019, the Company acquired a 51% controlling interest in Colgate Tolaram Pte. Ltd., a joint venture which owns the Nigeria-based Hypo Homecare Products Limited, for $31. </span></div>Pro forma results of operations have not been presented as the impact on the Company’s Consolidated Financial Statements is not material. 351000000 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price consideration of $351 has been allocated to the net assets acquired based on their respective estimated fair values as follows:</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.545%"><tr><td style="width:1.0%"/><td style="width:87.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price consideration of $1,712 has been allocated to the net assets acquired based on their respective estimated fair values as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.363%"><tr><td style="width:1.0%"/><td style="width:87.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.693%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,712 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 351000000 11000000 13000000 4000000 160000000 171000000 351000000 115000000 P25Y 45000000 P17Y 171000000 1516000000 1674000000 32000000 38000000 1712000000 30000000 53000000 70000000 18000000 1051000000 923000000 67000000 276000000 90000000 1712000000 774000000 277000000 P14Y 923000000 85000000 99000000 0.51 31000000 Restructuring and Related Implementation Charges <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s restructuring program (the “Global Growth and Efficiency Program”), which commenced in the fourth quarter of 2012, concluded on December 31, 2019. Initiatives under the Global Growth and Efficiency Program fit within the program’s three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions and optimizing the global supply chain and facilities. Substantially all initiatives under the Global Growth and Efficiency Program had been implemented as of December 31, 2019.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2020, the Company adjusted the accrual balances related to certain projects approved prior to the conclusion of the Global Growth and Efficiency Program to reflect its revised estimate of remaining liabilities. This adjustment resulted in a reduction of $16 ($13 aftertax), of which $3 was recorded in Selling, general and administrative expenses and $13 was recorded in Other (income) expense, net. During the year ended December 31, 2020, the Company also made cash payments of $53 related to projects approved prior to the conclusion of the Global Growth and Efficiency Program, and the remaining accrual balance at December 31, 2020 was $31. No new restructuring projects were approved for implementation during the year ended December 31, 2020.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2019 and 2018, restructuring and related implementation charges are reflected in the Consolidated Statements of Income as follows:  </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.636%"><tr><td style="width:1.0%"/><td style="width:70.635%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.264%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-service related postretirement costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Global Growth and Efficiency Program charges, pretax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Global Growth and Efficiency Program charges, aftertax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and related implementation charges in the preceding table and the adjustment recorded in the third quarter of 2020 were recorded in the Corporate segment as these initiatives were predominantly centrally directed and controlled and were not included in internal measures of segment operating performance.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total charges incurred for the Global Growth and Efficiency Program related to initiatives undertaken by the following reportable operating segments:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Program</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">’</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">s Pet Nutrition</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the course of the Global Growth and Efficiency Program, the Company incurred total pretax charges of $1,854 ($1,380 aftertax) in connection with the implementation of various projects as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.242%"><tr><td style="width:1.0%"/><td style="width:73.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Program Charges</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">as of December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee-Related Costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental Depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset Impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,854 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the course of the Global Growth and Efficiency Program, the majority of the costs incurred related to the following projects: the implementation of the Company’s overall hubbing strategy; the consolidation of facilities; the extension of shared business services and streamlining of global functions; the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; redesigning the European commercial organization; restructuring how the Company will provide future retirement benefits to substantially all of the U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan; and the implementation of a Corporate efficiencies program. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for the restructuring and related implementation charges for the years ended December 31, 2019 and 2018 and the related accruals:</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.238%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee-Related</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental<br/>Depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges against assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges against assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee-Related Costs primarily included severance and other termination benefits and were calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also included pension and other retiree benefit enhancements amounting to $7 and $9 for the years ended December 31, 2019 and 2018, respectively, which are reflected as Charges against assets within Employee-Related Costs in the preceding table as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities. See Note 10, Retirement Plans and Other Retiree Benefits for additional information. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental Depreciation was recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments were recorded to write down inventories and assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other charges consisted primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the Global Growth and Efficiency Program. These charges for the years ended December 31, 2019 and 2018 included third-party incremental costs related to the development and implementation of new business and strategic initiatives of $32 and $42, respectively, and contract termination costs and charges resulting directly from exit activities of $5 and $48, respectively. These charges were expensed as incurred. Also included in Other charges for the year ended December 31, 2019 were other exit costs of $28 related to the consolidation of facilities. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other decreases to the restructuring accruals reflect the reclassification of restructuring accruals to lease assets as a result of the Company’s adoption of ASU No. 2018-10, “Codification Improvement to Topic 842, Leases,” on January 1, 2019.</span></div> 16000000 13000000 3000000 13000000 53000000 31000000 0 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2019 and 2018, restructuring and related implementation charges are reflected in the Consolidated Statements of Income as follows:  </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.636%"><tr><td style="width:1.0%"/><td style="width:70.635%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.264%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-service related postretirement costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Global Growth and Efficiency Program charges, pretax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Global Growth and Efficiency Program charges, aftertax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 8000000 31000000 60000000 33000000 57000000 88000000 7000000 9000000 132000000 161000000 102000000 125000000 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total charges incurred for the Global Growth and Efficiency Program related to initiatives undertaken by the following reportable operating segments:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Program</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">’</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">s Pet Nutrition</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 0.04 0.18 0.17 0.12 0.10 0.05 0.04 -0.02 0.19 0.06 0.13 0.04 -0.01 0.05 0.05 0.02 0.19 0.08 0.73 0.37 0.42 1 1 1 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the course of the Global Growth and Efficiency Program, the Company incurred total pretax charges of $1,854 ($1,380 aftertax) in connection with the implementation of various projects as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.242%"><tr><td style="width:1.0%"/><td style="width:73.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Program Charges</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">as of December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee-Related Costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental Depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset Impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,854 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1854000000 1380000000 706000000 128000000 58000000 962000000 1854000000 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for the restructuring and related implementation charges for the years ended December 31, 2019 and 2018 and the related accruals:</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.238%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee-Related</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental<br/>Depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges against assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges against assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 127000000 0 0 107000000 234000000 53000000 2000000 16000000 90000000 161000000 107000000 0 0 60000000 167000000 9000000 2000000 16000000 0 27000000 4000000 0 0 0 4000000 0 0 0 5000000 5000000 60000000 0 0 142000000 202000000 25000000 36000000 6000000 65000000 132000000 55000000 0 0 58000000 113000000 7000000 36000000 6000000 27000000 76000000 -3000000 0 0 0 -3000000 0 0 0 -48000000 -48000000 26000000 0 0 74000000 100000000 7000000 9000000 32000000 42000000 5000000 48000000 28000000 Goodwill and Other Intangible Assets<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net carrying value of Goodwill as of December 31, 2020 and 2019 by segment was as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.024%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral, Personal and Home Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">737 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,234 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,809 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,824 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,508 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the amount of Goodwill during 2020 is primarily due to the acquisition of hello (see Note 3, Acquisitions for further information) and the impact of foreign currency translation. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets as of December 31, 2020 and 2019 were comprised of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.991%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.868%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.858%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks - finite life</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">771 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(381)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other finite life intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite life intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,865 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,865 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,553 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(659)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,894 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,217 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(550)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,667 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the net carrying amounts of Other intangible assets during 2020 was primarily due to the acquisition of hello (see Note 3, Acquisitions for further information) and amortization expense of $88. Annual estimated amortization expense for each of the next five years is expected to be approximately $83. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the COVID-19 pandemic, in the first quarter of 2020, the Company assessed whether a “triggering event” had occurred indicating a possible impairment of its goodwill and indefinite-life intangible assets. As a result of this assessment, the Company determined that a “triggering event” had occurred relative to its recently acquired Filorga skin health business and, as required, performed a quantitative analysis, with the assistance of a third-party valuation firm, of the value of the Filorga reporting unit and its indefinite-life intangible assets. Based on the analysis, the Company determined that the fair value of the Filorga reporting unit and the related indefinite-life intangible assets continued to exceed their carrying values and were not impaired. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of the annual goodwill impairment test, the fair value of the Filorga reporting unit exceeded its carrying value by approximately 10%. Either a reduction in the long-term growth rate of 50 basis points or an increase in the discount rate of 25 basis points would result in the fair value of the Filorga reporting unit exceeding its carrying value by less than 5%. As of the date of the annual impairment test, the fair value of the Filorga indefinite-life intangible assets exceeded their carrying value by less than 10%. Either a reduction in the long-term growth rate of 50 basis points or an increase in the discount rate of 25 basis points would result in the fair value of the Filorga indefinite-life intangible assets approximating their carrying value. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Determining the fair value of the Filorga reporting unit and indefinite-life intangible assets requires significant judgments and estimates by management regarding several key inputs, including future cash flows consistent with management’s strategic plans, sales growth rates and the selection of royalty rates and a discount rate, among others. Estimating sales growth rates requires significant judgment by management in areas such as future economic conditions, category and industry growth rates, product pricing, consumer tastes and preferences and future expansion expectations.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the inherent uncertainties in estimating the future impacts of the COVID-19 pandemic on global macroeconomic conditions and interest rates in general and on the Filorga business in particular, actual results may differ from management’s current estimates and could have an adverse impact on one or more of the assumptions used in our quantitative models related to the Filorga reporting unit and the related indefinite-life intangible assets, resulting in potential impairment charges in subsequent periods. Given the recent acquisition of Filorga, where there is inherently a lower surplus of fair value over carrying value, management will continue to assess triggering events that may necessitate additional qualitative or quantitative analyses of our reporting units and indefinite-life intangible assets in future periods.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for the recently acquired Filorga business, as described above, where there is inherently a lower surplus of fair value over carrying value, the estimated fair value of the Company’s reporting units substantially exceeds the recorded carrying value. The fair value of the Company’s indefinite-life intangible assets other than Filorga exceeds their recorded carrying value by at least 20%. Therefore, it is not reasonably likely that significant changes in these estimates would occur that would result in an impairment charge related to these assets.</span></div> <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net carrying value of Goodwill as of December 31, 2020 and 2019 by segment was as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.024%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral, Personal and Home Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">737 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,234 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,809 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,824 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,508 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 912000000 737000000 171000000 212000000 2415000000 2234000000 190000000 186000000 121000000 124000000 3809000000 3493000000 15000000 15000000 3824000000 3508000000 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets as of December 31, 2020 and 2019 were comprised of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.991%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.868%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.858%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks - finite life</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">771 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(381)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other finite life intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite life intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,865 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,865 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,553 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(659)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,894 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,217 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(550)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,667 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 902000000 422000000 480000000 771000000 381000000 390000000 786000000 237000000 549000000 699000000 169000000 530000000 1865000000 1865000000 1747000000 1747000000 3553000000 659000000 2894000000 3217000000 550000000 2667000000 88000000 83000000 83000000 83000000 83000000 83000000 0.10 0.0050 0.0025 0.05 0.10 0.0050 0.0025 0.20 Long-Term Debt and Credit Facilities<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following at December 31:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:52.314%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.165%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.211%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.013%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.252%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2078</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,170 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,988 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,139 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,343 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,587 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,334 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,333 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average interest rate on short-term borrowings included in Notes and loans payable in the Consolidated Balance Sheets as of December 31, 2020 and 2019 was 4.8% and 1.8%, respectively. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies commercial paper and notes maturing within the next twelve months as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis. Excluding such obligations, scheduled maturities of long-term debt and finance leases outstanding as of December 31, 2020, were as follows:  </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.204%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021<br/></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into interest rate swap agreements and foreign exchange contracts related to certain of these debt instruments. See Note 7, Fair Value Measurements and Financial Instruments for further information about the Company’s financial instruments.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s debt issuances and redemptions support its capital structure strategy objectives of funding its business and growth initiatives while minimizing its risk-adjusted cost of capital. During the first quarter of 2019, the Company issued €500 of seven-year notes at a fixed coupon rate of 0.500% and €500 of fifteen-year notes at a fixed coupon rate of 1.375%. During the fourth quarter of 2019, the Company issued €500 of two-year notes at a fixed coupon rate of 0.000% and €500 of twenty-year notes at a fixed coupon rate of 0.875%. The debt issuances were under the Company’s shelf registration statement. Proceeds from the debt issuances were used for general corporate purposes, which included the retirement of commercial paper and, in the case of the debt issuances in the first quarter of 2019, the repayment of the Company’s $500 1.750% fixed rate notes, which became due in March 2019, and €500 floating rate notes, which became due in May 2019.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company redeemed prior to maturity all of its outstanding 2.450% notes due 2021 with a principal amount $300, originally issued on November 8, 2011, and all of its outstanding 2.300% notes due 2022 with a principal amount of $500, originally issued on May 3, 2012. These redemptions were financed with commercial paper borrowings and cash. The Company recorded a loss on the early extinguishment of debt of $23, which is included in Interest (income) expense, net in the Consolidated Statements of Income, representing the difference between the redemption price and the carrying amount of the debt extinguished. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, the Company had access to unused domestic and foreign lines of credit of $4,657 (including under the facilities discussed below) and could also issue long-term debt pursuant to an effective shelf registration statement. In November 2018, the Company entered into an amended and restated $2,650 revolving credit facility with a syndicate of banks that was scheduled to expire in November 2023. In August 2019, the term of the facility was extended by one year and it now expires in November 2024. In August 2020, the Company entered into a $1,500 364-day credit facility with a syndicate of banks that is scheduled to expire in August 2021. Commitment fees related to the credit facilities are not material.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote.</span></div> <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following at December 31:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:52.314%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.165%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.211%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.013%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.252%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2078</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,170 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,988 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,139 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,343 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,587 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,334 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,333 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0.019 6170000000 6988000000 -0.003 1139000000 579000000 34000000 20000000 7343000000 7587000000 9000000 254000000 7334000000 7333000000 0.048 0.018 Excluding such obligations, scheduled maturities of long-term debt and finance leases outstanding as of December 31, 2020, were as follows:  <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.204%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021<br/></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 631000000 413000000 896000000 498000000 130000000 3636000000 500000000 P7Y 0.00500 500000000 P15Y 0.01375 500000000 P2Y 0.00000 500000000 P20Y 0.00875 500000000 0.01750 500000000 0.02450 300000000 0.02300 500000000 -23000000 4657000000 2650000000 P1Y 1500000000 P364D Fair Value Measurements and Financial Instruments <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Provided below are details of the Company’s exposures by type of risk and derivative instruments by type of hedge designation.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation Considerations</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s derivative instruments include interest rate swap contracts, forward-starting interest rate swaps, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are classified as follows:</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Based upon quoted market prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Based upon observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Based upon unobservable inputs reflecting the reporting entity’s own assumptions.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Risk</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company markets its products in over 200 countries and territories, it is exposed to currency fluctuations related to manufacturing and selling its products in currencies other than the U.S. dollar. The Company manages its foreign currency exposures through a combination of cost containment measures, sourcing strategies, selling price increases and the hedging of certain costs in an effort to minimize the impact on earnings of foreign currency rate movements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company primarily utilizes foreign currency contracts, including forward and swap contracts, option contracts, foreign and local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. The duration of foreign currency contracts generally does not exceed 12 months and the contracts are valued using observable market rates (Level 2 valuation).</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its targeted mix of fixed and floating rate debt with debt issuances and by entering into interest rate swaps in order to mitigate fluctuations in earnings and cash flows that may result from interest rate volatility. The Company utilizes forward-starting interest rate swaps to mitigate the risk of variability in interest rate for future debt issuances. The notional amount, interest payment and maturity date of the swaps generally match the principal, interest payment and maturity date of the related debt, and the swaps are valued using observable benchmark rates (Level 2 valuation).</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commodity Price Risk</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to price volatility related to raw materials used in production, such as essential oils, resins, pulp, tropical oils, tallow, corn, poultry and soybeans. The Company manages its raw material exposures through a combination of cost containment measures, sourcing strategies, ongoing productivity initiatives and the limited use of commodity hedging contracts. Futures contracts are used on a limited basis, primarily in the Hill’s Pet Nutrition segment, to manage volatility related to raw material inventory purchases of certain traded commodities, and these contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of the commodity contracts generally does not exceed 12 months.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Risk</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material as it is the Company’s policy to contract with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets as of December 31, 2020 and December 31, 2019:</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.057%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 10pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 10pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Account</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Account</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated derivative instruments</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total designated</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other financial instruments</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total other financial instruments</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of December 31, 2020 and 2019. The estimated fair value of the Company’s long-term debt, including the current portion, as of December 31, 2020 and 2019, was $8,175 and $8,056, respectively, and the related carrying value was $7,343 and $7,587, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts were recorded on the Consolidated Balance Sheet related to cumulative basis adjustment for fair value hedges as of:</span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of hedged item</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative hedging adjustment included in the carrying amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the notional values as of:</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.663%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign<br/>Currency<br/>Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Currency Debt</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-Starting Interest Rate Swaps</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> <br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Hedges </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow Hedges </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Investment Hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,051 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.663%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign<br/>Currency<br/>Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Currency Debt</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-Starting Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> <br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Hedges </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow Hedges </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Investment Hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,856 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and amount of gains (losses) on hedges recognized on the Company’s Consolidated Statements of Income:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on hedges recognized in income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate swaps designated as fair value hedges:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instrument</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency contracts designated as fair value hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instrument</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency contracts designated as cash flow hedges: </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from OCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commodity contracts designated as cash flow hedges:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from OCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total gain (loss) on hedges recognized in income</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and amount of unrealized gains (losses) on hedges included in OCI:</span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.363%"><tr><td style="width:1.0%"/><td style="width:57.862%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.396%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.686%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.556%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Twelve Months Ended</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward-starting interest rate swaps designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commodity contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency contracts designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on instruments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on hedged items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency debt designated as net investment hedges:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on hedged items</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total unrealized gain (loss) on hedges recognized in OCI</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 200 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets as of December 31, 2020 and December 31, 2019:</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.057%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 10pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 10pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Account</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Account</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated derivative instruments</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total designated</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other financial instruments</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total other financial instruments</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div> 14000000 4000000 0 0 5000000 0 0 0 7000000 6000000 93000000 15000000 0 0 0 14000000 3000000 0 0 0 29000000 10000000 93000000 29000000 37000000 23000000 37000000 23000000 8175000000 8056000000 7343000000 7587000000 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts were recorded on the Consolidated Balance Sheet related to cumulative basis adjustment for fair value hedges as of:</span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of hedged item</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative hedging adjustment included in the carrying amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 413000000 403000000 14000000 4000000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the notional values as of:</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.663%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign<br/>Currency<br/>Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Currency Debt</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-Starting Interest Rate Swaps</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> <br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Hedges </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow Hedges </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Investment Hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,051 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.663%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign<br/>Currency<br/>Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Currency Debt</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-Starting Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> <br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Hedges </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow Hedges </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Investment Hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,856 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 589000000 0 400000000 0 0 989000000 854000000 0 0 300000000 17000000 1171000000 528000000 4523000000 0 0 0 5051000000 388000000 0 400000000 0 0 788000000 761000000 0 0 0 20000000 781000000 478000000 3856000000 0 0 0 4334000000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and amount of gains (losses) on hedges recognized on the Company’s Consolidated Statements of Income:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on hedges recognized in income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate swaps designated as fair value hedges:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instrument</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency contracts designated as fair value hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instrument</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency contracts designated as cash flow hedges: </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from OCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commodity contracts designated as cash flow hedges:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from OCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total gain (loss) on hedges recognized in income</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 0 -10000000 0 0 -11000000 0 0 10000000 0 0 11000000 0 29000000 0 0 10000000 0 0 -29000000 0 0 -10000000 0 1000000 0 0 5000000 0 0 -1000000 0 0 1000000 0 0 0 0 0 6000000 0 0 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and amount of unrealized gains (losses) on hedges included in OCI:</span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.363%"><tr><td style="width:1.0%"/><td style="width:57.862%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.396%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.686%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.556%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Twelve Months Ended</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward-starting interest rate swaps designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commodity contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency contracts designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on instruments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on hedged items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency debt designated as net investment hedges:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on hedged items</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total unrealized gain (loss) on hedges recognized in OCI</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -11000000 -9000000 5000000 0 3000000 0 -52000000 4000000 52000000 -4000000 -356000000 12000000 356000000 -12000000 -3000000 -9000000 Capital Stock and Stock-Based Compensation Plans<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preference Stock</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has the authority to issue 50,262,150 shares of preference stock. </span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchases</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 18, 2018, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2018 Program”), which replaced a previously authorized share repurchase program. The Company commenced repurchases of shares of the Company’s common stock under the 2018 Program beginning June 19, 2018. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors. The Company repurchased its common stock at a cost of $1,476 during 2020 under the 2018 Program.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may use either authorized and unissued shares or treasury shares to meet share requirements resulting from the exercise of stock options and the vesting of restricted stock unit awards.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of common stock and treasury stock activity for the three years ended December 31 is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:71.889%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.649%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874,701,118 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591,005,242 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,786,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,786,897 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,040,920 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,040,920)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for restricted stock units and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957,651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(957,651)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862,912,792 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602,793,568 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,219,642)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,219,642 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,145,777 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,145,777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for restricted stock units and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862,852 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(862,852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854,701,779 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611,004,581 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,701,843)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,701,843 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,018,354 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,018,354)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for restricted stock units and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(875,311)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849,893,601 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615,812,759 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units, based on the fair value of those awards at the date of grant. The fair value of restricted stock units, generally based on market prices, is amortized on a straight-line basis over the requisite service period. The estimated fair value of stock options on the date of grant is amortized on a straight-line basis over the requisite service period for each separately vesting portion of the award. Awards to employees eligible for retirement prior to the award becoming fully vested are recognized as compensation cost from the grant date through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has one incentive compensation plan pursuant to which it issues restricted stock units (both performance-based and time-vested) and stock options to employees and shares of common stock and stock options to non-employee directors. The Personnel and Organization Committee of the Board of Directors, which is comprised entirely of independent directors, administers the incentive compensation plan. The total stock-based compensation expense charged against pretax income for this plan was $107, $100 and $109 for the years ended December 31, 2020, 2019 and 2018, respectively. The total income tax benefit recognized on stock-based compensation, excluding excess tax benefits discussed below, was approximately $20, $20 and $25 for the years ended December 31, 2020, 2019 and 2018, respectively.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense is recorded within Selling, general and administrative expenses in the Corporate segment as these amounts are not included in internal measures of segment operating performance.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes option pricing model to estimate the fair value of stock option awards. The weighted-average estimated fair value of stock options granted in the years ended December 31, 2020, 2019 and 2018 was $11.26, $10.48 and $9.48, respectively. Fair value is estimated using the Black-Scholes option pricing model with the assumptions summarized in the following table:</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:63.088%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.284%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term of options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average expected term of options granted each year was determined with reference to historical exercise and post-vesting cancellation experience, the vesting period of the awards and the contractual term of the awards, among other factors. Expected volatility incorporates implied share-price volatility derived from exchange traded options on the Company’s common stock. The risk-free interest rate for the expected term of the option is based on the yield of a zero-coupon U.S. Treasury bond with a maturity period equal to the option’s expected term.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance-based Restricted Stock Units</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company evolved its approach to granting long-term incentive compensation from granting time-vested restricted stock units following the conclusion of a three-year performance cycle to granting officers and other key employees a target number of unearned performance-based restricted stock units at the beginning of each three-year performance cycle. Awards are earned and vest following the conclusion of the performance period on the basis of achievement of performance goals established at the commencement of each three-year performance period.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of performance-based restricted stock unit activity for the year ended December 31, 2020 is presented below:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:62.784%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.781%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value Per Award</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance-based restricted stock units as of January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance-based restricted stock units as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">865 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, there was $41 of total unrecognized compensation expense related to unvested performance-based restricted stock unit awards, which will be recognized ratably over the remaining performance period.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a Monte-Carlo simulation model to estimate the fair value of performance-based restricted stock units at the date of grant.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Time-Vested Restricted Stock Units</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also grants time-vested restricted stock unit awards. As described above, under the Company’s previous long-term incentive program, time-vested restricted stock unit awards were granted to officers and other key employees following a three-year performance period. Awards vest at the end of the restriction period, which is three years from the date of grant. The most recent award granted under the previous long-term incentive program was in 2018 for the 2015-2017 performance period. No awards were granted for the 2016-2018 or 2017-2019 performance periods. Awards for the 2018-2020 performance period will be granted in 2021. As of December 31, 2020, approximately 12,420,000 shares of common stock were available for future restricted stock unit awards.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of restricted stock unit activity during 2020 is presented below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:62.784%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.781%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value Per Award</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units as of January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,737 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, there was $58 of total unrecognized compensation expense related to unvested restricted stock unit awards, which will be recognized over a weighted-average period of 2.1 years. The total fair value of restricted stock units vested during the years ended December 31, 2020, 2019 and 2018 was $58, $53 and $55, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issues non-qualified stock options to non-employee directors, officers and other employees. Beginning in 2019, stock options have a contractual term of eight years. Prior to 2019, stock options generally had a contractual term of six years. Stock options generally vest ratably over three years. As of December 31, 2020, approximately 36,144,000 shares of common stock were available for future stock option grants. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity during 2020 is presented below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.696%"><tr><td style="width:1.0%"/><td style="width:38.565%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.623%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.623%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.641%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.623%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.495%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic Value of Unexercised <br/>In-the-Money Options</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,185 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,976 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,019)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,541 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable, December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,084 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, there was $32 of total unrecognized compensation expense related to unvested options, which will be recognized over a weighted-average period of 1.5 years. The total intrinsic value of options exercised during the years ended December 31, 2020, 2019 and 2018 was $136, $84 and $92, respectively.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The benefits of tax deductions in excess of grant date fair value resulting from the exercise of stock options and vesting of restricted stock unit awards for the years ended December 31, 2020, 2019 and 2018 were $8, $6 and $12, respectively, and are recognized in the provision for income taxes as a discrete item in the quarterly period in which they occur and classified as an operating cash flow. Cash proceeds received from options exercised for the years ended December 31, 2020, 2019 and 2018 were $874, $498 and $329, respectively.</span></div> 50262150 5000000000 1476000000 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of common stock and treasury stock activity for the three years ended December 31 is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:71.889%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.649%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874,701,118 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591,005,242 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,786,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,786,897 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,040,920 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,040,920)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for restricted stock units and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957,651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(957,651)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862,912,792 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602,793,568 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,219,642)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,219,642 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,145,777 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,145,777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for restricted stock units and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862,852 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(862,852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854,701,779 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611,004,581 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,701,843)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,701,843 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,018,354 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,018,354)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for restricted stock units and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(875,311)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849,893,601 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615,812,759 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 874701118 591005242 18786897 18786897 6040920 6040920 957651 957651 862912792 602793568 17219642 17219642 8145777 8145777 862852 862852 854701779 611004581 18701843 18701843 13018354 13018354 875311 875311 849893601 615812759 1 107000000 100000000 109000000 20000000 20000000 25000000 11.26 10.48 9.48 Fair value is estimated using the Black-Scholes option pricing model with the assumptions summarized in the following table:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:63.088%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.284%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term of options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table> P6Y P6Y P4Y6M 0.218 0.192 0.177 0.005 0.015 0.028 0.023 0.023 0.025 P3Y P3Y P3Y <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of performance-based restricted stock unit activity for the year ended December 31, 2020 is presented below:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:62.784%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.781%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value Per Award</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance-based restricted stock units as of January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance-based restricted stock units as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">865 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of restricted stock unit activity during 2020 is presented below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:62.784%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.781%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value Per Award</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units as of January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,737 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 346000 67 557000 76 38000 69 865000 73 41000000 P3Y P3Y 12420000 2203000 71 727000 77 1130000 74 63000 71 1737000 73 58000000 P2Y1M6D 58000000 53000000 55000000 P8Y P6Y P3Y 36144000 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity during 2020 is presented below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.696%"><tr><td style="width:1.0%"/><td style="width:38.565%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.623%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.623%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.641%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.623%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.495%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic Value of Unexercised <br/>In-the-Money Options</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,185 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,976 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,019)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,541 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable, December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,084 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 36185000 69 4976000 76 13019000 67 601000 72 27541000 72 P4Y 386000000 18084000 70 P3Y 274000000 32000000 P1Y6M 136000000 84000000 92000000 8000000 6000000 12000000 874000000 498000000 329000000 Employee Stock Ownership Plan<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1989, the Company expanded its Employee Stock Ownership Plan (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ESOP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) through the introduction of a leveraged ESOP that funds certain benefits for employees who have met eligibility requirements. As of December 31, 2020 and 2019, there were 11,545,950 and 13,359,448 shares of common stock, respectively, outstanding and issued to the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">’</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s ESOP. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2000, the ESOP entered into a loan agreement with the Company under which the benefits of the ESOP may be extended through 2035. As of December 31, 2020, the ESOP had outstanding borrowings from the Company of $1, which represents unearned compensation shown as a reduction in Shareholders’ equity.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends on stock held by the ESOP are paid to the ESOP trust and, together with cash contributions from the Company, are (a) used by the ESOP to repay principal and interest, (b) credited to participant accounts or (c) used for contributions to the Company’s defined contribution plans. Stock is allocated to participants based upon the ratio of the current year’s debt service to the sum of total outstanding principal and interest payments over the life of the debt. As of December 31, 2020, 10,454,105 shares of common stock had been released and allocated to participant accounts and 1,091,845 shares of common stock were available for future allocation to participant accounts. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends on the stock used to repay principal and interest or credited to participant accounts are deductible for income tax purposes and, accordingly, are reflected net of their tax benefit in the Consolidated Statements of Changes in Shareholders’ Equity.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual expense related to the ESOP was $0 in 2020, 2019 and 2018. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company paid dividends on the shares held by the ESOP of $23 in 2020, $25 in 2019 and $29 in 2018. The Company did not make any contributions to the ESOP in 2020, 2019 or 2018.</span></div> 11545950 13359448 1000000 10454105 1091845 0 0 0 23000000 25000000 29000000 0 0 0 Retirement Plans and Other Retiree Benefits<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retirement Plans</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and certain of its U.S. and foreign subsidiaries maintain defined benefit retirement plans. Benefits under these plans are based primarily on years of service and employees’ earnings.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., effective January 1, 2014, the Company provides virtually all future retirement benefits through the Company’s defined contribution plan. As a result, service after December 31, 2013 is not considered for participants in the Company’s principal U.S. defined benefit retirement plan. Participants in the Company’s principal U.S. defined benefit retirement plan whose retirement benefit was determined under the cash balance formula continue to earn interest credits on their vested balances as of December 31, 2013 but no longer receive pay credits. Participants whose retirement benefit was determined under the final average earnings formula or career average earnings formula continue to have their accrued benefit adjusted for pay increases until termination of employment. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Company’s principal U.S. plans and certain funded foreign plans, funds are contributed to trusts in accordance with regulatory limits to provide for current service and for any unfunded projected benefit obligation over a reasonable period. The target asset allocation for the Company’s defined benefit plans is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:71.737%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.405%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate and other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:46.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.804%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level of Valuation<br/>Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Retiree<br/>Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. common stocks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International common stocks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pooled funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guaranteed investment contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments valued using NAV per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic, developed and emerging markets equity funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedge funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-asset funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At December 31, 2019, the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.696%"><tr><td style="width:1.0%"/><td style="width:46.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.210%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.210%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level of Valuation<br/>Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Retiree<br/>Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. common stocks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International common stocks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pooled funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guaranteed investment contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments valued using NAV per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic, developed and emerging markets equity funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedge funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-asset funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,806 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Pooled funds primarily invest in U.S. and foreign equity securities, debt and money market securities. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">The fixed income securities are traded over-the-counter and certain of these securities lack daily pricing or liquidity and as such are classified as Level 2. As of both December 31, 2020 and 2019, approximately 50% of the U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in other government bonds and corporate bonds.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">The guaranteed investment contracts (“GICs”) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Investments that are measured at fair value using net asset value (“NAV”) per share as a practical expedient have not been classified in the fair value hierarchy. The NAV is based on the value of the underlying investments owned, minus its liabilities, divided by the number of shares outstanding. There are no unfunded commitments related to these investments. Redemption notice period primarily ranges from 0-3 months and redemption frequency windows range from daily to quarterly.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Fixed income funds primarily invest in U.S. government and investment grade corporate bonds.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Consists of investments in underlying hedge fund strategies that are primarily implemented through the use of long and short equity and fixed income securities and derivative instruments such as futures and options.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Multi-asset funds primarily invest across a variety of asset classes, including global stocks and bonds, as well as alternative strategies.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">This category primarily includes unsettled trades for investments purchased and sold and dividend receivables. </span></div><div style="margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities in the U.S. plans include investments in the Company’s common stock representing 0% and 3% of U.S. plan assets at December 31, 2020 and December 31, 2019, respectively. In 2020 and 2019, the U.S. plans sold 739,869 and 588,334 shares, respectively, of the Company’s common stock to the Company. No shares of the Company’s stock were purchased by the U.S. plans in 2020 or 2019. The plans received dividends on the Company’s common stock of $0 in 2020 and $2 in 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Retiree Benefits</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and certain of its subsidiaries provide health care and life insurance benefits for retired employees to the extent not provided by government-sponsored plans.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a December 31 measurement date for its defined benefit and other retiree benefit plans. Summarized information for the Company’s defined benefit and other retiree benefit plans is as follows:</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.818%"><tr><td style="width:1.0%"/><td style="width:48.978%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.255%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.037%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.512%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Retiree Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Benefit Obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants’ contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions/plan amendments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss (gain)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailments and settlements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations at end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,363 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,806 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,568 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants’ contributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements and acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,806 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded Status</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations at end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,363 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,806 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(442)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(466)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,109)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,013)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in Balance Sheet</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,064)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(442)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,109)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,013)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in Accumulated Other Comprehensive Income (Loss)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition/prior service cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,236 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:50.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.646%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Retiree Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions Used to Determine Benefit Obligations</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.61 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.06 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.88 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.70 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.30 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.93 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.38 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.70 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.30 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.62 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESOP growth rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.00 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.00 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical cost trend rate of increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Crediting Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.48 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.21 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actuarial losses incurred during 2020 were primarily driven by a decrease in discount rates applied against future expected benefit payments that resulted in an increase in the benefit obligation for both the U.S. pension and Other retiree benefit plans. The actuarial gains recorded during 2019 for both the U.S. pension and other retiree benefit plans were primarily a result of an increase in discount rates applied against future estimated benefit payments. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The overall investment objective of the plans is to balance risk and return so that obligations to employees are met. The Company evaluates its expected long-term rate of return on plan assets on an annual basis. In determining the expected long-term rate of return, the Company considers the nature of the plans’ investments and the historical rates of return. The assumed expected long-term rate of return on plan assets as of December 31, 2020 for the U.S. plans was 5.70%. Average annual rates of return for the U.S. plans for the most recent 1-year, 5-year, 10-year, 15-year and 25-year periods were 15%, 9%, 8%, 7% and 7%, respectively. Similar assessments were performed in determining rates of return on international pension plan assets to arrive at the Company’s 2020 weighted-average expected long-term rate of return on plan assets of 2.93%.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 6.00% in 2021 to 4.75% by 2026, remaining at 4.75% for the years thereafter. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consisted of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:74.924%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Obligation Exceeds Fair Value of Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,092 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,094 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Retiree Benefit plans with accumulated postretirement benefit obligation in excess of plan assets as of December 31 consisted of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:74.924%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Obligation Exceeds Fair Value of Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated postretirement benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows:</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:27.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.862%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.425%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.013%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.013%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.013%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.196%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Retiree Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Net Periodic Benefit Cost</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of transition and prior service costs (credits)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other postretirement charges</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.06 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.04 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term rate of compensation increase</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.86 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESOP growth rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.00 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.00 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.00 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical cost trend rate of increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Crediting Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.73 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The service related component of pension and other postretirement benefit costs is included in Operating profit. The non-service related components (interest cost, expected return on assets and amortization of actuarial gains and losses) are included in the line item “Non-service related postretirement costs,” which is below Operating profit. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other postretirement charges in 2020, 2019 and 2018 include pension and other benefit enhancements amounting to $3, $7 and $9, respectively. Other postretirement charges from 2019 and 2018 were incurred pursuant to the Global Growth and Efficiency Program. Other postretirement charges in 2019 also include charges of $1, in part due to retirements under the Global Growth and Efficiency Program.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company made voluntary contributions of $0, $113 and $67 in 2020, 2019 and 2018, respectively, to its U.S. retirement plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expected Contributions and Benefit Payments</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not expect to make any voluntary contributions to its U.S. postretirement plans for the year ending December 31, 2021. Actual funding may differ from current estimates depending on the variability of the market value of the assets as compared to the obligation and other market or regulatory conditions.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit payments expected to be paid from the Company’s assets to participants in unfunded plans are estimated to be approximately $90 for the year ending December 31, 2021. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total benefit payments expected to be paid to participants in both funded and unfunded plans are estimated as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.026%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Retiree Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> The target asset allocation for the Company’s defined benefit plans is as follows:<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:71.737%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.405%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate and other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:46.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.804%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level of Valuation<br/>Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Retiree<br/>Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. common stocks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International common stocks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pooled funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guaranteed investment contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments valued using NAV per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic, developed and emerging markets equity funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedge funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-asset funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At December 31, 2019, the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.696%"><tr><td style="width:1.0%"/><td style="width:46.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.210%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.210%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level of Valuation<br/>Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Retiree<br/>Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. common stocks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International common stocks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pooled funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guaranteed investment contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments valued using NAV per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic, developed and emerging markets equity funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedge funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-asset funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,806 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Pooled funds primarily invest in U.S. and foreign equity securities, debt and money market securities. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">The fixed income securities are traded over-the-counter and certain of these securities lack daily pricing or liquidity and as such are classified as Level 2. As of both December 31, 2020 and 2019, approximately 50% of the U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in other government bonds and corporate bonds.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">The guaranteed investment contracts (“GICs”) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Investments that are measured at fair value using net asset value (“NAV”) per share as a practical expedient have not been classified in the fair value hierarchy. The NAV is based on the value of the underlying investments owned, minus its liabilities, divided by the number of shares outstanding. There are no unfunded commitments related to these investments. Redemption notice period primarily ranges from 0-3 months and redemption frequency windows range from daily to quarterly.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Fixed income funds primarily invest in U.S. government and investment grade corporate bonds.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Consists of investments in underlying hedge fund strategies that are primarily implemented through the use of long and short equity and fixed income securities and derivative instruments such as futures and options.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Multi-asset funds primarily invest across a variety of asset classes, including global stocks and bonds, as well as alternative strategies.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager. </span></div>(9)This category primarily includes unsettled trades for investments purchased and sold and dividend receivables. 0.21 0.38 0.74 0.46 0.05 0.16 1 1 50000000 12000000 0 0 1000000 0 0 8000000 0 65000000 117000000 0 1117000000 59000000 2000000 1000000 55000000 0 1233000000 252000000 2000000 456000000 183000000 1000000 136000000 225000000 0 0 6000000 0 77000000 2000000 0 34000000 30000000 0 703000000 446000000 1000000 -15000000 0 0 1921000000 698000000 3000000 41000000 15000000 1000000 49000000 3000000 1000000 0 3000000 0 29000000 104000000 2000000 1067000000 14000000 20000000 1000000 42000000 0 1187000000 181000000 24000000 328000000 165000000 7000000 177000000 196000000 3000000 3000000 17000000 0 155000000 2000000 2000000 41000000 25000000 1000000 704000000 405000000 13000000 -85000000 0 0 1806000000 586000000 37000000 0.50 0.50 0 0.03 739869 588334 0 0 0 2000000 The Company uses a December 31 measurement date for its defined benefit and other retiree benefit plans. Summarized information for the Company’s defined benefit and other retiree benefit plans is as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.818%"><tr><td style="width:1.0%"/><td style="width:48.978%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.255%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.037%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.512%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Retiree Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Benefit Obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants’ contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions/plan amendments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss (gain)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailments and settlements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations at end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,363 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,806 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,568 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants’ contributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements and acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,806 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded Status</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations at end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,363 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,806 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(442)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(466)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,109)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,013)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in Balance Sheet</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,064)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(442)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,109)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,013)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in Accumulated Other Comprehensive Income (Loss)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition/prior service cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,236 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:50.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.646%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Retiree Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions Used to Determine Benefit Obligations</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.61 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.06 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.88 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.70 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.30 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.93 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.38 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.70 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.30 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.62 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESOP growth rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.00 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.00 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical cost trend rate of increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Crediting Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.48 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.21 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table> 2272000000 2272000000 2147000000 876000000 787000000 1050000000 876000000 1000000 1000000 17000000 14000000 20000000 15000000 74000000 90000000 90000000 21000000 22000000 22000000 37000000 41000000 41000000 0 0 5000000 2000000 0 0 0 0 30000000 3000000 0 0 -171000000 -181000000 -65000000 -82000000 -61000000 -166000000 0 0 46000000 8000000 -9000000 1000000 3000000 7000000 0 0 0 0 3000000 0 7000000 9000000 0 0 155000000 154000000 40000000 35000000 47000000 49000000 0 0 0 2000000 0 0 2363000000 2272000000 2272000000 1013000000 876000000 876000000 1112000000 1050000000 1050000000 1806000000 1568000000 586000000 510000000 37000000 54000000 243000000 262000000 59000000 76000000 2000000 8000000 30000000 130000000 36000000 30000000 11000000 24000000 0 0 5000000 2000000 0 0 0 0 26000000 12000000 0 0 3000000 0 -26000000 9000000 0 0 155000000 154000000 40000000 35000000 47000000 49000000 0 0 0 0 0 0 1921000000 1806000000 1806000000 698000000 586000000 586000000 3000000 37000000 37000000 2363000000 2272000000 2272000000 1013000000 876000000 876000000 1112000000 1050000000 1050000000 1921000000 1806000000 1806000000 698000000 586000000 586000000 3000000 37000000 37000000 -442000000 -466000000 -315000000 -290000000 -1109000000 -1013000000 20000000 0 18000000 13000000 0 0 30000000 28000000 14000000 13000000 45000000 13000000 432000000 438000000 319000000 290000000 1064000000 1000000000 -442000000 -466000000 -315000000 -290000000 -1109000000 -1013000000 -902000000 -910000000 -255000000 -238000000 -429000000 -388000000 -1000000 -1000000 -7000000 -7000000 0 1000000 903000000 911000000 262000000 245000000 429000000 387000000 2325000000 2236000000 946000000 816000000 0 0 0.0265 0.0340 0.0161 0.0206 0.0288 0.0356 0.0570 0.0630 0.0293 0.0338 0.0570 0.0630 0.0350 0.0350 0.0262 0.0283 0.0350 0.0350 0 0 0 0 0.1000 0.1000 0 0 0 0 0.0600 0.0600 0.0248 0.0321 0.0083 0.0085 0 0 0.0570 0.15 0.09 0.08 0.07 0.07 0.0293 0.0600 0.0475 2026 0.0475 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consisted of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:74.924%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Obligation Exceeds Fair Value of Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,092 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,094 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Retiree Benefit plans with accumulated postretirement benefit obligation in excess of plan assets as of December 31 consisted of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:74.924%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Obligation Exceeds Fair Value of Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated postretirement benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1092000000 2862000000 299000000 2094000000 882000000 875000000 134000000 166000000 1112000000 958000000 3000000 37000000 Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:27.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.862%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.425%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.013%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.013%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.013%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.196%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Retiree Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Net Periodic Benefit Cost</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of transition and prior service costs (credits)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other postretirement charges</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.06 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.04 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term rate of compensation increase</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.86 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESOP growth rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.00 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.00 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.00 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical cost trend rate of increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Crediting Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.73 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table> 1000000 1000000 1000000 17000000 14000000 14000000 20000000 15000000 16000000 74000000 90000000 90000000 86000000 21000000 22000000 22000000 21000000 37000000 41000000 41000000 38000000 111000000 103000000 115000000 22000000 19000000 21000000 2000000 3000000 2000000 0 0 0 0 1000000 0 0 0 0 -46000000 -51000000 -47000000 -9000000 -9000000 -8000000 -18000000 -11000000 -14000000 10000000 39000000 19000000 25000000 27000000 22000000 73000000 64000000 66000000 4000000 7000000 9000000 0 1000000 2000000 0 0 0 14000000 46000000 28000000 25000000 28000000 24000000 73000000 64000000 66000000 0.0340 0.0438 0.0373 0.0206 0.0280 0.0253 0.0356 0.0443 0.0380 0.0630 0.0660 0.0660 0.0338 0.0406 0.0404 0.0630 0.0660 0.0660 0.0350 0.0350 0.0350 0.0283 0.0286 0.0279 0 0 0 0 0 0 0 0 0 0.1000 0.1000 0.1000 0 0 0 0 0 0 0.0600 0.0600 0.0600 0.0321 0.0426 0.0373 0.0085 0.0085 0.0085 0 0 0 3000000 7000000 9000000 1000000 0 113000000 67000000 90000000 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total benefit payments expected to be paid to participants in both funded and unfunded plans are estimated as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.026%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Retiree Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 154000000 42000000 49000000 245000000 156000000 41000000 49000000 246000000 157000000 42000000 50000000 249000000 156000000 46000000 51000000 253000000 155000000 45000000 52000000 252000000 741000000 244000000 269000000 1254000000 Income Taxes<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Income before income taxes are as follows for the years ended December 31:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:63.088%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.284%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,175 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,330 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,251 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,289 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,301 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,464 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Provision for income taxes consists of the following for the years ended December 31:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:63.088%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.284%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Temporary differences between accounting for financial statement purposes and accounting for tax purposes result in the current provision for taxes being higher (lower) than the total provision for income taxes as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:63.088%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.284%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other retiree benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets/lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits and tax loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred withholding tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax benefit (provision)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the statutory U.S. federal income tax rate and the Company’s global effective tax rate as reflected in the Consolidated Statements of Income is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:63.088%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.284%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of Income before income taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax at United States statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings taxed at other than United States statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge for U.S. tax reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit carryback</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit for foreign tax matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-derived intangible income benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.2pt">On December 22, 2017, the Tax Cuts and Jobs Act (the “TCJA”) was enacted, which, among other things, lowered the U.S. corporate income tax rate to 21% from 35% and established a modified territorial system requiring a mandatory deemed repatriation tax on undistributed earnings of foreign subsidiaries. Beginning in 2018, the TCJA also requires a minimum tax on certain earnings generated by foreign subsidiaries while providing for tax-free repatriation of such earnings through a 100% dividends-received deduction. The Company’s effective income tax rate in 2017 included a provisional charge of $275, recorded in the fourth quarter of 2017, based on its initial analysis of the TCJA using information and estimates available as of February 15, 2018, the date on which the Company filed its Annual Report on Form 10-K for the year ended December 31, 2017. During 2018, the Company finalized its assessment of the impact of the TCJA and recognized an additional tax expense of $80 reflecting the impact of transition tax guidance issued by the U.S. Treasury and the update of certain estimates and calculations based on information available through the end of 2018. Any further guidance issued after December 31, 2018 may have an impact to the Company’s Provision for income tax in the period such guidance is effective. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.2pt">In 2018, the Company generated excess foreign taxes associated with its foreign branch operations which are being carried back to 2017. This item is not expected to be recurring.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.2pt">In 2020, the provision for income taxes includes $71 of income tax benefits recorded on a discrete period basis, of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As part of the previously recorded charge for the TCJA, the Company has provided for foreign withholding taxes expected to be paid on the remittance of earnings from certain overseas subsidiaries no longer deemed indefinitely reinvested. As a result of a recent reorganization of the ownership structure of certain foreign subsidiaries, the Company determined that no withholding taxes will be due on the remittance by certain subsidiaries of earnings previously deemed reinvested and, accordingly, reversed $45 of previously recorded foreign withholding taxes. Also as part of the previously recorded charge for the TCJA, the Company provided a valuation allowance against a deferred tax asset related to the foreign tax credit carryforwards that the Company did not expect to be able to use due to changes made by the TCJA. As a result of a new operating structure being implemented within one of the Company's divisions, the Company believes the use of these foreign tax credit carryforwards will not be limited in the future and, accordingly, reversed the previously recorded valuation allowance of $26. In 2019, the provision for income taxes includes a net benefit of $29 related to changes enacted by the Swiss government to its corporate tax regime, which included, among other items, the repeal of certain preferential tax regimes and an increase to the cantonal tax rate for future periods. Additionally, the government provided transition rules which allowed companies to record goodwill for tax purposes, partially offsetting the impact on cash taxes of the higher cantonal rate over the next ten years. In 2018, the provision for income taxes includes a benefit of $15 related to several Supreme Court and Administrative Court rulings in a foreign jurisdiction allowing certain tax deductions which had the effect of reversing prior decisions. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of deferred tax assets (liabilities) are as follows at December 31:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:74.924%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(603)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred withholding tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,162)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,289)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other retiree benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits and tax loss carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation Allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:74.924%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes included within:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(426)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(507)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Applicable U.S. income and foreign withholding taxes have been provided on substantially all of the Company’s accumulated earnings of foreign subsidiaries. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net tax benefits of $101, $13 and $2 were recorded directly through equity in 2020, 2019 and 2018, respectively. The net tax benefits in 2020 and 2019 predominantly include current and future tax impacts related to benefit plans. The amount in 2018 includes current and future tax impacts related to employee equity compensation and benefit plans.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized tax benefits activity for the years ended December 31, 2020, 2019 and 2018 is summarized below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.172%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.388%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases as a result of tax positions taken during the current year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases of tax positions taken during prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases of tax positions taken during prior years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency rate movements</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If all of the unrecognized tax benefits for 2020 above were recognized, approximately $213 would impact the effective tax rate and would result in a cash outflow of approximately $223. Although it is possible that the amount of unrecognized benefits with respect to our uncertain tax positions will increase or decrease in the next twelve months, the Company does not expect material changes.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized approximately $9 of interest expense, $0 of interest expense, $1 of interest benefit related to the above unrecognized tax benefits within income tax expense in 2020, 2019 and 2018, respectively. The Company had accrued interest of approximately $24, $23 and $27 as of December 31, 2020, 2019 and 2018, respectively.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its subsidiaries file U.S. federal income tax returns as well as income tax returns in many state and foreign jurisdictions. All U.S. federal income tax returns through December 31, 2013 have been audited by the IRS and there are limited matters which the Company plans to appeal for years 2010 through 2013, the settlement of which is not expected to have a material effect on the Company’s results of operations, cash flows or financial condition. With a few exceptions, the Company is no longer subject to U.S. state and local income tax examinations for income tax returns through December 31, 2015. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations for tax audits generally ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxZjY5NTVhZDY0YzQ0ZGI5NjUzYzc0OTg0MGMxMTI1L3NlYzo0MWY2OTU1YWQ2NGM0NGRiOTY1M2M3NDk4NDBjMTEyNV8xOTAvZnJhZzo1MzU0ZGVmMjdmM2Y0NmM2OTRjMTdhZGZhYmY0MDZjYy90ZXh0cmVnaW9uOjUzNTRkZWYyN2YzZjQ2YzY5NGMxN2FkZmFiZjQwNmNjXzUyNTM_a25309e3-5314-40a7-b155-18916133f177">three</span> to six years. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made an accounting policy election to treat Global Intangible Low-Taxed Income taxes as a current period expense rather than including these amounts in the measurement of deferred taxes.</span></div> <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Income before income taxes are as follows for the years ended December 31:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:63.088%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.284%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,175 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,330 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,251 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,289 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,301 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,464 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1317000000 1050000000 1175000000 2330000000 2251000000 2289000000 3647000000 3301000000 3464000000 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Provision for income taxes consists of the following for the years ended December 31:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:63.088%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.284%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 259000000 180000000 213000000 528000000 594000000 693000000 787000000 774000000 906000000 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Temporary differences between accounting for financial statement purposes and accounting for tax purposes result in the current provision for taxes being higher (lower) than the total provision for income taxes as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:63.088%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.284%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other retiree benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets/lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits and tax loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred withholding tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax benefit (provision)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -1000000 -34000000 -2000000 -12000000 -12000000 15000000 -10000000 13000000 7000000 7000000 1000000 -9000000 1000000 0 0 -1000000 3000000 -4000000 -111000000 21000000 100000000 -18000000 33000000 -62000000 -143000000 19000000 53000000 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the statutory U.S. federal income tax rate and the Company’s global effective tax rate as reflected in the Consolidated Statements of Income is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:63.088%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.284%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of Income before income taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax at United States statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings taxed at other than United States statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge for U.S. tax reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit carryback</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit for foreign tax matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-derived intangible income benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.2pt">On December 22, 2017, the Tax Cuts and Jobs Act (the “TCJA”) was enacted, which, among other things, lowered the U.S. corporate income tax rate to 21% from 35% and established a modified territorial system requiring a mandatory deemed repatriation tax on undistributed earnings of foreign subsidiaries. Beginning in 2018, the TCJA also requires a minimum tax on certain earnings generated by foreign subsidiaries while providing for tax-free repatriation of such earnings through a 100% dividends-received deduction. The Company’s effective income tax rate in 2017 included a provisional charge of $275, recorded in the fourth quarter of 2017, based on its initial analysis of the TCJA using information and estimates available as of February 15, 2018, the date on which the Company filed its Annual Report on Form 10-K for the year ended December 31, 2017. During 2018, the Company finalized its assessment of the impact of the TCJA and recognized an additional tax expense of $80 reflecting the impact of transition tax guidance issued by the U.S. Treasury and the update of certain estimates and calculations based on information available through the end of 2018. Any further guidance issued after December 31, 2018 may have an impact to the Company’s Provision for income tax in the period such guidance is effective. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.2pt">In 2018, the Company generated excess foreign taxes associated with its foreign branch operations which are being carried back to 2017. This item is not expected to be recurring.</span></div>(3)In 2020, the provision for income taxes includes $71 of income tax benefits recorded on a discrete period basis, of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As part of the previously recorded charge for the TCJA, the Company has provided for foreign withholding taxes expected to be paid on the remittance of earnings from certain overseas subsidiaries no longer deemed indefinitely reinvested. As a result of a recent reorganization of the ownership structure of certain foreign subsidiaries, the Company determined that no withholding taxes will be due on the remittance by certain subsidiaries of earnings previously deemed reinvested and, accordingly, reversed $45 of previously recorded foreign withholding taxes. Also as part of the previously recorded charge for the TCJA, the Company provided a valuation allowance against a deferred tax asset related to the foreign tax credit carryforwards that the Company did not expect to be able to use due to changes made by the TCJA. As a result of a new operating structure being implemented within one of the Company's divisions, the Company believes the use of these foreign tax credit carryforwards will not be limited in the future and, accordingly, reversed the previously recorded valuation allowance of $26. In 2019, the provision for income taxes includes a net benefit of $29 related to changes enacted by the Swiss government to its corporate tax regime, which included, among other items, the repeal of certain preferential tax regimes and an increase to the cantonal tax rate for future periods. Additionally, the government provided transition rules which allowed companies to record goodwill for tax purposes, partially offsetting the impact on cash taxes of the higher cantonal rate over the next ten years. In 2018, the provision for income taxes includes a benefit of $15 related to several Supreme Court and Administrative Court rulings in a foreign jurisdiction allowing certain tax deductions which had the effect of reversing prior decisions. 0.210 0.210 0.210 0.010 0.006 0.010 0.033 0.046 0.056 0 0 0.023 0 0 -0.017 -0.020 -0.009 -0.004 -0.016 -0.013 -0.011 -0.001 -0.006 -0.005 0.216 0.234 0.262 1 275000000 80000000 -71000000 -45000000 -26000000 0 -45000000 -26000000 29000000 15000000 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of deferred tax assets (liabilities) are as follows at December 31:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:74.924%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(603)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred withholding tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,162)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,289)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other retiree benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits and tax loss carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation Allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:74.924%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes included within:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(426)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(507)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 603000000 598000000 281000000 303000000 131000000 135000000 95000000 207000000 52000000 46000000 1162000000 1289000000 404000000 381000000 42000000 93000000 144000000 152000000 250000000 221000000 73000000 88000000 125000000 83000000 1038000000 1018000000 11000000 59000000 1027000000 959000000 135000000 330000000 291000000 177000000 426000000 507000000 135000000 330000000 -101000000 -13000000 -2000000 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized tax benefits activity for the years ended December 31, 2020, 2019 and 2018 is summarized below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.172%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.388%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases as a result of tax positions taken during the current year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases of tax positions taken during prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases of tax positions taken during prior years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency rate movements</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 173000000 190000000 214000000 18000000 14000000 14000000 5000000 21000000 37000000 57000000 20000000 9000000 19000000 30000000 6000000 -3000000 0 4000000 227000000 173000000 190000000 213000000 223000000 9000000 0 -1000000 24000000 23000000 27000000 P6Y Earnings Per Share<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2020, 2019 and 2018, earnings per share were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.939%"><tr><td style="width:1.0%"/><td style="width:14.673%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Colgate-Palmolive Company</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares<br/>(millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per<br/>Share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Colgate-Palmolive Company</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares<br/>(millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per<br/>Share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Colgate-Palmolive Company</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares<br/>(millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per<br/>Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic EPS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,695 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.15 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,367 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.76 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.76 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and restricted stock units</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,695 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,367 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per common share is computed by dividing net income available for common stockholders by the weighted-average number of shares of common stock outstanding for the period. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per common share is computed using the treasury stock method on the basis of the weighted-average number of shares of common stock plus the dilutive effect of potential common shares outstanding during the period. Dilutive potential common shares include outstanding stock options and restricted stock units.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, 2019 and 2018, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 3,257,310, 19,901,202 and 18,039,961, respectively. As of December 31, 2020, 2019 and 2018, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 25,381, 4,516 and 9,529, respectively.</span></div> <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2020, 2019 and 2018, earnings per share were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.939%"><tr><td style="width:1.0%"/><td style="width:14.673%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.241%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Colgate-Palmolive Company</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares<br/>(millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per<br/>Share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Colgate-Palmolive Company</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares<br/>(millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per<br/>Share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Colgate-Palmolive Company</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares<br/>(millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per<br/>Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic EPS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,695 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.15 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,367 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.76 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.76 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and restricted stock units</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,695 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,367 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2695000000 856800000 3.15 2367000000 859100000 2.76 2400000000 870600000 2.76 2500000 2000000.0 2400000 2695000000 859300000 3.14 2367000000 861100000 2.75 2400000000 873000000.0 2.75 3257310 19901202 18039961 25381 4516 9529 Commitments and Contingencies<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company has various contractual commitments for future multi-year purchases of raw, packaging and other materials totaling approximately $715.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $425 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Brazilian Matters</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $113. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In each of September 2015, February 2017, June 2018, April 2019 and September 2020, the Company lost an administrative appeal and subsequently filed an appeal in Brazilian federal court. Currently, there are five appeals pending in the Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $50, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal, and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Competition Matter</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company’s subsidiaries were historically subject to actions and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status as of December 31, 2020 of such competition law matters pending against the Company during the year ended December 31, 2020 is set forth below.</span></div><div><span><br/></span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">▪</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11. The Company appealed the decision to the Greek courts. In April 2019, the Greek courts affirmed the judgment against the Company’s Greek subsidiary, but reduced the fine to $10.5 and dismissed the case against Colgate-Palmolive Company. The Company’s Greek subsidiary and the Greek competition authority have appealed the decision to the Greek Supreme Court.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Talcum Powder Matters</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of December 31, 2020, there were 137 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 121</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">cases as of December 31, 2019. During the year ended December 31, 2020,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">65 new cases were filed and 49 cases were resolved by voluntary dismissal, settlement or dismissal by the court. The value of the settlements in the years presented was not material, either individually or in the aggregate, to each such period’s results of operations. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A significant portion of the Company’s costs incurred in defending and resolving these claims has been, and the Company believes will continue to be, covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions and policy limits.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. With the exception of one case where the Company received an adverse jury verdict in the second quarter of 2019 that the Company has appealed, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases because the amount of any possible losses from such cases currently cannot be reasonably estimated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ERISA Matter</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals (the “Company Defendants”) in the United States District Court for the Southern District of New York (the “Court”). The relief sought includes recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. This action was certified as a class action in July 2017. In July 2020, the Court granted in part and denied in part the Company Defendants’ motion for summary judgment and dismissed certain claims on consent of the parties. In August 2020, the Court granted the plaintiffs’ motion for summary judgment on the remaining claims. The Company and the Plan are contesting this action vigorously and, in September 2020, appealed to the United States Court of Appeals for the Second Circuit.</span></div> 715000000 200 0 425000000 113000000 5 50000000 11000000 -10500000 137 121 65 49 1 Segment Information<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 70% of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Wal-Mart, Inc. and its affiliates represent approximately 12% of the Company’s Net sales in 2020. No other customer represents more than 10% of Net sales.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, Corporate Operating profit included benefits of $16 resulting from the Global Growth and Efficiency Program and a charge of $6 for acquisition-related costs. In 2019, Corporate Operating profit included charges of $125 resulting from the Global Growth and Efficiency Program, a charge of $24 for acquisition-related costs and a benefit of $30 from a value-added tax matter in Brazil. In 2018, Corporate Operating Profit included charges of $152 resulting from the Global Growth and Efficiency Program.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,741 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,348 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,418 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,606 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,605 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,450 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,502 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,701 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,588 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,168 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,156 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,883 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,525 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,471 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,693 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,544 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net sales in the U.S. for Oral, Personal and Home Care were $3,447, $3,166 and $3,091 in 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net sales in the U.S. for Pet Nutrition were $1,712, $1,441 and $1,304 in 2020, 2019 and 2018, respectively.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.696%"><tr><td style="width:1.0%"/><td style="width:57.866%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">982 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,594 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,505 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,616 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(502)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(602)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,885 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,554 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,694 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.696%"><tr><td style="width:1.0%"/><td style="width:57.866%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital expenditures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Capital expenditures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.696%"><tr><td style="width:1.0%"/><td style="width:57.866%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:57.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.257%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identifiable assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,576 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,310 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,251 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,384 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,386 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,883 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,155 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,646 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,809 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,068 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Identifiable assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,920 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,034 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,161 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">In 2020, Corporate identifiable assets primarily consist of investments in equity securities (95%). In 2019, Corporate identifiable assets primarily consist of derivative instruments (2%) and investments in equity securities (92%). In 2018, Corporate identifiable assets primarily consist of derivative instruments (7%) and investments in equity securities (88%). </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $10,911 in 2020, one-third of total long-lived assets of $10,192 in 2019, and one-half of total long-lived assets of $8,259 in 2018.</span></div> 2 5 5 0.70 0.45 0.12 16000000 6000000 125000000 24000000 30000000 152000000 <div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,741 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,348 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,418 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,606 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,605 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,450 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,502 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,701 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,588 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,168 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,156 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,883 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,525 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,471 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,693 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,544 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net sales in the U.S. for Oral, Personal and Home Care were $3,447, $3,166 and $3,091 in 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net sales in the U.S. for Pet Nutrition were $1,712, $1,441 and $1,304 in 2020, 2019 and 2018, respectively.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.696%"><tr><td style="width:1.0%"/><td style="width:57.866%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">982 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,594 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,505 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,616 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(502)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(602)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,885 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,554 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,694 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.696%"><tr><td style="width:1.0%"/><td style="width:57.866%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital expenditures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Capital expenditures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.696%"><tr><td style="width:1.0%"/><td style="width:57.866%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:57.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.257%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identifiable assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,576 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,310 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,251 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,384 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,386 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,883 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,155 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,646 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,809 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,068 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Identifiable assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,920 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,034 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,161 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">In 2020, Corporate identifiable assets primarily consist of investments in equity securities (95%). In 2019, Corporate identifiable assets primarily consist of derivative instruments (2%) and investments in equity securities (92%). In 2018, Corporate identifiable assets primarily consist of derivative instruments (7%) and investments in equity securities (88%). </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $10,911 in 2020, one-third of total long-lived assets of $10,192 in 2019, and one-half of total long-lived assets of $8,259 in 2018.</span></div> 3741000000 3424000000 3348000000 3418000000 3606000000 3605000000 2747000000 2450000000 2502000000 2701000000 2707000000 2734000000 981000000 981000000 967000000 13588000000 13168000000 13156000000 2883000000 2525000000 2388000000 16471000000 15693000000 15544000000 3447000000 3166000000 3091000000 1712000000 1441000000 1304000000 988000000 982000000 1037000000 975000000 963000000 995000000 652000000 624000000 634000000 773000000 749000000 777000000 206000000 187000000 173000000 3594000000 3505000000 3616000000 793000000 703000000 680000000 -502000000 -654000000 -602000000 3885000000 3554000000 3694000000 65000000 43000000 53000000 104000000 90000000 131000000 41000000 42000000 39000000 51000000 40000000 75000000 13000000 8000000 11000000 274000000 223000000 309000000 56000000 41000000 35000000 79000000 71000000 92000000 409000000 335000000 436000000 101000000 94000000 88000000 81000000 84000000 82000000 94000000 72000000 70000000 95000000 100000000 103000000 9000000 8000000 8000000 380000000 358000000 351000000 58000000 55000000 53000000 101000000 106000000 107000000 539000000 519000000 511000000 4132000000 3576000000 3310000000 2251000000 2384000000 2225000000 5386000000 5104000000 2883000000 2272000000 2155000000 2148000000 605000000 590000000 502000000 14646000000 13809000000 11068000000 1210000000 1175000000 1033000000 64000000 50000000 60000000 15920000000 15034000000 12161000000 0.95 0.02 0.92 0.07 0.88 10911000000 10192000000 8259000000 Leases <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted ASU No. 2016-02 “Leases (Topic 842)” on January 1, 2019, resulting in the recognition of right-of-use assets of $458 and liabilities of $574. The Company enters into leases for land, office space, warehouses and equipment. A number of the leases include one or more options to renew the lease terms, purchase the leased property or terminate the lease. The exercise of these options is at the Company’s discretion and is therefore recognized on the balance sheet when it is reasonably certain the Company will exercise such options. As the Company’s leases typically do not contain a readily determinable implicit rate, the Company determines the present value of the lease liability using its incremental borrowing rate at the lease commencement date. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s leases are considered operating leases. Finance leases were not material as of December 31, 2020 and 2019. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 and 2019, the Company’s right-of use assets and liabilities for operating leases were as follows:</span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.839%"><tr><td style="width:1.0%"/><td style="width:73.978%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.414%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.732%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxZjY5NTVhZDY0YzQ0ZGI5NjUzYzc0OTg0MGMxMTI1L3NlYzo0MWY2OTU1YWQ2NGM0NGRiOTY1M2M3NDk4NDBjMTEyNV8yMDgvZnJhZzo5NmYyYjRjNDdkOWY0MTI0OWI5M2Y1OWQ4ZTcxNWM5ZS90YWJsZTpiZDk1YzdlYzM2Njk0Nzk4YTRkNWRiZDBhOTM5ZmE4ZC90YWJsZXJhbmdlOmJkOTVjN2VjMzY2OTQ3OThhNGQ1ZGJkMGE5MzlmYThkXzEtMC0xLTEtNjE2Mg_975b1a1f-0dad-4ae4-8346-36a22957779b">Other assets</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liabilities for operating leases as of December 31, 2020 were as follows:</span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.148%"><tr><td style="width:1.0%"/><td style="width:87.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.693%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease commitments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s operating lease cost for the twelve months ended December 31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.839%"><tr><td style="width:1.0%"/><td style="width:73.978%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.414%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.732%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term lease cost represents the Company’s cost with respect to leases with a duration of 12 months or less and is not reflected on the Company’s Consolidated Balance Sheets. Variable lease costs are comprised of costs, such as the Company’s proportionate share of actual costs for utilities, common area maintenance, property taxes and insurance, that are not included in the lease liability and are recognized in the period in which they are incurred. </span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases for the twelve months ended December 31, 2020 and 2019 was as follows:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">▪</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Payments against amounts included in the measurement of lease liabilities: $193 and $202, respectively </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">▪</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Lease assets obtained in exchange for lease liabilities: $163 and $232, respectively.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 and 2019, the weighted-average remaining lease term for operating leases was 8 and 8 years, respectively, and the weighted-average discount rate for operating leases was 4.2% and 4.1%, respectively. </span></div>There were no material operating leases that the Company had entered into and that were yet to commence as of December 31, 2020. 458000000 574000000 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 and 2019, the Company’s right-of use assets and liabilities for operating leases were as follows:</span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.839%"><tr><td style="width:1.0%"/><td style="width:73.978%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.414%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.732%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxZjY5NTVhZDY0YzQ0ZGI5NjUzYzc0OTg0MGMxMTI1L3NlYzo0MWY2OTU1YWQ2NGM0NGRiOTY1M2M3NDk4NDBjMTEyNV8yMDgvZnJhZzo5NmYyYjRjNDdkOWY0MTI0OWI5M2Y1OWQ4ZTcxNWM5ZS90YWJsZTpiZDk1YzdlYzM2Njk0Nzk4YTRkNWRiZDBhOTM5ZmE4ZC90YWJsZXJhbmdlOmJkOTVjN2VjMzY2OTQ3OThhNGQ1ZGJkMGE5MzlmYThkXzEtMC0xLTEtNjE2Mg_975b1a1f-0dad-4ae4-8346-36a22957779b">Other assets</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 521000000 502000000 137000000 145000000 476000000 491000000 613000000 636000000 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liabilities for operating leases as of December 31, 2020 were as follows:</span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.148%"><tr><td style="width:1.0%"/><td style="width:87.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.693%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease commitments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 157000000 133000000 89000000 58000000 46000000 232000000 715000000 102000000 613000000 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s operating lease cost for the twelve months ended December 31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.839%"><tr><td style="width:1.0%"/><td style="width:73.978%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.414%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.732%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 155000000 169000000 3000000 5000000 20000000 30000000 178000000 204000000 193000000 202000000 163000000 232000000 P8Y P8Y 0.042 0.041 Supplemental Income Statement Information<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.845%"><tr><td style="width:1.0%"/><td style="width:63.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global Growth and Efficiency Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value-added tax matter in Brazil</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-off of certain investments and fixed assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges for a change in go-to-market strategy in certain countries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest capitalized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Interest (income) expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.729%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.998%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,694 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,590 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.845%"><tr><td style="width:1.0%"/><td style="width:63.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global Growth and Efficiency Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value-added tax matter in Brazil</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-off of certain investments and fixed assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges for a change in go-to-market strategy in certain countries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> -13000000 57000000 88000000 88000000 62000000 59000000 12000000 9000000 10000000 0 30000000 0 0 51000000 1000000 2000000 21000000 0 0 15000000 0 48000000 29000000 10000000 -113000000 -196000000 -148000000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest capitalized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Interest (income) expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 184000000 193000000 195000000 1000000 1000000 2000000 19000000 47000000 50000000 164000000 145000000 143000000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.729%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.998%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,694 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,590 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 290000000 281000000 277000000 1948000000 1694000000 1590000000 Supplemental Balance Sheet Information<div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories by major class are as follows at December 31:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:74.924%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">        </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Inventories, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">              Non-current inventory, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">        </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">            Current Inventories, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,673 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories valued under LIFO amounted to $439 and $303 at December 31, 2020 and 2019, respectively. The excess of current cost over LIFO cost at the end of each year was $65 and $62, respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2020, 2019 and 2018. Inventory classified as non-current at December 31, 2020 was recorded on the Consolidated Balance Sheets as “Other assets.”</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:74.924%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,623 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,409 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,309 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,553 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,751 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,580 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,035)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,830)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,716 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:74.924%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other accruals</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued advertising and coupon redemption</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and employee benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes other than income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other retiree benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease Liabilities Due in One Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other accruals</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,917 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:74.924%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other retiree benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,728 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Lease Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,655 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,598 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories by major class are as follows at December 31:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:74.924%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">        </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Inventories, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">              Non-current inventory, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">        </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">            Current Inventories, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,673 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 454000000 305000000 45000000 49000000 1256000000 1056000000 1755000000 1410000000 82000000 10000000 1673000000 1400000000 439000000 303000000 65000000 62000000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:74.924%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,623 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,409 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,309 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,553 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,751 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,580 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,035)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,830)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,716 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 166000000 153000000 1623000000 1600000000 5409000000 5309000000 1553000000 1518000000 8751000000 8580000000 5035000000 4830000000 3716000000 3750000000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:74.924%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other accruals</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued advertising and coupon redemption</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and employee benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes other than income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other retiree benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease Liabilities Due in One Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other accruals</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,917 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 728000000 525000000 401000000 340000000 116000000 104000000 21000000 85000000 89000000 54000000 137000000 145000000 39000000 43000000 93000000 16000000 717000000 605000000 2341000000 1917000000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"/><td style="width:74.924%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other retiree benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,728 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Lease Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,655 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,598 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 1815000000 1728000000 10000000 15000000 476000000 491000000 354000000 364000000 2655000000 2598000000 Supplemental Other Comprehensive Income (Loss) Information<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.020%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.020%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.020%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.027%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of Tax</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative translation adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Net actuarial gain (loss), prior<br/> service costs and settlements<br/> during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Amortization of net actuarial loss,</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   transition and prior service costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement Plan and other retiree benefit<br/>adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Unrealized gains (losses) on cash flow <br/> hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Reclassification of (gains) losses </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   into net earnings on cash flow </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">These (gains) losses are reclassified into Cost of sales. See Note 7, Fair Value Measurements and Financial Instruments for additional details.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div>Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments designated as cash flow hedges. At December 31, 2020 and 2019, Accumulated other comprehensive income (loss) consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $1,178 and $1,138, respectively, and cumulative foreign currency translation adjustments of $3,158 and $3,128, respectively. Foreign currency translation adjustments in 2020 primarily reflect losses from the Brazilian real and the Mexican peso. Foreign currency translation adjustments in 2019 primarily reflect gains from the Thai baht and the Mexican peso. <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.020%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.020%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.020%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.027%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of Tax</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative translation adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Net actuarial gain (loss), prior<br/> service costs and settlements<br/> during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Amortization of net actuarial loss,</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   transition and prior service costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement Plan and other retiree benefit<br/>adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Unrealized gains (losses) on cash flow <br/> hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Reclassification of (gains) losses </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   into net earnings on cash flow </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">These (gains) losses are reclassified into Cost of sales. See Note 7, Fair Value Measurements and Financial Instruments for additional details.</span></div> -119000000 -30000000 49000000 27000000 -233000000 -218000000 -125000000 -97000000 -204000000 -154000000 -21000000 -16000000 -74000000 -57000000 -72000000 -54000000 -69000000 -54000000 -51000000 -40000000 -132000000 -100000000 48000000 38000000 -3000000 -2000000 -9000000 -7000000 10000000 8000000 0 0 6000000 5000000 -3000000 -2000000 -3000000 -2000000 -15000000 -12000000 13000000 10000000 -173000000 -72000000 -98000000 -85000000 -172000000 -170000000 1178000000 1138000000 -3158000000 -3128000000 Quarterly Financial Data (Unaudited)<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.916%"><tr><td style="width:1.0%"/><td style="width:31.270%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.699%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.699%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.003%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.552%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First<br/>Quarter</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth<br/>Quarter</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,471 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,097 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,153 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,324 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,017 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,465 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income including noncontrolling interests</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,860 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Colgate-Palmolive Company</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,695 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.74 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,693 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,884 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,866 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,928 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,015 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,287 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(11)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,316 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(13)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(15)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income including noncontrolling interests</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,527 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(12)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(14)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(16)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Colgate-Palmolive Company</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(12)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(14)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(16)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.68 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(12)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(14)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(16)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.65 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.68 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(12)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(14)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(16)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note:    Basic and diluted earnings per share are computed independently for each quarter and the year-to-date period presented. Accordingly, the sum of the quarterly earnings per common share may not necessarily equal the earnings per share for the year-to-date period.</span></div><div style="margin-top:3pt"><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Gross profit for the full year of 2020 includes a $4 charge for acquisition-related costs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2020 include aftertax benefits of $13 resulting from the Global Growth and Efficiency Program, a $4 aftertax charge for acquisition-related costs, a $71 tax benefit related to subsidiary and operating structure initiatives and a $18 aftertax loss on the early extinguishment of debt. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Gross profit for the first quarter of 2020 includes a $4 charge for acquisition-related costs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2020 include a $4 aftertax charge for acquisition-related costs and a $71 tax benefit related to subsidiary and operating structure initiatives.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2020 include aftertax benefits of $13 resulting from the Global Growth and Efficiency Program.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2020 include a $18 aftertax loss on the early extinguishment of debt.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Gross profit for the full year of 2019 includes $8 of charges resulting from the Global Growth and Efficiency Program and a $3 charge for acquisit</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ion-related costs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(8)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2019 include $102 of aftertax charges resulting from the Global Growth and Efficiency Program, a $20 aftertax charge for acquisition-related costs, a $20 aftertax benefit related to a value added tax matter in Brazil and a $29 tax benefit related to Swiss income tax reform.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(9)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Gross profit for the first quarter of 2019 includes $11 of charges resulting from the Global Growth and Efficiency Program.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(10)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.28pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2019 include $22 of aftertax charges resulting from the Global Growth and Efficiency Program.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(11)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.28pt">Gross profit for the second quarter of 2019 includes $3 of charges resulting from the Global Growth and Efficiency Program.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(12)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.28pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the second quarter of 2019 include $31 of aftertax charges resulting from the Global Growth and Efficiency Program.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(13)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.28pt">Gross profit for the third quarter of 2019 includes $1 of charges resulting from the Global Growth and Efficiency Program.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(14)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.28pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2019 include $22 of aftertax charges resulting from the Global Growth and Efficiency Program and a $14 aftertax charge related to U.S. tax reform.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(15)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.28pt">Gross profit for the fourth quarter of 2019 includes $1 of benefit resulting from the Global Growth and Efficiency Program and a $3 charge for acquisition-related costs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(16)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.28pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2019 include $27 of aftertax charges resulting from the Global Growth and Efficiency Program, a $6 charge for acquisition-related costs, a $20 aftertax benefit related to a value added tax matter in Brazil and a $29 tax benefit related to Swiss income tax reform.</span></div> <div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.916%"><tr><td style="width:1.0%"/><td style="width:31.270%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.699%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.699%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.003%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.552%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First<br/>Quarter</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth<br/>Quarter</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,471 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,097 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,153 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,324 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,017 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,465 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income including noncontrolling interests</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,860 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Colgate-Palmolive Company</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,695 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.74 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,693 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,884 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,866 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,928 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,015 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,287 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(11)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,316 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(13)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(15)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income including noncontrolling interests</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,527 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(12)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(14)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(16)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Colgate-Palmolive Company</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(12)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(14)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(16)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.68 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(12)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(14)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(16)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.65 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.68 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(12)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(14)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(16)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note:    Basic and diluted earnings per share are computed independently for each quarter and the year-to-date period presented. Accordingly, the sum of the quarterly earnings per common share may not necessarily equal the earnings per share for the year-to-date period.</span></div><div style="margin-top:3pt"><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Gross profit for the full year of 2020 includes a $4 charge for acquisition-related costs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2020 include aftertax benefits of $13 resulting from the Global Growth and Efficiency Program, a $4 aftertax charge for acquisition-related costs, a $71 tax benefit related to subsidiary and operating structure initiatives and a $18 aftertax loss on the early extinguishment of debt. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Gross profit for the first quarter of 2020 includes a $4 charge for acquisition-related costs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2020 include a $4 aftertax charge for acquisition-related costs and a $71 tax benefit related to subsidiary and operating structure initiatives.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2020 include aftertax benefits of $13 resulting from the Global Growth and Efficiency Program.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2020 include a $18 aftertax loss on the early extinguishment of debt.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Gross profit for the full year of 2019 includes $8 of charges resulting from the Global Growth and Efficiency Program and a $3 charge for acquisit</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ion-related costs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(8)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2019 include $102 of aftertax charges resulting from the Global Growth and Efficiency Program, a $20 aftertax charge for acquisition-related costs, a $20 aftertax benefit related to a value added tax matter in Brazil and a $29 tax benefit related to Swiss income tax reform.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(9)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Gross profit for the first quarter of 2019 includes $11 of charges resulting from the Global Growth and Efficiency Program.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(10)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.28pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2019 include $22 of aftertax charges resulting from the Global Growth and Efficiency Program.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(11)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.28pt">Gross profit for the second quarter of 2019 includes $3 of charges resulting from the Global Growth and Efficiency Program.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(12)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.28pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the second quarter of 2019 include $31 of aftertax charges resulting from the Global Growth and Efficiency Program.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(13)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.28pt">Gross profit for the third quarter of 2019 includes $1 of charges resulting from the Global Growth and Efficiency Program.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(14)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.28pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2019 include $22 of aftertax charges resulting from the Global Growth and Efficiency Program and a $14 aftertax charge related to U.S. tax reform.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(15)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.28pt">Gross profit for the fourth quarter of 2019 includes $1 of benefit resulting from the Global Growth and Efficiency Program and a $3 charge for acquisition-related costs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(16)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.28pt">Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2019 include $27 of aftertax charges resulting from the Global Growth and Efficiency Program, a $6 charge for acquisition-related costs, a $20 aftertax benefit related to a value added tax matter in Brazil and a $29 tax benefit related to Swiss income tax reform.</span></div> 16471000000 4097000000 3897000000 4153000000 4324000000 10017000000 2465000000 2369000000 2540000000 2643000000 2860000000 748000000 675000000 745000000 692000000 2695000000 715000000 635000000 698000000 647000000 3.15 0.83 0.74 0.81 0.76 3.14 0.83 0.74 0.81 0.75 15693000000 3884000000 3866000000 3928000000 4015000000 9325000000 2287000000 2308000000 2316000000 2414000000 2527000000 600000000 618000000 627000000 682000000 2367000000 560000000 586000000 578000000 643000000 2.76 0.65 0.68 0.67 0.75 2.75 0.65 0.68 0.67 0.75 4000000 -13000000 4000000 -71000000 -18000000 4000000 4000000 -71000000 13000000 -18000000 8000000 3000000 102000000 20000000 20000000 29000000 11000000 22000000 3000000 31000000 1000000 22000000 14000000 -1000000 3000000 27000000 6000000 20000000 29000000 <div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in Millions)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.696%"><tr><td style="width:1.0%"/><td style="width:42.213%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.690%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.386%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.128%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at End of Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts and estimated returns</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts and estimated returns</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts and estimated returns</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 76000000 16000000 0 3000000 89000000 59000000 1000000 0 49000000 11000000 82000000 6000000 0 12000000 76000000 54000000 12000000 0 7000000 59000000 77000000 15000000 0 10000000 82000000 9000000 45000000 0 0 54000000 (1) As a result of the early adoption of ASU 2018-02, the Company reclassified the stranded tax effects in Accumulated other comprehensive income (loss) resulting from the Tax Cuts and Jobs Act to Retained earnings. * Two dividends were declared in each of the first quarters of 2020, 2019 and 2018. (1) For the year ended December 31, 2020, Principal payments on debt includes cash charges of $20 related to the extinguishment of debt prior to maturity. See Note 6, Long-Term Debt and Credit Facilities for additional information. XML 21 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Cover - USD ($)
$ in Billions
12 Months Ended
Dec. 31, 2020
Jan. 31, 2021
Jun. 30, 2020
Entity Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2020    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 1-644    
Entity Registrant Name COLGATE-PALMOLIVE COMPANY    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 13-1815595    
Entity Address, Address Line One 300 Park Avenue    
Entity Address, City or Town New York,    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 10022    
City Area Code 212    
Local Phone Number 310-2000    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 62.8
Entity Common Stock, Shares Outstanding   848,562,678  
Documents Incorporated by Reference
DocumentsForm 10-K Reference
Portions of Proxy Statement for the 2021 Annual Meeting of StockholdersPart III, Items 10 through 14
   
Entity Central Index Key 0000021665    
Document Fiscal Year Focus 2020    
Document Fiscal Period Focus FY    
Amendment Flag false    
Common Stock      
Entity Information [Line Items]      
Title of 12(b) Security Common Stock, $1.00 par value    
Trading Symbol CL    
Security Exchange Name NYSE    
0.000% Notes due 2021      
Entity Information [Line Items]      
Title of 12(b) Security 0.000% Notes due 2021    
Trading Symbol CL21A    
Security Exchange Name NYSE    
0.500% Notes Due 2026      
Entity Information [Line Items]      
Title of 12(b) Security 0.500% Notes due 2026    
Trading Symbol CL26    
Security Exchange Name NYSE    
1.375% Notes Due 2034      
Entity Information [Line Items]      
Title of 12(b) Security 1.375% Notes due 2034    
Trading Symbol CL34    
Security Exchange Name NYSE    
0.875% Notes due 2039      
Entity Information [Line Items]      
Title of 12(b) Security 0.875% Notes due 2039    
Trading Symbol CL39    
Security Exchange Name NYSE    
XML 22 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Income - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]      
Net sales $ 16,471 $ 15,693 $ 15,544
Cost of sales 6,454 6,368 6,313
Gross profit 10,017 9,325 9,231
Selling, general and administrative expenses 6,019 5,575 5,389
Other (income) expense, net 113 196 148
Operating profit 3,885 3,554 3,694
Non-service related postretirement costs 74 108 87
Interest (income) expense, net 164 145 143
Income before income taxes 3,647 3,301 3,464
Provision for income taxes 787 774 906
Net income including noncontrolling interests 2,860 2,527 2,558
Less: Net income attributable to noncontrolling interests 165 160 158
Net income attributable to Colgate-Palmolive Company $ 2,695 $ 2,367 $ 2,400
Earnings per common share, basic (in dollars per share) $ 3.15 $ 2.76 $ 2.76
Earnings per common share, diluted (in dollars per share) $ 3.14 $ 2.75 $ 2.75
XML 23 R3.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Statement of Comprehensive Income [Abstract]      
Net income including noncontrolling interests $ 2,860 $ 2,527 $ 2,558
Other comprehensive income (loss), net of tax:      
Cumulative translation adjustments (24) 25 (237)
Retirement plan and other retiree benefit adjustments (40) (100) 38
Gains (losses) on cash flow hedges (2) (12)  
Gains (losses) on cash flow hedges     10
Total Other comprehensive income (loss), net of tax (66) (87) (189)
Total Comprehensive income including noncontrolling interests 2,794 2,440 2,369
Less: Net income attributable to noncontrolling interests 165 160 158
Less: Cumulative translation adjustments attributable to noncontrolling interests 6 (2) (19)
Total Comprehensive income attributable to noncontrolling interests 171 158 139
Total Comprehensive income attributable to Colgate-Palmolive Company $ 2,623 $ 2,282 $ 2,230
XML 24 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 888 $ 883
Receivables (net of allowances of $89 and $76, respectively) 1,264 1,440
Inventories 1,673 1,400
Other current assets 513 456
Total current assets 4,338 4,179
Property, plant and equipment, net 3,716 3,750
Goodwill 3,824 3,508
Other intangible assets, net 2,894 2,667
Deferred income taxes 291 177
Other assets 857 753
Total assets 15,920 15,034
Current Liabilities    
Notes and loans payable 258 260
Current portion of long-term debt 9 254
Accounts payable 1,393 1,237
Accrued income taxes 403 370
Other accruals 2,341 1,917
Total current liabilities 4,404 4,038
Long-term debt 7,334 7,333
Deferred income taxes 426 507
Other liabilities 2,655 2,598
Total liabilities 14,819 14,476
Commitments and contingent liabilities 0 0
Shareholders’ Equity    
Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued) 1,466 1,466
Additional paid-in capital 2,969 2,488
Retained earnings 23,699 22,501
Accumulated other comprehensive income (loss) (4,345) (4,273)
Unearned compensation (1) (2)
Treasury stock, at cost (23,045) (22,063)
Total Colgate-Palmolive Company shareholders’ equity 743 117
Noncontrolling interests 358 441
Total equity 1,101 558
Total liabilities and equity $ 15,920 $ 15,034
XML 25 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Current Assets    
Allowance for doubtful accounts receivable, current $ 89 $ 76
Shareholders’ Equity    
Common stock par value (in USD per share) $ 1 $ 1
Common stock authorized (in shares) 2,000,000,000 2,000,000,000
Common stock issued (in shares) 1,465,706,360 1,465,706,360
XML 26 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Unearned Compensation
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Beginning balance at Dec. 31, 2017   $ 1,466 $ 1,984 $ (5) $ (20,181) $ 20,531 $ (3,855) $ 303
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income $ 2,558         2,400   158
Other comprehensive income (loss), net of tax (189)           (170) (19)
Dividends (in dollars per share) [1]           (1,448)   (143)
Stock-based compensation expense     109          
Shares issued for stock options     137   190      
Shares issued for restricted stock awards     (31)   31      
Treasury stock acquired         (1,238)      
Other     5 2 2 132 (163) [2]  
Ending balance at Dec. 31, 2018   1,466 2,204 (3) (21,196) 21,615 (4,188) 299
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 2,527         2,367   160
Other comprehensive income (loss), net of tax (87)           (85) (2)
Dividends (in dollars per share) [1]           (1,472)   (141)
Stock-based compensation expense     100          
Shares issued for stock options     210   305      
Shares issued for restricted stock awards     (29)   29      
Noncontrolling interests acquired               125
Treasury stock acquired         (1,202)      
Other [2]     3 1 1 (9)  
Ending balance at Dec. 31, 2019 558 1,466 2,488 (2) (22,063) 22,501 (4,273) 441
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 2,860         2,695   165
Other comprehensive income (loss), net of tax (66)           (72) 6
Dividends (in dollars per share) [1]           (1,502)   (152)
Stock-based compensation expense     107          
Shares issued for stock options     400   462      
Shares issued for restricted stock awards     (31)   31      
Noncontrolling interests acquired               (99)
Treasury stock acquired         (1,476)      
Other     5 1 1 5   (3)
Ending balance at Dec. 31, 2020 $ 1,101 $ 1,466 $ 2,969 $ (1) $ (23,045) $ 23,699 $ (4,345) $ 358
[1] * Two dividends were declared in each of the first quarters of 2020, 2019 and 2018.
[2] (1) As a result of the early adoption of ASU 2018-02, the Company reclassified the stranded tax effects in Accumulated other comprehensive income (loss) resulting from the Tax Cuts and Jobs Act to Retained earnings.
XML 27 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Changes in Shareholders' Equity (Parenthetical)
3 Months Ended 12 Months Ended
Mar. 31, 2020
Dividend
Mar. 31, 2019
Dividend
Mar. 31, 2018
Dividend
Dec. 31, 2020
$ / shares
[1]
Dec. 31, 2019
$ / shares
[1]
Dec. 31, 2018
$ / shares
Statement of Stockholders' Equity [Abstract]            
Dividends declared per common share (in USD per share) | $ / shares       $ 1.75 $ 1.71 $ 1.66
Number of dividends declared per quarter | Dividend 2 2 2      
[1] * Two dividends were declared in each of the first quarters of 2020, 2019 and 2018.
XML 28 R8.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating Activities      
Net income including noncontrolling interests $ 2,860 $ 2,527 $ 2,558
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:      
Depreciation and amortization 539 519 511
Restructuring and termination benefits, net of cash (71) 18 (7)
Stock-based compensation expense 107 100 109
Loss on early extinguishment of debt 23 0 0
Charge for U.S. tax reform 0 0 80
Deferred income taxes (120) 17 27
Voluntary benefit plan contributions 0 (113) (67)
Cash effects of changes in:      
Receivables 138 19 (79)
Inventories (251) (77) (58)
Accounts payable and other accruals 520 36 18
Other non-current assets and liabilities (26) 87 (36)
Net cash provided by operations 3,719 3,133 3,056
Investing Activities      
Capital expenditures (410) (335) (436)
Purchases of marketable securities and investments (143) (184) (169)
Proceeds from sale of marketable securities and investments 124 131 156
Payment for acquisitions, net of cash acquired (353) (1,711) (728)
Other 3 0 7
Net cash used in investing activities (779) (2,099) (1,170)
Financing Activities      
Short-term borrowing/(repayment) less than 90 days - net 497 294 546
Principal payments on debt [1] (1,061) (1,441) (725)
Proceeds from issuance of debt 0 2,595 0
Dividends paid (1,654) (1,614) (1,591)
Purchases of treasury shares (1,476) (1,202) (1,238)
Proceeds from exercise of stock options 874 498 329
Purchases of non-controlling interests in subsidiaries (99) 0 0
Net cash used in financing activities (2,919) (870) (2,679)
Effect of exchange rate changes on Cash and cash equivalents (16) (7) (16)
Net (decrease) increase in Cash and cash equivalents 5 157 (809)
Cash and cash equivalents at beginning of year 883 726 1,535
Cash and cash equivalents at end of year 888 883 726
Supplemental Cash Flow Information      
Income taxes paid 845 803 847
Interest paid $ 188 $ 185 $ 194
[1] (1) For the year ended December 31, 2020, Principal payments on debt includes cash charges of $20 related to the extinguishment of debt prior to maturity. See Note 6, Long-Term Debt and Credit Facilities for additional information.
XML 29 R9.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows (Parenthetical)
$ in Millions
12 Months Ended
Dec. 31, 2020
USD ($)
Statement of Cash Flows [Abstract]  
Cash charges for extinguishment of debt prior to maturity $ 20
XML 30 R10.htm IDEA: XBRL DOCUMENT v3.20.4
Nature of Operations
12 Months Ended
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of Operations Nature of Operations    
The Company manufactures and markets a wide variety of products in the U.S. and around the world in two product segments: Oral, Personal and Home Care; and Pet Nutrition. Oral, Personal and Home Care products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners and other similar items. These products are sold primarily to a variety of traditional and eCommerce retailers, wholesalers and distributors worldwide. Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The principal customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and eCommerce retailers. Principal global and regional trademarks include Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA Skin, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet.

The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years:
  202020192018
Oral Care44 %46 %47 %
Personal Care21 %20 %20 %
Home Care18 %18 %18 %
Pet Nutrition17 %16 %15 %
Total100 %100 %100 %
XML 31 R11.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Principles of Consolidation

The Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50%, where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2020 and 2019, equity method investments included in Other assets in the Consolidated Balance Sheets were $56 and $50, respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are recorded at cost and periodically adjusted based on observable price changes or quoted market prices in active markets, if applicable.

Use of Estimates

The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances, legal and other contingency reserves. Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates.

Revenue Recognition

The Company’s revenue contracts represent a single performance obligation to sell its products to trade customers. Sales are recorded at the time control of the products is transferred to trade customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for the products. Control is the ability of trade customers to “direct the use of” and “obtain” the benefit from our products. In evaluating the timing of the transfer of control of products to trade customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are generally recognized when products are delivered to trade customers.

Net sales reflect the transaction prices for contracts, which include units shipped at selling list prices reduced by variable consideration. Variable consideration includes expected sales returns and the cost of current and continuing promotional programs. Current promotional programs primarily include product listing allowances and co-operative advertising arrangements. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements. The cost of promotional programs is estimated using the expected value method considering all reasonably available information, including the Company’s historical experience and its current expectations, and is reflected in the transaction price when sales are recorded. Adjustments to the cost of promotional programs in subsequent periods are generally not material, as the Company’s promotional programs are typically of short duration, thereby reducing the uncertainty inherent in such estimates.

Sales returns are generally accepted at the Company’s discretion and are not material to the Company’s Consolidated Financial Statements. The Company’s contracts with trade customers do not have significant financing components or non-cash consideration and the Company does not have unbilled revenue or significant amounts of prepayments from customers. The Company records Net sales excluding taxes collected on its sales to its trade customers. Shipping and handling activities are accounted for as contract fulfillment costs and classified as Selling, general and administrative expenses.
Shipping and Handling Costs

Shipping and handling costs are classified as Selling, general and administrative expenses and were $1,392, $1,275 and $1,255 for the years ended December 31, 2020, 2019 and 2018, respectively.

Marketing Costs

The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales.

Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.

Inventories

The cost of approximately 75% of inventories is determined using the FIFO method, which is stated at the lower of cost or net realizable value. The cost of all other inventories, in the U.S. and Mexico, is determined using the LIFO method, which is stated at the lower of cost or market. Inventories in excess of one year of forecasted sales are classified in the Consolidated Balance Sheets as non-current “Other assets.”

Property, Plant and Equipment

Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over-estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses.

Goodwill and Other Intangibles

Goodwill and indefinite-life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually or when events or changes in circumstances indicate that an asset may be impaired. These tests were performed and did not result in an impairment charge. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their estimated useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit.

Income Taxes

The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return. The Company recognizes interest expense and penalties related to unrecognized tax benefits within Provision for income taxes.
Financial Instruments

Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged. Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows.

The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7, Fair Value Measurements and Financial Instruments along with the related fair value measurement considerations.

Stock-Based Compensation

The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units (both performance-based and time-vested), based on the fair value of those awards at the date of grant over the requisite service period. The Company uses the Black-Scholes-Merton (Black-Scholes) option pricing model to estimate the fair value of stock option awards. In addition to performance conditions, performance-based restricted stock units also include a total shareholder return modifier. Because the total shareholder return modifier is considered a market condition, the Company uses a Monte-Carlo simulation model to determine the fair value of performance-based restricted stock units. The fair value of time-vested restricted stock units is determined based on the closing market price of the Company’s stock at the date of grant. Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8, Capital Stock and Stock-Based Compensation Plans.

Currency Translation

The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year.

For subsidiaries operating in highly inflationary environments, local currency-denominated non-monetary assets, including inventories, goodwill and property, plant and equipment, are remeasured at their historical exchange rates, while local currency-denominated monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company.
Recent Accounting Pronouncements

In January 2021, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2021-1, “Reference Rate Reform (Topic 848): Scope” This ASU clarifies that certain optional expedients and exceptions in Topic 848 apply to derivatives that are affected by the discounting transition due to reference rate reform. This guidance was effective upon issuance for the Company and is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In October 2020, the FASB issued ASU No. 2020-10, “Codification Improvements.” This ASU improves the consistency of the codification topics by including all disclosure guidance in the appropriate disclosure section and also clarifies the application of various provisions in the codification. This guidance was effective for the Company beginning on January 1, 2021 and is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (“GAAP”) to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This guidance was effective upon issuance of this ASU for contract modifications and hedging relationships on a prospective basis and is not expected to have a material impact on the Company’s Consolidated Financial Statements.
In March 2020, the FASB issued ASU No. 2020-03, “Codification to Financial Instruments.” This ASU improves and clarifies various financial instruments topics, including the current expected credit losses (“CECL”) standard issued in 2016. The ASU addresses seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments related to Issue 1, Issue 2, Issue 4 and Issue 5 were effective upon issuance of this update. The amendments related to Issue 3, Issue 6 and Issue 7 were effective for the Company beginning on January 1, 2020. The guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)-Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This guidance was effective for the Company beginning on January 1, 2021. This guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In December 2019, the FASB issued ASU No. 2019-12, “Income taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This guidance was effective for the Company beginning on January 1, 2021. This guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In November 2019, the FASB issued ASU No. 2019-11, “Codification Improvements to Topic 326, Financial Instruments - Credit Losses.” This ASU clarifies and addresses certain items related to amendments in ASU 2016-13. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In April 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825).” This ASU clarifies three topics related to financial instruments accounting. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.
In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU No. 2017-04, “Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate implied fair value, essentially eliminating step two from the goodwill impairment test. The standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard was effective for the Company on a prospective basis beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326).” This ASU introduces the current expected credit loss (CECL) model, which requires an entity to measure credit losses for certain financial instruments and financial assets, including trade receivables. Under this update, on initial recognition and at each reporting period, an entity is required to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. The Company adopted the new standard, which primarily impacts the Company’s trade receivables and related methodology for assessing the collectability of its customer accounts, on January 1, 2020, on a “modified retrospective” basis. The adoption of this ASU did not have a material impact on the Company’s Consolidated Financial Statements.

Reclassifications
Certain prior year amounts have been reclassified to conform to the current year presentation.
XML 32 R12.htm IDEA: XBRL DOCUMENT v3.20.4
Acquisitions
12 Months Ended
Dec. 31, 2020
Business Combinations [Abstract]  
Acquisitions Acquisitions
Hello Products LLC (“hello”)

On January 31, 2020, the Company acquired hello, an oral care business, for cash consideration of $351. The acquisition was financed with a combination of debt and cash. This acquisition is part of the Company’s strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses.

The total purchase price consideration of $351 has been allocated to the net assets acquired based on their respective estimated fair values as follows:

Receivables $11 
Inventories 13 
Other assets and liabilities, net (4)
Other intangible assets 160 
Goodwill171 
Fair value of net assets acquired$351 

Other intangible assets acquired include trademarks, valued at $115, which are considered to have a finite useful life of 25 years, and customer relationships valued at $45, which are considered to have a finite useful life of 17 years. Goodwill of $171 was allocated to the North America segment. The Company expects that goodwill will be deductible for tax purposes.

Pro forma results of operations have not been presented as the impact on the Company’s Consolidated Financial Statements is not material.

Laboratoires Filorga Cosmétiques (“Filorga”)

On September 19, 2019, the Company acquired the Filorga skin health business for cash consideration of €1,516 (approximately $1,674), which included interest on the equity purchase price plus additional consideration of €32 (approximately $38), the majority of which related to repayment of loans from former shareholders of Filorga. Filorga is a premium anti-aging skin health brand focused primarily on facial care. This acquisition is part of the Company’s strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses, including by expanding its portfolio in premium skin health.

The total purchase price consideration of $1,712 has been allocated to the net assets acquired based on their respective estimated fair values as follows:
Cash$30 
Receivables53 
Inventories70 
Other current assets18 
Other intangible assets1,051 
Goodwill923 
Other current liabilities(67)
Deferred income taxes(276)
Noncontrolling interests(90)
Fair value of net assets acquired$1,712 
Other intangible assets acquired include trademarks of $774, which are considered to have an indefinite useful life, and customer relationships of $277, which are considered to have a finite useful life of 14 years. Goodwill of $923 was allocated to the Europe segment. Goodwill will not be deductible for tax purposes.

In the third quarter of 2020, the Company completed the purchase of the outstanding non-controlling interest of Filorga’s joint venture based in Hong Kong and covering the Hong Kong and China markets for approximately €85 (approximately $99) in cash.

    The results of operations of Filorga are reported on a lag basis. As such, Filorga’s results of operations from December 1, 2019 through November 30, 2020 and from the Acquisition Date through November 30, 2019 are included in the Company’s Consolidated Results of Operations for the periods ended December 31, 2020 and 2019, respectively.

Pro forma results of operations have not been presented as the impact on the Company’s Consolidated Financial Statements is not material.

Nigeria Joint Venture

On August 15, 2019, the Company acquired a 51% controlling interest in Colgate Tolaram Pte. Ltd., a joint venture which owns the Nigeria-based Hypo Homecare Products Limited, for $31.
Pro forma results of operations have not been presented as the impact on the Company’s Consolidated Financial Statements is not material.
XML 33 R13.htm IDEA: XBRL DOCUMENT v3.20.4
Restructuring and Related Implementation Charges
12 Months Ended
Dec. 31, 2020
Restructuring and Related Activities [Abstract]  
Restructuring and Related Implementation Charges Restructuring and Related Implementation Charges
 
The Company’s restructuring program (the “Global Growth and Efficiency Program”), which commenced in the fourth quarter of 2012, concluded on December 31, 2019. Initiatives under the Global Growth and Efficiency Program fit within the program’s three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions and optimizing the global supply chain and facilities. Substantially all initiatives under the Global Growth and Efficiency Program had been implemented as of December 31, 2019.

In the third quarter of 2020, the Company adjusted the accrual balances related to certain projects approved prior to the conclusion of the Global Growth and Efficiency Program to reflect its revised estimate of remaining liabilities. This adjustment resulted in a reduction of $16 ($13 aftertax), of which $3 was recorded in Selling, general and administrative expenses and $13 was recorded in Other (income) expense, net. During the year ended December 31, 2020, the Company also made cash payments of $53 related to projects approved prior to the conclusion of the Global Growth and Efficiency Program, and the remaining accrual balance at December 31, 2020 was $31. No new restructuring projects were approved for implementation during the year ended December 31, 2020.

For the years ended December 31, 2019 and 2018, restructuring and related implementation charges are reflected in the Consolidated Statements of Income as follows:  
20192018
Cost of sales$$31 
Selling, general and administrative expenses60 33 
Other (income) expense, net57 88 
Non-service related postretirement costs
Total Global Growth and Efficiency Program charges, pretax$132 $161 
Total Global Growth and Efficiency Program charges, aftertax$102 $125 

Restructuring and related implementation charges in the preceding table and the adjustment recorded in the third quarter of 2020 were recorded in the Corporate segment as these initiatives were predominantly centrally directed and controlled and were not included in internal measures of segment operating performance.

Total charges incurred for the Global Growth and Efficiency Program related to initiatives undertaken by the following reportable operating segments:
Total Program
20192018Charges
North America%18 %17 %
Latin America12 %10 %%
Europe%(2)%19 %
Asia Pacific%13 %%
Africa/Eurasia(1)%%%
Hills Pet Nutrition
%19 %%
Corporate73 %37 %42 %
Total100 %100 %100 %
Over the course of the Global Growth and Efficiency Program, the Company incurred total pretax charges of $1,854 ($1,380 aftertax) in connection with the implementation of various projects as follows:
Total Program Charges
as of December 31, 2019
Employee-Related Costs$706 
Incremental Depreciation128 
Asset Impairments58 
Other962 
Total$1,854 

Over the course of the Global Growth and Efficiency Program, the majority of the costs incurred related to the following projects: the implementation of the Company’s overall hubbing strategy; the consolidation of facilities; the extension of shared business services and streamlining of global functions; the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; redesigning the European commercial organization; restructuring how the Company will provide future retirement benefits to substantially all of the U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan; and the implementation of a Corporate efficiencies program.

The following table summarizes the activity for the restructuring and related implementation charges for the years ended December 31, 2019 and 2018 and the related accruals:

 
Employee-Related
Costs 
Incremental
Depreciation
Asset
Impairments
Other
Total
Balance at December 31, 2017$127 $— $— $107 $234 
Charges53 16 90 161 
Cash payments(107)— — (60)(167)
Charges against assets(9)(2)(16)— (27)
Foreign exchange(4)— — — (4)
Other— — — 
Balance at December 31, 2018$60 $— $— $142 $202 
Charges25 36 65 132 
Cash payments(55)— — (58)(113)
Charges against assets(7)(36)(6)(27)(76)
Foreign exchange— — — 
Other— — — (48)(48)
Balance at December 31, 2019$26 $— $— $74 $100 

Employee-Related Costs primarily included severance and other termination benefits and were calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also included pension and other retiree benefit enhancements amounting to $7 and $9 for the years ended December 31, 2019 and 2018, respectively, which are reflected as Charges against assets within Employee-Related Costs in the preceding table as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities. See Note 10, Retirement Plans and Other Retiree Benefits for additional information.
Incremental Depreciation was recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments were recorded to write down inventories and assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consisted primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the Global Growth and Efficiency Program. These charges for the years ended December 31, 2019 and 2018 included third-party incremental costs related to the development and implementation of new business and strategic initiatives of $32 and $42, respectively, and contract termination costs and charges resulting directly from exit activities of $5 and $48, respectively. These charges were expensed as incurred. Also included in Other charges for the year ended December 31, 2019 were other exit costs of $28 related to the consolidation of facilities.

Other decreases to the restructuring accruals reflect the reclassification of restructuring accruals to lease assets as a result of the Company’s adoption of ASU No. 2018-10, “Codification Improvement to Topic 842, Leases,” on January 1, 2019.
XML 34 R14.htm IDEA: XBRL DOCUMENT v3.20.4
Goodwill and Other Intangible Assets
12 Months Ended
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets
The net carrying value of Goodwill as of December 31, 2020 and 2019 by segment was as follows:
  20202019
Oral, Personal and Home Care  
North America$912 $737 
Latin America171 212 
Europe2,415 2,234 
Asia Pacific190 186 
Africa/Eurasia121 124 
Total Oral, Personal and Home Care3,809 3,493 
Pet Nutrition15 15 
Total Goodwill$3,824 $3,508 

The change in the amount of Goodwill during 2020 is primarily due to the acquisition of hello (see Note 3, Acquisitions for further information) and the impact of foreign currency translation.

Other intangible assets as of December 31, 2020 and 2019 were comprised of the following:
  20202019
  Gross Carrying AmountAccumulated AmortizationNetGross Carrying AmountAccumulated AmortizationNet
Trademarks - finite life$902 $(422)$480 $771 $(381)$390 
Other finite life intangible assets786 (237)549 699 (169)530 
Indefinite life intangible assets1,865 — 1,865 1,747 — 1,747 
Total Other intangible assets$3,553 $(659)$2,894 $3,217 $(550)$2,667 

The change in the net carrying amounts of Other intangible assets during 2020 was primarily due to the acquisition of hello (see Note 3, Acquisitions for further information) and amortization expense of $88. Annual estimated amortization expense for each of the next five years is expected to be approximately $83.

As a result of the COVID-19 pandemic, in the first quarter of 2020, the Company assessed whether a “triggering event” had occurred indicating a possible impairment of its goodwill and indefinite-life intangible assets. As a result of this assessment, the Company determined that a “triggering event” had occurred relative to its recently acquired Filorga skin health business and, as required, performed a quantitative analysis, with the assistance of a third-party valuation firm, of the value of the Filorga reporting unit and its indefinite-life intangible assets. Based on the analysis, the Company determined that the fair value of the Filorga reporting unit and the related indefinite-life intangible assets continued to exceed their carrying values and were not impaired.

As of the date of the annual goodwill impairment test, the fair value of the Filorga reporting unit exceeded its carrying value by approximately 10%. Either a reduction in the long-term growth rate of 50 basis points or an increase in the discount rate of 25 basis points would result in the fair value of the Filorga reporting unit exceeding its carrying value by less than 5%. As of the date of the annual impairment test, the fair value of the Filorga indefinite-life intangible assets exceeded their carrying value by less than 10%. Either a reduction in the long-term growth rate of 50 basis points or an increase in the discount rate of 25 basis points would result in the fair value of the Filorga indefinite-life intangible assets approximating their carrying value.
Determining the fair value of the Filorga reporting unit and indefinite-life intangible assets requires significant judgments and estimates by management regarding several key inputs, including future cash flows consistent with management’s strategic plans, sales growth rates and the selection of royalty rates and a discount rate, among others. Estimating sales growth rates requires significant judgment by management in areas such as future economic conditions, category and industry growth rates, product pricing, consumer tastes and preferences and future expansion expectations.

Given the inherent uncertainties in estimating the future impacts of the COVID-19 pandemic on global macroeconomic conditions and interest rates in general and on the Filorga business in particular, actual results may differ from management’s current estimates and could have an adverse impact on one or more of the assumptions used in our quantitative models related to the Filorga reporting unit and the related indefinite-life intangible assets, resulting in potential impairment charges in subsequent periods. Given the recent acquisition of Filorga, where there is inherently a lower surplus of fair value over carrying value, management will continue to assess triggering events that may necessitate additional qualitative or quantitative analyses of our reporting units and indefinite-life intangible assets in future periods.

Except for the recently acquired Filorga business, as described above, where there is inherently a lower surplus of fair value over carrying value, the estimated fair value of the Company’s reporting units substantially exceeds the recorded carrying value. The fair value of the Company’s indefinite-life intangible assets other than Filorga exceeds their recorded carrying value by at least 20%. Therefore, it is not reasonably likely that significant changes in these estimates would occur that would result in an impairment charge related to these assets.
XML 35 R15.htm IDEA: XBRL DOCUMENT v3.20.4
Long-Term Debt and Credit Facilities
12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Long-Term Debt and Credit Facilities Long-Term Debt and Credit Facilities
Long-term debt consisted of the following at December 31:
  Weighted Average Interest RateMaturities20202019
Notes1.9%2021-2078$6,170 $6,988 
Commercial paper(0.3)%20211,139 579 
Finance Lease ObligationsVariousVarious34 20 
7,343 7,587 
Less: Current portion of long-term debt(9)(254)
Total $7,334 $7,333 

The weighted-average interest rate on short-term borrowings included in Notes and loans payable in the Consolidated Balance Sheets as of December 31, 2020 and 2019 was 4.8% and 1.8%, respectively.

The Company classifies commercial paper and notes maturing within the next twelve months as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis. Excluding such obligations, scheduled maturities of long-term debt and finance leases outstanding as of December 31, 2020, were as follows:  
Years Ended December 31,
2021
$631 
2022413 
2023896 
2024498 
2025130 
Thereafter3,636 

The Company has entered into interest rate swap agreements and foreign exchange contracts related to certain of these debt instruments. See Note 7, Fair Value Measurements and Financial Instruments for further information about the Company’s financial instruments.

The Company’s debt issuances and redemptions support its capital structure strategy objectives of funding its business and growth initiatives while minimizing its risk-adjusted cost of capital. During the first quarter of 2019, the Company issued €500 of seven-year notes at a fixed coupon rate of 0.500% and €500 of fifteen-year notes at a fixed coupon rate of 1.375%. During the fourth quarter of 2019, the Company issued €500 of two-year notes at a fixed coupon rate of 0.000% and €500 of twenty-year notes at a fixed coupon rate of 0.875%. The debt issuances were under the Company’s shelf registration statement. Proceeds from the debt issuances were used for general corporate purposes, which included the retirement of commercial paper and, in the case of the debt issuances in the first quarter of 2019, the repayment of the Company’s $500 1.750% fixed rate notes, which became due in March 2019, and €500 floating rate notes, which became due in May 2019.

During the fourth quarter of 2020, the Company redeemed prior to maturity all of its outstanding 2.450% notes due 2021 with a principal amount $300, originally issued on November 8, 2011, and all of its outstanding 2.300% notes due 2022 with a principal amount of $500, originally issued on May 3, 2012. These redemptions were financed with commercial paper borrowings and cash. The Company recorded a loss on the early extinguishment of debt of $23, which is included in Interest (income) expense, net in the Consolidated Statements of Income, representing the difference between the redemption price and the carrying amount of the debt extinguished.
At December 31, 2020, the Company had access to unused domestic and foreign lines of credit of $4,657 (including under the facilities discussed below) and could also issue long-term debt pursuant to an effective shelf registration statement. In November 2018, the Company entered into an amended and restated $2,650 revolving credit facility with a syndicate of banks that was scheduled to expire in November 2023. In August 2019, the term of the facility was extended by one year and it now expires in November 2024. In August 2020, the Company entered into a $1,500 364-day credit facility with a syndicate of banks that is scheduled to expire in August 2021. Commitment fees related to the credit facilities are not material.

Certain agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote.
XML 36 R16.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurements and Financial Instruments
12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
Fair Value Measurements and Financial Instruments Fair Value Measurements and Financial Instruments
The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Provided below are details of the Company’s exposures by type of risk and derivative instruments by type of hedge designation.

Valuation Considerations

The Company’s derivative instruments include interest rate swap contracts, forward-starting interest rate swaps, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are classified as follows:

Level 1: Based upon quoted market prices in active markets for identical assets or liabilities.
Level 2: Based upon observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Based upon unobservable inputs reflecting the reporting entity’s own assumptions.

Foreign Exchange Risk

As the Company markets its products in over 200 countries and territories, it is exposed to currency fluctuations related to manufacturing and selling its products in currencies other than the U.S. dollar. The Company manages its foreign currency exposures through a combination of cost containment measures, sourcing strategies, selling price increases and the hedging of certain costs in an effort to minimize the impact on earnings of foreign currency rate movements.

The Company primarily utilizes foreign currency contracts, including forward and swap contracts, option contracts, foreign and local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. The duration of foreign currency contracts generally does not exceed 12 months and the contracts are valued using observable market rates (Level 2 valuation).

Interest Rate Risk

The Company manages its targeted mix of fixed and floating rate debt with debt issuances and by entering into interest rate swaps in order to mitigate fluctuations in earnings and cash flows that may result from interest rate volatility. The Company utilizes forward-starting interest rate swaps to mitigate the risk of variability in interest rate for future debt issuances. The notional amount, interest payment and maturity date of the swaps generally match the principal, interest payment and maturity date of the related debt, and the swaps are valued using observable benchmark rates (Level 2 valuation).
Commodity Price Risk

The Company is exposed to price volatility related to raw materials used in production, such as essential oils, resins, pulp, tropical oils, tallow, corn, poultry and soybeans. The Company manages its raw material exposures through a combination of cost containment measures, sourcing strategies, ongoing productivity initiatives and the limited use of commodity hedging contracts. Futures contracts are used on a limited basis, primarily in the Hill’s Pet Nutrition segment, to manage volatility related to raw material inventory purchases of certain traded commodities, and these contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of the commodity contracts generally does not exceed 12 months.

Credit Risk

The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material as it is the Company’s policy to contract with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets as of December 31, 2020 and December 31, 2019:

 AssetsLiabilities
 AccountFair ValueAccountFair Value
Designated derivative instruments
 December 31, 2020December 31, 2019 December 31, 2020December 31, 2019
Interest rate swap contractsOther assets14 Other liabilities— — 
Forward-starting interest rate swapsOther assets— Other liabilities— — 
Foreign currency contractsOther current assetsOther accruals93 15 
Foreign currency contractsOther assets— — Other liabilities— 14 
Commodity contractsOther current assets— Other accruals— — 
Total designated $29 $10  $93 $29 
Other financial instruments      
Marketable securitiesOther current assets37 23    
Total other financial instruments $37 $23    
The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of December 31, 2020 and 2019. The estimated fair value of the Company’s long-term debt, including the current portion, as of December 31, 2020 and 2019, was $8,175 and $8,056, respectively, and the related carrying value was $7,343 and $7,587, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

The following amounts were recorded on the Consolidated Balance Sheet related to cumulative basis adjustment for fair value hedges as of:
December 31, 2020December 31, 2019
Long-term debt:  
Carrying amount of hedged item$413 $403 
Cumulative hedging adjustment included in the carrying amount$14 $

The following tables present the notional values as of:

 December 31, 2020
 Foreign
Currency
Contracts
Foreign Currency DebtInterest Rate SwapsForward-Starting Interest Rate SwapsCommodity Contracts 
Total
Fair Value Hedges $589 $— $400 $— $— $989 
Cash Flow Hedges 854 — — 300 17 1,171 
Net Investment Hedges528 4,523 — — — 5,051 


 December 31, 2019
 Foreign
Currency
Contracts
Foreign Currency DebtInterest Rate SwapsForward-Starting Interest Rate SwapsCommodity Contracts 
Total
Fair Value Hedges $388 $— $400 $— $— $788 
Cash Flow Hedges 761 — — — 20 781 
Net Investment Hedges478 3,856 — — — 4,334 
The following table presents the location and amount of gains (losses) on hedges recognized on the Company’s Consolidated Statements of Income:
Twelve Months Ended December 31,
 20202019
Cost of sales Selling, general and administrative expensesInterest (income) expense, netCost of salesSelling, general and administrative expensesInterest (income) expense, net
Gain (loss) on hedges recognized in income:
Interest rate swaps designated as fair value hedges:
Derivative instrument$— $— $(10)$— $— $(11)
Hedged items— — 10 — — 11 
Foreign currency contracts designated as fair value hedges:
Derivative instrument— 29 — — 10 — 
Hedged items— (29)— — (10)— 
Foreign currency contracts designated as cash flow hedges:
Amount reclassified from OCI— — — — 
Commodity contracts designated as cash flow hedges:
Amount reclassified from OCI(1)— — — — 
Total gain (loss) on hedges recognized in income$— $— $— $$— $— 
The following table presents the location and amount of unrealized gains (losses) on hedges included in OCI:
 Twelve Months Ended
December 31,
20202019
Foreign currency contracts designated as cash flow hedges:
Gain (loss) recognized in OCI$(11)$(9)
Forward-starting interest rate swaps designated as cash flow hedges:
Gain (loss) recognized in OCI— 
Commodity contracts designated as cash flow hedges:
Gain (loss) recognized in OCI— 
Foreign currency contracts designated as net investment hedges:
Gain (loss) on instruments(52)
Gain (loss) on hedged items52 (4)
Foreign currency debt designated as net investment hedges:
Gain (loss) on instruments(356)12 
Gain (loss) on hedged items356 (12)
Total unrealized gain (loss) on hedges recognized in OCI$(3)$(9)
XML 37 R17.htm IDEA: XBRL DOCUMENT v3.20.4
Capital Stock and Stock-Based Compensation Plans
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Capital Stock and Stock-Based Compensation Plans Capital Stock and Stock-Based Compensation Plans
Preference Stock

The Company has the authority to issue 50,262,150 shares of preference stock. 

Stock Repurchases

On June 18, 2018, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2018 Program”), which replaced a previously authorized share repurchase program. The Company commenced repurchases of shares of the Company’s common stock under the 2018 Program beginning June 19, 2018. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors. The Company repurchased its common stock at a cost of $1,476 during 2020 under the 2018 Program.

The Company may use either authorized and unissued shares or treasury shares to meet share requirements resulting from the exercise of stock options and the vesting of restricted stock unit awards.

A summary of common stock and treasury stock activity for the three years ended December 31 is as follows:
  Common Stock OutstandingTreasury Stock
Balance, January 1, 2018874,701,118 591,005,242 
Common stock acquired(18,786,897)18,786,897 
Shares issued for stock options6,040,920 (6,040,920)
Shares issued for restricted stock units and other957,651 (957,651)
Balance, December 31, 2018862,912,792 602,793,568 
Common stock acquired(17,219,642)17,219,642 
Shares issued for stock options8,145,777 (8,145,777)
Shares issued for restricted stock units and other862,852 (862,852)
Balance, December 31, 2019854,701,779 611,004,581 
Common stock acquired(18,701,843)18,701,843 
Shares issued for stock options13,018,354 (13,018,354)
Shares issued for restricted stock units and other875,311 (875,311)
Balance, December 31, 2020849,893,601 615,812,759 
Stock-Based Compensation

The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units, based on the fair value of those awards at the date of grant. The fair value of restricted stock units, generally based on market prices, is amortized on a straight-line basis over the requisite service period. The estimated fair value of stock options on the date of grant is amortized on a straight-line basis over the requisite service period for each separately vesting portion of the award. Awards to employees eligible for retirement prior to the award becoming fully vested are recognized as compensation cost from the grant date through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award.

The Company has one incentive compensation plan pursuant to which it issues restricted stock units (both performance-based and time-vested) and stock options to employees and shares of common stock and stock options to non-employee directors. The Personnel and Organization Committee of the Board of Directors, which is comprised entirely of independent directors, administers the incentive compensation plan. The total stock-based compensation expense charged against pretax income for this plan was $107, $100 and $109 for the years ended December 31, 2020, 2019 and 2018, respectively. The total income tax benefit recognized on stock-based compensation, excluding excess tax benefits discussed below, was approximately $20, $20 and $25 for the years ended December 31, 2020, 2019 and 2018, respectively.

Stock-based compensation expense is recorded within Selling, general and administrative expenses in the Corporate segment as these amounts are not included in internal measures of segment operating performance.

The Company uses the Black-Scholes option pricing model to estimate the fair value of stock option awards. The weighted-average estimated fair value of stock options granted in the years ended December 31, 2020, 2019 and 2018 was $11.26, $10.48 and $9.48, respectively. Fair value is estimated using the Black-Scholes option pricing model with the assumptions summarized in the following table:

  202020192018
Expected term of options6 years6 years4.5 years
Expected volatility rate21.8 %19.2 %17.7 %
Risk-free interest rate0.5 %1.5 %2.8 %
Expected dividend yield2.3 %2.3 %2.5 %

The weighted-average expected term of options granted each year was determined with reference to historical exercise and post-vesting cancellation experience, the vesting period of the awards and the contractual term of the awards, among other factors. Expected volatility incorporates implied share-price volatility derived from exchange traded options on the Company’s common stock. The risk-free interest rate for the expected term of the option is based on the yield of a zero-coupon U.S. Treasury bond with a maturity period equal to the option’s expected term.
Performance-based Restricted Stock Units

In 2019, the Company evolved its approach to granting long-term incentive compensation from granting time-vested restricted stock units following the conclusion of a three-year performance cycle to granting officers and other key employees a target number of unearned performance-based restricted stock units at the beginning of each three-year performance cycle. Awards are earned and vest following the conclusion of the performance period on the basis of achievement of performance goals established at the commencement of each three-year performance period.

A summary of performance-based restricted stock unit activity for the year ended December 31, 2020 is presented below:

  Shares
(in thousands)
Weighted Average Grant Date Fair Value Per Award
Performance-based restricted stock units as of January 1, 2020346 $67 
Activity:
Granted557 76 
Forfeited(38)69 
Performance-based restricted stock units as of December 31, 2020865 $73 


As of December 31, 2020, there was $41 of total unrecognized compensation expense related to unvested performance-based restricted stock unit awards, which will be recognized ratably over the remaining performance period.

The Company uses a Monte-Carlo simulation model to estimate the fair value of performance-based restricted stock units at the date of grant.

Time-Vested Restricted Stock Units

The Company also grants time-vested restricted stock unit awards. As described above, under the Company’s previous long-term incentive program, time-vested restricted stock unit awards were granted to officers and other key employees following a three-year performance period. Awards vest at the end of the restriction period, which is three years from the date of grant. The most recent award granted under the previous long-term incentive program was in 2018 for the 2015-2017 performance period. No awards were granted for the 2016-2018 or 2017-2019 performance periods. Awards for the 2018-2020 performance period will be granted in 2021. As of December 31, 2020, approximately 12,420,000 shares of common stock were available for future restricted stock unit awards.

A summary of restricted stock unit activity during 2020 is presented below:
  Shares
(in thousands)
Weighted Average Grant Date Fair Value Per Award
Restricted stock units as of January 1, 20202,203 $71 
Activity:
Granted727 77 
Vested(1,130)74 
Forfeited(63)71 
Restricted stock units as of December 31, 20201,737 $73 
As of December 31, 2020, there was $58 of total unrecognized compensation expense related to unvested restricted stock unit awards, which will be recognized over a weighted-average period of 2.1 years. The total fair value of restricted stock units vested during the years ended December 31, 2020, 2019 and 2018 was $58, $53 and $55, respectively.

Stock Options

The Company issues non-qualified stock options to non-employee directors, officers and other employees. Beginning in 2019, stock options have a contractual term of eight years. Prior to 2019, stock options generally had a contractual term of six years. Stock options generally vest ratably over three years. As of December 31, 2020, approximately 36,144,000 shares of common stock were available for future stock option grants.

A summary of stock option activity during 2020 is presented below:
  Shares
(in thousands)
Weighted Average Exercise PriceWeighted Average Remaining Contractual Life
(in years)
Intrinsic Value of Unexercised
In-the-Money Options
Options outstanding, January 1, 202036,185 $69 
Granted4,976 76   
Exercised(13,019)67   
Forfeited or expired(601)72   
Options outstanding, December 31, 202027,541 72 4$386 
Options exercisable, December 31, 202018,084 $70 3$274 

As of December 31, 2020, there was $32 of total unrecognized compensation expense related to unvested options, which will be recognized over a weighted-average period of 1.5 years. The total intrinsic value of options exercised during the years ended December 31, 2020, 2019 and 2018 was $136, $84 and $92, respectively.

The benefits of tax deductions in excess of grant date fair value resulting from the exercise of stock options and vesting of restricted stock unit awards for the years ended December 31, 2020, 2019 and 2018 were $8, $6 and $12, respectively, and are recognized in the provision for income taxes as a discrete item in the quarterly period in which they occur and classified as an operating cash flow. Cash proceeds received from options exercised for the years ended December 31, 2020, 2019 and 2018 were $874, $498 and $329, respectively.
XML 38 R18.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Stock Ownership Plan
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Employee Stock Ownership Plan Employee Stock Ownership Plan
In 1989, the Company expanded its Employee Stock Ownership Plan (ESOP) through the introduction of a leveraged ESOP that funds certain benefits for employees who have met eligibility requirements. As of December 31, 2020 and 2019, there were 11,545,950 and 13,359,448 shares of common stock, respectively, outstanding and issued to the Companys ESOP.

During 2000, the ESOP entered into a loan agreement with the Company under which the benefits of the ESOP may be extended through 2035. As of December 31, 2020, the ESOP had outstanding borrowings from the Company of $1, which represents unearned compensation shown as a reduction in Shareholders’ equity.

Dividends on stock held by the ESOP are paid to the ESOP trust and, together with cash contributions from the Company, are (a) used by the ESOP to repay principal and interest, (b) credited to participant accounts or (c) used for contributions to the Company’s defined contribution plans. Stock is allocated to participants based upon the ratio of the current year’s debt service to the sum of total outstanding principal and interest payments over the life of the debt. As of December 31, 2020, 10,454,105 shares of common stock had been released and allocated to participant accounts and 1,091,845 shares of common stock were available for future allocation to participant accounts.

Dividends on the stock used to repay principal and interest or credited to participant accounts are deductible for income tax purposes and, accordingly, are reflected net of their tax benefit in the Consolidated Statements of Changes in Shareholders’ Equity.

Annual expense related to the ESOP was $0 in 2020, 2019 and 2018.

The Company paid dividends on the shares held by the ESOP of $23 in 2020, $25 in 2019 and $29 in 2018. The Company did not make any contributions to the ESOP in 2020, 2019 or 2018.
XML 39 R19.htm IDEA: XBRL DOCUMENT v3.20.4
Retirement Plans and Other Retiree Benefits
12 Months Ended
Dec. 31, 2020
Retirement Benefits [Abstract]  
Retirement Plans and Other Retiree Benefits Retirement Plans and Other Retiree Benefits
Retirement Plans

The Company and certain of its U.S. and foreign subsidiaries maintain defined benefit retirement plans. Benefits under these plans are based primarily on years of service and employees’ earnings.

In the U.S., effective January 1, 2014, the Company provides virtually all future retirement benefits through the Company’s defined contribution plan. As a result, service after December 31, 2013 is not considered for participants in the Company’s principal U.S. defined benefit retirement plan. Participants in the Company’s principal U.S. defined benefit retirement plan whose retirement benefit was determined under the cash balance formula continue to earn interest credits on their vested balances as of December 31, 2013 but no longer receive pay credits. Participants whose retirement benefit was determined under the final average earnings formula or career average earnings formula continue to have their accrued benefit adjusted for pay increases until termination of employment.
In the Company’s principal U.S. plans and certain funded foreign plans, funds are contributed to trusts in accordance with regulatory limits to provide for current service and for any unfunded projected benefit obligation over a reasonable period. The target asset allocation for the Company’s defined benefit plans is as follows:
  United StatesInternational
Asset Category
Equity securities21 %38 %
Fixed income securities74 %46 %
Real estate and other investments%16 %
Total100 %100 %

At December 31, 2020, the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:
 Level of Valuation
Input
Pension Plans 
  United StatesInternationalOther Retiree
Benefit Plans
     
Cash and cash equivalentsLevel 1$50 $12 $— 
U.S. common stocksLevel 1— — 
International common stocksLevel 1— — 
Pooled funds(1)
Level 165 117 — 
Fixed income securities(2)
Level 21,117 59 
Guaranteed investment contracts(3)
Level 255 — 
  1,233 252 
Investments valued using NAV per share(4)
  
Domestic, developed and emerging markets equity funds  456 183 
Fixed income funds(5)
  136 225 — 
Hedge funds(6)
  — — 
Multi-asset funds(7)
  77 — 
Real estate funds(8)
34 30 — 
  703 446 
Other assets and liabilities, net(9)
(15)— — 
Total Investments$1,921 $698 $
At December 31, 2019, the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:
 Level of Valuation
Input
Pension Plans 
  United StatesInternationalOther Retiree
Benefit Plans
    
Cash and cash equivalentsLevel 1$41 $15 $
U.S. common stocksLevel 149 
International common stocksLevel 1— — 
Pooled funds(1)
Level 129 104 
Fixed income securities(2)
Level 21,067 14 20 
Guaranteed investment contracts(3)
Level 242 — 
  1,187 181 24 
Investments valued using NAV per share(4)
  
Domestic, developed and emerging markets equity funds  328 165 
Fixed income funds(5)
  177 196 
Hedge funds(6)
  17 — 
Multi-asset funds(7)
  155 
Real estate funds(8)
41 25 
704 405 13 
Other assets and liabilities, net(9)
(85)— — 
Total Investments  $1,806 $586 $37 
_______
(1)Pooled funds primarily invest in U.S. and foreign equity securities, debt and money market securities.
(2)The fixed income securities are traded over-the-counter and certain of these securities lack daily pricing or liquidity and as such are classified as Level 2. As of both December 31, 2020 and 2019, approximately 50% of the U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in other government bonds and corporate bonds.
(3)The guaranteed investment contracts (“GICs”) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption.
(4)Investments that are measured at fair value using net asset value (“NAV”) per share as a practical expedient have not been classified in the fair value hierarchy. The NAV is based on the value of the underlying investments owned, minus its liabilities, divided by the number of shares outstanding. There are no unfunded commitments related to these investments. Redemption notice period primarily ranges from 0-3 months and redemption frequency windows range from daily to quarterly.
(5)Fixed income funds primarily invest in U.S. government and investment grade corporate bonds.
(6)Consists of investments in underlying hedge fund strategies that are primarily implemented through the use of long and short equity and fixed income securities and derivative instruments such as futures and options.
(7)Multi-asset funds primarily invest across a variety of asset classes, including global stocks and bonds, as well as alternative strategies.
(8)Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager.
(9)This category primarily includes unsettled trades for investments purchased and sold and dividend receivables.
Equity securities in the U.S. plans include investments in the Company’s common stock representing 0% and 3% of U.S. plan assets at December 31, 2020 and December 31, 2019, respectively. In 2020 and 2019, the U.S. plans sold 739,869 and 588,334 shares, respectively, of the Company’s common stock to the Company. No shares of the Company’s stock were purchased by the U.S. plans in 2020 or 2019. The plans received dividends on the Company’s common stock of $0 in 2020 and $2 in 2019.

Other Retiree Benefits

The Company and certain of its subsidiaries provide health care and life insurance benefits for retired employees to the extent not provided by government-sponsored plans.

The Company uses a December 31 measurement date for its defined benefit and other retiree benefit plans. Summarized information for the Company’s defined benefit and other retiree benefit plans is as follows:
  Pension PlansOther Retiree Benefit Plans
 202020192020201920202019
  United StatesInternational  
Change in Benefit Obligations      
Benefit obligations at beginning of year$2,272 $2,147 $876 $787 $1,050 $876 
Service cost17 14 20 15 
Interest cost74 90 21 22 37 41 
Participants’ contributions— — — — 
Acquisitions/plan amendments— — 30 — — 
Actuarial loss (gain)171 181 65 82 61 166 
Foreign exchange impact— — 46 (9)
Termination benefits— — — — 
Curtailments and settlements(3)— (7)(9)— — 
Benefit payments(155)(154)(40)(35)(47)(49)
Other— — — — — 
Benefit obligations at end of year$2,363 $2,272 $1,013 $876 $1,112 $1,050 
Change in Plan Assets  
Fair value of plan assets at beginning of year$1,806 $1,568 $586 $510 $37 $54 
Actual return on plan assets243 262 59 76 
Company contributions30 130 36 30 11 24 
Participants’ contributions— — — — 
Foreign exchange impact— — 26 12 — — 
Settlements and acquisitions(3)— 26 (9)— — 
Benefit payments(155)(154)(40)(35)(47)(49)
Other— — — — — — 
Fair value of plan assets at end of year$1,921 $1,806 $698 $586 $$37 
Funded Status  
Benefit obligations at end of year$2,363 $2,272 $1,013 $876 $1,112 $1,050 
Fair value of plan assets at end of year1,921 1,806 698 586 37 
Net amount recognized$(442)$(466)$(315)$(290)$(1,109)$(1,013)
Amounts Recognized in Balance Sheet    
Noncurrent assets$20 $— $18 $13 $— $— 
Current liabilities(30)(28)(14)(13)(45)(13)
Noncurrent liabilities(432)(438)(319)(290)(1,064)(1,000)
Net amount recognized$(442)$(466)$(315)$(290)$(1,109)$(1,013)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
  
Actuarial loss$902 $910 $255 $238 $429 $388 
Transition/prior service cost— (1)
  $903 $911 $262 $245 $429 $387 
Accumulated benefit obligation$2,325 $2,236 $946 $816 $— $— 
  Pension PlansOther Retiree Benefit Plans
  202020192020201920202019
  United StatesInternational  
Weighted-Average Assumptions Used to Determine Benefit Obligations
      
Discount rate2.65 %3.40 %1.61 %2.06 %2.88 %3.56 %
Expected long-term rate of return on plan assets5.70 %6.30 %2.93 %3.38 %5.70 %6.30 %
Long-term rate of compensation increase3.50 %3.50 %2.62 %2.83 %3.50 %3.50 %
ESOP growth rate— %— %— %— %10.00 %10.00 %
Medical cost trend rate of increase— %— %— %— %6.00 %6.00 %
Interest Crediting Rate2.48 %3.21 %0.83 %0.85 %— %— %

The actuarial losses incurred during 2020 were primarily driven by a decrease in discount rates applied against future expected benefit payments that resulted in an increase in the benefit obligation for both the U.S. pension and Other retiree benefit plans. The actuarial gains recorded during 2019 for both the U.S. pension and other retiree benefit plans were primarily a result of an increase in discount rates applied against future estimated benefit payments.
The overall investment objective of the plans is to balance risk and return so that obligations to employees are met. The Company evaluates its expected long-term rate of return on plan assets on an annual basis. In determining the expected long-term rate of return, the Company considers the nature of the plans’ investments and the historical rates of return. The assumed expected long-term rate of return on plan assets as of December 31, 2020 for the U.S. plans was 5.70%. Average annual rates of return for the U.S. plans for the most recent 1-year, 5-year, 10-year, 15-year and 25-year periods were 15%, 9%, 8%, 7% and 7%, respectively. Similar assessments were performed in determining rates of return on international pension plan assets to arrive at the Company’s 2020 weighted-average expected long-term rate of return on plan assets of 2.93%.

The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 6.00% in 2021 to 4.75% by 2026, remaining at 4.75% for the years thereafter.
Pension plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consisted of the following:
  20202019
Benefit Obligation Exceeds Fair Value of Plan Assets  
Projected benefit obligation$1,092 $2,862 
Fair value of plan assets299 2,094 
Accumulated benefit obligation882 875 
Fair value of plan assets134 166 

Other Retiree Benefit plans with accumulated postretirement benefit obligation in excess of plan assets as of December 31 consisted of the following:
  20202019
Benefit Obligation Exceeds Fair Value of Plan Assets  
Accumulated postretirement benefit obligation$1,112 $958 
Fair value of plan assets37 

Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows:
  Pension PlansOther Retiree Benefit Plans
  202020192018202020192018202020192018
  United StatesInternational   
Components of Net Periodic Benefit Cost
         
Service cost$$$$17 $14 $14 $20 $15 $16 
Interest cost74 90 86 21 22 21 37 41 38 
Expected return on plan assets
(111)(103)(115)(22)(19)(21)(2)(3)(2)
Amortization of transition and prior service costs (credits)
— — — — — — — — 
Amortization of actuarial loss
46 51 47 18 11 14 
Net periodic benefit cost$10 $39 $19 $25 $27 $22 $73 $64 $66 
Other postretirement charges
— — — — 
Total pension cost$14 $46 $28 $25 $28 $24 $73 $64 $66 
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
         
Discount rate3.40 %4.38 %3.73 %

2.06 %2.80 %2.53 %3.56 %4.43 %3.80 %
Expected long-term rate of return on plan assets6.30 %6.60 %6.60 %3.38 %4.06 %4.04 %6.30 %6.60 %6.60 %
Long-term rate of compensation increase
3.50 %3.50 %3.50 %2.83 %2.86 %2.79 %— %— %— %
ESOP growth rate— %— %— %— %— %— %10.00 %10.00 %10.00 %
Medical cost trend rate of increase— %— %— %— %— %— %6.00 %6.00 %6.00 %
Interest Crediting Rate3.21 %4.26 %3.73 %0.85 %0.85 %0.85 %— %— %— %
The service related component of pension and other postretirement benefit costs is included in Operating profit. The non-service related components (interest cost, expected return on assets and amortization of actuarial gains and losses) are included in the line item “Non-service related postretirement costs,” which is below Operating profit.

Other postretirement charges in 2020, 2019 and 2018 include pension and other benefit enhancements amounting to $3, $7 and $9, respectively. Other postretirement charges from 2019 and 2018 were incurred pursuant to the Global Growth and Efficiency Program. Other postretirement charges in 2019 also include charges of $1, in part due to retirements under the Global Growth and Efficiency Program.

The Company made voluntary contributions of $0, $113 and $67 in 2020, 2019 and 2018, respectively, to its U.S. retirement plans.

Expected Contributions and Benefit Payments

The Company does not expect to make any voluntary contributions to its U.S. postretirement plans for the year ending December 31, 2021. Actual funding may differ from current estimates depending on the variability of the market value of the assets as compared to the obligation and other market or regulatory conditions.

Benefit payments expected to be paid from the Company’s assets to participants in unfunded plans are estimated to be approximately $90 for the year ending December 31, 2021.

Total benefit payments expected to be paid to participants in both funded and unfunded plans are estimated as follows:
  Pension Plans 
Years Ended December 31,United StatesInternationalOther Retiree Benefit PlansTotal
2021$154 $42 $49 $245 
2022156 41 49 246 
2023157 42 50 249 
2024156 46 51 253 
2025155 45 52 252 
2026-2030741 244 269 1,254 
XML 40 R20.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The components of Income before income taxes are as follows for the years ended December 31:
  202020192018
United States$1,317 $1,050 $1,175 
International2,330 2,251 2,289 
Total Income before income taxes$3,647 $3,301 $3,464 

The Provision for income taxes consists of the following for the years ended December 31:
  202020192018
United States$259 $180 $213 
International528 594 693 
Total Provision for income taxes$787 $774 $906 

Temporary differences between accounting for financial statement purposes and accounting for tax purposes result in the current provision for taxes being higher (lower) than the total provision for income taxes as follows:
  202020192018
Goodwill and intangible assets$$34 $
Property, plant and equipment12 12 (15)
Pension and other retiree benefits10 (13)(7)
Stock-based compensation(7)(1)
Right-of-use assets/lease liabilities(1)— — 
Tax credits and tax loss carryforwards(1)(4)
Deferred withholding tax111 (21)(100)
Other, net18 (33)62 
Total deferred tax benefit (provision)$143 $(19)$(53)
The difference between the statutory U.S. federal income tax rate and the Company’s global effective tax rate as reflected in the Consolidated Statements of Income is as follows:
Percentage of Income before income taxes202020192018
Tax at United States statutory rate21.0 %21.0 %21.0 %
State income taxes, net of federal benefit1.0 0.6 1.0 
Earnings taxed at other than United States statutory rate3.3 4.6 5.6 
Charge for U.S. tax reform(1)
— — 2.3 
Foreign tax credit carryback(2)
— — (1.7)
Benefit for foreign tax matters(3)
(2.0)(0.9)(0.4)
Foreign-derived intangible income benefit(1.6)(1.3)(1.1)
Other, net(0.1)(0.6)(0.5)
Effective tax rate21.6 %23.4 %26.2 %
_________
(1)On December 22, 2017, the Tax Cuts and Jobs Act (the “TCJA”) was enacted, which, among other things, lowered the U.S. corporate income tax rate to 21% from 35% and established a modified territorial system requiring a mandatory deemed repatriation tax on undistributed earnings of foreign subsidiaries. Beginning in 2018, the TCJA also requires a minimum tax on certain earnings generated by foreign subsidiaries while providing for tax-free repatriation of such earnings through a 100% dividends-received deduction. The Company’s effective income tax rate in 2017 included a provisional charge of $275, recorded in the fourth quarter of 2017, based on its initial analysis of the TCJA using information and estimates available as of February 15, 2018, the date on which the Company filed its Annual Report on Form 10-K for the year ended December 31, 2017. During 2018, the Company finalized its assessment of the impact of the TCJA and recognized an additional tax expense of $80 reflecting the impact of transition tax guidance issued by the U.S. Treasury and the update of certain estimates and calculations based on information available through the end of 2018. Any further guidance issued after December 31, 2018 may have an impact to the Company’s Provision for income tax in the period such guidance is effective.
(2)In 2018, the Company generated excess foreign taxes associated with its foreign branch operations which are being carried back to 2017. This item is not expected to be recurring.
(3)In 2020, the provision for income taxes includes $71 of income tax benefits recorded on a discrete period basis, of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As part of the previously recorded charge for the TCJA, the Company has provided for foreign withholding taxes expected to be paid on the remittance of earnings from certain overseas subsidiaries no longer deemed indefinitely reinvested. As a result of a recent reorganization of the ownership structure of certain foreign subsidiaries, the Company determined that no withholding taxes will be due on the remittance by certain subsidiaries of earnings previously deemed reinvested and, accordingly, reversed $45 of previously recorded foreign withholding taxes. Also as part of the previously recorded charge for the TCJA, the Company provided a valuation allowance against a deferred tax asset related to the foreign tax credit carryforwards that the Company did not expect to be able to use due to changes made by the TCJA. As a result of a new operating structure being implemented within one of the Company's divisions, the Company believes the use of these foreign tax credit carryforwards will not be limited in the future and, accordingly, reversed the previously recorded valuation allowance of $26. In 2019, the provision for income taxes includes a net benefit of $29 related to changes enacted by the Swiss government to its corporate tax regime, which included, among other items, the repeal of certain preferential tax regimes and an increase to the cantonal tax rate for future periods. Additionally, the government provided transition rules which allowed companies to record goodwill for tax purposes, partially offsetting the impact on cash taxes of the higher cantonal rate over the next ten years. In 2018, the provision for income taxes includes a benefit of $15 related to several Supreme Court and Administrative Court rulings in a foreign jurisdiction allowing certain tax deductions which had the effect of reversing prior decisions.
The components of deferred tax assets (liabilities) are as follows at December 31:
  20202019
Deferred tax liabilities: 
Goodwill and intangible assets$(603)$(598)
Property, plant and equipment(281)(303)
Right-of-use assets(131)(135)
Deferred withholding tax(95)(207)
Other(52)(46)
Total deferred tax liabilities(1,162)(1,289)
Deferred tax assets: 
Pension and other retiree benefits404 381 
Tax credits and tax loss carryforwards42 93 
Lease liabilities144 152 
Accrued liabilities250 221 
Stock-based compensation73 88 
Other125 83 
Total deferred tax assets1,038 1,018 
Valuation Allowance$(11)$(59)
Net deferred tax assets$1,027 $959 
Net deferred income taxes$(135)$(330)

20202019
Deferred taxes included within:  
Assets:
Deferred income taxes$291 $177 
Liabilities:
Deferred income taxes(426)(507)
Net deferred income taxes$(135)$(330)

Applicable U.S. income and foreign withholding taxes have been provided on substantially all of the Company’s accumulated earnings of foreign subsidiaries.

Net tax benefits of $101, $13 and $2 were recorded directly through equity in 2020, 2019 and 2018, respectively. The net tax benefits in 2020 and 2019 predominantly include current and future tax impacts related to benefit plans. The amount in 2018 includes current and future tax impacts related to employee equity compensation and benefit plans.

The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return.
Unrecognized tax benefits activity for the years ended December 31, 2020, 2019 and 2018 is summarized below:
  202020192018
Unrecognized tax benefits:   
Balance, January 1$173 $190 $214 
Increases as a result of tax positions taken during the current year18 14 14 
Decreases of tax positions taken during prior years(5)(21)(37)
Increases of tax positions taken during prior years57 20 
Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations
(19)(30)(6)
Effect of foreign currency rate movements
— (4)
Balance, December 31$227 $173 $190 

If all of the unrecognized tax benefits for 2020 above were recognized, approximately $213 would impact the effective tax rate and would result in a cash outflow of approximately $223. Although it is possible that the amount of unrecognized benefits with respect to our uncertain tax positions will increase or decrease in the next twelve months, the Company does not expect material changes.

The Company recognized approximately $9 of interest expense, $0 of interest expense, $1 of interest benefit related to the above unrecognized tax benefits within income tax expense in 2020, 2019 and 2018, respectively. The Company had accrued interest of approximately $24, $23 and $27 as of December 31, 2020, 2019 and 2018, respectively.

The Company and its subsidiaries file U.S. federal income tax returns as well as income tax returns in many state and foreign jurisdictions. All U.S. federal income tax returns through December 31, 2013 have been audited by the IRS and there are limited matters which the Company plans to appeal for years 2010 through 2013, the settlement of which is not expected to have a material effect on the Company’s results of operations, cash flows or financial condition. With a few exceptions, the Company is no longer subject to U.S. state and local income tax examinations for income tax returns through December 31, 2015. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations for tax audits generally ranging from three to six years.

The Company has made an accounting policy election to treat Global Intangible Low-Taxed Income taxes as a current period expense rather than including these amounts in the measurement of deferred taxes.
XML 41 R21.htm IDEA: XBRL DOCUMENT v3.20.4
Earnings Per Share
12 Months Ended
Dec. 31, 2020
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
For the years ended December 31, 2020, 2019 and 2018, earnings per share were as follows:
 202020192018
 Net income attributable to Colgate-Palmolive CompanyShares
(millions)
Per
Share
Net income attributable to Colgate-Palmolive CompanyShares
(millions)
Per
Share
Net income attributable to Colgate-Palmolive CompanyShares
(millions)
Per
Share
Basic EPS$2,695 856.8 $3.15 $2,367 859.1 $2.76 $2,400 870.6 $2.76 
Stock options and restricted stock units
2.5   2.0   2.4  
Diluted EPS$2,695 859.3 $3.14 $2,367 861.1 $2.75 $2,400 873.0 $2.75 

Basic earnings per common share is computed by dividing net income available for common stockholders by the weighted-average number of shares of common stock outstanding for the period.

Diluted earnings per common share is computed using the treasury stock method on the basis of the weighted-average number of shares of common stock plus the dilutive effect of potential common shares outstanding during the period. Dilutive potential common shares include outstanding stock options and restricted stock units.

As of December 31, 2020, 2019 and 2018, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 3,257,310, 19,901,202 and 18,039,961, respectively. As of December 31, 2020, 2019 and 2018, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 25,381, 4,516 and 9,529, respectively.
XML 42 R22.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments and Contingencies
12 Months Ended
Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
As of December 31, 2020, the Company has various contractual commitments for future multi-year purchases of raw, packaging and other materials totaling approximately $715.

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $425 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $113. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001.

In each of September 2015, February 2017, June 2018, April 2019 and September 2020, the Company lost an administrative appeal and subsequently filed an appeal in Brazilian federal court. Currently, there are five appeals pending in the Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously.
 
In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.
 
In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $50, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal, and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.

Competition Matter

Certain of the Company’s subsidiaries were historically subject to actions and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status as of December 31, 2020 of such competition law matters pending against the Company during the year ended December 31, 2020 is set forth below.

In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11. The Company appealed the decision to the Greek courts. In April 2019, the Greek courts affirmed the judgment against the Company’s Greek subsidiary, but reduced the fine to $10.5 and dismissed the case against Colgate-Palmolive Company. The Company’s Greek subsidiary and the Greek competition authority have appealed the decision to the Greek Supreme Court.
Talcum Powder Matters

The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of December 31, 2020, there were 137 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 121 cases as of December 31, 2019. During the year ended December 31, 2020, 65 new cases were filed and 49 cases were resolved by voluntary dismissal, settlement or dismissal by the court. The value of the settlements in the years presented was not material, either individually or in the aggregate, to each such period’s results of operations.

A significant portion of the Company’s costs incurred in defending and resolving these claims has been, and the Company believes will continue to be, covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions and policy limits.

While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. With the exception of one case where the Company received an adverse jury verdict in the second quarter of 2019 that the Company has appealed, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases because the amount of any possible losses from such cases currently cannot be reasonably estimated.

ERISA Matter

In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals (the “Company Defendants”) in the United States District Court for the Southern District of New York (the “Court”). The relief sought includes recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. This action was certified as a class action in July 2017. In July 2020, the Court granted in part and denied in part the Company Defendants’ motion for summary judgment and dismissed certain claims on consent of the parties. In August 2020, the Court granted the plaintiffs’ motion for summary judgment on the remaining claims. The Company and the Plan are contesting this action vigorously and, in September 2020, appealed to the United States Court of Appeals for the Second Circuit.
XML 43 R23.htm IDEA: XBRL DOCUMENT v3.20.4
Segment Information
12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. 

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Approximately 70% of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Wal-Mart, Inc. and its affiliates represent approximately 12% of the Company’s Net sales in 2020. No other customer represents more than 10% of Net sales.

In 2020, Corporate Operating profit included benefits of $16 resulting from the Global Growth and Efficiency Program and a charge of $6 for acquisition-related costs. In 2019, Corporate Operating profit included charges of $125 resulting from the Global Growth and Efficiency Program, a charge of $24 for acquisition-related costs and a benefit of $30 from a value-added tax matter in Brazil. In 2018, Corporate Operating Profit included charges of $152 resulting from the Global Growth and Efficiency Program.

 202020192018
Net sales  
Oral, Personal and Home Care  
North America(1)
$3,741 $3,424 $3,348 
Latin America3,418 3,606 3,605 
Europe2,747 2,450 2,502 
Asia Pacific2,701 2,707 2,734 
Africa/Eurasia981 981 967 
Total Oral, Personal and Home Care13,588 13,168 13,156 
Pet Nutrition(2)
2,883 2,525 2,388 
Total Net sales$16,471 $15,693 $15,544 
_________
(1)    Net sales in the U.S. for Oral, Personal and Home Care were $3,447, $3,166 and $3,091 in 2020, 2019 and 2018, respectively.
(2)    Net sales in the U.S. for Pet Nutrition were $1,712, $1,441 and $1,304 in 2020, 2019 and 2018, respectively.
202020192018
Operating profit  
Oral, Personal and Home Care  
North America$988 $982 $1,037 
Latin America975 963 995 
Europe652 624 634 
Asia Pacific773 749 777 
Africa/Eurasia206 187 173 
Total Oral, Personal and Home Care3,594 3,505 3,616 
Pet Nutrition793 703 680 
Corporate(502)(654)(602)
Total Operating profit$3,885 $3,554 $3,694 

202020192018
Capital expenditures  
Oral, Personal and Home Care  
North America$65 $43 $53 
Latin America104 90 131 
Europe41 42 39 
Asia Pacific51 40 75 
Africa/Eurasia13 11 
Total Oral, Personal and Home Care274 223 309 
Pet Nutrition56 41 35 
Corporate79 71 92 
Total Capital expenditures$409 $335 $436 

202020192018
Depreciation and amortization  
Oral, Personal and Home Care  
North America$101 $94 $88 
Latin America81 84 82 
Europe94 72 70 
Asia Pacific95 100 103 
Africa/Eurasia
Total Oral, Personal and Home Care380 358 351 
Pet Nutrition58 55 53 
Corporate101 106 107 
Total Depreciation and amortization$539 $519 $511 
202020192018
Identifiable assets
Oral, Personal and Home Care   
North America$4,132 $3,576 $3,310 
Latin America2,251 2,384 2,225 
Europe5,386 5,104 2,883 
Asia Pacific2,272 2,155 2,148 
Africa/Eurasia605 590 502 
Total Oral, Personal and Home Care14,646 13,809 11,068 
Pet Nutrition1,210 1,175 1,033 
Corporate(1)
64 50 60 
Total Identifiable assets(2)
$15,920 $15,034 $12,161 
____________
(1)In 2020, Corporate identifiable assets primarily consist of investments in equity securities (95%). In 2019, Corporate identifiable assets primarily consist of derivative instruments (2%) and investments in equity securities (92%). In 2018, Corporate identifiable assets primarily consist of derivative instruments (7%) and investments in equity securities (88%). 
(2)Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $10,911 in 2020, one-third of total long-lived assets of $10,192 in 2019, and one-half of total long-lived assets of $8,259 in 2018.
XML 44 R24.htm IDEA: XBRL DOCUMENT v3.20.4
Leases
12 Months Ended
Dec. 31, 2020
Leases [Abstract]  
Leases Leases
The Company adopted ASU No. 2016-02 “Leases (Topic 842)” on January 1, 2019, resulting in the recognition of right-of-use assets of $458 and liabilities of $574. The Company enters into leases for land, office space, warehouses and equipment. A number of the leases include one or more options to renew the lease terms, purchase the leased property or terminate the lease. The exercise of these options is at the Company’s discretion and is therefore recognized on the balance sheet when it is reasonably certain the Company will exercise such options. As the Company’s leases typically do not contain a readily determinable implicit rate, the Company determines the present value of the lease liability using its incremental borrowing rate at the lease commencement date.

Substantially all of the Company’s leases are considered operating leases. Finance leases were not material as of December 31, 2020 and 2019.

As of December 31, 2020 and 2019, the Company’s right-of use assets and liabilities for operating leases were as follows:
20202019
Other assets$521 $502 
Other accruals$137 $145 
Other liabilities476 491 
Total operating lease liabilities $613 $636 

Lease liabilities for operating leases as of December 31, 2020 were as follows:
2021$157 
2022133 
202389 
202458 
202546 
Thereafter232 
Total lease commitments$715 
Less: Interest(102)
Present value of lease liabilities$613 

The components of the Company’s operating lease cost for the twelve months ended December 31, 2020 and 2019 were as follows:
20202019
Operating lease cost$155 $169 
Short-term lease cost
Variable lease cost20 30 
Total lease cost$178 $204 

Short-term lease cost represents the Company’s cost with respect to leases with a duration of 12 months or less and is not reflected on the Company’s Consolidated Balance Sheets. Variable lease costs are comprised of costs, such as the Company’s proportionate share of actual costs for utilities, common area maintenance, property taxes and insurance, that are not included in the lease liability and are recognized in the period in which they are incurred.
Supplemental cash flow information related to operating leases for the twelve months ended December 31, 2020 and 2019 was as follows:
Payments against amounts included in the measurement of lease liabilities: $193 and $202, respectively
Lease assets obtained in exchange for lease liabilities: $163 and $232, respectively.

As of December 31, 2020 and 2019, the weighted-average remaining lease term for operating leases was 8 and 8 years, respectively, and the weighted-average discount rate for operating leases was 4.2% and 4.1%, respectively.
There were no material operating leases that the Company had entered into and that were yet to commence as of December 31, 2020.
XML 45 R25.htm IDEA: XBRL DOCUMENT v3.20.4
Supplemental Income Statement Information
12 Months Ended
Dec. 31, 2020
Supplemental Income Statement Elements [Abstract]  
Supplemental Income Statement Information Supplemental Income Statement Information
Other (income) expense, net202020192018
Global Growth and Efficiency Program$(13)$57 $88 
Amortization of intangible assets88 62 59 
Equity income(12)(9)(10)
Value-added tax matter in Brazil— (30)— 
Write-off of certain investments and fixed assets— 51 
Acquisition-related costs21 — 
Charges for a change in go-to-market strategy in certain countries— 15 — 
Other, net48 29 10 
Total Other (income) expense, net$113 $196 $148 

Interest (income) expense, net202020192018
Interest incurred$184 $193 $195 
Interest capitalized(1)(1)(2)
Interest income(19)(47)(50)
Total Interest (income) expense, net$164 $145 $143 

 202020192018
Research and development$290 $281 $277 
Advertising$1,948 $1,694 $1,590 
XML 46 R26.htm IDEA: XBRL DOCUMENT v3.20.4
Supplemental Balance Sheet Information
12 Months Ended
Dec. 31, 2020
Balance Sheet Related Disclosures [Abstract]  
Supplemental Balance Sheet Information Supplemental Balance Sheet Information
Inventories by major class are as follows at December 31:
Inventories20202019
Raw materials and supplies$454 $305 
Work-in-process45 49 
Finished goods1,256 1,056 
        Total Inventories, net
$1,755 $1,410 
              Non-current inventory, net(82)(10)
                    Current Inventories, net
$1,673 $1,400 

Inventories valued under LIFO amounted to $439 and $303 at December 31, 2020 and 2019, respectively. The excess of current cost over LIFO cost at the end of each year was $65 and $62, respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2020, 2019 and 2018. Inventory classified as non-current at December 31, 2020 was recorded on the Consolidated Balance Sheets as “Other assets.”

Property, plant and equipment, net20202019
Land$166 $153 
Buildings1,623 1,600 
Manufacturing machinery and equipment5,409 5,309 
Other equipment1,553 1,518 
 8,751 8,580 
Accumulated depreciation(5,035)(4,830)
Total Property, plant and equipment, net$3,716 $3,750 

Other accruals20202019
Accrued advertising and coupon redemption$728 $525 
Accrued payroll and employee benefits401 340 
Accrued taxes other than income taxes116 104 
Restructuring accrual21 85 
Pension and other retiree benefits89 54 
Lease Liabilities Due in One Year137 145 
Accrued interest39 43 
Derivatives93 16 
Other717 605 
Total Other accruals$2,341 $1,917 

Other liabilities20202019
Pension and other retiree benefits$1,815 $1,728 
Restructuring accrual10 15 
Long-Term Lease Liabilities476 491 
Other354 364 
Total Other liabilities$2,655 $2,598 
XML 47 R27.htm IDEA: XBRL DOCUMENT v3.20.4
Supplemental Other Comprehensive Income (Loss) Information
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Supplemental Other Comprehensive Income (Loss) Information Supplemental Other Comprehensive Income (Loss) Information
Other comprehensive income (loss) components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows:
 202020192018
PretaxNet of TaxPretaxNet of TaxPretaxNet of Tax
Cumulative translation adjustments$(119)$(30)$49 $27 $(233)$(218)
Pension and other benefits:
   Net actuarial gain (loss), prior
service costs and settlements
during the period
(125)(97)(204)(154)(21)(16)
   Amortization of net actuarial loss,
   transition and prior service costs(1)
74 57 72 54 69 54 
Retirement Plan and other retiree benefit
adjustments
(51)(40)(132)(100)48 38 
Cash flow hedges:
   Unrealized gains (losses) on cash flow
hedges
(3)(2)(9)(7)10 
   Reclassification of (gains) losses
   into net earnings on cash flow
   hedges(2)
— — (6)(5)
Gains (losses) on cash flow hedges(3)(2)(15)(12)13 10 
Total Other comprehensive income (loss)$(173)$(72)$(98)$(85)$(172)$(170)
_________
(1)These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.
(2)These (gains) losses are reclassified into Cost of sales. See Note 7, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.

Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments designated as cash flow hedges. At December 31, 2020 and 2019, Accumulated other comprehensive income (loss) consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $1,178 and $1,138, respectively, and cumulative foreign currency translation adjustments of $3,158 and $3,128, respectively. Foreign currency translation adjustments in 2020 primarily reflect losses from the Brazilian real and the Mexican peso. Foreign currency translation adjustments in 2019 primarily reflect gains from the Thai baht and the Mexican peso.
XML 48 R28.htm IDEA: XBRL DOCUMENT v3.20.4
Quarterly Financial Data (Unaudited)
12 Months Ended
Dec. 31, 2020
Quarterly Financial Data [Abstract]  
Quarterly Financial Data (Unaudited) Quarterly Financial Data (Unaudited)
  Total First
Quarter
 Second
Quarter
Third
Quarter
Fourth
Quarter
 
2020        
Net sales$16,471  $4,097  $3,897 $4,153 $4,324  
Gross profit10,017 
(1)
2,465 
(3)
2,369 2,540 2,643 
Net income including noncontrolling interests
2,860 
(2)
748 
(4)
675 745 
(5)
692 
(6)
Net income attributable to Colgate-Palmolive Company
2,695 
(2)
715 
(4)
635 698 
(5)
647 
(6)
Earnings per common share:   
Basic3.15 
(2)
0.83 
(4)
0.74 0.81 
(5)
0.76 
(6)
Diluted3.14 
(2)
0.83 
(4)
0.74 0.81 
(5)
0.75 
(6)
2019          
Net sales$15,693  $3,884 $3,866 $3,928 $4,015 
Gross profit9,325 
(7)
2,287 
(9)
2,308 
(11)
2,316 
(13)
2,414 
(15)
Net income including noncontrolling interests
2,527 
(8)
600 
(10)
618 
(12)
627 
(14)
682 
(16)
Net income attributable to Colgate-Palmolive Company
2,367 
(8)
560 
(10)
586 
(12)
578 
(14)
643 
(16)
Earnings per common share:
Basic2.76 
(8)
0.65 
(10)
0.68 
(12)
0.67 
(14)
0.75 
(16)
Diluted2.75 
(8)
0.65 
(10)
0.68 
(12)
0.67 
(14)
0.75 
(16)
____________
Note:    Basic and diluted earnings per share are computed independently for each quarter and the year-to-date period presented. Accordingly, the sum of the quarterly earnings per common share may not necessarily equal the earnings per share for the year-to-date period.

(1)Gross profit for the full year of 2020 includes a $4 charge for acquisition-related costs.
(2)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2020 include aftertax benefits of $13 resulting from the Global Growth and Efficiency Program, a $4 aftertax charge for acquisition-related costs, a $71 tax benefit related to subsidiary and operating structure initiatives and a $18 aftertax loss on the early extinguishment of debt.
(3)Gross profit for the first quarter of 2020 includes a $4 charge for acquisition-related costs.
(4)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2020 include a $4 aftertax charge for acquisition-related costs and a $71 tax benefit related to subsidiary and operating structure initiatives.
(5)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2020 include aftertax benefits of $13 resulting from the Global Growth and Efficiency Program.
(6)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2020 include a $18 aftertax loss on the early extinguishment of debt.
(7)Gross profit for the full year of 2019 includes $8 of charges resulting from the Global Growth and Efficiency Program and a $3 charge for acquisition-related costs.
(8)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2019 include $102 of aftertax charges resulting from the Global Growth and Efficiency Program, a $20 aftertax charge for acquisition-related costs, a $20 aftertax benefit related to a value added tax matter in Brazil and a $29 tax benefit related to Swiss income tax reform.
(9)Gross profit for the first quarter of 2019 includes $11 of charges resulting from the Global Growth and Efficiency Program.
(10)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2019 include $22 of aftertax charges resulting from the Global Growth and Efficiency Program.
(11)Gross profit for the second quarter of 2019 includes $3 of charges resulting from the Global Growth and Efficiency Program.
(12)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the second quarter of 2019 include $31 of aftertax charges resulting from the Global Growth and Efficiency Program.
(13)Gross profit for the third quarter of 2019 includes $1 of charges resulting from the Global Growth and Efficiency Program.
(14)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2019 include $22 of aftertax charges resulting from the Global Growth and Efficiency Program and a $14 aftertax charge related to U.S. tax reform.
(15)Gross profit for the fourth quarter of 2019 includes $1 of benefit resulting from the Global Growth and Efficiency Program and a $3 charge for acquisition-related costs.
(16)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2019 include $27 of aftertax charges resulting from the Global Growth and Efficiency Program, a $6 charge for acquisition-related costs, a $20 aftertax benefit related to a value added tax matter in Brazil and a $29 tax benefit related to Swiss income tax reform.
XML 49 R29.htm IDEA: XBRL DOCUMENT v3.20.4
Schedule II - Valuation and Qualifying Accounts
12 Months Ended
Dec. 31, 2020
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
(Dollars in Millions)
   Additions  
  Balance at Beginning of PeriodCharged to Costs and ExpensesOtherDeductionsBalance at End of Period
Year Ended December 31, 2020
Allowance for doubtful accounts and estimated returns
$76 $16 $— $$89 
Valuation allowance for deferred tax assets$59 $$— $49 $11 
Year Ended December 31, 2019     
Allowance for doubtful accounts and estimated returns
$82 $$— $12 $76 
Valuation allowance for deferred tax assets$54 $12 $— $$59 
Year Ended December 31, 2018     
Allowance for doubtful accounts and estimated returns
$77 $15 $— $10 $82 
Valuation allowance for deferred tax assets$$45 $— $— $54 
XML 50 R30.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Principles of Consolidation Principles of ConsolidationThe Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50%, where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2020 and 2019, equity method investments included in Other assets in the Consolidated Balance Sheets were $56 and $50, respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are recorded at cost and periodically adjusted based on observable price changes or quoted market prices in active markets, if applicable.
Use of Estimates
Use of Estimates

The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances, legal and other contingency reserves. Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates.
Revenue Recognition
Revenue Recognition

The Company’s revenue contracts represent a single performance obligation to sell its products to trade customers. Sales are recorded at the time control of the products is transferred to trade customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for the products. Control is the ability of trade customers to “direct the use of” and “obtain” the benefit from our products. In evaluating the timing of the transfer of control of products to trade customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are generally recognized when products are delivered to trade customers.

Net sales reflect the transaction prices for contracts, which include units shipped at selling list prices reduced by variable consideration. Variable consideration includes expected sales returns and the cost of current and continuing promotional programs. Current promotional programs primarily include product listing allowances and co-operative advertising arrangements. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements. The cost of promotional programs is estimated using the expected value method considering all reasonably available information, including the Company’s historical experience and its current expectations, and is reflected in the transaction price when sales are recorded. Adjustments to the cost of promotional programs in subsequent periods are generally not material, as the Company’s promotional programs are typically of short duration, thereby reducing the uncertainty inherent in such estimates.

Sales returns are generally accepted at the Company’s discretion and are not material to the Company’s Consolidated Financial Statements. The Company’s contracts with trade customers do not have significant financing components or non-cash consideration and the Company does not have unbilled revenue or significant amounts of prepayments from customers. The Company records Net sales excluding taxes collected on its sales to its trade customers. Shipping and handling activities are accounted for as contract fulfillment costs and classified as Selling, general and administrative expenses.
Shipping and Handling Costs
Shipping and Handling Costs

Shipping and handling costs are classified as Selling, general and administrative expenses and were $1,392, $1,275 and $1,255 for the years ended December 31, 2020, 2019 and 2018, respectively.
Marketing Costs
Marketing Costs

The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales.
Cash and Cash equivalents
Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.
Inventories
Inventories

The cost of approximately 75% of inventories is determined using the FIFO method, which is stated at the lower of cost or net realizable value. The cost of all other inventories, in the U.S. and Mexico, is determined using the LIFO method, which is stated at the lower of cost or market. Inventories in excess of one year of forecasted sales are classified in the Consolidated Balance Sheets as non-current “Other assets.”
Property, Plant and Equipment
Property, Plant and Equipment

Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over-estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses.
Goodwill and Other Intangibles
Goodwill and Other Intangibles

Goodwill and indefinite-life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually or when events or changes in circumstances indicate that an asset may be impaired. These tests were performed and did not result in an impairment charge. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their estimated useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit.
Income Taxes
Income Taxes

The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return. The Company recognizes interest expense and penalties related to unrecognized tax benefits within Provision for income taxes.
Financial Instruments
Financial Instruments

Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged. Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows.

The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7, Fair Value Measurements and Financial Instruments along with the related fair value measurement considerations.
Stock-Based Compensation
Stock-Based Compensation

The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units (both performance-based and time-vested), based on the fair value of those awards at the date of grant over the requisite service period. The Company uses the Black-Scholes-Merton (Black-Scholes) option pricing model to estimate the fair value of stock option awards. In addition to performance conditions, performance-based restricted stock units also include a total shareholder return modifier. Because the total shareholder return modifier is considered a market condition, the Company uses a Monte-Carlo simulation model to determine the fair value of performance-based restricted stock units. The fair value of time-vested restricted stock units is determined based on the closing market price of the Company’s stock at the date of grant. Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8, Capital Stock and Stock-Based Compensation Plans.
Currency Translation
Currency Translation

The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year.
For subsidiaries operating in highly inflationary environments, local currency-denominated non-monetary assets, including inventories, goodwill and property, plant and equipment, are remeasured at their historical exchange rates, while local currency-denominated monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company.
Recent Accounting Pronouncements
Recent Accounting Pronouncements

In January 2021, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2021-1, “Reference Rate Reform (Topic 848): Scope” This ASU clarifies that certain optional expedients and exceptions in Topic 848 apply to derivatives that are affected by the discounting transition due to reference rate reform. This guidance was effective upon issuance for the Company and is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In October 2020, the FASB issued ASU No. 2020-10, “Codification Improvements.” This ASU improves the consistency of the codification topics by including all disclosure guidance in the appropriate disclosure section and also clarifies the application of various provisions in the codification. This guidance was effective for the Company beginning on January 1, 2021 and is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (“GAAP”) to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This guidance was effective upon issuance of this ASU for contract modifications and hedging relationships on a prospective basis and is not expected to have a material impact on the Company’s Consolidated Financial Statements.
In March 2020, the FASB issued ASU No. 2020-03, “Codification to Financial Instruments.” This ASU improves and clarifies various financial instruments topics, including the current expected credit losses (“CECL”) standard issued in 2016. The ASU addresses seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments related to Issue 1, Issue 2, Issue 4 and Issue 5 were effective upon issuance of this update. The amendments related to Issue 3, Issue 6 and Issue 7 were effective for the Company beginning on January 1, 2020. The guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)-Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This guidance was effective for the Company beginning on January 1, 2021. This guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In December 2019, the FASB issued ASU No. 2019-12, “Income taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This guidance was effective for the Company beginning on January 1, 2021. This guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In November 2019, the FASB issued ASU No. 2019-11, “Codification Improvements to Topic 326, Financial Instruments - Credit Losses.” This ASU clarifies and addresses certain items related to amendments in ASU 2016-13. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In April 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825).” This ASU clarifies three topics related to financial instruments accounting. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.
In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU No. 2017-04, “Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate implied fair value, essentially eliminating step two from the goodwill impairment test. The standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard was effective for the Company on a prospective basis beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326).” This ASU introduces the current expected credit loss (CECL) model, which requires an entity to measure credit losses for certain financial instruments and financial assets, including trade receivables. Under this update, on initial recognition and at each reporting period, an entity is required to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. The Company adopted the new standard, which primarily impacts the Company’s trade receivables and related methodology for assessing the collectability of its customer accounts, on January 1, 2020, on a “modified retrospective” basis. The adoption of this ASU did not have a material impact on the Company’s Consolidated Financial Statements.
Reclassifications ReclassificationsCertain prior year amounts have been reclassified to conform to the current year presentation.
XML 51 R31.htm IDEA: XBRL DOCUMENT v3.20.4
Nature of Operations (Tables)
12 Months Ended
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Percentage of worldwide sales
The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years:
  202020192018
Oral Care44 %46 %47 %
Personal Care21 %20 %20 %
Home Care18 %18 %18 %
Pet Nutrition17 %16 %15 %
Total100 %100 %100 %
XML 52 R32.htm IDEA: XBRL DOCUMENT v3.20.4
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2020
Business Combinations [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The total purchase price consideration of $351 has been allocated to the net assets acquired based on their respective estimated fair values as follows:

Receivables $11 
Inventories 13 
Other assets and liabilities, net (4)
Other intangible assets 160 
Goodwill171 
Fair value of net assets acquired$351 
The total purchase price consideration of $1,712 has been allocated to the net assets acquired based on their respective estimated fair values as follows:
Cash$30 
Receivables53 
Inventories70 
Other current assets18 
Other intangible assets1,051 
Goodwill923 
Other current liabilities(67)
Deferred income taxes(276)
Noncontrolling interests(90)
Fair value of net assets acquired$1,712 
XML 53 R33.htm IDEA: XBRL DOCUMENT v3.20.4
Restructuring and Related Implementation Charges (Tables)
12 Months Ended
Dec. 31, 2020
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Related Costs
For the years ended December 31, 2019 and 2018, restructuring and related implementation charges are reflected in the Consolidated Statements of Income as follows:  
20192018
Cost of sales$$31 
Selling, general and administrative expenses60 33 
Other (income) expense, net57 88 
Non-service related postretirement costs
Total Global Growth and Efficiency Program charges, pretax$132 $161 
Total Global Growth and Efficiency Program charges, aftertax$102 $125 
Schedule of Percent of Total Restructuring Charges Related To Segment for the period
Total charges incurred for the Global Growth and Efficiency Program related to initiatives undertaken by the following reportable operating segments:
Total Program
20192018Charges
North America%18 %17 %
Latin America12 %10 %%
Europe%(2)%19 %
Asia Pacific%13 %%
Africa/Eurasia(1)%%%
Hills Pet Nutrition
%19 %%
Corporate73 %37 %42 %
Total100 %100 %100 %
Schedule of Restructuring and Related Costs Incurred to Date
Over the course of the Global Growth and Efficiency Program, the Company incurred total pretax charges of $1,854 ($1,380 aftertax) in connection with the implementation of various projects as follows:
Total Program Charges
as of December 31, 2019
Employee-Related Costs$706 
Incremental Depreciation128 
Asset Impairments58 
Other962 
Total$1,854 
Schedule of Restructuring Reserve by Type of Cost
The following table summarizes the activity for the restructuring and related implementation charges for the years ended December 31, 2019 and 2018 and the related accruals:

 
Employee-Related
Costs 
Incremental
Depreciation
Asset
Impairments
Other
Total
Balance at December 31, 2017$127 $— $— $107 $234 
Charges53 16 90 161 
Cash payments(107)— — (60)(167)
Charges against assets(9)(2)(16)— (27)
Foreign exchange(4)— — — (4)
Other— — — 
Balance at December 31, 2018$60 $— $— $142 $202 
Charges25 36 65 132 
Cash payments(55)— — (58)(113)
Charges against assets(7)(36)(6)(27)(76)
Foreign exchange— — — 
Other— — — (48)(48)
Balance at December 31, 2019$26 $— $— $74 $100 
XML 54 R34.htm IDEA: XBRL DOCUMENT v3.20.4
Goodwill and Other Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The net carrying value of Goodwill as of December 31, 2020 and 2019 by segment was as follows:
  20202019
Oral, Personal and Home Care  
North America$912 $737 
Latin America171 212 
Europe2,415 2,234 
Asia Pacific190 186 
Africa/Eurasia121 124 
Total Oral, Personal and Home Care3,809 3,493 
Pet Nutrition15 15 
Total Goodwill$3,824 $3,508 
Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class
Other intangible assets as of December 31, 2020 and 2019 were comprised of the following:
  20202019
  Gross Carrying AmountAccumulated AmortizationNetGross Carrying AmountAccumulated AmortizationNet
Trademarks - finite life$902 $(422)$480 $771 $(381)$390 
Other finite life intangible assets786 (237)549 699 (169)530 
Indefinite life intangible assets1,865 — 1,865 1,747 — 1,747 
Total Other intangible assets$3,553 $(659)$2,894 $3,217 $(550)$2,667 
XML 55 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Long-Term Debt and Credit Facilities (Tables)
12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Schedule of Long-term Debt Instruments
Long-term debt consisted of the following at December 31:
  Weighted Average Interest RateMaturities20202019
Notes1.9%2021-2078$6,170 $6,988 
Commercial paper(0.3)%20211,139 579 
Finance Lease ObligationsVariousVarious34 20 
7,343 7,587 
Less: Current portion of long-term debt(9)(254)
Total $7,334 $7,333 
Schedule of Maturities of Long-term Debt Excluding such obligations, scheduled maturities of long-term debt and finance leases outstanding as of December 31, 2020, were as follows:  
Years Ended December 31,
2021
$631 
2022413 
2023896 
2024498 
2025130 
Thereafter3,636 
XML 56 R36.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurements and Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
Schedule of Derivative Instruments
The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets as of December 31, 2020 and December 31, 2019:

 AssetsLiabilities
 AccountFair ValueAccountFair Value
Designated derivative instruments
 December 31, 2020December 31, 2019 December 31, 2020December 31, 2019
Interest rate swap contractsOther assets14 Other liabilities— — 
Forward-starting interest rate swapsOther assets— Other liabilities— — 
Foreign currency contractsOther current assetsOther accruals93 15 
Foreign currency contractsOther assets— — Other liabilities— 14 
Commodity contractsOther current assets— Other accruals— — 
Total designated $29 $10  $93 $29 
Other financial instruments      
Marketable securitiesOther current assets37 23    
Total other financial instruments $37 $23    
Activity related to fair value hedges
The following amounts were recorded on the Consolidated Balance Sheet related to cumulative basis adjustment for fair value hedges as of:
December 31, 2020December 31, 2019
Long-term debt:  
Carrying amount of hedged item$413 $403 
Cumulative hedging adjustment included in the carrying amount$14 $
Schedule of Notional Amounts of Outstanding Derivative Positions
The following tables present the notional values as of:

 December 31, 2020
 Foreign
Currency
Contracts
Foreign Currency DebtInterest Rate SwapsForward-Starting Interest Rate SwapsCommodity Contracts 
Total
Fair Value Hedges $589 $— $400 $— $— $989 
Cash Flow Hedges 854 — — 300 17 1,171 
Net Investment Hedges528 4,523 — — — 5,051 


 December 31, 2019
 Foreign
Currency
Contracts
Foreign Currency DebtInterest Rate SwapsForward-Starting Interest Rate SwapsCommodity Contracts 
Total
Fair Value Hedges $388 $— $400 $— $— $788 
Cash Flow Hedges 761 — — — 20 781 
Net Investment Hedges478 3,856 — — — 4,334 
Derivative Instruments, Gain (Loss)
The following table presents the location and amount of gains (losses) on hedges recognized on the Company’s Consolidated Statements of Income:
Twelve Months Ended December 31,
 20202019
Cost of sales Selling, general and administrative expensesInterest (income) expense, netCost of salesSelling, general and administrative expensesInterest (income) expense, net
Gain (loss) on hedges recognized in income:
Interest rate swaps designated as fair value hedges:
Derivative instrument$— $— $(10)$— $— $(11)
Hedged items— — 10 — — 11 
Foreign currency contracts designated as fair value hedges:
Derivative instrument— 29 — — 10 — 
Hedged items— (29)— — (10)— 
Foreign currency contracts designated as cash flow hedges:
Amount reclassified from OCI— — — — 
Commodity contracts designated as cash flow hedges:
Amount reclassified from OCI(1)— — — — 
Total gain (loss) on hedges recognized in income$— $— $— $$— $— 
Schedule Of Cash Flow And Net Investment Hedges Included In Accumulated Other Comprehensive Income (Loss)
The following table presents the location and amount of unrealized gains (losses) on hedges included in OCI:
 Twelve Months Ended
December 31,
20202019
Foreign currency contracts designated as cash flow hedges:
Gain (loss) recognized in OCI$(11)$(9)
Forward-starting interest rate swaps designated as cash flow hedges:
Gain (loss) recognized in OCI— 
Commodity contracts designated as cash flow hedges:
Gain (loss) recognized in OCI— 
Foreign currency contracts designated as net investment hedges:
Gain (loss) on instruments(52)
Gain (loss) on hedged items52 (4)
Foreign currency debt designated as net investment hedges:
Gain (loss) on instruments(356)12 
Gain (loss) on hedged items356 (12)
Total unrealized gain (loss) on hedges recognized in OCI$(3)$(9)
XML 57 R37.htm IDEA: XBRL DOCUMENT v3.20.4
Capital Stock and Stock-Based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule Of Common And Treasury Stock Activity
A summary of common stock and treasury stock activity for the three years ended December 31 is as follows:
  Common Stock OutstandingTreasury Stock
Balance, January 1, 2018874,701,118 591,005,242 
Common stock acquired(18,786,897)18,786,897 
Shares issued for stock options6,040,920 (6,040,920)
Shares issued for restricted stock units and other957,651 (957,651)
Balance, December 31, 2018862,912,792 602,793,568 
Common stock acquired(17,219,642)17,219,642 
Shares issued for stock options8,145,777 (8,145,777)
Shares issued for restricted stock units and other862,852 (862,852)
Balance, December 31, 2019854,701,779 611,004,581 
Common stock acquired(18,701,843)18,701,843 
Shares issued for stock options13,018,354 (13,018,354)
Shares issued for restricted stock units and other875,311 (875,311)
Balance, December 31, 2020849,893,601 615,812,759 
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions Fair value is estimated using the Black-Scholes option pricing model with the assumptions summarized in the following table:
  202020192018
Expected term of options6 years6 years4.5 years
Expected volatility rate21.8 %19.2 %17.7 %
Risk-free interest rate0.5 %1.5 %2.8 %
Expected dividend yield2.3 %2.3 %2.5 %
Schedule of Share-based Compensation, Performance Restricted Stock and Time-based Restricted Stock Units Activity
A summary of performance-based restricted stock unit activity for the year ended December 31, 2020 is presented below:

  Shares
(in thousands)
Weighted Average Grant Date Fair Value Per Award
Performance-based restricted stock units as of January 1, 2020346 $67 
Activity:
Granted557 76 
Forfeited(38)69 
Performance-based restricted stock units as of December 31, 2020865 $73 
A summary of restricted stock unit activity during 2020 is presented below:
  Shares
(in thousands)
Weighted Average Grant Date Fair Value Per Award
Restricted stock units as of January 1, 20202,203 $71 
Activity:
Granted727 77 
Vested(1,130)74 
Forfeited(63)71 
Restricted stock units as of December 31, 20201,737 $73 
Schedule of Share-based Compensation, Stock Options, Activity
A summary of stock option activity during 2020 is presented below:
  Shares
(in thousands)
Weighted Average Exercise PriceWeighted Average Remaining Contractual Life
(in years)
Intrinsic Value of Unexercised
In-the-Money Options
Options outstanding, January 1, 202036,185 $69 
Granted4,976 76   
Exercised(13,019)67   
Forfeited or expired(601)72   
Options outstanding, December 31, 202027,541 72 4$386 
Options exercisable, December 31, 202018,084 $70 3$274 
XML 58 R38.htm IDEA: XBRL DOCUMENT v3.20.4
Retirement Plans and Other Retiree Benefits (Tables)
12 Months Ended
Dec. 31, 2020
Retirement Benefits [Abstract]  
Schedule of Allocation of Plan Assets The target asset allocation for the Company’s defined benefit plans is as follows:
  United StatesInternational
Asset Category
Equity securities21 %38 %
Fixed income securities74 %46 %
Real estate and other investments%16 %
Total100 %100 %

At December 31, 2020, the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:
 Level of Valuation
Input
Pension Plans 
  United StatesInternationalOther Retiree
Benefit Plans
     
Cash and cash equivalentsLevel 1$50 $12 $— 
U.S. common stocksLevel 1— — 
International common stocksLevel 1— — 
Pooled funds(1)
Level 165 117 — 
Fixed income securities(2)
Level 21,117 59 
Guaranteed investment contracts(3)
Level 255 — 
  1,233 252 
Investments valued using NAV per share(4)
  
Domestic, developed and emerging markets equity funds  456 183 
Fixed income funds(5)
  136 225 — 
Hedge funds(6)
  — — 
Multi-asset funds(7)
  77 — 
Real estate funds(8)
34 30 — 
  703 446 
Other assets and liabilities, net(9)
(15)— — 
Total Investments$1,921 $698 $
At December 31, 2019, the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:
 Level of Valuation
Input
Pension Plans 
  United StatesInternationalOther Retiree
Benefit Plans
    
Cash and cash equivalentsLevel 1$41 $15 $
U.S. common stocksLevel 149 
International common stocksLevel 1— — 
Pooled funds(1)
Level 129 104 
Fixed income securities(2)
Level 21,067 14 20 
Guaranteed investment contracts(3)
Level 242 — 
  1,187 181 24 
Investments valued using NAV per share(4)
  
Domestic, developed and emerging markets equity funds  328 165 
Fixed income funds(5)
  177 196 
Hedge funds(6)
  17 — 
Multi-asset funds(7)
  155 
Real estate funds(8)
41 25 
704 405 13 
Other assets and liabilities, net(9)
(85)— — 
Total Investments  $1,806 $586 $37 
_______
(1)Pooled funds primarily invest in U.S. and foreign equity securities, debt and money market securities.
(2)The fixed income securities are traded over-the-counter and certain of these securities lack daily pricing or liquidity and as such are classified as Level 2. As of both December 31, 2020 and 2019, approximately 50% of the U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in other government bonds and corporate bonds.
(3)The guaranteed investment contracts (“GICs”) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption.
(4)Investments that are measured at fair value using net asset value (“NAV”) per share as a practical expedient have not been classified in the fair value hierarchy. The NAV is based on the value of the underlying investments owned, minus its liabilities, divided by the number of shares outstanding. There are no unfunded commitments related to these investments. Redemption notice period primarily ranges from 0-3 months and redemption frequency windows range from daily to quarterly.
(5)Fixed income funds primarily invest in U.S. government and investment grade corporate bonds.
(6)Consists of investments in underlying hedge fund strategies that are primarily implemented through the use of long and short equity and fixed income securities and derivative instruments such as futures and options.
(7)Multi-asset funds primarily invest across a variety of asset classes, including global stocks and bonds, as well as alternative strategies.
(8)Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager.
(9)This category primarily includes unsettled trades for investments purchased and sold and dividend receivables.
Defined benefit plans disclosures The Company uses a December 31 measurement date for its defined benefit and other retiree benefit plans. Summarized information for the Company’s defined benefit and other retiree benefit plans is as follows:
  Pension PlansOther Retiree Benefit Plans
 202020192020201920202019
  United StatesInternational  
Change in Benefit Obligations      
Benefit obligations at beginning of year$2,272 $2,147 $876 $787 $1,050 $876 
Service cost17 14 20 15 
Interest cost74 90 21 22 37 41 
Participants’ contributions— — — — 
Acquisitions/plan amendments— — 30 — — 
Actuarial loss (gain)171 181 65 82 61 166 
Foreign exchange impact— — 46 (9)
Termination benefits— — — — 
Curtailments and settlements(3)— (7)(9)— — 
Benefit payments(155)(154)(40)(35)(47)(49)
Other— — — — — 
Benefit obligations at end of year$2,363 $2,272 $1,013 $876 $1,112 $1,050 
Change in Plan Assets  
Fair value of plan assets at beginning of year$1,806 $1,568 $586 $510 $37 $54 
Actual return on plan assets243 262 59 76 
Company contributions30 130 36 30 11 24 
Participants’ contributions— — — — 
Foreign exchange impact— — 26 12 — — 
Settlements and acquisitions(3)— 26 (9)— — 
Benefit payments(155)(154)(40)(35)(47)(49)
Other— — — — — — 
Fair value of plan assets at end of year$1,921 $1,806 $698 $586 $$37 
Funded Status  
Benefit obligations at end of year$2,363 $2,272 $1,013 $876 $1,112 $1,050 
Fair value of plan assets at end of year1,921 1,806 698 586 37 
Net amount recognized$(442)$(466)$(315)$(290)$(1,109)$(1,013)
Amounts Recognized in Balance Sheet    
Noncurrent assets$20 $— $18 $13 $— $— 
Current liabilities(30)(28)(14)(13)(45)(13)
Noncurrent liabilities(432)(438)(319)(290)(1,064)(1,000)
Net amount recognized$(442)$(466)$(315)$(290)$(1,109)$(1,013)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
  
Actuarial loss$902 $910 $255 $238 $429 $388 
Transition/prior service cost— (1)
  $903 $911 $262 $245 $429 $387 
Accumulated benefit obligation$2,325 $2,236 $946 $816 $— $— 
  Pension PlansOther Retiree Benefit Plans
  202020192020201920202019
  United StatesInternational  
Weighted-Average Assumptions Used to Determine Benefit Obligations
      
Discount rate2.65 %3.40 %1.61 %2.06 %2.88 %3.56 %
Expected long-term rate of return on plan assets5.70 %6.30 %2.93 %3.38 %5.70 %6.30 %
Long-term rate of compensation increase3.50 %3.50 %2.62 %2.83 %3.50 %3.50 %
ESOP growth rate— %— %— %— %10.00 %10.00 %
Medical cost trend rate of increase— %— %— %— %6.00 %6.00 %
Interest Crediting Rate2.48 %3.21 %0.83 %0.85 %— %— %
Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets
Pension plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consisted of the following:
  20202019
Benefit Obligation Exceeds Fair Value of Plan Assets  
Projected benefit obligation$1,092 $2,862 
Fair value of plan assets299 2,094 
Accumulated benefit obligation882 875 
Fair value of plan assets134 166 

Other Retiree Benefit plans with accumulated postretirement benefit obligation in excess of plan assets as of December 31 consisted of the following:
  20202019
Benefit Obligation Exceeds Fair Value of Plan Assets  
Accumulated postretirement benefit obligation$1,112 $958 
Fair value of plan assets37 
Schedule of Net Benefit Costs Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows:
  Pension PlansOther Retiree Benefit Plans
  202020192018202020192018202020192018
  United StatesInternational   
Components of Net Periodic Benefit Cost
         
Service cost$$$$17 $14 $14 $20 $15 $16 
Interest cost74 90 86 21 22 21 37 41 38 
Expected return on plan assets
(111)(103)(115)(22)(19)(21)(2)(3)(2)
Amortization of transition and prior service costs (credits)
— — — — — — — — 
Amortization of actuarial loss
46 51 47 18 11 14 
Net periodic benefit cost$10 $39 $19 $25 $27 $22 $73 $64 $66 
Other postretirement charges
— — — — 
Total pension cost$14 $46 $28 $25 $28 $24 $73 $64 $66 
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
         
Discount rate3.40 %4.38 %3.73 %

2.06 %2.80 %2.53 %3.56 %4.43 %3.80 %
Expected long-term rate of return on plan assets6.30 %6.60 %6.60 %3.38 %4.06 %4.04 %6.30 %6.60 %6.60 %
Long-term rate of compensation increase
3.50 %3.50 %3.50 %2.83 %2.86 %2.79 %— %— %— %
ESOP growth rate— %— %— %— %— %— %10.00 %10.00 %10.00 %
Medical cost trend rate of increase— %— %— %— %— %— %6.00 %6.00 %6.00 %
Interest Crediting Rate3.21 %4.26 %3.73 %0.85 %0.85 %0.85 %— %— %— %
Schedule of Expected Benefit Payments
Total benefit payments expected to be paid to participants in both funded and unfunded plans are estimated as follows:
  Pension Plans 
Years Ended December 31,United StatesInternationalOther Retiree Benefit PlansTotal
2021$154 $42 $49 $245 
2022156 41 49 246 
2023157 42 50 249 
2024156 46 51 253 
2025155 45 52 252 
2026-2030741 244 269 1,254 
XML 59 R39.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Components of income before income taxes
The components of Income before income taxes are as follows for the years ended December 31:
  202020192018
United States$1,317 $1,050 $1,175 
International2,330 2,251 2,289 
Total Income before income taxes$3,647 $3,301 $3,464 
Provision for income taxes
The Provision for income taxes consists of the following for the years ended December 31:
  202020192018
United States$259 $180 $213 
International528 594 693 
Total Provision for income taxes$787 $774 $906 
Schedule of components of deferred income tax benefit
Temporary differences between accounting for financial statement purposes and accounting for tax purposes result in the current provision for taxes being higher (lower) than the total provision for income taxes as follows:
  202020192018
Goodwill and intangible assets$$34 $
Property, plant and equipment12 12 (15)
Pension and other retiree benefits10 (13)(7)
Stock-based compensation(7)(1)
Right-of-use assets/lease liabilities(1)— — 
Tax credits and tax loss carryforwards(1)(4)
Deferred withholding tax111 (21)(100)
Other, net18 (33)62 
Total deferred tax benefit (provision)$143 $(19)$(53)
Effective tax rate reconciliation
The difference between the statutory U.S. federal income tax rate and the Company’s global effective tax rate as reflected in the Consolidated Statements of Income is as follows:
Percentage of Income before income taxes202020192018
Tax at United States statutory rate21.0 %21.0 %21.0 %
State income taxes, net of federal benefit1.0 0.6 1.0 
Earnings taxed at other than United States statutory rate3.3 4.6 5.6 
Charge for U.S. tax reform(1)
— — 2.3 
Foreign tax credit carryback(2)
— — (1.7)
Benefit for foreign tax matters(3)
(2.0)(0.9)(0.4)
Foreign-derived intangible income benefit(1.6)(1.3)(1.1)
Other, net(0.1)(0.6)(0.5)
Effective tax rate21.6 %23.4 %26.2 %
_________
(1)On December 22, 2017, the Tax Cuts and Jobs Act (the “TCJA”) was enacted, which, among other things, lowered the U.S. corporate income tax rate to 21% from 35% and established a modified territorial system requiring a mandatory deemed repatriation tax on undistributed earnings of foreign subsidiaries. Beginning in 2018, the TCJA also requires a minimum tax on certain earnings generated by foreign subsidiaries while providing for tax-free repatriation of such earnings through a 100% dividends-received deduction. The Company’s effective income tax rate in 2017 included a provisional charge of $275, recorded in the fourth quarter of 2017, based on its initial analysis of the TCJA using information and estimates available as of February 15, 2018, the date on which the Company filed its Annual Report on Form 10-K for the year ended December 31, 2017. During 2018, the Company finalized its assessment of the impact of the TCJA and recognized an additional tax expense of $80 reflecting the impact of transition tax guidance issued by the U.S. Treasury and the update of certain estimates and calculations based on information available through the end of 2018. Any further guidance issued after December 31, 2018 may have an impact to the Company’s Provision for income tax in the period such guidance is effective.
(2)In 2018, the Company generated excess foreign taxes associated with its foreign branch operations which are being carried back to 2017. This item is not expected to be recurring.
(3)In 2020, the provision for income taxes includes $71 of income tax benefits recorded on a discrete period basis, of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As part of the previously recorded charge for the TCJA, the Company has provided for foreign withholding taxes expected to be paid on the remittance of earnings from certain overseas subsidiaries no longer deemed indefinitely reinvested. As a result of a recent reorganization of the ownership structure of certain foreign subsidiaries, the Company determined that no withholding taxes will be due on the remittance by certain subsidiaries of earnings previously deemed reinvested and, accordingly, reversed $45 of previously recorded foreign withholding taxes. Also as part of the previously recorded charge for the TCJA, the Company provided a valuation allowance against a deferred tax asset related to the foreign tax credit carryforwards that the Company did not expect to be able to use due to changes made by the TCJA. As a result of a new operating structure being implemented within one of the Company's divisions, the Company believes the use of these foreign tax credit carryforwards will not be limited in the future and, accordingly, reversed the previously recorded valuation allowance of $26. In 2019, the provision for income taxes includes a net benefit of $29 related to changes enacted by the Swiss government to its corporate tax regime, which included, among other items, the repeal of certain preferential tax regimes and an increase to the cantonal tax rate for future periods. Additionally, the government provided transition rules which allowed companies to record goodwill for tax purposes, partially offsetting the impact on cash taxes of the higher cantonal rate over the next ten years. In 2018, the provision for income taxes includes a benefit of $15 related to several Supreme Court and Administrative Court rulings in a foreign jurisdiction allowing certain tax deductions which had the effect of reversing prior decisions.
Components of deferred tax assets (liabilities)
The components of deferred tax assets (liabilities) are as follows at December 31:
  20202019
Deferred tax liabilities: 
Goodwill and intangible assets$(603)$(598)
Property, plant and equipment(281)(303)
Right-of-use assets(131)(135)
Deferred withholding tax(95)(207)
Other(52)(46)
Total deferred tax liabilities(1,162)(1,289)
Deferred tax assets: 
Pension and other retiree benefits404 381 
Tax credits and tax loss carryforwards42 93 
Lease liabilities144 152 
Accrued liabilities250 221 
Stock-based compensation73 88 
Other125 83 
Total deferred tax assets1,038 1,018 
Valuation Allowance$(11)$(59)
Net deferred tax assets$1,027 $959 
Net deferred income taxes$(135)$(330)

20202019
Deferred taxes included within:  
Assets:
Deferred income taxes$291 $177 
Liabilities:
Deferred income taxes(426)(507)
Net deferred income taxes$(135)$(330)
Unrecognized tax benefits activity
Unrecognized tax benefits activity for the years ended December 31, 2020, 2019 and 2018 is summarized below:
  202020192018
Unrecognized tax benefits:   
Balance, January 1$173 $190 $214 
Increases as a result of tax positions taken during the current year18 14 14 
Decreases of tax positions taken during prior years(5)(21)(37)
Increases of tax positions taken during prior years57 20 
Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations
(19)(30)(6)
Effect of foreign currency rate movements
— (4)
Balance, December 31$227 $173 $190 
XML 60 R40.htm IDEA: XBRL DOCUMENT v3.20.4
Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2020
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
For the years ended December 31, 2020, 2019 and 2018, earnings per share were as follows:
 202020192018
 Net income attributable to Colgate-Palmolive CompanyShares
(millions)
Per
Share
Net income attributable to Colgate-Palmolive CompanyShares
(millions)
Per
Share
Net income attributable to Colgate-Palmolive CompanyShares
(millions)
Per
Share
Basic EPS$2,695 856.8 $3.15 $2,367 859.1 $2.76 $2,400 870.6 $2.76 
Stock options and restricted stock units
2.5   2.0   2.4  
Diluted EPS$2,695 859.3 $3.14 $2,367 861.1 $2.75 $2,400 873.0 $2.75 
XML 61 R41.htm IDEA: XBRL DOCUMENT v3.20.4
Segment Information (Tables)
12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
Net Sales and Operating Profit by Segment
 202020192018
Net sales  
Oral, Personal and Home Care  
North America(1)
$3,741 $3,424 $3,348 
Latin America3,418 3,606 3,605 
Europe2,747 2,450 2,502 
Asia Pacific2,701 2,707 2,734 
Africa/Eurasia981 981 967 
Total Oral, Personal and Home Care13,588 13,168 13,156 
Pet Nutrition(2)
2,883 2,525 2,388 
Total Net sales$16,471 $15,693 $15,544 
_________
(1)    Net sales in the U.S. for Oral, Personal and Home Care were $3,447, $3,166 and $3,091 in 2020, 2019 and 2018, respectively.
(2)    Net sales in the U.S. for Pet Nutrition were $1,712, $1,441 and $1,304 in 2020, 2019 and 2018, respectively.
202020192018
Operating profit  
Oral, Personal and Home Care  
North America$988 $982 $1,037 
Latin America975 963 995 
Europe652 624 634 
Asia Pacific773 749 777 
Africa/Eurasia206 187 173 
Total Oral, Personal and Home Care3,594 3,505 3,616 
Pet Nutrition793 703 680 
Corporate(502)(654)(602)
Total Operating profit$3,885 $3,554 $3,694 

202020192018
Capital expenditures  
Oral, Personal and Home Care  
North America$65 $43 $53 
Latin America104 90 131 
Europe41 42 39 
Asia Pacific51 40 75 
Africa/Eurasia13 11 
Total Oral, Personal and Home Care274 223 309 
Pet Nutrition56 41 35 
Corporate79 71 92 
Total Capital expenditures$409 $335 $436 

202020192018
Depreciation and amortization  
Oral, Personal and Home Care  
North America$101 $94 $88 
Latin America81 84 82 
Europe94 72 70 
Asia Pacific95 100 103 
Africa/Eurasia
Total Oral, Personal and Home Care380 358 351 
Pet Nutrition58 55 53 
Corporate101 106 107 
Total Depreciation and amortization$539 $519 $511 
202020192018
Identifiable assets
Oral, Personal and Home Care   
North America$4,132 $3,576 $3,310 
Latin America2,251 2,384 2,225 
Europe5,386 5,104 2,883 
Asia Pacific2,272 2,155 2,148 
Africa/Eurasia605 590 502 
Total Oral, Personal and Home Care14,646 13,809 11,068 
Pet Nutrition1,210 1,175 1,033 
Corporate(1)
64 50 60 
Total Identifiable assets(2)
$15,920 $15,034 $12,161 
____________
(1)In 2020, Corporate identifiable assets primarily consist of investments in equity securities (95%). In 2019, Corporate identifiable assets primarily consist of derivative instruments (2%) and investments in equity securities (92%). In 2018, Corporate identifiable assets primarily consist of derivative instruments (7%) and investments in equity securities (88%). 
(2)Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $10,911 in 2020, one-third of total long-lived assets of $10,192 in 2019, and one-half of total long-lived assets of $8,259 in 2018.
XML 62 R42.htm IDEA: XBRL DOCUMENT v3.20.4
Leases (Tables)
12 Months Ended
Dec. 31, 2020
Leases [Abstract]  
Schedule of Right-of-use Assets and Liabilities for Operating Leases
As of December 31, 2020 and 2019, the Company’s right-of use assets and liabilities for operating leases were as follows:
20202019
Other assets$521 $502 
Other accruals$137 $145 
Other liabilities476 491 
Total operating lease liabilities $613 $636 
Schedule of Operating Lease Liabilities
Lease liabilities for operating leases as of December 31, 2020 were as follows:
2021$157 
2022133 
202389 
202458 
202546 
Thereafter232 
Total lease commitments$715 
Less: Interest(102)
Present value of lease liabilities$613 
Schedule of Components of Operating Lease Expense
The components of the Company’s operating lease cost for the twelve months ended December 31, 2020 and 2019 were as follows:
20202019
Operating lease cost$155 $169 
Short-term lease cost
Variable lease cost20 30 
Total lease cost$178 $204 
XML 63 R43.htm IDEA: XBRL DOCUMENT v3.20.4
Supplemental Income Statement Information (Tables)
12 Months Ended
Dec. 31, 2020
Supplemental Income Statement Elements [Abstract]  
Other (income) expense, net
Other (income) expense, net202020192018
Global Growth and Efficiency Program$(13)$57 $88 
Amortization of intangible assets88 62 59 
Equity income(12)(9)(10)
Value-added tax matter in Brazil— (30)— 
Write-off of certain investments and fixed assets— 51 
Acquisition-related costs21 — 
Charges for a change in go-to-market strategy in certain countries— 15 — 
Other, net48 29 10 
Total Other (income) expense, net$113 $196 $148 
Interest expense, net
Interest (income) expense, net202020192018
Interest incurred$184 $193 $195 
Interest capitalized(1)(1)(2)
Interest income(19)(47)(50)
Total Interest (income) expense, net$164 $145 $143 
Research and development and Advertising
 202020192018
Research and development$290 $281 $277 
Advertising$1,948 $1,694 $1,590 
XML 64 R44.htm IDEA: XBRL DOCUMENT v3.20.4
Supplemental Balance Sheet Information (Tables)
12 Months Ended
Dec. 31, 2020
Balance Sheet Related Disclosures [Abstract]  
Schedule of Inventories by Major Class
Inventories by major class are as follows at December 31:
Inventories20202019
Raw materials and supplies$454 $305 
Work-in-process45 49 
Finished goods1,256 1,056 
        Total Inventories, net
$1,755 $1,410 
              Non-current inventory, net(82)(10)
                    Current Inventories, net
$1,673 $1,400 
Schedule of Property, Plant and Equipment
Property, plant and equipment, net20202019
Land$166 $153 
Buildings1,623 1,600 
Manufacturing machinery and equipment5,409 5,309 
Other equipment1,553 1,518 
 8,751 8,580 
Accumulated depreciation(5,035)(4,830)
Total Property, plant and equipment, net$3,716 $3,750 
Schedule of Other Accruals
Other accruals20202019
Accrued advertising and coupon redemption$728 $525 
Accrued payroll and employee benefits401 340 
Accrued taxes other than income taxes116 104 
Restructuring accrual21 85 
Pension and other retiree benefits89 54 
Lease Liabilities Due in One Year137 145 
Accrued interest39 43 
Derivatives93 16 
Other717 605 
Total Other accruals$2,341 $1,917 
Schedule of Other Liabilities
Other liabilities20202019
Pension and other retiree benefits$1,815 $1,728 
Restructuring accrual10 15 
Long-Term Lease Liabilities476 491 
Other354 364 
Total Other liabilities$2,655 $2,598 
XML 65 R45.htm IDEA: XBRL DOCUMENT v3.20.4
Supplemental Other Comprehensive Income (Loss) Information (Tables)
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Schedule of Comprehensive Income (Loss)
Other comprehensive income (loss) components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows:
 202020192018
PretaxNet of TaxPretaxNet of TaxPretaxNet of Tax
Cumulative translation adjustments$(119)$(30)$49 $27 $(233)$(218)
Pension and other benefits:
   Net actuarial gain (loss), prior
service costs and settlements
during the period
(125)(97)(204)(154)(21)(16)
   Amortization of net actuarial loss,
   transition and prior service costs(1)
74 57 72 54 69 54 
Retirement Plan and other retiree benefit
adjustments
(51)(40)(132)(100)48 38 
Cash flow hedges:
   Unrealized gains (losses) on cash flow
hedges
(3)(2)(9)(7)10 
   Reclassification of (gains) losses
   into net earnings on cash flow
   hedges(2)
— — (6)(5)
Gains (losses) on cash flow hedges(3)(2)(15)(12)13 10 
Total Other comprehensive income (loss)$(173)$(72)$(98)$(85)$(172)$(170)
_________
(1)These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.
(2)These (gains) losses are reclassified into Cost of sales. See Note 7, Fair Value Measurements and Financial Instruments for additional details.
XML 66 R46.htm IDEA: XBRL DOCUMENT v3.20.4
Quarterly Financial Data (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2020
Quarterly Financial Data [Abstract]  
Schedule of Quarterly Financial Information
  Total First
Quarter
 Second
Quarter
Third
Quarter
Fourth
Quarter
 
2020        
Net sales$16,471  $4,097  $3,897 $4,153 $4,324  
Gross profit10,017 
(1)
2,465 
(3)
2,369 2,540 2,643 
Net income including noncontrolling interests
2,860 
(2)
748 
(4)
675 745 
(5)
692 
(6)
Net income attributable to Colgate-Palmolive Company
2,695 
(2)
715 
(4)
635 698 
(5)
647 
(6)
Earnings per common share:   
Basic3.15 
(2)
0.83 
(4)
0.74 0.81 
(5)
0.76 
(6)
Diluted3.14 
(2)
0.83 
(4)
0.74 0.81 
(5)
0.75 
(6)
2019          
Net sales$15,693  $3,884 $3,866 $3,928 $4,015 
Gross profit9,325 
(7)
2,287 
(9)
2,308 
(11)
2,316 
(13)
2,414 
(15)
Net income including noncontrolling interests
2,527 
(8)
600 
(10)
618 
(12)
627 
(14)
682 
(16)
Net income attributable to Colgate-Palmolive Company
2,367 
(8)
560 
(10)
586 
(12)
578 
(14)
643 
(16)
Earnings per common share:
Basic2.76 
(8)
0.65 
(10)
0.68 
(12)
0.67 
(14)
0.75 
(16)
Diluted2.75 
(8)
0.65 
(10)
0.68 
(12)
0.67 
(14)
0.75 
(16)
____________
Note:    Basic and diluted earnings per share are computed independently for each quarter and the year-to-date period presented. Accordingly, the sum of the quarterly earnings per common share may not necessarily equal the earnings per share for the year-to-date period.

(1)Gross profit for the full year of 2020 includes a $4 charge for acquisition-related costs.
(2)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2020 include aftertax benefits of $13 resulting from the Global Growth and Efficiency Program, a $4 aftertax charge for acquisition-related costs, a $71 tax benefit related to subsidiary and operating structure initiatives and a $18 aftertax loss on the early extinguishment of debt.
(3)Gross profit for the first quarter of 2020 includes a $4 charge for acquisition-related costs.
(4)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2020 include a $4 aftertax charge for acquisition-related costs and a $71 tax benefit related to subsidiary and operating structure initiatives.
(5)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2020 include aftertax benefits of $13 resulting from the Global Growth and Efficiency Program.
(6)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2020 include a $18 aftertax loss on the early extinguishment of debt.
(7)Gross profit for the full year of 2019 includes $8 of charges resulting from the Global Growth and Efficiency Program and a $3 charge for acquisition-related costs.
(8)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2019 include $102 of aftertax charges resulting from the Global Growth and Efficiency Program, a $20 aftertax charge for acquisition-related costs, a $20 aftertax benefit related to a value added tax matter in Brazil and a $29 tax benefit related to Swiss income tax reform.
(9)Gross profit for the first quarter of 2019 includes $11 of charges resulting from the Global Growth and Efficiency Program.
(10)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2019 include $22 of aftertax charges resulting from the Global Growth and Efficiency Program.
(11)Gross profit for the second quarter of 2019 includes $3 of charges resulting from the Global Growth and Efficiency Program.
(12)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the second quarter of 2019 include $31 of aftertax charges resulting from the Global Growth and Efficiency Program.
(13)Gross profit for the third quarter of 2019 includes $1 of charges resulting from the Global Growth and Efficiency Program.
(14)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2019 include $22 of aftertax charges resulting from the Global Growth and Efficiency Program and a $14 aftertax charge related to U.S. tax reform.
(15)Gross profit for the fourth quarter of 2019 includes $1 of benefit resulting from the Global Growth and Efficiency Program and a $3 charge for acquisition-related costs.
(16)Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2019 include $27 of aftertax charges resulting from the Global Growth and Efficiency Program, a $6 charge for acquisition-related costs, a $20 aftertax benefit related to a value added tax matter in Brazil and a $29 tax benefit related to Swiss income tax reform.
XML 67 R47.htm IDEA: XBRL DOCUMENT v3.20.4
Nature of Operations (Details) - business_segment
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Number of product segments (in segments) 2    
Sales Revenue, Net | Product Concentration Risk      
Entity-Wide Information, Revenue from External Customer [Line Items]      
Percent of net sales 100.00% 100.00% 100.00%
Sales Revenue, Net | Product Concentration Risk | Oral Care      
Entity-Wide Information, Revenue from External Customer [Line Items]      
Percent of net sales 44.00% 46.00% 47.00%
Sales Revenue, Net | Product Concentration Risk | Personal Care      
Entity-Wide Information, Revenue from External Customer [Line Items]      
Percent of net sales 21.00% 20.00% 20.00%
Sales Revenue, Net | Product Concentration Risk | Home Care      
Entity-Wide Information, Revenue from External Customer [Line Items]      
Percent of net sales 18.00% 18.00% 18.00%
Sales Revenue, Net | Product Concentration Risk | Pet Nutrition      
Entity-Wide Information, Revenue from External Customer [Line Items]      
Percent of net sales 17.00% 16.00% 15.00%
XML 68 R48.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies - Principles of Consolidation, Shipping and Handling Costs, Inventories, & Property, Plant, and Equipment (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Principles of Consolidation [Abstract]      
Investments accounted for using the equity method, minimum interest 20.00%    
Investments accounted for using the equity method, maximum interest 50.00%    
Equity method investments included in other assets $ 56 $ 50  
Investments accounted for using the cost method, maximum interest 20.00%    
Property, Plant and Equipment [Line Items]      
Selling, general and administrative expenses $ 6,019 5,575 $ 5,389
Inventories [Abstract]      
Approximate percentage of inventories determined using the first-in, first-out (FIFO) method 75.00%    
Minimum | Machinery and equipment      
Property, Plant and Equipment [Line Items]      
Estimated useful life 3 years    
Maximum | Machinery and equipment      
Property, Plant and Equipment [Line Items]      
Estimated useful life 15 years    
Maximum | Buildings      
Property, Plant and Equipment [Line Items]      
Estimated useful life 40 years    
Shipping and Handling      
Property, Plant and Equipment [Line Items]      
Selling, general and administrative expenses $ 1,392 $ 1,275 $ 1,255
XML 69 R49.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies - Goodwill and Other Intangibles (Details) - Local Brands, Trademarks, Customer Relationships, and Non-Compete Agreements
12 Months Ended
Dec. 31, 2020
Minimum  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful life of finite-lived intangible assets 5 years
Maximum  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful life of finite-lived intangible assets 40 years
XML 70 R50.htm IDEA: XBRL DOCUMENT v3.20.4
Acquisitions - Narrative (Details)
€ in Millions, $ in Millions
3 Months Ended 12 Months Ended
Jan. 31, 2020
USD ($)
Sep. 19, 2019
USD ($)
Sep. 19, 2019
EUR (€)
Aug. 15, 2019
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2020
EUR (€)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Business Acquisition [Line Items]                  
Goodwill             $ 3,824 $ 3,508  
Purchases of non-contolling interests in subsidiaries             $ 99 $ 0 $ 0
hello                  
Business Acquisition [Line Items]                  
Payments to acquire business $ 351                
Purchase price consideration 351                
Other intangible assets 160                
Goodwill 171                
hello | North America                  
Business Acquisition [Line Items]                  
Goodwill 171                
hello | Trademarks                  
Business Acquisition [Line Items]                  
Other intangible assets $ 115                
Useful life 25 years                
hello | Customer Relationships                  
Business Acquisition [Line Items]                  
Other intangible assets $ 45                
Useful life 17 years                
Filorga                  
Business Acquisition [Line Items]                  
Payments to acquire business   $ 1,674 € 1,516            
Consideration transferred, other   38 € 32            
Purchase price consideration   1,712              
Other intangible assets   1,051              
Goodwill   923              
Purchases of non-contolling interests in subsidiaries         $ 99 € 85      
Filorga | Trademarks                  
Business Acquisition [Line Items]                  
Other intangible assets   774              
Filorga | Europe                  
Business Acquisition [Line Items]                  
Goodwill   923              
Filorga | Customer Relationships                  
Business Acquisition [Line Items]                  
Other intangible assets   $ 277              
Useful life   14 years 14 years            
Nigeria Joint Venture                  
Business Acquisition [Line Items]                  
Purchase price consideration       $ 31          
Percentage of voting interests acquired       51.00%          
XML 71 R51.htm IDEA: XBRL DOCUMENT v3.20.4
Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Jan. 31, 2020
Dec. 31, 2019
Sep. 19, 2019
Business Acquisition [Line Items]        
Goodwill $ 3,824   $ 3,508  
hello        
Business Acquisition [Line Items]        
Receivables   $ 11    
Inventories   13    
Other assets and liabilities, net   (4)    
Other intangible assets   160    
Goodwill   171    
Fair value of net assets acquired   $ 351    
Filorga        
Business Acquisition [Line Items]        
Cash       $ 30
Receivables       53
Inventories       70
Other current assets       18
Other intangible assets       1,051
Goodwill       923
Other current liabilities       (67)
Deferred income taxes       (276)
Noncontrolling interests       (90)
Fair value of net assets acquired       $ 1,712
XML 72 R52.htm IDEA: XBRL DOCUMENT v3.20.4
Restructuring and Related Implementation Charges - Narrative (Details)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
case
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Restructuring Cost and Reserve [Line Items]          
Number of new approved restructuring projects | case   0      
Total Global Growth and Efficiency Program charges, pretax   $ (13) $ 57 $ 88  
Global Growth and Efficiency Program          
Restructuring Cost and Reserve [Line Items]          
Restructuring reduction $ 16        
Restructuring reduction after tax 13        
Payments for Restructuring   53 113 167  
Restructuring Reserve 31 31 100 202 $ 234
Pretax charges related to the Restructuring Program to date     1,854    
Restructuring and related cost incurred cost to date after tax     1,380    
Charges against assets     76 27  
Total Global Growth and Efficiency Program charges, pretax     132 161  
Global Growth and Efficiency Program | Employee-Related Costs          
Restructuring Cost and Reserve [Line Items]          
Payments for Restructuring     55 107  
Restructuring Reserve     26 60 $ 127
Pretax charges related to the Restructuring Program to date     706    
Charges against assets   $ 3 7 9  
Total Global Growth and Efficiency Program charges, pretax     25 53  
Global Growth and Efficiency Program | Third party Incremental Cost          
Restructuring Cost and Reserve [Line Items]          
Total Global Growth and Efficiency Program charges, pretax     32 42  
Global Growth and Efficiency Program | Contract Termination          
Restructuring Cost and Reserve [Line Items]          
Total Global Growth and Efficiency Program charges, pretax     5 48  
Global Growth and Efficiency Program | Land and Building          
Restructuring Cost and Reserve [Line Items]          
Total Global Growth and Efficiency Program charges, pretax     28    
Global Growth and Efficiency Program | Selling, general and administrative expenses          
Restructuring Cost and Reserve [Line Items]          
Restructuring reduction 3        
Total Global Growth and Efficiency Program charges, pretax     60 33  
Global Growth and Efficiency Program | Other (income) expense, net          
Restructuring Cost and Reserve [Line Items]          
Restructuring reduction $ 13        
Total Global Growth and Efficiency Program charges, pretax     $ 57 $ 88  
XML 73 R53.htm IDEA: XBRL DOCUMENT v3.20.4
Restructuring and Related Implementation Charges - Summary of Restructuring and Related Costs (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]              
Total Global Growth and Efficiency Program charges, pretax         $ (13) $ 57 $ 88
Global Growth and Efficiency Program              
Restructuring Cost and Reserve [Line Items]              
Total Global Growth and Efficiency Program charges, pretax           132 161
Total Global Growth and Efficiency Program charges, aftertax           102 125
Global Growth and Efficiency Program | Cost of sales              
Restructuring Cost and Reserve [Line Items]              
Total Global Growth and Efficiency Program charges, pretax $ (1) $ 1 $ 3 $ 11   8 31
Global Growth and Efficiency Program | Selling, general and administrative expenses              
Restructuring Cost and Reserve [Line Items]              
Total Global Growth and Efficiency Program charges, pretax           60 33
Global Growth and Efficiency Program | Other (income) expense, net              
Restructuring Cost and Reserve [Line Items]              
Total Global Growth and Efficiency Program charges, pretax           57 88
Global Growth and Efficiency Program | Non-service related postretirement costs              
Restructuring Cost and Reserve [Line Items]              
Total Global Growth and Efficiency Program charges, pretax           $ 7 $ 9
XML 74 R54.htm IDEA: XBRL DOCUMENT v3.20.4
Restructuring and Related Implementation Charges - Restructuring Charges Incurred, by Segment (Details) - Global Growth and Efficiency Program
12 Months Ended 87 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Restructuring Cost and Reserve [Line Items]      
Percent of total restructuring charges related to segment 100.00% 100.00%  
Percent of restructuring charges related to segment, total program accumulated charges     100.00%
Pet Nutrition      
Restructuring Cost and Reserve [Line Items]      
Percent of total restructuring charges related to segment 2.00% 19.00%  
Percent of restructuring charges related to segment, total program accumulated charges     8.00%
Corporate      
Restructuring Cost and Reserve [Line Items]      
Percent of total restructuring charges related to segment 73.00% 37.00%  
Percent of restructuring charges related to segment, total program accumulated charges     42.00%
North America      
Restructuring Cost and Reserve [Line Items]      
Percent of total restructuring charges related to segment 4.00% 18.00%  
Percent of restructuring charges related to segment, total program accumulated charges     17.00%
Latin America      
Restructuring Cost and Reserve [Line Items]      
Percent of total restructuring charges related to segment 12.00% 10.00%  
Percent of restructuring charges related to segment, total program accumulated charges     5.00%
Europe      
Restructuring Cost and Reserve [Line Items]      
Percent of total restructuring charges related to segment 4.00% (2.00%)  
Percent of restructuring charges related to segment, total program accumulated charges     19.00%
Asia Pacific      
Restructuring Cost and Reserve [Line Items]      
Percent of total restructuring charges related to segment 6.00% 13.00%  
Percent of restructuring charges related to segment, total program accumulated charges     4.00%
Africa/Eurasia      
Restructuring Cost and Reserve [Line Items]      
Percent of total restructuring charges related to segment (1.00%) 5.00%  
Percent of restructuring charges related to segment, total program accumulated charges     5.00%
XML 75 R55.htm IDEA: XBRL DOCUMENT v3.20.4
Restructuring and Related Implementation Charges - Summary of Restructuring Charges, Cumulative to Date (Details) - Global Growth and Efficiency Program
$ in Millions
Dec. 31, 2019
USD ($)
Restructuring Cost and Reserve [Line Items]  
Pretax charges related to the Restructuring Program to date $ 1,854
Employee-Related Costs  
Restructuring Cost and Reserve [Line Items]  
Pretax charges related to the Restructuring Program to date 706
Incremental Depreciation  
Restructuring Cost and Reserve [Line Items]  
Pretax charges related to the Restructuring Program to date 128
Asset Impairments  
Restructuring Cost and Reserve [Line Items]  
Pretax charges related to the Restructuring Program to date 58
Other  
Restructuring Cost and Reserve [Line Items]  
Pretax charges related to the Restructuring Program to date $ 962
XML 76 R56.htm IDEA: XBRL DOCUMENT v3.20.4
Restructuring and Related Implementation Charges - Restructuring Activity and Related Accruals (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Restructuring Reserve [Roll Forward]      
Restructuring and related charges (benefits) $ (13) $ 57 $ 88
Global Growth and Efficiency Program      
Restructuring Reserve [Roll Forward]      
Beginning balance 100 202 234
Restructuring and related charges (benefits)   132 161
Cash payments (53) (113) (167)
Charges against assets   (76) (27)
Foreign exchange   3 (4)
Other   (48) 5
Ending balance 31 100 202
Global Growth and Efficiency Program | Employee-Related Costs      
Restructuring Reserve [Roll Forward]      
Beginning balance 26 60 127
Restructuring and related charges (benefits)   25 53
Cash payments   (55) (107)
Charges against assets (3) (7) (9)
Foreign exchange   3 (4)
Other   0 0
Ending balance   26 60
Global Growth and Efficiency Program | Incremental Depreciation      
Restructuring Reserve [Roll Forward]      
Beginning balance 0 0 0
Restructuring and related charges (benefits)   36 2
Cash payments   0 0
Charges against assets   (36) (2)
Foreign exchange   0 0
Other   0 0
Ending balance   0 0
Global Growth and Efficiency Program | Asset Impairments      
Restructuring Reserve [Roll Forward]      
Beginning balance 0 0 0
Restructuring and related charges (benefits)   6 16
Cash payments   0 0
Charges against assets   (6) (16)
Foreign exchange   0 0
Other   0 0
Ending balance   0 0
Global Growth and Efficiency Program | Other      
Restructuring Reserve [Roll Forward]      
Beginning balance $ 74 142 107
Restructuring and related charges (benefits)   65 90
Cash payments   (58) (60)
Charges against assets   (27) 0
Foreign exchange   0 0
Other   (48) 5
Ending balance   $ 74 $ 142
XML 77 R57.htm IDEA: XBRL DOCUMENT v3.20.4
Goodwill and Other Intangible Assets - Schedule of Goodwill (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Goodwill [Line Items]    
Goodwill $ 3,824 $ 3,508
Oral, Personal and Home Care    
Goodwill [Line Items]    
Goodwill 3,809 3,493
Pet Nutrition    
Goodwill [Line Items]    
Goodwill 15 15
North America | Oral, Personal and Home Care    
Goodwill [Line Items]    
Goodwill 912 737
Latin America | Oral, Personal and Home Care    
Goodwill [Line Items]    
Goodwill 171 212
Europe | Oral, Personal and Home Care    
Goodwill [Line Items]    
Goodwill 2,415 2,234
Asia Pacific | Oral, Personal and Home Care    
Goodwill [Line Items]    
Goodwill 190 186
Africa/Eurasia | Oral, Personal and Home Care    
Goodwill [Line Items]    
Goodwill $ 121 $ 124
XML 78 R58.htm IDEA: XBRL DOCUMENT v3.20.4
Goodwill and Other Intangible Assets - Summary of Other Intangible Assets (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Finite and indefinite-lived intangible assets [Line Items]    
Finite & indefinite lived intangibles, gross $ 3,553 $ 3,217
Finite-lived intangible assets, accumulated amortization, net (659) (550)
Intangible assets, net (excluding goodwill) 2,894 2,667
Indefinite life intangible assets    
Finite and indefinite-lived intangible assets [Line Items]    
Indefinite-lived intangible assets (excluding goodwill) 1,865 1,747
Trademarks    
Finite and indefinite-lived intangible assets [Line Items]    
Finite-lived intangible assets, gross 902 771
Finite-lived intangible assets, accumulated amortization, net (422) (381)
Finite-lived intangible assets, net 480 390
Other finite life intangible assets    
Finite and indefinite-lived intangible assets [Line Items]    
Finite-lived intangible assets, gross 786 699
Finite-lived intangible assets, accumulated amortization, net (237) (169)
Finite-lived intangible assets, net $ 549 $ 530
XML 79 R59.htm IDEA: XBRL DOCUMENT v3.20.4
Goodwill and Other Intangible Assets - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Goodwill [Line Items]      
Amortization of intangible assets $ 88 $ 62 $ 59
Annual estimated amortization expense, year 1 83    
Annual estimated amortization expense, year 2 83    
Annual estimated amortization expense, year 3 83    
Annual estimated amortization expense, year 4 83    
Annual estimated amortization expense, year 5 $ 83    
Filorga Reporting Unit      
Goodwill [Line Items]      
Reporting unit, percentage of fair value in excess of carrying amount 10.00%    
Reporting unit, impairment analysis, projected reduction in fair value, percentage 5.00%    
Filorga Reporting Unit | Indefinite life intangible assets      
Goodwill [Line Items]      
Indefinite-lived intangible assets, percentage of fair value in excess of carrying amount 10.00%    
Filorga Reporting Unit | Scenario One      
Goodwill [Line Items]      
Reporting unit, impairment analysis, reduction in long-term growth rate, percentage 0.50%    
Filorga Reporting Unit | Scenario One | Indefinite life intangible assets      
Goodwill [Line Items]      
Reporting unit, impairment analysis, reduction in long-term growth rate, percentage 0.50%    
Filorga Reporting Unit | Scenario Two      
Goodwill [Line Items]      
Reporting unit, impairment analysis, increase in discount rate, percentage 0.25%    
Filorga Reporting Unit | Scenario Two | Indefinite life intangible assets      
Goodwill [Line Items]      
Reporting unit, impairment analysis, increase in discount rate, percentage 0.25%    
Reporting Units Other Than Filorga      
Goodwill [Line Items]      
Indefinite-lived intangible assets, percentage of fair value in excess of carrying amount 20.00%    
XML 80 R60.htm IDEA: XBRL DOCUMENT v3.20.4
Long-Term Debt and Credit Facilities - Components of Long-term Debt (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Debt Instrument [Line Items]    
Total debt $ 7,343 $ 7,587
Less: Current portion of long-term debt (9) (254)
Total debt, excluding current portion of long-term debt $ 7,334 7,333
Notes    
Debt Instrument [Line Items]    
Weighted average interest rate 1.90%  
Total debt $ 6,170 6,988
Commercial paper    
Debt Instrument [Line Items]    
Weighted average interest rate (0.30%)  
Total debt $ 1,139 579
Finance Lease Obligations    
Debt Instrument [Line Items]    
Total debt $ 34 $ 20
XML 81 R61.htm IDEA: XBRL DOCUMENT v3.20.4
Long-Term Debt and Credit Facilities - Schedule of Long-Term Debt and Finance Lease Maturities (Details)
$ in Millions
Dec. 31, 2020
USD ($)
Debt Disclosure [Abstract]  
2021 $ 631
2022 413
2023 896
2024 498
2025 130
Thereafter $ 3,636
XML 82 R62.htm IDEA: XBRL DOCUMENT v3.20.4
Long-Term Debt and Credit Facilities - Narrative (Details)
$ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 31, 2020
USD ($)
Aug. 31, 2019
Dec. 31, 2020
USD ($)
Dec. 31, 2019
EUR (€)
Mar. 31, 2019
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Mar. 31, 2019
EUR (€)
Nov. 30, 2018
USD ($)
Debt Instrument [Line Items]                    
Weighted-average interest rate on short term borrowings     4.80% 1.80%   4.80%        
Debt instrument term 364 days                  
Loss on early extinguishment of debt           $ 23 $ 0 $ 0    
Unused borrowing capacity     $ 4,657     $ 4,657        
Amended Domestic Revolving Credit Facility 2650 Million Capacity                    
Debt Instrument [Line Items]                    
Maximum borrowing capacity                   $ 2,650
Term extension   1 year                
Amended Foreign Revolving Credit Facility 1500 Million Capacity                    
Debt Instrument [Line Items]                    
Maximum borrowing capacity $ 1,500                  
Seven Year notes at 0.50 Percent                    
Debt Instrument [Line Items]                    
Face amount | €                 € 500,000,000  
Debt instrument term         7 years          
Fixed interest rate         0.50%       0.50%  
Fifteen Year notes at 1.375 Percent                    
Debt Instrument [Line Items]                    
Face amount | €                 € 500,000,000  
Debt instrument term         15 years          
Fixed interest rate         1.375%       1.375%  
Two Year Notes at 0.00 Percent                    
Debt Instrument [Line Items]                    
Face amount | €       € 500,000,000            
Debt instrument term       2 years            
Fixed interest rate       0.00%            
Twenty Year Notes at 0.875 Percent                    
Debt Instrument [Line Items]                    
Face amount | €       € 500,000,000            
Debt instrument term       20 years            
Fixed interest rate       0.875%            
1.75 Percent                    
Debt Instrument [Line Items]                    
Face amount         $ 500       € 500,000,000  
Fixed interest rate         1.75%       1.75%  
2.45% Notes Due 2021                    
Debt Instrument [Line Items]                    
Fixed interest rate     2.45%     2.45%        
Repayments of Debt     $ 300              
2.30% Notes Due 2022                    
Debt Instrument [Line Items]                    
Fixed interest rate     2.30%     2.30%        
Repayments of Debt     $ 500              
2.45% Notes Due 2021 and 2.30% Notes Due 2022                    
Debt Instrument [Line Items]                    
Loss on early extinguishment of debt     $ 23              
XML 83 R63.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurements and Financial Instruments - Narrative (Details)
$ in Millions
12 Months Ended
Dec. 31, 2020
USD ($)
country_and_territory
Dec. 31, 2019
USD ($)
Debt Instrument [Line Items]    
Minimum number of countries and territories serving consumers (more than) (in countries and territories) | country_and_territory 200  
Carrying Value    
Debt Instrument [Line Items]    
Carrying value of long-term debt $ 7,343 $ 7,587
Fair Value, Inputs, Level 2    
Debt Instrument [Line Items]    
Estimated fair value of long-term debt $ 8,175 $ 8,056
XML 84 R64.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Designated derivative instruments    
Derivative asset $ 29 $ 10
Derivative liability 93 29
Other financial instruments    
Investments fair value 37 23
Other assets | Interest rate swap contracts    
Designated derivative instruments    
Derivative asset 14 4
Other assets | Forward-starting interest rate swaps    
Designated derivative instruments    
Derivative asset 5 0
Other assets | Foreign currency contracts    
Designated derivative instruments    
Derivative asset 0 0
Other current assets    
Other financial instruments    
Marketable securities 37 23
Other current assets | Foreign currency contracts    
Designated derivative instruments    
Derivative asset 7 6
Other current assets | Commodity contracts    
Designated derivative instruments    
Derivative asset 3 0
Other liabilities | Interest rate swap contracts    
Designated derivative instruments    
Derivative liability 0 0
Other liabilities | Forward-starting interest rate swaps    
Designated derivative instruments    
Derivative liability 0 0
Other liabilities | Foreign currency contracts    
Designated derivative instruments    
Derivative liability 0 14
Other accruals | Foreign currency contracts    
Designated derivative instruments    
Derivative liability 93 15
Other accruals | Commodity contracts    
Designated derivative instruments    
Derivative liability $ 0 $ 0
XML 85 R65.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details) - Long-term Debt - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Debt Instrument [Line Items]    
Carrying amount of hedged item $ 413 $ 403
Cumulative hedging adjustment included in the carrying amount $ 14 $ 4
XML 86 R66.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Fair Value Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative $ 989 $ 788
Fair Value Hedges | Foreign currency contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative 589 388
Fair Value Hedges | Foreign Currency Debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative 0 0
Fair Value Hedges | Interest rate swap contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative 400 400
Fair Value Hedges | Forward-starting interest rate swaps    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative 0 0
Fair Value Hedges | Commodity contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative 0 0
Cash Flow Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative 1,171 781
Cash Flow Hedges | Foreign currency contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative 854 761
Cash Flow Hedges | Foreign Currency Debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative 0 0
Cash Flow Hedges | Interest rate swap contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative 0 0
Cash Flow Hedges | Forward-starting interest rate swaps    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative 300 0
Cash Flow Hedges | Commodity contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative 17 20
Net Investment Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative 5,051 4,334
Net Investment Hedges | Foreign currency contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative 528 478
Net Investment Hedges | Foreign Currency Debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative 4,523 3,856
Net Investment Hedges | Interest rate swap contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative 0 0
Net Investment Hedges | Forward-starting interest rate swaps    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative 0 0
Net Investment Hedges | Commodity contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional value of derivative $ 0 $ 0
XML 87 R67.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Statements of Income (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Cost of sales    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain (loss) on hedges recognized in income $ 0 $ 6
Cost of sales | Interest rate swap contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument 0 0
Gain (loss) on hedged items 0 0
Cost of sales | Foreign currency contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument 0 0
Gain (loss) on hedged items 0 0
Amount reclassified from OCI 1 5
Cost of sales | Commodity contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI (1) 1
Selling, general and administrative expenses    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain (loss) on hedges recognized in income 0 0
Selling, general and administrative expenses | Interest rate swap contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument 0 0
Gain (loss) on hedged items 0 0
Selling, general and administrative expenses | Foreign currency contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument 29 10
Gain (loss) on hedged items (29) (10)
Amount reclassified from OCI 0 0
Selling, general and administrative expenses | Commodity contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI 0 0
Interest (income) expense, net    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain (loss) on hedges recognized in income 0 0
Interest (income) expense, net | Interest rate swap contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument (10) (11)
Gain (loss) on hedged items 10 11
Interest (income) expense, net | Foreign currency contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument 0 0
Gain (loss) on hedged items 0 0
Amount reclassified from OCI 0 0
Interest (income) expense, net | Commodity contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI $ 0 $ 0
XML 88 R68.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Cash flow hedges [Abstract]    
Gain (loss) recognized in OCI $ (3) $ (9)
Foreign currency contracts    
Cash flow hedges [Abstract]    
Gain (loss) recognized in OCI (11) (9)
Net investment hedges [Abstract]    
Gain (loss) on instruments (52) 4
Gain (loss) on hedged items 52 (4)
Forward-starting interest rate swaps    
Cash flow hedges [Abstract]    
Gain (loss) recognized in OCI 5 0
Commodity contracts    
Cash flow hedges [Abstract]    
Gain (loss) recognized in OCI 3 0
Foreign Currency Debt    
Net investment hedges [Abstract]    
Gain (loss) on instruments (356) 12
Gain (loss) on hedged items $ 356 $ (12)
XML 89 R69.htm IDEA: XBRL DOCUMENT v3.20.4
Capital Stock and Stock-Based Compensation Plans - Narrative (Details)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2020
USD ($)
plan
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
Dec. 31, 2018
USD ($)
$ / shares
Jun. 18, 2018
USD ($)
Preference Stock [Abstract]        
Shares authorized (in shares) | shares 50,262,150      
Stock Repurchases [Abstract]        
Repurchased stock $ 1,476 $ 1,202 $ 1,238  
Stock-Based Compensation [Abstract]        
Number of stockholder approved plans, current | plan 1      
Total stock-based compensation expense charged against pretax income $ 107 100 109  
Total income tax benefit from stock compensation $ 20 $ 20 $ 25  
Weighted-average estimated fair value of stock options granted (in dollars per share) | $ / shares $ 11.26 $ 10.48 $ 9.48  
Stock-based compensation, additional disclosures [Abstract]        
Tax benefit from exercise of stock options and vesting of restricted stock unit awards $ 8 $ 6 $ 12  
Proceeds from exercise of stock options $ 874 $ 498 329  
Stock Option Plans        
Additional disclosures pertaining to stock based compensation [Abstract]        
Vesting period (in years) 3 years      
Unrecognized compensation expense $ 32      
Number of shares available for grant (in shares) | shares 36,144,000      
Unrecognized compensation expense, weighted-average period of recognition in years 1 year 6 months      
Stock-based compensation, additional disclosures [Abstract]        
Contractual term (in years) 8 years 6 years    
Total intrinsic value of options exercised $ 136 $ 84 92  
Performance Shares | Incentive Stock Plans        
Additional disclosures pertaining to stock based compensation [Abstract]        
Vesting period (in years) 3 years      
Unrecognized compensation expense $ 41      
Time-Vested Stock | Incentive Stock Plans        
Additional disclosures pertaining to stock based compensation [Abstract]        
Vesting period (in years) 3 years      
Unrecognized compensation expense $ 58      
Number of shares available for grant (in shares) | shares 12,420,000      
Unrecognized compensation expense, weighted-average period of recognition in years 2 years 1 month 6 days      
Total fair value of shares vested $ 58 $ 53 $ 55  
Program 2018        
Stock Repurchases [Abstract]        
Stock repurchase program, authorized amount       $ 5,000
Repurchased stock $ 1,476      
XML 90 R70.htm IDEA: XBRL DOCUMENT v3.20.4
Capital Stock and Stock-Based Compensation Plans - Summary of Common Stock and Treasury Stock Activity (Details) - shares
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Common Stock Outstanding      
Common stock balance, January 1 (in shares) 854,701,779 862,912,792 874,701,118
Common stock acquired (in shares) 18,701,843 17,219,642 18,786,897
Shares issued for stock options (in shares) 13,018,354 8,145,777 6,040,920
Shares issued for restricted stock and other (in shares) 875,311 862,852 957,651
Common stock balance, December 31 (in shares) 849,893,601 854,701,779 862,912,792
Treasury Stock      
Treasury stock balance, January 1 (in shares) 611,004,581 602,793,568 591,005,242
Common stock acquired (in shares) 18,701,843 17,219,642 18,786,897
Shares issued for stock options (in shares) 13,018,354 8,145,777 6,040,920
Shares issued for restricted stock and other (in shares) 875,311 862,852 957,651
Treasury stock balance, December 31 (in shares) 615,812,759 611,004,581 602,793,568
XML 91 R71.htm IDEA: XBRL DOCUMENT v3.20.4
Capital Stock and Stock-Based Compensation Plans - Fair Value Assumptions (Details)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Share-based Payment Arrangement [Abstract]      
Expected term of options 6 years 6 years 4 years 6 months
Expected volatility rate 21.80% 19.20% 17.70%
Risk-free interest rate 0.50% 1.50% 2.80%
Expected dividend yield 2.30% 2.30% 2.50%
XML 92 R72.htm IDEA: XBRL DOCUMENT v3.20.4
Capital Stock and Stock-Based Compensation Plans - Summary of Performance Restricted Stock Activity (Details) - Performance Shares
shares in Thousands
12 Months Ended
Dec. 31, 2020
$ / shares
shares
Shares (in thousands)  
Restricted stock awards - beginning balance (in shares) | shares 346
Granted (in shares) | shares 557
Forfeited (in shares) | shares (38)
Restricted stock awards - ending balance (in shares) | shares 865
Weighted Average Grant Date Fair Value Per Award  
Restricted stock awards - beginning of period (in dollars per share) | $ / shares $ 67
Restricted stock awards - shares granted (in dollars per share) | $ / shares 76
Restricted stock awards - shares forfeited (in dollars per share) | $ / shares 69
Restricted stock awards - end of period (in dollars per share) | $ / shares $ 73
XML 93 R73.htm IDEA: XBRL DOCUMENT v3.20.4
Capital Stock and Stock-Based Compensation Plans - Summary of Restricted Stock Activity (Details) - Time-Vested Stock
shares in Thousands
12 Months Ended
Dec. 31, 2020
$ / shares
shares
Shares (in thousands)  
Restricted stock awards - beginning balance (in shares) | shares 2,203
Granted (in shares) | shares 727
Vested (in shares) | shares (1,130)
Forfeited (in shares) | shares (63)
Restricted stock awards - ending balance (in shares) | shares 1,737
Weighted Average Grant Date Fair Value Per Award  
Restricted stock awards - beginning of period (in dollars per share) | $ / shares $ 71
Restricted stock awards - shares granted (in dollars per share) | $ / shares 77
Weighted average grant date fair value of restricted stock awards - shares vested (in dollars per share) | $ / shares 74
Restricted stock awards - shares forfeited (in dollars per share) | $ / shares 71
Restricted stock awards - end of period (in dollars per share) | $ / shares $ 73
XML 94 R74.htm IDEA: XBRL DOCUMENT v3.20.4
Capital Stock and Stock-Based Compensation Plans - Summary of Stock Option Activity (Details)
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2020
USD ($)
$ / shares
shares
Shares (in thousands)  
Options - beginning balance (in shares) | shares 36,185
Granted (in shares) | shares 4,976
Exercised (in shares) | shares (13,019)
Forfeited or expired (in shares) | shares (601)
Options - ending balance (in shares) | shares 27,541
Options exercisable (in shares) | shares 18,084
Weighted Average Exercise Price  
Options - beginning of period (in dollars per share) | $ / shares $ 69
Options - shares granted (in dollars per share) | $ / shares 76
Options - shares exercised (in dollars per share) | $ / shares 67
Options - shares forfeited or expired (in dollars per share) | $ / shares 72
Options - end of period (in dollars per share) | $ / shares 72
Options exercisable - end of period (in dollars per share) | $ / shares $ 70
Weighted average remaining contractual life, options outstanding (in years) 4 years
Weighted average remaining contractual life, options exercisable (in years) 3 years
Intrinsic value of unexercised in-the-money options, options outstanding | $ $ 386
Intrinsic value of unexercised in-the-money options, options exercisable | $ $ 274
XML 95 R75.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Stock Ownership Plan (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Share-based Payment Arrangement [Abstract]      
Shares in ESOP (in shares) 11,545,950 13,359,448  
Outstanding borrowings in the ESOP $ 1    
Common shares released and allocated to participant accounts (in shares) 10,454,105    
Common shares available for future allocation to participant accounts (in shares) 1,091,845    
Annual ESOP expense $ 0 $ 0 $ 0
Dividends paid by the Company on shares held by the ESOP 23 25 29
Company contributions to the ESOP $ 0 $ 0 $ 0
XML 96 R76.htm IDEA: XBRL DOCUMENT v3.20.4
Retirement Plans and Other Retiree Benefits - Schedule of Target Asset Allocation (Details)
Dec. 31, 2020
United States  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Target asset allocation 100.00%
International  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Target asset allocation 100.00%
Equity securities | United States  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Target asset allocation 21.00%
Equity securities | International  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Target asset allocation 38.00%
Fixed income securities | United States  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Target asset allocation 74.00%
Fixed income securities | International  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Target asset allocation 46.00%
Real estate and other investments | United States  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Target asset allocation 5.00%
Real estate and other investments | International  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Target asset allocation 16.00%
XML 97 R77.htm IDEA: XBRL DOCUMENT v3.20.4
Retirement Plans and Other Retiree Benefits - Allocation of Plan Assets and Level of Valuation Input, by Major Asset Category (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Defined Benefit Plan Disclosure [Line Items]      
Percent of fixed income assets invested in US treasury or agency securities 50.00% 50.00%  
Other assets and liabilities, net      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets   $ 0  
Other Retiree Benefit Plans      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets $ 3 37 $ 54
Other Retiree Benefit Plans | Fair Value, Inputs, Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 2 24  
Other Retiree Benefit Plans | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 1 13  
Other Retiree Benefit Plans | Cash and cash equivalents | Fair Value, Inputs, Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 1  
Other Retiree Benefit Plans | U.S. common stocks | Fair Value, Inputs, Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 1  
Other Retiree Benefit Plans | International common stocks | Fair Value, Inputs, Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
Other Retiree Benefit Plans | Pooled funds | Fair Value, Inputs, Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 2  
Other Retiree Benefit Plans | Fixed income securities | Fair Value, Inputs, Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 2 20  
Other Retiree Benefit Plans | Guaranteed investment contracts | Fair Value, Inputs, Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
Other Retiree Benefit Plans | Domestic, developed and emerging markets equity funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 1 7  
Other Retiree Benefit Plans | Fixed income funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 3  
Other Retiree Benefit Plans | Hedge funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
Other Retiree Benefit Plans | Multi-Asset funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 2  
Other Retiree Benefit Plans | Real estate funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 1  
Other Retiree Benefit Plans | Other assets and liabilities, net      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0    
United States | Pension Plans      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 1,921 1,806 1,568
United States | Pension Plans | Fair Value, Inputs, Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 1,233 1,187  
United States | Pension Plans | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 703 704  
United States | Pension Plans | Cash and cash equivalents | Fair Value, Inputs, Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 50 41  
United States | Pension Plans | U.S. common stocks | Fair Value, Inputs, Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 49  
United States | Pension Plans | International common stocks | Fair Value, Inputs, Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
United States | Pension Plans | Pooled funds | Fair Value, Inputs, Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 65 29  
United States | Pension Plans | Fixed income securities | Fair Value, Inputs, Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 1,117 1,067  
United States | Pension Plans | Guaranteed investment contracts | Fair Value, Inputs, Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 1 1  
United States | Pension Plans | Domestic, developed and emerging markets equity funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 456 328  
United States | Pension Plans | Fixed income funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 136 177  
United States | Pension Plans | Hedge funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 3  
United States | Pension Plans | Multi-Asset funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 77 155  
United States | Pension Plans | Real estate funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 34 41  
United States | Pension Plans | Other assets and liabilities, net      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets (15) (85)  
International | Pension Plans      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 698 586 $ 510
International | Pension Plans | Fair Value, Inputs, Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 252 181  
International | Pension Plans | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 446 405  
International | Pension Plans | Cash and cash equivalents | Fair Value, Inputs, Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 12 15  
International | Pension Plans | U.S. common stocks | Fair Value, Inputs, Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 1 3  
International | Pension Plans | International common stocks | Fair Value, Inputs, Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 8 3  
International | Pension Plans | Pooled funds | Fair Value, Inputs, Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 117 104  
International | Pension Plans | Fixed income securities | Fair Value, Inputs, Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 59 14  
International | Pension Plans | Guaranteed investment contracts | Fair Value, Inputs, Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 55 42  
International | Pension Plans | Domestic, developed and emerging markets equity funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 183 165  
International | Pension Plans | Fixed income funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 225 196  
International | Pension Plans | Hedge funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 6 17  
International | Pension Plans | Multi-Asset funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 2 2  
International | Pension Plans | Real estate funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 30 25  
International | Pension Plans | Other assets and liabilities, net      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets $ 0 $ 0  
XML 98 R78.htm IDEA: XBRL DOCUMENT v3.20.4
Retirement Plans and Other Retiree Benefits - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Defined Benefit Plan Disclosure [Line Items]      
Expected benefit payments from company assets $ 90    
Global Growth and Efficiency Program      
Defined Benefit Plan Disclosure [Line Items]      
Charges against assets   $ 76 $ 27
Employee-Related Costs | Global Growth and Efficiency Program      
Defined Benefit Plan Disclosure [Line Items]      
Charges against assets $ 3 $ 7 9
Pension Plans      
Defined Benefit Plan Disclosure [Line Items]      
Expected long-term rate of return on plan assets 5.70%    
Pension Plans | United States      
Defined Benefit Plan Disclosure [Line Items]      
Percentage of investments in Company's common stock 0.00% 3.00%  
U.S. plans assets sold to Company (in shares) 739,869 588,334  
U.S. plans assets purchased to Company (in shares) 0 0  
Defined Benefit Plan Dividends Received On Employer Securities $ 0 $ 2  
Expected long-term rate of return on plan assets 5.70% 6.30%  
Average annual rates of return for the most recent 1-year period 15.00%    
Average annual rates of return for the most recent 5-year period 9.00%    
Average annual rates of return for the most recent 10-year period 8.00%    
Average annual rates of return for the most recent 15-year period 7.00%    
Average annual rates of return for the most recent 25-year period 7.00%    
Other postretirement charges $ 4 $ 7 9
Voluntary contributions to postretirement plans $ 0 $ 113 67
Pension Plans | International      
Defined Benefit Plan Disclosure [Line Items]      
Expected long-term rate of return on plan assets 2.93% 3.38%  
Other postretirement charges $ 0 $ 1 2
Other Retiree Benefit Plans      
Defined Benefit Plan Disclosure [Line Items]      
Expected long-term rate of return on plan assets 5.70% 6.30%  
Medical cost trend rate assumed for next fiscal year 6.00%    
Ultimate medical cost trend rate 4.75%    
Year which ultimate medical cost trend rate is reached 2026    
Other postretirement charges $ 0 $ 0 $ 0
XML 99 R79.htm IDEA: XBRL DOCUMENT v3.20.4
Retirement Plans and Other Retiree Benefits - Summary of Defined Benefit and Other Retiree Benefit Plans (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Amounts Recognized in Balance Sheet      
Current liabilities $ (89) $ (54)  
Pension Plans      
Weighted-Average Assumptions Used to Determine Benefit Obligations      
Expected long-term rate of return on plan assets 5.70%    
Other Retiree Benefit Plans      
Change in Benefit Obligations      
Benefit obligations at beginning of year $ 1,050 876  
Service cost 20 15 $ 16
Interest cost 37 41 38
Participants’ contributions 0 0  
Acquisitions/plan amendments 0 0  
Actuarial loss (gain) 61 166  
Foreign exchange impact (9) 1  
Termination benefits 0 0  
Curtailments and settlements 0 0  
Benefit payments (47) (49)  
Other 0 0  
Benefit obligations at end of year 1,112 1,050 876
Change in Plan Assets      
Fair value of plan assets at beginning of year 37 54  
Actual return on plan assets 2 8  
Company contributions 11 24  
Participants’ contributions 0 0  
Foreign exchange impact 0 0  
Settlements and acquisitions 0 0  
Benefit payments (47) (49)  
Other 0 0  
Fair value of plan assets at end of year 3 37 54
Funded Status      
Benefit obligations at end of year 1,112 1,050 876
Fair value of plan assets at end of year 3 37 54
Net amount recognized (1,109) (1,013)  
Amounts Recognized in Balance Sheet      
Noncurrent assets 0 0  
Current liabilities (45) (13)  
Noncurrent liabilities (1,064) (1,000)  
Net amount recognized (1,109) (1,013)  
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)      
Actuarial loss 429 388  
Transition/prior service cost 0 (1)  
Amounts recognized in accumulated other comprehensive income 429 387  
Accumulated benefit obligation $ 0 $ 0  
Weighted-Average Assumptions Used to Determine Benefit Obligations      
Discount rate 2.88% 3.56%  
Expected long-term rate of return on plan assets 5.70% 6.30%  
Long-term rate of compensation increase 3.50% 3.50%  
ESOP growth rate 10.00% 10.00%  
Medical cost trend rate of increase 6.00% 6.00%  
Interest Crediting Rate 0.00% 0.00%  
United States | Pension Plans      
Change in Benefit Obligations      
Benefit obligations at beginning of year $ 2,272 $ 2,147  
Service cost 1 1 1
Interest cost 74 90 86
Participants’ contributions 0 0  
Acquisitions/plan amendments 0 0  
Actuarial loss (gain) 171 181  
Foreign exchange impact 0 0  
Termination benefits 3 7  
Curtailments and settlements (3) 0  
Benefit payments (155) (154)  
Other 0 0  
Benefit obligations at end of year 2,363 2,272 2,147
Change in Plan Assets      
Fair value of plan assets at beginning of year 1,806 1,568  
Actual return on plan assets 243 262  
Company contributions 30 130  
Participants’ contributions 0 0  
Foreign exchange impact 0 0  
Settlements and acquisitions (3) 0  
Benefit payments (155) (154)  
Other 0 0  
Fair value of plan assets at end of year 1,921 1,806 1,568
Funded Status      
Benefit obligations at end of year 2,363 2,272 2,147
Fair value of plan assets at end of year 1,921 1,806 1,568
Net amount recognized (442) (466)  
Amounts Recognized in Balance Sheet      
Noncurrent assets 20 0  
Current liabilities (30) (28)  
Noncurrent liabilities (432) (438)  
Net amount recognized (442) (466)  
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)      
Actuarial loss 902 910  
Transition/prior service cost 1 1  
Amounts recognized in accumulated other comprehensive income 903 911  
Accumulated benefit obligation $ 2,325 $ 2,236  
Weighted-Average Assumptions Used to Determine Benefit Obligations      
Discount rate 2.65% 3.40%  
Expected long-term rate of return on plan assets 5.70% 6.30%  
Long-term rate of compensation increase 3.50% 3.50%  
ESOP growth rate 0.00% 0.00%  
Medical cost trend rate of increase 0.00% 0.00%  
Interest Crediting Rate 2.48% 3.21%  
International | Pension Plans      
Change in Benefit Obligations      
Benefit obligations at beginning of year $ 876 $ 787  
Service cost 17 14 14
Interest cost 21 22 21
Participants’ contributions 5 2  
Acquisitions/plan amendments 30 3  
Actuarial loss (gain) 65 82  
Foreign exchange impact 46 8  
Termination benefits 0 0  
Curtailments and settlements (7) (9)  
Benefit payments (40) (35)  
Other 0 2  
Benefit obligations at end of year 1,013 876 787
Change in Plan Assets      
Fair value of plan assets at beginning of year 586 510  
Actual return on plan assets 59 76  
Company contributions 36 30  
Participants’ contributions 5 2  
Foreign exchange impact 26 12  
Settlements and acquisitions 26 (9)  
Benefit payments (40) (35)  
Other 0 0  
Fair value of plan assets at end of year 698 586 510
Funded Status      
Benefit obligations at end of year 1,013 876 787
Fair value of plan assets at end of year 698 586 $ 510
Net amount recognized (315) (290)  
Amounts Recognized in Balance Sheet      
Noncurrent assets 18 13  
Current liabilities (14) (13)  
Noncurrent liabilities (319) (290)  
Net amount recognized (315) (290)  
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)      
Actuarial loss 255 238  
Transition/prior service cost 7 7  
Amounts recognized in accumulated other comprehensive income 262 245  
Accumulated benefit obligation $ 946 $ 816  
Weighted-Average Assumptions Used to Determine Benefit Obligations      
Discount rate 1.61% 2.06%  
Expected long-term rate of return on plan assets 2.93% 3.38%  
Long-term rate of compensation increase 2.62% 2.83%  
ESOP growth rate 0.00% 0.00%  
Medical cost trend rate of increase 0.00% 0.00%  
Interest Crediting Rate 0.83% 0.85%  
XML 100 R80.htm IDEA: XBRL DOCUMENT v3.20.4
Retirement Plans and Other Retiree Benefits - Benefit Obligation Exceeds Fair Value of Plan Assets (Details) - Pension Plans - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]    
Projected benefit obligation $ 1,092 $ 2,862
Fair value of plan assets 299 2,094
Accumulated benefit obligation 882 875
Fair value of plan assets $ 134 $ 166
XML 101 R81.htm IDEA: XBRL DOCUMENT v3.20.4
Retirement Plans and Other Retiree Benefits - Summary of Other Retiree Benefit Plans (Details) - Other Retiree Benefit Plans - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]    
Accumulated benefit obligation $ 1,112 $ 958
Fair value of plan assets $ 3 $ 37
XML 102 R82.htm IDEA: XBRL DOCUMENT v3.20.4
Retirement Plans and Other Retiree Benefits - Summary of Net Periodic Benefit Costs (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Other Retiree Benefit Plans      
Components of Net Periodic Benefit Cost      
Service cost $ 20 $ 15 $ 16
Interest cost 37 41 38
Expected return on plan assets (2) (3) (2)
Amortization of transition and prior service costs (credits) 0 0 0
Amortization of actuarial loss 18 11 14
Net periodic benefit cost 73 64 66
Other postretirement charges 0 0 0
Total pension cost $ 73 $ 64 $ 66
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost      
Discount rate 3.56% 4.43% 3.80%
Expected long-term rate of return on plan assets 6.30% 6.60% 6.60%
Long-term rate of compensation increase 0.00% 0.00% 0.00%
ESOP growth rate 10.00% 10.00% 10.00%
Medical cost trend rate of increase 6.00% 6.00% 6.00%
Interest Crediting Rate 0.00% 0.00% 0.00%
United States | Pension Plans      
Components of Net Periodic Benefit Cost      
Service cost $ 1 $ 1 $ 1
Interest cost 74 90 86
Expected return on plan assets (111) (103) (115)
Amortization of transition and prior service costs (credits) 0 0 0
Amortization of actuarial loss 46 51 47
Net periodic benefit cost 10 39 19
Other postretirement charges 4 7 9
Total pension cost $ 14 $ 46 $ 28
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost      
Discount rate 3.40% 4.38% 3.73%
Expected long-term rate of return on plan assets 6.30% 6.60% 6.60%
Long-term rate of compensation increase 3.50% 3.50% 3.50%
ESOP growth rate 0.00% 0.00% 0.00%
Medical cost trend rate of increase 0.00% 0.00% 0.00%
Interest Crediting Rate 3.21% 4.26% 3.73%
International | Pension Plans      
Components of Net Periodic Benefit Cost      
Service cost $ 17 $ 14 $ 14
Interest cost 21 22 21
Expected return on plan assets (22) (19) (21)
Amortization of transition and prior service costs (credits) 0 1 0
Amortization of actuarial loss 9 9 8
Net periodic benefit cost 25 27 22
Other postretirement charges 0 1 2
Total pension cost $ 25 $ 28 $ 24
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost      
Discount rate 2.06% 2.80% 2.53%
Expected long-term rate of return on plan assets 3.38% 4.06% 4.04%
Long-term rate of compensation increase 2.83% 2.86% 2.79%
ESOP growth rate 0.00% 0.00% 0.00%
Medical cost trend rate of increase 0.00% 0.00% 0.00%
Interest Crediting Rate 0.85% 0.85% 0.85%
XML 103 R83.htm IDEA: XBRL DOCUMENT v3.20.4
Retirement Plans and Other Retiree Benefits - Expected Contributions and Benefit Payments (Details)
$ in Millions
Dec. 31, 2020
USD ($)
Total benefit payments [Abstract]  
2021 $ 245
2022 246
2023 249
2024 253
2025 252
2026-2030 1,254
Other Retiree Benefit Plans  
Total benefit payments [Abstract]  
2021 49
2022 49
2023 50
2024 51
2025 52
2026-2030 269
United States | Pension Plans  
Total benefit payments [Abstract]  
2021 154
2022 156
2023 157
2024 156
2025 155
2026-2030 741
International | Pension Plans  
Total benefit payments [Abstract]  
2021 42
2022 41
2023 42
2024 46
2025 45
2026-2030 $ 244
XML 104 R84.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Components of Income Before Income Taxes (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Tax Disclosure [Abstract]      
United States $ 1,317 $ 1,050 $ 1,175
International 2,330 2,251 2,289
Income before income taxes $ 3,647 $ 3,301 $ 3,464
XML 105 R85.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Provision for Income Taxes (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Tax Disclosure [Abstract]      
United States $ 259 $ 180 $ 213
International 528 594 693
Total Provision for income taxes $ 787 $ 774 $ 906
XML 106 R86.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Income Tax Provision Reconciliation (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Tax Disclosure [Abstract]      
Goodwill and intangible assets $ 1 $ 34 $ 2
Property, plant and equipment 12 12 (15)
Pension and other retiree benefits 10 (13) (7)
Stock-based compensation (7) (1) 9
Right-of-use assets/lease liabilities (1) 0 0
Tax credits and tax loss carryforwards (1) 3 (4)
Deferred withholding tax 111 (21) (100)
Other, net 18 (33) 62
Total deferred tax benefit (provision) $ 143 $ (19) $ (53)
XML 107 R87.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Effective Tax Rate Reconciliation (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Dec. 31, 2017
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]            
Tax at United States statutory rate       21.00% 21.00% 21.00%
State income taxes, net of federal benefit       1.00% 0.60% 1.00%
Earnings taxed at other than United States statutory rate       3.30% 4.60% 5.60%
Charge for U.S. tax reform       0 0 0.023
Foreign Tax Credit Carryback       0.00% 0.00% (1.70%)
(Benefit) charge for previously disclosed tax matters       (2.00%) (0.90%) (0.40%)
Foreign-derived intangible income benefit       (1.60%) (1.30%) (1.10%)
Other, net       (0.10%) (0.60%) (0.50%)
Effective tax rate       21.60% 23.40% 26.20%
Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent       100.00%    
Tax reform, provisional charge   $ 14,000,000 $ 275,000,000 $ 0 $ 0 $ 80,000,000
Discrete Income Tax Provision (Benefit)       71,000,000    
Foreign Withholding Income Tax       45,000,000    
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount       26,000,000    
Withholding Tax Due       $ 0    
Income tax benefit related to changes in swiss preferential tax regime and increase to cantonal tax rate $ 29,000,000          
SWITZERLAND            
Restructuring Cost and Reserve [Line Items]            
Benefit from foreign tax matter $ 29,000,000       $ 29,000,000 $ 15,000,000
XML 108 R88.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Components of Deferred Tax Assets (Liabilities) (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Deferred tax liabilities:    
Goodwill and intangible assets $ (603) $ (598)
Property, plant and equipment (281) (303)
Right-of-use assets (131) (135)
Deferred withholding tax (95) (207)
Other (52) (46)
Total deferred tax liabilities (1,162) (1,289)
Deferred tax assets:    
Pension and other retiree benefits 404 381
Tax credits and tax loss carryforwards 42 93
Lease liabilities 144 152
Accrued liabilities 250 221
Stock-based compensation 73 88
Other 125 83
Total deferred tax assets 1,038 1,018
Valuation Allowance (11) (59)
Net deferred tax assets 1,027 959
Assets:    
Deferred income taxes 291 177
Liabilities:    
Deferred income taxes (426) (507)
Net deferred income taxes $ (135) $ (330)
XML 109 R89.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Taxes [Line Items]      
Income tax expense (benefit) allocated directly to equity $ (101) $ (13) $ (2)
Unrecognized tax benefits that would impact effective tax rate 213    
Cash outflow from unrecognized tax benefit that would impact effective tax rate 223    
Interest (income) expense recognized related to unrecognized tax benefits 9 0 (1)
Accrued interest related to unrecognized tax benefits $ 24 $ 23 $ 27
Minimum      
Income Taxes [Line Items]      
Statue of limitations on foreign jurisdictions for tax audits 3 years    
Maximum      
Income Taxes [Line Items]      
Statue of limitations on foreign jurisdictions for tax audits 6 years    
XML 110 R90.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Unrecognized tax benefits:      
Balance, January 1 $ 173 $ 190 $ 214
Increases as a result of tax positions taken during the current year 18 14 14
Decreases of tax positions taken during prior years (5) (21) (37)
Increases of tax positions taken during prior years 57 20 9
Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations (19) (30) (6)
Effect of foreign currency rate movements 3 0 (4)
Balance, December 31 $ 227 $ 173 $ 190
XML 111 R91.htm IDEA: XBRL DOCUMENT v3.20.4
Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Net income attributable to Colgate-Palmolive Company                      
Basic EPS                 $ 2,695 $ 2,367 $ 2,400
Diluted EPS                 $ 2,695 $ 2,367 $ 2,400
Shares (millions)                      
Basic EPS (in shares)                 856.8 859.1 870.6
Stock options and restricted stock units (in shares)                 2.5 2.0 2.4
Diluted EPS (in shares)                 859.3 861.1 873.0
Earnings Per Share, Basic [Abstract]                      
Basic EPS (in dollars per share) $ 0.76 $ 0.81 $ 0.74 $ 0.83 $ 0.75 $ 0.67 $ 0.68 $ 0.65 $ 3.15 $ 2.76 $ 2.76
Earnings Per Share, Diluted [Abstract]                      
Diluted EPS (in dollars per share) $ 0.75 $ 0.81 $ 0.74 $ 0.83 $ 0.75 $ 0.67 $ 0.68 $ 0.65 $ 3.14 $ 2.75 $ 2.75
XML 112 R92.htm IDEA: XBRL DOCUMENT v3.20.4
Earnings Per Share - Narrative (Details) - shares
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Employee Stock Option      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares) 3,257,310 19,901,202 18,039,961
Restricted Stock Units (RSUs)      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares) 25,381 4,516 9,529
XML 113 R93.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments and Contingencies (Details)
$ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Apr. 30, 2019
USD ($)
Jun. 30, 2019
country_and_territory
Dec. 31, 2020
USD ($)
country_and_territory
case
Dec. 31, 2019
case
Jul. 31, 2017
USD ($)
Loss Contingencies [Line Items]          
Contractual commitments, amount     $ 715.0    
Number of countries in which entity operates | country_and_territory     200    
Brazilian internal revenue authority, matter 1     $ 113.0    
Loss Contingency, Number Of Cases On Appeal | country_and_territory     5    
Brazilian internal revenue authority, matter 2     $ 50.0    
Fine imposed by greek competition authority         $ 11.0
Increase (decrease) in fine imposed by Greek competition authority $ 10.5        
Loss contingency, pending claims, number (in cases) | case     137 121  
Loss contingency, new claims filed, number (in cases) | case     65    
Loss contingency, claims dismissed or settled, number (in cases) | case     49    
Number of cases resulting in adverse jury verdict | country_and_territory   1      
Minimum          
Loss Contingencies [Line Items]          
Range of reasonably possible losses     $ 0.0    
Maximum          
Loss Contingencies [Line Items]          
Range of reasonably possible losses     $ 425.0    
XML 114 R94.htm IDEA: XBRL DOCUMENT v3.20.4
Segment Information - Narrative (Details)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2019
USD ($)
Dec. 31, 2020
USD ($)
business_segment
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Segment Reporting Information [Line Items]        
Number of product segments (in segments) | business_segment   2    
Number of reportable segments (in segments) | business_segment   5    
Number of operating segments (in segments) | business_segment   5    
Restructuring and related charges (benefits)   $ (13) $ 57 $ 88
Acquisition-related costs $ 6      
Global Growth and Efficiency Program        
Segment Reporting Information [Line Items]        
Restructuring and related charges (benefits)     132 161
Operating Profit | Corporate        
Segment Reporting Information [Line Items]        
Acquisition-related costs   6 24  
Benefit from foreign tax matter     30  
Operating Profit | Global Growth and Efficiency Program        
Segment Reporting Information [Line Items]        
Restructuring and related charges (benefits)   $ 16 $ 125 $ 152
Sales Revenue, Net        
Segment Reporting Information [Line Items]        
Percentage of consolidated Net sales represented by sales outside US   70.00%    
Percentage of consolidated Net sales coming from emerging markets   45.00%    
Sales Revenue, Net | Customer Concentration Risk        
Segment Reporting Information [Line Items]        
Percentage of consolidated sales represented by one customer   12.00%    
XML 115 R95.htm IDEA: XBRL DOCUMENT v3.20.4
Segment Information - Schedule of Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Segment Reporting Information [Line Items]                      
Net sales $ 4,324 $ 4,153 $ 3,897 $ 4,097 $ 4,015 $ 3,928 $ 3,866 $ 3,884 $ 16,471 $ 15,693 $ 15,544
Operating profit                 3,885 3,554 3,694
Capital expenditures                 409 335 436
Depreciation and amortization                 539 519 511
Identifiable assets $ 15,920       $ 15,034       $ 15,920 $ 15,034 $ 12,161
Percentage of corporate identifiable assets consisting of investments in equity securities 95.00%       92.00%       95.00% 92.00% 88.00%
Percentage of corporate identifiable assets consisting of derivative instruments         2.00%         2.00% 7.00%
Total long lived assets $ 10,911       $ 10,192       $ 10,911 $ 10,192 $ 8,259
Oral, Personal and Home Care | United States                      
Segment Reporting Information [Line Items]                      
Net sales                 3,447 3,166 3,091
Pet Nutrition | United States                      
Segment Reporting Information [Line Items]                      
Net sales                 1,712 1,441 1,304
Operating Segments | Oral, Personal and Home Care                      
Segment Reporting Information [Line Items]                      
Net sales                 13,588 13,168 13,156
Operating profit                 3,594 3,505 3,616
Capital expenditures                 274 223 309
Depreciation and amortization                 380 358 351
Identifiable assets 14,646       13,809       14,646 13,809 11,068
Operating Segments | Oral, Personal and Home Care | North America                      
Segment Reporting Information [Line Items]                      
Net sales                 3,741 3,424 3,348
Operating profit                 988 982 1,037
Capital expenditures                 65 43 53
Depreciation and amortization                 101 94 88
Identifiable assets 4,132       3,576       4,132 3,576 3,310
Operating Segments | Oral, Personal and Home Care | Latin America                      
Segment Reporting Information [Line Items]                      
Net sales                 3,418 3,606 3,605
Operating profit                 975 963 995
Capital expenditures                 104 90 131
Depreciation and amortization                 81 84 82
Identifiable assets 2,251       2,384       2,251 2,384 2,225
Operating Segments | Oral, Personal and Home Care | Europe                      
Segment Reporting Information [Line Items]                      
Net sales                 2,747 2,450 2,502
Operating profit                 652 624 634
Capital expenditures                 41 42 39
Depreciation and amortization                 94 72 70
Identifiable assets 5,386       5,104       5,386 5,104 2,883
Operating Segments | Oral, Personal and Home Care | Asia Pacific                      
Segment Reporting Information [Line Items]                      
Net sales                 2,701 2,707 2,734
Operating profit                 773 749 777
Capital expenditures                 51 40 75
Depreciation and amortization                 95 100 103
Identifiable assets 2,272       2,155       2,272 2,155 2,148
Operating Segments | Oral, Personal and Home Care | Africa/Eurasia                      
Segment Reporting Information [Line Items]                      
Net sales                 981 981 967
Operating profit                 206 187 173
Capital expenditures                 13 8 11
Depreciation and amortization                 9 8 8
Identifiable assets 605       590       605 590 502
Operating Segments | Pet Nutrition                      
Segment Reporting Information [Line Items]                      
Net sales                 2,883 2,525 2,388
Operating profit                 793 703 680
Capital expenditures                 56 41 35
Depreciation and amortization                 58 55 53
Identifiable assets 1,210       1,175       1,210 1,175 1,033
Corporate                      
Segment Reporting Information [Line Items]                      
Operating profit                 (502) (654) (602)
Capital expenditures                 79 71 92
Depreciation and amortization                 101 106 107
Identifiable assets $ 64       $ 50       $ 64 $ 50 $ 60
XML 116 R96.htm IDEA: XBRL DOCUMENT v3.20.4
Leases - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Jan. 01, 2019
Lessee, Lease, Description [Line Items]      
Other assets $ 521 $ 502  
Operating lease, liability 613 636  
Operating lease, payments 193 202  
Right-of-use asset obtained in exchange for operating lease liability $ 163 $ 232  
Operating lease, weighted average remaining lease term 8 years 8 years  
Operating lease, weighted average discount rate 4.20% 4.10%  
Accounting Standards Update 2016-02      
Lessee, Lease, Description [Line Items]      
Other assets     $ 458
Operating lease, liability     $ 574
XML 117 R97.htm IDEA: XBRL DOCUMENT v3.20.4
Leases - Balance Sheet (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Leases [Abstract]    
Other assets $ 521 $ 502
Other accruals 137 145
Other liabilities 476 491
Total operating lease liabilities $ 613 $ 636
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] us-gaap:OtherAssets  
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] us-gaap:OtherAccruedLiabilitiesCurrent  
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] us-gaap:OtherLiabilitiesNoncurrent  
XML 118 R98.htm IDEA: XBRL DOCUMENT v3.20.4
Leases - Schedule of Minimum Lease Commitments (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Leases [Abstract]    
2021 $ 157  
2022 133  
2023 89  
2024 58  
2025 46  
Thereafter 232  
Total lease commitments 715  
Less: Interest (102)  
Present value of lease liabilities $ 613 $ 636
XML 119 R99.htm IDEA: XBRL DOCUMENT v3.20.4
Leases - Schedule of Lease Cost (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Leases [Abstract]    
Operating lease cost $ 155 $ 169
Short-term lease cost 3 5
Variable lease cost 20 30
Total lease cost $ 178 $ 204
XML 120 R100.htm IDEA: XBRL DOCUMENT v3.20.4
Supplemental Income Statement Information (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Other (income) expense, net      
Total Global Growth and Efficiency Program charges, pretax $ (13) $ 57 $ 88
Amortization of intangible assets 88 62 59
Equity income (12) (9) (10)
Value-added tax matter in Brazil 0 (30) 0
Write-off of certain investments and fixed assets 0 51 1
Acquisition-related costs 2 21 0
Charges for a change in go-to-market strategy in certain countries 0 15 0
Other, net 48 29 10
Total Other (income) expense, net 113 196 148
Interest (income) expense, net      
Interest incurred 184 193 195
Interest capitalized (1) (1) (2)
Interest income (19) (47) (50)
Total Interest (income) expense, net 164 145 143
Research and development 290 281 277
Advertising $ 1,948 $ 1,694 $ 1,590
XML 121 R101.htm IDEA: XBRL DOCUMENT v3.20.4
Supplemental Balance Sheet Information - Schedule of Inventories by Major Class (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Inventories    
Raw materials and supplies $ 454 $ 305
Work-in-process 45 49
Finished goods 1,256 1,056
Total Inventories, net 1,755 1,410
Non-current inventory, net (82) (10)
Current Inventories, net $ 1,673 $ 1,400
XML 122 R102.htm IDEA: XBRL DOCUMENT v3.20.4
Supplemental Balance Sheet Information - Narrative (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Inventories valued under LIFO $ 439 $ 303
Excess of current cost over LIFO cost $ 65 $ 62
XML 123 R103.htm IDEA: XBRL DOCUMENT v3.20.4
Supplemental Balance Sheet Information - Schedule of Property, Plant and Equipment (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Property, plant and equipment, net    
Land $ 166 $ 153
Buildings 1,623 1,600
Manufacturing machinery and equipment 5,409 5,309
Other equipment 1,553 1,518
Property, plant and equipment, gross 8,751 8,580
Accumulated depreciation (5,035) (4,830)
Property, plant and equipment, net $ 3,716 $ 3,750
XML 124 R104.htm IDEA: XBRL DOCUMENT v3.20.4
Supplemental Balance Sheet Information - Schedule of Other Accruals (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Other accruals    
Accrued advertising and coupon redemption $ 728 $ 525
Accrued payroll and employee benefits 401 340
Accrued taxes other than income taxes 116 104
Restructuring accrual 21 85
Pension and other retiree benefits 89 54
Other accruals 137 145
Accrued interest 39 43
Derivatives 93 16
Other 717 605
Other accruals $ 2,341 $ 1,917
XML 125 R105.htm IDEA: XBRL DOCUMENT v3.20.4
Supplemental Balance Sheet Information - Schedule of Other Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Other liabilities    
Pension and other retiree benefits $ 1,815 $ 1,728
Restructuring accrual 10 15
Long-Term Lease Liabilities 476 491
Other 354 364
Total Other liabilities $ 2,655 $ 2,598
XML 126 R106.htm IDEA: XBRL DOCUMENT v3.20.4
Supplemental Other Comprehensive Income (Loss) Information - Schedule of Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Total Other comprehensive income (loss), net of tax $ (66) $ (87) $ (189)
Cumulative translation adjustments      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Other comprehensive income (loss), Pretax (119) 49 (233)
Total Other comprehensive income (loss), net of tax (30) 27 (218)
Pension and other benefits      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Other comprehensive income (loss), before reclassifications, Pretax (125) (204) (21)
Reclassification from AOCI, Pretax 74 72 69
Other comprehensive income (loss), Pretax (51) (132) 48
Other comprehensive income (loss), before reclassifications, Net of Tax (97) (154) (16)
Reclassification from AOCI, Net of Tax 57 54 54
Total Other comprehensive income (loss), net of tax (40) (100) 38
Cash flow hedges      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Other comprehensive income (loss), before reclassifications, Pretax (3) (9)  
Reclassification from AOCI, Pretax 0 (6)  
Other comprehensive income (loss), Pretax (3) (15)  
Other comprehensive income (loss), before reclassifications, Net of Tax (2) (7)  
Reclassification from AOCI, Net of Tax 0 (5)  
Total Other comprehensive income (loss), net of tax (2) (12)  
Cash flow hedges      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Other comprehensive income (loss), before reclassifications, Pretax     10
Reclassification from AOCI, Pretax     3
Other comprehensive income (loss), Pretax     13
Other comprehensive income (loss), before reclassifications, Net of Tax     8
Reclassification from AOCI, Net of Tax     2
Total Other comprehensive income (loss), net of tax     10
Accumulated Other Comprehensive Income (Loss)      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Other comprehensive income (loss), Pretax (173) (98) (172)
Total Other comprehensive income (loss), net of tax $ (72) $ (85) $ (170)
XML 127 R107.htm IDEA: XBRL DOCUMENT v3.20.4
Supplemental Other Comprehensive Income (Loss) Information - Narrative (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Equity [Abstract]    
Unrecognized pension and other retiree benefit costs, aftertax $ 1,178 $ 1,138
Foreign currency translation adjustments $ 3,158 $ 3,128
XML 128 R108.htm IDEA: XBRL DOCUMENT v3.20.4
Quarterly Financial Data (Unaudited) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2017
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Quarterly financial data (Unaudited) [Abstract]                        
Net sales $ 4,324 $ 4,153 $ 3,897 $ 4,097 $ 4,015 $ 3,928 $ 3,866 $ 3,884   $ 16,471 $ 15,693 $ 15,544
Gross profit 2,643 2,540 2,369 2,465 2,414 2,316 2,308 2,287   10,017 9,325 9,231
Net income including noncontrolling interests 692 745 675 748 682 627 618 600   2,860 2,527 2,558
Net income attributable to Colgate-Palmolive Company $ 647 $ 698 $ 635 $ 715 $ 643 $ 578 $ 586 $ 560   $ 2,695 $ 2,367 $ 2,400
Earnings per common share:                        
Basic EPS (in dollars per share) $ 0.76 $ 0.81 $ 0.74 $ 0.83 $ 0.75 $ 0.67 $ 0.68 $ 0.65   $ 3.15 $ 2.76 $ 2.76
Diluted EPS (in dollars per share) $ 0.75 $ 0.81 $ 0.74 $ 0.83 $ 0.75 $ 0.67 $ 0.68 $ 0.65   $ 3.14 $ 2.75 $ 2.75
Quarterly Financial Information Disclosure [Abstract]                        
Acquisition-related costs         $ 6              
Restructuring and related cost, incurred cost, including noncontrolling interest, after tax       $ 4           $ 4 $ 20  
Tax benefit                   787 774 $ 906
Extinguishment of debt, gain (loss), net of tax $ (18)                 (18)    
Restructuring and related charges (benefits)                   (13) 57 88
Charge for U.S. tax reform           $ 14     $ 275 0 0 80
Subsidiaries                        
Quarterly Financial Information Disclosure [Abstract]                        
Tax benefit       (71)           (71)    
Gross Profit                        
Quarterly Financial Information Disclosure [Abstract]                        
Acquisition-related costs       $ 4           4    
BRAZIL                        
Quarterly Financial Information Disclosure [Abstract]                        
Benefit from foreign tax matter         20           20  
SWITZERLAND                        
Quarterly Financial Information Disclosure [Abstract]                        
Benefit from foreign tax matter         29           29 15
Global Growth and Efficiency Program                        
Quarterly Financial Information Disclosure [Abstract]                        
Restructuring and related cost, incurred cost, including noncontrolling interest, after tax   $ 13               $ (13)    
Restructuring and related charges (benefits)                     132 161
Global Growth and Efficiency Program | Gross Profit                        
Quarterly Financial Information Disclosure [Abstract]                        
Acquisition-related costs         3           3  
Restructuring and related cost, incurred cost, including noncontrolling interest, after tax         27 22 $ 31 $ 22     102  
Restructuring and related charges (benefits)         $ (1) $ 1 $ 3 $ 11     $ 8 $ 31
XML 129 R109.htm IDEA: XBRL DOCUMENT v3.20.4
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Allowance for doubtful accounts and estimated returns      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Beginning balance of valuation allowance and reserves $ 76 $ 82 $ 77
Charged to Costs and Expenses, additions 16 6 15
Other, additions 0 0 0
Deductions 3 12 10
Ending balance of valuation allowance and reserves 89 76 82
Valuation allowance for deferred tax assets      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Beginning balance of valuation allowance and reserves 59 54 9
Charged to Costs and Expenses, additions 1 12 45
Other, additions 0 0 0
Deductions 49 7 0
Ending balance of valuation allowance and reserves $ 11 $ 59 $ 54
EXCEL 130 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

A(Y'7D8_4(H95- MP:WAC%E 8>#@%8^\8B^OO]66-U"R?6XQ2V[U!&-C[@C/^9F8,(KM M])*17N*E]U4J)HZ@EYA34SK/3PL()YF=8#H23+T$;QK0ID8]+5$-74AUJ:A+ MJ0;14$L$*6NCFQI,:(+C&5T;*'(L=S;2S;QT_Y0RWT-'M)'*S/E2,J\-"R@* M4CLI'$SM/#@B"XM*L6I30+$/*^V,WV#ND 9)LSE7&RJ.$P?9 ^W!7K+7_(%# M/N; =RU+CA3[:2_JP);.?"G9?B$(9#?NEW:G_ M8[\ ?)$*!$NW!R%9U:*:/6E9LT; ;/0DFC9,\::$?>:]O1K-QI_-V9H0$KG6:A('[%>']^NUW,&&Q1M,L^MCFLVE MRX8BU%6&DSA@OSH P69W3*

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�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end XML 131 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 132 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 133 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 563 641 1 true 131 0 false 10 false false R1.htm 000010001 - Document - Cover Sheet http://www.colgate.com/role/Cover Cover Cover 1 false false R2.htm 100010002 - Statement - Consolidated Statements of Income Sheet http://www.colgate.com/role/ConsolidatedStatementsofIncome Consolidated Statements of Income Statements 2 false false R3.htm 100020003 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome Consolidated Statements of Comprehensive Income Statements 3 false false R4.htm 100030004 - Statement - Consolidated Balance Sheets Sheet http://www.colgate.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 4 false false R5.htm 100040005 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.colgate.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 5 false false R6.htm 100050006 - Statement - Consolidated Statements of Changes in Shareholders' Equity Sheet http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity Consolidated Statements of Changes in Shareholders' Equity Statements 6 false false R7.htm 100060007 - Statement - Consolidated Statements of Changes in Shareholders' Equity (Parenthetical) Sheet http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquityParenthetical Consolidated Statements of Changes in Shareholders' Equity (Parenthetical) Statements 7 false false R8.htm 100070008 - Statement - Consolidated Statements of Cash Flows Sheet http://www.colgate.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 8 false false R9.htm 140084001 - Statement - Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.colgate.com/role/ConsolidatedStatementsofCashFlowsParenthetical Consolidated Statements of Cash Flows (Parenthetical) Statements 9 false false R10.htm 210011001 - Disclosure - Nature of Operations Sheet http://www.colgate.com/role/NatureofOperations Nature of Operations Notes 10 false false R11.htm 210041002 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.colgate.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 11 false false R12.htm 210081003 - Disclosure - Acquisitions Sheet http://www.colgate.com/role/Acquisitions Acquisitions Notes 12 false false R13.htm 210121004 - Disclosure - Restructuring and Related Implementation Charges Sheet http://www.colgate.com/role/RestructuringandRelatedImplementationCharges Restructuring and Related Implementation Charges Notes 13 false false R14.htm 210191005 - Disclosure - Goodwill and Other Intangible Assets Sheet http://www.colgate.com/role/GoodwillandOtherIntangibleAssets Goodwill and Other Intangible Assets Notes 14 false false R15.htm 210241006 - Disclosure - Long-Term Debt and Credit Facilities Sheet http://www.colgate.com/role/LongTermDebtandCreditFacilities Long-Term Debt and Credit Facilities Notes 15 false false R16.htm 210291007 - Disclosure - Fair Value Measurements and Financial Instruments Sheet http://www.colgate.com/role/FairValueMeasurementsandFinancialInstruments Fair Value Measurements and Financial Instruments Notes 16 false false R17.htm 210371008 - Disclosure - Capital Stock and Stock-Based Compensation Plans Sheet http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlans Capital Stock and Stock-Based Compensation Plans Notes 17 false false R18.htm 210451009 - Disclosure - Employee Stock Ownership Plan Sheet http://www.colgate.com/role/EmployeeStockOwnershipPlan Employee Stock Ownership Plan Notes 18 false false R19.htm 210471010 - Disclosure - Retirement Plans and Other Retiree Benefits Sheet http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefits Retirement Plans and Other Retiree Benefits Notes 19 false false R20.htm 210571011 - Disclosure - Income Taxes Sheet http://www.colgate.com/role/IncomeTaxes Income Taxes Notes 20 false false R21.htm 210661012 - Disclosure - Earnings Per Share Sheet http://www.colgate.com/role/EarningsPerShare Earnings Per Share Notes 21 false false R22.htm 210701013 - Disclosure - Commitments and Contingencies Sheet http://www.colgate.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 22 false false R23.htm 210721014 - Disclosure - Segment Information Sheet http://www.colgate.com/role/SegmentInformation Segment Information Notes 23 false false R24.htm 210761015 - Disclosure - Leases Sheet http://www.colgate.com/role/Leases Leases Notes 24 false false R25.htm 210821016 - Disclosure - Supplemental Income Statement Information Sheet http://www.colgate.com/role/SupplementalIncomeStatementInformation Supplemental Income Statement Information Notes 25 false false R26.htm 210851017 - Disclosure - Supplemental Balance Sheet Information Sheet http://www.colgate.com/role/SupplementalBalanceSheetInformation Supplemental Balance Sheet Information Notes 26 false false R27.htm 210921018 - Disclosure - Supplemental Other Comprehensive Income (Loss) Information Sheet http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformation Supplemental Other Comprehensive Income (Loss) Information Notes 27 false false R28.htm 210961019 - Disclosure - Quarterly Financial Data (Unaudited) Sheet http://www.colgate.com/role/QuarterlyFinancialDataUnaudited Quarterly Financial Data (Unaudited) Notes 28 false false R29.htm 210991020 - Disclosure - Schedule II - Valuation and Qualifying Accounts Sheet http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccounts Schedule II - Valuation and Qualifying Accounts Notes 29 false false R30.htm 220052001 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.colgate.com/role/SummaryofSignificantAccountingPolicies 30 false false R31.htm 230023001 - Disclosure - Nature of Operations (Tables) Sheet http://www.colgate.com/role/NatureofOperationsTables Nature of Operations (Tables) Tables http://www.colgate.com/role/NatureofOperations 31 false false R32.htm 230093002 - Disclosure - Acquisitions (Tables) Sheet http://www.colgate.com/role/AcquisitionsTables Acquisitions (Tables) Tables http://www.colgate.com/role/Acquisitions 32 false false R33.htm 230133003 - Disclosure - Restructuring and Related Implementation Charges (Tables) Sheet http://www.colgate.com/role/RestructuringandRelatedImplementationChargesTables Restructuring and Related Implementation Charges (Tables) Tables http://www.colgate.com/role/RestructuringandRelatedImplementationCharges 33 false false R34.htm 230203004 - Disclosure - Goodwill and Other Intangible Assets (Tables) Sheet http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsTables Goodwill and Other Intangible Assets (Tables) Tables http://www.colgate.com/role/GoodwillandOtherIntangibleAssets 34 false false R35.htm 230253005 - Disclosure - Long-Term Debt and Credit Facilities (Tables) Sheet http://www.colgate.com/role/LongTermDebtandCreditFacilitiesTables Long-Term Debt and Credit Facilities (Tables) Tables http://www.colgate.com/role/LongTermDebtandCreditFacilities 35 false false R36.htm 230303006 - Disclosure - Fair Value Measurements and Financial Instruments (Tables) Sheet http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsTables Fair Value Measurements and Financial Instruments (Tables) Tables http://www.colgate.com/role/FairValueMeasurementsandFinancialInstruments 36 false false R37.htm 230383007 - Disclosure - Capital Stock and Stock-Based Compensation Plans (Tables) Sheet http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansTables Capital Stock and Stock-Based Compensation Plans (Tables) Tables http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlans 37 false false R38.htm 230483008 - Disclosure - Retirement Plans and Other Retiree Benefits (Tables) Sheet http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsTables Retirement Plans and Other Retiree Benefits (Tables) Tables http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefits 38 false false R39.htm 230583009 - Disclosure - Income Taxes (Tables) Sheet http://www.colgate.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.colgate.com/role/IncomeTaxes 39 false false R40.htm 230673010 - Disclosure - Earnings Per Share (Tables) Sheet http://www.colgate.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.colgate.com/role/EarningsPerShare 40 false false R41.htm 230733011 - Disclosure - Segment Information (Tables) Sheet http://www.colgate.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.colgate.com/role/SegmentInformation 41 false false R42.htm 230773012 - Disclosure - Leases (Tables) Sheet http://www.colgate.com/role/LeasesTables Leases (Tables) Tables http://www.colgate.com/role/Leases 42 false false R43.htm 230833013 - Disclosure - Supplemental Income Statement Information (Tables) Sheet http://www.colgate.com/role/SupplementalIncomeStatementInformationTables Supplemental Income Statement Information (Tables) Tables http://www.colgate.com/role/SupplementalIncomeStatementInformation 43 false false R44.htm 230863014 - Disclosure - Supplemental Balance Sheet Information (Tables) Sheet http://www.colgate.com/role/SupplementalBalanceSheetInformationTables Supplemental Balance Sheet Information (Tables) Tables http://www.colgate.com/role/SupplementalBalanceSheetInformation 44 false false R45.htm 230933015 - Disclosure - Supplemental Other Comprehensive Income (Loss) Information (Tables) Sheet http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationTables Supplemental Other Comprehensive Income (Loss) Information (Tables) Tables http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformation 45 false false R46.htm 230973016 - Disclosure - Quarterly Financial Data (Unaudited) (Tables) Sheet http://www.colgate.com/role/QuarterlyFinancialDataUnauditedTables Quarterly Financial Data (Unaudited) (Tables) Tables http://www.colgate.com/role/QuarterlyFinancialDataUnaudited 46 false false R47.htm 240034002 - Disclosure - Nature of Operations (Details) Sheet http://www.colgate.com/role/NatureofOperationsDetails Nature of Operations (Details) Details http://www.colgate.com/role/NatureofOperationsTables 47 false false R48.htm 240064003 - Disclosure - Summary of Significant Accounting Policies - Principles of Consolidation, Shipping and Handling Costs, Inventories, & Property, Plant, and Equipment (Details) Sheet http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails Summary of Significant Accounting Policies - Principles of Consolidation, Shipping and Handling Costs, Inventories, & Property, Plant, and Equipment (Details) Details 48 false false R49.htm 240074004 - Disclosure - Summary of Significant Accounting Policies - Goodwill and Other Intangibles (Details) Sheet http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesGoodwillandOtherIntangiblesDetails Summary of Significant Accounting Policies - Goodwill and Other Intangibles (Details) Details 49 false false R50.htm 240104005 - Disclosure - Acquisitions - Narrative (Details) Sheet http://www.colgate.com/role/AcquisitionsNarrativeDetails Acquisitions - Narrative (Details) Details 50 false false R51.htm 240114006 - Disclosure - Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details) Sheet http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details) Details 51 false false R52.htm 240144007 - Disclosure - Restructuring and Related Implementation Charges - Narrative (Details) Sheet http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails Restructuring and Related Implementation Charges - Narrative (Details) Details http://www.colgate.com/role/RestructuringandRelatedImplementationChargesTables 52 false false R53.htm 240154008 - Disclosure - Restructuring and Related Implementation Charges - Summary of Restructuring and Related Costs (Details) Sheet http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringandRelatedCostsDetails Restructuring and Related Implementation Charges - Summary of Restructuring and Related Costs (Details) Details 53 false false R54.htm 240164009 - Disclosure - Restructuring and Related Implementation Charges - Restructuring Charges Incurred, by Segment (Details) Sheet http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails Restructuring and Related Implementation Charges - Restructuring Charges Incurred, by Segment (Details) Details 54 false false R55.htm 240174010 - Disclosure - Restructuring and Related Implementation Charges - Summary of Restructuring Charges, Cumulative to Date (Details) Sheet http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringChargesCumulativetoDateDetails Restructuring and Related Implementation Charges - Summary of Restructuring Charges, Cumulative to Date (Details) Details 55 false false R56.htm 240184011 - Disclosure - Restructuring and Related Implementation Charges - Restructuring Activity and Related Accruals (Details) Sheet http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails Restructuring and Related Implementation Charges - Restructuring Activity and Related Accruals (Details) Details 56 false false R57.htm 240214012 - Disclosure - Goodwill and Other Intangible Assets - Schedule of Goodwill (Details) Sheet http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillDetails Goodwill and Other Intangible Assets - Schedule of Goodwill (Details) Details 57 false false R58.htm 240224013 - Disclosure - Goodwill and Other Intangible Assets - Summary of Other Intangible Assets (Details) Sheet http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails Goodwill and Other Intangible Assets - Summary of Other Intangible Assets (Details) Details 58 false false R59.htm 240234014 - Disclosure - Goodwill and Other Intangible Assets - Narrative (Details) Sheet http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails Goodwill and Other Intangible Assets - Narrative (Details) Details 59 false false R60.htm 240264015 - Disclosure - Long-Term Debt and Credit Facilities - Components of Long-term Debt (Details) Sheet http://www.colgate.com/role/LongTermDebtandCreditFacilitiesComponentsofLongtermDebtDetails Long-Term Debt and Credit Facilities - Components of Long-term Debt (Details) Details 60 false false R61.htm 240274016 - Disclosure - Long-Term Debt and Credit Facilities - Schedule of Long-Term Debt and Finance Lease Maturities (Details) Sheet http://www.colgate.com/role/LongTermDebtandCreditFacilitiesScheduleofLongTermDebtandFinanceLeaseMaturitiesDetails Long-Term Debt and Credit Facilities - Schedule of Long-Term Debt and Finance Lease Maturities (Details) Details 61 false false R62.htm 240284017 - Disclosure - Long-Term Debt and Credit Facilities - Narrative (Details) Sheet http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails Long-Term Debt and Credit Facilities - Narrative (Details) Details 62 false false R63.htm 240314018 - Disclosure - Fair Value Measurements and Financial Instruments - Narrative (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails Fair Value Measurements and Financial Instruments - Narrative (Details) Details http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsTables 63 false false R64.htm 240324019 - Disclosure - Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details) Details 64 false false R65.htm 240334020 - Disclosure - Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details) Details 65 false false R66.htm 240344021 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details) Details 66 false false R67.htm 240354022 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Statements of Income (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Statements of Income (Details) Details 67 false false R68.htm 240364023 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details) Details 68 false false R69.htm 240394024 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Narrative (Details) Sheet http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails Capital Stock and Stock-Based Compensation Plans - Narrative (Details) Details http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansTables 69 false false R70.htm 240404025 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Summary of Common Stock and Treasury Stock Activity (Details) Sheet http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofCommonStockandTreasuryStockActivityDetails Capital Stock and Stock-Based Compensation Plans - Summary of Common Stock and Treasury Stock Activity (Details) Details 70 false false R71.htm 240414026 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Fair Value Assumptions (Details) Sheet http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansFairValueAssumptionsDetails Capital Stock and Stock-Based Compensation Plans - Fair Value Assumptions (Details) Details 71 false false R72.htm 240424027 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Summary of Performance Restricted Stock Activity (Details) Sheet http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofPerformanceRestrictedStockActivityDetails Capital Stock and Stock-Based Compensation Plans - Summary of Performance Restricted Stock Activity (Details) Details 72 false false R73.htm 240434028 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Summary of Restricted Stock Activity (Details) Sheet http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails Capital Stock and Stock-Based Compensation Plans - Summary of Restricted Stock Activity (Details) Details 73 false false R74.htm 240444029 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Summary of Stock Option Activity (Details) Sheet http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails Capital Stock and Stock-Based Compensation Plans - Summary of Stock Option Activity (Details) Details 74 false false R75.htm 240464030 - Disclosure - Employee Stock Ownership Plan (Details) Sheet http://www.colgate.com/role/EmployeeStockOwnershipPlanDetails Employee Stock Ownership Plan (Details) Details http://www.colgate.com/role/EmployeeStockOwnershipPlan 75 false false R76.htm 240494031 - Disclosure - Retirement Plans and Other Retiree Benefits - Schedule of Target Asset Allocation (Details) Sheet http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsScheduleofTargetAssetAllocationDetails Retirement Plans and Other Retiree Benefits - Schedule of Target Asset Allocation (Details) Details 76 false false R77.htm 240504032 - Disclosure - Retirement Plans and Other Retiree Benefits - Allocation of Plan Assets and Level of Valuation Input, by Major Asset Category (Details) Sheet http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails Retirement Plans and Other Retiree Benefits - Allocation of Plan Assets and Level of Valuation Input, by Major Asset Category (Details) Details 77 false false R78.htm 240514033 - Disclosure - Retirement Plans and Other Retiree Benefits - Narrative (Details) Sheet http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails Retirement Plans and Other Retiree Benefits - Narrative (Details) Details 78 false false R79.htm 240524034 - Disclosure - Retirement Plans and Other Retiree Benefits - Summary of Defined Benefit and Other Retiree Benefit Plans (Details) Sheet http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails Retirement Plans and Other Retiree Benefits - Summary of Defined Benefit and Other Retiree Benefit Plans (Details) Details 79 false false R80.htm 240534035 - Disclosure - Retirement Plans and Other Retiree Benefits - Benefit Obligation Exceeds Fair Value of Plan Assets (Details) Sheet http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsBenefitObligationExceedsFairValueofPlanAssetsDetails Retirement Plans and Other Retiree Benefits - Benefit Obligation Exceeds Fair Value of Plan Assets (Details) Details 80 false false R81.htm 240544036 - Disclosure - Retirement Plans and Other Retiree Benefits - Summary of Other Retiree Benefit Plans (Details) Sheet http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofOtherRetireeBenefitPlansDetails Retirement Plans and Other Retiree Benefits - Summary of Other Retiree Benefit Plans (Details) Details 81 false false R82.htm 240554037 - Disclosure - Retirement Plans and Other Retiree Benefits - Summary of Net Periodic Benefit Costs (Details) Sheet http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails Retirement Plans and Other Retiree Benefits - Summary of Net Periodic Benefit Costs (Details) Details 82 false false R83.htm 240564038 - Disclosure - Retirement Plans and Other Retiree Benefits - Expected Contributions and Benefit Payments (Details) Sheet http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails Retirement Plans and Other Retiree Benefits - Expected Contributions and Benefit Payments (Details) Details 83 false false R84.htm 240594039 - Disclosure - Income Taxes - Components of Income Before Income Taxes (Details) Sheet http://www.colgate.com/role/IncomeTaxesComponentsofIncomeBeforeIncomeTaxesDetails Income Taxes - Components of Income Before Income Taxes (Details) Details 84 false false R85.htm 240604040 - Disclosure - Income Taxes - Provision for Income Taxes (Details) Sheet http://www.colgate.com/role/IncomeTaxesProvisionforIncomeTaxesDetails Income Taxes - Provision for Income Taxes (Details) Details 85 false false R86.htm 240614041 - Disclosure - Income Taxes - Income Tax Provision Reconciliation (Details) Sheet http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails Income Taxes - Income Tax Provision Reconciliation (Details) Details 86 false false R87.htm 240624042 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details) Sheet http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails Income Taxes - Effective Tax Rate Reconciliation (Details) Details 87 false false R88.htm 240634043 - Disclosure - Income Taxes - Components of Deferred Tax Assets (Liabilities) (Details) Sheet http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails Income Taxes - Components of Deferred Tax Assets (Liabilities) (Details) Details 88 false false R89.htm 240644044 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.colgate.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 89 false false R90.htm 240654045 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details) Sheet http://www.colgate.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails Income Taxes - Unrecognized Tax Benefits (Details) Details 90 false false R91.htm 240684046 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) Sheet http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) Details 91 false false R92.htm 240694047 - Disclosure - Earnings Per Share - Narrative (Details) Sheet http://www.colgate.com/role/EarningsPerShareNarrativeDetails Earnings Per Share - Narrative (Details) Details 92 false false R93.htm 240714048 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.colgate.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.colgate.com/role/CommitmentsandContingencies 93 false false R94.htm 240744049 - Disclosure - Segment Information - Narrative (Details) Sheet http://www.colgate.com/role/SegmentInformationNarrativeDetails Segment Information - Narrative (Details) Details 94 false false R95.htm 240754050 - Disclosure - Segment Information - Schedule of Segment Information (Details) Sheet http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails Segment Information - Schedule of Segment Information (Details) Details 95 false false R96.htm 240784051 - Disclosure - Leases - Narrative (Details) Sheet http://www.colgate.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 96 false false R97.htm 240794052 - Disclosure - Leases - Balance Sheet (Details) Sheet http://www.colgate.com/role/LeasesBalanceSheetDetails Leases - Balance Sheet (Details) Details 97 false false R98.htm 240804053 - Disclosure - Leases - Schedule of Minimum Lease Commitments (Details) Sheet http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails Leases - Schedule of Minimum Lease Commitments (Details) Details 98 false false R99.htm 240814054 - Disclosure - Leases - Schedule of Lease Cost (Details) Sheet http://www.colgate.com/role/LeasesScheduleofLeaseCostDetails Leases - Schedule of Lease Cost (Details) Details 99 false false R100.htm 240844055 - Disclosure - Supplemental Income Statement Information (Details) Sheet http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails Supplemental Income Statement Information (Details) Details http://www.colgate.com/role/SupplementalIncomeStatementInformationTables 100 false false R101.htm 240874056 - Disclosure - Supplemental Balance Sheet Information - Schedule of Inventories by Major Class (Details) Sheet http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofInventoriesbyMajorClassDetails Supplemental Balance Sheet Information - Schedule of Inventories by Major Class (Details) Details 101 false false R102.htm 240884057 - Disclosure - Supplemental Balance Sheet Information - Narrative (Details) Sheet http://www.colgate.com/role/SupplementalBalanceSheetInformationNarrativeDetails Supplemental Balance Sheet Information - Narrative (Details) Details 102 false false R103.htm 240894058 - Disclosure - Supplemental Balance Sheet Information - Schedule of Property, Plant and Equipment (Details) Sheet http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails Supplemental Balance Sheet Information - Schedule of Property, Plant and Equipment (Details) Details 103 false false R104.htm 240904059 - Disclosure - Supplemental Balance Sheet Information - Schedule of Other Accruals (Details) Sheet http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails Supplemental Balance Sheet Information - Schedule of Other Accruals (Details) Details 104 false false R105.htm 240914060 - Disclosure - Supplemental Balance Sheet Information - Schedule of Other Liabilities (Details) Sheet http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherLiabilitiesDetails Supplemental Balance Sheet Information - Schedule of Other Liabilities (Details) Details 105 false false R106.htm 240944061 - Disclosure - Supplemental Other Comprehensive Income (Loss) Information - Schedule of Comprehensive Income (Loss) (Details) Sheet http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails Supplemental Other Comprehensive Income (Loss) Information - Schedule of Comprehensive Income (Loss) (Details) Details http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationTables 106 false false R107.htm 240954062 - Disclosure - Supplemental Other Comprehensive Income (Loss) Information - Narrative (Details) Sheet http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationNarrativeDetails Supplemental Other Comprehensive Income (Loss) Information - Narrative (Details) Details http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationTables 107 false false R108.htm 240984063 - Disclosure - Quarterly Financial Data (Unaudited) (Details) Sheet http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails Quarterly Financial Data (Unaudited) (Details) Details http://www.colgate.com/role/QuarterlyFinancialDataUnauditedTables 108 false false R109.htm 241004064 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details) Sheet http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccountsDetails Schedule II - Valuation and Qualifying Accounts (Details) Details http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccounts 109 false false All Reports Book All Reports cl-20201231.htm cl-20201231.xsd cl-20201231_cal.xml cl-20201231_def.xml cl-20201231_lab.xml cl-20201231_pre.xml exhibit10-db12312020.htm exhibit10-lb12312020.htm exhibit2112312020.htm exhibit2312312020.htm exhibit2412312020.htm exhibit31a12312020.htm exhibit31b12312020.htm exhibit3212312020.htm exhibit4a12312020.htm cl-20201231_g1.jpg cl-20201231_g2.jpg cl-20201231_g3.jpg cl-20201231_g4.jpg http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/country/2020-01-31 http://fasb.org/us-gaap/2020-01-31 true true JSON 136 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cl-20201231.htm": { "axisCustom": 1, "axisStandard": 36, "contextCount": 563, "dts": { "calculationLink": { "local": [ "cl-20201231_cal.xml" ] }, "definitionLink": { "local": [ "cl-20201231_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "cl-20201231.htm" ] }, "labelLink": { "local": [ "cl-20201231_lab.xml" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "cl-20201231_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "cl-20201231.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 908, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 3, "http://www.colgate.com/20201231": 1, "http://xbrl.sec.gov/dei/2020-01-31": 4, "total": 8 }, "keyCustom": 103, "keyStandard": 538, "memberCustom": 55, "memberStandard": 72, "nsprefix": "cl", "nsuri": "http://www.colgate.com/20201231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000010001 - Document - Cover", "role": "http://www.colgate.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210011001 - Disclosure - Nature of Operations", "role": "http://www.colgate.com/role/NatureofOperations", "shortName": "Nature of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "cl:OtherIncomeExpenseNetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedCostIncurredCost", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240844055 - Disclosure - Supplemental Income Statement Information (Details)", "role": "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails", "shortName": "Supplemental Income Statement Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "cl:OtherIncomeExpenseNetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240874056 - Disclosure - Supplemental Balance Sheet Information - Schedule of Inventories by Major Class (Details)", "role": "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofInventoriesbyMajorClassDetails", "shortName": "Supplemental Balance Sheet Information - Schedule of Inventories by Major Class (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LIFOInventoryAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240884057 - Disclosure - Supplemental Balance Sheet Information - Narrative (Details)", "role": "http://www.colgate.com/role/SupplementalBalanceSheetInformationNarrativeDetails", "shortName": "Supplemental Balance Sheet Information - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LIFOInventoryAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Land", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240894058 - Disclosure - Supplemental Balance Sheet Information - Schedule of Property, Plant and Equipment (Details)", "role": "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails", "shortName": "Supplemental Balance Sheet Information - Schedule of Property, Plant and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Land", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "cl:OtherAccrualsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "cl:AccruedAdvertisingAndCouponRedemptionCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240904059 - Disclosure - Supplemental Balance Sheet Information - Schedule of Other Accruals (Details)", "role": "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails", "shortName": "Supplemental Balance Sheet Information - Schedule of Other Accruals (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "cl:OtherAccrualsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "cl:AccruedAdvertisingAndCouponRedemptionCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R105": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:OtherLiabilitiesTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240914060 - Disclosure - Supplemental Balance Sheet Information - Schedule of Other Liabilities (Details)", "role": "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherLiabilitiesDetails", "shortName": "Supplemental Balance Sheet Information - Schedule of Other Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:OtherLiabilitiesTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R106": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240944061 - Disclosure - Supplemental Other Comprehensive Income (Loss) Information - Schedule of Comprehensive Income (Loss) (Details)", "role": "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails", "shortName": "Supplemental Other Comprehensive Income (Loss) Information - Schedule of Comprehensive Income (Loss) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "ib8e9a772c3e94fe0a9ffbd71c528d626_D20200101-20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R107": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240954062 - Disclosure - Supplemental Other Comprehensive Income (Loss) Information - Narrative (Details)", "role": "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationNarrativeDetails", "shortName": "Supplemental Other Comprehensive Income (Loss) Information - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R108": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "if1dd00a48ce14a8790284ad3a94216f5_D20201001-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240984063 - Disclosure - Quarterly Financial Data (Unaudited) (Details)", "role": "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails", "shortName": "Quarterly Financial Data (Unaudited) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "if1dd00a48ce14a8790284ad3a94216f5_D20201001-20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R109": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "ib5bbd0e26ad44eb58795e4e3c418fd2e_I20191231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241004064 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)", "role": "http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccountsDetails", "shortName": "Schedule II - Valuation and Qualifying Accounts (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i1c32c2035f13448b8a76be67fba47636_I20171231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210041002 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.colgate.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210081003 - Disclosure - Acquisitions", "role": "http://www.colgate.com/role/Acquisitions", "shortName": "Acquisitions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210121004 - Disclosure - Restructuring and Related Implementation Charges", "role": "http://www.colgate.com/role/RestructuringandRelatedImplementationCharges", "shortName": "Restructuring and Related Implementation Charges", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210191005 - Disclosure - Goodwill and Other Intangible Assets", "role": "http://www.colgate.com/role/GoodwillandOtherIntangibleAssets", "shortName": "Goodwill and Other Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210241006 - Disclosure - Long-Term Debt and Credit Facilities", "role": "http://www.colgate.com/role/LongTermDebtandCreditFacilities", "shortName": "Long-Term Debt and Credit Facilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210291007 - Disclosure - Fair Value Measurements and Financial Instruments", "role": "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstruments", "shortName": "Fair Value Measurements and Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210371008 - Disclosure - Capital Stock and Stock-Based Compensation Plans", "role": "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlans", "shortName": "Capital Stock and Stock-Based Compensation Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "cl:EmployeeStockOwnershipPlanESOPDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210451009 - Disclosure - Employee Stock Ownership Plan", "role": "http://www.colgate.com/role/EmployeeStockOwnershipPlan", "shortName": "Employee Stock Ownership Plan", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "cl:EmployeeStockOwnershipPlanESOPDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210471010 - Disclosure - Retirement Plans and Other Retiree Benefits", "role": "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefits", "shortName": "Retirement Plans and Other Retiree Benefits", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010002 - Statement - Consolidated Statements of Income", "role": "http://www.colgate.com/role/ConsolidatedStatementsofIncome", "shortName": "Consolidated Statements of Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210571011 - Disclosure - Income Taxes", "role": "http://www.colgate.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210661012 - Disclosure - Earnings Per Share", "role": "http://www.colgate.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210701013 - Disclosure - Commitments and Contingencies", "role": "http://www.colgate.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210721014 - Disclosure - Segment Information", "role": "http://www.colgate.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210761015 - Disclosure - Leases", "role": "http://www.colgate.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "cl:SupplementalIncomeStatementInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210821016 - Disclosure - Supplemental Income Statement Information", "role": "http://www.colgate.com/role/SupplementalIncomeStatementInformation", "shortName": "Supplemental Income Statement Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "cl:SupplementalIncomeStatementInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "cl:SupplementalBalanceSheetInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210851017 - Disclosure - Supplemental Balance Sheet Information", "role": "http://www.colgate.com/role/SupplementalBalanceSheetInformation", "shortName": "Supplemental Balance Sheet Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "cl:SupplementalBalanceSheetInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210921018 - Disclosure - Supplemental Other Comprehensive Income (Loss) Information", "role": "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformation", "shortName": "Supplemental Other Comprehensive Income (Loss) Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210961019 - Disclosure - Quarterly Financial Data (Unaudited)", "role": "http://www.colgate.com/role/QuarterlyFinancialDataUnaudited", "shortName": "Quarterly Financial Data (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210991020 - Disclosure - Schedule II - Valuation and Qualifying Accounts", "role": "http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccounts", "shortName": "Schedule II - Valuation and Qualifying Accounts", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020003 - Statement - Consolidated Statements of Comprehensive Income", "role": "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome", "shortName": "Consolidated Statements of Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "220052001 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230023001 - Disclosure - Nature of Operations (Tables)", "role": "http://www.colgate.com/role/NatureofOperationsTables", "shortName": "Nature of Operations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230093002 - Disclosure - Acquisitions (Tables)", "role": "http://www.colgate.com/role/AcquisitionsTables", "shortName": "Acquisitions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230133003 - Disclosure - Restructuring and Related Implementation Charges (Tables)", "role": "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesTables", "shortName": "Restructuring and Related Implementation Charges (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230203004 - Disclosure - Goodwill and Other Intangible Assets (Tables)", "role": "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsTables", "shortName": "Goodwill and Other Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230253005 - Disclosure - Long-Term Debt and Credit Facilities (Tables)", "role": "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesTables", "shortName": "Long-Term Debt and Credit Facilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230303006 - Disclosure - Fair Value Measurements and Financial Instruments (Tables)", "role": "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsTables", "shortName": "Fair Value Measurements and Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "cl:ScheduleOfCommonAndTreasuryStockActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230383007 - Disclosure - Capital Stock and Stock-Based Compensation Plans (Tables)", "role": "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansTables", "shortName": "Capital Stock and Stock-Based Compensation Plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "cl:ScheduleOfCommonAndTreasuryStockActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230483008 - Disclosure - Retirement Plans and Other Retiree Benefits (Tables)", "role": "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsTables", "shortName": "Retirement Plans and Other Retiree Benefits (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230583009 - Disclosure - Income Taxes (Tables)", "role": "http://www.colgate.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030004 - Statement - Consolidated Balance Sheets", "role": "http://www.colgate.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230673010 - Disclosure - Earnings Per Share (Tables)", "role": "http://www.colgate.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230733011 - Disclosure - Segment Information (Tables)", "role": "http://www.colgate.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "cl:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230773012 - Disclosure - Leases (Tables)", "role": "http://www.colgate.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "cl:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "cl:OtherIncomeExpenseNetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230833013 - Disclosure - Supplemental Income Statement Information (Tables)", "role": "http://www.colgate.com/role/SupplementalIncomeStatementInformationTables", "shortName": "Supplemental Income Statement Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "cl:OtherIncomeExpenseNetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230863014 - Disclosure - Supplemental Balance Sheet Information (Tables)", "role": "http://www.colgate.com/role/SupplementalBalanceSheetInformationTables", "shortName": "Supplemental Balance Sheet Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230933015 - Disclosure - Supplemental Other Comprehensive Income (Loss) Information (Tables)", "role": "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationTables", "shortName": "Supplemental Other Comprehensive Income (Loss) Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230973016 - Disclosure - Quarterly Financial Data (Unaudited) (Tables)", "role": "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedTables", "shortName": "Quarterly Financial Data (Unaudited) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "cl:NumberOfProductSegments", "reportCount": 1, "unitRef": "business_segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240034002 - Disclosure - Nature of Operations (Details)", "role": "http://www.colgate.com/role/NatureofOperationsDetails", "shortName": "Nature of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "ibce4dd91a1b742eebe7e34cae7346393_D20200101-20201231", "decimals": "2", "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "cl:EquityMethodInvestmentOwnershipPercentageMinimum", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240064003 - Disclosure - Summary of Significant Accounting Policies - Principles of Consolidation, Shipping and Handling Costs, Inventories, & Property, Plant, and Equipment (Details)", "role": "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails", "shortName": "Summary of Significant Accounting Policies - Principles of Consolidation, Shipping and Handling Costs, Inventories, & Property, Plant, and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "cl:EquityMethodInvestmentOwnershipPercentageMinimum", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i42db0faac675447ebf3670621a3472a0_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240074004 - Disclosure - Summary of Significant Accounting Policies - Goodwill and Other Intangibles (Details)", "role": "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesGoodwillandOtherIntangiblesDetails", "shortName": "Summary of Significant Accounting Policies - Goodwill and Other Intangibles (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i42db0faac675447ebf3670621a3472a0_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040005 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://www.colgate.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240104005 - Disclosure - Acquisitions - Narrative (Details)", "role": "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "shortName": "Acquisitions - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "ie4a323bbecfe45be9f840b3d85ce9183_D20200131-20200131", "decimals": "-6", "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240114006 - Disclosure - Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details)", "role": "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails", "shortName": "Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i2510b1c1cab649c59613dc06fbea04d1_I20200131", "decimals": "-6", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "cl:NumberOfNewApprovedRestructuringProjects", "reportCount": 1, "unique": true, "unitRef": "case", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240144007 - Disclosure - Restructuring and Related Implementation Charges - Narrative (Details)", "role": "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "shortName": "Restructuring and Related Implementation Charges - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "cl:NumberOfNewApprovedRestructuringProjects", "reportCount": 1, "unique": true, "unitRef": "case", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "cl:OtherIncomeExpenseNetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedCostIncurredCost", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240154008 - Disclosure - Restructuring and Related Implementation Charges - Summary of Restructuring and Related Costs (Details)", "role": "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringandRelatedCostsDetails", "shortName": "Restructuring and Related Implementation Charges - Summary of Restructuring and Related Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i198658e2a34a49bdaa60322633c01994_D20190101-20191231", "decimals": "-6", "lang": "en-US", "name": "cl:RestructuringAndRelatedCostIncurredCostAfterTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:ScheduleOfPercentOfTotalRestructuringChargesRelatedToSegmentForThePeriodTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i198658e2a34a49bdaa60322633c01994_D20190101-20191231", "decimals": "2", "first": true, "lang": "en-US", "name": "cl:PercentOfTotalRestructuringChargesRelatedToSegmentForThePeriod", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240164009 - Disclosure - Restructuring and Related Implementation Charges - Restructuring Charges Incurred, by Segment (Details)", "role": "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails", "shortName": "Restructuring and Related Implementation Charges - Restructuring Charges Incurred, by Segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:ScheduleOfPercentOfTotalRestructuringChargesRelatedToSegmentForThePeriodTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i198658e2a34a49bdaa60322633c01994_D20190101-20191231", "decimals": "2", "first": true, "lang": "en-US", "name": "cl:PercentOfTotalRestructuringChargesRelatedToSegmentForThePeriod", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:ScheduleOfRestructuringAndRelatedCostsIncurredToDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "if3b3252484c341de947e820022821641_I20191231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedCostCostIncurredToDate1", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240174010 - Disclosure - Restructuring and Related Implementation Charges - Summary of Restructuring Charges, Cumulative to Date (Details)", "role": "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringChargesCumulativetoDateDetails", "shortName": "Restructuring and Related Implementation Charges - Summary of Restructuring Charges, Cumulative to Date (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:ScheduleOfRestructuringAndRelatedCostsIncurredToDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i9f891a302e1e43728a30449d921b0d65_I20191231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedCostCostIncurredToDate1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "cl:OtherIncomeExpenseNetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedCostIncurredCost", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240184011 - Disclosure - Restructuring and Related Implementation Charges - Restructuring Activity and Related Accruals (Details)", "role": "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails", "shortName": "Restructuring and Related Implementation Charges - Restructuring Activity and Related Accruals (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i198658e2a34a49bdaa60322633c01994_D20190101-20191231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:RestructuringReserveTranslationAdjustment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240214012 - Disclosure - Goodwill and Other Intangible Assets - Schedule of Goodwill (Details)", "role": "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillDetails", "shortName": "Goodwill and Other Intangible Assets - Schedule of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i93e8a704e6bd4ccfa246ac54b304181d_I20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240224013 - Disclosure - Goodwill and Other Intangible Assets - Summary of Other Intangible Assets (Details)", "role": "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails", "shortName": "Goodwill and Other Intangible Assets - Summary of Other Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "cl:OtherIncomeExpenseNetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240234014 - Disclosure - Goodwill and Other Intangible Assets - Narrative (Details)", "role": "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails", "shortName": "Goodwill and Other Intangible Assets - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i3c1885979d4c4700919e8a8489de25ea_I20171231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050006 - Statement - Consolidated Statements of Changes in Shareholders' Equity", "role": "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "shortName": "Consolidated Statements of Changes in Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i3c1885979d4c4700919e8a8489de25ea_I20171231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240264015 - Disclosure - Long-Term Debt and Credit Facilities - Components of Long-term Debt (Details)", "role": "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesComponentsofLongtermDebtDetails", "shortName": "Long-Term Debt and Credit Facilities - Components of Long-term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240274016 - Disclosure - Long-Term Debt and Credit Facilities - Schedule of Long-Term Debt and Finance Lease Maturities (Details)", "role": "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesScheduleofLongTermDebtandFinanceLeaseMaturitiesDetails", "shortName": "Long-Term Debt and Credit Facilities - Schedule of Long-Term Debt and Finance Lease Maturities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtWeightedAverageInterestRate", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240284017 - Disclosure - Long-Term Debt and Credit Facilities - Narrative (Details)", "role": "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails", "shortName": "Long-Term Debt and Credit Facilities - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "ic8ed285949e449bc8ef91066f7ab0807_I20191231", "decimals": "3", "lang": "en-US", "name": "us-gaap:ShortTermDebtWeightedAverageInterestRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-2", "first": true, "lang": "en-US", "name": "cl:MinimumNumberOfCountriesAndTerritoriesServingConsumers", "reportCount": 1, "unique": true, "unitRef": "country_and_territory", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240314018 - Disclosure - Fair Value Measurements and Financial Instruments - Narrative (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails", "shortName": "Fair Value Measurements and Financial Instruments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-2", "first": true, "lang": "en-US", "name": "cl:MinimumNumberOfCountriesAndTerritoriesServingConsumers", "reportCount": 1, "unique": true, "unitRef": "country_and_territory", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240324019 - Disclosure - Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails", "shortName": "Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id91bea58e3cb4726a5a2249b485e8168_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:HedgedLiabilityFairValueHedge", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240334020 - Disclosure - Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails", "shortName": "Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id91bea58e3cb4726a5a2249b485e8168_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:HedgedLiabilityFairValueHedge", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i05a9952c868749a6bffa1953c16501b9_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240344021 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails", "shortName": "Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i05a9952c868749a6bffa1953c16501b9_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i15802f4e4ea742bbacca13a05584252b_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240354022 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Statements of Income (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails", "shortName": "Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Statements of Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i15802f4e4ea742bbacca13a05584252b_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:ScheduleOfCashFlowAndNetInvestmentHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240364023 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails", "shortName": "Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:ScheduleOfCashFlowAndNetInvestmentHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240394024 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Narrative (Details)", "role": "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails", "shortName": "Capital Stock and Stock-Based Compensation Plans - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100060007 - Statement - Consolidated Statements of Changes in Shareholders' Equity (Parenthetical)", "role": "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquityParenthetical", "shortName": "Consolidated Statements of Changes in Shareholders' Equity (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:ScheduleOfCommonAndTreasuryStockActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "ic8ed285949e449bc8ef91066f7ab0807_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240404025 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Summary of Common Stock and Treasury Stock Activity (Details)", "role": "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofCommonStockandTreasuryStockActivityDetails", "shortName": "Capital Stock and Stock-Based Compensation Plans - Summary of Common Stock and Treasury Stock Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:ScheduleOfCommonAndTreasuryStockActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "ibb42a43b4ce34f6780bf41a8579f2fa4_I20171231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240414026 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Fair Value Assumptions (Details)", "role": "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansFairValueAssumptionsDetails", "shortName": "Capital Stock and Stock-Based Compensation Plans - Fair Value Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i81255b26c7bf458da5113532d5232c2c_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240424027 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Summary of Performance Restricted Stock Activity (Details)", "role": "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofPerformanceRestrictedStockActivityDetails", "shortName": "Capital Stock and Stock-Based Compensation Plans - Summary of Performance Restricted Stock Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i81255b26c7bf458da5113532d5232c2c_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i0bfb267f42b64a5581cbd23fcd7449be_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240434028 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Summary of Restricted Stock Activity (Details)", "role": "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails", "shortName": "Capital Stock and Stock-Based Compensation Plans - Summary of Restricted Stock Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i0bfb267f42b64a5581cbd23fcd7449be_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "ic8ed285949e449bc8ef91066f7ab0807_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240444029 - Disclosure - Capital Stock and Stock-Based Compensation Plans - Summary of Stock Option Activity (Details)", "role": "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails", "shortName": "Capital Stock and Stock-Based Compensation Plans - Summary of Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "ic8ed285949e449bc8ef91066f7ab0807_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeStockOwnershipPlanESOPSharesInESOP", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240464030 - Disclosure - Employee Stock Ownership Plan (Details)", "role": "http://www.colgate.com/role/EmployeeStockOwnershipPlanDetails", "shortName": "Employee Stock Ownership Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeStockOwnershipPlanESOPSharesInESOP", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i90229f1e30a7449189ab512c3ae9b0e4_I20201231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240494031 - Disclosure - Retirement Plans and Other Retiree Benefits - Schedule of Target Asset Allocation (Details)", "role": "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsScheduleofTargetAssetAllocationDetails", "shortName": "Retirement Plans and Other Retiree Benefits - Schedule of Target Asset Allocation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i90229f1e30a7449189ab512c3ae9b0e4_I20201231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "2", "first": true, "lang": "en-US", "name": "cl:PercentageOfFixedIncomePortfolioInvestedInUsTreasuryOrAgencySecurities", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240504032 - Disclosure - Retirement Plans and Other Retiree Benefits - Allocation of Plan Assets and Level of Valuation Input, by Major Asset Category (Details)", "role": "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails", "shortName": "Retirement Plans and Other Retiree Benefits - Allocation of Plan Assets and Level of Valuation Input, by Major Asset Category (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "2", "first": true, "lang": "en-US", "name": "cl:PercentageOfFixedIncomePortfolioInvestedInUsTreasuryOrAgencySecurities", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "cl:ExpectedBenefitPaymentsFromCompanyAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240514033 - Disclosure - Retirement Plans and Other Retiree Benefits - Narrative (Details)", "role": "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "shortName": "Retirement Plans and Other Retiree Benefits - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "cl:ExpectedBenefitPaymentsFromCompanyAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "cl:OtherAccrualsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240524034 - Disclosure - Retirement Plans and Other Retiree Benefits - Summary of Defined Benefit and Other Retiree Benefit Plans (Details)", "role": "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails", "shortName": "Retirement Plans and Other Retiree Benefits - Summary of Defined Benefit and Other Retiree Benefit Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i5e47af0dfb6841409b5ddc4264db78f3_D20200101-20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100070008 - Statement - Consolidated Statements of Cash Flows", "role": "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "lang": "en-US", "name": "cl:RestructuringNetOfCash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i80be271a05404bac90b459e9d6f9574e_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240534035 - Disclosure - Retirement Plans and Other Retiree Benefits - Benefit Obligation Exceeds Fair Value of Plan Assets (Details)", "role": "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsBenefitObligationExceedsFairValueofPlanAssetsDetails", "shortName": "Retirement Plans and Other Retiree Benefits - Benefit Obligation Exceeds Fair Value of Plan Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i80be271a05404bac90b459e9d6f9574e_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8ba46ff8ac204c56919a436f7579d554_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240544036 - Disclosure - Retirement Plans and Other Retiree Benefits - Summary of Other Retiree Benefit Plans (Details)", "role": "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofOtherRetireeBenefitPlansDetails", "shortName": "Retirement Plans and Other Retiree Benefits - Summary of Other Retiree Benefit Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8ba46ff8ac204c56919a436f7579d554_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i5e47af0dfb6841409b5ddc4264db78f3_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240554037 - Disclosure - Retirement Plans and Other Retiree Benefits - Summary of Net Periodic Benefit Costs (Details)", "role": "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails", "shortName": "Retirement Plans and Other Retiree Benefits - Summary of Net Periodic Benefit Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i5e47af0dfb6841409b5ddc4264db78f3_D20200101-20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240564038 - Disclosure - Retirement Plans and Other Retiree Benefits - Expected Contributions and Benefit Payments (Details)", "role": "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails", "shortName": "Retirement Plans and Other Retiree Benefits - Expected Contributions and Benefit Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240594039 - Disclosure - Income Taxes - Components of Income Before Income Taxes (Details)", "role": "http://www.colgate.com/role/IncomeTaxesComponentsofIncomeBeforeIncomeTaxesDetails", "shortName": "Income Taxes - Components of Income Before Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:ProvisionForIncomeTaxesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240604040 - Disclosure - Income Taxes - Provision for Income Taxes (Details)", "role": "http://www.colgate.com/role/IncomeTaxesProvisionforIncomeTaxesDetails", "shortName": "Income Taxes - Provision for Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:ProvisionForIncomeTaxesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:ScheduleofComponentsofDeferredIncomeTaxBenefitProvisionTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240614041 - Disclosure - Income Taxes - Income Tax Provision Reconciliation (Details)", "role": "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails", "shortName": "Income Taxes - Income Tax Provision Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:ScheduleofComponentsofDeferredIncomeTaxBenefitProvisionTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240624042 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)", "role": "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails", "shortName": "Income Taxes - Effective Tax Rate Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240634043 - Disclosure - Income Taxes - Components of Deferred Tax Assets (Liabilities) (Details)", "role": "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails", "shortName": "Income Taxes - Components of Deferred Tax Assets (Liabilities) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240644044 - Disclosure - Income Taxes - Narrative (Details)", "role": "http://www.colgate.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "link:footnote", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsOfDebtExtinguishmentCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "140084001 - Statement - Consolidated Statements of Cash Flows (Parenthetical)", "role": "http://www.colgate.com/role/ConsolidatedStatementsofCashFlowsParenthetical", "shortName": "Consolidated Statements of Cash Flows (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "link:footnote", "div", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsOfDebtExtinguishmentCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "ic8ed285949e449bc8ef91066f7ab0807_I20191231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240654045 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)", "role": "http://www.colgate.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails", "shortName": "Income Taxes - Unrecognized Tax Benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "ibb42a43b4ce34f6780bf41a8579f2fa4_I20171231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240684046 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details)", "role": "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails", "shortName": "Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i9980a46323114b3eacfb39b26501847a_D20200101-20201231", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240694047 - Disclosure - Earnings Per Share - Narrative (Details)", "role": "http://www.colgate.com/role/EarningsPerShareNarrativeDetails", "shortName": "Earnings Per Share - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i9980a46323114b3eacfb39b26501847a_D20200101-20201231", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LongTermPurchaseCommitmentAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240714048 - Disclosure - Commitments and Contingencies (Details)", "role": "http://www.colgate.com/role/CommitmentsandContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LongTermPurchaseCommitmentAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "cl:NumberOfProductSegments", "reportCount": 1, "unitRef": "business_segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240744049 - Disclosure - Segment Information - Narrative (Details)", "role": "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "shortName": "Segment Information - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:NumberOfOperatingSegments", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "business_segment", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "if1dd00a48ce14a8790284ad3a94216f5_D20201001-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240754050 - Disclosure - Segment Information - Schedule of Segment Information (Details)", "role": "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails", "shortName": "Segment Information - Schedule of Segment Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240784051 - Disclosure - Leases - Narrative (Details)", "role": "http://www.colgate.com/role/LeasesNarrativeDetails", "shortName": "Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240794052 - Disclosure - Leases - Balance Sheet (Details)", "role": "http://www.colgate.com/role/LeasesBalanceSheetDetails", "shortName": "Leases - Balance Sheet (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R98": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240804053 - Disclosure - Leases - Schedule of Minimum Lease Commitments (Details)", "role": "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails", "shortName": "Leases - Schedule of Minimum Lease Commitments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "id5d3c19c8e26451e949890214dd42d4d_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240814054 - Disclosure - Leases - Schedule of Lease Cost (Details)", "role": "http://www.colgate.com/role/LeasesScheduleofLeaseCostDetails", "shortName": "Leases - Schedule of Lease Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20201231.htm", "contextRef": "i8248b25f358b445494490b02acd5f7f4_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } } }, "segmentCount": 131, "tag": { "cl_A0.000Notesdue2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "0.000% Notes due 2021 [Member]", "label": "0.000% Notes due 2021 [Member]", "terseLabel": "0.000% Notes due 2021" } } }, "localname": "A0.000Notesdue2021Member", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "domainItemType" }, "cl_A0.500NotesDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "0.500% Notes Due 2026 [Member]", "label": "0.500% Notes Due 2026 [Member]", "terseLabel": "0.500% Notes Due 2026" } } }, "localname": "A0.500NotesDue2026Member", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "domainItemType" }, "cl_A0.875Notesdue2039Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "0.875% Notes due 2039 [Member]", "label": "0.875% Notes due 2039 [Member]", "terseLabel": "0.875% Notes due 2039" } } }, "localname": "A0.875Notesdue2039Member", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "domainItemType" }, "cl_A1.375NotesDue2034Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "1.375% Notes Due 2034 [Member]", "label": "1.375% Notes Due 2034 [Member]", "terseLabel": "1.375% Notes Due 2034" } } }, "localname": "A1.375NotesDue2034Member", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "domainItemType" }, "cl_A1.75percentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "1.75 percent [Member]", "label": "1.75 percent [Member]", "terseLabel": "1.75 Percent" } } }, "localname": "A1.75percentMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_A230MediumTermNotesDue2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.30% Medium-Term Notes Due 2022", "label": "2.30% Medium-Term Notes Due 2022 [Member]", "terseLabel": "2.30% Notes Due 2022" } } }, "localname": "A230MediumTermNotesDue2022Member", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_A245MediumTermNotesDue2021And230MediumTermNotesDue2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.45% Medium-Term Notes Due 2021 And 2.30% Medium-Term Notes Due 2022", "label": "2.45% Medium-Term Notes Due 2021 And 2.30% Medium-Term Notes Due 2022 [Member]", "terseLabel": "2.45% Notes Due 2021 and 2.30% Notes Due 2022" } } }, "localname": "A245MediumTermNotesDue2021And230MediumTermNotesDue2022Member", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_A245MediumTermNotesDue2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.45% Medium-Term Notes Due 2021", "label": "2.45% Medium-Term Notes Due 2021 [Member]", "terseLabel": "2.45% Notes Due 2021" } } }, "localname": "A245MediumTermNotesDue2021Member", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_AccruedAdvertisingAndCouponRedemptionCurrent": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails": { "order": 8.0, "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for advertising of the entity's goods and services as well as for coupon redemption. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Advertising And Coupon Redemption Current", "terseLabel": "Accrued advertising and coupon redemption" } } }, "localname": "AccruedAdvertisingAndCouponRedemptionCurrent", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "cl_AfricaEurasiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A specified group of foreign regions about which segment information is provided by the entity.", "label": "Africa Eurasia [Member]", "terseLabel": "Africa/Eurasia" } } }, "localname": "AfricaEurasiaMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cl_AllowanceForDoubtfulAccountsAndEstimatedReturnsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Allowance established for amounts due that are unlikely to be received, and the valuation allowance for the amount of products sold that the entity expects to be returned by the purchaser.", "label": "Allowance For Doubtful Accounts And Estimated Returns Member", "verboseLabel": "Allowance for doubtful accounts and estimated returns" } } }, "localname": "AllowanceForDoubtfulAccountsAndEstimatedReturnsMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "cl_AmendedDomesticRevolvingCreditFacility1500MillionCapacityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended Domestic Revolving Credit Facility 1500 Million Capacity [Member]", "label": "Amended Domestic Revolving Credit Facility 1500 Million Capacity [Member]", "terseLabel": "Amended Foreign Revolving Credit Facility 1500 Million Capacity" } } }, "localname": "AmendedDomesticRevolvingCreditFacility1500MillionCapacityMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_AmendedDomesticRevolvingCreditFacility2650MillionCapacityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended Domestic Revolving Credit Facility 2650 Million Capacity [Member]", "label": "Amended Domestic Revolving Credit Facility 2650 Million Capacity [Member]", "terseLabel": "Amended Domestic Revolving Credit Facility 2650 Million Capacity" } } }, "localname": "AmendedDomesticRevolvingCreditFacility2650MillionCapacityMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_AssetImpairmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset Impairment [Member]", "label": "Asset Impairment [Member]", "terseLabel": "Asset Impairments" } } }, "localname": "AssetImpairmentMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringChargesCumulativetoDateDetails" ], "xbrltype": "domainItemType" }, "cl_AssetsAndLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets And Liabilities, Lessee [Table Text Block]", "label": "Assets And Liabilities, Lessee [Table Text Block]", "terseLabel": "Schedule of Right-of-use Assets and Liabilities for Operating Leases" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "cl_AverageAnnualRateOfReturnForMostRecentFifteenYearPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The average annual rate of return on pension plan assets for the most recent 15 year period.", "label": "Average Annual Rate Of Return For Most Recent Fifteen Year Period", "terseLabel": "Average annual rates of return for the most recent 15-year period" } } }, "localname": "AverageAnnualRateOfReturnForMostRecentFifteenYearPeriod", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "cl_AverageAnnualRateOfReturnForMostRecentFiveYearPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The average annual rate of return on pension plan assets for the most recent 5 year period.", "label": "Average Annual Rate Of Return For Most Recent Five Year Period", "terseLabel": "Average annual rates of return for the most recent 5-year period" } } }, "localname": "AverageAnnualRateOfReturnForMostRecentFiveYearPeriod", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "cl_AverageAnnualRateOfReturnForMostRecentOneYearPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The average annual rate of return on pension plan assets for the most recent 1 year period.", "label": "Average Annual Rate Of Return For Most Recent One Year Period", "terseLabel": "Average annual rates of return for the most recent 1-year period" } } }, "localname": "AverageAnnualRateOfReturnForMostRecentOneYearPeriod", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "cl_AverageAnnualRateOfReturnForMostRecentTenYearPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The average annual rate of return on pension plan assets for the most recent 10 year period.", "label": "Average Annual Rate Of Return For Most Recent Ten Year Period", "terseLabel": "Average annual rates of return for the most recent 10-year period" } } }, "localname": "AverageAnnualRateOfReturnForMostRecentTenYearPeriod", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "cl_AverageAnnualRateOfReturnForMostRecentTwentyFiveYearPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The average annual rate of return on pension plan assets for the most recent 25 year period.", "label": "Average Annual Rate Of Return For Most Recent Twenty Five Year Period", "terseLabel": "Average annual rates of return for the most recent 25-year period" } } }, "localname": "AverageAnnualRateOfReturnForMostRecentTwentyFiveYearPeriod", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "cl_BenefitFromForeignTaxMatter": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Benefit From Foreign Tax Matter", "label": "Benefit From Foreign Tax Matter", "terseLabel": "Benefit from foreign tax matter" } } }, "localname": "BenefitFromForeignTaxMatter", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails", "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cl_BenefitFromForeignTaxMatterBrazil": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails": { "order": 4.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Benefit From Foreign Tax Matter, Brazil", "label": "Benefit From Foreign Tax Matter, Brazil", "negatedTerseLabel": "Value-added tax matter in Brazil" } } }, "localname": "BenefitFromForeignTaxMatterBrazil", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "monetaryItemType" }, "cl_BusinessCombinationAcquisitionRelatedCostsNet": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails": { "order": 6.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Acquisition Related Costs, Net", "label": "Business Combination, Acquisition Related Costs, Net", "terseLabel": "Acquisition-related costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCostsNet", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "monetaryItemType" }, "cl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAndLiabilitiesOtherNet": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets And Liabilities, Other, Net", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets And Liabilities, Other, Net", "negatedTerseLabel": "Other assets and liabilities, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAndLiabilitiesOtherNet", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "cl_CashOutflowfromUnrecognizedTaxBenefitthatWouldImpactEffectiveTaxRate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of cash outflow of unrecognized tax benefit that, if recognized, would impact effective tax rate", "label": "Cash Outflow from Unrecognized Tax Benefit that Would Impact Effective Tax Rate", "terseLabel": "Cash outflow from unrecognized tax benefit that would impact effective tax rate" } } }, "localname": "CashOutflowfromUnrecognizedTaxBenefitthatWouldImpactEffectiveTaxRate", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cl_CostMethodInvestmentOwnershipPercentageMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum percentage of ownership of common stock or equity participation in the investee accounted for under the cost method of accounting. This maximum is up to, but not including, the maximum value.", "label": "Cost Method Investment Ownership Percentage Maximum", "verboseLabel": "Investments accounted for using the cost method, maximum interest" } } }, "localname": "CostMethodInvestmentOwnershipPercentageMaximum", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "percentItemType" }, "cl_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensionsAndOtherRetireeBenefits": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The tax effect as of the balance sheet date of the amount of estimated future tax deductions arising from pension costs and other retiree benefits, which can only be deducted for tax purposes when actual costs are incurred, and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken.", "label": "Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions And Other Retiree Benefits", "verboseLabel": "Pension and other retiree benefits" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensionsAndOtherRetireeBenefits", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "cl_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiabilities": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Lease Liabilities", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Lease Liabilities", "terseLabel": "Lease liabilities" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiabilities", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "cl_DeferredTaxAssetsTaxLossAndTaxCreditCarryforwards": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The tax effect as of the balance sheet date of the amount of future tax deductions arising from all unused tax loss and tax credit carryforwards which have been reduced by a valuation allowance.", "label": "Deferred Tax Assets Tax Loss And Tax Credit Carryforwards", "verboseLabel": "Tax credits and tax loss carryforwards" } } }, "localname": "DeferredTaxAssetsTaxLossAndTaxCreditCarryforwards", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "cl_DeferredTaxLiabilitiesDeferredWithholdingTax": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liabilities, Deferred Withholding Tax", "label": "Deferred Tax Liabilities, Deferred Withholding Tax", "negatedTerseLabel": "Deferred withholding tax" } } }, "localname": "DeferredTaxLiabilitiesDeferredWithholdingTax", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "cl_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAndNetPriorServiceCostCreditBeforeTax": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of accumulated other comprehensive income comprised of net prior service cost/credit and net transition assets (obligations), before tax.", "label": "Defined Benefit Plan Accumulated Other Comprehensive Income Net Transition Assets Obligations And Net Prior Service Cost Credit Before Tax", "negatedLabel": "Transition/prior service cost" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAndNetPriorServiceCostCreditBeforeTax", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "cl_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationESOPGrowthRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expected growth rate of company stock held by the employee stock ownership plans used to determine benefit obligations for defined benefit plans.", "label": "Defined Benefit Plan Assumptions Used Calculating Benefit Obligation ESOP Growth Rate", "terseLabel": "ESOP growth rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationESOPGrowthRate", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "percentItemType" }, "cl_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationExpectedLongTermReturnOnPlanAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Expected Long Term Return On Plan Assets", "label": "Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Expected Long Term Return On Plan Assets", "terseLabel": "Expected long-term rate of return on plan assets" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationExpectedLongTermReturnOnPlanAssets", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "percentItemType" }, "cl_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationMedicalCostTrendRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Medical Cost Trend Rate for next fiscal.", "label": "Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Medical Cost Trend Rate", "terseLabel": "Medical cost trend rate of increase" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationMedicalCostTrendRate", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "percentItemType" }, "cl_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicCostEsopGrowthRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expected growth rate of company stock held by the employee stock ownership plans used to determine benefit obligations for defined benefit plans.", "label": "Defined Benefit Plan Assumptions Used Calculating Net Periodic Cost Esop Growth Rate", "terseLabel": "ESOP growth rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicCostEsopGrowthRate", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "percentItemType" }, "cl_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicMedicalCostTrendRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan Assumptions Used Calculating Net Periodic Medical Cost Trend Rate", "label": "Defined Benefit Plan Assumptions Used Calculating Net Periodic Medical Cost Trend Rate", "terseLabel": "Medical cost trend rate of increase" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicMedicalCostTrendRate", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "percentItemType" }, "cl_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlements": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease For Curtailment And Settlements", "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease For Curtailment And Settlements", "negatedLabel": "Curtailments and settlements" } } }, "localname": "DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlements", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "cl_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForPlanAmendmentAndBusinessCombination": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) For Plan Amendment And Business Combination", "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) For Plan Amendment And Business Combination", "terseLabel": "Acquisitions/plan amendments" } } }, "localname": "DefinedBenefitPlanBenefitObligationIncreaseDecreaseForPlanAmendmentAndBusinessCombination", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "cl_DefinedBenefitPlanChangeInPlanAssetOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other change in plan assets", "label": "Defined Benefit Plan Change in Plan Asset Other", "terseLabel": "Other" } } }, "localname": "DefinedBenefitPlanChangeInPlanAssetOther", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "cl_DefinedBenefitPlanDividendsReceivedOnEmployerSecurities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of dividends received by the defined benefit plan on the Company's common stock.", "label": "Defined Benefit Plan Dividends Received On Employer Securities", "terseLabel": "Defined Benefit Plan Dividends Received On Employer Securities" } } }, "localname": "DefinedBenefitPlanDividendsReceivedOnEmployerSecurities", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cl_DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Domestic, Developed and Emerging Markets Equity Funds [Member]", "label": "Defined Benefit Plan, Domestic, Developed and Emerging Markets Equity Funds [Member]", "terseLabel": "Domestic, developed and emerging markets equity funds" } } }, "localname": "DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "cl_DefinedBenefitPlanFixedIncomeFundsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Fixed Income Funds [Member]", "label": "Defined Benefit Plan, Fixed Income Funds [Member]", "terseLabel": "Fixed income funds" } } }, "localname": "DefinedBenefitPlanFixedIncomeFundsMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "cl_DefinedBenefitPlanFixedIncomeSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Fixed Income Securities [Member]", "label": "Defined Benefit Plan, Fixed Income Securities [Member]", "terseLabel": "Fixed income securities" } } }, "localname": "DefinedBenefitPlanFixedIncomeSecuritiesMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "cl_DefinedBenefitPlanGuaranteedInvestmentContractsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents investments in contracts with insurance companies measured at the cash surrender value of each contract.", "label": "Defined Benefit Plan, Guaranteed Investment Contracts [Member]", "terseLabel": "Guaranteed investment contracts" } } }, "localname": "DefinedBenefitPlanGuaranteedInvestmentContractsMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "cl_DefinedBenefitPlanHedgeFundsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Hedge Funds [Member]", "label": "Defined Benefit Plan, Hedge Funds [Member]", "terseLabel": "Hedge funds" } } }, "localname": "DefinedBenefitPlanHedgeFundsMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "cl_DefinedBenefitPlanInternationalCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This category includes information about ownership interests in international corporations and other legal entities for which ownership interest is represented by shares of common stock.", "label": "Defined Benefit Plan, International Common Stock [Member]", "terseLabel": "International common stocks" } } }, "localname": "DefinedBenefitPlanInternationalCommonStockMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "cl_DefinedBenefitPlanMultiAssetFundsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Multi-Asset Funds [Member]", "label": "Defined Benefit Plan, Multi-Asset Funds [Member]", "terseLabel": "Multi-Asset funds" } } }, "localname": "DefinedBenefitPlanMultiAssetFundsMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "cl_DefinedBenefitPlanOtherPostretirementCharges": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails": { "order": 2.0, "parentTag": "us-gaap_PensionAndOtherPostretirementBenefitExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "include pension and other benefit enhancements amounting incurred pursuant to the Global Growth and Efficiency Program.", "label": "Defined Benefit Plan Other Postretirement Charges", "terseLabel": "Other postretirement charges" } } }, "localname": "DefinedBenefitPlanOtherPostretirementCharges", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "cl_DefinedBenefitPlanPercentageOfEquitySecuritiesInvestedInEmployerSecurities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of equity securities of the defined benefit plan invested in the Company's common stock.", "label": "Defined Benefit Plan Percentage Of Equity Securities Invested In Employer Securities", "terseLabel": "Percentage of investments in Company's common stock" } } }, "localname": "DefinedBenefitPlanPercentageOfEquitySecuritiesInvestedInEmployerSecurities", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "cl_DefinedBenefitPlanPlanAssetsDivestitureShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Plan Assets, Divestiture, Shares", "label": "Defined Benefit Plan, Plan Assets, Divestiture, Shares", "terseLabel": "U.S. plans assets sold to Company (in shares)" } } }, "localname": "DefinedBenefitPlanPlanAssetsDivestitureShares", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "cl_DefinedBenefitPlanPlanAssetsPurchasesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Plan Assets, Purchases, Shares", "label": "Defined Benefit Plan, Plan Assets, Purchases, Shares", "terseLabel": "U.S. plans assets purchased to Company (in shares)" } } }, "localname": "DefinedBenefitPlanPlanAssetsPurchasesShares", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "cl_DefinedBenefitPlanPooledFundsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Pooled Funds [Member]", "label": "Defined Benefit Plan, Pooled Funds [Member]", "terseLabel": "Pooled funds" } } }, "localname": "DefinedBenefitPlanPooledFundsMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "cl_DefinedBenefitPlanUSCommonStocksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This category includes information about ownership interests in United States corporations and other legal entities for which ownership interest is represented by shares of common stock.", "label": "Defined Benefit Plan, US Common Stocks [Member]", "terseLabel": "U.S. common stocks" } } }, "localname": "DefinedBenefitPlanUSCommonStocksMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "cl_DefinedBenefitPlanVoluntaryContributionsByEmployer": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Voluntary contributions made by the Company to its postretirement plans.", "label": "Defined Benefit Plan Voluntary Contributions By Employer", "terseLabel": "Voluntary contributions to postretirement plans" } } }, "localname": "DefinedBenefitPlanVoluntaryContributionsByEmployer", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cl_DiscreteIncomeTaxProvisionBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Discrete Income Tax Provision (Benefit)", "label": "Discrete Income Tax Provision (Benefit)", "negatedTerseLabel": "Discrete Income Tax Provision (Benefit)" } } }, "localname": "DiscreteIncomeTaxProvisionBenefit", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "cl_EffectiveIncomeTaxRateReconciliationDeferredWithholdingTaxAmount": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Deferred Withholding Tax, Amount", "label": "Effective Income Tax Rate Reconciliation, Deferred Withholding Tax, Amount", "negatedTerseLabel": "Deferred withholding tax" } } }, "localname": "EffectiveIncomeTaxRateReconciliationDeferredWithholdingTaxAmount", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "cl_EffectiveIncomeTaxRateReconciliationTaxCreditCarrybacksForeignPercent": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 5.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Tax Credit Carrybacks, Foreign, Percent", "label": "Effective Income Tax Rate Reconciliation, Tax Credit Carrybacks, Foreign, Percent", "terseLabel": "Foreign Tax Credit Carryback" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditCarrybacksForeignPercent", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "cl_EffectiveIncomeTaxReconciliationTaxLossAndTaxCreditCarryforwards": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The sum of the differences between total income tax expense (benefit) as reported in the Income Statement for the period and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations attributable to tax loss and tax credit carryforwards.", "label": "Effective Income Tax Reconciliation, Tax Loss And Tax Credit Carryforwards", "terseLabel": "Tax credits and tax loss carryforwards" } } }, "localname": "EffectiveIncomeTaxReconciliationTaxLossAndTaxCreditCarryforwards", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "cl_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptionsAndVestingOfRestrictedStockUnitAwards": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Employee Service Share-Based Compensation, Tax Benefit From Exercise Of Stock Options And Vesting Of Restricted Stock Unit Awards", "label": "Employee Service Share-Based Compensation, Tax Benefit From Exercise Of Stock Options And Vesting Of Restricted Stock Unit Awards", "terseLabel": "Tax benefit from exercise of stock options and vesting of restricted stock unit awards" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptionsAndVestingOfRestrictedStockUnitAwards", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cl_EmployeeStockOwnershipPlanESOPDebtStructureEmployerLoanAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of advances from the Company to the ESOP which remain outstanding as of the balance sheet date.", "label": "Employee Stock Ownership Plan ESOP Debt Structure Employer Loan Amount", "verboseLabel": "Outstanding borrowings in the ESOP" } } }, "localname": "EmployeeStockOwnershipPlanESOPDebtStructureEmployerLoanAmount", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/EmployeeStockOwnershipPlanDetails" ], "xbrltype": "monetaryItemType" }, "cl_EmployeeStockOwnershipPlanESOPDisclosuresTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Stock Ownership Plan ESOP Disclosures [Text Block]", "label": "Employee Stock Ownership Plan ESOP Disclosures [Text Block]", "terseLabel": "Employee Stock Ownership Plan" } } }, "localname": "EmployeeStockOwnershipPlanESOPDisclosuresTextBlock", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/EmployeeStockOwnershipPlan" ], "xbrltype": "textBlockItemType" }, "cl_EquityMethodInvestmentOwnershipPercentageMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment Ownership Percentage Maximum", "verboseLabel": "Investments accounted for using the equity method, maximum interest" } } }, "localname": "EquityMethodInvestmentOwnershipPercentageMaximum", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "percentItemType" }, "cl_EquityMethodInvestmentOwnershipPercentageMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment Ownership Percentage Minimum", "verboseLabel": "Investments accounted for using the equity method, minimum interest" } } }, "localname": "EquityMethodInvestmentOwnershipPercentageMinimum", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "percentItemType" }, "cl_ExpectedBenefitPaymentsFromCompanyAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expected Benefit Payments From Company's Assets to be paid in year one.", "label": "Expected Benefit Payments From Company Assets", "terseLabel": "Expected benefit payments from company assets" } } }, "localname": "ExpectedBenefitPaymentsFromCompanyAssets", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cl_Fifteenyearnotesat1.375percentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fifteen year notes at 1.375 percent [Member]", "label": "Fifteen year notes at 1.375 percent [Member]", "terseLabel": "Fifteen Year notes at 1.375 Percent" } } }, "localname": "Fifteenyearnotesat1.375percentMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_FilorgaReportingUnitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Filorga Reporting Unit", "label": "Filorga Reporting Unit [Member]", "terseLabel": "Filorga Reporting Unit" } } }, "localname": "FilorgaReportingUnitMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_FinanceLeaseObligationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Finance Lease Obligation [Member]", "label": "Finance Lease Obligation [Member]", "terseLabel": "Finance Lease Obligations" } } }, "localname": "FinanceLeaseObligationMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesComponentsofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "cl_FineImposedByGreekCompetitionAuthority": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fine Imposed by Greek Competition Authority", "label": "Fine Imposed By Greek Competition Authority", "terseLabel": "Fine imposed by greek competition authority" } } }, "localname": "FineImposedByGreekCompetitionAuthority", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "cl_FiniteAndIndefiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite And Indefinite Lived Intangible Assets [Line Items]", "verboseLabel": "Finite and indefinite-lived intangible assets [Line Items]" } } }, "localname": "FiniteAndIndefiniteLivedIntangibleAssetsLineItems", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "cl_ForeignWithholdingIncomeTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Foreign Withholding Income Tax", "label": "Foreign Withholding Income Tax", "negatedTerseLabel": "Foreign Withholding Income Tax" } } }, "localname": "ForeignWithholdingIncomeTax", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "cl_GlobalGrowthandEfficiencyProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Global Growth and Efficiency Program [Member]", "label": "Global Growth and Efficiency Program [Member]", "terseLabel": "Global Growth and Efficiency Program" } } }, "localname": "GlobalGrowthandEfficiencyProgramMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringChargesCumulativetoDateDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringandRelatedCostsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_GrossProfitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross Profit [Member]", "label": "Gross Profit [Member]", "terseLabel": "Gross Profit", "verboseLabel": "Cost of sales" } } }, "localname": "GrossProfitMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringandRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "cl_HelloProductLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hello Product LLC [Member]", "label": "Hello Product LLC [Member]", "terseLabel": "hello" } } }, "localname": "HelloProductLLCMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "cl_HomeCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Home Care products include laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches and other similar items.", "label": "Home Care [Member]", "terseLabel": "Home Care" } } }, "localname": "HomeCareMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/NatureofOperationsDetails" ], "xbrltype": "domainItemType" }, "cl_IncentiveStockPlansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Company has plans that provide for grants of restricted stock awards for officers and other employees. A committee of independent members of the Board of Directors administers the plan.", "label": "Incentive Stock Plans Member", "terseLabel": "Incentive Stock Plans" } } }, "localname": "IncentiveStockPlansMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_IncomeTaxBenefitRelatedToChangesInSwissPreferentialTaxRegimeAndIncreaseToCantonalTaxRate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income Tax Benefit Related To Changes In Swiss Preferential Tax Regime And Increase To Cantonal Tax Rate", "label": "Income Tax Benefit Related To Changes In Swiss Preferential Tax Regime And Increase To Cantonal Tax Rate", "terseLabel": "Income tax benefit related to changes in swiss preferential tax regime and increase to cantonal tax rate" } } }, "localname": "IncomeTaxBenefitRelatedToChangesInSwissPreferentialTaxRegimeAndIncreaseToCantonalTaxRate", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "cl_IncreaseDecreaseInFineImposedByGreekCompetitionAuthority": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Fine Imposed By Greek Competition Authority", "label": "Increase (Decrease) In Fine Imposed By Greek Competition Authority", "negatedTerseLabel": "Increase (decrease) in fine imposed by Greek competition authority" } } }, "localname": "IncreaseDecreaseInFineImposedByGreekCompetitionAuthority", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "cl_IncrementalDepreciationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Incremental Depreciation [Member]", "label": "Incremental Depreciation [Member]", "terseLabel": "Incremental Depreciation" } } }, "localname": "IncrementalDepreciationMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringChargesCumulativetoDateDetails" ], "xbrltype": "domainItemType" }, "cl_IndefiniteLivedIntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indefinite-Lived Intangible Assets, Percentage Of Fair Value In Excess Of Carrying Amount", "label": "Indefinite-Lived Intangible Assets, Percentage Of Fair Value In Excess Of Carrying Amount", "terseLabel": "Indefinite-lived intangible assets, percentage of fair value in excess of carrying amount" } } }, "localname": "IndefiniteLivedIntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "percentItemType" }, "cl_InterestExpenseNet": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofIncome": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 }, "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate interest and debt related expenses associated with nonoperating financing activities of the entity, less the amount of income derived from investments in debt securities and on cash and cash equivalents, the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money.", "label": "Interest expense, net", "terseLabel": "Interest (income) expense, net", "totalLabel": "Total Interest (income) expense, net" } } }, "localname": "InterestExpenseNet", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofIncome", "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "monetaryItemType" }, "cl_InterestExpenseNetTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Expense, net [Table Text Block]", "label": "Interest expense, net [Table Text Block]", "terseLabel": "Interest expense, net" } } }, "localname": "InterestExpenseNetTableTextBlock", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformationTables" ], "xbrltype": "textBlockItemType" }, "cl_InterestIncomeExpenseNetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest (Income) Expense, Net [Member]", "label": "Interest (Income) Expense, Net [Member]", "terseLabel": "Interest (income) expense, net" } } }, "localname": "InterestIncomeExpenseNetMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails" ], "xbrltype": "domainItemType" }, "cl_InventoryNetIncludingNoncurrent": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofInventoriesbyMajorClassDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofInventoriesbyMajorClassDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventory, Net, Including Noncurrent", "label": "Inventory, Net, Including Noncurrent", "totalLabel": "Total Inventories, net" } } }, "localname": "InventoryNetIncludingNoncurrent", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofInventoriesbyMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "cl_LaboratoiresFilorgaCosmtiquesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Laboratoires Filorga Cosm\u00e9tiques [Member]", "label": "Laboratoires Filorga Cosm\u00e9tiques [Member]", "terseLabel": "Filorga" } } }, "localname": "LaboratoiresFilorgaCosmtiquesMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "cl_LineofCreditFacilityTermExtension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Term Extension", "label": "Line of Credit Facility, Term Extension", "terseLabel": "Term extension" } } }, "localname": "LineofCreditFacilityTermExtension", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "durationItemType" }, "cl_LocalBrandsTrademarksCustomerRelationshipsAndNonCompeteAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Finite-lived intangible assets consisting of: Payments made to third parties in exchange for their agreement not to engage in specified competitive practices in specified geographic territories for a specified period of time, an asset acquired in a business combination representing a customer relationship that exists between an entity and its customer, rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, and local brand value.", "label": "Local Brands, Trademarks, Customer Relationships And Non Compete Agreements Member", "verboseLabel": "Local Brands, Trademarks, Customer Relationships, and Non-Compete Agreements" } } }, "localname": "LocalBrandsTrademarksCustomerRelationshipsAndNonCompeteAgreementsMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesGoodwillandOtherIntangiblesDetails" ], "xbrltype": "domainItemType" }, "cl_LossContingencyCasesResultingInAdverseJuryVerdictNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Cases Resulting In Adverse Jury Verdict, Number", "label": "Loss Contingency, Cases Resulting In Adverse Jury Verdict, Number", "terseLabel": "Number of cases resulting in adverse jury verdict" } } }, "localname": "LossContingencyCasesResultingInAdverseJuryVerdictNumber", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "integerItemType" }, "cl_LossContingencyNumberOfCasesOnAppeal": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Number of Cases On Appeal", "label": "Loss Contingency, Number Of Cases On Appeal", "terseLabel": "Loss Contingency, Number Of Cases On Appeal" } } }, "localname": "LossContingencyNumberOfCasesOnAppeal", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "integerItemType" }, "cl_MinimumNumberOfCountriesAndTerritoriesServingConsumers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum Number Of Countries And Territories Serving Consumers", "label": "Minimum Number Of Countries And Territories Serving Consumers", "terseLabel": "Minimum number of countries and territories serving consumers (more than) (in countries and territories)" } } }, "localname": "MinimumNumberOfCountriesAndTerritoriesServingConsumers", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "integerItemType" }, "cl_NigeriaJointVentureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nigeria Joint Venture [Member]", "label": "Nigeria Joint Venture [Member]", "terseLabel": "Nigeria Joint Venture" } } }, "localname": "NigeriaJointVentureMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_NonServiceRelatedPostretirementCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-Service Related Postretirement Costs [Member]", "label": "Non-Service Related Postretirement Costs [Member]", "terseLabel": "Non-service related postretirement costs" } } }, "localname": "NonServiceRelatedPostretirementCostsMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringandRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "cl_NumberOfDividendsDeclaredPerQuarter": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Dividends Declared Per Quarter", "label": "Number Of Dividends Declared Per Quarter", "terseLabel": "Number of dividends declared per quarter" } } }, "localname": "NumberOfDividendsDeclaredPerQuarter", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquityParenthetical" ], "xbrltype": "integerItemType" }, "cl_NumberOfNewApprovedRestructuringProjects": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of New Approved Restructuring Projects", "label": "Number Of New Approved Restructuring Projects", "terseLabel": "Number of new approved restructuring projects" } } }, "localname": "NumberOfNewApprovedRestructuringProjects", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails" ], "xbrltype": "integerItemType" }, "cl_NumberOfProductSegments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Product Segments", "label": "Number Of Product Segments", "terseLabel": "Number of product segments (in segments)" } } }, "localname": "NumberOfProductSegments", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/NatureofOperationsDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "cl_NumberofStockholderApprovedPlansCurrent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Stockholder Approved Plans, Current", "label": "Number of Stockholder Approved Plans, Current", "terseLabel": "Number of stockholder approved plans, current" } } }, "localname": "NumberofStockholderApprovedPlansCurrent", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "integerItemType" }, "cl_OralCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Oral Care products include toothpaste, toothbrushes, mouth rinses and other similar items.", "label": "Oral Care [Member]", "terseLabel": "Oral Care" } } }, "localname": "OralCareMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/NatureofOperationsDetails" ], "xbrltype": "domainItemType" }, "cl_OralPersonalAndHomeCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Oral, Personal and Home Care", "label": "Oral, Personal and Home Care [Member]", "terseLabel": "Oral, Personal and Home Care", "verboseLabel": "Oral, Personal and Home Care" } } }, "localname": "OralPersonalAndHomeCareMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cl_OtherAccrualsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Accruals [Table Text Block]", "label": "Other Accruals [Table Text Block]", "verboseLabel": "Schedule of Other Accruals" } } }, "localname": "OtherAccrualsTableTextBlock", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationTables" ], "xbrltype": "textBlockItemType" }, "cl_OtherAccruedLiabilitiesCurrentOther": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails": { "order": 9.0, "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of other obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Other Accrued Liabilities Current Other", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrentOther", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "cl_OtherAssetsandLiabilitiesNetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Assets and Liabilities, Net [Member]", "label": "Other Assets and Liabilities, Net [Member]", "terseLabel": "Other assets and liabilities, net" } } }, "localname": "OtherAssetsandLiabilitiesNetMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "cl_OtherComprehensiveIncomeLossHedgedItemInNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive Income (Loss), Hedged Item In Net Investment Hedge, Gain (Loss), Before Reclassification and Tax", "label": "Other Comprehensive Income (Loss), Hedged Item In Net Investment Hedge, Gain (Loss), Before Reclassification And Tax", "terseLabel": "Gain (loss) on hedged items" } } }, "localname": "OtherComprehensiveIncomeLossHedgedItemInNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails" ], "xbrltype": "monetaryItemType" }, "cl_OtherIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails": { "order": 8.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other operating income, not previously categorized, from items that are associated with the entity's normal revenue producing operation, and the amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.", "label": "Other (income) expense, net", "terseLabel": "Other, net" } } }, "localname": "OtherIncomeExpenseNet", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "monetaryItemType" }, "cl_OtherIncomeExpenseNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income Expense Net Abstract", "terseLabel": "Other (income) expense, net" } } }, "localname": "OtherIncomeExpenseNetAbstract", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "stringItemType" }, "cl_OtherIncomeExpenseNetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other (Income) Expense, Net [Member]", "label": "Other (Income) Expense, Net [Member]", "terseLabel": "Other (income) expense, net" } } }, "localname": "OtherIncomeExpenseNetMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringandRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "cl_OtherIncomeExpenseNetTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other (income) expense, net [Table Text Block]", "label": "Other (income) expense, net [Table Text Block]", "verboseLabel": "Other (income) expense, net" } } }, "localname": "OtherIncomeExpenseNetTableTextBlock", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformationTables" ], "xbrltype": "textBlockItemType" }, "cl_OtherNoncurrentLiability": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Obligations not otherwise itemized or previously categorized that are due beyond one year (or operating cycle, if longer) from the balance sheet date.", "label": "Other Noncurrent Liability", "verboseLabel": "Other" } } }, "localname": "OtherNoncurrentLiability", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "cl_PercentOfTotalRestructuringChargesRelatedToSegmentForThePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percent Of Total Restructuring Charges Related To Segment For The Period", "label": "Percent Of Total Restructuring Charges Related To Segment For The Period", "terseLabel": "Percent of total restructuring charges related to segment" } } }, "localname": "PercentOfTotalRestructuringChargesRelatedToSegmentForThePeriod", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails" ], "xbrltype": "percentItemType" }, "cl_PercentageOfConsolidatedNetSalesComingFromEmergingMarkets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Consolidated Net Sales coming from Emerging Markets", "label": "Percentage Of Consolidated Net Sales Coming From Emerging Markets", "terseLabel": "Percentage of consolidated Net sales coming from emerging markets" } } }, "localname": "PercentageOfConsolidatedNetSalesComingFromEmergingMarkets", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "percentItemType" }, "cl_PercentageOfConsolidatedNetSalesRepresentedBySalesOutsideUS": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Consolidated Net Sales represented by Sales outside US", "label": "Percentage Of Consolidated Net Sales Represented By Sales Outside US", "terseLabel": "Percentage of consolidated Net sales represented by sales outside US" } } }, "localname": "PercentageOfConsolidatedNetSalesRepresentedBySalesOutsideUS", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "percentItemType" }, "cl_PercentageOfCorporateIdentifiableAssetsConsistingOfDerivativeInstruments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Corporate identifiable assets consisting of derivative instruments.", "label": "Percentage Of Corporate Identifiable Assets Consisting Of Derivative Instruments", "terseLabel": "Percentage of corporate identifiable assets consisting of derivative instruments" } } }, "localname": "PercentageOfCorporateIdentifiableAssetsConsistingOfDerivativeInstruments", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "percentItemType" }, "cl_PercentageOfCorporateIdentifiableAssetsConsistingOfInvestmentsInEquitySecurities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Corporate identifiable assets consisting of investments in equity securities.", "label": "Percentage Of Corporate Identifiable Assets Consisting Of Investments In Equity Securities", "terseLabel": "Percentage of corporate identifiable assets consisting of investments in equity securities" } } }, "localname": "PercentageOfCorporateIdentifiableAssetsConsistingOfInvestmentsInEquitySecurities", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "percentItemType" }, "cl_PercentageOfFixedIncomePortfolioInvestedInUsTreasuryOrAgencySecurities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of fixed income portfolio invested in U.S. treasury or agency securities.", "label": "Percentage Of Fixed Income Portfolio Invested In Us Treasury Or Agency Securities", "terseLabel": "Percent of fixed income assets invested in US treasury or agency securities" } } }, "localname": "PercentageOfFixedIncomePortfolioInvestedInUsTreasuryOrAgencySecurities", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "percentItemType" }, "cl_Percentofrestructuringchargesreportablesegmentprogramchargesincurredtodate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PercentOfRestructuringChargesReportableSegmentProgramChargesIncurredToDate", "label": "PercentOfRestructuringChargesReportableSegmentProgramChargesIncurredToDate", "terseLabel": "Percent of restructuring charges related to segment, total program accumulated charges" } } }, "localname": "Percentofrestructuringchargesreportablesegmentprogramchargesincurredtodate", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails" ], "xbrltype": "percentItemType" }, "cl_PerformanceBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Based Restricted Stock Units [Member]", "label": "Performance Based Restricted Stock Units [Member]", "terseLabel": "Performance Shares" } } }, "localname": "PerformanceBasedRestrictedStockUnitsMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofPerformanceRestrictedStockActivityDetails" ], "xbrltype": "domainItemType" }, "cl_PersonalCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Personal Care products include bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants and other similar items.", "label": "Personal Care [Member]", "terseLabel": "Personal Care" } } }, "localname": "PersonalCareMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/NatureofOperationsDetails" ], "xbrltype": "domainItemType" }, "cl_PetNutritionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pet Nutrition", "label": "Pet Nutrition [Member]", "terseLabel": "Pet Nutrition" } } }, "localname": "PetNutritionMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillDetails", "http://www.colgate.com/role/NatureofOperationsDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cl_PrinciplesOfConsolidationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Principles Of Consolidation Abstract", "verboseLabel": "Principles of Consolidation [Abstract]" } } }, "localname": "PrinciplesOfConsolidationAbstract", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "cl_Program2018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Program 2018 [Member]", "label": "Program 2018 [Member]", "terseLabel": "Program 2018" } } }, "localname": "Program2018Member", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_ProvisionForIncomeTaxesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the domestic and foreign components of the provision for income", "label": "Provision for Income Taxes [Table Text Block]", "terseLabel": "Provision for income taxes" } } }, "localname": "ProvisionForIncomeTaxesTableTextBlock", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "cl_RealEstateandOtherInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real Estate and Other Investments", "label": "Real Estate and Other Investments [Member]", "terseLabel": "Real estate and other investments" } } }, "localname": "RealEstateandOtherInvestmentsMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsScheduleofTargetAssetAllocationDetails" ], "xbrltype": "domainItemType" }, "cl_ReportingUnitImpairmentAnalysisAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reporting Unit Impairment Analysis", "label": "Reporting Unit Impairment Analysis [Axis]", "terseLabel": "Reporting Unit Impairment Analysis [Axis]" } } }, "localname": "ReportingUnitImpairmentAnalysisAxis", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "stringItemType" }, "cl_ReportingUnitImpairmentAnalysisDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reporting Unit Impairment Analysis", "label": "Reporting Unit Impairment Analysis [Domain]", "terseLabel": "Reporting Unit Impairment Analysis [Domain]" } } }, "localname": "ReportingUnitImpairmentAnalysisDomain", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_ReportingUnitImpairmentAnalysisIncreaseInDiscountRatePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reporting Unit, Impairment Analysis, Increase In Discount Rate, Percentage", "label": "Reporting Unit, Impairment Analysis, Increase In Discount Rate, Percentage", "terseLabel": "Reporting unit, impairment analysis, increase in discount rate, percentage" } } }, "localname": "ReportingUnitImpairmentAnalysisIncreaseInDiscountRatePercentage", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "percentItemType" }, "cl_ReportingUnitImpairmentAnalysisProjectedReductionInFairValuePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reporting Unit, Impairment Analysis, Projected Reduction In Fair Value, Percentage", "label": "Reporting Unit, Impairment Analysis, Projected Reduction In Fair Value, Percentage", "terseLabel": "Reporting unit, impairment analysis, projected reduction in fair value, percentage" } } }, "localname": "ReportingUnitImpairmentAnalysisProjectedReductionInFairValuePercentage", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "percentItemType" }, "cl_ReportingUnitImpairmentAnalysisProjectedReductionInLongTermGrowthRatePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reporting Unit, Impairment Analysis, Projected Reduction In Long-Term Growth Rate, Percentage", "label": "Reporting Unit, Impairment Analysis, Projected Reduction In Long-Term Growth Rate, Percentage", "terseLabel": "Reporting unit, impairment analysis, reduction in long-term growth rate, percentage" } } }, "localname": "ReportingUnitImpairmentAnalysisProjectedReductionInLongTermGrowthRatePercentage", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "percentItemType" }, "cl_ReportingUnitsOtherThanFilorgaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reporting Units Other Than Filorga", "label": "Reporting Units Other Than Filorga [Member]", "terseLabel": "Reporting Units Other Than Filorga" } } }, "localname": "ReportingUnitsOtherThanFilorgaMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_ResearchAndDevelopmentAndAdvertisingTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element is used to disclose supplemental income statement information related to research and development and advertising expense.", "label": "Research And Development And Advertising [Table Text Block]", "verboseLabel": "Research and development and Advertising" } } }, "localname": "ResearchAndDevelopmentAndAdvertisingTableTextBlock", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformationTables" ], "xbrltype": "textBlockItemType" }, "cl_RestructuringAndRelatedCostIncurredCostAfterTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Restructuring And Related Cost, Incurred Cost, After Tax", "label": "Restructuring And Related Cost, Incurred Cost, After Tax", "terseLabel": "Total Global Growth and Efficiency Program charges, aftertax" } } }, "localname": "RestructuringAndRelatedCostIncurredCostAfterTax", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringandRelatedCostsDetails" ], "xbrltype": "monetaryItemType" }, "cl_RestructuringAndRelatedCostIncurredCostIncludingNoncontrollingInterestAfterTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Restructuring And Related Cost, Incurred Cost, Including Noncontrolling Interest, After Tax", "label": "Restructuring And Related Cost, Incurred Cost, Including Noncontrolling Interest, After Tax", "terseLabel": "Restructuring and related cost, incurred cost, including noncontrolling interest, after tax" } } }, "localname": "RestructuringAndRelatedCostIncurredCostIncludingNoncontrollingInterestAfterTax", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "monetaryItemType" }, "cl_RestructuringAndRelatedCostIncurredCostRelatedToChangesInMarketStrategy": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails": { "order": 7.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Restructuring And Related Cost, Incurred Cost Related To Changes In Market Strategy", "label": "Restructuring And Related Cost, Incurred Cost Related To Changes In Market Strategy", "terseLabel": "Charges for a change in go-to-market strategy in certain countries" } } }, "localname": "RestructuringAndRelatedCostIncurredCostRelatedToChangesInMarketStrategy", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "monetaryItemType" }, "cl_RestructuringAndRelatedCostIncurredCostToDateAfterTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Restructuring And Related Cost Incurred Cost To Date After Tax", "label": "Restructuring And Related Cost Incurred Cost To Date After Tax", "terseLabel": "Restructuring and related cost incurred cost to date after tax" } } }, "localname": "RestructuringAndRelatedCostIncurredCostToDateAfterTax", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cl_RestructuringNetOfCash": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of noncash restructuring costs net of cash payments.", "label": "Restructuring, net of cash", "terseLabel": "Restructuring and termination benefits, net of cash" } } }, "localname": "RestructuringNetOfCash", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "cl_RestructuringReserveAccrualAdjustmentAfterTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Restructuring Reserve, Accrual Adjustment, After Tax", "label": "Restructuring Reserve, Accrual Adjustment, After Tax", "terseLabel": "Restructuring reduction after tax" } } }, "localname": "RestructuringReserveAccrualAdjustmentAfterTax", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cl_RestructuringReserveChargesAgainstAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Restructuring Reserve, Charges Against Assets", "label": "Restructuring Reserve, Charges Against Assets", "negatedLabel": "Charges against assets", "terseLabel": "Charges against assets" } } }, "localname": "RestructuringReserveChargesAgainstAssets", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cl_ScenarioOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Scenario One", "label": "Scenario One [Member]", "terseLabel": "Scenario One" } } }, "localname": "ScenarioOneMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_ScenarioTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Scenario Two", "label": "Scenario Two [Member]", "terseLabel": "Scenario Two" } } }, "localname": "ScenarioTwoMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_ScheduleOfCashFlowAndNetInvestmentHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Cash Flow And Net Investment Hedges Included In Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "label": "Schedule Of Cash Flow And Net Investment Hedges Included In Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule Of Cash Flow And Net Investment Hedges Included In Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfCashFlowAndNetInvestmentHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "cl_ScheduleOfCommonAndTreasuryStockActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Common And Treasury Stock Activity [Table Text Block]", "label": "Schedule Of Common And Treasury Stock Activity [Table Text Block]", "terseLabel": "Schedule Of Common And Treasury Stock Activity" } } }, "localname": "ScheduleOfCommonAndTreasuryStockActivityTableTextBlock", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansTables" ], "xbrltype": "textBlockItemType" }, "cl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the carrying value of amortizable intangible assets by major class. Finite-lived intangible assets have a stated useful life over which their gross carrying value is amortized. Disclosure of the details of intangible assets not subject to amortization, excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class [Table]", "terseLabel": "Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class [Table]" } } }, "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTable", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "cl_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of amortizable intangible assets, in total and by major class, including the gross carrying amount and accumulated amortization. Disclosure of the carrying value of intangible assets not subject to amortization, excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class [Table Text Block]", "terseLabel": "Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class" } } }, "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "cl_ScheduleOfPercentOfTotalRestructuringChargesRelatedToSegmentForThePeriodTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Percent Of Total Restructuring Charges Related To Segment for the period", "label": "Schedule Of Percent Of Total Restructuring Charges Related To Segment For The Period [Table Text Block]", "terseLabel": "Schedule of Percent of Total Restructuring Charges Related To Segment for the period" } } }, "localname": "ScheduleOfPercentOfTotalRestructuringChargesRelatedToSegmentForThePeriodTableTextBlock", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesTables" ], "xbrltype": "textBlockItemType" }, "cl_ScheduleOfRestructuringAndRelatedCostsIncurredToDateTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Restructuring and Related Costs Incurred to Date [Table Text Block]", "label": "Schedule of Restructuring and Related Costs Incurred to Date [Table Text Block]", "terseLabel": "Schedule of Restructuring and Related Costs Incurred to Date" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsIncurredToDateTableTextBlock", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesTables" ], "xbrltype": "textBlockItemType" }, "cl_ScheduleofComponentsofDeferredIncomeTaxBenefitProvisionTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the temporary differences between accounting for financial statement purposes and accounting for tax purposes that result in the current provision for taxes being higher (lower) than the total provision for income taxes.", "label": "Schedule of Components of Deferred Income Tax Benefit (Provision) [Table Text Block]", "terseLabel": "Schedule of components of deferred income tax benefit" } } }, "localname": "ScheduleofComponentsofDeferredIncomeTaxBenefitProvisionTableTextBlock", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "cl_Sevenyearnotesat0.50percentnumberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "seven year notes at 0.50percent number [Member]", "label": "seven year notes at 0.50percent number [Member]", "terseLabel": "Seven Year notes at 0.50 Percent" } } }, "localname": "Sevenyearnotesat0.50percentnumberMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_ShippingAndHandlingCostsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shipping And Handling Costs Policy [Policy Text Block]", "label": "Shipping And Handling Costs Policy [Policy Text Block]", "terseLabel": "Shipping and Handling Costs" } } }, "localname": "ShippingAndHandlingCostsPolicyPolicyTextBlock", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "cl_StatueOfLimitationsOfCertainForeignEntities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Statue Of Limitations Of Certain Foreign Entities", "label": "Statue Of Limitations Of Certain Foreign Entities", "terseLabel": "Statue of limitations on foreign jurisdictions for tax audits" } } }, "localname": "StatueOfLimitationsOfCertainForeignEntities", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "durationItemType" }, "cl_StockOptionPlansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Company's stock option plans provide for the issuance to directors, officers and other employees of non-qualified stock options that generally have a contractual term of six years and vest over three years.", "label": "Stock Option Plans Member", "verboseLabel": "Stock Option Plans" } } }, "localname": "StockOptionPlansMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_SummaryOfCommonStockActivityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary Of Common Stock Activity [Roll Forward]", "label": "Summary Of Common Stock Activity [Roll Forward]", "terseLabel": "Common Stock Outstanding" } } }, "localname": "SummaryOfCommonStockActivityRollForward", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofCommonStockandTreasuryStockActivityDetails" ], "xbrltype": "stringItemType" }, "cl_SummaryOfTreasuryStockActivityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Summary Of Treasury Stock Activity [Roll Forward]", "terseLabel": "Treasury Stock" } } }, "localname": "SummaryOfTreasuryStockActivityRollForward", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofCommonStockandTreasuryStockActivityDetails" ], "xbrltype": "stringItemType" }, "cl_SupplementalBalanceSheetInformationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element is used to disclose supplemental balance sheet information for the periods disclosed.", "label": "Supplemental Balance Sheet Information [Text Block]", "verboseLabel": "Supplemental Balance Sheet Information" } } }, "localname": "SupplementalBalanceSheetInformationTextBlock", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformation" ], "xbrltype": "textBlockItemType" }, "cl_SupplementalIncomeStatementInformationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element is used to disclose supplemental income statement information for the periods disclosed.", "label": "Supplemental Income Statement Information [Text Block]", "verboseLabel": "Supplemental Income Statement Information" } } }, "localname": "SupplementalIncomeStatementInformationTextBlock", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformation" ], "xbrltype": "textBlockItemType" }, "cl_TaxAssessmentsWithInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of tax assessment with estimated interest accrued as of the balance sheet date arising from income tax examinations related to an acquisition.", "label": "Tax Assessments With Interest", "verboseLabel": "Brazilian internal revenue authority, matter 1" } } }, "localname": "TaxAssessmentsWithInterest", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "cl_TaxAssessmentsWithInterestAndPenalties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of tax assessment with estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations related to investments held by a foreign subsidiary.", "label": "Tax Assessments With Interest And Penalties", "verboseLabel": "Brazilian internal revenue authority, matter 2" } } }, "localname": "TaxAssessmentsWithInterestAndPenalties", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "cl_TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit1": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax Cuts and Jobs Act, Incomplete Accounting, Provisional Income Tax Expense (Benefit) 1", "label": "Tax Cuts and Jobs Act, Incomplete Accounting, Provisional Income Tax Expense (Benefit) 1", "terseLabel": "Charge for U.S. tax reform", "verboseLabel": "Tax reform, provisional charge" } } }, "localname": "TaxCutsAndJobsActIncompleteAccountingProvisionalIncomeTaxExpenseBenefit1", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows", "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails", "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "monetaryItemType" }, "cl_ThirdPartyIncrementalCostMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third party Incremental Cost", "label": "Third party Incremental Cost [Member]", "terseLabel": "Third party Incremental Cost" } } }, "localname": "ThirdPartyIncrementalCostMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_TimeVestedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Time-Vested Restricted Stock Units [Member]", "label": "Time-Vested Restricted Stock Units [Member]", "terseLabel": "Time-Vested Stock" } } }, "localname": "TimeVestedRestrictedStockUnitsMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails" ], "xbrltype": "domainItemType" }, "cl_TotalLongLivedAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of total long-lived assets, primarily property, plant and equipment and goodwill and other intangibles.", "label": "Total Long Lived Assets", "terseLabel": "Total long lived assets" } } }, "localname": "TotalLongLivedAssets", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "cl_Twentyyearnotesat0.875percentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Twenty year notes at 0.875 percent [Member]", "label": "Twenty year notes at 0.875 percent [Member]", "terseLabel": "Twenty Year Notes at 0.875 Percent" } } }, "localname": "Twentyyearnotesat0.875percentMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_Twoyearnotesat0.00percentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "two year notes at 0.00 percent [Member]", "label": "two year notes at 0.00 percent [Member]", "terseLabel": "Two Year Notes at 0.00 Percent" } } }, "localname": "Twoyearnotesat0.00percentMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_UnearnedCompensation": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for unearned compensation is also recorded.", "label": "Unearned Compensation", "negatedLabel": "Unearned compensation" } } }, "localname": "UnearnedCompensation", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "cl_UnearnedCompensationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for unearned compensation is also recorded.", "label": "Unearned Compensation [Member]", "terseLabel": "Unearned Compensation" } } }, "localname": "UnearnedCompensationMember", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "xbrltype": "domainItemType" }, "cl_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthoritiesAndLapseOfApplicableStatuteOfLimitations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The gross amount of decreases in unrecognized tax benefits resulting from settlements with taxing authorities and lapses of the applicable statutes of limitations.", "label": "Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities And Lapse Of Applicable Statute Of Limitations", "negatedLabel": "Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthoritiesAndLapseOfApplicableStatuteOfLimitations", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "cl_UnrecognizedTaxBenefitsEffectOfForeignCurrencyRateMovements": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The impact in unrecognized tax benefits resulting from foreign currency rate movements.", "label": "Unrecognized Tax Benefits Effect Of Foreign Currency Rate Movements", "negatedLabel": "Effect of foreign currency rate movements" } } }, "localname": "UnrecognizedTaxBenefitsEffectOfForeignCurrencyRateMovements", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "cl_VenezuelaRemeasurementChargesBenefitTaxImpactPercent": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 7.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Venezuela Remeasurement Charges (Benefit), Tax Impact, Percent", "label": "Venezuela Remeasurement Charges (Benefit), Tax Impact, Percent", "terseLabel": "Foreign-derived intangible income benefit" } } }, "localname": "VenezuelaRemeasurementChargesBenefitTaxImpactPercent", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "cl_WithholdingTaxDue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Withholding Tax Due", "label": "Withholding Tax Due", "terseLabel": "Withholding Tax Due" } } }, "localname": "WithholdingTaxDue", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "cl_WriteOffOfCertainInvestmentsAndFixedassets": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails": { "order": 5.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Write-Off Of Certain Investments And Fixed assets", "label": "Write-Off Of Certain Investments And Fixed assets", "terseLabel": "Write-off of certain investments and fixed assets" } } }, "localname": "WriteOffOfCertainInvestmentsAndFixedassets", "nsuri": "http://www.colgate.com/20201231", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "monetaryItemType" }, "country_BR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BRAZIL", "terseLabel": "BRAZIL" } } }, "localname": "BR", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "domainItemType" }, "country_CH": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SWITZERLAND", "terseLabel": "SWITZERLAND" } } }, "localname": "CH", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails", "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsScheduleofTargetAssetAllocationDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r757", "r758", "r759" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r760" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r755" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r761" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r761" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r761" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r762" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r761" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r761" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r761" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r761" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r757", "r758", "r759" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r754" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r756" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "srt_AsiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continent of Asia.", "label": "Asia [Member]", "terseLabel": "Asia Pacific" } } }, "localname": "AsiaMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region of Asia Pacific.", "label": "Asia Pacific [Member]", "terseLabel": "Asia Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r564", "r565", "r573", "r574", "r752", "r764" ], "lang": { "en-us": { "role": { "documentation": "Information by consolidated entity or group of entities.", "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r564", "r565", "r573", "r574" ], "lang": { "en-us": { "role": { "documentation": "Entity or group of entities consolidated into reporting entity.", "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r212", "r225", "r226", "r227", "r228", "r230", "r232", "r236" ], "lang": { "en-us": { "role": { "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r212", "r225", "r226", "r227", "r228", "r230", "r232", "r236" ], "lang": { "en-us": { "role": { "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continent of Europe.", "label": "Europe [Member]", "terseLabel": "Europe", "verboseLabel": "Europe" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_LatinAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region of Latin America.", "label": "Latin America [Member]", "terseLabel": "Latin America" } } }, "localname": "LatinAmericaMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r437", "r442", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r722", "r725" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails", "http://www.colgate.com/role/IncomeTaxesNarrativeDetails", "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesGoodwillandOtherIntangiblesDetails", "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r437", "r442", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r722", "r725" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails", "http://www.colgate.com/role/IncomeTaxesNarrativeDetails", "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesGoodwillandOtherIntangiblesDetails", "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continent of North America.", "label": "North America [Member]", "terseLabel": "North America" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r239", "r346", "r347", "r670", "r721", "r723" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/NatureofOperationsDetails", "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r239", "r346", "r347", "r670", "r721", "r723" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/NatureofOperationsDetails", "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r377", "r437", "r442", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r722", "r725" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails", "http://www.colgate.com/role/IncomeTaxesNarrativeDetails", "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesGoodwillandOtherIntangiblesDetails", "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r377", "r437", "r442", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r722", "r725" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails", "http://www.colgate.com/role/IncomeTaxesNarrativeDetails", "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesGoodwillandOtherIntangiblesDetails", "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "auth_ref": [ "r150", "r766" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "terseLabel": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS" } } }, "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccounts" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r240", "r241", "r346", "r348", "r724", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillDetails", "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails", "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r240", "r241", "r346", "r348", "r724", "r739", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r763", "r765" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillDetails", "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails", "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "srt_SubsidiariesMember": { "auth_ref": [ "r404", "r657", "r658", "r659" ], "lang": { "en-us": { "role": { "documentation": "Entity owned or controlled by another entity.", "label": "Subsidiaries [Member]", "verboseLabel": "Subsidiaries" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "domainItemType" }, "srt_ValuationAndQualifyingAccountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "localname": "ValuationAndQualifyingAccountsAbstract", "nsuri": "http://fasb.org/srt/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201602Member": { "auth_ref": [ "r640" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).", "label": "Accounting Standards Update 2016-02 [Member]", "terseLabel": "Accounting Standards Update 2016-02" } } }, "localname": "AccountingStandardsUpdate201602Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r50" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r6", "r28", "r245", "r246" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Receivables (net of allowances of $89 and $76, respectively)" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": { "auth_ref": [ "r12", "r55", "r495" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrual for Taxes Other than Income Taxes, Current", "terseLabel": "Accrued taxes other than income taxes" } } }, "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r20", "r681", "r703" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "verboseLabel": "Accrued income taxes" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r76", "r81", "r83", "r572" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Pension and other benefits" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r47", "r286" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r81", "r91", "r571" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "terseLabel": "Cash flow hedges" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": { "auth_ref": [ "r75", "r81", "r83", "r571" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.", "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]", "terseLabel": "Cash flow hedges" } } }, "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": { "auth_ref": [ "r77", "r81", "r398" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax", "verboseLabel": "Unrecognized pension and other retiree benefit costs, aftertax" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": { "auth_ref": [ "r73", "r79", "r80", "r81", "r621" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.", "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax", "negatedTerseLabel": "Foreign currency translation adjustments" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r31", "r79", "r80", "r81", "r705", "r733", "r737" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r78", "r81", "r83", "r152", "r153", "r154", "r572", "r728", "r729" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r74", "r81", "r83", "r572", "r630", "r631", "r632", "r633", "r635" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Cumulative translation adjustments" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Useful life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r29", "r486" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r152", "r153", "r154", "r483", "r484", "r485" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r155", "r156", "r157", "r158", "r253", "r254", "r255", "r256", "r257", "r258", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r527", "r528", "r529", "r530", "r672", "r673", "r674", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r736", "r737" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r444", "r446", "r489", "r490" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Cost [Policy Text Block]", "terseLabel": "Marketing Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r497" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense", "terseLabel": "Advertising" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r446", "r475", "r488" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Total stock-based compensation expense charged against pretax income" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r35", "r247", "r259" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Allowance for doubtful accounts receivable, current" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r124", "r271", "r280" ], "calculation": { "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails": { "order": 2.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails", "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r181" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r181" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r181" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r133", "r220", "r227", "r234", "r252", "r564", "r573", "r627", "r679", "r702" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Identifiable assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets", "verboseLabel": "Assets:" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets", "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r7", "r8", "r69", "r133", "r252", "r564", "r573", "r627" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets", "http://www.colgate.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r447", "r477" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofPerformanceRestrictedStockActivityDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r587", "r592" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BalanceSheetRelatedDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Balance Sheet Related Disclosures [Abstract]", "terseLabel": "Balance Sheet Related Disclosures [Abstract]" } } }, "localname": "BalanceSheetRelatedDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r285" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Buildings" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingsAndImprovementsGross": { "auth_ref": [ "r10", "r285" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Buildings and Improvements, Gross", "terseLabel": "Buildings" } } }, "localname": "BuildingsAndImprovementsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r433", "r438" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r433", "r438", "r545", "r546" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r544" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of voting interests acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": { "auth_ref": [ "r549" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 10.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.", "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value", "negatedTerseLabel": "Noncontrolling interests" } } }, "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r543" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition-related costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r553", "r554", "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Purchase price consideration" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredOther1": { "auth_ref": [ "r557" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.", "label": "Business Combination, Consideration Transferred, Other", "terseLabel": "Consideration transferred, other" } } }, "localname": "BusinessCombinationConsiderationTransferredOther1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r548" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r548" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "terseLabel": "Other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r548" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Receivables" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "auth_ref": [ "r548" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "negatedTerseLabel": "Other current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r548" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 9.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "negatedTerseLabel": "Deferred income taxes" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r548" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Other intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r547", "r548" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "auth_ref": [ "r548" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest", "totalLabel": "Fair value of net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]", "terseLabel": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r623", "r624" ], "lang": { "en-us": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Value" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r4", "r43", "r126" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r15", "r127", "r130" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r118", "r126", "r129" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of year", "periodStartLabel": "Cash and cash equivalents at beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r118", "r628" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net (decrease) increase in Cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r583" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedges" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": { "auth_ref": [ "r610" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.", "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments", "terseLabel": "Gain (loss) on derivative instrument" } } }, "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": { "auth_ref": [ "r610" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.", "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge", "terseLabel": "Gain (loss) on hedged items" } } }, "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r132", "r133", "r170", "r174", "r175", "r178", "r180", "r191", "r192", "r193", "r252", "r627" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_CommercialPaperMember": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.", "label": "Commercial Paper [Member]", "terseLabel": "Commercial paper" } } }, "localname": "CommercialPaperMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesComponentsofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r60", "r307", "r686", "r710" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingent liabilities" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r304", "r305", "r306", "r317" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommodityContractMember": { "auth_ref": [ "r378", "r602" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices.", "label": "Commodity Contract [Member]", "terseLabel": "Commodity contracts" } } }, "localname": "CommodityContractMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Dividends declared per common share (in USD per share)" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquityParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r152", "r153" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "http://www.colgate.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]", "terseLabel": "Shareholders\u2019 Equity" } } }, "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock par value (in USD per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r27", "r328" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Common stock balance, December 31 (in shares)", "periodStartLabel": "Common stock balance, January 1 (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofCommonStockandTreasuryStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r27" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued)" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]", "terseLabel": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r86", "r88", "r89", "r98", "r694", "r717" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Total Comprehensive income attributable to Colgate-Palmolive Company" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r86", "r88", "r97", "r562", "r563", "r577", "r693", "r716" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "totalLabel": "Total Comprehensive income attributable to noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r86", "r88", "r96", "r561", "r577", "r692", "r715" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Total Comprehensive income including noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r95", "r104", "r691", "r714" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Supplemental Other Comprehensive Income (Loss) Information" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r201", "r202", "r243", "r625", "r626" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/NatureofOperationsDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r201", "r202", "r243", "r625", "r626", "r738" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/NatureofOperationsDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r201", "r202", "r243", "r625", "r626", "r738" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/NatureofOperationsDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r201", "r202", "r243", "r625", "r626" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Percent of net sales", "verboseLabel": "Percentage of consolidated sales represented by one customer" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/NatureofOperationsDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r201", "r202", "r243", "r625", "r626" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/NatureofOperationsDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r130", "r566" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractTerminationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of a contract associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Contract Termination [Member]", "terseLabel": "Contract Termination" } } }, "localname": "ContractTerminationMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateMember": { "auth_ref": [ "r207" ], "lang": { "en-us": { "role": { "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.", "label": "Corporate Segment [Member]", "terseLabel": "Corporate" } } }, "localname": "CorporateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r225", "r226", "r227", "r228", "r230", "r236", "r238" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate", "verboseLabel": "Corporate" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r101", "r133", "r252", "r627" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofIncome": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of sales" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r199", "r243" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r552" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer Relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Long-Term Debt and Credit Facilities" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r19", "r20", "r21", "r680", "r683", "r700" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r638", "r639" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r622" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Estimated fair value of long-term debt" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Fixed interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails", "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesComponentsofLongtermDebtDetails", "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r58" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r58", "r136", "r329", "r330", "r331", "r332", "r637", "r638", "r639", "r698" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails", "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesComponentsofLongtermDebtDetails", "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt instrument term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual obligation to pay money on demand or on fixed or determinable dates.", "label": "Debt [Member]", "terseLabel": "Foreign Currency Debt" } } }, "localname": "DebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of debt outstanding.", "label": "Debt, Weighted Average Interest Rate", "terseLabel": "Weighted average interest rate" } } }, "localname": "DebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesComponentsofLongtermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r502", "r503" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails_1": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred income taxes", "verboseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets", "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r124", "r135", "r524", "r533", "r534", "r535" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "negatedTotalLabel": "Total deferred tax benefit (provision)" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r23", "r24", "r516", "r682", "r699" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r502", "r503" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails_1": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "negatedLabel": "Deferred income taxes", "verboseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets", "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "auth_ref": [ "r125" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.", "label": "Deferred Income Taxes and Tax Credits", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxesAndTaxCredits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r517" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net, Classification [Abstract]", "terseLabel": "Deferred taxes included within:" } } }, "localname": "DeferredTaxAssetsLiabilitiesNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r519" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net [Abstract]", "terseLabel": "Deferred tax assets:" } } }, "localname": "DeferredTaxAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r522", "r523" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "verboseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r522", "r523" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost", "verboseLabel": "Stock-based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "auth_ref": [ "r522", "r523" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities", "terseLabel": "Accrued liabilities" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r518" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedTerseLabel": "Valuation Allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r503", "r519" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Net deferred income taxes" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross [Abstract]", "terseLabel": "Deferred tax liabilities:" } } }, "localname": "DeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": { "auth_ref": [ "r522", "r523" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.", "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets", "negatedLabel": "Goodwill and intangible assets" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "auth_ref": [ "r522", "r523" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.", "label": "Deferred Tax Liabilities, Leasing Arrangements", "negatedTerseLabel": "Right-of-use assets" } } }, "localname": "DeferredTaxLiabilitiesLeasingArrangements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r522", "r523" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "negatedLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r522", "r523" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "negatedLabel": "Property, plant and equipment" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": { "auth_ref": [ "r386" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.", "label": "Defined Benefit Plan, Accumulated Benefit Obligation", "terseLabel": "Accumulated benefit obligation" } } }, "localname": "DefinedBenefitPlanAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": { "auth_ref": [ "r77", "r81", "r398" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax", "totalLabel": "Amounts recognized in accumulated other comprehensive income" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax [Abstract]", "terseLabel": "Amounts Recognized in Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": { "auth_ref": [ "r81", "r398" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax", "negatedLabel": "Actuarial loss" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": { "auth_ref": [ "r367", "r426" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.", "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)", "terseLabel": "Actual return on plan assets" } } }, "localname": "DefinedBenefitPlanActualReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActuarialGainLoss": { "auth_ref": [ "r360" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.", "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)", "negatedTerseLabel": "Actuarial loss (gain)" } } }, "localname": "DefinedBenefitPlanActuarialGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r354", "r393", "r420", "r426", "r427" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails": { "order": 5.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "negatedLabel": "Amortization of actuarial loss" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r354", "r394", "r421", "r426", "r427" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "terseLabel": "Amortization of transition and prior service costs (credits)" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": { "auth_ref": [ "r352", "r375" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.", "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position", "totalLabel": "Net amount recognized" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]", "terseLabel": "Amounts Recognized in Balance Sheet" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": { "auth_ref": [ "r18", "r352", "r353", "r375", "r426", "r678", "r701" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.", "label": "Assets for Plan Benefits, Defined Benefit Plan", "terseLabel": "Noncurrent assets" } } }, "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAssetsTargetAllocationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Plan Assets, Allocations [Abstract]", "terseLabel": "Defined Benefit Plan, Plan Assets, Allocations [Abstract]" } } }, "localname": "DefinedBenefitPlanAssetsTargetAllocationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsScheduleofTargetAssetAllocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate", "terseLabel": "Discount rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase", "terseLabel": "Long-term rate of compensation increase" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average interest crediting rate used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Weighted-Average Interest Crediting Rate", "terseLabel": "Interest Crediting Rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate", "terseLabel": "Discount rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": { "auth_ref": [ "r401", "r425" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets", "terseLabel": "Expected long-term rate of return on plan assets" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase", "terseLabel": "Long-term rate of compensation increase" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate", "terseLabel": "Interest Crediting Rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligation": { "auth_ref": [ "r355" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Benefit Obligation", "periodEndLabel": "Benefit obligations at end of year", "periodStartLabel": "Benefit obligations at beginning of year" } } }, "localname": "DefinedBenefitPlanBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": { "auth_ref": [ "r362", "r430" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid", "negatedTerseLabel": "Benefit payments" } } }, "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": { "auth_ref": [ "r359" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.", "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant", "terseLabel": "Participants\u2019 contributions" } } }, "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": { "auth_ref": [ "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r404", "r426" ], "lang": { "en-us": { "role": { "documentation": "Information by defined benefit plan asset investment.", "label": "Defined Benefit Plan, Plan Assets, Category [Axis]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]" } } }, "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsScheduleofTargetAssetAllocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": { "auth_ref": [ "r378" ], "lang": { "en-us": { "role": { "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested.", "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]", "terseLabel": "Cash and cash equivalents" } } }, "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]", "terseLabel": "Change in Benefit Obligations" } } }, "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]", "terseLabel": "Change in Plan Assets" } } }, "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r369", "r378", "r380", "r424", "r426", "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "verboseLabel": "Company contributions" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsBenefitObligationExceedsFairValueofPlanAssetsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsScheduleofTargetAssetAllocationDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofOtherRetireeBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": { "auth_ref": [ "r378", "r426" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan, Equity Securities [Member]", "terseLabel": "Equity securities" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsScheduleofTargetAssetAllocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Expected Future Benefit Payment [Abstract]", "terseLabel": "Total benefit payments [Abstract]" } } }, "localname": "DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": { "auth_ref": [ "r387" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years", "terseLabel": "2026-2030" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": { "auth_ref": [ "r387" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One", "terseLabel": "2021" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": { "auth_ref": [ "r387" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five", "terseLabel": "2025" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": { "auth_ref": [ "r387" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four", "terseLabel": "2024" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": { "auth_ref": [ "r387" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three", "terseLabel": "2023" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": { "auth_ref": [ "r387" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two", "terseLabel": "2022" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r354", "r392", "r419", "r426", "r427" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "negatedLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": { "auth_ref": [ "r366", "r378", "r380", "r381", "r426" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.", "label": "Defined Benefit Plan, Plan Assets, Amount", "periodEndLabel": "Fair value of plan assets at end of year", "periodStartLabel": "Fair value of plan assets at beginning of year", "terseLabel": "Fair value of plan assets" } } }, "localname": "DefinedBenefitPlanFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": { "auth_ref": [ "r361" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign exchange impact" } } }, "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "auth_ref": [ "r352", "r375", "r426" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.", "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan", "totalLabel": "Net amount recognized" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlan", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]", "terseLabel": "Funded Status" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlanAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.", "label": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year", "terseLabel": "Medical cost trend rate assumed for next fiscal year" } } }, "localname": "DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r354", "r358", "r391", "r418", "r426", "r427" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r389", "r416", "r426", "r427" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails": { "order": 1.0, "parentTag": "us-gaap_PensionAndOtherPostretirementBenefitExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "totalLabel": "Net periodic benefit cost" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]", "terseLabel": "Components of Net Periodic Benefit Cost" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanOtherChanges": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change, classified as other.", "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change", "terseLabel": "Other" } } }, "localname": "DefinedBenefitPlanOtherChanges", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets": { "auth_ref": [ "r412" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of plan asset for defined benefit pension plan with projected benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets", "terseLabel": "Fair value of plan assets" } } }, "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsBenefitObligationExceedsFairValueofPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation": { "auth_ref": [ "r412" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of projected benefit obligation for defined benefit pension plan with projected benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation", "terseLabel": "Projected benefit obligation" } } }, "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsBenefitObligationExceedsFairValueofPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": { "auth_ref": [ "r412", "r413", "r426" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation", "terseLabel": "Accumulated benefit obligation" } } }, "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsBenefitObligationExceedsFairValueofPlanAssetsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets": { "auth_ref": [ "r412", "r413", "r426" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets", "terseLabel": "Fair value of plan assets" } } }, "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsBenefitObligationExceedsFairValueofPlanAssetsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": { "auth_ref": [ "r371", "r430" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan, Plan Assets, Benefits Paid", "negatedTerseLabel": "Benefit payments" } } }, "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": { "auth_ref": [ "r370" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant", "terseLabel": "Participants\u2019 contributions" } } }, "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r368" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign exchange impact" } } }, "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": { "auth_ref": [ "r377", "r426" ], "lang": { "en-us": { "role": { "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.", "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage", "terseLabel": "Target asset allocation" } } }, "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsScheduleofTargetAssetAllocationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanRealEstateMember": { "auth_ref": [ "r378", "r426" ], "lang": { "en-us": { "role": { "documentation": "Property composed of building, land and land improvement; in which defined benefit plan asset is invested.", "label": "Defined Benefit Plan, Real Estate [Member]", "terseLabel": "Real estate funds" } } }, "localname": "DefinedBenefitPlanRealEstateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r356", "r390", "r417", "r426", "r427" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": { "auth_ref": [ "r374" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.", "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement", "negatedTerseLabel": "Settlements and acquisitions" } } }, "localname": "DefinedBenefitPlanSettlementsPlanAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanSpecialTerminationBenefits": { "auth_ref": [ "r357" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in benefit obligation for benefits provided to employees payable from defined benefit plan or payable upon retirement.", "label": "Defined Benefit Plan, Benefit Obligation, Special and Contractual Termination Benefits", "terseLabel": "Termination benefits" } } }, "localname": "DefinedBenefitPlanSpecialTerminationBenefits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Ultimate trend rate for health care cost for defined benefit postretirement plan.", "label": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate", "terseLabel": "Ultimate medical cost trend rate" } } }, "localname": "DefinedBenefitPlanUltimateHealthCareCostTrendRate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]", "terseLabel": "Weighted-Average Assumptions Used to Determine Benefit Obligations" } } }, "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]", "terseLabel": "Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost" } } }, "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Year ultimate health care cost trend rate is expected to be reached, in CCYY format.", "label": "Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate", "terseLabel": "Year which ultimate medical cost trend rate is reached" } } }, "localname": "DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "gYearListItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r124", "r215" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r70", "r71", "r622" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative asset" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract Type [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r589" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Total gain (loss) on hedges recognized in income" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r588", "r591", "r597", "r603" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]", "verboseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r585", "r588", "r597" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r585", "r588", "r597", "r603", "r604", "r608", "r611" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r70", "r71", "r622" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r70" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails": { "order": 6.0, "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivatives" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r579", "r581" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Notional value of derivative" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r130", "r139", "r578", "r580", "r585", "r586", "r607" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Financial Instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Capital Stock and Stock-Based Compensation Plans" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r333", "r697" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Common Stock", "negatedTerseLabel": "Dividends (in dollars per share)" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DomesticPlanMember": { "auth_ref": [ "r432", "r436", "r441" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Domestic Plan [Member]", "terseLabel": "Domestic Plan" } } }, "localname": "DomesticPlanMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsScheduleofTargetAssetAllocationDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]", "verboseLabel": "Earnings per common share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r99", "r159", "r160", "r161", "r162", "r163", "r167", "r170", "r178", "r179", "r180", "r184", "r185", "r695", "r718" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic EPS (in dollars per share)", "verboseLabel": "Earnings per common share, basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofIncome", "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails", "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Earnings Per Share, Basic [Abstract]" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r99", "r159", "r160", "r161", "r162", "r163", "r170", "r178", "r179", "r180", "r184", "r185", "r695", "r718" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted EPS (in dollars per share)", "verboseLabel": "Earnings per common share, diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofIncome", "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails", "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Earnings Per Share, Diluted [Abstract]" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r181", "r182", "r183", "r186" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Effect of Cash Flow Hedges on Results of Operations [Abstract]", "terseLabel": "Cash flow hedges [Abstract]" } } }, "localname": "EffectOfCashFlowHedgesOnResultsOfOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r628" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of exchange rate changes on Cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r505" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r505", "r537" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Tax at United States statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends": { "auth_ref": [ "r505", "r537" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for dividend.", "label": "Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent", "terseLabel": "Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationDeductionsDividends", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r505", "r537" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent", "terseLabel": "Earnings taxed at other than United States statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r505", "r537" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 8.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "terseLabel": "Other, net" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r505", "r537" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "terseLabel": "State income taxes, net of federal benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent": { "auth_ref": [ "r505" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 4.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to Tax Cuts and Jobs Act.", "label": "Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent", "terseLabel": "Charge for U.S. tax reform" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "pureItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign": { "auth_ref": [ "r505", "r537" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "order": 6.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax settlement.", "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Percent", "terseLabel": "(Benefit) charge for previously disclosed tax matters" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r55" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued payroll and employee benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Additional Disclosure [Abstract]", "terseLabel": "Stock-based compensation, additional disclosures [Abstract]" } } }, "localname": "EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r476" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r476" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Unrecognized compensation expense, weighted-average period of recognition in years" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "auth_ref": [ "r475" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Expense, Tax Benefit", "terseLabel": "Total income tax benefit from stock compensation" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r474" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Employee Stock Option" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP": { "auth_ref": [ "r491" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the amount of cash contributions during the period made by the entity to the Employee Stock Ownership Plan (ESOP).", "label": "Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP", "terseLabel": "Company contributions to the ESOP" } } }, "localname": "EmployeeStockOwnershipPlanESOPCashContributionsToESOP", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EmployeeStockOwnershipPlanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense": { "auth_ref": [ "r492" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of plan compensation cost recognized during the period.", "label": "Employee Stock Ownership Plan (ESOP), Compensation Expense", "terseLabel": "Annual ESOP expense" } } }, "localname": "EmployeeStockOwnershipPlanESOPCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EmployeeStockOwnershipPlanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOwnershipPlanESOPDividendsPaidToESOP": { "auth_ref": [ "r491" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Dividends paid on stock held by an employee stock ownership plan.", "label": "Employee Stock Ownership Plan (ESOP), Dividends Paid to ESOP", "terseLabel": "Dividends paid by the Company on shares held by the ESOP" } } }, "localname": "EmployeeStockOwnershipPlanESOPDividendsPaidToESOP", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EmployeeStockOwnershipPlanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "documentation": "The shares or units in an ESOP trust that have been assigned to individual participant accounts based on a known formula. IRS rules require allocations to be nondiscriminatory generally based on compensation, length of service, or a combination of both. For any particular participant such shares or units may be vested, unvested, or partially vested.", "label": "Employee Stock Ownership Plan (ESOP), Number of Allocated Shares", "terseLabel": "Common shares released and allocated to participant accounts (in shares)" } } }, "localname": "EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EmployeeStockOwnershipPlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "documentation": "Shares contributed to the ESOP that have not yet been released, committed to be released, or allocated to participant accounts. Suspense shares generally collateralize ESOP debt.", "label": "Employee Stock Ownership Plan (ESOP), Number of Suspense Shares", "terseLabel": "Common shares available for future allocation to participant accounts (in shares)" } } }, "localname": "EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EmployeeStockOwnershipPlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "documentation": "Sum of the allocated, committed-to-be-released and suspense shares of the entity held by the plan.", "label": "Employee Stock Ownership Plan (ESOP), Shares in ESOP", "terseLabel": "Shares in ESOP (in shares)" } } }, "localname": "EmployeeStockOwnershipPlanESOPSharesInESOP", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EmployeeStockOwnershipPlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue from External Customer [Line Items]", "terseLabel": "Entity-Wide Information, Revenue from External Customer [Line Items]" } } }, "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/NatureofOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r152", "r153", "r154", "r156", "r164", "r166", "r190", "r256", "r328", "r333", "r483", "r484", "r485", "r529", "r530", "r629", "r630", "r631", "r632", "r633", "r635", "r728", "r729", "r730" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r44", "r221", "r250" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity method investments included in other assets" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue": { "auth_ref": [ "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The excess of replacement or current cost over the stated LIFO (last in first out) inventory value when the LIFO inventory method is utilized.", "label": "Excess of Replacement or Current Costs over Stated LIFO Value", "terseLabel": "Excess of current cost over LIFO cost" } } }, "localname": "ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ExtinguishmentOfDebtGainLossNetOfTax": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax.", "label": "Extinguishment of Debt, Gain (Loss), Net of Tax", "terseLabel": "Extinguishment of debt, gain (loss), net of tax" } } }, "localname": "ExtinguishmentOfDebtGainLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Derivative and Financial Instruments, Fair Value [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r426", "r614", "r660", "r661", "r662" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r616", "r617" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]", "terseLabel": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r613", "r618" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueHedgingMember": { "auth_ref": [ "r582" ], "lang": { "en-us": { "role": { "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.", "label": "Fair Value Hedging [Member]", "terseLabel": "Fair Value Hedges" } } }, "localname": "FairValueHedgingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel12And3Member": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3).", "label": "Fair Value, Inputs, Level 1, 2 and 3 [Member]", "terseLabel": "Fair Value, Inputs, Level 1, 2 and 3" } } }, "localname": "FairValueInputsLevel12And3Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r378", "r380", "r385", "r426", "r614", "r660" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Fair Value, Inputs, Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r378", "r380", "r385", "r426", "r614", "r661" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r615" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": { "auth_ref": [ "r380", "r612", "r619" ], "lang": { "en-us": { "role": { "documentation": "Fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Measured at Net Asset Value Per Share [Member]", "terseLabel": "Fair Value Measured at Net Asset Value Per Share" } } }, "localname": "FairValueMeasuredAtNetAssetValuePerShareMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r426", "r660", "r661", "r662" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r587", "r593", "r608" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": { "auth_ref": [ "r134", "r504" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesProvisionforIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.", "label": "Federal Income Tax Expense (Benefit), Continuing Operations", "verboseLabel": "United States" } } }, "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.", "label": "Financial Instruments Disclosure [Text Block]", "verboseLabel": "Fair Value Measurements and Financial Instruments" } } }, "localname": "FinancialInstrumentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments, Owned, at Fair Value [Abstract]", "verboseLabel": "Other financial instruments" } } }, "localname": "FinancialInstrumentsOwnedAtFairValueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Estimated useful life of finite-lived intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesGoodwillandOtherIntangiblesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r279" ], "calculation": { "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedTerseLabel": "Finite-lived intangible assets, accumulated amortization, net" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r281" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "Annual estimated amortization expense, year 1" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r281" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "Annual estimated amortization expense, year 5" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r281" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "Annual estimated amortization expense, year 4" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r281" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "Annual estimated amortization expense, year 3" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r281" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "Annual estimated amortization expense, year 2" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r272", "r275", "r279", "r283", "r671", "r675" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails", "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesGoodwillandOtherIntangiblesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r279", "r675" ], "calculation": { "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Finite-lived intangible assets, gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesGoodwillandOtherIntangiblesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r272", "r278" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails", "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesGoodwillandOtherIntangiblesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r279", "r671" ], "calculation": { "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Finite-lived intangible assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FixedIncomeSecuritiesMember": { "auth_ref": [ "r378", "r426" ], "lang": { "en-us": { "role": { "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity.", "label": "Fixed Income Securities [Member]", "terseLabel": "Fixed income securities" } } }, "localname": "FixedIncomeSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsScheduleofTargetAssetAllocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r130", "r636" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r378", "r601" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign currency contracts" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations": { "auth_ref": [ "r138" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesProvisionforIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.", "label": "Foreign Income Tax Expense (Benefit), Continuing Operations", "verboseLabel": "International" } } }, "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignPlanMember": { "auth_ref": [ "r432", "r436", "r441" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Foreign Plan [Member]", "terseLabel": "International" } } }, "localname": "ForeignPlanMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsScheduleofTargetAssetAllocationDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForwardContractsMember": { "auth_ref": [ "r599" ], "lang": { "en-us": { "role": { "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.", "label": "Forward Contracts [Member]", "terseLabel": "Forward-starting interest rate swaps" } } }, "localname": "ForwardContractsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r124", "r325", "r326" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedTerseLabel": "Loss on early extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows", "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r264", "r265", "r677" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 }, "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.colgate.com/role/ConsolidatedBalanceSheets", "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Other Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r130", "r266", "r276" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill and Other Intangibles" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails", "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r100", "r133", "r220", "r226", "r230", "r233", "r236", "r252", "r627" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofIncome": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "terseLabel": "Gross profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofIncome", "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgedLiabilityFairValueHedge": { "auth_ref": [ "r605" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability hedged in fair value hedging relationship.", "label": "Hedged Liability, Fair Value Hedge", "terseLabel": "Carrying amount of hedged item" } } }, "localname": "HedgedLiabilityFairValueHedge", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": { "auth_ref": [ "r606" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.", "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)", "terseLabel": "Cumulative hedging adjustment included in the carrying amount" } } }, "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r585" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r137", "r536" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofIncomeBeforeIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "verboseLabel": "United States" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofIncomeBeforeIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r92", "r220", "r226", "r230", "r233", "r236", "r676", "r689", "r696", "r719" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofIncome": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 }, "http://www.colgate.com/role/IncomeTaxesComponentsofIncomeBeforeIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofIncome", "http://www.colgate.com/role/IncomeTaxesComponentsofIncomeBeforeIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r137", "r536" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesComponentsofIncomeBeforeIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "verboseLabel": "International" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofIncomeBeforeIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r93", "r124", "r217", "r250", "r688", "r712" ], "calculation": { "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails": { "order": 3.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedTerseLabel": "Equity income" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r288" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails", "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringandRelatedCostsDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails", "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringandRelatedCostsDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Contingency [Line Items]", "terseLabel": "Income Taxes [Line Items]" } } }, "localname": "IncomeTaxContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxContingencyTable": { "auth_ref": [ "r508", "r513", "r515", "r526" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Income Tax Contingency [Table]", "terseLabel": "Income Tax Contingency [Table]" } } }, "localname": "IncomeTaxContingencyTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r506", "r514", "r521", "r531", "r538", "r540", "r541", "r542" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity": { "auth_ref": [ "r504" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The sum of the tax effects of all items occurring during the period that have been charged or credited directly to other comprehensive income or to related components of shareholders' equity.", "label": "Income Tax Effects Allocated Directly to Equity", "terseLabel": "Income tax expense (benefit) allocated directly to equity" } } }, "localname": "IncomeTaxEffectsAllocatedDirectlyToEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r135", "r165", "r166", "r218", "r504", "r532", "r539", "r720" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofIncome": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 }, "http://www.colgate.com/role/IncomeTaxesProvisionforIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Provision for income taxes", "totalLabel": "Total Provision for income taxes", "verboseLabel": "Tax benefit" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofIncome", "http://www.colgate.com/role/IncomeTaxesProvisionforIncomeTaxesDetails", "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r90", "r130", "r500", "r501", "r514", "r515", "r520", "r525", "r740" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization": { "auth_ref": [ "r505" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible amortization.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount", "negatedTerseLabel": "Goodwill and intangible assets" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation": { "auth_ref": [ "r505" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible depreciation.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Depreciation, Amount", "negatedTerseLabel": "Property, plant and equipment" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseDepreciation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseLeases": { "auth_ref": [ "r505" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible lease expense.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Leases, Amount", "negatedTerseLabel": "Right-of-use assets/lease liabilities" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseLeases", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": { "auth_ref": [ "r505" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount", "negatedTerseLabel": "Pension and other retiree benefits" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [ "r505" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount", "negatedTerseLabel": "Stock-based compensation" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": { "auth_ref": [ "r505" ], "calculation": { "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount", "negatedTerseLabel": "Other, net" } } }, "localname": "IncomeTaxReconciliationOtherReconcilingItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesIncomeTaxProvisionReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r120", "r128" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Income taxes paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r123" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and other accruals" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r123" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Cash effects of changes in:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r123" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "negatedLabel": "Other non-current assets and liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInReceivables": { "auth_ref": [ "r123" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Receivables", "negatedLabel": "Receivables" } } }, "localname": "IncreaseDecreaseInReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r171", "r172", "r173", "r180" ], "calculation": { "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "verboseLabel": "Stock options and restricted stock units (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r274", "r282" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails", "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r282" ], "calculation": { "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "verboseLabel": "Indefinite-lived intangible assets (excluding goodwill)" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r274", "r282" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails", "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "totalLabel": "Finite & indefinite lived intangibles, gross" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r270", "r277" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "totalLabel": "Intangible assets, net (excluding goodwill)", "verboseLabel": "Other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets", "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestCostsCapitalizedAdjustment": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails": { "order": 2.0, "parentTag": "cl_InterestExpenseNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest costs capitalized disclosed as an adjusting item to interest costs incurred.", "label": "Interest Costs Capitalized Adjustment", "negatedLabel": "Interest capitalized" } } }, "localname": "InterestCostsCapitalizedAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r103", "r324" ], "calculation": { "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails": { "order": 1.0, "parentTag": "cl_InterestExpenseNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Interest incurred" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest Income (Expense), Net [Abstract]", "verboseLabel": "Interest (income) expense, net" } } }, "localname": "InterestIncomeExpenseNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails": { "order": 3.0, "parentTag": "cl_InterestExpenseNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income, Other", "negatedTerseLabel": "Interest income" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r115", "r119", "r128" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r12", "r13", "r55" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateContractMember": { "auth_ref": [ "r378", "r600" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.", "label": "Interest Rate Contract [Member]", "terseLabel": "Interest rate swap contracts" } } }, "localname": "InterestRateContractMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r36", "r262" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofInventoriesbyMajorClassDetails": { "order": 1.0, "parentTag": "cl_InventoryNetIncludingNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofInventoriesbyMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r5", "r64" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofInventoriesbyMajorClassDetails_1": { "order": 1.0, "parentTag": "cl_InventoryNetIncludingNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Current Inventories, net", "verboseLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets", "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofInventoriesbyMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory, Net [Abstract]", "terseLabel": "Inventories", "verboseLabel": "Inventories [Abstract]" } } }, "localname": "InventoryNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails", "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofInventoriesbyMajorClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryNoncurrent": { "auth_ref": [ "r67" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofInventoriesbyMajorClassDetails_1": { "order": 2.0, "parentTag": "cl_InventoryNetIncludingNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.", "label": "Inventory, Noncurrent", "negatedLabel": "Non-current inventory, net" } } }, "localname": "InventoryNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofInventoriesbyMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r14", "r65", "r130", "r187", "r260", "r261", "r263" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": { "auth_ref": [ "r38", "r39", "r262" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofInventoriesbyMajorClassDetails": { "order": 3.0, "parentTag": "cl_InventoryNetIncludingNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.", "label": "Inventory, Raw Materials and Supplies, Net of Reserves", "terseLabel": "Raw materials and supplies" } } }, "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofInventoriesbyMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r37", "r262" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofInventoriesbyMajorClassDetails": { "order": 2.0, "parentTag": "cl_InventoryNetIncludingNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work-in-process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofInventoriesbyMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r613" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Investments fair value" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LIFOInventoryAmount": { "auth_ref": [ "r14" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of LIFO (last in first out) inventory present at the reporting date when inventory is also valued using different valuation methods.", "label": "LIFO Inventory Amount", "terseLabel": "Inventories valued under LIFO" } } }, "localname": "LIFOInventoryAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Land": { "auth_ref": [ "r9", "r46" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails": { "order": 3.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.", "label": "Land", "terseLabel": "Land" } } }, "localname": "Land", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandAndBuildingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate held for productive use and structures used in the conduct of business, including but not limited to, office, production, storage and distribution facilities.", "label": "Land and Building [Member]", "terseLabel": "Land and Building" } } }, "localname": "LandAndBuildingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r653", "r655" ], "calculation": { "http://www.colgate.com/role/LeasesScheduleofLeaseCostDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesScheduleofLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r653" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule of Components of Operating Lease Expense" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r645" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r654" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of Operating Lease Liabilities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r654" ], "calculation": { "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total lease commitments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r654" ], "calculation": { "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r654" ], "calculation": { "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r654" ], "calculation": { "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r654" ], "calculation": { "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r654" ], "calculation": { "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r654" ], "calculation": { "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r654" ], "calculation": { "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less: Interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r54", "r133", "r228", "r252", "r565", "r573", "r574", "r627" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r34", "r133", "r252", "r627", "r685", "r708" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Shareholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r56", "r133", "r252", "r565", "r573", "r574", "r627" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r52" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r52" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Unused borrowing capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r21", "r323", "r683", "r704" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "terseLabel": "Carrying value of long-term debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesComponentsofLongtermDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.", "label": "Long-term Debt and Lease Obligation, Including Current Maturities", "totalLabel": "Total debt" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesComponentsofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r53" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesComponentsofLongtermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "negatedLabel": "Less: Current portion of long-term debt", "terseLabel": "Current portion of long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets", "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesComponentsofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "auth_ref": [ "r141", "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesScheduleofLongTermDebtandFinanceLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r141", "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesScheduleofLongTermDebtandFinanceLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "auth_ref": [ "r141", "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Five", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesScheduleofLongTermDebtandFinanceLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r141", "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Four", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesScheduleofLongTermDebtandFinanceLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r141", "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesScheduleofLongTermDebtandFinanceLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r141", "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesScheduleofLongTermDebtandFinanceLeaseMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.", "label": "Long-term Debt [Member]", "terseLabel": "Long-term Debt" } } }, "localname": "LongTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r58" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesComponentsofLongtermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Total debt, excluding current portion of long-term debt", "verboseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets", "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesComponentsofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermPurchaseCommitmentAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.", "label": "Long-term Purchase Commitment, Amount", "terseLabel": "Contractual commitments, amount" } } }, "localname": "LongTermPurchaseCommitmentAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r58" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesComponentsofLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r58", "r322" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesComponentsofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r307", "r308", "r309", "r312", "r313", "r314", "r316", "r318", "r319" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyClaimsSettledAndDismissedNumber": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "The number of claims settled and dismissed during the period.", "label": "Loss Contingency, Claims Settled and Dismissed, Number", "terseLabel": "Loss contingency, claims dismissed or settled, number (in cases)" } } }, "localname": "LossContingencyClaimsSettledAndDismissedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_LossContingencyEstimateOfPossibleLoss": { "auth_ref": [ "r311", "r315", "r318" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.", "label": "Loss Contingency, Estimate of Possible Loss", "terseLabel": "Range of reasonably possible losses" } } }, "localname": "LossContingencyEstimateOfPossibleLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyNewClaimsFiledNumber": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.", "label": "Loss Contingency, New Claims Filed, Number", "terseLabel": "Loss contingency, new claims filed, number (in cases)" } } }, "localname": "LossContingencyNewClaimsFiledNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_LossContingencyPendingClaimsNumber": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Number of pending claims pertaining to a loss contingency.", "label": "Loss Contingency, Pending Claims, Number", "terseLabel": "Loss contingency, pending claims, number (in cases)" } } }, "localname": "LossContingencyPendingClaimsNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_MachineryAndEquipmentGross": { "auth_ref": [ "r10", "r285" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails": { "order": 4.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment, Gross", "terseLabel": "Manufacturing machinery and equipment" } } }, "localname": "MachineryAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MarketableSecurities": { "auth_ref": [ "r687" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security.", "label": "Marketable Securities", "terseLabel": "Marketable securities" } } }, "localname": "MarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "auth_ref": [ "r3", "r558" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.", "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]", "terseLabel": "Acquisitions" } } }, "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/Acquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r63", "r133", "r252", "r627", "r684", "r707" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MovementInValuationAllowancesAndReservesRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]", "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]" } } }, "localname": "MovementInValuationAllowancesAndReservesRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r194", "r206" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Nature of Operations" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/NatureofOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r118" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r118" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r118", "r122", "r125" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operations" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r2", "r84", "r87", "r94", "r125", "r133", "r155", "r159", "r160", "r161", "r162", "r165", "r166", "r176", "r220", "r226", "r230", "r233", "r236", "r252", "r627", "r690", "r713" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income attributable to Colgate-Palmolive Company", "totalLabel": "Net income attributable to Colgate-Palmolive Company" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofIncome", "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r84", "r87", "r165", "r166", "r568", "r576" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.colgate.com/role/ConsolidatedStatementsofIncome": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Less: Net income attributable to noncontrolling interests", "verboseLabel": "Less: Net income attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.colgate.com/role/ConsolidatedStatementsofIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r159", "r160", "r161", "r162", "r167", "r168", "r177", "r180", "r220", "r226", "r230", "r233", "r236" ], "calculation": { "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Basic EPS" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r169", "r177", "r180" ], "calculation": { "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Diluted EPS" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]", "terseLabel": "Net income attributable to Colgate-Palmolive Company" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r584" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedges" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent": { "auth_ref": [ "r354" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofIncome": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.", "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component", "terseLabel": "Non-service related postretirement costs" } } }, "localname": "NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "verboseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": { "auth_ref": [ "r334", "r549", "r570" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in noncontrolling interest from a business combination.", "label": "Noncontrolling Interest, Increase from Business Combination", "terseLabel": "Noncontrolling interests acquired" } } }, "localname": "NoncontrollingInterestIncreaseFromBusinessCombination", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r152", "r153", "r154", "r333", "r559" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NotesPayableOtherPayablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A written promise to pay a note to a third party.", "label": "Notes Payable, Other Payables [Member]", "terseLabel": "Notes" } } }, "localname": "NotesPayableOtherPayablesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesComponentsofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of countries in which the entity operates as of balance sheet date.", "label": "Number of Countries in which Entity Operates", "terseLabel": "Number of countries in which entity operates" } } }, "localname": "NumberOfCountriesInWhichEntityOperates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments (in segments)" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments (in segments)" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OneTimeTerminationBenefitsMember": { "auth_ref": [ "r290" ], "lang": { "en-us": { "role": { "documentation": "A lump sum payment to an involuntarily terminated employee in conjunction with exit or disposal activities.", "label": "One-time Termination Benefits [Member]", "terseLabel": "Employee-Related Costs" } } }, "localname": "OneTimeTerminationBenefitsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringChargesCumulativetoDateDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r220", "r226", "r230", "r233", "r236" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofIncome": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Operating profit", "totalLabel": "Operating profit" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofIncome", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLossMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing operating income (loss).", "label": "Operating Income (Loss) [Member]", "terseLabel": "Operating Profit" } } }, "localname": "OperatingIncomeLossMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r646", "r655" ], "calculation": { "http://www.colgate.com/role/LeasesScheduleofLeaseCostDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesScheduleofLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r642" ], "calculation": { "http://www.colgate.com/role/LeasesBalanceSheetDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "netLabel": "Operating lease, liability", "terseLabel": "Present value of lease liabilities", "totalLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesBalanceSheetDetails", "http://www.colgate.com/role/LeasesNarrativeDetails", "http://www.colgate.com/role/LeasesScheduleofMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r642" ], "calculation": { "http://www.colgate.com/role/LeasesBalanceSheetDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails": { "order": 5.0, "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Other accruals" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesBalanceSheetDetails", "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r643" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]", "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]" } } }, "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesBalanceSheetDetails" ], "xbrltype": "extensibleListItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r642" ], "calculation": { "http://www.colgate.com/role/LeasesBalanceSheetDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Long-Term Lease Liabilities", "verboseLabel": "Other liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesBalanceSheetDetails", "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r643" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.", "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]", "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]" } } }, "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesBalanceSheetDetails" ], "xbrltype": "extensibleListItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r644", "r649" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating lease, payments" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r641" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Other assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesBalanceSheetDetails", "http://www.colgate.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r643" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]", "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]" } } }, "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesBalanceSheetDetails" ], "xbrltype": "extensibleListItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r652", "r655" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Operating lease, weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r651", "r655" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Operating lease, weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r225", "r226", "r227", "r228", "r230", "r236" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r11", "r12", "r13", "r55" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other accruals", "totalLabel": "Other accruals" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets", "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r68" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r587", "r608" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r48" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r561", "r562", "r571" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to noncontrolling interests.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest", "terseLabel": "Less: Cumulative translation adjustments attributable to noncontrolling interests" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "auth_ref": [ "r81", "r629", "r631", "r635" ], "calculation": { "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "terseLabel": "Other comprehensive income (loss), before reclassifications, Pretax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r81", "r91", "r629", "r631", "r635" ], "calculation": { "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "terseLabel": "Other comprehensive income (loss), before reclassifications, Net of Tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "auth_ref": [ "r95", "r251", "r629", "r634", "r635", "r691", "r714" ], "calculation": { "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Tax", "totalLabel": "Other comprehensive income (loss), Pretax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r75", "r79" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "terseLabel": "Gains (losses) on cash flow hedges" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r75", "r79", "r590", "r595", "r609" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Gain (loss) recognized in OCI" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "auth_ref": [ "r79", "r82", "r596" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "terseLabel": "Amount reclassified from OCI" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": { "auth_ref": [ "r75" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax", "verboseLabel": "Gains (losses) on cash flow hedges" } } }, "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r73" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Cumulative translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r598" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Gain (loss) on instruments" } } }, "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r85", "r88", "r91", "r95", "r328", "r629", "r634", "r635", "r691", "r714" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive income (loss), net of tax", "totalLabel": "Total Other comprehensive income (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss), net of tax:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r77", "r79" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedLabel": "Retirement plan and other retiree benefit adjustments" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r587", "r608" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other current assets" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current liabilities.", "label": "Other Current Liabilities [Member]", "terseLabel": "Other accruals" } } }, "localname": "OtherCurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Other finite life intangible assets" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities [Abstract]", "verboseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesMember": { "auth_ref": [ "r587", "r608" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other liabilities.", "label": "Other Liabilities [Member]", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r59" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities", "totalLabel": "Total Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets", "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other liabilities.", "label": "Other Liabilities [Table Text Block]", "verboseLabel": "Schedule of Other Liabilities" } } }, "localname": "OtherLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofIncome": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 }, "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "negatedTerseLabel": "Other (income) expense, net", "negatedTotalLabel": "Total Other (income) expense, net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofIncome", "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r351", "r352", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r401", "r402", "r404", "r407", "r411", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r431", "r432", "r433", "r434", "r435", "r436" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefits Plan [Member]", "terseLabel": "Other Retiree Benefit Plans" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofOtherRetireeBenefitPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherRestructuringMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restructuring and related activities classified as other.", "label": "Other Restructuring [Member]", "terseLabel": "Other" } } }, "localname": "OtherRestructuringMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringChargesCumulativetoDateDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]", "terseLabel": "Other accruals" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r105", "r108", "r140" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedLabel": "Other" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r111" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Purchases of treasury shares", "terseLabel": "Repurchased stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails", "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payments for Repurchase of Equity [Abstract]", "terseLabel": "Stock Repurchases [Abstract]" } } }, "localname": "PaymentsForRepurchaseOfEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r116", "r293" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "negatedLabel": "Cash payments", "terseLabel": "Payments for Restructuring" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "auth_ref": [ "r113" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.", "label": "Payment for Debt Extinguishment or Debt Prepayment Cost", "terseLabel": "Cash charges for extinguishment of debt prior to maturity" } } }, "localname": "PaymentsOfDebtExtinguishmentCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfOrdinaryDividends": { "auth_ref": [ "r111" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.", "label": "Payments of Ordinary Dividends", "negatedLabel": "Dividends paid" } } }, "localname": "PaymentsOfOrdinaryDividends", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r106", "r556" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payments to acquire business" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r106" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Payment for acquisitions, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r249" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedLabel": "Purchases of marketable securities and investments" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r107" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Payments to Acquire Productive Assets", "negatedLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r107" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "terseLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToMinorityShareholders": { "auth_ref": [ "r114" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.", "label": "Payments to Noncontrolling Interests", "negatedTerseLabel": "Purchases of non-controlling interests in subsidiaries", "terseLabel": "Purchases of non-contolling interests in subsidiaries" } } }, "localname": "PaymentsToMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r22", "r352", "r353", "r375" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as noncurrent.", "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent", "verboseLabel": "Pension and other retiree benefits" } } }, "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitContributions": { "auth_ref": [ "r121" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.", "label": "Payment for Pension and Other Postretirement Benefits", "negatedTerseLabel": "Voluntary benefit plan contributions" } } }, "localname": "PensionAndOtherPostretirementBenefitContributions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitExpense": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits.", "label": "Pension and Other Postretirement Benefits Cost (Reversal of Cost)", "totalLabel": "Total pension cost" } } }, "localname": "PensionAndOtherPostretirementBenefitExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r377", "r379", "r385", "r403", "r405", "r406", "r407", "r408", "r409", "r426", "r428", "r429", "r431", "r443" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Retirement Benefits [Text Block]", "terseLabel": "Retirement Plans and Other Retiree Benefits" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefits" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": { "auth_ref": [ "r20", "r352", "r353", "r375", "r426" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet", "weight": -1.0 }, "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.", "label": "Liability, Defined Benefit Plan, Current", "negatedLabel": "Current liabilities", "terseLabel": "Pension and other retiree benefits" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails", "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r22", "r352", "r353", "r375", "r426" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.", "label": "Liability, Defined Benefit Plan, Noncurrent", "negatedTerseLabel": "Noncurrent liabilities" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r350", "r352", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r401", "r402", "r404", "r407", "r411", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r431", "r432", "r438", "r439", "r440", "r441" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Pension Plans" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsBenefitObligationExceedsFairValueofPlanAssetsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PercentageOfFIFOInventory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of FIFO (first in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.", "label": "Percentage of FIFO Inventory", "terseLabel": "Approximate percentage of inventories determined using the first-in, first-out (FIFO) method" } } }, "localname": "PercentageOfFIFOInventory", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "percentItemType" }, "us-gaap_PlanAssetCategoriesDomain": { "auth_ref": [ "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r404", "r426" ], "lang": { "en-us": { "role": { "documentation": "Defined benefit plan asset investment.", "label": "Defined Benefit Plan, Plan Assets, Category [Domain]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]" } } }, "localname": "PlanAssetCategoriesDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsScheduleofTargetAssetAllocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r447", "r477" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r620" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]", "terseLabel": "Preference Stock [Abstract]" } } }, "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "verboseLabel": "Reclassifications" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromOtherDebt": { "auth_ref": [ "r110" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from debt classified as other.", "label": "Proceeds from Other Debt", "terseLabel": "Proceeds from issuance of debt" } } }, "localname": "ProceedsFromOtherDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromOtherShortTermDebt": { "auth_ref": [ "r110" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from short-term debt classified as other.", "label": "Proceeds from Other Short-term Debt", "verboseLabel": "Short-term borrowing/(repayment) less than 90 days - net" } } }, "localname": "ProceedsFromOtherShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds from Sale and Maturity of Marketable Securities", "terseLabel": "Proceeds from sale of marketable securities and investments" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r109", "r478" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails", "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductConcentrationRiskMember": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.", "label": "Product Concentration Risk [Member]", "terseLabel": "Product Concentration Risk" } } }, "localname": "ProductConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/NatureofOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r2", "r84", "r87", "r117", "r133", "r155", "r165", "r166", "r220", "r226", "r230", "r233", "r236", "r252", "r561", "r567", "r569", "r576", "r577", "r627", "r696" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.colgate.com/role/ConsolidatedStatementsofIncome": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "netLabel": "Net income including noncontrolling interests", "terseLabel": "Net income", "totalLabel": "Net income including noncontrolling interests", "verboseLabel": "Net income including noncontrolling interests" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows", "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "http://www.colgate.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.colgate.com/role/ConsolidatedStatementsofIncome", "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, plant and equipment, net", "verboseLabel": "Property, Plant, and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails", "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r47", "r287" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment by Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r46", "r285" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "totalLabel": "Property, plant and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r16", "r17", "r287", "r709" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment, net", "totalLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets", "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentOther": { "auth_ref": [ "r287" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Other, Gross", "terseLabel": "Other equipment" } } }, "localname": "PropertyPlantAndEquipmentOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r45", "r130", "r287", "r741", "r742" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r16", "r287" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r16", "r285" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Estimated useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_QuarterlyFinancialDataAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Quarterly Financial Data [Abstract]", "terseLabel": "Quarterly Financial Data [Abstract]" } } }, "localname": "QuarterlyFinancialDataAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Quarterly Financial Information Disclosure [Abstract]", "terseLabel": "Quarterly Financial Information Disclosure [Abstract]" } } }, "localname": "QuarterlyFinancialInformationDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_QuarterlyFinancialInformationTextBlock": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.", "label": "Quarterly Financial Information [Text Block]", "terseLabel": "Quarterly Financial Data (Unaudited)" } } }, "localname": "QuarterlyFinancialInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnaudited" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]", "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r81", "r83", "r629", "r633", "r635" ], "calculation": { "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "negatedTerseLabel": "Reclassification from AOCI, Pretax" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r81", "r83", "r91", "r629", "r633", "r635" ], "calculation": { "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "negatedTerseLabel": "Reclassification from AOCI, Net of Tax" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Unrecognized tax benefits:" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r112" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "terseLabel": "Repayments of Debt" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfOtherDebt": { "auth_ref": [ "r112" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for the payment of debt classified as other.", "label": "Repayments of Other Debt", "negatedTerseLabel": "Principal payments on debt" } } }, "localname": "RepaymentsOfOtherDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReportingUnitAxis": { "auth_ref": [ "r267", "r268" ], "lang": { "en-us": { "role": { "documentation": "Information by reporting unit.", "label": "Reporting Unit [Axis]", "terseLabel": "Reporting Unit [Axis]" } } }, "localname": "ReportingUnitAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReportingUnitDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Level of reporting at which goodwill is tested for impairment.", "label": "Reporting Unit [Domain]", "terseLabel": "Reporting Unit [Domain]" } } }, "localname": "ReportingUnitDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of fair value of reporting unit in excess of carrying amount.", "label": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount", "terseLabel": "Reporting unit, percentage of fair value in excess of carrying amount" } } }, "localname": "ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r498", "r753" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs)" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]", "terseLabel": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r303" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring and Related Implementation Charges" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationCharges" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": { "auth_ref": [ "r292", "r294", "r300", "r302" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of costs incurred to date for the specified restructuring cost.", "label": "Restructuring and Related Cost, Cost Incurred to Date", "terseLabel": "Pretax charges related to the Restructuring Program to date" } } }, "localname": "RestructuringAndRelatedCostCostIncurredToDate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringChargesCumulativetoDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedCostIncurredCost": { "auth_ref": [ "r292", "r294", "r300", "r302" ], "calculation": { "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails": { "order": 1.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.", "label": "Restructuring and Related Cost, Incurred Cost", "terseLabel": "Total Global Growth and Efficiency Program charges, pretax", "verboseLabel": "Restructuring and related charges (benefits)" } } }, "localname": "RestructuringAndRelatedCostIncurredCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringandRelatedCostsDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SupplementalIncomeStatementInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringChargesCumulativetoDateDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails", "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringChargesCumulativetoDateDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringandRelatedCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]", "terseLabel": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringChargesCumulativetoDateDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringandRelatedCostsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]", "terseLabel": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringChargesCumulativetoDateDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringandRelatedCostsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r293", "r298" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Restructuring Reserve" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveAccrualAdjustment1": { "auth_ref": [ "r291", "r297" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.", "label": "Restructuring Reserve, Accrual Adjustment", "terseLabel": "Restructuring reduction" } } }, "localname": "RestructuringReserveAccrualAdjustment1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r291", "r301" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails": { "order": 7.0, "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Current", "terseLabel": "Restructuring accrual" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveNoncurrent": { "auth_ref": [ "r291" ], "calculation": { "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Noncurrent", "terseLabel": "Restructuring accrual" } } }, "localname": "RestructuringReserveNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationScheduleofOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserveTranslationAdjustment": { "auth_ref": [ "r293", "r301" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.", "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)", "negatedTerseLabel": "Foreign exchange" } } }, "localname": "RestructuringReserveTranslationAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": { "auth_ref": [ "r293", "r297" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).", "label": "Restructuring Reserve, Translation and Other Adjustment", "terseLabel": "Other" } } }, "localname": "RestructuringReserveTranslationAndOtherAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r30", "r333", "r486", "r706", "r732", "r737" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r152", "r153", "r154", "r156", "r164", "r166", "r256", "r483", "r484", "r485", "r529", "r530", "r728", "r730" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanSponsorLocationAxis": { "auth_ref": [ "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r404", "r407", "r412", "r413", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r432", "r436", "r441" ], "lang": { "en-us": { "role": { "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Axis]", "terseLabel": "Retirement Plan Sponsor Location [Axis]" } } }, "localname": "RetirementPlanSponsorLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsScheduleofTargetAssetAllocationDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanSponsorLocationDomain": { "auth_ref": [ "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r404", "r407", "r412", "r413", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r432", "r436", "r441" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Domain]", "terseLabel": "Retirement Plan Sponsor Location [Domain]" } } }, "localname": "RetirementPlanSponsorLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsScheduleofTargetAssetAllocationDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r350", "r351", "r352", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r401", "r402", "r404", "r407", "r411", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r431", "r432", "r433", "r434", "r435", "r436", "r438", "r439", "r440", "r441" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsBenefitObligationExceedsFairValueofPlanAssetsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofOtherRetireeBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r350", "r351", "r352", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r401", "r402", "r404", "r407", "r411", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r431", "r432", "r433", "r434", "r435", "r436", "r438", "r439", "r440", "r441" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsBenefitObligationExceedsFairValueofPlanAssetsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofOtherRetireeBenefitPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r211", "r212", "r225", "r231", "r232", "r239", "r240", "r243", "r345", "r346", "r670" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofIncome": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Net sales", "verboseLabel": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofIncome", "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r131", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r349" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r650", "r655" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-use asset obtained in exchange for operating lease liability" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r201", "r243" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Sales Revenue, Net" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/NatureofOperationsDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": { "auth_ref": [ "r412", "r413", "r426" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]", "terseLabel": "Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets" } } }, "localname": "ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.", "label": "Schedule of Allocation of Plan Assets [Table Text Block]", "terseLabel": "Schedule of Allocation of Plan Assets" } } }, "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r181" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r545", "r546" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.", "label": "Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r58", "r136", "r329", "r330", "r331", "r332", "r637", "r638", "r639", "r698" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Long-term Debt Instruments" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "verboseLabel": "Components of deferred tax assets (liabilities)" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r410", "r411", "r414", "r415", "r426" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsAllocationofPlanAssetsandLevelofValuationInputbyMajorAssetCategoryDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsBenefitObligationExceedsFairValueofPlanAssetsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsExpectedContributionsandBenefitPaymentsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsScheduleofTargetAssetAllocationDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofDefinedBenefitandOtherRetireeBenefitPlansDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofNetPeriodicBenefitCostsDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsSummaryofOtherRetireeBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": { "auth_ref": [ "r410", "r411", "r414", "r415", "r426" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.", "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]", "terseLabel": "Defined benefit plans disclosures" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r588", "r597", "r604" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Derivative Instruments, Gain (Loss)" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of Derivative Instruments" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "verboseLabel": "Effective tax rate reconciliation" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table]", "terseLabel": "Schedule of Entity-Wide Information, Revenue from External Customers by Products and Services [Table]" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/NatureofOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table Text Block]", "terseLabel": "Percentage of worldwide sales" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/NatureofOperationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": { "auth_ref": [ "r387" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.", "label": "Schedule of Expected Benefit Payments [Table Text Block]", "terseLabel": "Schedule of Expected Benefit Payments" } } }, "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r594" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]", "terseLabel": "Activity related to fair value hedges" } } }, "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r272", "r278", "r671" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets by Major Class [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesGoodwillandOtherIntangiblesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r266", "r269" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails", "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r266", "r269" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "verboseLabel": "Components of income before income taxes" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r14", "r40", "r41", "r42" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventories by Major Class" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SupplementalBalanceSheetInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-term Debt [Table Text Block]", "terseLabel": "Schedule of Maturities of Long-term Debt" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Schedule of Net Benefit Costs" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r579" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r47", "r287" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Schedule of Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.", "label": "Quarterly Financial Information [Table Text Block]", "terseLabel": "Schedule of Quarterly Financial Information" } } }, "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r295", "r296", "r299" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails", "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringChargesCumulativetoDateDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringandRelatedCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r295", "r296", "r299" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Restructuring and Related Costs [Table Text Block]", "terseLabel": "Schedule of Restructuring and Related Costs" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r293", "r301" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of Restructuring Reserve by Type of Cost" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r220", "r223", "r229", "r266" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r220", "r223", "r229", "r266" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Net Sales and Operating Profit by Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r447", "r477" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofPerformanceRestrictedStockActivityDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r452", "r464", "r467" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of Share-based Compensation, Stock Options, Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of Share-based Compensation, Performance Restricted Stock and Time-based Restricted Stock Units Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r513", "r526" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]", "terseLabel": "Unrecognized tax benefits activity" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r207", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r225", "r226", "r227", "r228", "r230", "r231", "r232", "r233", "r234", "r236", "r243", "r721" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]", "verboseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r207", "r209", "r210", "r220", "r224", "r230", "r234", "r235", "r236", "r237", "r239", "r242", "r243", "r244" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SelectedQuarterlyFinancialInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Selected Quarterly Financial Information [Abstract]", "terseLabel": "Quarterly financial data (Unaudited) [Abstract]" } } }, "localname": "SelectedQuarterlyFinancialInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/QuarterlyFinancialDataUnauditedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r102" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofIncome": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofIncome", "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinStatementsofIncomeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringandRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r123" ], "calculation": { "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Abstract]", "terseLabel": "Stock-Based Compensation [Abstract]" } } }, "localname": "ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]", "terseLabel": "Additional disclosures pertaining to stock based compensation [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofPerformanceRestrictedStockActivityDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Restricted stock awards - shares forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofPerformanceRestrictedStockActivityDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "verboseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofPerformanceRestrictedStockActivityDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Restricted stock awards - shares granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofPerformanceRestrictedStockActivityDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Restricted stock awards - ending balance (in shares)", "periodStartLabel": "Restricted stock awards - beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofPerformanceRestrictedStockActivityDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Shares (in thousands)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofPerformanceRestrictedStockActivityDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Restricted stock awards - end of period (in dollars per share)", "periodStartLabel": "Restricted stock awards - beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofPerformanceRestrictedStockActivityDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Grant Date Fair Value Per Award" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofPerformanceRestrictedStockActivityDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r466" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Total fair value of shares vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair value of restricted stock awards - shares vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r472" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansFairValueAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansFairValueAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r473" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansFairValueAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofPerformanceRestrictedStockActivityDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r477" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Number of shares available for grant (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Options exercisable (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Options exercisable - end of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r466" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Total intrinsic value of options exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period", "negatedTerseLabel": "Forfeited or expired (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Options - shares forfeited or expired (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures", "verboseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r465" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted-average estimated fair value of stock options granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r477" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Intrinsic value of unexercised in-the-money options, options outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r454", "r477" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Options - ending balance (in shares)", "periodStartLabel": "Options - beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Shares (in thousands)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r453" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Options - end of period (in dollars per share)", "periodStartLabel": "Options - beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r445", "r450" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofPerformanceRestrictedStockActivityDetails", "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofRestrictedStockActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Options - shares exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Options - shares granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r130", "r447", "r451" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Payment Arrangement [Policy Text Block]", "verboseLabel": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase Program [Axis]", "terseLabel": "Share Repurchase Program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]", "terseLabel": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r449" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Contractual term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r470", "r487" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term of options" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansFairValueAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r477" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Intrinsic value of unexercised in-the-money options, options exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r477" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average remaining contractual life, options exercisable (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average remaining contractual life, options outstanding (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r347" ], "lang": { "en-us": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping and Handling [Member]", "terseLabel": "Shipping and Handling" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPrinciplesofConsolidationShippingandHandlingCostsInventoriesPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermBankLoansAndNotesPayable": { "auth_ref": [ "r49", "r711" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.", "label": "Short-term Bank Loans and Notes Payable", "terseLabel": "Notes and loans payable" } } }, "localname": "ShortTermBankLoansAndNotesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermDebtWeightedAverageInterestRate": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time.", "label": "Short-term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Weighted-average interest rate on short term borrowings" } } }, "localname": "ShortTermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LongTermDebtandCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r647", "r655" ], "calculation": { "http://www.colgate.com/role/LeasesScheduleofLeaseCostDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term Lease, Cost", "terseLabel": "Short-term lease cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesScheduleofLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r1", "r207", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r225", "r226", "r227", "r228", "r230", "r231", "r232", "r233", "r234", "r236", "r243", "r266", "r289", "r294", "r302", "r721" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringChargesIncurredbySegmentDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r25", "r26", "r27", "r132", "r133", "r170", "r174", "r175", "r178", "r180", "r191", "r192", "r193", "r252", "r328", "r627" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r62", "r152", "r153", "r154", "r156", "r164", "r166", "r190", "r256", "r328", "r333", "r483", "r484", "r485", "r529", "r530", "r629", "r630", "r631", "r632", "r633", "r635", "r728", "r729", "r730" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "http://www.colgate.com/role/SupplementalOtherComprehensiveIncomeLossInformationScheduleofComprehensiveIncomeLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r152", "r153", "r154", "r190", "r670" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r26", "r27", "r328", "r333" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Shares issued for restricted stock and other (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofCommonStockandTreasuryStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r26", "r27", "r328", "r333" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Shares issued for stock options (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofCommonStockandTreasuryStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r26", "r27", "r328", "r333", "r457" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedTerseLabel": "Exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r328", "r333" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Shares issued for restricted stock awards" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r62", "r328", "r333" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Shares issued for stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock repurchase program, authorized amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r27", "r32", "r33", "r133", "r248", "r252", "r627" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Colgate-Palmolive Company shareholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r133", "r152", "r153", "r154", "r156", "r164", "r252", "r256", "r333", "r483", "r484", "r485", "r529", "r530", "r559", "r560", "r575", "r627", "r629", "r630", "r635", "r729", "r730" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets", "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.", "label": "Stockholders' Equity, Other", "negatedLabel": "Other" } } }, "localname": "StockholdersEquityOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_SummaryOfDerivativeInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Derivative Instruments [Abstract]", "terseLabel": "Designated derivative instruments" } } }, "localname": "SummaryOfDerivativeInstrumentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Net Investment Hedge Activity [Abstract]", "terseLabel": "Net investment hedges [Abstract]" } } }, "localname": "SummaryOfNetInvestmentHedgeActivityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental Cash Flow Information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalIncomeStatementElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Income Statement Elements [Abstract]", "terseLabel": "Supplemental Income Statement Elements [Abstract]" } } }, "localname": "SupplementalIncomeStatementElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r551" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]", "terseLabel": "Trademarks" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r61", "r335" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r61", "r335" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "periodEndLabel": "Treasury stock balance, December 31 (in shares)", "periodStartLabel": "Treasury stock balance, January 1 (in shares)" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofCommonStockandTreasuryStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r27", "r328", "r333" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "terseLabel": "Common stock acquired (in shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CapitalStockandStockBasedCompensationPlansSummaryofCommonStockandTreasuryStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r61", "r335", "r336" ], "calculation": { "http://www.colgate.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r328", "r333", "r335" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedLabel": "Treasury stock acquired" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r155", "r156", "r157", "r158", "r253", "r254", "r255", "r256", "r257", "r258", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r527", "r528", "r529", "r530", "r672", "r673", "r674", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r736", "r737" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesRestructuringActivityandRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesSummaryofRestructuringChargesCumulativetoDateDetails", "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Costs of contractual or legal rights meeting the criteria for capitalization as intangible assets apart from goodwill, which have indefinite life and that are not otherwise specified in the taxonomy.", "label": "Unclassified Indefinite-lived Intangible Assets [Member]", "verboseLabel": "Indefinite life intangible assets" } } }, "localname": "UnclassifiedIndefinitelivedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails", "http://www.colgate.com/role/GoodwillandOtherIntangibleAssetsSummaryofOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r499", "r509" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Balance, December 31", "periodStartLabel": "Balance, January 1" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r510" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "negatedTerseLabel": "Decreases of tax positions taken during prior years" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r511" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "verboseLabel": "Increases as a result of tax positions taken during the current year" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r510" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "terseLabel": "Increases of tax positions taken during prior years" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": { "auth_ref": [ "r507" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense accrued for an underpayment of income taxes.", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued", "terseLabel": "Accrued interest related to unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": { "auth_ref": [ "r507" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense for an underpayment of income taxes.", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense", "terseLabel": "Interest (income) expense recognized related to unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r512" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "terseLabel": "Unrecognized tax benefits that would impact effective tax rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r195", "r196", "r197", "r198", "r203", "r204", "r205" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "verboseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r519" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "negatedTerseLabel": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowanceLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Valuation Allowance [Line Items]", "terseLabel": "Valuation Allowance [Line Items]" } } }, "localname": "ValuationAllowanceLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": { "auth_ref": [ "r149" ], "lang": { "en-us": { "role": { "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.", "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]", "terseLabel": "Valuation allowance for deferred tax assets" } } }, "localname": "ValuationAllowanceOfDeferredTaxAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowanceTable": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "A listing of an entity's valuation allowances to reduce deferred tax assets to amounts which it is more likely than not will not be realized, including a description of the deferred tax assets for which the valuation allowance has been recorded and the amount of the valuation allowance.", "label": "Valuation Allowance [Table]", "terseLabel": "Valuation Allowance [Table]" } } }, "localname": "ValuationAllowanceTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationAllowancesAndReservesBalance": { "auth_ref": [ "r142", "r148" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "periodEndLabel": "Ending balance of valuation allowance and reserves", "periodStartLabel": "Beginning balance of valuation allowance and reserves" } } }, "localname": "ValuationAllowancesAndReservesBalance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "auth_ref": [ "r145" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "terseLabel": "Charged to Costs and Expenses, additions" } } }, "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": { "auth_ref": [ "r146" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account", "terseLabel": "Other, additions" } } }, "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "auth_ref": [ "r147" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction", "terseLabel": "Deductions" } } }, "localname": "ValuationAllowancesAndReservesDeductions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDomain": { "auth_ref": [ "r142", "r143", "r144", "r147", "r148" ], "lang": { "en-us": { "role": { "documentation": "Valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "terseLabel": "Valuation allowances type [Domain]" } } }, "localname": "ValuationAllowancesAndReservesDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "auth_ref": [ "r142", "r143", "r144", "r147", "r148" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]" } } }, "localname": "ValuationAllowancesAndReservesTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r648", "r655" ], "calculation": { "http://www.colgate.com/role/LeasesScheduleofLeaseCostDetails": { "order": 3.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable Lease, Cost", "terseLabel": "Variable lease cost" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/LeasesScheduleofLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r169", "r180" ], "calculation": { "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Diluted EPS (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Shares (millions)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r167", "r180" ], "calculation": { "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic EPS (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 10 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r104": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(n))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04.(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(ColumnA))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r151": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r186": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306" }, "r189": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "270", "URI": "http://asc.fasb.org/topic&trid=2126967" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r206": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r244": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r263": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r284": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=2122178" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r303": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r306": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r317": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629" }, "r327": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r349": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r443": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929" }, "r494": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r542": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r558": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(i)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "4EE", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109999712-113959" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "4EE", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109999712-113959" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117332851&loc=SL7495116-110257" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=SL116692626-108610" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r636": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918631-209977" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r656": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(d))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.4)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e526-108580" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r754": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r755": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r756": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r757": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r758": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r759": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r760": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r761": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r762": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r763": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r764": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r765": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r766": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "09" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" } }, "version": "2.1" } ZIP 137 0000021665-21-000007-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000021665-21-000007-xbrl.zip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

  •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

  •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